ANNUAL REPORT
FY 2026 — Annual report
FY 2026PDF · 186 pages5.3 MB
-- 1 of 186 --
INCREASING VELOCITY
for the AI era
-- 2 of 186 --
Accelerating what comes next
Progress waits for no one. Chipmakers are driving innovations at
unprecedented speeds, fueling a demand for partners who can stay
ahead. But even at a time where urgency is mission-critical, speed alone
isn’t enough. True advancement requires more – the ability to rapidly
move ahead with a clear sense of where to go next. Speed plus direction.
That’s why Lam Research is increasing velocity to help propel our industry
forward with purpose.
Through collaborative innovation and a network of labs around the globe,
we seek to enable customers to unlock breakthroughs faster. Our leading
technologies deliver game-changing performance to create the most
advanced chips in the world. And we’re making it all happen exactly where
we believe it is most effective: closer to our customers, where our resilient
operations work to eliminate distance and delay and our advanced services
help our customers to maximize efficiency to enable the fab of the future.
By accelerating the pace of innovation with a relentless focus on what
comes next, we are working to get there faster – because that’s what today’s
chipmakers demand. At Lam Research, we’re helping to build the AI era, atom
by atom.
-- 3 of 186 --
LETTER TO OUR STOCKHOLDERS
Dear Lam Stockholders,
Lam delivered the strongest financial results in our history in fiscal year 2026. We owe our success
to the dedicated efforts of our employees around the world as well as close partnerships with our
customers, suppliers, and industry partners. Revenue in fiscal year 2026 grew 26% year over year to
a record $23.2 billion and diluted earnings per share increased 39% to a new fiscal year high of $5.76.
We expanded gross margin to greater than 50% and achieved a record 35.3% operating margin. These
results underscore the benefits we are seeing from our disciplined execution and the increased scale
of our global operations. This performance also enabled us to invest a record $2.4 billion in research
and development while returning $4.7 billion to stockholders through share repurchases
and dividends.
Growing global investment in artificial intelligence (AI) is driving strong demand for higher
performance semiconductor devices and manufacturing equipment. AI requires unprecedented levels
of computational power, memory bandwidth, and storage capacity.
To enable these advances, semiconductor device architectures are becoming increasingly three-
dimensional, with higher aspect ratios and new materials. These technology shifts align closely with
Lam’s strengths in deposition, etch, and clean, expanding our opportunity with each new device
generation. Together with the strength of our product
portfolio, we believe these trends position us well to outperform
overall wafer fabrication equipment spending growth over the
long term.
The demand environment for Lam’s equipment shifted decisively
higher through the fiscal year as our customers reported record
revenue and profitability and announced multi-year investment
timelines for new fabs. In response, we are expanding our
manufacturing capacity and strengthening our supply chain
to support our customers when they need us.
Demand was strong across all of our device market segments,
and we are seeing additional opportunities being created
for Lam as foundry-logic and DRAM devices move to three-
dimensional architectures to deliver improved performance.
We have more than a decade of technology leadership in 3D NAND, and we are benefiting from that
experience as vertical scaling comes to foundry-logic and DRAM.
As Lam’s business has grown, so has our installed base. Importantly, we continue to generate value
long after each system ships. Our installed base now exceeds 100,000 chambers, with each chamber
generating spares, service, and upgrade demand that has been more resilient across industry
cycles. Revenue in our Customer Support Business Group (CSBG) grew 20% year over year, more
than twice the rate of installed base chamber growth. We are also innovating to make our installed
base tools more productive for our customers. Lam’s Equipment Intelligence® solutions analyze data
from hundreds of sensors on our tools, and our Dextro™ cobots use that data to perform automated
preventive maintenance safely, precisely, and efficiently, work that a technician once did manually.
This enables our customers’ tools to spend more time processing wafers.
-- 4 of 186 --
Supporting our customers at the pace of AI adoption has required us to increase both our
manufacturing and innovation velocity. Over the past four years, we have nearly doubled our
manufacturing capacity. In fiscal year 2026, we added approximately 3,400 employees across all
functions of the company. We have expanded our global manufacturing footprint, extended our
supply chain, and automated our warehouses. In August 2026, we broke ground in Oregon on what is
intended to become our most advanced R&D lab, the first milestone of a planned investment of more
than $3 billion in our global lab network over the next five years. This investment in our global labs is
aimed at building competitive advantage for Lam in the devices and equipment the industry will need
five to ten years from now. Locating labs close to our customers is intended to increase innovation
velocity by allowing a wafer to leave a customer’s fab, be processed on a Lam tool still in the early
stages of development, and return the wafer for evaluation and further processing on the same day.
This is velocity made possible by proximity.
In the global communities in which we operate, how we do our work matters as much as what we
build. We met or exceeded nearly all the multi-year sustainability goals we set for calendar year 2025,
and we have established a new set of 2030+ goals that reflect both the opportunity ahead and the
responsibility that comes with industry leadership. These and other efforts are described in our 2025
Global Impact Report.
As we enter fiscal year 2027, we are equipped with a product portfolio built for the technology
inflections ahead and see an industry investing at record levels. With AI evolving at an unprecedented
pace, there has never been a more exciting time to be part of this industry. We are confident Lam
will continue to deliver the innovations that enable the next generation of semiconductor scaling,
positioning Lam to create lasting value for our customers, employees, stockholders, and communities.
Sincerely,
Timothy M. Archer Abhijit Y. Talwalkar
President Chair of the Board
and Chief Executive Officer
September 24, 2026
-- 5 of 186 --
Delivered record financial performance with continued
investment in innovation to extend technology leadership
In fiscal 2026, Lam achieved consecutive record revenue and diluted earnings per share,
supported by sustained customer demand.
Performance Overview - Fiscal Year 2026
$
Revenue
Operating
cash
flows
** The Company effected a ten-for-one stock split of its common stock in October
2024, all values prior to that time have been restated for comparability.
Share repurchases
Dividends paid
Revenue (Billions)
R&D Spend (Millions)
Diluted Earnings per Share**
Diluted earnings
per share
$ $
35.3%
$5.76
R&D expenses
$2.38
billion Operating
margin
$23.23
billion
$5.86
billion
$3.47 billion
$1.27 billion
$0
$5
$10
$15
$20
$25
FY'22 FY'23 FY'24 FY'25 FY'26
Revenue (Billions)
$0
$500
$1,000
$1,500
$2,000
$2,500
FY'22 FY'23 FY'24 FY'25 FY'26
R&D (Millions)
$0.00
$1.00
$2.00
$3.00
$4.00
$5.00
$6.00
$7.00
FY'22 FY'23 FY'24 FY'25 FY'26
Diluted Earnings Per Share**
$0
$5
$10
$15
$20
$25
FY'22 FY'23 FY'24 FY'25 FY'26
Revenue (Billions)
$0
$500
$1,000
$1,500
$2,000
$2,500
FY'22 FY'23 FY'24 FY'25 FY'26
R&D (Millions)
$0.00
$1.00
$2.00
$3.00
$4.00
$5.00
$6.00
$7.00
FY'22 FY'23 FY'24 FY'25 FY'26
Diluted Earnings Per Share**
$0
$5
$10
$15
$20
$25
FY'22 FY'23 FY'24 FY'25 FY'26
Revenue (Billions)
$0
$500
$1,000
$1,500
$2,000
$2,500
FY'22 FY'23 FY'24 FY'25 FY'26
R&D (Millions)
$0.00
$1.00
$2.00
$3.00
$4.00
$5.00
$6.00
$7.00
FY'22 FY'23 FY'24 FY'25 FY'26
Diluted Earnings Per Share**
$
-- 6 of 186 --
-- 7 of 186 --
TRANSFER AGENT AND REGISTRAR
For a response to questions regarding misplaced
stock certificates, changes of address, or the
consolidation of accounts, please contact the
Company’s transfer agent.
Computershare Investor Services
P.O. Box 43078
Providence, RI 02940-3078
1-877-265-2630
Private Couriers/Registered Mail:
Computershare Investor Services
150 Royall St., Suite 101
Canton, MA 02021
TDD for Hearing Impaired:
1-800-952-9245
Foreign Stockholders:
1-201-680-6578
Website Address:
www.computershare.com/investor
STOCK LISTING
The Company’s common stock is traded on the
Nasdaq Global Select Market SM under the symbol
LRCX. Lam Research Corporation is a Nasdaq-100
Index ® and S&P 500 ® company.
INVESTOR RELATIONS
Lam Research Corporation welcomes inquiries from
its stockholders and other interested investors. For
additional copies of this report or other financial
information, please contact:
Investor Relations
Lam Research Corporation
4650 Cushing Parkway
Fremont, California 94538
1-510-572-1615
investor.relations@lamresearch.com
ANNUAL MEETING
The Annual Meeting of Stockholders will be held at
9:30 a.m. Pacific Time on Tuesday, November 3, 2026.
CAUTIONARY STATEMENT REGARDING
FORWARD-LOOKING STATEMENTS
This annual report, including the letter to our stockholders
contained herein, contains forward-looking statements
within the meaning of the Private Securities Litigation
Reform Act of 1995. All statements other than statements
of historical fact contained in this annual report are
forward-looking statements. In some cases, forward-
looking statements can be identified by words such as
“accelerate,” “ahead,” “aim,” “become,” “believe,” “come,”
“confident,” “continue,” “drive,” “evolve,” “expand,” “goal,”
“grow,” “increase,” “intend,” “move,” “multi-year,” “next,”
“opportunity,” “plan,” “position,” “possible,” “require,”
“see,” “seek,” “shift,” “toward,” “will,” or variations of these
words or other similar expressions. However, the absence
of these words or similar expressions does not mean
that a statement is not forward-looking. Forward-looking
statements in this annual report include, but are not limited
to, statements concerning: our partnerships with our
customers, suppliers, and industry partners; the perceived
benefits from our operational execution and scale; industry,
technology, and demand trends, including related to artificial
intelligence (“AI”) and the pace of its evolution, higher
performance semiconductor devices and manufacturing
equipment, power, memory and storage requirements,
device architecture structures, aspect ratios, and materials,
technology inflections, and investment levels, and the
related opportunities or perceived benefits, including
in foundry-logic and dynamic random-access memory
(“DRAM”); our belief regarding our position to outperform
overall wafer fabrication equipment (“WFE”) spending
growth over the long term; the benefit of our experience
in 3D NAND in relation to opportunities in foundry-logic
and DRAM; our plans to expand manufacturing capacity,
strengthen our supply chain, and support our customers;
our customers’ investment timelines for new fabs; our
installed base generating value or increasing productivity;
the resilience of spares, service, and upgrade demand
across industry cycles; the safety, precision, or efficiency
of our cobots; our planned investments in research and
development (“R&D”) and the intended benefits; our 2030+
goals; the capabilities of our product portfolio relative
to future device generations and technology inflections;
and our ability to innovate and create lasting value. These
forward-looking statements are not a guarantee of future
performance and involve a number of risks, uncertainties,
and other factors that could cause our actual results or
outcomes, or the timing of our results or outcomes, to differ
materially from those expressed or implied in this annual
report. Such risks, uncertainties, and other factors include,
among others, the following: our assumptions related
to continued expansion of the WFE market, growth of
deposition and etch intensity, and scaling of our operating
framework may prove invalid; business, economic, political
and/or regulatory conditions in the consumer electronics
industry, including wafer fabrication equipment spending,
the semiconductor industry and the overall economy
may deteriorate or change; the actions, performance, or
investment levels of our customers and competitors may be
inconsistent with our expectations; customer and product
mix, including across market segments and geographical
regions, may change; we may be unable to effectively
manage and implement pricing actions, realize the value of
our products and technology, successfully commercialize
new products and technologies, or execute on perceived
opportunities; we may be unable to achieve anticipated
operational, manufacturing, supply chain, procurement,
and scale efficiencies; customer technology transitions,
capacity expansions, and fab construction projects may
have different timing or be less successful than we expect;
we may be unable to manage operating expenses effectively
while continuing to invest in R&D, product innovation,
customer support, and future growth opportunities; trade
regulations, export controls, tariffs, trade disputes, and
other geopolitical developments may inhibit our ability
to sell our products; supply chain cost increases, tariffs,
and other inflationary pressures have impacted and may
continue to impact our profitability; supply chain disruptions
or manufacturing capacity constraints may limit our ability
to manufacture and sell our products; natural and human-
caused disasters, disease outbreaks, war, terrorism, political
or governmental unrest or instability, or other events
beyond our control may impact our operations and revenue
in affected areas; and the other factors described in Part
I, Item 1, “Business,” Part I, Item 1A, “Risk Factors,” Part II,
Item 7, “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” and Part II, Item 7A,
“Quantitative and Qualitative Disclosures About Market
Risk” of our Annual Report on Form 10-K for the fiscal year
ended June 28, 2026 and other documents we file from
time to time with the Securities and Exchange Commission,
such as our quarterly reports on Form 10-Q and our current
reports on Form 8-K. You should evaluate all forward-looking
statements made in this annual report in the context of
these risks, uncertainties, and other factors. Readers are
cautioned not to place undue reliance on these forward-
looking statements, which speak only as of the date hereof
and are based on our current beliefs, expectations, and
assumptions about future events. Except as required by
law, we do not undertake any obligation to revise or update
these forward-looking statements as a result of events
or circumstances that occur after the date of this annual
report or to reflect the occurrence or effect of anticipated or
unanticipated events.
TRADEMARK INFORMATION
The Lam Research logo, Lam Research, and all
Lam Research product and service names used
herein are either registered trademarks or trademarks
of Lam Research Corporation or its subsidiaries in
the United States and/or other countries. All other
marks mentioned herein are the property of their
respective holders.
-- 8 of 186 --
September 24, 2026
Dear Lam Research Stockholders,
We cordially invite you to attend the Lam Research Corporation 2026 Annual Meeting of Stockholders. The annual meeting will be
held on Tuesday, November 3, 2026, at 9:30 a.m. Pacific Time. This year’s annual meeting will be virtual. You may attend the annual
meeting, vote, and submit your questions during the live webcast of the annual meeting by visiting virtualshareholdermeeting.com/
LRCX2026 and entering the 16‐digit control number included in our Notice of Internet Availability or on your proxy card.
At this year’s annual meeting, stockholders will be asked to:
(1) elect the 10 nominees named in the accompanying proxy statement as directors to serve until the next annual meeting
of stockholders and until their respective successors are elected and qualified;
(2) cast an advisory vote to approve our named executive officer compensation;
(3) ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2027; and
(4) vote on the stockholder proposal described in the proxy statement, if properly presented at the annual meeting.
The Board of Directors recommends that you vote in favor of each director nominee and for Proposals Nos. 2 and 3. In addition,
stockholders will also be asked to consider Proposal No. 4, if properly presented, which is a stockholder proposal, and which the
Board of Directors recommends you vote against. Management will not provide a business update during the annual meeting; please
refer to our latest quarterly earnings report for our most recently provided outlook.
Please refer to the proxy statement for more detailed information about the annual meeting, each director nominee, each of the
proposals, and instructions on how to cast your vote. Your vote is important, and we strongly urge you to cast your vote as
soon as possible by internet, telephone, or mail, even if you plan to attend the meeting.
Sincerely yours,
Abhijit Y. Talwalkar
Chair of the Board
-- 9 of 186 --
26-')2* 117%/))6-1+2*!62'.,2/()45
%66E:?8!?7@C>2E:@?
2E62?5,:>6 1K;I:7O +EL;C8;H
7C-79?<?91?C;
(=246 3?7J>;&DJ;HD;J7J
?2;=>*5<1*;.185-.;6..=270,86#(
*64@C52E6 ,DBOIJE9A>EB:;HIE<H;9EH:7JJ>;9BEI;E<
8KI?D;IIED0;FJ;C8;H 7H;
;DJ?JB;:JEDEJ?9;E< 7D:JELEJ;7J J>;
7DDK7BC;;J?D=?D9BK:?D=7DO
7:@EKHDC;DJEHFEIJFED;C;DJJ>;H;E<
2E68@CJ 6E2:=D
(C@IJ%2E6C:2=D
!%('*,&,&',!**!&, .!$!$!,1'
(*'01%,*!$+'*, &&-$%,!&
'+,'# '$*+,' $&'.%*
,KHFHENOIJ7J;C;DJ7D:DDK7B/;FEHJ7H;7L7?B78B;7J
27?.<=8;5*6;.<.*;,1,867D:@@@9;8AB?8=.,86
/)'6/)'6421-')/-8)4;
!
IF7HJE<EKH;<<EHJIJE8;7D;DL?HEDC;DJ7BBOH;IFEDI?8B;
9EHFEH7J;9?J?P;D M;;D9EKH7=;)7CIJE9A>EB:;HIJELEBKDJ7H?BO
;B;9JJEH;9;?L;<KJKH;FHENOC7J;H?7BI;B;9JHED?97BBO
Z&<OEK7H;7H;=?IJ;H;:IJE9A>EB:;H FB;7I;L?I?J
@@@27?.<=8;-.52?.;B,86<EHI?CFB;?DIJHK9J?EDI
G&<OEK7H;7IJE9A>EB:;HM>EEMDIIJE9AJ>HEK=>78HEA;H
EH8HEA;H7=;799EKDJ FB;7I;EFJ<EH; :;B?L;HO7J
@@@27?.<=8;-.52?.;B,86EH8O9EDJ79J?D=OEKHDEC?D;;
2E6@7:DEC:3FE:@?
1>;FHENOC7J;H?7BI7H;<?HIJ8;?D=C7:;7L7?B78B;EHC7?B;:
JEEKHIJE9A>EB:;HIEDEH78EKJ0;FJ;C8;H
!E6>D@7FD:?6DD
"B;9J?EDE<:?H;9JEHID7C;:?DJ>;
FHENOIJ7J;C;DJJEI;HL;KDJ?BJ>;
D;NJ7DDK7BC;;J?D=E<IJE9A>EB:;HI
7D:KDJ?BJ>;?HH;IF;9J?L;IK99;IIEHI
7H;;B;9J;:7D:GK7B?<?;:
'*;79>
!?H;9JEH
+EC?D;;
:L?IEHOLEJ;JE7FFHEL;EKHD7C;:
;N;9KJ?L;E<<?9;H9ECF;DI7J?ED '*
/7J?<?97J?EDE<J>;7FFE?DJC;DJE<
(-*$))-7IEKH?D:;F;D:;DJ
H;=?IJ;H;:FK8B?9799EKDJ?D=<?HC<EH
<?I97BO;7H
'*
0JE9A>EB:;HFHEFEI7B ?<FHEF;HBO
FH;I;DJ;:7JJ>;7DDK7BC;;J?D= !&+,
1H7DI79J?EDE<IK9>EJ>;H8KI?D;II7IC7OFHEF;HBO9EC;
8;<EH;J>;7DDK7BC;;J?D=?D9BK:?D=7DO7:@EKHDC;DJEH
FEIJFED;C;DJJ>;H;E<
(C@A@D2=
'FC@2C5MD
*64@>>6?52E:
@?
.@E:?8
-B;7I;LEJ;7IIEED7IFEII?8B; ;L;D?<OEKFB7DJE7JJ;D:
J>;7DDK7BC;;J?D= ED7BBE<J>;LEJ?D=C7JJ;HI6EK>7L;
J>H;;EFJ?EDI<EHIK8C?JJ?D=OEKHLEJ;8;<EH;J>;7DDK7B
C;;J?D=
J:?E6C?6E JA9@?6 J>2:=
@@@9;8AB?8=.,86
ECFB;J; I?=D 7D:
:7J;OEKHFHENO
97H:7D:H;JKHD?J?D
J>;FEIJ7=; F7?:
;DL;BEF;
1>;FHENOIJ7J;C;DJ7D:OEKHFHENO97H:FHEL?:;CEH;
:;J7?B;:LEJ?D=?DIJHK9J?EDI
!,!+!%('*,&,, ,1'-.',JEFB7O7F7HJ?DJ>;
<KJKH;E<J>; ECF7DO-B;7I;97H;<KBBOH;L?;MJ>;FHENO
C7J;H?7BI<EHJ>;DDK7B*;;J?D=E<0JE9A>EB:;HI
O,H:;HE<J>;E7H:E<!?H;9JEHI
L7%7HJ;H
0;9H;J7HO
#H;CEDJ 7B?<EHD?7
!7J;:0;FJ;C8;H
-- 10 of 186 --
Lam Research Corporation Proxy Statement
TABLE OF CONTENTS
Proxy Statement Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
About Lam Research Corporation . . . . . . . . . . . . . . . 1 Director Nominee Composition Highlights and
Skills Matrix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Fiscal Year 2026 Financial Highlights . . . . . . . . . . . . 1
Proposals and Voting Recommendations . . . . . . . . 1 Corporate Governance Highlights . . . . . . . . . . . . . . . 5
Summary Information Regarding Director
Nominees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Executive Compensation Highlights . . . . . . . . . . . . . 6
Environmental, Social, and Governance Highlights 7
Stock Ownership . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Security Ownership of Certain Beneficial Owners
and Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Governance Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . . 11 Meeting Attendance . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Corporate Governance Policies . . . . . . . . . . . . . . . . . 11 Board Committees . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Our Approach to Promoting Board Effectiveness . . 11 Board’s Role and Engagement . . . . . . . . . . . . . . . . . 17
Board Nomination Policies and Procedures . . . . . . 13 Stockholder Engagement . . . . . . . . . . . . . . . . . . . . . . 20
Director Independence Policies . . . . . . . . . . . . . . . . . 14 Culture and Human Capital Management . . . . . . . . 23
Leadership Structure of the Board . . . . . . . . . . . . . . . 14 Environmental, Social, and Governance . . . . . . . . . 24
Other Governance Practices . . . . . . . . . . . . . . . . . . . 15 Director Compensation . . . . . . . . . . . . . . . . . . . . . . . . 25
Compensation Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Executive Compensation and Other Information . 28 Executive Compensation Tables . . . . . . . . . . . . . . . . 49
Compensation Discussion and Analysis (see Table
of Contents on page 28) . . . . . . . . . . . . . . . . . . . . . . . 28
CEO Pay Ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
58
Compensation Committee Report . . . . . . . . . . . . . . . 48 Pay Versus Performance . . . . . . . . . . . . . . . . . . . . . . . 59
Compensation Committee Interlocks and Insider
Participation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Securities Authorized for Issuance under Equity
Compensation Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
Audit Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
Audit Committee Report . . . . . . . . . . . . . . . . . . . . . . . . 63 Policy on Audit Committee Pre-Approval of Audit 65
Relationship with Independent Registered Public 64 Certain Relationships and Related Party 65
Annual Evaluation and Selection of Independent 64
Fees Billed by our Independent Registered Public
Accounting Firm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
Voting Proposals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
Proposal No. 1: Election of Directors . . . . . . . . . . . . 67 Proposal No. 3: Ratification of the Appointment
7
9
2026 Nominees for Director . . . . . . . . . . . . . . . . . . . . 68 Proposal No. 4: Stockholder Proposal . . . . . . . . . . . 80
Proposal No. 2: Advisory Vote to Approve Our
Named Executive Officer Compensation . . . . . . . . . 78
Other Voting Matters . . . . . . . . . . . . . . . . . . . . . . . . . . .
82
Voting and Meeting Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
Information Concerning Solicitation and Voting . . 84 Other Meeting Information . . . . . . . . . . . . . . . . . . . . . . 87
Appendices . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-1
Appendix A — Information Regarding Non-GAAP
Financial Measures . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-1
Lam Research Corporation 2026 Proxy Statement i
-- 11 of 186 --
This proxy statement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
All statements other than statements of historical fact contained in this proxy statement are forward-looking statements. In some
cases, forward-looking statements can be identified by words such as “aim,” “annual,” “assume,” “become,” “believe,” “can,” “commit,”
“continue,” “could,” “drive,” “endeavor,” “estimate,” “every year,” “expand,” “expect,” “focus,” “future,” “goal,” “grow,” “initiative,”
“intend,” “likely,” “long-term,” “maintain,” “may,” “might,” “objective,” “ongoing,” “opportunity,” “over time,” “plan,” “possible,” “potential,”
“preliminary,” “progress,” “regular,” “remain,” “seek,” “short-term,” “should,” “strategy,” “strive,” “target,” “transition,” “view,” “will,”
“would,” or variations of these words or other similar expressions. However, the absence of these words or similar expressions does
not mean that a statement is not forward-looking. Forward-looking statements in this proxy statement include, but are not limited to,
statements concerning: environmental, social, and governance (“ESG”) plans, targets, and goals; corporate governance practices;
director and executive compensation programs; and equity compensation utilization. These forward-looking statements are not a
guarantee of future performance and involve a number of risks, uncertainties, and other factors that could cause our actual results or
outcomes, or the timing of our results or outcomes, to differ materially from those expressed or implied in this proxy statement. Such
risks, uncertainties, and other factors include, among others, those described in Part I, Item 1, “Business,” Part I, Item 1A, “Risk
Factors,” Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part II, Item
7A, “Quantitative and Qualitative Disclosures About Market Risk” of our Annual Report on Form 10-K for the fiscal year ended June
28, 2026 (“2026 Annual Report”) and other documents we file from time to time with the Securities and Exchange Commission
(“SEC”), such as our quarterly reports on Form 10-Q and our current reports on Form 8-K. You should evaluate all forward-looking
statements made in this proxy statement in the context of these risks, uncertainties, and other factors. Readers are cautioned not to
place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on our current
beliefs, expectations, and assumptions about future events. Except as required by law, we do not undertake any obligation to revise
or update these forward-looking statements as a result of events or circumstances that occur after the date of this proxy statement or
to reflect the occurrence or effect of anticipated or unanticipated events.
Website references throughout this document are inactive textual references and provided for convenience only, and the content of
any website or report referred to in this proxy statement is not a part of nor incorporated by reference in this proxy statement. The
Global Impact report shall not be deemed soliciting material.
ii
-- 12 of 186 --
42:;!6%6)0)16!700%4;
4;7H;C7A?D=J>;I;FHENOC7J;H?7BI7L7?B78B;JEOEK?D9EDD;9J?EDM?J>J>;IEB?9?J7J?EDE<FHEN?;I8OJ>;E7H:E<!?H;9JEHIJ>;
XE7H:Y E<)7C/;I;7H9> EHFEH7J?EDX)7C/;I;7H9> YX)7C YJ>;X ECF7DO YXM; YXEKH YEHXKIY <EHKI;7JEKHDDK7B
*;;J?D=E<0JE9A>EB:;HIJ>;X7DDK7BC;;J?D=Y JE8;>;B:L?HJK7BBOED+EL;C8;H 7J7C-79?<?91?C; EH7J7DOEJ>;H
J?C;<EBBEM?D=7:@EKHDC;DJEHFEIJFED;C;DJJ>;H;E<6EK7H;?DL?J;:JEF7HJ?9?F7J;?DJ>;7DDK7BC;;J?D=7D:JELEJ;EDJ>;FHEFEI7BI
:;I9H?8;:?DJ>?IFHENOIJ7J;C;DJJ>;XFHENOIJ7J;C;DJY 1>;FHENOC7J;H?7BI7H;<?HIJ8;?D=C7:;7L7?B78B;EHC7?B;:JEEKH
IJE9A>EB:;HIEDEH78EKJ0;FJ;C8;H 1>;<EBBEM?D=IKCC7HO:E;IDEJ9EDJ7?D7BBE<J>;?D<EHC7J?EDJ>7JOEKI>EKB:
9EDI?:;H6EKI>EKB:H;7:J>;;DJ?H;FHENOIJ7J;C;DJ97H;<KBBO8;<EH;LEJ?D=
,9?>+7$/=/+<-29<:9<+>398
4;7H;7=BE87BIKFFB?;HE<?DDEL7J?L;M7<;H<78H?97J?ED;GK?FC;DJ7D:I;HL?9;IJEJ>;I;C?9ED:K9JEH?D:KIJHO,KH9KIJEC;H87I;
?D9BK:;IB;7:?D=I;C?9ED:K9JEHC;CEHO <EKD:HO 7D:?DJ;=H7J;::;L?9;C7DK<79JKH;HIJ>7JC7A;FHE:K9JIIK9>7IDED LEB7J?B;
C;CEHO :OD7C?9H7D:EC 799;IIC;CEHO 7D:BE=?9:;L?9;I4;>7L;8K?BJ7IJHED==BE87BFH;I;D9;M?J>9EH;9ECF;J;D9?;I?D
7H;7IIK9>7ID7DEI97B;C7DK<79JKH?D=;D78B;C;DJ 9>;C?IJHO FB7IC77D:<BK?:?9I 7:L7D9;:IOIJ;CI;D=?D;;H?D= 7D:78HE7:
H7D=;E<EF;H7J?ED7B:?I9?FB?D;I,KH9EH;J;9>D?97B9ECF;J;D9O?I?DJ;=H7J?D=>7H:M7H; FHE9;II C7J;H?7BI IE<JM7H; 7D:FHE9;II
9EDJHEB;D78B?D=H;IKBJIEDJ>;M7<;H,KHFHE:K9JI7D:I;HL?9;I7H;:;I?=D;:JE>;BFEKH9KIJEC;HI8K?B:IC7BB;H7D:8;JJ;H
F;H<EHC?D=:;L?9;IJ>7J7H;KI;:?D7L7H?;JOE<;B;9JHED?9FHE:K9JI ?D9BK:?D=CE8?B;F>ED;I F;HIED7B9ECFKJ;HI 9BEK:7D:
;DJ;HFH?I;I;HL;HI M;7H78B;I 7KJECEJ?L;L;>?9B;I 7D::7J7IJEH7=;:;L?9;I
3=-+6*/+< 38+8-3+63126312>=
#?=KH;I<EH97F?J7BH;JKHD;:JEIJE9A>EB:;HI7D:7CEKDJIH;FKH9>7I;:?D9BK:;8HEA;H7=;<;;I7D:9ECC?II?EDI7D:;N9?I;J7N;I
#<9:9=+6=+8.(9>381$/-977/8.+>398=
!E6>D@7FD:?6DD
@2C5.@E6
*64@>>6?52E:@?
(C@A@D2=&@ =64E:@?@7:C64E@C&@>:?66D '*;79>
:?H;9JEHDEC?D;;
(C@A@D2=&@ 5G:D@CJ.@E6E@AAC@G6'FC&2>65I64FE:G6'77:46C@>A6?D2E:@? '*
(C@A@D2=&@ *2E:7:42E:@?@7E96AA@:?E>6?E@7#(%$$(2D@FC!?56A6?56?E*68:DE6C65(F3=:4
44@F?E:?8:C>7@C:D42=162C
'*
(C@A@D2=&@ +E@4<9@=56CAC@A@D2= :7AC@A6C=JAC6D6?E652EE96>66E:?8 !&+,
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 13 of 186 --
%?77+<C809<7+>398$/1+<.3813</->9<!9738//=
1>;E7H:7D:DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;;8;B?;L;J>7J;79>E<J>;:?H;9JEHDEC?D;;IB?IJ;:8;BEM7H;>?=>BOGK7B?<?;:7D:
FEII;IIJ>;IA?BBI7D:;NF;H?;D9;H;GK?H;:JE;D78B;J>;CJE;<<;9J?L;BO9EDJH?8KJ;JEJ>;E7H:WIEL;HI?=>J7D::?H;9J?EDE<J>;
ECF7DO:;I9H?FJ?EDE<J>;IF;9?<?9;NF;H?;D9;I GK7B?<?97J?EDI 7JJH?8KJ;I 7D:IA?BBIJ>7JB;:EKHE7H:JE9ED9BK:;J>7J;79>E<J>;
:?H;9JEHDEC?D;;II>EKB:I;HL;7I7:?H;9JEH<EBBEMIJ>;8?E=H7F>?97B?D<EHC7J?EDE<;79>:?H;9JEHDEC?D;;9EDJ7?D;:?DJ>;X'8=270
";898<*5<C";898<*5 8 5.,=2878/2;.,=8; 8627..<C 8627..</8;2;.,=8;YI;9J?ED8;=?DD?D=EDF7=;
:C64E@C
@>>:EE66
%6>36CD9:A
'E96CFCC6?E(F3=:4@2C5D &2>6 86 +:?46 !?56A6?56?E & !,
1?CEJ>O*H9>;H +E 'E>DIED EDJHEBI
"H?9(H7D:J 6;I #" *
$;D!?=?J7B
+KJ7D?N
,FJ?ED 7H;%;7BJ>
&J7*H;DD7D 6;I *#" 7:;D9;!;I?=D0OIJ;CI
-B7D;J)78I
D?HK:>!;L=7D 6;I * 7:;D9;!;I?=D0OIJ;CI
'E>D*!?D;;D 6;I * E=D?P7DJ1;9>DEBE=O0EBKJ?EDI
*7HA#?;B:I 6;I * .2) ,**
%E(OK(7D= 6;I
;J>7DO'*7O;H 6;I *#" * *
IJ;H7)78I
EN
%;MB;JJ-79A7H:"DJ;HFH?I;
'OEJ?(*;>H7 6;I
8>?@?J617BM7BA7H 6;I
>7?H * * *
:L7D9;:*?9HE!;L?9;I
?/>OJ>C1;9>DEBE=?;I
1" EDD;9J?L?JO
&D:;F;D:;D9;:;J;HC?D;:?D799EH:7D9;M?J>+7I:7GB?IJ?D=HKB;I
*;C8;HI>?FII>EMD7IE<J>;:7J;E<J>?IFHENOIJ7J;C;DJ,D+EL;C8;H 9;HJ7?DC;C8;HI>?F9>7D=;IM?BBJ7A;;<<;9J0;;X8?.;7*7,.
*==.;<C8;98;*=.8?.;7*7,.C8*;-8662==..<Y<EH:;J7?BI
CK:?J9ECC?JJ;; C >7?H
C ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;; % C*;C8;H
& C+EC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;; CK:?J9ECC?JJ;;<?D7D9?7B;NF;HJ7I:;J;HC?D;:87I;:ED0" HKB;I
!, C&DDEL7J?ED7D:J;9>DEBE=O9ECC?JJ;; C.K7B?<?;I7I7D7K:?J9ECC?JJ;;<?D7D9?7B;NF;HJ7I:;J;HC?D;:8O0" HKB;I
-- 14 of 186 --
3</->9<!9738//97:9=3>3983126312>=+8.%5366= +><3B
,KHDEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;;H;=KB7HBO;L7BK7J;IJ>;E7H:WI9ECFEI?J?ED7D:C;C8;HI>?F9H?J;H?7JE7II;IIJ>;
7FFHEFH?7J;87B7D9;E<;NF;H?;D9; GK7B?<?97J?EDI IA?BBI J;DKH; 7D:EJ>;H9>7H79J;H?IJ?9I9EDI?:;H;:?CFEHJ7DJJEIKFFEHJJ>;D;;:I
E<EKH8KI?D;II EL;H7BBE7H:;<<;9J?L;D;II7D: KBJ?C7J;BO J>;BED= J;HC?DJ;H;IJIE<J>; ECF7DO7D:?JIIJE9A>EB:;HI ECFEI?J?ED
>?=>B?=>JI7D:7IA?BBIC7JH?N9EDJ7?D?D=A;OGK7B?<?97J?EDI IA?BBI 7D:;NF;H?;D9;I9EDI?:;H;:CEIJH;B;L7DJ?DJ>;DEC?D7J?D=7D:
=EL;HD7D9;9ECC?JJ;;WI:;9?I?EDJEDEC?D7J;97D:?:7J;IJEI;HL;EDEKHE7H:7H;FHEL?:;:8;BEM+EJ>7L?D=7C7HA:E;IDEJ
C;7DJ>;:?H;9JEHDEC?D;;:E;IDEJFEII;IIJ>7JGK7B?<?97J?ED IA?BB EH;NF;H?;D9;
#EHCEH;?D<EHC7J?ED78EKJ;79>:?H;9JEHDEC?D;; ?D9BK:?D=8?E=H7F>?97B?D<EHC7J?ED GK7B?<?97J?EDI IA?BBI 7D:;NF;H?;D9;I 7D:EKH
E7H:WI7FFHE79>JEH;<H;I>C;DJ FB;7I;H;<;HJEJ>;I;9J?EDIJ?JB;:X'8=270";898<*5<C";898<*5 8 5.,=2878/2;.,=8;
8627..<C 8627..</8;2;.,=8;Y8;=?DD?D=EDF7=;7D:X8?.;7*7,.*==.;<C8;98;*=.8?.;7*7,.C!>;99;8*,1
=8";868=2708*;-//.,=2?.7.<<F8;=?DD?D=EDF7=; H;IF;9J?L;BO
&/8?</
@/<+1/90 C/+<=
OHI OHI OHI
1/
@/<+1/90
OHI OHI
8./:/8./8-/
90
&D:;F;D:;DJ +ED &D:;F;D:;DJ
#6J)F2=:7:42E:@?D +<:==D IA6C:6?46D@7:C64E@C&@>:?66D
,:>@E9J% C496C
C:4# C2?5E
!E2% C6??2?
?:CF596G82?
"@9?% :?66?
%2C<:6=5D
@#JF#2?8
6E92?J" %2J6C
"J@E:# %69C2
39:;:E1 ,2=H2=<2C
3):897>34<1*),* C(DEMB;:=;E<7D:;NF;H?;D9;M?J>I;C?9ED:K9JEH7D:
8HE7:;HJ;9>DEBE=O?D:KIJH?;I7D:C7HA;JIFHEL?:;IEKHE7H:C;C8;HIM?J>7
:;;F;HKD:;HIJ7D:?D=E<EKHFHE:K9JI7D:I;HL?9;I J>;C7HA;JI;9JEHI?DM>?9>M;
7D:EKH9KIJEC;HI9ECF;J; 7D:J>;8HE7:;HJ;9>DEBE=O;D:C7HA;JIJ>7J:H?L;
:;C7D:?DEKH?D:KIJHO
:8942*7 **5#*(-3414,>34<1*),* T!?H;9JEHIM>EFEII;II:;;F
ADEMB;:=;7D:KD:;HIJ7D:?D=E<I;C?9ED:K9JEHFHE9;II?D=;GK?FC;DJJ;9>DEBE=?;I
7II?IJEKHE7H:?DEL;HI;;?D=EKH8KI?D;II7D:IJH7J;=?;I7D:;D>7D9;J>;E7H:WI
KD:;HIJ7D:?D=E<EKH9KIJEC;HIWC7HA;JI7D:D;;:I
&70*9.3,.87:59.;*#*(-3414,>&3)"97&9*,>=5*7.*3(*T!?H;9JEHIM?J>
;NJ;DI?L;ADEMB;:=;7D:;NF;H?;D9;?D8KI?D;II JE 8KI?D;IIC7HA;J?D=7D:I7B;I
7D:I;HL?9;I7D:EH8KI?D;II:;L;BEFC;DJ EH;NF;H?;D9;?:;DJ?<O?D=7D::;L;BEF?D=
:?IHKFJ?L;J;9>DEBE=?;I7D:B;7:?D=9EHFEH7J;IJH7J;=O FHEL?:;L7BK;JEJ>;E7H:8O
E<<;H?D=9H?J?97B?DI?=>JI7D:;NF;HJ?I;ED?:;DJ?<O?D=7D:KD:;HIJ7D:?D=D;MC7HA;JI
;NF7D:?D=C7HA;JI>7H; 7D:9ECCKD?97J?D=M?J>9KIJEC;HI F7HJ?9KB7HBOM>;H;
IK9>;NF;H?;D9;?I?D797F?J7B;GK?FC;DJ?D:KIJHO 7D:7BIEFHEL?:;J>;E7H:M?J>
9H?J?97B=K?:7D9;D;;:;:JEFHE=H;II?DEKH?DDEL7J?ED=E7BI7D::H?L;I;C?9ED:K9JEH
8H;7AJ>HEK=>I
*&)*78-.5=5*7.*3(* C KHH;DJEH<EHC;H;NF;H?;D9;?D7D;N;9KJ?L; B;L;B
B;7:;HI>?FFEI?J?ED7J7I?=D?<?97DJ8KI?D;II7BBEMIEKH:?H;9JEHIJEFHEL?:;J>;E7H:
M?J>?CFEHJ7DJF;HIF;9J?L;I7D:ADEMB;:=;H;=7H:?D=8KI?D;IIIJH7J;=O EF;H7J?EDI
9EHFEH7J;9KBJKH; IK99;II?EDFB7DD?D= 7D:C7D7=;C;DJ7D:B;7:;HI>?F8;IJ
FH79J?9;I
=*+5.,87=27>.<877.A=9*0.
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 15 of 186 --
#6J)F2=:7:42E:@?D +<:==D IA6C:6?46D@7:C64E@C&@>:?66D
,:>@E9J% C496C
C:4# C2?5E
!E2% C6??2?
?:CF596G82?
"@9?% :?66?
%2C<:6=5D
@#JF#2?8
6E92?J" %2J6C
"J@E:# %69C2
39:;:E1 ,2=H2=<2C
.3&3(*=5*7.*3(* C!?H;9JEHIM?J>FHE<?J7D:BEIIX-)Y 7D:<?D7D9?D=
;NF;H?;D9;7I7D;N;9KJ?L;H;IFEDI?8B;<EH<?D7D9?7BH;IKBJIE<78H;7:J>7D:B;L;BE<
9ECFB;N?JO9ECF7H78B;JEJ>; ECF7DO>;BFEKHE7H:EL;HI;;J>; ECF7DOWI
<?D7D9?7BFB7DD?D= EF;H7J?EDI ?DL;IJC;DJIJH7J;=?;I 97F?J7B7BBE97J?ED 7D:<?D7D9?7B
H;FEHJ?D=
14'&1:8.3*88=5*7.*3(* C"NF;H?;D9;7I79KHH;DJEH<EHC;H8KI?D;II
;N;9KJ?L;E<78KI?D;IIM?J>IK8IJ7DJ?7B=BE87BEF;H7J?EDIFHEL?:;IEKHE7H:M?J>
KD?GK;?DI?=>JIEDC7D7=?D=7D?DJ;HD7J?ED7B8KI?D;II =BE87BI97B;;NF7DI?ED 7D:
KD:;HIJ7D:?D=9KBJKH7BDEHCI
*7,*78&3)(6:.8.9.438@A=5*7.*3(* C!?H;9JEHIM?J>*7D:
?DJ;=H7J?ED;NF;H?;D9;?D9BK:?D=8KO 7D:I;BB I?:;7D:>EIJ?B;*;NF;H?;D9; 7I
7FK8B?99ECF7DO:?H;9JEHEHE<<?9;HFHEL?:;EKHE7H:M?J>A;O879A=HEKD:7D:
?DI?=>JI?D7II?IJ?D=C7D7=;C;DJM?J>H;L?;M?D=IJH7J;=?97BJ;HD7J?L;I 7D7BOP?D=
FEJ;DJ?7BJ7H=;JI FEIJ :;7B?DJ;=H7J?ED 7D:EL;HI?=>JE<JH7DI79J?EDI
425&7&9.;*4&7) 4;*73&3(*=5*7.*3(* C/;9;DJEH9KHH;DJ;NF;H?;D9;7I7
:?H;9JEHE<7DEJ>;HFK8B?99ECF7DOEHI?=D?<?97DJ?DLEBL;C;DJM?J>J>;9EHFEH7J;
=EL;HD7D9;H;GK?H;C;DJI7D:FH79J?9;IE<7FK8B?99ECF7DO8E7H:M>?B;I;HL?D=?D7
I;D?EHB;7:;HI>?FFEI?J?ED7J7DEJ>;HFK8B?99ECF7DO FHEL?:;IEKHE7H:M?J>7D
KD:;HIJ7D:?D=E<J>;8E7H:WIHEB;?D;II;DJ?7BC7JJ;HI ?D9BK:?D=EL;HI?=>JE<IJH7J;=O
EF;H7J?EDI H?IA 9ECFB?7D9;7D:IK99;II?EDFB7DD?D= ;<<;9J?L;?DJ;H79J?EDIM?J>
I?=D?<?97DJIJE9A>EB:;HI 7D:J>;FHEF;H:OD7C?9I8;JM;;DJ>;8E7H:7D:I;D?EH
C7D7=;C;DJ
>'*78*(:7.9>=5*7.*3(* CDKD:;HIJ7D:?D=E<7D:EH;NF;H?;D9;EL;HI;;?D=
9EHFEH7J;9O8;HI;9KH?JOEH?D<EHC7J?EDI;9KH?JOFHE=H7CI7D:7>?IJEHOE<
F7HJ?9?F7J?ED?DH;B;L7DJ9O8;H;:K97J?ED ?I7D?D9H;7I?D=BO?CFEHJ7DJ879A=HEKD:<EH
EKH:?H;9JEHIJEFEII;II7D:FHEL?:;IEKHE7H:M?J>L7BK78B;ADEMB;:=;?D
EL;HI;;?D=7D:D7L?=7J?D=9O8;HI;9KH?JOJ>H;7JI
:2&3&5.9&1&3&,*2*39=5*7.*3(* C"NF;H?;D9;I;HL?D=7I7C;C8;HE<J>;
9ECF;DI7J?ED9ECC?JJ;;E<7FK8B?99ECF7DO >;7:E<>KC7DH;IEKH9;I EH7I:?H;9J
C7D7=;HE<J>;>;7:E<>KC7DH;IEKH9;I EHEJ>;H;NF;H?;D9;?DI;JJ?D=J7B;DJ
C7D7=;C;DJFEB?9?;I?DB7H=;EH=7D?P7J?EDI 7?:IEKHE7H:?DEL;HI;;?D=J>;
C7D7=;C;DJE<>KC7D97F?J7B ?D9BK:?D=9KBJKH; ;D=7=;C;DJ H;9HK?J?D= H;J;DJ?ED
9ECF;DI7J?ED 7D:IK99;II?EDFB7DD?D=
!.80&3&,*2*39=5*7.*3(* C!?H;9JEHIM?J>;NF;H?;D9;I;HL?D=7I7C;C8;HE<
J>;7K:?J9ECC?JJ;;E<7FK8B?99ECF7DO EH:?H;9JBOEL;HI;;?D=;DJ;HFH?I;H?IA
C7D7=;C;DJEH8KI?D;II9EDJ?DK?JOFB7DD?D=?D7B7H=;EH=7D?P7J?ED EHEJ>;H
;NF;H?;D9;?DC7D7=?D=H?IA7JJ>;;DJ;HFH?I;B;L;BEH?D7I;D?EH9ECFB?7D9;EH
H;=KB7JEHOHEB;7II?IJEKHE7H:?DKD:;HIJ7D:?D=>EMJE;<<;9J?L;BO;L7BK7J;7D:
EL;HI;;J>;C7D7=;C;DJ7D:H;FEHJ?D=E<;DJ;HFH?I;H?IAI
&3:+&(9:7.3, 5*7&9.438=5*7.*3(*C!?H;9JEHIM?J>H;B;L7DJ;NF;H?;D9;?D
C7DK<79JKH?D=7D:EF;H7J?EDIFHE9;II;IEHC7D7=;C;DJ;NF;H?;D9;?DEF;H7J?EDI
7J79ECF7DO9ECF7H78B;JE)7CI;HL;7I7L7BK78B;7II;JJEEKHE7H:7D:>7L;
:;;F;HADEMB;:=;E<EKH8KI?D;II FHE:K9JI I;HL?9;I 7D:9KIJEC;HI
-- 16 of 186 --
9<:9<+>/9@/<8+8-/3126312>=
@2C52?5'E96C@G6C?2?46!?7@C>2E:@? D@7+6AE6>36C
0?P;E<E7H:7I+EC?D7J;:
+KC8;HE<&D:;F;D:;DJ+EC?D7J;:!?H;9JEHI
+KC8;HE<+EC?D7J;:!?H;9JEHI4>EJJ;D:;:[E<*;;J?D=I
+KC8;HE<+EC?D7J;:!?H;9JEHIED*EH;1>7D#EKH-K8B?9 ECF7DOE7H:I
+KC8;HE<+EC?D7J;:+ED "CFBEO;;"N;9KJ?L;,<<?9;H!?H;9JEHI4>EH;ED*EH;1>7D1ME-K8B?9
ECF7DOE7H:I
)?C?J7J?EDIED!?H;9JEH ECC?JC;DJI &D9BK:?D=,J>;HE7H:7D: ECC?JJ;;*;C8;HI>?FI7D:
);7:;HI>?F 4?J> ECC?JC;DJI"L7BK7J;:DDK7BBO-7=;
6;I
!?H;9JEHI0K8@;9JJE0JE9A,MD;HI>?F$K?:;B?D;I-7=; 6;I
%;:=?D=7D:-B;:=?D=-HE>?8?J;:-7=; 6;I
DDK7B"B;9J?EDE<BB!?H;9JEHI-7=; 6;I
3EJ?D=0J7D:7H:-7=; *7@EH?JOE<LEJ;I97IJ
-BKH7B?JO3EJ?D= 7HL;EKJ<EH EDJ;IJ;:"B;9J?EDI 6;I
0;F7H7J; >7?H7D: ", 6;I
&D:;F;D:;DJE7H: >7?H-7=; 6;I
&D:;F;D:;DJ!?H;9JEHI*;;J4?J>EKJ*7D7=;C;DJ-H;I;DJ-7=; 6;I
DDK7BE7H:&D9BK:?D=&D:?L?:K7B!?H;9JEH 7D: ECC?JJ;;0;B< "L7BK7J?EDI-7=; 6;I
DDK7B&D:;F;D:;DJ!?H;9JEH"L7BK7J?EDE< ",-7=; 6;I
/?IA,L;HI?=>J8O#KBBE7H:7D: ECC?JJ;;I-7=; 6;I
E7H:/;<H;I>C;DJ-7=; 6;I
/E8KIJ!?H;9JEH+EC?D7J?ED-HE9;II-7=; 6;I
0?=D?<?97DJE7H:"D=7=;C;DJ-7=; 6;I
E7H:,H?;DJ7J?ED":K97J?ED-HE=H7C-7=; 6;I
E:;E<"J>?9IFFB?978B;JE!?H;9JEHI-7=; 6;I
0JE9A>EB:;H-HENO99;II-7=;I 6;I
0JE9A>EB:;H/?=>JJE9J8O4H?JJ;D EDI;DJ 6;I
0JE9A>EB:;H/?=>JJE 7BB70F;9?7B*;;J?D= 6;I
0JE9A>EB:;H"D=7=;C;DJ-HE=H7C-7=; 6;I
-E?IED-?BB +E
E7H:,L;HI?=>JE<"DL?HEDC;DJ7B 0E9?7B7D:$EL;HD7D9;&D9BK:?D= B?C7J; %KC7D 7F?J7B
&D<EHC7J?ED0;9KH?JO&D9BK:?D= O8;HI;9KH?JO -EB?J?97B9J?L?J?;I-7=; 6;I
-K8B?97J?EDE<DDK7B$BE87B&CF79J/;FEHJ7B?=D;:M?J>$/& 00 7D:1 #! IJ7D:7H:I-7=;I
6;I
DEC?D;;M?BB8;;B;9J;:7I7:?H;9JEH7JJ>;7DDK7BC;;J?D=EDBO?<J>;LEJ;I97IJ<EHIK9>DEC?D;;WI;B;9J?ED;N9;;:J>;LEJ;I97IJ7=7?DIJIK9>
DEC?D;;WI;B;9J?ED&<7D?D9KC8;DJ<7?BIJEH;9;?L;J>;H;GK?H;:C7@EH?JO J>;?HFH;L?EKIBOIK8C?JJ;:H;I?=D7J?EDM?BB8;FHECFJBO9EDI?:;H;:8OJ>;
E7H:
X$/&YH;<;HIJEJ>;$BE87B/;FEHJ?D=&D?J?7J?L; X00YH;<;HIJEJ>;0KIJ7?D78?B?JO99EKDJ?D=0J7D:7H:IE7H: 7D:X1 #!YH;<;HIJEJ>;17IA
#EH9;ED B?C7J; /;B7J;:#?D7D9?7B!?I9BEIKH;I
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 17 of 186 --
B/-?>3@/97:/8=+>3983126312>=
/92E/6@
(2J7@C(6C7@C>2?46-7=;I T,KH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C?I:;I?=D;:JEF7O<EHF;H<EHC7D9;EL;HE<
J>;7DDK7B?D9;DJ?L;FHE=H7C?IJ?;:JE9ECF7DO<?D7D9?7B IJH7J;=?9 7D:EF;H7J?ED7BF;H<EHC7D9;C;JH?9IJ>;BED= J;HC?D9;DJ?L;
FHE=H7CKI;I79EC8?D7J?EDE<C7HA;J 87I;:F;H<EHC7D9;H;IJH?9J;:IJE9AKD?JI;79> 7X*7HA;J 87I;:-/02Y M?J>F;H<EHC7D9;
87I;:EDH;B7J?L;JEJ7BI>7H;>EB:;HH;JKHDX10/Y 7D:I;HL?9; 87I;:H;IJH?9J;:IJE9AKD?JI;79> 7DX/02Y
,9C66 162C(6C7@C>2?46(6C:@57@C'FC$@?8 ,6C>!?46?E:G6(C@8C2>-7=; T,KH9KHH;DJBED= J;HC?D9;DJ?L;FHE=H7C?I
:;I?=D;:JEF7O<EHF;H<EHC7D9;EL;H7F;H?E:E<J>H;;O;7HI
3D@=FE62?5*6=2E:G6(6C7@C>2?46%6EC:4D-7=;I T,KH7DDK7B7D:BED= J;HC?D9;DJ?L;FHE=H7CI<EH;N;9KJ?L;
E<<?9;HI?D9BK:;J>;KI;E<78IEBKJ;7D:H;B7J?L;F;H<EHC7D9;<79JEHI
2=2?46@7??F2=2?5$@?8 ,6C>!?46?E:G6DT,KH?D9;DJ?L;FHE=H7CIFHEL?:;787B7D9;E<7DDK7B7D:BED= J;HC?D9;DJ?L;I
:776C6?E(6C7@C>2?46%6EC:4D7@C??F2=2?5$@?8 ,6C>!?46?E:G6(C@8C2>D-7=;I T,KH7DDK7B7D:BED= J;HC
?D9;DJ?L;FHE=H7CIKI;:?<<;H;DJF;H<EHC7D9;C;JH?9I
2AA65>@F?ED-7=;I TCEKDJIJ>7J97D8;;7HD;:KD:;HJ>;7DDK7B7D:BED= J;HC?D9;DJ?L;FHE=H7CI7H;97FF;:
;=?DD?D=M?J>EKHBED= J;HC?D9;DJ?L;FHE=H7C J>;C7N?CKCF7OEKJ?I97FF;:7JE<J7H=;J?<EKH78IEBKJ;10/?I
D;=7J?L;
@>A6?D2E:@?*64@G6CJ =2H324<(@=:4J-7=; T4;>7L;79B7M879AFEB?9OM>?9>7FFB?;IJEJ>; ECF7DOWI9KHH;DJ7D:
<EHC;H;N;9KJ?L;E<<?9;HI9EL;H;:8O0;9J?EDE<J>;200;9KH?J?;I"N9>7D=;9JE< 7I7C;D:;:J>;X"N9>7D=;9JY
FKHIK7DJJEM>?9>M;CKIJH;9EKF ED7FH; J7N87I?I J>;;N9;II7CEKDJE<?D9;DJ?L; 87I;:9ECF;DI7J?ED=H7DJ;: ;7HD;: EH
L;IJ;:M>EBBOEH?DF7HJEDJ>;7JJ7?DC;DJE<7DO<?D7D9?7BH;FEHJ?D=C;7IKH;:KH?D=J>;J>H;;9ECFB;J;:<?I97BO;7HI?CC;:?7J;BO
FH;9;:?D=J>;:7J;EDM>?9>J>; ECF7DO?IH;GK?H;:JEFH;F7H;7H;IJ7J;C;DJ1>;FEB?9O7FFB?;IH;=7H:B;IIE<<7KBJ <H7K: EH
C?I9ED:K9JM?J>H;IF;9JJE7DO7D:7BB?D9;DJ?L; 87I;:9ECF;DI7J?EDJ>7JM7IH;9;?L;:EDEH7<J;H,9JE8;H
(C@9:3:E'AE:@?*6AC:4:?8T,KHIJE9A?D9;DJ?L;FB7DIFHE>?8?JEFJ?EDH;FH?9?D=M?J>EKJIJE9A>EB:;H7FFHEL7B
+E@4<'H?6CD9:AF:56=:?6D-7=; T4;>7L;IJE9AEMD;HI>?F=K?:;B?D;I<EH;79>E<EKH;N;9KJ?L;E<<?9;HI7D:9;HJ7?DEJ>;H
I;D?EH;N;9KJ?L;I;79>E<EKHD7C;:;N;9KJ?L;E<<?9;HI>7IC;JJ>;?H?D:?L?:K7BEMD;HI>?FB;L;BKD:;HJ>;9KHH;DJFHE=H7CEH>7I7
F;H?E:E<J?C;H;C7?D?D=KD:;HJ>;=K?:;B?D;IJE:EIE
!?56A6?56?E@>A6?D2E:@?5G:D@C-7=; T1>;9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;8;D;<?JI<HEC?JIKJ?B?P7J?ED
E<7D?D:;F;D:;DJ9ECF;DI7J?ED7:L?IEHH;J7?D;::?H;9JBO8OJ>;9ECC?JJ;;J>7JFHEL?:;IDEEJ>;HI;HL?9;IJEJ>; ECF7DO
+E@4<9@=56C?8286>6?E-7=; T4;;D=7=;M?J>IJE9A>EB:;HIED7D7DDK7B87I?I7D:IJE9A>EB:;H7:L?IEHO<?HCIED7D7I
D;;:;:87I?IJEE8J7?D<;;:879A9ED9;HD?D=EKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C
/92E/6@?ME@
,2INC@DD -ADO7@C(6CBF:D:E6D 7@C'E96C6?67:ED@CFA@?292?86:?@?EC@=-7=;I T,KH;N;9KJ?L;E<<?9;HI
:EDEJH;9;?L;J7NX=HEII KFIY<EHF;HGK?I?J;I <EHEJ>;H8;D;<?JI EHKFED79>7D=;?D9EDJHEB
+:?8=6 ,C:886C92?86:?@?EC@=(C@G:D:@?D-7=;I T,KH;N;9KJ?L;9>7D=;?D9EDJHEBFEB?9O:E;IDEJ>7L;I?D=B;
JH?==;HFHEL?I?EDI
,KH;N;9KJ?L;E<<?9;HIC7OH;9;?L;J7N=HEII KFI?D9EDD;9J?EDM?J>H;BE97J?ED8;D;<?JI7D:7DD?L;HI7HOC?B;IJED;7M7H:I M>?9>7H;M?:;BO
7L7?B78B;JE7BBE<EKH;CFBEO;;I
-- 18 of 186 --
Environmental, Social, and Governance Highlights
Our ESG strategy supports the success of our business. It provides a framework for meaningful investments, proactive risk
management, support for our customers to achieve their goals, and globally focused action. Our approach emphasizes engagement,
goal setting, and accountability. In calendar year 2025, we introduced our refreshed strategy, “Impact plus”, through three pillars:
Product+, People+, and Planet+, which are supported by our business and governance practices. In calendar year 2025, we
achieved or exceeded many of our 2025 ESG goals, which are highlighted in the table below. We have also received recognition from
our customers and from independent raters and rankers, including being named among the World’s Most Ethical Companies by
Ethisphere and being included on the Dow Jones Best-in-Class North America Index. References to specific years in the paragraph
and table below are to calendar years.
Building on the progress we made through 2025, we refreshed our goal program through a cross-functional review, assessing which
goals to reset, retire, or reframe, as well as where to set our sights next. The result is a new set of 2030+ goals grounded in action
plans and industry best practices, and approved through our ESG governance structure. Our ESG strategy, 2030+ goals, and status
are described in our 2025 Global Impact report, available at www.lamresearch.com/global-impact-report/.
Product+
Achieve more than 90% compliance with our
social and environmental expectations across
our top-tier suppliers(1)
We assess compliance with our expectations in a variety of ways,
including responses to our annual Conflict Minerals Reporting
Template survey. In 2025, 96% of our top 100 direct suppliers
responded to this survey.
Engage with at least 50% of our top-tier
suppliers on environmental sustainability
opportunities.
The Supply Chain ESG team conducted 17 energy assessments at
supplier facilities in 2025. Through these assessments, we identified
potential savings of 16.5 million kilowatt-hours (“kWh”).
Increase engagement with all suppliers on
social and environmental topics through
assessment, training, and capacity building.
We identified and deepened engagement with suppliers critical to
future business growth and provided targeted training on our Global
Supplier Code of Conduct, ethics, compliance, and broader ESG
expectations to reinforce alignment with our standards, engaging 75
suppliers through 10 webinars and four in-person SBT workshops,
with 425 participants.
46.5% of suppliers measured by emissions
have science-based targets (“SBTs”) by 2025.
We exceeded this goal in 2025, with 53.8% of suppliers measured by
emissions having set SBTs.
83% of customers measured by emissions
have SBTs.(2)
By the end of 2025, 35.1% of customers by emissions had SBTs, a
significant increase from 9% in 2024.
People+
Build on our high-performance culture with
best-in-class employee engagement at the
global benchmark as measured by our annual
employee survey.
In 2025, we achieved an 85 engagement score, five points above the
global benchmark, and a 77 Belong and Connect Index score, one
point above the global benchmark.
Determine key targets for larger-scale impact
aligned to a new strategic focus.
Lam’s Powering Breakthroughs Together community impact
framework continued to guide our giving and signature program
initiatives in 2025.
Implement measurement of outcomes for key
program and large-scale grants.
Our 2030 goal, combined with our long-term grant making process
across our three impact pillars, provides the framework for
measuring outcomes over the next five years.
Increase annual unique participation rate in all
employee giving programs from 10% to 30%.
In 2025, Lam exceeded this goal, achieving a 55% participation rate
across employee giving and volunteer programs.
Contribute 40,000 employee volunteer hours
annually.
In 2025, we exceeded this goal, with employees contributing 48,868
volunteer hours globally.
Maintain an Occupational Safety and Health
Administration recordable injury rate at or
below 0.4 annually.
In 2025, we achieved a recordable injury rate of 0.26, well below
industry averages and a 7% decrease from 2024. We also reduced
lost-time injuries by 17%.
Pillar 2025 Goal 2025 Progress
Lam Research Corporation 2026 Proxy Statement 7
-- 19 of 186 --
(=2?6E
9>?;L;C?BB?EDA4>?DJEJ7B;D;H=OI7L?D=I
8O<HEC787I;B?D;
&D M;;N9;;:;:J>?I=E7B >7L?D=9KCKB7J?L;BOI7L;:CEH;
J>7DC?BB?EDA4>
9>?;L;P;HEM7IJ;JEB7D:<?BB<EH>7P7H:EKI
M7IJ;
,DBOE<>7P7H:EKIM7IJ;M7I:?IFEI;:JEB7D:<?BB4;9EDJ?DK;:
JEFH?EH?J?P;7BJ;HD7J?L;IJEB7D:<?BBM>;DFEII?8B;
/;:K9;78IEBKJ;09EF;7D:C7HA;J
87I;: $%$;C?II?EDI8O<HEC7
87I;B?D;
OJ>;;D:E< M;>7:H;:K9;:09EF;7D:C7HA;J 87I;:
$%$;C?II?EDICEH;J>7D<HEC787I;B?D;J>HEK=>
H;FB79;C;DJE<7>?=>=BE87BM7HC?D=FEJ;DJ?7B>;7JJH7DI<;H<BK?:
H;D;M78B;;D;H=O9H;:?JI 7D:;D;H=O;<<?9?;D9OFHE@;9JI79HEIIJ>;
=BE8;
9>?;L;C?BB?ED=7BBEDIE<M7J;HI7L?D=I?D
M7J;H IJH;II;:H;=?EDI<HEC787I;B?D;
9>?;L;:CEH;J>7DC?BB?ED=7BBEDIE<M7J;HI7L?D=I<HEC7
87I;B?D;
FD:?6DD
2?5
@G6C?2?46
EDJ?DK;JE;NF7D:EKH:?I9BEIKH;7D:
7B?=DC;DJM?J>?D:KIJHO H;9E=D?P;:
<H7C;MEHAI7D:IJ7D:7H:I
(;OFE?DJIE<FHE=H;IIC7:;I?D9;?D9BK:;7::?D=007D:
1 #!<H7C;MEHAIJEEKHH;FEHJ?D= ?CFHEL?D=I9EH;IM?J> !-
*0 & 7D:0KIJ7?D7BOJ?9I KF:7J?D=A;OFEB?9?;I <EHC?D=79HEII
<KD9J?ED7BMEHA?D==HEKFED;C;H=?D="0$:?I9BEIKH;7D:
9ECFB?7D9;H;GK?H;C;DJI 7D:I>?<J?D=EKH:7J7C7D7=;C;DJ
FB7J<EHCJEIJH;7CB?D;H;FEHJ?D=
(:==2C @2= (C@8C6DD
1EF J?;HIKFFB?;HI7H;:;<?D;:7IJ>;JEF:?H;9JIKFFB?;HI8OIF;D: M>?9>799EKDJ<EH7FFHEN?C7J;BOE<:?H;9JIF;D:7D:E<:?H;9J
IKFFB?;H;C?II?EDI M?J>IEC;L7H?78?B?JOO;7H EL;H O;7H!?H;9JIKFFB?;HI7H;:;<?D;:7IJ>EI;M>EFHEL?:;F7HJI 7II;C8B?;I 7D:I;HL?9;IJE
FHE:K9;F7HJIKI;:JEC7DK<79JKH;7D:IKFFEHJ)7CWIFHE:K9JI&D:?H;9JIKFFB?;HI7H;7BBEJ>;H=EE:I7D:I;HL?9;IKI;:8O)7CWI:7?BOEF;H7J?EDI
J>7J7H;DEJF7HJI 7II;C8B?;I EHI;HL?9;I:?H;9JBOJ?;:JEFHE:K9?D=F7HJIKI;:JEC7DK<79JKH;EHIKFFEHJ)7CWIFHE:K9JI
)7C :?: DEJ 79>?;L; ?JI =E7B E< E< ?JI 9KIJEC;HI C;7IKH;: 8O ;C?II?EDI >7L?D= I;J 01I 8O !;IF?J; 9KIJEC;HI >7L?D= BED=J;HC =E7BI
?DFB79; 09?;D9; 7I;:17H=;JI?D?J?7J?L;X01?Y H;GK?H;C;DJI:EDEJFHEL?:;J>;<B;N?8?B?JOIEC;E<EKH9KIJEC;HIH;GK?H;?DI;JJ?D=7D:
C;7IKH?D= J>;?H I>EHJJ;HC =E7BI
-- 20 of 186 --
!62'.91)45,-3
%/-?<3>C"A8/<=23:90/<>+38/8/03-3+6"A8/<=+8. +8+1/7/8>
1>;J78B;8;BEMI;JI<EHJ>9;HJ7?D?D<EHC7J?EDH;=7H:?D=J>;8;D;<?9?7BEMD;HI>?FE<I>7H;IE<)7C9ECCEDIJE9A7IE<0;FJ;C8;H
;N9;FJ7IEJ>;HM?I;?D:?97J;: 8O ;79>F;HIEDEH;DJ?JOADEMD8OKIJE8;D;<?9?7BBOEMDCEH;J>7DE<)7CWI9ECCED
IJE9A ;79>:?H;9JEHE<J>; ECF7DO ;79>+",?:;DJ?<?;:?DJ>;I;9J?EDJ?JB;:X869.7<*=287*==.;<CA.,>=2?.
869.7<*=287*7-!=1.;7/8;6*=287C869.7<*=2872<,><<287*7-7*5B<2<Y8;BEM7D: 7BB9KHH;DJ:?H;9JEHI7D:;N;9KJ?L;
E<<?9;HI7I7=HEKF1>;?D<EHC7J?ED?DJ>;J78B;8;BEM?I87I;:EDEKHH;L?;ME<<?B?D=IC7:;M?J>J>;0" EHEKHH;9EH:I"N9;FJ7I
EJ>;HM?I;?D:?97J;:?DJ>;<EEJDEJ;IJEJ>;J78B;8;BEM 7D:IK8@;9JJE9ECCKD?JOFHEF;HJOB7MIM>;H;7FFB?978B; M;8;B?;L;;79>E<
J>;IJE9A>EB:;HID7C;:?DJ>?IJ78B;>7IIEB;LEJ?D=7D:?DL;IJC;DJFEM;HM?J>H;IF;9JJEJ>;I>7H;I?D:?97J;:7I8;D;<?9?7BBOEMD;:
1>;F;H9;DJ7=;E<I>7H;I8;D;<?9?7BBOEMD;:?I97B9KB7J;:KI?D= 7IJ>;DKC8;HE<I>7H;IE<)7C9ECCEDIJE9A
EKJIJ7D:?D=ED0;FJ;C8;H
/8/03-3+6"A8/<=23:&+,6/
&2>62?555C6DD@76?67:4:2='H?6C
&F>36C@7+92C6D
6?67:4:2==J
'H?65
(6C46?E286
@7+92C6D
6?67:4:2==J'H?65
"94(0-41)*78
B79A/E9A &D9
%K:IED67H:I
+;M6EHA +6
37D=K7H: 7F?J7B*7D7=;C;DJ
37D=K7H:EKB;L7H:
*7BL;HD -
.7*(9478
0E>7?B2>C;:
1?CEJ>O*H9>;H7BIE7+7C;:"N;9KJ?L;,<<?9;H
"H?9(H7D:J
&J7*H;DD7D
*?9>7;B/ 7DDED
D?HK:>!;L=7D
'E>D*!?D;;D
*7HA#?;B:I
%E(OK(7D=
;J>7DO'*7O;H
'OEJ?(*;>H7
8>?@?J617BM7BA7H
&2*)=*(:9.;*++.(*78@8A
!EK=B7I/;JJ?D=;H
0;I>7I7O;;0;I>7 37H7:7H7@7D
+;?B'#;HD7D:;I
37>?:37>;:?
BB9KHH;DJ:?H;9JEHI7D:;N;9KJ?L;E<<?9;HI7I7=HEKFF;EFB;
+EJ;2DB;IIEJ>;HM?I;?D:?97J;: J>;FH?D9?F7B7::H;IIE<;79>E<J>;IJE9A>EB:;HI78EL;?I9E)7C/;I;7H9> EHFEH7J?ED KI>?D=-7HAM7O
#H;CEDJ 7B?<EHD?7
);IIJ>7D
&D9BK:;II>7H;IIK8@;9JJEEKJIJ7D:?D=IJE9AEFJ?EDIJ>7J7H;;N;H9?I78B;M?J>?D:7OIE<0;FJ;C8;H 7IM;BB7II>7H;I?IIK78B;KFED
I;JJB;C;DJE</02IJ>7JL;IJM?J>?DJ>7JJ?C;F;H?E: 7I<EBBEMI
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 21 of 186 --
&F>36C@7
+92C6D
0E>7?B2>C;:
1?CEJ>O*H9>;H
"H?9(H7D:J
*?9>7;B/ 7DDED
&J7*H;DD7D
D?HK:>!;L=7D
'E>D*!?D;;D
*7HA#?;B:I
%E(OK(7D=
;J>7DO'*7O;H
'OEJ?(*;>H7
8>?@?J617BM7BA7H
!EK=B7I/;JJ?D=;H U
+;?B'#;HD7D:;I
37>?:37>;:?
0;I>7I7O;;0;I>7 37H7:7H7@7D
BB9KHH;DJ:?H;9JEHI7D:;N;9KJ?L;E<<?9;HI7I7=HEKFF;EFB;
1>;J;HCIE<7DOEKJIJ7D:?D=IJE9AEFJ?EDIJ>7J7H;;N;H9?I78B;M?J>?D:7OIE<0;FJ;C8;H 7D:/02IJ>7JL;IJM?J>?DJ>7JJ?C;F;H?E:
7H;H;<B;9J;:?DJ>;J78B;X,KJIJ7D:?D="GK?JOM7H:I7J#?I97B6;7H6;7H "D:YEDF7=;
I:?I9KII;:?DX$EL;HD7D9;*7JJ;HIT!?H;9JEH ECF;DI7J?EDY8;BEM DED ;CFBEO;;:?H;9JEHIH;9;?L;7D7DDK7B;GK?JO7M7H:7IF7HJE<J>;?H
9ECF;DI7J?ED1>;I;7M7H:I=;D;H7BBOL;IJED,9JE8;H IK8@;9JJE9EDJ?DK;:I;HL?9;EDJ>;E7H:7IE<J>7J:7J; M?J>?CC;:?7J;
:;B?L;HOE<J>;I>7H;IKFEDL;IJ?D=#EH *;IIHI>C;: H7D:J 7DDED !?D;;D #?;B:I 7D:17BM7BA7H*IIH;DD7D *7O;H 7D:*;>H7
7D:!H(7D=;79>H;9;?L;:7M7H:IE< /02I 7D:!H!;L=7D M>E@E?D;:J>;E7H:ED#;8HK7HO H;9;?L;:7D7M7H:E<
/02I
BB?D<EHC7J?EDH;=7H:?D=B79A/E9A &D9XB79A/E9AY ?I87I;:IEB;BOED?D<EHC7J?ED:?I9BEI;:?D7C;D:C;DJDKC8;HJE09>;:KB;$<?B;:
8OB79A/E9AM?J>J>;0" ED'7DK7HO ED8;>7B<E<B79A/E9A7D:9;HJ7?DIK8I?:?7H?;I99EH:?D=JEJ>;09>;:KB;$<?B?D= E<
I>7H;IE<)7C9ECCEDIJE9AH;FEHJ;:7I8;D;<?9?7BBOEMD;:8OB79A/E9A7IE<!;9;C8;H B79A/E9A>7:IEB;LEJ?D=
FEM;HM?J>H;IF;9JJE I>7H;I :?:DEJ>7L;I>7H;:LEJ?D=FEM;HM?J>H;IF;9JJE7DOI>7H;I >7:IEB;:?IFEI?J?L;FEM;HM?J>H;IF;9JJE
I>7H;I 7D::?:DEJ>7L;I>7H;::?IFEI?J?L;FEM;HM?J>H;IF;9JJE7DOI>7H;IE<)7C9ECCEDIJE9A,D,9JE8;H J>;
ECF7DO;<<;9J;:7J;D <EH ED;IJE9AIFB?JE<?JI9ECCEDIJE9A7D:7FHEFEHJ?ED7J;?D9H;7I;?DJ>;DKC8;HE<7KJ>EH?P;:I>7H;I1>;H;<;H;D9;I
JEI>7H;I8;D;<?9?7BBOEMD;:8OB79A/E9A?DJ>?IFHENOIJ7J;C;DJ>7L;8;;DH;JHE79J?L;BO7:@KIJ;:JEH;<B;9JJ>;IJE9AIFB?J
BB?D<EHC7J?EDH;=7H:?D=37D=K7H: 7F?J7B*7D7=;C;DJX37D=K7H:Y ?I87I;:IEB;BOED?D<EHC7J?ED:?I9BEI;:?D709>;:KB;$<?B;:8O
37D=K7H:M?J>J>;0" EDFH?B 99EH:?D=JEJ>;09>;:KB;$<?B?D= E<J>; I>7H;IE<)7C9ECCEDIJE9AH;FEHJ;:7I
8;D;<?9?7BBOEMD;:8O37D=K7H:7IE<*7H9> 37D=K7H:>7:IEB;LEJ?D=FEM;HM?J>H;IF;9JJE I>7H;I :?:DEJ>7L;I>7H;:
LEJ?D=FEM;HM?J>H;IF;9JJE7DOI>7H;I >7:IEB;:?IFEI?J?L;FEM;HM?J>H;IF;9JJE I>7H;I 7D::?:DEJ>7L;I>7H;::?IFEI?J?L;FEM;H
M?J>H;IF;9JJE7DOI>7H;I
-- 22 of 186 --
Governance Matters
Corporate Governance
Our Board and members of management are committed to responsible corporate governance to manage the Company for the long-
term benefit of its stockholders. To that end, the Board and management periodically review and update, as appropriate, the
Company’s corporate governance policies and practices. As part of that process, the Board and management consider the
requirements of federal and state law, including rules and regulations of the SEC; the listing standards of The Nasdaq Stock Market
LLC (“Nasdaq”); published guidelines and recommendations of proxy advisory firms; published guidelines of certain of our top
stockholders; published guidelines of other selected public companies; the results of stockholder votes; and any feedback we receive
from our stockholders. A list of key corporate governance practices is provided in the section titled “Proxy Statement Summary”
above.
Corporate Governance Policies
We have instituted a variety of policies and procedures to promote responsible corporate governance, including the following:
Policies and Procedures Summary
Policy or
Procedure Summary
Board
committee
charters*
Each of the Board’s audit, compensation and human resources, nominating and governance, and innovation and
technology committees has a written charter adopted by the Board that delegates authority and responsibilities to the
committee.
Each committee reviews its charter, and the nominating and governance committee reviews the charters of all of the
committees annually and recommends changes to the Board, as appropriate. See “ – Board Committees” below for
additional information regarding these committees.
Corporate
governance
guidelines*
Our Board has adopted written corporate governance guidelines that outline governance practices and procedures
and are reviewed annually by the nominating and governance committee and the Board.
Selected provisions of the guidelines are discussed below, including in the “ – Board Nomination Policies and
Procedures,” “ – Director Independence Policies,” and “ – Other Governance Practices” sections below.
Corporate
Code of
Ethics*
We maintain a code of ethics that applies to all employees, officers, and members of the Board.
The code of ethics establishes standards reasonably necessary to promote honest and ethical conduct, including the
ethical handling of actual or apparent conflicts of interest between personal and professional relationships, and full,
fair, accurate, timely, and understandable disclosure in the periodic reports we file with the SEC and in other public
communications. We intend to disclose future amendments to certain provisions of the code of ethics, and waivers of
the code of ethics granted to executive officers and directors, on the Investor Relations page of our website at
investor.lamresearch.com within four business days following the date of the amendment or waiver.
Code of
Conduct*
We maintain a written code of conduct to address a variety of situations that apply to our worldwide workforce.
Among other items, the code of conduct addresses relationships and/or conduct with one another, with Lam
(including conflicts of interest, safeguarding of Company assets, and protection of confidential information), and with
other companies and stakeholders (including anti-corruption).
Insider
Trading
Policy**
Our insider trading policy addresses the trading of Company stock by our directors, officers, employees, and other
individuals associated with us, as well as the Company itself, insider blackout periods, preclearance protocols, and
prohibitions on hedging and pledging Company stock. For additional information, see the section titled
“Compensation Matters – Executive Compensation and Other Information – Compensation Discussion and Analysis
– II. CY2025 and CY2026 Compensation Programs” below.
* A copy is available on our website at investor.lamresearch.com/corporate-governance.
** A copy is available as Exhibit 19.1 to our 2026 Annual Report.
Our Approach To Promoting Board Effectiveness
As part of the Board’s commitment to responsible corporate governance, we have developed a number of practices to enable the
Board to function in an effective manner that serves the long-term interests of the Company and its stockholders. Several of the
practices that we consider to be most important are summarized in the figure that follows, and the practices themselves are described
in greater detail below.
Lam Research Corporation 2026 Proxy Statement 11
-- 23 of 186 --
Board Effectiveness Practices
Board and committee evaluations. Every year, the Board conducts a self-evaluation of the Board, its committees, and the individual
directors, overseen by the nominating and governance committee. From time to time, the evaluation is facilitated by an independent
third-party consultant. The evaluation solicits the opinions of the directors regarding the effectiveness of the Board, Board
committees, and individual directors in fulfilling their obligations. Feedback on Board effectiveness is provided to the full Board for
discussion, feedback on each committee’s effectiveness is provided to each committee for discussion, and feedback regarding
individual director performance is provided to each individual director. The Board and committees identify and hold themselves
accountable for action items stemming from the evaluation. The results of the evaluations are also considered by the nominating and
governance committee and the Board as part of the director nomination process.
Board composition and refreshment. The Board and the nominating and governance committee regard Board refreshment as a
priority and, in light of the Company’s evolving strategic priorities, regularly evaluate the Board’s composition, tenure, turnover,
backgrounds, skills, experiences, time commitments, and committee assignments to help cultivate an appropriate balance of skills,
experience, perspectives, and tenure to support the needs of the Company and the Board and to help the Board function effectively.
See “Proxy Statement Summary – Director Nominee Composition Highlights and Skills Matrix” for additional information regarding the
key qualifications, skills, experiences and characteristics considered by the Board and the nominating and governance committee in
nominating our nominees. Since 2023, the Board has gained five new independent directors.
Over a number of years, the Board has appointed directors who have expanded the experiences, areas of substantive expertise, and
geographic and industry breadth of the Board, as illustrated by the information provided in their biographies under “Voting Proposals
– Proposal No. 1: Election of Directors – 2026 Nominees for Director” below.
The Board is also committed to the pursuit of Board refreshment and balanced tenure. The Board believes that new perspectives and
ideas are important to a forward-looking and strategic board, as is the ability to benefit from the valuable experience and familiarity of
longer-serving directors who can leverage their experience with the Company and with the industry and business environment in
which the Company operates. Our corporate governance guidelines do not impose a term limit on Board service; however, the Board
regularly assesses the directors’ tenure mix and strives to maintain an appropriate balance of both fresh perspectives and experience
on the Board. In addition, our corporate governance guidelines impose an age limitation for directors to be nominated to the Board,
as described under “ – Board Nomination Policies and Procedures – Board Membership Criteria” below.
The Board also considers refreshment and tenure with respect to the leadership and membership of its standing committees, and the
nominating and governance committee evaluates short-term and long-term roadmaps for committee membership and leadership on a
regular basis. When reviewing committee assignments, the nominating and governance committee considers the rotation of chairs
and members with a view toward balancing the benefits derived from the diversity of experience and viewpoints of the various
directors. The nominating and governance committee also considers individual directors’ skills, experiences and qualifications, prior
committee experience, and other positions and commitments.
12
-- 24 of 186 --
Director onboarding and education. To help new directors effectively participate in and contribute to the Board as quickly as
possible, we provide a comprehensive orientation and onboarding program for our new directors. Upon joining the Board, new
directors participate in an orientation program that includes introductions to other Board members and our senior management team,
and in-depth learning about our industry, business, technology, operations, culture, people, performance, strategic plans, risk
management, and corporate governance practices, among other topics. The onboarding process may also include tours of one or
more of our manufacturing or lab facilities. First time directors (i.e., those without prior public company board experience) are
encouraged to attend an outside course shortly after joining the Board.
Our Board is also committed to ongoing education. Our corporate governance guidelines provide that directors are expected to
participate in educational events sufficient to maintain their understanding of their duties as directors and to enhance their ability to
fulfill their responsibilities. In addition to any external educational opportunities that the directors find useful, the Company and the
board leadership are expected to facilitate such participation by arranging for appropriate educational presentations from time to time.
In recent years, our Board heard from external advisors on multiple subjects, including industry-related focus areas (such as
advanced packaging and specialty technologies), cybersecurity, employee engagement and retention, crisis management, and the
geopolitical environment.
Board Nomination Policies and Procedures
Board membership criteria. Under our corporate governance guidelines, the nominating and governance committee is responsible
for recommending nominees to the independent directors, and the independent directors nominate the slate of directors for approval
by our stockholders. In making its recommendations, whether for new or incumbent directors, the nominating and governance
committee assesses the appropriate balance of experience, skills, and characteristics required for the Board at the time.
Our corporate governance guidelines set out a non-exclusive list of factors to be considered by the nominating and governance
committee in recommending nominees, which were selected by the Board to promote proper board composition and effectiveness.
These factors are reviewed and updated by the Board on a regular basis. The factors include, but are not limited to:
• experience;
• business acumen;
• wisdom;
• integrity;
• judgment;
• the ability to make independent analytical inquiries;
• the ability to understand the Company’s business environment;
• the candidate’s willingness and ability to devote adequate time to board duties;
• specific skills, background, or experience considered necessary or desirable for board or committee service;
• specific experiences with other businesses or organizations that may be relevant to the Company or its industry;
• the interplay of a candidate’s experiences and skills with those of other Board members; and
• any other attribute(s) the Board considers appropriate.
In addition, our corporate governance guidelines provide that a director may not be nominated for re-election or reappointment to the
Board after having attained the age of 75 years. To be nominated, a new or incumbent candidate must provide an irrevocable
conditional resignation that will be effective upon (1) the director’s failure to receive the required majority vote at an annual meeting at
which the nominee faces re-election and (2) the Board’s acceptance of such resignation.
Upon the recommendations of the nominating and governance committee, the independent members of the Board have nominated
ten of our current directors for re-election to serve on the Board. As previously disclosed in a current report on Form 8-K, Sohail U.
Ahmed and Michael R. Cannon will retire from the Board, effective November 2, 2026, and are not standing for re-election. The size
of the Board will be reduced to 10 directors effective upon the retirement of Messrs. Ahmed and Cannon. The Board would like to
thank Messrs. Ahmed and Cannon for their dedicated service to the Company. Each nominee’s key qualifications, skills, and
attributes considered most relevant to the nomination of the candidate to serve on the Board are reflected in their biography under
“Voting Proposals – Proposal No. 1: Election of Directors – 2026 Nominees for Director” below. For a summary of the key
qualifications, skills, and attributes of the nominees to the Board, see “Proxy Statement Summary – Director Nominee Composition
Highlights and Skills Matrix.”
Nomination procedure. The nominating and governance committee sets specific qualifications for new directors, and identifies,
screens, evaluates, and recommends qualified candidates for appointment or election to the Board. The committee considers
recommendations from a variety of sources, including search firms, Board members, executive officers, and stockholders.
Nominations for election by the stockholders are made by the independent members of the Board. New candidates to join the Board
typically meet with our chair, our lead independent director (if applicable), members of the nominating and governance committee,
additional board members, and our president and chief executive officer (“CEO”), as well as representatives of the Company’s
executive team, prior to being considered for recommendation by the nominating and governance committee for appointment to the
Board. See “Voting Proposals – Proposal No. 1: Election of Directors – 2026 Nominees for Director” below for additional information
regarding the 2026 candidates for election to the Board.
Lam Research Corporation 2026 Proxy Statement 13
-- 25 of 186 --
The nominating and governance committee will consider for nomination persons properly nominated by stockholders in accordance
with the Company’s bylaws and nomination procedures. Our bylaws provide that under certain circumstances, a stockholder, or group
of up to 20 stockholders, who have maintained continuous ownership of at least three percent (3%) of our common stock for at least
three years may nominate and include a specified number of director nominees in our annual meeting proxy statement that cannot
exceed the greater of two or 20% of the aggregate number of directors then serving on the Board (rounded down). Information
regarding the nomination procedures is provided in the “Voting and Meeting Information – Other Meeting Information – Stockholder-
Initiated Proposals and Nominations for 2027 Annual Meeting” section below. Subject to then-applicable law, stockholder nominations
for directors will be evaluated by the Company’s nominating and governance committee in accordance with the same criteria as are
applied to candidates identified by the committee or other sources.
Director Independence Policies
Board independence requirements. Our corporate governance guidelines require that a majority of the Board members be
independent. The nominating and governance committee annually reviews the independence of each director, including with respect
to the Board and each individual committee, and recommends to the Board director independence determinations to be made with
respect to continuing and prospective directors. No director will qualify as “independent” unless the Board affirmatively determines
that the director qualifies as independent under the Nasdaq rules and has no relationship that would interfere with the exercise of
independent judgment as a director. In addition, no non-employee director may serve as a consultant or service provider to the
Company without the approval of a majority of the independent directors (and any such director’s independence must be reassessed
by the full Board following such approval).
Board member independence. The Board has determined that, with the exception of Mr. Archer, all current directors are
independent in accordance with Nasdaq criteria for director independence. In making the determination, the Board considered any
prior employment with the Company, disclosed related party transactions, known familial relationships of directors with employees,
and certain commercial transactions involving other parties, none of which were considered by the Board to interfere with the
exercise of independent judgment as a director or impair independence.
Board committee independence. All members of the Board’s audit, compensation and human resources, and nominating and
governance committees must be independent in accordance with applicable Nasdaq criteria as well as, for compensation and human
resources committee members, non-employee directors in accordance with Rule 16b-3 under the Exchange Act. See “ – Board
Committees” below for additional information regarding these committees.
Lead independent director. Our corporate governance guidelines provide that the Board shall designate a lead independent director
from among the independent members, if the chair is not independent. As described below under “ – Leadership Structure of the
Board,” an independent director, Mr. Talwalkar, currently serves as chair of the Board, and as a result, the Board has not designated a
lead independent director.
Executive sessions of independent directors. The Board and its audit, compensation and human resources, and nominating and
governance committees hold meetings of the independent directors and committee members, without management present, as part
of each regularly scheduled meeting and at any other time at the discretion of the Board or committee, as applicable.
Board access to independent advisors. The Board as a whole, and each standing Board committee separately, has the complete
authority to retain, at the Company’s expense, and terminate, in their discretion, any independent consultants, counselors, or advisors
as they deem necessary or appropriate to fulfill their responsibilities.
Leadership Structure of the Board
The Company’s governance framework provides the Board with the authority and flexibility necessary to select the appropriate
leadership structure for the Board. In making determinations about the leadership structure, the Board considers many factors,
including the specific needs of the business and what is in the best interests of the Company’s stockholders.
Under our corporate governance guidelines, the Board’s leadership structure includes a chair and may also include a separate lead
independent director. Currently, Mr. Talwalkar, an independent director, serves as chair of the Board, and as a result, the Board has
not designated a lead independent director.
The chair’s duties include (1) preparing the agenda for the Board meetings with input from the CEO, the Board, and the committee
chairs; (2) upon invitation, attending meetings of any of the Board committees of which they are not a member; (3) conveying to the
CEO, together with the chair of the compensation and human resources committee, the results of the CEO’s performance evaluation;
(4) reviewing proposals submitted by stockholders for action at meetings of stockholders and, depending on the subject matter,
determining the appropriate body, among the Board or any of the Board committees, to evaluate each proposal, and making
recommendations to the Board regarding action to be taken in response to such proposal; (5) as requested by the Board, providing
reports to the Board on the chair’s activities; (6) coordinating and developing the agenda for, and moderating executive sessions of
the Board’s independent directors; (7) conveying to the CEO, as appropriate, discussions from executive sessions of the Board’s
independent directors; and (8) performing such other duties as the Board may reasonably request from time to time.
14
-- 26 of 186 --
Other Governance Practices
In addition to the principal policies and procedures described above, we have established a variety of other practices that are
intended to promote responsible corporate governance, including the following:
Director resignation or notification of change in executive officer status. Under our corporate governance guidelines, any
director who is also an executive officer of the Company must offer to submit their resignation as a director to the Board if the director
ceases to be an executive officer of the Company. The Board may accept or decline the offer, in its discretion. The corporate
governance guidelines also require a non-employee director to notify the nominating and governance committee if the director
changes or retires from their executive position at another public company. The nominating and governance committee reviews the
appropriateness of the director’s continuing Board membership under the circumstances, and the director is expected to act in
accordance with the nominating and governance committee’s recommendations.
Limitations on director commitments, including other board and committee memberships and leadership. The Board
believes that it is critical that directors dedicate sufficient time to their service on the Board. Under our corporate governance
guidelines, the nominating and governance committee considers a director’s other board and committee leadership positions and
memberships that may affect a director’s ability to contribute effectively to the Board, and evaluates director commitments by
reviewing director time devoted to service on our Board and committees (considering both time spent in Board and committee
meetings and other time commitments outside of meetings), requiring directors to assess their time commitments, and monitoring the
number of directors’ outside directorships and committee memberships, among other items, at least annually. In particular, our
corporate governance guidelines provide that Board members may not serve on more than four public company boards (including
service on the Company’s Board), and non-employee directors who are executive officers at other public companies may not serve
on more than two public company boards (including the Company’s Board), except if a temporary waiver is approved by the chair of
the nominating and governance committee. In addition, non-employee directors may not serve on more than three audit committees
of public company boards (including the Company’s audit committee), unless otherwise approved by the nominating and governance
committee. Finally, the Company’s CEO may not serve on more than one other public company board without obtaining prior
approval of such directorship by the nominating and governance committee. All of our directors are currently in compliance with the
limitations on director commitments in our corporate governance guidelines.
Director and executive stock ownership. Under the corporate governance guidelines, each non-employee director is expected to
own at least five times the value of the annual cash retainer (not including any committee chair or other supplemental retainers for
directors) of Lam common stock, by the fifth anniversary of their initial election to the Board. The value is translated into a number of
shares by dividing the applicable multiple of the annual cash retainer by the average closing price of our common stock for the 30
trading days through the last trading day of the most recently completed fiscal year as of the measurement date. Guidelines for stock
ownership by designated members of the executive management team are described below under “Compensation Matters –
Executive Compensation and Other Information – Compensation Discussion and Analysis.” All of our directors and designated
members of our executive management team were in compliance with the Company’s applicable stock ownership guidelines at the
end of fiscal year 2026 or have a period of time remaining under the guidelines to meet the requirements.
Communications with board members. Any stockholder who wishes to communicate directly with the Board, with any Board
committee, or with any individual director regarding the Company may write to the Board, the committee, or the director c/o Secretary,
Lam Research Corporation, 4650 Cushing Parkway, Fremont, California 94538. Subject to certain exceptions specified in our
corporate governance guidelines, the Secretary will forward communications to the appropriate director(s).
Any stockholder, employee, or other person may communicate any complaint regarding any accounting, internal accounting control,
or audit matter to the attention of the Board’s audit committee by sending written correspondence by mail (to Lam Research
Corporation, Attention: Board Audit Committee, P.O. Box 5010, Fremont, California 94537-5010) or by telephone (855-208-8578) or
internet (through the Company’s third-party provider website at www.lamhelpline.ethicspoint.com). The audit committee has
established procedures for employee complaints or concerns regarding audit or accounting matters to be received and treated
anonymously (if the complaint or concern is submitted anonymously and if permitted under applicable law).
Meeting Attendance
Our Board held a total of five meetings during fiscal year 2026. The number of committee meetings held is shown below under “ –
Board Committees”. All of the directors attended at least 75% of the aggregate number of Board meetings and meetings of Board
committees on which they served during their tenure in fiscal year 2026.
We expect our directors to attend the annual meeting of stockholders each year unless unusual circumstances make attendance
impractical. All of the individuals who were directors as of the 2025 annual meeting of stockholders attended that meeting.
Board Committees
The Board has four standing committees: an audit committee, a compensation and human resources committee, a nominating and
governance committee, and an innovation and technology committee. The functions, membership, and charter of each are described
below. Copies of each committee’s charter are available on our website at investor.lamresearch.com/corporate-governance.
Lam Research Corporation 2026 Proxy Statement 15
-- 27 of 186 --
9*/8422/88++
.6+.;<129;2,;*7-=1*2;=*;.77*781727..7*7-.=1*7B*B.;
..=270<1.5-27/2<,*5B.*; %.7
(;OH;IFEDI?8?B?J?;I
Z EL;HI;;J>; ECF7DOWI799EKDJ?D=7D:<?D7D9?7BH;FEHJ?D=FHE9;II;I ?D:;F;D:;DJ7K:?JEHI?D9BK:?D=8O97HHO?D=EKJ7D
7II;IIC;DJE<J>;?HGK7B?<?97J?EDI7D:?D:;F;D:;D9; ?DJ;HD7B7K:?JFHE=H7C 7D:J>;7K:?JIE<?JI<?D7D9?7BIJ7J;C;DJI
Z EL;HI;;J>; ECF7DOWI?DL;IJC;DJFEB?9?;I7D:F;H<EHC7D9;
Z H;L?;MJ>; ECF7DOWI>;:=?D=IJH7J;=O7D:J7NIJH7J;=?;I
Z EL;HI;;J>; ECF7DOWI;J>?9I7D:9ECFB?7D9;FHE=H7C
Z EL;HI;;J>; ECF7DOWI9O8;HI;9KH?JO7D:?D<EHC7J?EDI;9KH?JOFEB?9?;I7D:?DJ;HD7B9EDJHEBI
Z EL;HI;;C7D7=;C;DJWI?CFB;C;DJ7J?ED7D:C7?DJ;D7D9;E<?DJ;HD7B9EDJHEBEL;H799EKDJ?D=7D:<?D7D9?7BH;FEHJ?D=7D:E<
H;FEHJ?D=IOIJ;CI7D:FHE9;:KH;I:;I?=D;:JE?:;DJ?<OC7J;H?7BC?IIJ7J;C;DJI?D<?D7D9?7BH;FEHJ?D= M>;J>;H:K;JE;HHEHEH
<H7K: ?D9BK:?D=J>;H;L?;ME<7DOC7J;H?7B9>7D=;IJEJ>;IOIJ;CE<?DJ;HD7B9EDJHEBEL;H<?D7D9?7BH;FEHJ?D=
Z H;L?;M7D:CED?JEHH?IA7IIE9?7J;:M?J>J>; ECF7DOWI? ?DL;IJC;DJFEB?9O7D:?JI?DL;IJC;DJFEHJ<EB?EF;H<EHC7D9; ??
9EKDJ;HF7HJOH?IA ?D9BK:?D=J>;<?D7D9?7BFEI?J?EDE<A;O9EKDJ;HF7HJ?;I ?D9BK:?D=A;O9KIJEC;HI 7D:??? :;8J7D:87DA?D=
9EL;D7DJI B?GK?:?JO 7L7?B78B;9H;:?JKD:;HH;LEBL?D=EHEJ>;HB?D;IE<9H;:?J 7D:799;IIJE<?D7D9?D=
Z H;L?;M7D:7FFHEL;J>; ECF7DOWI?DI?:;HJH7:?D=FEB?9O ?D9BK:?D=7C;D:C;DJI7D:9>7D=;IJ>;H;JE
Z H;L?;MJ>; ECF7DOWI;7HD?D=IFH;IIH;B;7I;I 7IM;BB7I<?D7D9?7B?D<EHC7J?ED7D:;7HD?D=I=K?:7D9;FHEL?:;:J>;H;?D
Z H;L?;M7D:EL;HI;;FEJ;DJ?7BH;B7J;:F7HJO7D:9ED<B?9JE<?DJ;H;IJI?JK7J?EDI JH7DI79J?EDIH;GK?H;:JE8;:?I9BEI;:FKHIK7DJJE
&J;CE</;=KB7J?ED0 (E<J>;0" 7D:7DOEJ>;HJH7DI79J?ED?DLEBL?D=7D;N;9KJ?L;EHE7H:C;C8;H 7D: 7I
7FFHEFH?7J; 7FFHEL;EHH7J?<OIK9>JH7DI79J?EDI7D:
Z EL;HI;;? J>;:;J;HC?D7J?EDE<M>;J>;H7D799EKDJ?D=H;IJ7J;C;DJ?IH;GK?H;::K;JEJ>;C7J;H?7BDED9ECFB?7D9;E<J>;
ECF7DOM?J>7DO<?D7D9?7BH;FEHJ?D=H;GK?H;C;DJKD:;HJ>;I;9KH?J?;IB7MI7D:?? J>;FH;F7H7J?EDE<J>; ECF7DOWI
799EKDJ?D=H;IJ7J;C;DJIJE9EHH;9JIK9>DED9ECFB?7D9;
1>;E7H:9ED9BK:;:J>7J7BBC;C8;HIE<J>;7K:?J9ECC?JJ;;7H;?D:;F;D:;DJ?D799EH:7D9;M?J>J>;+7I:7GB?IJ?D=IJ7D:7H:I7D:
0" HKB;I<EH7K:?J9ECC?JJ;;C;C8;H?D:;F;D:;D9;#KHJ>;HCEH; ;79>C;C8;H?I78B;JEH;7:7D:KD:;HIJ7D:<KD:7C;DJ7B
<?D7D9?7BIJ7J;C;DJI7IH;GK?H;:8OJ>;+7I:7GB?IJ?D=IJ7D:7H:I 7D:J>;E7H:>7I:;J;HC?D;:J>7J*HH7D:J7D:*IIH;DD7D
7D:*7O;H7H;;79>7DX7K:?J9ECC?JJ;;<?D7D9?7B;NF;HJY7I:;<?D;:?DJ>;0" HKB;I
425+37'8/43'3*92'3+7496)+7422/88++
.6+.;<129 2,1*.5#*7787*;42.5-<B8=2.1;*1*2;*7-+1232=)%*5@*54*;
..=270<1.5-27/2<,*5B.*; 2?.
(;OH;IFEDI?8?B?J?;I
Z H;L?;M7D:7FFHEL;J>; ECF7DOWI;N;9KJ?L;E<<?9;H9ECF;DI7J?EDF>?BEIEF>O E8@;9J?L;I 7D:IJH7J;=?;I
Z H;9ECC;D:JEJ>;?D:;F;D:;DJC;C8;HIE<J>;E7H:9EHFEH7J;=E7BI7D:E8@;9J?L;IKD:;HEKH9ECF;DI7J?EDFB7DI
Z H;9ECC;D: 87I;:EDJ>;E7H:WIF;H<EHC7D9;;L7BK7J?EDE<J>; ", JEJ>;?D:;F;D:;DJC;C8;HIE<J>;E7H:
9ECF;DI7J?EDF79A7=;I7D:9ECF;DI7J?EDF7OEKJI<EHJ>; ", 7D:7FFHEL;J>;9ECF;DI7J?EDF79A7=;I7D:9ECF;DI7J?ED
F7OEKJI<EHEKHEJ>;H;N;9KJ?L;E<<?9;HI
Z EL;HI;;?D9;DJ?L; ;GK?JO 87I;:FB7DI 7D:EJ>;H9ECF;DI7JEHOFB7DI?DM>?9>EKH;N;9KJ?L;E<<?9;HI7D:EH:?H;9JEHI
F7HJ?9?F7J;
Z 7FFHEL;J>;9ECC?JJ;;H;FEHJED;N;9KJ?L;9ECF;DI7J?ED<EH?D9BKI?ED 7IH;GK?H;: ?DEKH7DDK7BH;FEHJ7D:FHENOIJ7J;C;DJ
Z EL;HI;;C7D7=;C;DJWI:;J;HC?D7J?ED7IJEM>;J>;HEKH9ECF;DI7J?EDFEB?9?;I7D:FH79J?9;I ?D9BK:?D=J>EI;H;B7J;:JEF7O
;GK?JOB7MI 9H;7J;H?IAIJ>7J7H;H;7IED78BOB?A;BOJE>7L;7C7J;H?7B7:L;HI;;<<;9JEDJ>; ECF7DO7D:
Z :?I9>7H=;9;HJ7?DH;IFEDI?8?B?J?;IE<J>;E7H:M?J>H;IF;9JJEEH=7D?P7J?ED7D:F;EFB;C7JJ;HI ?D9BK:?D=;N;9KJ?L;IK99;II?ED
FB7DD?D= ;CFBEO;;;D=7=;C;DJFHE=H7CI 7D:7II?IJ?D=J>;E7H:?DEL;HI;;?D=;DL?HEDC;DJ7B IE9?7B7D:=EL;HD7D9;
C7JJ;HIH;B7J?D=JEEKHMEHA<EH9;
1>;E7H:9ED9BK:;:J>7J;79>E<*?9>7;B/ 7DDED D?HK:>!;L=7D *7HA#?;B:I 'OEJ?(*;>H7 7D:8>?@?J617BM7BA7H?I
?D:;F;D:;DJ?D799EH:7D9;M?J>J>;+7I:7GB?IJ?D=IJ7D:7H:I7D:0" HKB;I<EH9ECF;DI7J?ED9ECC?JJ;;C;C8;H?D:;F;D:;D9;7D:
7DED ;CFBEO;;:?H;9JEH?D799EH:7D9;M?J>/KB;8 KD:;HJ>;"N9>7D=;9J
"<<;9J?L;+EL;C8;H J>;C;C8;HIE<J>;9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;M?BB8;D?HK:>!;L=7D *7HA#?;B:I 'OEJ?(
*;>H7 >7?H 7D:8>?@?J617BM7BA7H
-- 28 of 186 --
42/3'8/3-'3*4:+63'3)+422/88++
.6+.;<129 ;2,;*7-=2,1*.5#*77871*2;.=1*7B*B.;*7-+1232=)%*5@*54*;
..=270<1.5-27/2<,*5B.*; 8>;
(;OH;IFEDI?8?B?J?;I
Z ?:;DJ?<O?D:?L?:K7BIGK7B?<?;:JEI;HL;7IC;C8;HIE<J>;E7H:7D:H;9ECC;D:DEC?D;;I<EH;B;9J?ED7I:?H;9JEHI
Z H;9ECC;D:9ECC?JJ;;C;C8;HI>?F7D:B;7:;HI>?F7II?=DC;DJI
Z H;L?;MEKH9EHFEH7J;=EL;HD7D9;=K?:;B?D;I7D:EJ>;H=EL;HD?D=:E9KC;DJI7D:H;9ECC;D:7C;D:C;DJIJEJ>;E7H:
Z EL;HI;;I;B< ;L7BK7J?EDIE<J>;E7H: 9ECC?JJ;;I 7D:?D:?L?:K7B:?H;9JEHI
Z 7II?IJJ>;E7H:?DEL;HI;;?D=;DL?HEDC;DJ7B IE9?7B7D:=EL;HD7D9;C7JJ;HIDEJ7II?=D;:JEEJ>;H9ECC?JJ;;I ?D9BK:?D=EKH
EL;H7BBIJH7J;=O7D:=E7BIM?J>H;IF;9JJEIK9>C7JJ;HI IKIJ7?D78?B?JO?D?J?7J?L;I 9B?C7J; H;B7J;:=E7BI 7D: ?D;79>?DIJ7D9;
EKHFHE=H;IIJEM7H:79>?;L?D=J>EI;=E7BI 7IM;BB7I?JIH;B7J;:H;FEHJ?D=
Z EL;HI;;J>; ECF7DOWIFEB?J?97B79J?L?J?;I7D:H;L?;MEKHFEB?9OH;=7H:?D=FEB?J?97B9EDJH?8KJ?EDI7D:IF;D:?D=
Z :;L;BEF 7II;II 7D:C7A;H;9ECC;D:7J?EDIJEJ>;E7H:9ED9;HD?D=9EHFEH7J;=EL;HD7D9;C7JJ;HI
Z H;L?;MJ>;?D:;F;D:;D9;E<J>;E7H:7D:?JI9ECC?JJ;;I7D:H;9ECC;D::?H;9JEH?D:;F;D:;D9;:;J;HC?D7J?EDIJEJ>;E7H:
Z CED?JEH7D:;L7BK7J;J>;;:K97J?ED7BD;;:IE<:?H;9JEHI7D:C7A;H;9ECC;D:7J?EDIJEJ>;E7H:M>;H;7FFHEFH?7J;7D:
Z 7:C?D?IJ;HJ>;FHE9;II<EH:?H;9JEH97D:?:7J;IDEC?D7J;:8OIJE9A>EB:;HI
1>;E7H:9ED9BK:;:J>7J;79>E<"H?9(H7D:J *?9>7;B/ 7DDED'E>D!?D;;D ;J>7DO'*7O;H 7D:8>?@?J617BM7BA7H?I
?D:;F;D:;DJ?D799EH:7D9;M?J>J>;+7I:7GB?IJ?D=IJ7D:7H:I<EH:?H;9JEH?D:;F;D:;D9;
334:'8/43'3*!+).3414-=422/88++
.6+.;<129 $81*25&16.-72;>-1.?0*7 8B>*701*2;.=1*7B*B.;*7-+1232=)%*5@*54*;
..=270<1.5-27/2<,*5B.*; 8>;
(;OH;IFEDI?8?B?J?;I
Z 7II?IJJ>;E7H:?DEL;HI;;?D=J>; ECF7DOWIC7D7=;C;DJE<H?IAI7IIE9?7J;:M?J>J>;I9EF; :?H;9J?ED 7D:GK7B?JOE<J>;
ECF7DOWIC7@EHJ;9>DEBE=OFB7DI7D:IJH7J;=?;I ?D9BK:?D=?JIH;I;7H9>7D::;L;BEFC;DJX/!Y FHE=H7CI 97F78?B?J?;I 7D:
79J?L?J?;I B;L;BIE<?DL;IJC;DJ 9ECF;J?J?L;FEI?J?ED?D=7D:?DJ;BB;9JK7BFHEF;HJOFHEJ;9J?ED 7D:J>;J;9>D?97B C7HA;J 7D:
8KI?D;IIH?IAI7IIE9?7J;:M?J>FHE:K9J:;L;BEFC;DJ7D:?DL;IJC;DJ
Z H;L?;M7D:7II;IIJ>;F;H<EHC7D9; FHE=H;II 7D:;<<;9J?L;D;IIE<J>; ECF7DOWI;N;9KJ?EDE<?JIJ;9>DEBE=OIJH7J;=?;I7D:
Z 7II?IJJ>;E7H:?DEL;HI;;?D=J>; ECF7DOWIC7D7=;C;DJE<H?IAI7IIE9?7J;:M?J>;N?IJ?D=7D:<KJKH;JH;D:I?DJ;9>DEBE=O
7D:H;B;L7DJC7HA;JIJ>7JC7O7<<;9JJ>; ECF7DOWIFB7DI7D:IJH7J;=?;I
9+<.I=$96/+8.81+1/7/8>
*3*7&1 1>;E7H:EL;HI;;IJ>;C7D7=;C;DJE<J>;8KI?D;II7D:7<<7?HIE<J>; ECF7DO&DJ>?IEL;HI?=>JHEB; J>;E7H:I;HL;I
7IJ>;KBJ?C7J;:;9?I?ED C7A?D=8E:OE<J>; ECF7DO ;N9;FJ<EHJ>EI;C7JJ;HIH;I;HL;:<EHJ>;IJE9A>EB:;HIE7H:7=;D:7I
<79?B?J7J;:?7BE=K;8;JM;;DJ>;E7H:7D:C7D7=;C;DJH;=7H:?D=:H?L;HIE<BED= J;HCIJE9A>EB:;HL7BK;7D:A;OIJH7J;=?97D:
EF;H7J?ED7BH?IAI1>;E7H:WI7D:?JI9ECC?JJ;;IW7=;D:7I?D9BK:;8EJ>H;=KB7H H;9KHH?D=JEF?9I7IM;BB7IJ?C;<EHIF;9?7B7=;D:7
JEF?9IJ>7J7H;I9>;:KB;:ED7D7I D;;:;:87I?I8OJ>;E7H:EH9ECC?JJ;;9>7?HI 7I7FFB?978B;
1>;E7H:7D:?JI9ECC?JJ;;I>7L;J>;FH?C7HOH;IFEDI?8?B?J?;I<EH
Z EL;HI;;?D=J>; ECF7DOWI8KI?D;IIIJH7J;=?;I 7D:7FFHEL?D=J>; ECF7DOWI97F?J7B7BBE97J?EDFB7DI7D:FH?EH?J?;I 7DDK7B
EF;H7J?D=FB7D 7D:C7@EH9EHFEH7J;79J?EDI7II;J<EHJ>?DJ>;8;BEMIK8 8KBB;JI
\ 7IJH7J;=?9FB7D?IFH;I;DJ;:JEJ>;E7H:<EH:?I9KII?EDED7D7DDK7B87I?I
\ 7DEF;H7J?D=FB7D?IFH;I;DJ;:JEJ>;E7H:<EH:?I9KII?EDED7D7DDK7B87I?I 7D:KF:7J;I7H;FH;I;DJ;:7J;79>
GK7HJ;HBOE7H:C;;J?D=7D:
\ 97F?J7B7BBE97J?EDFB7DI7D:FH?EH?J?;I7D:EJ>;HC7@EH9EHFEH7J;79J?EDI7H;FH;I;DJ;:7D::?I9KII;:7IF7HJE<H;=KB7H
C7D7=;C;DJKF:7J;I7D:7IIF;9?7B7=;D:7JEF?9I 7I7FFHEFH?7J;
Z 7FFE?DJ?D= 7DDK7BBO;L7BK7J?D=J>;F;H<EHC7D9;E< 7D:7FFHEL?D=J>;9ECF;DI7J?EDE< EKH ",
Z H;L?;M?D=M?J>EKH ",J>;F;H<EHC7D9;E<J>; ECF7DOWIEJ>;H;N;9KJ?L;E<<?9;HI7D:7FFHEL?D=J>;?H9ECF;DI7J?ED
Z H;L?;M?D=7D:7FFHEL?D= ",7D:JEFB;7:;HI>?FIK99;II?EDFB7DD?D=
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
"<<;9J?L;+EL;C8;H J>;C;C8;HIE<J>;DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;;M?BB8;"H?9(H7D:J 'E>D!?D;;D ;J>7DO'*7O;H
9>7?H 7D:8>?@?J617BM7BA7H
"<<;9J?L;+EL;C8;H J>;C;C8;HIE<J>;?DDEL7J?ED7D:J;9>DEBE=O9ECC?JJ;;M?BB8;D?HK:>!;L=7D %E(OK(7D=9>7?H ;J>7DO'
*7O;H 7D:8>?@?J617BM7BA7H
!H!;L=7D@E?D;:J>;9ECC?JJ;;ED#;8HK7HO
-- 29 of 186 --
• advising and mentoring the Company’s senior management;
• overseeing the Company’s internal control over financial reporting and disclosure controls and procedures;
• overseeing the Company’s material risks and enterprise risk management processes and programs, with critical enterprise
risks presented to the full Board at least annually;
• overseeing the Company’s ethics and compliance programs, including the Company’s code of ethics, with updates presented
to Board annually and to the audit committee or Board quarterly;
• overseeing the Company’s information security programs (including cybersecurity), with updates presented to the Board
annually and to the audit committee or Board quarterly;
• overseeing the Company’s human capital management, with updates presented to the compensation and human resources
committee quarterly and to the full Board annually;
• overseeing the Company’s environmental, health, and safety (“EHS”) program, with updates presented to the full Board
annually;
• overseeing environmental, social and governance matters, with quarterly updates on our program and performance provided
to the nominating and governance committee, and the Company’s strategy, goals and performance presented to, and its
related reporting reviewed by, the full Board annually; and
• overseeing the Company’s political activities, with updates presented quarterly to the nominating and governance committee
and annually to the full Board.
Risk Oversight. Effective and comprehensive risk management is critical to our success, given the dynamic economic, geopolitical,
technological (including AI), and social landscape in which we operate. Our Board is actively engaged in risk oversight both directly
and through its committees. As a general matter, the Board exercises its oversight responsibility directly, including by overseeing
management’s implementation of our Enterprise Risk Management (“ERM”) program. Our process for identifying, assessing, and
managing emerging and evolving areas of risk, such as AI, is integrated into our ERM program. In addition, the Board delegates
oversight of certain risks to its various committees as further detailed below. The Board and, as applicable, each of its committees,
oversee our risk profile by regularly reviewing management’s assessment of the Company’s material risks and evaluating
management’s risk mitigation strategies.
Our ERM program is an enterprise-wide program designed to leverage existing management processes to enable effective
identification of critical enterprise risks, design and implementation of appropriate risk mitigation strategies, and regular assessment
of the status of risks and mitigation plans. The ERM program (i) establishes a comprehensive, enterprise-wide system to identify,
evaluate, manage, and report risks, (ii) clearly defines management’s roles and responsibilities by allocating responsibility for specific
risks to specific members of our senior management team, and (iii) facilitates dialogue between senior management and the Board
regarding the Company’s top risks. The ERM program also complements and works in parallel with our Business Continuity
Management System with respect to the management of risks that have the potential to disrupt our business operations.
As part of the ERM framework, our management team seeks to create a comprehensive index of the Company’s top enterprise risks
by gathering information and input regarding specific categories of risk from designated individuals representing each of the
Company’s business units on a quarterly basis. The ERM process involves the identification and ranking of the Company’s top risks,
as well as an assessment of the interactions among those risks. The imminence and timeframe of each relevant enterprise risk
informs, in part, the relevant risk mitigation strategy and response time. Further, risks are evaluated based on their likelihood and
impact, and appropriate risk mitigation strategies are designed based on such evaluation. On an as needed basis, we employ outside
advisors to aid in assessing specific risks, provide benchmarking data, or provide information regarding trends or recent regulatory
changes applicable to the Company’s risk profile. In calendar year 2026, management placed particular emphasis on evaluating risks
and opportunities associated with AI and addressing them appropriately through the Company’s ERM program.
Our chief legal officer (“CLO”), who reports to the chief executive officer, has overall responsibility for the ERM program. The CLO is
responsible for coordinating the annual ERM risk reviews. Further, our CLO and/or the relevant risk owners provide the Board with
annual reports regarding the critical enterprise risks, including an assessment of the likelihood and impact of each identified risk and
related risk mitigation strategies. Updates on critical risks are also provided through regular reports to the Board related to the
Company’s business operations, strategy, and financial results. In addition, our chief information security officer and chief compliance
officer provide quarterly reports to the Audit Committee on relevant information security and compliance issues, respectively, and
annually report to the Board regarding the Company’s information security and ethics and compliance programs. Further, members of
our Internal Audit function provide the Audit Committee with quarterly reports regarding the effectiveness and adequacy of the
Company’s controls, risk management, compliance, financial reporting, and governance processes.
In specific cases, the Board has delegated its risk oversight responsibility to committees of the Board based on each committees’
respective areas of responsibility and expertise, as described in further detail above in “ – Board Committees” and in the charters of
the respective committees. Committees that have been charged with risk oversight regularly report to the Board on those risk matters
within their areas of responsibility. Risk oversight responsibility has been allocated between the Board and its committees as
summarized in the following figure and described in more detail below.
18
-- 30 of 186 --
Risk Oversight
Information Security (including Cybersecurity) Oversight. Our Board recognizes the significant role of information security in
safeguarding our valuable intellectual property, along with the confidentiality, integrity, and availability of the data of our customers,
employees, and suppliers. The Board is responsible for overseeing our strategy and approach to addressing information security
risks, including the management and assessment of risks from cybersecurity threats, both directly and through the audit committee.
The audit committee is responsible for reviewing and monitoring the Company’s cybersecurity and information security policies and
its internal controls regarding cybersecurity and information security. In addition, the audit committee is responsible for regularly
reporting to the Board on the substance of such reviews and, as necessary, recommending to the Board such actions as it deems
appropriate. Our chief information security officer (“CISO”) reports on information security risks at least annually to the Board and
quarterly to the audit committee or Board.
In addition, we have implemented processes, which are integrated into the Company’s ERM program, for the identification,
assessment, and management of material risks from cybersecurity threats. Our CISO, who has over 30 years of experience in
information security and technology leadership, has primary responsibility for (i) leading our global information security program, (ii)
managing the cybersecurity risks identified as part of the ERM program, and (iii) developing, implementing, and enforcing security
policies and maintaining information security systems.
A key component within our ERM framework is a robust information security risk management program, which includes:
• risk assessments designed to help identify risks to our critical systems, information, services, and our broader global
information systems environment;
• a security team principally responsible for managing (i) our cybersecurity risk assessment processes, (ii) our security controls,
and (iii) our response to cybersecurity incidents;
• the use of external service providers, where appropriate, to aid in assessing specific risks, provide benchmarking data, provide
information regarding trends or recent regulatory changes applicable to our risk profile, or to test or otherwise assist with
aspects of our security processes;
• the periodic engagement of an independent third-party expert to evaluate our security capabilities;
• mandatory annual cybersecurity awareness training of our employees, including incident response personnel and senior
management, as well as conducting periodic tests with our user population to reinforce good information security practices;
• a cybersecurity incident response plan that includes procedures for responding to cybersecurity incidents, including those
impacting the Company’s manufacturing sites;
• processes to identify vulnerabilities, breach attempts, and possible criminal activity by external parties; and
Lam Research Corporation 2026 Proxy Statement 19
-- 31 of 186 --
• processes to assess the practices of our suppliers and third-party service providers relative to protecting the security of our
information.
Additionally, the Company holds International Organization for Standardization 27001-2022 certification for information security at our
corporate headquarters. For further details about our information security oversight, please see our 2026 Annual Report.
Political Activity Oversight. Engagement in the political and public policy process is essential to the Company’s strategic priorities
and serves the interests of its stockholders and employees. Our nominating and governance committee oversees the Company’s
political activities for alignment with Company policy. The committee is also responsible for reviewing the Company’s policy regarding
political activities, and for reviewing payments to trade associations and other third parties that may be used for political or lobbying
purposes. Our political activities are led by our Corporate Vice President of Global Trade and Government Affairs (“GTGA”), who is
responsible for reporting to the full Board at least annually, and to the nominating and governance committee at least quarterly on the
Company’s political activities, which includes a review as necessary of updates to the Company’s policy regarding political activities
and payments to trade associations and other third parties that may be used for political or lobbying purposes.
Our GTGA group plays a central role in helping us navigate export control requirements and works closely with our leadership to
facilitate a compliant, proactive response to new requirements. Externally, the GTGA group plays a leading role in industry efforts to
amplify our voice in the wafer fabrication equipment industry and larger semiconductor ecosystem.
We have also established an employee-funded political action committee, Leading American Microelectronics Political Action
Committee (“LAMPAC”). Using voluntary contributions from eligible employees, LAMPAC supports candidates whose policy goals
align with our advocacy agenda. To promote proper administration of the LAMPAC and to maintain compliance with federal regulatory
requirements, only authorized GTGA personnel are involved in LAMPAC’s operations. The political action committee files routine
public disclosures of its activity with the Federal Election Commission.
As a matter of company policy, we do not make direct political contributions of any kind to political parties, candidates, or political
committees, nor do we make payments to influence the outcome of ballot measures, engage in independent political expenditures in
direct support of or opposition to candidates, or engage in indirect political spending, such as through our supply chain, consultants,
or third-party organizations, including 501(c)(4) or 527 entities. For more details regarding our political activities, please refer to our
public policy engagement and political activity statement located on the Investors section of our website at investor.lamresearch.com/
corporate-governance.
Stockholder Engagement
We believe that engagement with our stockholders is an important part of effective corporate governance. Our senior management,
including our president and CEO, chief financial officer, and members of our Investor Relations team, maintain regular contact with a
broad base of investors through quarterly earnings calls, meetings, investor day events, industry conferences, and other investor and
industry events. Through these interactions, over the course of calendar year 2025, senior management and Investor Relations met
with stockholders collectively holding approximately 47% of our shares (based on averaged quarterly holdings, as reported by
investors to the SEC). In addition, we engage with major stockholders on governance, executive compensation, environmental and
social topics of interest to them. This outreach is generally conducted outside of our proxy solicitation period and, depending on the
topics, includes members of our Investor Relations, Human Resources, Legal, and other functions, and may also include members of
the Board. During the proxy solicitation period, we may also engage with our stockholders about topics to be addressed at our annual
meeting of stockholders. Our process for engaging with stockholders on governance topics and annual meeting proposals is
illustrated below.
Stockholder Governance Engagement Cycle
Through these engagements, we receive valuable input from our stockholders, which helps us evaluate key initiatives from additional
perspectives. We share the opinions and information received from our stockholders with the Board. Over the last few years, we have
heard from stockholders about their views on subjects such as executive compensation, environmental, social, and governance goals
20
-- 32 of 186 --
and related progress, culture, leadership transitions, returning capital to stockholders, director tenure, board refreshment and
composition, director skills and experiences, director time commitments, stockholders’ right to call special meetings, political activities,
AI, geopolitical considerations, and supply chain management. Understanding the feedback shared with us, we have maintained our
focus on board composition and refreshment based on skills and experiences, workforce culture, pay for performance, and risk
oversight. In addition, we have added additional areas of board oversight, including oversight over political activities, augmented the
Board’s oversight of technology strategy and risk through the creation of the board innovation and technology committee, enhanced
our proxy statement and annual Global Impact report disclosures, and amended our bylaws to enable stockholders who have owned
at least 20% of the outstanding shares of our common stock continuously for at least one year to call a special meeting of
stockholders.
We engaged in extensive stockholder outreach on governance topics and annual meeting proposals in 2025 during the proxy
solicitation period, as illustrated below. We have also summarized our governance outreach efforts and described the topics
discussed below:
Lam Research Corporation 2026 Proxy Statement 21
-- 33 of 186 --
%>9-5296./<9@/<8+8-/"?></+-2%?77+<C
,@A:4D /92EH6962C57C@>@FCDE@4<9@=56CD:? 'FC(6CDA64E:G6 @HH6C6DA@?565
@2C5
@>A@D:E:@?
2?5
@G6C?2?46
0JE9A>EB:;HI9EDJ?DK;:JE;NFH;IIFEI?J?L;<;;:879AED
EKHEL;H7BB=EL;HD7D9;FH79J?9;I ?D9BK:?D=E7H:
9ECFEI?J?ED IJHK9JKH; H;<H;I>C;DJ J>;E7H:WI
7FFHE79>JE9EDI?:;H?D=:?H;9JEHIA?BBI7D:;NF;H?;D9;I
7D:EKH=EL;HD7D9;:?I9BEIKH;IDKC8;HE<
IJE9A>EB:;HI9ECCKD?97J;:7FH;<;H;D9;JEH;L?I?JEH
BEM;HJ>;EMD;HI>?FJ>H;I>EB:H;GK?H;:<EHIJE9A>EB:;HI
JE97BB7IF;9?7BC;;J?D= 7D:7FFHEN?C7J;BOE<
LEJ;I97IJ7JEKH7DDK7BC;;J?D=LEJ;:?D<7LEHE<
7IJE9A>EB:;HFHEFEI7BH;GK;IJ?D=J>; ECF7DOJE
BEM;HJ>;EMD;HI>?FJ>H;I>EB:<EHEKH;N?IJ?D=
IJE9A>EB:;HH?=>JJE97BB7IF;9?7BC;;J?D=<HECJE
IC7BBDKC8;HE<IJE9A>EB:;HIH;?J;H7J;:
;NF;9J7J?EDI<EH>?=>;HB;L;BE<=;D:;H:?L;HI?JO0EC;
IJE9A>EB:;HI>7L;CEH;IJH?D=;DJEL;H8E7H:?D=FEB?9?;I
;IF;9?7BBO<EH8E7H:9>7?HI
,KHE7H:9EDI?:;H;:J>;LEJ?D=H;IKBJIE<EKH
7DDK7BC;;J?D=7D:J>;H;B7J;:IJE9A>EB:;H<;;:879A
7D:9EDJ?DK;IJE8;B?;L;7EMD;HI>?FJ>H;I>EB:
JE=;J>;HM?J>7ED; O;7H>EB:?D=F;H?E: <EH97BB?D=7
IF;9?7BC;;J?D=?I?DJ>;8;IJ?DJ;H;IJIE<IJE9A>EB:;HI
4;7BIE9EDJ?DK;:JEH;<H;I>EKHE7H:9ECFEI?J?ED
M?J>7<E9KIEDC7?DJ7?D?D=E7H:;<<;9J?L;D;II8O
7::?D=7D;M:?H;9JEH?DM?J>IJHED=B;7:;HI>?F
<?D7D9?7B 7D:?D:KIJHO;NF;H?;D9;4;9EDJ?DK;JE
CED?JEH;LEBL?D=IJE9A>EB:;H;NF;9J7J?EDI H;=KB7JEHO
:;L;BEFC;DJI 7D:F;;HFH79J?9;I7IM;;L7BK7J;
M>;J>;HEKHE7H:9ECFEI?J?ED7D:I;HL?9;B?C?J7J?EDI
H;C7?D7FFHEFH?7J;
?G:C@?>6?E2=
+@4:2=2?5
F>2?2A:E2=
'G6CD:89E
0JE9A>EB:;HIFHEL?:;:<7LEH78B;<;;:879AEDEKH"0$
IJH7J;=O ?D?J?7J?L;I 7D::?I9BEIKH;I0EC;IJE9A>EB:;HI
;NFH;II;:?DJ;H;IJ?DEKHFHE=H;IIJEM7H:EKH09EF;
7D:;C?II?EDI=E7BI ?D9BK:?D=EKH;C?II?EDI
H;:K9J?EDI 9KIJEC;H7D:IKFFB?;H;D=7=;C;DJ 7D:
7:L7D9;C;DJE<I9?;D9; 87I;:J7H=;JI 7IM;BB7IEKH
H;D;M78B;;D;H=O=E7BI7D:M7J;HH?IAC7D7=;C;DJ
4;9EDJ?DK;JEC7A;FHE=H;IIEDEKH9B?C7J;7D:
IKIJ7?D78?B?JO=E7BI 7II;IIEFFEHJKD?J?;IJE;D>7D9;
:?I9BEIKH;I 7D:;D=7=;M?J>IKFFB?;HI7D:?D:KIJHO
F7HJD;HIED;C?II?EDIH;:K9J?ED H;IFEDI?8B;IEKH9?D=
7D:M7J;HIJ;M7H:I>?F#EH<KHJ>;H?D<EHC7J?ED FB;7I;
I;;EKH$BE87B&CF79JH;FEHJ<EH97B;D:7HO;7H
7L7?B78B;EDEKHM;8I?J;7J5*6;.<.*;,1,86,869*7B
.7?2;876.7=*5<8,2*5*7-08?.;7*7,.
!@G6C?2?46
2?5'G6CD:89E
0EC;IJE9A>EB:;HI7IA;:GK;IJ?EDIH;=7H:?D=&H?IAI
7D:EFFEHJKD?J?;I F7HJ?9KB7HBOH;B7J;:JEFHE:K9J
?DDEL7J?ED E7H:EL;HI?=>JE<& 7D:?DJ;HD7B
7FFB?97J?EDIE<&JEEBI
4;;NF7D:;:EKH:?I9KII?EDE<H?IAEL;HI?=>J?DJ>?I
FHENOIJ7J;C;DJJE7BIE7::H;II&7D:M?BB9EDJ?DK;JE
CED?JEHJ>;H;=KB7JEHOB7D:I97F; J;9>DEBE=?97B
:;L;BEFC;DJI 7D:F;;HFH79J?9;IJE;LEBL;EKH&
=EL;HD7D9;<H7C;MEHA H?IAEL;HI?=>J7FFHE79> 7D:
:?I9BEIKH;I,KH$BE87B&CF79JH;FEHJ7BIE?D9BK:;I
:?I9BEIKH;IH;=7H:?D=J>; ECF7DOWI=K?:;B?D;I<EHJ>;
KI;E<=;D;H7J?L;&JEEBI?DJ>;MEHAFB79;
*:D<'G6CD:89E 0EC;IJE9A>EB:;HI;NFH;II;:?DJ;H;IJ?DH?IAIH;B7J;:JE
;NFEHJ9EDJHEBI IKFFBO9>7?DH;I?B?;D9; 7D:=;EFEB?J?9I
?D9BK:?D=J>;E7H:WIEL;HI?=>JE<J>;I;H?IAI
,KHE7H:8;D;<?JI<HECI?=D?<?97DJ=BE87BC7DK<79JKH?D=
7D:IKFFBO9>7?DC7D7=;C;DJ;NF;H?;D9; IKFFEHJ?D=
EL;HI?=>JE<;NFEHJ 9EDJHEB9ECFB?7D9; IKFFBO9>7?D
H;I?B?;D9; 7D:=;EFEB?J?97BH?IAC7D7=;C;DJ1>?I
EL;HI?=>J?I9ECFB;C;DJ;:8OEKH$1$=HEKFJ>7J
;D=7=;IEDFEB?9O7D:H;=KB7JEHO:;L;BEFC;DJI
?D9BK:?D=;NFEHJ9EDJHEBI IKFFEHJIEKH9ECFB?7D9;
;<<EHJIM?J>9KIJEC;HI=BE87BBO 7D:H;FEHJIH;=KB7HBOJE
J>;E7H:7D:J>;DEC?D7J?D=7D:=EL;HD7D9;
9ECC?JJ;;#EH7::?J?ED7B?D<EHC7J?ED I;;XC8*;-D<
#85.*7-70*0.6.7=C#2<4!?.;<201=Y78EL;
I64FE:G6
@>A6?D2E:@?
0;;X869.7<*=287*==.;<CA.,>=2?.869.7<*=287*7-!=1.;7/8;6*=287C869.7<*=2872<,><<287*7-
7*5B<2<C!?.;?2.@8/A.,>=2?.869.7<*=287C $*B87"*B'8=270#.<>5=<*7-$=8,4185-.;!>=;.*,1Y
8;=?DD?D=EDF7=;
-- 34 of 186 --
Culture and Human Capital Management
Lam is proud to be a driving force in shaping the global semiconductor talent workforce. The Board is actively engaged in overseeing
our culture and the management of human capital, both directly and through its compensation and human resources committee. The
compensation and human resources committee’s responsibilities include organizational and people matters, including reviewing
executive officer succession plans as described below, reviewing employee engagement programs, and reviewing and assisting the
Board in overseeing both human capital management and our workforce. Our chief human resources officer reports to the
compensation and human resources committee on at least a quarterly basis on key human capital metrics and our progress relative
to our human capital goals, to assist the committee in assessing organizational health. While the metrics and areas of focus are
subject to change over time, reflecting changing areas of operational focus, during fiscal year 2026, they included metrics and goals
relating to retention, hiring, engagement, and other workforce-related matters.
One of the Board’s responsibilities is to oversee the performance, development, and succession of our executive talent. In addition,
members of the Board support executive development through mentorship opportunities. However, the Board’s involvement in people
development extends beyond the executive team. The Board and the compensation and human resources committee engage with
management across a broad range of human capital related topics. Beyond supporting professional development, we offer programs
designed to enhance safety and well-being, foster teamwork and connection, and support future-ready communities worldwide. To
this end, we have focused on learning and development, employee engagement and recognition, providing a comprehensive
compensation and benefits package, and the health and safety of our employees. All of our named executive officers have
compensation goals related to employee engagement and talent, to help align members of our executive team with our corporate
goals in these areas and hold them accountable for the results achieved (see “Compensation Matters – Executive Compensation and
Other Information – Compensation Discussion and Analysis” below for more details).
In addition, employee engagement and voice are important to Lam’s culture. We regularly engage employees to find out what’s
working and how we can better meet their evolving needs. We conduct a global survey at a regular cadence to gather input on
employees’ workplace experience, including culture, career growth, manager effectiveness, and other topics. We also solicit
employee feedback through in-person and online employee forums, engagement sessions, all-employee meetings, conversations
with managers, and our human resource and employee relations teams. The Board believes that visits to our facilities and regular
direct engagement with employees enable it to assess our culture first-hand. Since 2017, the Board has visited our facilities in
California; Malaysia; Oregon; Taiwan; and South Korea; and regularly meets directly with employees in small groups to engage with
and hear directly from them. Our Board has conducted engagement sessions with a range of groups, including recent college
graduates, vice presidents, members of employee resource groups, managers, executives in customer-facing roles, and other
employees. These surveys and engagements provide management and the Board with valuable employee feedback and help the
executive leadership team to focus on promoting a culture and workplace environment that is consistent with Lam’s core values and
with achieving our human capital and strategic goals.
Our teams need a high level of expertise, varied perspectives, and complementary skill sets. To support Lam’s business needs, it is
important that employees feel comfortable sharing and responding to new ideas, which requires a sense of belonging, mutual trust,
and respect. With this in mind, we strive to align our workplace with Lam’s Core Values to help us recruit, retain, and advance our
employees, and promote both their professional and personal well-being. We endeavor to enhance our employee development
programs by expanding resources available for professional development, facilitating the creation of additional employee resource
groups, providing new job rotation and mentoring programs, and expanding our management training offerings. Further, we recognize
our employees for excellence and celebrate moments that matter through a variety of both in-person and virtual recognition
programs.
Prioritizing the health, safety, and well-being of our employees is important to our ongoing success. Through training and
engagement, we seek to foster a robust safety culture, mitigating risks by implementing safety protocols and controls. Our goal is to
apply our environmental, health, and safety policies, programs, and response plans (“EHS Policies”) to any location in which we
operate. In addition, we seek to extend our EHS Policies to anyone who works on our sites with the intent to provide a safe
environment during both routine and extraordinary circumstances. We monitor our safety performance at the enterprise, regional, and
site levels, and our Board receives updates on our EHS program at least annually. We also offer flexible work arrangements and seek
to provide benefits and resources that support the needs, wellbeing, and health of our employees.
We aim to maintain and cultivate a workplace where every employee has opportunities to perform to their highest potential.
Consistent with our Core Value of accountability, we regularly reflect on our progress in recruiting, hiring, and retaining a
high‐performing workforce. We conduct an annual compensation practices (pay equity) assessment of our pay practices and systems
designed to promote fairness across the workforce and compliance with applicable laws. The charter of our compensation and
human resources committee includes oversight responsibility for our compensation policies and practices related to pay equity laws.
We maintain employment policies and procedures aimed at reinforcing our commitment to non-discrimination, a harassment-free
environment, and compliance with applicable laws in our employment practices. We prohibit unlawful discrimination, harassment, and
retaliation in any aspect of employment, including recruiting, hiring, promotion, compensation, and employee interactions. Our Global
Employment Practices Statement declares our support of equal employment opportunities, workers’ rights to freedom of association,
and collective bargaining, to the extent permitted under local laws. In addition, our human rights policy aims to further promote the
protection, safety, and dignity of all of our employees. Our most recent EEO-1 report can be found in the environmental, social, and
governance section of our website at lamresearch.com/company/environmental-social-and-governance/. Our EEO-1 report shall not
Lam Research Corporation 2026 Proxy Statement 23
-- 35 of 186 --
be deemed “filed” with the SEC for purposes of federal securities law, and it shall not, under any circumstances, be incorporated by
reference into any of the Company’s past or future SEC filings. The EEO-1 report shall not be deemed soliciting material.
For further details about our human capital management, please see our 2026 Annual Report, as well as our most recent Global
Impact report.
Environmental, Social, and Governance
Our governance framework for ESG matters is illustrated below. While our Board is actively engaged in the overall oversight of these
matters, the nominating and governance committee has the primary responsibility for oversight of our priorities related to ESG
matters. For human capital and workforce-related issues, the compensation and human resources committee holds oversight
responsibility. The audit committee is responsible for oversight of ethics and compliance and information security. Our executive
leadership provides regular updates to the Board and its committees and engages them to discuss strategy, gain alignment on goals,
and report on progress. Our CEO and members of the CEO staff participate in our ESG and net zero executive steering committees,
which are responsible for guiding our strategy, approving and supporting initiatives, and holding business leaders accountable. Our
cross-functional ESG leadership team is responsible for proposing goals, developing and executing strategy, and embedding strategy
into our operations management system. Our net zero leadership team is responsible for working with business units to integrate
climate considerations into decision-making processes, driving progress on our net zero strategy, and tracking performance against
our climate goals. In addition, we have topic-specific working groups to address key issues.
Lam’s ESG Governance Structure
24
-- 36 of 186 --
#EHCEH;?D<EHC7J?ED78EKJEKH"0$;<<EHJI ?D9BK:?D=9B?C7J; H;B7J;:;<<EHJI FB;7I;H;<;HJEEKH7DDK7B$BE87B&CF79JH;FEHJ
7L7?B78B;EDEKHM;8I?J;7J@@@5*6;.<.*;,1,86058+*5269*,=;.98;=,KH$BE87B&CF79JH;FEHJI>7BBDEJ8;:;;C;:X<?B;:YM?J>J>;
0" <EHFKHFEI;IE<<;:;H7BI;9KH?J?;IB7M 7D:?JI>7BBDEJ KD:;H7DO9?H9KCIJ7D9;I 8;?D9EHFEH7J;:8OH;<;H;D9;?DJE7DOE<J>;
ECF7DOWIF7IJEH<KJKH;0" <?B?D=I1>;$BE87B&CF79JH;FEHJI>7BBDEJ8;:;;C;:IEB?9?J?D=C7J;H?7B
3</->9<97:/8=+>398
,KH:?H;9JEH9ECF;DI7J?ED?I:;I?=D;:JE7JJH79J7D:H;J7?D>?=> 97B?8;H:?H;9JEHI7D:JE7B?=D:?H;9JEH?DJ;H;IJIM?J>J>EI;E<
IJE9A>EB:;HI1>;9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;WI?D:;F;D:;DJ9ECF;DI7J?ED9EDIKBJ7DJ7:L?I;IJ>;9ECC?JJ;;
M?J>H;IF;9JJEDED ;CFBEO;;:?H;9JEH9ECF;DI7J?ED7D:7II?IJIM?J>J>;H;L?;ME<9ECF;J?J?L;D;IIE<IK9>9ECF;DI7J?ED&DK=KIJ
EKHE7H:?D?J?7BBO7:EFJ;:EKH9KHH;DJDED ;CFBEO;;:?H;9JEH9ECF;DI7J?EDFHE=H7C M>?9>M7ICEIJH;9;DJBO7C;D:;:7D:
7FFHEL;:8OJ>;E7H:?D *7O1>;E8@;9J?L;E<J>;DED ;CFBEO;;:?H;9JEH9ECF;DI7J?EDFHE=H7C?IJEJ7H=;J7D:F7OJ>;DED
;CFBEO;;:?H;9JEHI7JJ>;C;:?7DE<EKH-;;H$HEKF7I:;<?D;:7D::;I9H?8;:8;BEMKD:;HX869.7<*=287*==.;<CA.,>=2?.
869.7<*=287*7-!=1.;7/8;6*=287C869.7<*=2872<,><<287*7-7*5B<2<CA.,>=2?.869.7<*=2878?.;7*7,.*7-
";8,.->;.<C"..;;8>9";*,=2,.<*7-$>;?.B*=*F 7IC;7IKH;:;L;HOEJ>;HO;7H
2D:;HJ>;DED ;CFBEO;;:?H;9JEH9ECF;DI7J?EDFHE=H7C DED ;CFBEO;;:?H;9JEH9ECF;DI7J?ED?I9ECF7H;:JEEKH-;;H$HEKFM?J>
J>;H;IKBJIFHEL?:;:JEJ>;9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;7DDK7BBO"L;HOEJ>;HO;7H ?<J>?I9ECF7H?IEDI>EMI7DO
;B;C;DJE<DED ;CFBEO;;:?H;9JEH9ECF;DI7J?EDJE8;8;BEMJ>;J>F;H9;DJ?B;M>;D9ECF7H;:JEEKH-;;H$HEKF J>?I;B;C;DJM?BB
8;7KJEC7J?97BBO?D9H;7I;:JE7L7BK;;GK7B 7ID;7HBO7IFH79J?978B; JEJ>;J>F;H9;DJ?B;DO9>7D=;I7H;;<<;9J?L;EDJ>;:7J;E<
EKHD;NJ7DDK7BC;;J?D=E<IJE9A>EB:;HI<EHI;HL?9;?DJ>;<EBBEM?D=97B;D:7HO;7H;= 7D7:@KIJC;DJM7IC7:;?D9EDD;9J?EDM?J>
J>;K=KIJ9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;C;;J?D= 7D:IK9>7:@KIJC;DJM7I;<<;9J?L;EDJ>;:7J;E<EKH
7DDK7BIJE9A>EB:;HC;;J?D=?D+EL;C8;H<EHI;HL?9;?D97B;D:7HO;7H 1>;9ECC?JJ;;C7O7J7DOJ?C;H;9ECC;D:J>7J
J>;E7H:;N;H9?I; 7D:J>;E7H:C7O7J7DOJ?C;;N;H9?I; D;=7J?L;:?I9H;J?EDJEH;:K9;EHDEJ?D9H;7I;7DO;B;C;DJE<DED
;CFBEO;;:?H;9JEH9ECF;DI7J?ED 8KJJ>;FHE=H7C:E;IDEJ7KJ>EH?P;J>;;N;H9?I;E<FEI?J?L;:?I9H;J?EDEL;HDED ;CFBEO;;:?H;9JEH
9ECF;DI7J?ED1>;E7H:C7OCE:?<O H;FB79; IKF;HI;:;EH97D9;BJ>;DED ;CFBEO;;:?H;9JEH9ECF;DI7J?EDFHE=H7C7J7DOJ?C;
1>;;B;C;DJIE<J>;FHE=H7C7H;:;I9H?8;:8;BEM
2D:;HEKH0JE9A&D9;DJ?L;-B7D J>;JEJ7BL7BK;E<7M7H:I=H7DJ;:JE7DODED ;CFBEO;;:?H;9JEH?D7I?D=B;97B;D:7HO;7H FBKI
97I><;;IF7O78B;JEJ>;:?H;9JEH<EHJ>;:?H;9JEHWII;HL?9;?DIK9>97B;D:7HO;7H C7ODEJ;N9;;:7D7==H;=7J;L7BK;9ECFKJ;:7IE<
J>;:7J;E<=H7DJ E< #EH7DED ;CFBEO;;9>7?HE<J>;E7H: J>;B?C?J?I 1>;I;C7N?CKCL7BK;IM;H;
:;J;HC?D;:8OEKH9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;?D9EDIKBJ7J?EDM?J> ECF;DI?7 ?JI?D:;F;D:;DJ9ECF;DI7J?ED
9EDIKBJ7DJ 7D::;I?=D;:JEFHEL?:;7IK?J78B;B?C?J<EHJ>;B?<;E<J>;0JE9A&D9;DJ?L;-B7D
&DJ>;97I;E<*HH9>;H EKHFH;I?:;DJ7D: ", >?I;N;9KJ?L;9ECF;DI7J?EDM>?9>?I:;I9H?8;:8;BEMKD:;HX869.7<*=287
*==.;<CA.,>=2?.869.7<*=287*7-!=1.;7/8;6*=287C869.7<*=2872<,><<287*7-7*5B<2<Y ?IH;L?;M;:7DDK7BBO8OJ>;
?D:;F;D:;DJC;C8;HIE<J>;E7H:*HH9>;H:E;IDEJH;9;?L;7::?J?ED7B9ECF;DI7J?ED<EH>?II;HL?9;EDJ>;E7H:
43*2514>**).7*(947(425*38&9.43 +ED ;CFBEO;;:?H;9JEHIH;9;?L;7DDK7B97I>H;J7?D;HI7D:;GK?JO7M7H:I1>;9>7?HE<J>;
E7H: J>;B;7:?D:;F;D:;DJ:?H;9JEH?<7FFB?978B; 7D:9ECC?JJ;;9>7?HI7D:C;C8;HIH;9;?L;7::?J?ED7B97I>H;J7?D;HI+ED
;CFBEO;;:?H;9JEHIM>E@E?DJ>;E7H:EH79ECC?JJ;;C?: O;7HH;9;?L;FHE H7J;:97I>H;J7?D;HI7D:;GK?JO7M7H:I 7I7FFB?978B;
,KHDED ;CFBEO;;:?H;9JEH9ECF;DI7J?EDFHE=H7C?I87I;:EDI;HL?9;:KH?D=J>;97B;D:7HO;7H>EM;L;H 0" HKB;IH;GK?H;KIJE
H;FEHJ9ECF;DI7J?ED?DJ>?IFHENOIJ7J;C;DJED7<?I97BO;7H87I?I 7I>9ECF;DI7J?EDF7?:JEDED ;CFBEO;;:?H;9JEHI<EHJ>;<?I97B
O;7H;D:;:'KD; JE=;J>;HM?J>J>;7DDK7B97I>9ECF;DI7J?EDFHE=H7C9ECFED;DJI?D;<<;9J<EH97B;D:7HO;7HI7D:
?II>EMD8;BEM
3</->9<88?+6$/>+38/<=
??F2=*6E2:?6CD
2=6?52C162C
2=6?52C162C
:D42=162C
+ED ;CFBEO;;!?H;9JEH
>7?H
K:?J ECC?JJ;;T >7?H
K:?J ECC?JJ;;T*;C8;H
ECF;DI7J?ED7D:%KC7D/;IEKH9;I ECC?JJ;;T >7?H
ECF;DI7J?ED7D:%KC7D/;IEKH9;I ECC?JJ;;T*;C8;H
&DDEL7J?ED7D:1;9>DEBE=O ECC?JJ;;C >7?H
&DDEL7J?ED7D:1;9>DEBE=O ECC?JJ;;C*;C8;H
+EC?D7J?D=7D:$EL;HD7D9; ECC?JJ;;T >7?H
+EC?D7J?D=7D:$EL;HD7D9; ECC?JJ;;T*;C8;H
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 37 of 186 --
"79>!?H;9JEH?I;DJ?JB;:JE7D7DDK7BDED ;CFBEO;;:?H;9JEH97I>H;J7?D;H!?H;9JEHI7H;7BIE;DJ?JB;:JEIKFFB;C;DJ7BH;J7?D;H<;;I?<J>;O>7L;
8E7H:B;7:;HI>?FFEI?J?EDI;= 9>7?H 7D:EH7H;;?J>;H9ECC?JJ;;9>7?HIEHC;C8;HI
"79>DED ;CFBEO;;:?H;9JEH7BIEH;9;?L;I7D7DDK7B/027M7H:EDJ>;<?HIJ#H?:7O<EBBEM?D=J>;7DDK7BC;;J?D=#EHJ>;;GK?JO
7M7H:I=H7DJ;:?D+EL;C8;H J>;I;>7:7J7H=;J;:L7BK;;GK7BJE 1>;I;7M7H:I=;D;H7BBOL;IJED,9JE8;H?DJ>;
O;7H<EBBEM?D=J>;=H7DJ7D:7H;IK8@;9JJEJ>;J;HCI7D:9ED:?J?EDIE<J>; ECF7DOWI0JE9A&D9;DJ?L;-B7D 7I7C;D:;: EH
EJ>;H;GK?JOFB7DJ>;X"GK?JO-B7DY 7D:J>;7FFB?978B;7M7H:7=H;;C;DJI1>;I;7M7H:I?CC;:?7J;BOL;IJ?D<KBB ?<7DED
;CFBEO;;:?H;9JEH:?;I KFEDJ>;E99KHH;D9;E<7X EHFEH7J;1H7DI79J?EDY7I:;<?D;:?DJ>;"GK?JO-B7D EH EDJ>;:7J;E<J>;
7DDK7BC;;J?D= ?<J>;7DDK7BC;;J?D=:KH?D=J>;O;7H?DM>?9>J>;7M7H:M7I;NF;9J;:JEL;IJE99KHIFH?EHJEJ>;L;IJ:7J;7D:J>;
DED ;CFBEO;;:?H;9JEH?IDEJH; ;B;9J;:EHH;J?H;IEHH;I?=DI;<<;9J?L;?CC;:?7J;BOFH?EHJEJ>;7DDK7BC;;J?D=+ED ;CFBEO;;
:?H;9JEHIM>E9ECC;D9;I;HL?9;7<J;HJ>;7DDK7B;GK?JO7M7H:>7I8;;D=H7DJ;:H;9;?L;EDJ>;<?HIJ#H?:7O<EBBEM?D=J>;<?HIJ
H;=KB7HBOI9>;:KB;: GK7HJ;HBOE7H:C;;J?D=7JJ;D:;:7FHE H7J;:7M7H:87I;:EDJ>;DKC8;HE<H;=KB7HBOI9>;:KB;: GK7HJ;HBO
E7H:C;;J?D=IH;C7?D?D=?DJ>;O;7H7IE<J>;;<<;9J?L;:7J;7D:J?C;E<J>;:?H;9JEHWI7FFE?DJC;DJ1>;FHE H7J;:7M7H:I7H;
IK8@;9JJEJ>;I7C;L;IJ?D=I9>;:KB; J;HCI7D:9ED:?J?EDI7IJ>;7DDK7B;GK?JO7M7H:I ;N9;FJJ>7J?<J>;7M7H:?I=H7DJ;:EDJ>;
<?HIJ#H?:7O<EBBEM?D=J>;H;=KB7HBOI9>;:KB;:GK7HJ;HBO+EL;C8;HE7H:C;;J?D= J>;7M7H:L;IJI?CC;:?7J;BO2DB;IIJ>;H;?I7D
799;B;H7J?ED;L;DJ J>;/02I=H7DJ;:JE;79>9KHH;DJ:?H;9JEH<EHI;HL?9;:KH?D=97B;D:7HO;7HM?BBL;IJ?D<KBBED,9JE8;H
IK8@;9JJEJ>;:?H;9JEHWI9EDJ?DK;:I;HL?9;EDJ>;E7H:
1>;<EBBEM?D=J78B;I>EMI9ECF;DI7J?ED<EH<?I97BO;7H<EHF;HIEDII;HL?D=7I:?H;9JEHI:KH?D=<?I97BO;7HEJ>;HJ>7D
*HH9>;H
3</->9<97:/8=+>39809<3=-+6*/+<
66D2C?65@C
(2:5:?2D9
+E@4<H2C5D
,@E2=
0E>7?B2>C;:
"H?9(H7D:J
&J7*H;DD7D
*?9>7;B/ 7DDED
D?HK:>!;L=7D
'E>D*!?D;;D
*7HA#?;B:I
%E(OK(7D=
;J>7DO'*7O;H
'OEJ?(*;>H7
8>?@?J617BM7BA7H
1>;7CEKDJII>EMD?DJ>?I9EBKCDH;FH;I;DJJ>;=H7DJ:7J;<7?HL7BK;E<KDL;IJ;:/027M7H:I=H7DJ;::KH?D=<?I97BO;7H?D799EH:7D9;M?J>
#?D7D9?7B99EKDJ?D=0J7D:7H:IE7H:99EKDJ?D=0J7D:7H:I E:?<?97J?EDX0 Y ECF;DI7J?EDU0JE9A ECF;DI7J?EDX0 Y
%EM;L;H FKHIK7DJJE0" HKB;I J>;I;L7BK;I7H;DEJH;:K9;:8O7D;IJ?C7J;<EHJ>;FHE878?B?JOE<<EH<;?JKH;1>;<7?HL7BK;E</02IM7I
97B9KB7J;:87I;:EDJ>;<7?HC7HA;JL7BK;E<J>; ECF7DOWI9ECCEDIJE9A7JJ>;:7J;E<=H7DJ :?I9EKDJ;:<EH:?L?:;D:II?D9;J>;/02I:EDEJ
>7L;:?L?:;D:;GK?L7B;DJH?=>JI
*H>C;:H;9;?L;: H;FH;I;DJ?D=>?I7DDK7BH;J7?D;HI<EH97B;D:7HO;7HE< <EHI;HL?9;7I7:?H;9JEH7D: <EH
I;HL?9;7I7C;C8;HE<J>;?DDEL7J?ED7D:J;9>DEBE=O9ECC?JJ;;
,D+EL;C8;H ;79>DED ;CFBEO;;:?H;9JEHM>EM7IEDJ>;E7H:7JIK9>J?C;H;9;?L;:7D7DDK7B=H7DJ<EH97B;D:7HO;7HE<
/02I 87I;:EDJ>;J7H=;JL7BK;E< :?L?:;:8OJ>;JH7:?D=:7O7L;H7=;E<J>;9BEI?D=FH?9;F;HI>7H;E<)7CWI9ECCEDIJE9AFH?EHJE
J>;=H7DJ:7J; HEKD:;::EMDJEJ>;D;7H;IJI>7H;BBE<J>;I;/02IM;H;EKJIJ7D:?D=7D:KDL;IJ;:7IE<'KD;
*HH7D:JH;9;?L;: H;FH;I;DJ?D=>?I7DDK7BH;J7?D;HI<EH97B;D:7HO;7HE< <EHI;HL?9;7I7:?H;9JEH <EHI;HL?9;
7IJ>;9>7?HE<J>;7K:?J9ECC?JJ;; 7D: <EHI;HL?9;7I7C;C8;HE<J>;DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;;
*IH;DD7DH;9;?L;: H;FH;I;DJ?D=>;H7DDK7BH;J7?D;HI<EH97B;D:7HO;7HE< <EHI;HL?9;7I7:?H;9JEH7D: <EH
I;HL?9;7I7C;C8;HE<J>;7K:?J9ECC?JJ;;
*H 7DDEDH;9;?L;: H;FH;I;DJ?D=>?I7DDK7BH;J7?D;HI<EH97B;D:7HO;7HE< <EHI;HL?9;7I7:?H;9JEH <EHI;HL?9;
7IJ>;9>7?HE<J>;DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;; 7D: <EHI;HL?9;7I7C;C8;HE<J>;9ECF;DI7J?ED7D:>KC7DH;IEKH9;I
9ECC?JJ;;
!H!;L=7DH;9;?L;: H;FH;I;DJ?D=>?I7DDK7BH;J7?D;HI<EH97B;D:7HO;7HE< <EHI;HL?9;7I7:?H;9JEH7D: <EH
I;HL?9;7I7C;C8;HE<J>;?DDEL7J?ED7D:J;9>DEBE=O9ECC?JJ;;
,D#;8HK7HO !H!;L=7DH;9;?L;:7D7DDK7B=H7DJ<EH97B;D:7HO;7HE< /02I 87I;:EDJ>;J7H=;JL7BK;E< :?L?:;:
8OJ>;JH7:?D=:7O7L;H7=;E<J>;9BEI?D=FH?9;F;HI>7H;E<)7CWI9ECCEDIJE9AFH?EHJEJ>;=H7DJ:7J; HEKD:;::EMDJEJ>;D;7H;IJ
I>7H;
*H!?D;;DH;9;?L;: H;FH;I;DJ?D=>?I7DDK7BH;J7?D;HI<EH97B;D:7HO;7HE< <EHI;HL?9;7I7:?H;9JEH7D: <EH
I;HL?9;7I7C;C8;HE<J>;7K:?J9ECC?JJ;;
*H#?;B:IH;9;?L;: H;FH;I;DJ?D=>?I7DDK7BH;J7?D;HI<EH97B;D:7HO;7HE< <EHI;HL?9;7I7:?H;9JEH7D: <EH
I;HL?9;7I7C;C8;HE<J>;9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;
-- 38 of 186 --
(11) Dr. Kang received $120,000, representing his annual retainers for calendar year 2026 of $100,000 service as a director and $20,000 for service as
the chair of the innovation and technology committee.
(12) Ms. Mayer received $135,000, representing her annual retainers for calendar year 2026 of $100,000 for service as a director, $15,000 for service
as a member of the audit committee, $10,000 for service as a member of the innovation and technology committee, and $10,000 for service as a
member of the nominating and governance committee.
(13) Ms. Mehra received $130,000, representing her annual retainers for calendar year 2026 of $100,000 for service as a director and $30,000 for
service as the chair of the compensation and human resources committee.
(14) Mr. Talwalkar received $287,500, representing his annual retainers for calendar year 2026 of $100,000 for service as a director, $155,000 for
service as chair of the Board, $12,500 for service as a member of the compensation and human resources committee, $10,000 for service as a
member of the innovation and technology committee, and $10,000 for service as a member of the nominating and governance committee.
Lam Research Corporation 2026 Proxy Statement 27
-- 39 of 186 --
203)15%6-21%66)45
B/-?>3@/97:/8=+>398+8.">2/<809<7+>398
97:/8=+>3983=-?==398+8.8+6C=3=
1>?I ECF;DI7J?ED!?I9KII?ED7D:D7BOI?IX !Y :;I9H?8;IEKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C ?D9BK:?D=J>;9ECF;DI7J?ED
;7HD;:8OEKH<?I97BO;7HX+7C;:"N;9KJ?L;,<<?9;HIYX+",IY M>E7H;7I<EBBEMI
!+7/.B/-?>3@/"003-/<=09<3=-+6*/+<
&2>65I64FE:G6'77:46C (@D:E:@?
1?CEJ>O*H9>;H -H;I?:;DJ >?;<"N;9KJ?L;,<<?9;H
!EK=B7I/;JJ?D=;H "N;9KJ?L;3?9;-H;I?:;DJ >?;<#?D7D9?7B,<<?9;H
0;I>7I7O;;0;I>7 37H7:7H7@7D "N;9KJ?L;3?9;-H;I?:;DJ >?;<,F;H7J?D=,<<?9;H
+;?B'#;HD7D:;I 0;D?EH3?9;-H;I?:;DJ $BE87B KIJEC;H,F;H7J?EDI
37>?:37>;:? 0;D?EH3?9;-H;I?:;DJ >?;<1;9>DEBE=O7D:0KIJ7?D78?B?JO,<<?9;H
,KH !?IEH=7D?P;:799EH:?D=JEJ>;<EBBEM?D=IJHK9JKH;
"@/<@3/A90B/-?>3@/97:/8=+>398
,KH ECF;DI7J?ED O9B;
,KHKI?D;II ,KH&D:KIJHO"DL?HEDC;DJ 7D:,KH#?D7D9?7B-;H<EHC7D9;
,KH-7O <EH -;H<EHC7D9;,H?;DJ7J?ED
"N;9KJ?L; ECF;DI7J?ED0D7FI>EJ-HE=H7CI7D:/;9;DJ,KJ9EC;I
"N;9KJ?L; ECF;DI7J?ED->?BEIEF>O7D:-HE=H7C!;I?=D
07OED-7O3EJ?D=/;IKBJI7D:0JE9A>EB:;H,KJH;79>
* +8.* 97:/8=+>398#<91<+7=
+", ECF;DI7J?ED);L;BI
7I;07B7HO
DDK7B&D9;DJ?L;-HE=H7C
)ED= 1;HC&D9;DJ?L;-HE=H7C
ECF;DI7J?ED/;9EL;HO-EB?9O EHX B7M879AY-EB?9O
&DI?:;H1H7:?D=-EB?9O7D:%;:=?D=7D:-B;:=?D=-HE>?8?J?ED
0JE9A,MD;HI>?F$K?:;B?D;I
0;L;H7D9; >7D=;?D EDJHEBHH7D=;C;DJI
,J>;H;D;<?JI+EJL7?B78B;JEBB"CFBEO;;I
B/-?>3@/97:/8=+>3989@/<8+8-/+8.#<9-/.?</=
/EB;E<J>; ECF;DI7J?ED7D:%KC7D/;IEKH9;I ECC?JJ;;
/EB;E< ECC?JJ;;:L?IEHI
/EB;E<*7D7=;C;DJ
-;;H$HEKF-H79J?9;I7D:0KHL;O!7J7
II;IIC;DJE< ECF;DI7J?ED/?IA
-EB?9?;I7D:-H79J?9;I/;B7J;:JEJ>;1?C?D=E<,FJ?EDM7H:I
17N7D:99EKDJ?D= EDI?:;H7J?EDI
&+,6/9098>/8>= %+)
-- 40 of 186 --
##$%"!# !
96425+37'8/43=)1+
BJ>EK=>M;>7L;7'KD;<?I97BO;7H;D: EKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C?I=;D;H7BBO:;I?=D;:7D:EH?;DJ;:ED797B;D:7HO;7H
87I?IJE9EHH;IFED:M?J>EKH97B;D:7HO;7H 87I;:8KI?D;IIFB7DD?D=1>?I !=;D;H7BBOH;<B;9JI797B;D:7HO;7HX 6Y EH?;DJ7J?ED
H7J>;HJ>7D7<?I97BO;7HX#6Y EH?;DJ7J?ED 7II>EMD8;BEM1>;"N;9KJ?L; ECF;DI7J?ED178B;I<EBBEM?D=J>?I !7H;87I;:ED
EKH<?I97BO;7H 7IH;GK?H;:8O0" H;=KB7J?EDI
B/-?>3@/97:/8=+>398+6/8.+<*/+<"<3/8>+>398
9697/3+77963*9786=3:/6432+38'3*96/3'3)/'1+6,462'3)+
,L;H7BB 97B;D:7HO;7HM7I7=HEMJ>O;7H<EH)7CWIH;L;DK; 7IEL;H7BBM7<;H<78H?97J?ED;GK?FC;DJIF;D:?D==H;MIJHED=BO
%?=>B?=>JI<EH97B;D:7HO;7H
Z 79>?;L;:H;L;DK;E<7FFHEN?C7J;BO8?BB?ED<EHJ>;97B;D:7HO;7H H;FH;I;DJ?D=7D7FFHEN?C7J;BO?D9H;7I;EL;H
97B;D:7HO;7H
Z =;D;H7J;:EF;H7J?D=97I><BEME<7FFHEN?C7J;BO8?BB?ED M>?9>H;FH;I;DJI7FFHEN?C7J;BOE<H;L;DK;I7D:
Z =;D;H7J;:IK<<?9?;DJ97I><BEMJEIKFFEHJF7OC;DJE<7FFHEN?C7J;BO8?BB?ED?D:?L?:;D:IJEIJE9A>EB:;HI
&DJ>;<?HIJ>7B<E<97B;D:7HO;7H M;I7M?CFHEL;:C;CEHO H;B7J;:?DL;IJC;DJI7IM;BB7I=HEMJ>?DIF;D:?D=<HECB;7:?D=;:=;
<EKD:HO7D:BE=?99KIJEC;HI
#EHJ>;*7H9>7D:'KD;GK7HJ;HI9EC8?D;: )7C:;B?L;H;:H;L;DK;IE<7FFHEN?C7J;BO8?BB?ED7D:EF;H7J?D=97I><BEMIE<
7FFHEN?C7J;BO8?BB?ED
96'=,46+6,462'3)+6/+38'8/43
1E7B?=DM?J>IJE9A>EB:;HIW?DJ;H;IJI EKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C?I:;I?=D;:JE<EIJ;H7F7O <EH F;H<EHC7D9;9KBJKH;7D:
79>?;L;J>;;N;9KJ?L;9ECF;DI7J?EDE8@;9J?L;I:;I9H?8;:?DXCA.,>=2?.869.7<*=287"1258<891B*7-";80;*6.<207C
A.,>=2?.869.7<*=287"1258<891BY8;BEM4;>7L;IJHK9JKH;:EKH9ECF;DI7J?EDFHE=H7C7D:F7OEKJIJEH;<B;9JJ>;I;=E7BI
%?=>B?=>JIE<EKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C7H;B?IJ;:?DX";8AB$=*=.6.7=$>66*;BCA.,>=2?.869.7<*=2872015201=<YED
F7=;78EL;7D:?DXCA.,>=2?.869.7<*=287$7*9<18=";80;*6<*7-#.,.7=!>=,86.<FEDF7=;8;BEM,KHFH;I?:;DJ7D:
",WI9ECF;DI7J?ED?DH;B7J?EDJEEKHH;L;DK;7D:D;J?D9EC;?II>EMD8;BEM
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 41 of 186 --
"#+C09<#/<09<7+8-/09<3=-+6*/+<=
/;L;DK;7D:+;J&D9EC;?DJ>EKI7D:I
1EJ7B
ECF;DI7J?ED?DJ>EKI7D:I
",1EJ7B ECF;DI7J?ED /;L;DK; +;J&D9EC;
#6 #6 #6 #6 #6 #6
U
U
X ",1EJ7B ECF;DI7J?EDY9EDI?IJIE<87I;I7B7HO 7DDK7B?D9;DJ?L;F7OC;DJI 7D:XBB,J>;H ECF;DI7J?EDY7IH;FEHJ;:?DJ>;X0KCC7HO
ECF;DI7J?ED178B;Y8;BEM 7D:J>;J7H=;J7M7H:EFFEHJKD?J?;I<EH;GK?JO 87I;:7M7H:I8EJ>KD:;HJ>;)ED= 1;HC&D9;DJ?L;-HE=H7CEH
EJ>;HM?I;17H=;J7M7H:EFFEHJKD?J?;I<EH;GK?JO 87I;:7M7H:IKD:;HJ>;)ED= 1;HC&D9;DJ?L;-HE=H7C;NFH;II;:7I720:EBB7HL7BK; 7H;
9EDL;HJ;:JE;GK?JO7M7H:IEDJ>;=H7DJ:7J;KI?D=J>;JH7:?D=:7O7L;H7=;E<J>;9BEI?D=FH?9;E<EKH9ECCEDIJE9AFH?EHJEJ>;=H7DJ:7J;
17H=;J7M7H:EFFEHJKD?J?;I:?<<;H<HECJ>;L7BK;IE<;GK?JO7M7H:II>EMD?DJ>;X0KCC7HO ECF;DI7J?ED178B;Y8;BEM M>?9>H;FH;I;DJJ>;=H7DJ
:7J;L7BK;E<J>;7M7H:I:;J;HC?D;:?D799EH:7D9;M?J>0
1>;97B;D:7HO;7H?D9H;7I;?DEKH ",WIJEJ7B9ECF;DI7J?ED7II>EMD78EL;M7IFH?C7H?BO:H?L;D8O7D?D9H;7I;?D>?I)ED=
1;HC&D9;DJ?L;-HE=H7CX)1&-Y 7M7H:EFFEHJKD?JO&D:;J;HC?D?D=J>; ",WI97B;D:7HO;7H)1&-J7H=;JEFFEHJKD?JO J>;
9ECC?JJ;;9EDI?:;H;:?JI:;I?H;JE9EDJ?DK;JE?D9;DJ?L?P;EKJF;H<EHC7D9;7D:H;C7?D9ECF;J?J?L;H;B7J?L;JEC7HA;JFH79J?9;I
1>;=H7F>8;BEM9ECF7H;I)7CWI9KCKB7J?L;<?L; O;7H10/M?J>J>;JEJ7BH;JKHDIE<J>;+7I:7G ECFEI?J;1EJ7B/;JKHD&D:;N J>;
0J7D:7H:-EEHWIX0-Y 1/ &D:;N 7D:J>;->?B7:;BF>?70;C?9ED:K9JEH0;9JEH1EJ7B/;JKHD&D:;N
97:+<3=9890?7?6+>3@/3@/*/+<&9>+6$/>?<8
)7C/;I;7H9> EHFEH7J?ED
->?B7:;BF>?70;C?9ED:K9JEH0;9JEH1EJ7B/;JKHD&D:;N
+7I:7G ECFEI?J;1EJ7B/;JKHD&D:;N
0-1/ &D:;N
?DL;IJ;:ED'KD; ?DIJE9AEH?D:;N ?D9BK:?D=H;?DL;IJC;DJE<:?L?:;D:I
EFOH?=>JR0J7D:7H:-EEHWI 7:?L?I?EDE<0-$BE87BBBH?=>JIH;I;HL;:
#EHFKHFEI;IE<J>?I ! 7H;<;H;D9;JE79ECF;DI7J?ED79J?EDEH:;9?I?ED8OJ>;9ECC?JJ;;M?J>H;IF;9JJEEKH ",C;7DI7D79J?EDEH
:;9?I?ED8OJ>;?D:;F;D:;DJC;C8;HIE<EKHE7H:7<J;H9EDI?:;H?D=J>;H;9ECC;D:7J?EDE<J>;9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;
7D: ?DJ>;97I;E<7BBEJ>;H+",I 7D79J?EDEH:;9?I?ED8OJ>;9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;
-- 42 of 186 --
<+)98/:+425+37'8/43 3'57.4864-6'27'3*+)+3898)42+7
1>;J78B;I8;BEMFHEL?:;7IKCC7HOE<EKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7CI ?D9BK:?D=EKHDDK7B&D9;DJ?L;-HE=H7CX&-Y 7D:
EKH)1&- 7BED=M?J>H;9;DJF7OEKJ9EC;IKD:;H;79>FHE=H7C
+6/8.+<*/+< 88?+68-/8>3@/#<91<+7
!;J;HC?D;:87I;:EDJ>;<?D7BH;IKBJ<EHJ>; ECF7DOWIDED $-EF;H7J?D=?D9EC;7I7F;H9;DJ7=;E<H;L;DK;XDED $-EF;H7J?D=C7H=?DY
<EH 6+ED $-EF;H7J?D=C7H=?D?I:;H?L;:<HECH;IKBJI:;J;HC?D;:?D799EH:7D9;M?J>=;D;H7BBO799;FJ;:799EKDJ?D=FH?D9?FB;I
X$-Y M?J>9>7H=;I7D:9H;:?JI?DJ>;<EBBEM?D=B?D;?J;CI;N9BK:;:<HEC$-H;IKBJI<EH7FFB?978B;GK7HJ;HI:KH?D=97B;D:7HO;7H
7CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:J>HEK=>9;HJ7?D8KI?D;II9EC8?D7J?EDI;B;9J?L;:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JO?D9H;7I;
7D:?CF7?HC;DJE<BED= B?L;:7II;JI#EH7::?J?ED7B?D<EHC7J?ED I;;J>;I;9J?EDJ?JB;:XFF;D:?9;ITFF;D:?NT&D<EHC7J?ED/;=7H:?D=+ED
$-#?D7D9?7B*;7IKH;IY8;BEM
!;J;HC?D;:87I;:EDJ>;<?D7BH;IKBJ<EHJ>; ECF7DOWIDED $-=HEIIC7H=?D7I7F;H9;DJ7=;E<H;L;DK;XDED $-=HEIIC7H=?DY <EH
6+ED $-=HEIIC7H=?D?I:;H?L;:<HECH;IKBJI:;J;HC?D;:?D799EH:7D9;M?J>$- M?J>9>7H=;I7D:9H;:?JI?DJ>;<EBBEM?D=B?D;?J;CI
;N9BK:;:<HEC$-H;IKBJI<EH7FFB?978B;GK7HJ;HI:KH?D=97B;D:7HO;7H7CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:J>HEK=>9;HJ7?D
8KI?D;II9EC8?D7J?EDI7D:;B;9J?L;:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JO?D9H;7I;#EH7::?J?ED7B?D<EHC7J?ED I;;J>;I;9J?EDJ?JB;:XFF;D:?9;I
TFF;D:?NT&D<EHC7J?ED/;=7H:?D=+ED $-#?D7D9?7B*;7IKH;IY8;BEM
&D:?L?:K7BF;H<EHC7D9;<79JEH<EH+",IH7D=;:<HECJE7L;H7=;E<
&D:?L?:K7BF7OEKJI<EH+",IH7D=;:<HECJEE<J7H=;J7L;H7=;E<
#EHJ>;97B;D:7HO;7H&- J>;9ECC?JJ;;:;J;HC?D;:JE9>7D=;J>;C7DD;H?DM>?9>?J:;J;HC?D;:J>;&D:?L?:K7B-;H<EHC7D9;
#79JEHI<EHEKH+",I<HECJ>;C;J>E:KI;:?DFH?EHO;7HI1>;L?;ME<J>;9ECC?JJ;;M7IJ>7J8EJ>7B?=DC;DJJE9EHFEH7J;E8@;9J?L;I
7D::?<<;H;DJ?7J?EDE<?D:?L?:K7B+",I9EKB:8;?CFHEL;:8OH;FB79?D=J>;FH?EH7FFHE79> M>?9>9EC8?D;:79EHFEH7J;I9EH;97H:
?D:?L?:K7B?P;:M;?=>J?D=I 7D:7D?D:?L?:K7B79>?;L;C;DJI9EH;J>;B7JJ;HM;?=>;:7JE<J>;EL;H7BB&D:?L?:K7B-;H<EHC7D9;
#79JEH M?J>7I?CFB?<?;:7FFHE79>799EH:?D=JEM>?9>J>;9ECC?JJ;;:;J;HC?D;:787I;B?D;&D:?L?:K7B-;H<EHC7D9;#79JEH87I;:ED
J>; ECF7DOWIF;H<EHC7D9;H;B7J?L;JE9EHFEH7J; B;L;BDDK7B,F;H7J?D=-B7D=E7BI 7D:J>;D7FFB?;:7:@KIJC;DJIJEJ>7J87I;B?D;
<EH?D:?L?:K7B+",I87I;:ED:?<<;H;DJ?7J;:?D:?L?:K7BF;H<EHC7D9;#EH7:?I9KII?EDE<J>;9EHFEH7J; B;L;BDDK7B,F;H7J?D=-B7D
=E7BIKD:;HBO?D=J>;97B;D:7HO;7H&- 7IM;BB7I?D:?L?:K7BH;IKBJI79>?;L;: I;;XC) *7-) 869.7<*=287
";80;*6<C77>*57,.7=2?.";80;*6C*5.7-*;).*; 77>*57,.7=2?.";80;*6"*;*6.=.;<*7-"*B8>=.,2<287<C
77>*57,.7=2?.";80;*67-2?2->*5".;/8;6*7,.*,=8;<Y8;BEM
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 43 of 186 --
981&/<78-/8>3@/#<91<+7/=318
+<5/>,+=/.#$%'#+C9?>
-H?EHJEEKH)1&- 10/F;H<EHC7D9;<EH*7HA;J 87I;:-/02IM7I:;J;HC?D;:8O9ECF7H?D=EKHJEJ7BH;JKHDJEJ>;C7HA;JFH?9;
F;H<EHC7D9;E<J>;50,5?D:;N0J7HJ?D=M?J>EKH)1&- J>;9ECC?JJ;;8;=7DC;7IKH?D=H;B7J?L;10/F;H<EHC7D9;8OJ>;F;H9;DJ?B;
H7DA?D=E<EKH10/H;B7J?L;JEJ>;10/I<EHJ>;9ECF7D?;IC7A?D=KFJ>;?D:;N
<+)98/:+425+37'8/43./14745.='3*64-6'2+7/-3
B/-?>3@/97:/8=+>398#2369=9:2C
1>;F>?BEIEF>OE<EKH9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;J>7J=K?:;:J>?IO;7HWI7M7H:I7D:F7OEKJ:;9?I?EDI?IJ>7JEKH
;N;9KJ?L;9ECF;DI7J?EDFHE=H7CI>EKB:
Z FHEL?:;9ECF;J?J?L;9ECF;DI7J?EDJE7JJH79J7D:H;J7?DJEFJ7B;DJ
Z FHEL?:;JEJ7B9ECF;DI7J?EDF79A7=;IJ>7J7H;<7?HJE;CFBEO;;I7D:H;M7H:9EHFEH7J; EH=7D?P7J?ED7B 7D:?D:?L?:K7B
F;H<EHC7D9;
Z 7B?=DF7OM?J>8KI?D;IIE8@;9J?L;IM>?B;:H?L?D=;N9;FJ?ED7BF;H<EHC7D9;
Z EFJ?C?P;L7BK;JE;CFBEO;;IM>?B;C7?DJ7?D?D=9EIJ ;<<;9J?L;D;IIJEJ>; ECF7DO
Z 9H;7J;IJE9A>EB:;HL7BK;EL;HJ>;BED= J;HC
Z 7B?=DEKH7DDK7BFHE=H7CJE7DDK7BF;H<EHC7D9;7D:EKHBED= J;HCFHE=H7CJEBED=;H J;HCF;H<EHC7D9;
-- 44 of 186 --
Z H;9E=D?P;J>7J7BED= J;HC >?=> GK7B?JOC7D7=;C;DJJ;7C?I79ECF;J?J?L;:?<<;H;DJ?7JEH<EH)7C ;D>7D9?D=9KIJEC;HJHKIJ
C7HA;JI>7H;7D: J>;H;<EH; IJE9A>EB:;HL7BK;7D:
Z FHEL?:;H;M7H:IM>;DH;IKBJI>7L;8;;D:;CEDIJH7J;:
,KH9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;WI;N;9KJ?L;9ECF;DI7J?EDE8@;9J?L;I7H;JECEJ?L7J;
Z F;H<EHC7D9;J>7J9H;7J;IBED= J;HCIJE9A>EB:;HL7BK;
Z EKJIJ7D:?D=F;H<EHC7D9;7JJ>;9EHFEH7J; EH=7D?P7J?ED 7D:?D:?L?:K7BB;L;BI7D:
Z H;J;DJ?EDE<7BED= J;HC >?=> GK7B?JOC7D7=;C;DJJ;7C
#<91<+7/=318
,KHFHE=H7C:;I?=D?D9EHFEH7J;I7D7DDK7BH;L?;ME<;79>E<J>;9ECF;DI7J?ED;B;C;DJI%EM;L;H 7::?J?ED7BH;L?;MIC7O8;
KD:;HJ7A;DM>;D;L;HJ>;H;?I79>7D=;?DHEB;IEHH;IFEDI?8?B?J?;IEH7D;M>?H;@E?DIJ>; ECF7DO
,KHFHE=H7C:;I?=DKI;I7C?NE<7DDK7B7D:BED= J;HC9ECFED;DJI 7D:7C?NE<97I>7D:;GK?JO9ECFED;DJI,KH;N;9KJ?L;
9ECF;DI7J?EDFHE=H7C?D9BK:;I87I;I7B7HO&-)1&-FHECEJ?ED H;J;DJ?ED7D:EHD;M>?H;7M7H:IM>;D;L;HD;9;II7HO7IM;BB7I
IJE9AEMD;HI>?F=K?:;B?D;I7D:79ECF;DI7J?EDH;9EL;HOFEB?9O1>;FH?C7HO;B;C;DJIE<EKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C7H;
B?IJ;:?DJ>;J78B;8;BEM7D:7H;:;I9H?8;:?DCEH;:;J7?B?DXC) *7-) 869.7<*=287";80;*6<Y8;BEM
97:/8=+>39897:98/8>=
=6>6?E @H:E:D(2:5 (FCA@D6 6D:8?
2D6+2=2CJ 7I> 4;8;B?;L;J>;FKHFEI;E<87I;I7B7HO?IJEFHEL?:;9ECF;J?J?L;9ECF;DI7J?EDJE7JJH79J7D:H;J7?DJEFJ7B;DJ7D:
JEFHEL?:;;CFBEO;;I ?D9BK:?D=EKH+",I M?J>7<?N;:7D:<7?H7CEKDJE<9ECF;DI7J?ED<EHJ>;@E8IJ>;O
F;H<EHC99EH:?D=BO M;I;;AJE;DIKH;J>7JEKH87I;I7B7HOB;L;BI7H;9ECF;J?J?L;?DH;<;H;D9;JEF;;H=HEKF
FH79J?9;7D:C7HA;JIKHL;O:7J7
??F2=
!?46?E:G6
(C@8C2>
7I> ,KH&-?I:;I?=D;:JEFHEL?:;7DDK7B F;H<EHC7D9; 87I;:9ECF;DI7J?EDJ>7J?I87I;:EDJ>;79>?;L;C;DJE<
FH; I;J7DDK7B<?D7D9?7B IJH7J;=?9 7D:EF;H7J?ED7BE8@;9J?L;I7B?=D;:M?J>EKJIJ7D:?D=F;H<EHC7D9; 7D:M?BB
7BBEMKIJE7JJH79J7D:H;J7?DJEFJ7B;DJ M>?B;C7?DJ7?D?D=9EIJ ;<<;9J?L;D;IIJEJ>; ECF7DO
#EHCEH;:;J7?BIH;=7H:?D=J>;:;I?=DE<J>;&- I;;XC) *7-) 869.7<*=287";80;*6<C
77>*57,.7=2?.";80;*6Y8;BEM
$@?8 ,6C>
!?46?E:G6
(C@8C2>
9EC8?D7J?EDE<
Z *7HA;J 87I;:
-/02I
7D:
Z I;HL?9; 87I;:
/02I
,KH)1&-?I:;I?=D;:JE7JJH79J7D:H;J7?DJEFJ7B;DJ FHEL?:;9ECF;J?J?L;B;L;BIE<9ECF;DI7J?ED 7B?=DF7OM?J>
IJE9AF;H<EHC7D9;EL;H7CKBJ? O;7HF;H?E: H;M7H:EKH+",I<EHEKJIJ7D:?D= ECF7DOF;H<EHC7D9; 7D:
9H;7J;IJE9A>EB:;HL7BK;EL;HJ>;BED= J;HC
1E799ECFB?I>J>;I;E8@;9J?L;I J>;)1&-:;I?=DFHEL?:;IJ>7JJ>;J7H=;J7M7H:EFFEHJKD?JO?I7M7H:;:?D7
9EC8?D7J?EDE<*7HA;J 87I;:-/02I7D:I;HL?9; 87I;:/02I
#EHCEH;:;J7?BIH;=7H:?D=J>;:;I?=DE<J>;)1&- I;;XC) *7-) 869.7<*=287";80;*6<C
870%.;67,.7=2?.";80;*6C.<207Y8;BEM
1>; ECF7DOWI)1&-FH;L?EKIBO?D9BK:;:IJE9AEFJ?EDIFH?EHJE7DKF:7J;C7:;8OJ>;9ECC?JJ;;<EHJ>;)1&-
I?BBKIJH7J;:8;BEM EKHFHE=H7C:;I?=D?IM;?=>J;:JEM7H:F;H<EHC7D9;7D:?D9;DJ?L?P?D=IJE9A>EB:;HL7BK;9H;7J?ED1>;
F;H<EHC7D9; 87I;:FHE=H7C9ECFED;DJI?D9BK:;&-97I>F7OEKJEFFEHJKD?J?;I7D:C7HA;J 87I;:;GK?JO7M7H:IKD:;HJ>;)1&-
!"97:/8=+>398&+<1/>#+C 3B@/<+1/=
1>;97B;D:7HO;7H7L;H7=;+",J7H=;JF7OC?N?I87I;:EDJ>; ECF7DOWI+",I<EH<?I97BO;7H 7D:J>;97B;D:7HO;7H7L;H7=;
+",J7H=;JF7OC?N?I87I;:EDJ>;+",I<EH<?I97BO;7HIIK9> J>;97B;D:7HO;7H7L;H7=;F7OC?N?D9BK:;I9ECF;DI7J?EDF7?:JE
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 45 of 186 --
L7%7HJ;H7D:-7JH?9A')EH: ;79>E<M>ECM7I9B7II?<?;:7I7D+",<EH<?I97BO;7H8KJM7IDEJ9B7II?<?;:7I7D+",<EH<?I97BO;7H
7D::E;IDEJ?D9BK:;*H#;HD7D:;IEH!H37>;:? ;79>E<M>ECM7I9B7II?<?;:7I7D+",<EH<?I97BO;7H8KJM7IDEJ9B7II?<?;:7I7D
+",<EH<?I97BO;7H
1>;J;HCXJ H?IAF7OY 7IKI;:?DJ>?I<?=KH; H;<;HIJE7BB9ECF;DI7J?EDEJ>;HJ>7D87I;I7B7HO
1>; ECF7DOWI)1&-:;I?=DFHEL?:;IJ>7JJ>;J7H=;J7M7H:EFFEHJKD?JO?I7M7H:;:?D79EC8?D7J?EDE<*7HA;J 87I;:-/02I7D:I;HL?9; 87I;:
/02I4;9EDI?:;H*7HA;J 87I;:-/02IJE8;F;H<EHC7D9; 87I;: 8KJ:EDEJ9B7II?<OI;HL?9; 87I;:/02I7IF;H<EHC7D9; 87I;:
DEJM?J>IJ7D:?D=J>;L7H?78B;F7OEKJ9EC;J>;OFHEL?:;&D97B;D:7HO;7HI7D: <EHEKH ",7D:+",IM>E7H;;N;9KJ?L;L?9;
FH;I?:;DJIX"3-IY J>;F;H9;DJ7=;IE<J>;)1&-J7H=;J7M7H:EFFEHJKD?JO7M7H:;:?D*7HA;J 87I;:-/02I7D:I;HL?9; 87I;:/02IM;H;
7D: H;IF;9J?L;BOM>?B;<EH+",IM>E7H;I;D?EHL?9;FH;I?:;DJIX03-IY J>;F;H9;DJ7=;IE<J>;)1&-J7H=;J7M7H:EFFEHJKD?JO7M7H:;:?D
*7HA;J 87I;:-/02I7D:I;HL?9; 87I;:/02IM;H; 7D: H;IF;9J?L;BO0;;XC) *7-) 869.7<*=287";80;*6<C
870%.;67,.7=2?.";80;*6C.<207Y<EH<KHJ>;H?D<EHC7J?EDH;=7H:?D=J>;?CF79JE<IK9>7J7H=;JF7OC?N
'=43'=#48/3-+79187'3* 84)0.41*+6986+').
4;;L7BK7J;EKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C7D:FH79J?9;I7JB;7IJ7DDK7BBOCED=EJ>;HJ>?D=I M;9EDI?:;HJ>;EKJ9EC;E<
EKHCEIJH;9;DJ7:L?IEHOLEJ;JE7FFHEL;D7C;:;N;9KJ?L;E<<?9;H9ECF;DI7J?ED EHX07OED-7OY&DH;9;DJO;7HI EKHIJE9A>EB:;HI
>7L;FHEL?:;:IJHED=IKFFEHJ<EHEKH7DDK7B07OED-7OFHEFEI7B ?D;N9;IIE<<HECJE4;7BIE9EDI?:;H?DFKJM;
H;9;?L;<HECEKHIJE9A>EB:;HI
I?I:;I9H?8;:78EL;?DCEH;:;J7?B?DX8?.;7*7,.*==.;<C8;98;*=.8?.;7*7,.C$=8,4185-.;70*0.6.7=YM;;D=7=;
H;=KB7HBOM?J>EKHIJE9A>EB:;HIEDC7JJ;HI?D9BK:?D=;N;9KJ?L;9ECF;DI7J?ED 7D:?D M;97HH?;:EKJJ>?IEKJH;79>FH?EHJEEKH
7DDK7BIJE9A>EB:;HC;;J?D=1>;J78B;8;BEMIKCC7H?P;IM>7JM;>;7H:<HECEKHIJE9A>EB:;HI 7D:EKHF;HIF;9J?L;EDJ>EI;L?;MI
,J>;HJ>7DJ>;9>7D=;I:;I9H?8;:8;BEM?DJ>?I ! J>;9ECC?JJ;;:;J;HC?D;:JEC7?DJ7?DEKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C
7D:FH79J?9;I?DJ>;?H9KHH;DJ<EHC<EH97B;D:7HO;7H ?DB?=>JE<EKHIJE9A>EB:;HIW9EDJ?DK?D=IKFFEHJ
B/-?>3@/97:/8=+>398%>9-5296./<"?></+-2
,@A:4D /92EH6962C57C@>@FCDE@4<9@=56CD 'FCA6CDA64E:G6 @HH6C6DA@?565
'FC??F2=
!?46?E:G6
(C@8C2>
,L;H7BB IJE9A>EB:;HI:?:DEJ;NFH;II
9ED9;HDIH;=7H:?D=J>;:;I?=DEHF7O <EH
F;H<EHC7D9;7B?=DC;DJE<EKH&-I?DFH?EH
O;7HI 9;HJ7?DIJE9A>EB:;HI;NFH;II;:7D
?DJ;H;IJ?DKD:;HIJ7D:?D=J>;H7J?ED7B;<EH
9;HJ7?D=E7BI7D:C;JH?9I?DEKH&-
,L;H7BB M;C7?DJ7?D;:J>;IJHK9JKH;E<EKH&-<EH97B;D:7HO;7HI7D:
#EH97B;D:7HO;7H JE?D9H;7I;7B?=DC;DJ7HEKD:9EHFEH7J; B;L;B=E7BI
KD:;HBO?D=J>;&D:?L?:K7B-;H<EHC7D9;#79JEH9ECFED;DJE<J>;&- 7D:JE
FHEL?:;?D9H;7I;:EFFEHJKD?JO<EH?D:?L?:K7B:?<<;H;DJ?7J?ED?DEKJ9EC;I J>;
9ECC?JJ;;9>7D=;:J>;C7DD;H?DM>?9>?J:;J;HC?D;:J>;&D:?L?:K7B-;H<EHC7D9;
#79JEHI<EHEKH+",I7I:;I9H?8;:78EL;?DXC A.,>=2?.869.7<*=287
$7*9<18=";80;*6<*7-#.,.7=!>=,86.<Y1>;=E7BI7D:?D:?L?:K7BH;IKBJI
79>?;L;:7H;:;I9H?8;:?DXC) *7-) 869.7<*=287";80;*6<C
77>*57,.7=2?.";80;*6C*5.7-*;).*; 77>*57,.7=2?.";80;*6
"*;*6.=.;<*7-"*B8>=.,2<287<C 77>*57,.7=2?.";80;*67-2?2->*5
".;/8;6*7,.*,=8;<Y8;BEM
'FC$@?8 ,6C>
!?46?E:G6
(C@8C2>
,L;H7BB IJE9A>EB:;HI9EDJ?DK;:JE8;I7J?I<?;:
M?J>J>;:;I?=D7D:F7O <EH F;H<EHC7D9;
7B?=DC;DJE<EKH)1&-<;MIJE9A>EB:;HI
DEJ;:?DJ;H;IJ?DI;;?D=7M7H:IM?J>BED=;H
L;IJ?D=F;H?E:IJEH;?D<EH9;BED= J;HC
7B?=DC;DJ?DIEC;97I;I J>;I;IJE9A>EB:;HI
;NFH;II;:7FH;<;H;D9;J>7JJ>;I;BED=;H
L;IJ?D=I;HL?9; 87I;:/02IJ7A;J>;FB79;E<
7M7H:IIK8@;9JJEF;H<EHC7D9; 87I;:L;IJ?D=
1>;9ECC?JJ;;H;=KB7HBO;L7BK7J;IJ>;IJHK9JKH;E<EKH9ECF;DI7J?EDFHE=H7CI
M?J>J>;7II?IJ7D9;E<?JI9ECF;DI7J?ED9EDIKBJ7DJ JE;DIKH;J>7JEKHFHE=H7CI
9EDJ?DK;JEI;HL;J>;?H?DJ;D:;:FKHFEI;I&DB?=>JE<J>;9EDJ?DK?D=IKFFEHJ
H;9;?L;:<HECJ>;B7H=;C7@EH?JOE<EKHIJE9A>EB:;HI7D:J>;9ECC?JJ;;WIL?;MJ>7J
EKH)1&-M7I7FFHEFH?7J;BO7B?=D?D=F7O7D:F;H<EHC7D9; M;C7?DJ7?D;:J>;
IJHK9JKH;E<EKH)1&-<EH97B;D:7HO;7H
& & !
1>?II;9J?ED:;I9H?8;IJ>;9ECFED;DJIE<EKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C&J7BIE:;I9H?8;I <EH;79>9ECFED;DJ J>;F7OEKJI
JEEKH+",I<EH97B;D:7HO;7H7D:J>;<EHM7H: BEEA?D=79J?EDIJ7A;DM?J>H;IF;9JJEEKH+",I?D97B;D:7HO;7H
425+37'8/43+:+17
1>;9ECC?JJ;;;IJ78B?I>;IJ7H=;J9ECF;DI7J?EDB;L;BI<EH;79>97B;D:7HO;7H<EHEKH+",I87I;:EDJ>;<79JEHI:;I9H?8;:?DXC
!?.;?2.@8/A.,>=2?.869.7<*=287";80;*6<CA.,>=2?.869.7<*=287"1258<891B*7-";80;*6.<207Y78EL;:@KIJC;DJIJE
J7H=;J9ECF;DI7J?EDB;L;BI7H;=;D;H7BBO9EDI?:;H;:8OJ>;9ECC?JJ;;;79>O;7H?D#;8HK7HODDK7B?D9H;7I;I7H;87I;:ED7D
;L7BK7J?EDE<F;H<EHC7D9;8OJ>; ",7D:J>;9ECC?JJ;;EH ?DJ>;97I;E<J>; ", 87I;:ED7D;L7BK7J?EDE<J>; ",WI
F;H<EHC7D9;8OJ>;?D:;F;D:;DJC;C8;HIE<EKHE7H: 7IM;BB7IJ>; ECF7DOWIF;H<EHC7D9;7D:EKJBEEA<EHJ>;KF9EC?D=
97B;D:7HO;7H 7D:9ECF;DI7J?ED:7J7<HECEKH-;;H$HEKF9ECF7D?;I7D:IKHL;O:7J7 ?D799EH:7D9;M?J>J>;FH?D9?FB;I:;I9H?8;:
8;BEMKD:;HXCA.,>=2?.869.7<*=2878?.;7*7,.*7-";8,.->;.<C"..;;8>9";*,=2,.<*7-$>;?.B*=7Y
-- 46 of 186 --
#EH97B;D:7HO;7HI7D: JEJ7BJ7H=;J:?H;9J9ECF;DI7J?EDX11! Y 7CEKDJI<EHEKH+",IM;H;7I<EBBEMI
+6/8.+<*/+< &9>+6&+<1/>3</->97:/8=+>398
??F2=2D6+2=2CJ
!(,2C86E
$,!(,2C86E
,,
,,
!?4C62D6
&2>65I64FE:G6'77:46C 1 1
1?CEJ>O*H9>;H
!EK=B7I/;JJ?D=;H
0;I>7I7O;;0;I>7 37H7:7H7@7D
+;?B'#;HD7D:;I
37>?:37>;:?
"<<;9J?L;#;8HK7HO
"<<;9J?L;#;8HK7HO
)1&-J7H=;J7M7H:EFFEHJKD?J?;I;NFH;II;:7I720:EBB7HL7BK; 7H;7FFHEL;:8OJ>;9ECC?JJ;;7D:9EDL;HJ;:JE7M7H:IEDJ>;=H7DJ:7J;7I
:;I9H?8;:?DJ>;J78B;X)1&-"GK?JO3;>?9B;IYEDF7=;8;BEMKI?D=J>;JH7:?D=:7O7L;H7=;E<J>;9BEI?D=FH?9;E<EKH9ECCED
IJE9AFH?EHJEJ>;$H7DJ!7J;17H=;J7M7H:EFFEHJKD?J?;I:?<<;H<HECJ>;7CEKDJII>EMD?DXT"N;9KJ?L; ECF;DI7J?ED178B;IY<EBBEM?D=J>?I
! M>?9>H;FH;I;DJJ>;=H7DJ:7J;<7?HL7BK;E<J>;7M7H:I:;J;HC?D;:?D799EH:7D9;M?J>0
1>;9ECC?JJ;;7:@KIJ;:J>;9ECF;DI7J?EDE<;79>E<J>;+",I<EH97B;D:7HO;7HJEH;<B;9J;79>;N;9KJ?L;WIF;H<EHC7D9;7D:
J;DKH;?DHEB; 7D:JEH;C7?D9ECF;J?J?L;H;B7J?L;JEEKH-;;H$HEKF?D7D;IF;9?7BBO9ECF;J?J?L;C7HA;J<EHEKH;N;9KJ?L;I*7HA;J
C;:?7D11! :7J779HEII+",HEB;I?D9H;7I;:8O7FFHEN?C7J;BOO;7H EL;H O;7HED7L;H7=; M?J>CEH;FHEDEKD9;:?D9H;7I;I
<EH*H#;HD7D:;IW7D:!H37>;:?WIHEB;I ?BBKIJH7J?D=J>;>?=>BO9ECF;J?J?L;C7HA;J<EH9ECF7H78B;;N;9KJ?L;J7B;DJ1>;9ECC?JJ;;
9EDI?:;H;:J>?IH;B7J?L;JEJ>;97B?8;HE<EKH;N;9KJ?L;I M>E>7L;9EDI?IJ;DJBOEKJF;H<EHC;:J>;C7HA;JEL;HJ>;?HJ;DKH;I4?J>
H;IF;9JJE*H37H7:7H7@7D J>;9ECC?JJ;;7BIE7:@KIJ;:>?I9ECF;DI7J?EDJEH;<B;9JJ>;8HE7:;HHEB;>;M7I7IIKC?D=?D?D
9EDD;9J?EDM?J>>?I7FFE?DJC;DJ7I"N;9KJ?L;3?9;-H;I?:;DJ7D: >?;<,F;H7J?D=,<<?9;H M?J>EL;HI?=>JE<EKH EHFEH7J;0JH7J;=O
KIJEC;H0KFFEHJKI?D;II$HEKFX 0$A 7D:$BE87B1H7:;7D:$EL;HDC;DJ<<7?HI=HEKFI7::;:JE>?I;N?IJ?D=HEB;EL;HI;;?D=
EKH$BE87B-HE:K9J$HEKF
'7+ '1'6=
:@KIJC;DJIJE87I;I7B7HO7H;=;D;H7BBO9EDI?:;H;:8OJ>;9ECC?JJ;;;79>O;7H?D#;8HK7HO
#EH97B;D:7HO;7HI7D: 87I;I7B7H?;I<EHJ>;D ;CFBEO;:+",IM;H;:;J;HC?D;:8OJ>;9ECC?JJ;;?D#;8HK7HOE<;79>
O;7H 87I;:EDJ>;<79JEHI:;I9H?8;:?DJ>;J78B;X869.7<*=28786987.7=<YEDF7=;78EL;1>;87I;I7B7H?;IE<J>;+",I<EH
97B;D:7HO;7HI7D:7H;I>EMD8;BEM
!"88?+6+=/%+6+<3/=
&2>65I64FE:G6'77:46C
??F2=2D6+2=2CJ
??F2=2D6+2=2CJ
??F2=2D6+2=2CJ
!?4C62D61 1
1?CEJ>O*H9>;H
!EK=B7I/;JJ?D=;H
0;I>7I7O;;0;I>7 37H7:7H7@7D
+;?B'#;HD7D:;I
37>?:37>;:?
"<<;9J?L;#;8HK7HO
"<<;9J?L;#;8HK7HO
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 47 of 186 --
339'13)+38/:+64-6'2
88?+68-/8>3@/#<91<+797:98/8>=
1>;9ECFED;DJIE<EKH&- ;79>E<M>?9>FB7OI7HEB;?D:;J;HC?D?D=79JK7BF7OC;DJIC7:; 7H;:;I9H?8;:8;BEM
88?+68-/8>3@/#<91<+797:98/8>=
O;N9BK:?D=9;HJ7?D9EIJI7D:;NF;DI;IJ>7J7H;DEJ?D:?97J?L;E<9EH;H;IKBJI M;8;B?;L;DED $-H;IKBJI7H;KI;<KB<EH7D7BOP?D=8KI?D;II
JH;D:IEL;HCKBJ?FB;F;H?E:I
#EH7:;I9H?FJ?EDE<9EHFEH7J; B;L;BDDK7B,F;H7J?D=-B7D=E7BI I;;XC*5.7-*;).*; 77>*57,.7=2?.";80;*6"*;*6.=.;<*7-"*B8>=
.,2<287<C 77>*57,.7=2?.";80;*67-2?2->*5".;/8;6*7,.*,=8;<Y8;BEM
1>;#KD:?D=#79JEH?II;J8OJ>;9ECC?JJ;;JE9H;7J;7C7N?CKCF7OEKJ7CEKDJ<HECM>?9>&-F7OEKJIC7O8;C7:;1E
:;J;HC?D;;79>+",WI&-H;IKBJ J>;9ECC?JJ;;7II;II;IJ>;H;IKBJIE<;79>E<J>;F;H<EHC7D9;<79JEHI1>;9ECC?JJ;;C7?DJ7?DI
:?I9H;J?EDJE7:@KIJJ>;F;H<EHC7D9;<79JEHH;IKBJIKFM7H:EH:EMDM7H: IK8@;9JJEJ>;EL;H7BBC7N?CKC;IJ78B?I>;:8OJ>;#KD:?D=
#79JEH 7BJ>EK=>?J:?:DEJ;N;H9?I;7DOIK9>:?I9H;J?ED?D:;J;HC?D?D= 6F7OEKJI
1>;C;JH?9I7D:=E7BI<EHJ>;&-7H;I;J7DDK7BBO?D9EDD;9J?EDM?J>EKH7DDK7B8KI?D;IIFB7DD?D=9O9B;7D:7H;:?H;9JBO9EDD;9J;:
JEEKH7DDK7B8KI?D;IIFB7DI7D:=E7BI1>;?DJ;HFB7O8;JM;;DEKH9EHFEH7J;FB7DD?D=9O9B;7D:EKH9ECF;DI7J?EDFB7DD?D=7D:
;L7BK7J?ED9O9B;?IIKCC7H?P;:?DJ>;<?=KH;8;BEM
-- 48 of 186 --
Annual Planning and Compensation Decision Cycle
We believe that, over time, outstanding business results create stockholder value. Consistent with this belief, multiple performance-
based metrics (non-GAAP operating margin, non-GAAP gross margin, product market share, and strategic, operational, and
organizational metrics embodied in organizational Annual Operating Plans) are established for our NEOs as part of the AIP. We
believe the metrics and goals set under this program have been effective to motivate our NEOs and the organizations they lead, and
to achieve pay-for-performance results.
Goals are set depending on the business environment and the Company’s annual objectives and strategies, encompassed in the
Annual Operating Plans for the Company and the organizations managed by each of the NEOs, to ensure that they remain stretch
goals regardless of changes in the business environment, which can vary significantly from year-to-year in our industry. Accordingly,
as business conditions improve, Corporate Performance Factor and Profitability Performance Factor goals are calibrated to require
better performance, and if business conditions deteriorate, these goals are calibrated to incentivize stretch performance under more
difficult conditions. Annual Operating Plan objectives are also reflected in the Individual Performance Factor, which is based primarily
on NEOs’ performance to corporate-level Annual Operating Plan goals, as well as individual contributions during the performance
period.
As shown in the figure below, the committee establishes the Corporate Performance Factor and Profitability Performance Factor for
each year to incorporate stretch goals that are challenging to achieve relative to our Annual Operating Plan, taking into consideration
our business cycle and the overall industry outlook.
• Over the two years through calendar year 2022, the committee raised the Corporate Performance Factor goal year-over-
year as our outlook and the industry outlook improved (there was no Profitability Performance Factor in these years).
• For calendar year 2023, the weakened industry outlook for wafer fabrication equipment spending prompted the committee to
establish a Corporate Performance Factor goal that was below that of the prior year, reflecting the increased difficulty of
achieving similar profitability on a significantly smaller revenue base. The committee also for the first time established a
Profitability Performance Factor goal, with the metric of non-GAAP gross margin, in light of the focus by the Board,
committee, and management team on the profitability of the Company, setting a stretch goal relative to our Annual Operating
Plan.
• In calendar year 2024, the committee established a slightly increased Corporate Performance Factor goal to incentivize
improved performance relative to calendar year 2023, despite continued industry uncertainty. The committee also continued
to include a Profitability Performance Factor, and established a significantly increased goal, reflecting the continued focus on
profitability.
• In calendar year 2025, the committee raised both the Corporate Performance Factor goal and the Profitability Performance
Factor goal incrementally year-over-year, to continue to incentivize improved performance in light of a stronger industry and
company outlook.
Lam Research Corporation 2026 Proxy Statement 37
-- 49 of 186 --
9<:9<+>/+8.#<903>+,363>C#/<09<7+8-/+->9<9+6=09<+6/8.+<*/+<=
EHFEH7J;-;H<EHC7D9;#79JEH$E7B+ED $-,F;H7J?D=*7H=?D
-HE<?J78?B?JO-;H<EHC7D9;#79JEH$E7B+ED $-$HEII*7H=?D
6 6 6 6 6
1>;IF;9?<?9C;JH?9I7D:=E7BI7D:J>;H;B7J?L;M;?=>J?D=I<EHJ>;-;H<EHC7D9;#79JEHI7H;:;J;HC?D;:8OJ>;9ECC?JJ;;9EDI?:;H?D=
J>;H;9ECC;D:7J?EDE<EKH ", EJ>;HJ>7DJ>;C;JH?9I7D:=E7BI<EHJ>;&D:?L?:K7B-;H<EHC7D9;#79JEH M>?9>7H;:;J;HC?D;:8O
EKH ", EH?DJ>;97I;E<J>; ", 8OJ>;9ECC?JJ;;&D7::?J?ED J>;9ECC?JJ;;;IJ78B?I>;I?D:?L?:K7BJ7H=;J7M7H:EFFEHJKD?J?;I<EH
;79>+",7I7F;H9;DJ7=;E<87I;I7B7HO0F;9?<?9J7H=;J7M7H:EFFEHJKD?J?;I7H;:;J;HC?D;:87I;:ED@E8I9EF;7D:
H;IFEDI?8?B?J?;I 7IM;BB7I7D7II;IIC;DJE<-;;H$HEKF:7J7M7H:I>7L;7C7N?CKCF7OC;DJ7CEKDJ:;<?D;:7I7CKBJ?FB;E<J>;
J7H=;J7M7H:EFFEHJKD?JO
+6/8.+<*/+< 88?+68-/8>3@/#<91<+7#+<+7/>/<=+8.#+C9?>/-3=398=
&D#;8HK7HO J>;9ECC?JJ;;I;JJ>;97B;D:7HO;7HJ7H=;J7M7H:EFFEHJKD?J?;I ;IJ78B?I>;:J>;C;JH?9I7D:=E7BI<EHJ>;
#KD:?D=#79JEH J>; EHFEH7J;-;H<EHC7D9;#79JEH 7D:J>;-HE<?J78?B?JO-;H<EHC7D9;#79JEH :;J;HC?D;:J>7JJ>;J>H;;-;H<EHC7D9;
#79JEHII>EKB:8;M;?=>J;:;GK7BBO 7D:;IJ78B?I>;:J>;C;JH?9I7D:=E7BI<EHJ>;&D:?L?:K7B-;H<EHC7D9;#79JEHI<EH;79>J>;D
;CFBEO;:+",&D#;8HK7HO J>;9ECC?JJ;;9EDI?:;H;:J>;79JK7BH;IKBJIKD:;HJ>;I;<79JEHI7D:C7:;F7OEKJ:;9?I?EDI<EH
J>;97B;D:7HO;7HFHE=H7C
33:&13(*39.;*74,7&2#&7,*9<&7)55479:3.9.*8 1>;&-J7H=;J7M7H:EFFEHJKD?J?;I<EH97B;D:7HO;7H<EH;79>
+",M;H;7II;J<EHJ>J>;<?=KH;8;BEM?D799EH:7D9;M?J>J>;FH?D9?FB;I:;I9H?8;:8;BEMKD:;HXCA.,>=2?.869.7<*=287
8?.;7*7,.*7-";8,.->;.<C"..;;8>9";*,=2,.<*7-$>;?.B*=*Y1>;J7H=;J7M7H:EFFEHJKD?J?;I7I7F;H9;DJ7=;E<87I;
I7B7HO <EH;79>E<EKH+",IH;C7?D;:J>;I7C;<EH97B;D:7HO;7HH;B7J?L;JEJ>;FH?EHO;7H1>;9ECC?JJ;;7BIEI;J7C7N?CKC
7M7H:EFFEHJKD?JO M>?9><EH97B;D:7HO;7HM7I;GK7BJEJ?C;IJ>;J7H=;J7M7H:EFFEHJKD?JO
88?+68-/8>3@/#<91<+7&+<1/>A+<."::9<>?83>3/=09<+6/8.+<*/+<
&2>65I64FE:G6'77:46C
,2C86EH2C5
'AA@CEF?:EJ
@72D6+2=2CJ
,2C86EH2C5
'AA@CEF?:EJ
1?CEJ>O*H9>;H
!EK=B7I/;JJ?D=;H
0;I>7I7O;;0;I>7 37H7:7H7@7D
+;?B'#;HD7D:;I
37>?:37>;:?
7B9KB7J;:8OCKBJ?FBO?D=;79>+",WI7DDK7B87I;I7B7HO7IE<,9JE8;H 8OJ>;?HH;IF;9J?L;J7H=;J7M7H:EFFEHJKD?JOF;H9;DJ7=;
33:&13(*39.;*74,7&2:3).3,&(94747547&9**7+472&3(*&(947&3)74+.9&'.1.9>*7+472&3(*&(947&D
#;8HK7HO J>;9ECC?JJ;;I;JDED $-EF;H7J?D=C7H=?D7IJ>;C;JH?9<EHJ>;#KD:?D=#79JEH7D: EHFEH7J;-;H<EHC7D9;
#79JEH 7D:I;JDED $-=HEIIC7H=?D7IJ>;C;JH?9<EHJ>;-HE<?J78?B?JO-;H<EHC7D9;#79JEH<EH97B;D:7HO;7H M?J>J>;
F7H7C;J;HI7II>EMD?DJ>;<?=KH;8;BEM
-- 50 of 186 --
Calendar Year 2025 Annual Incentive Program Metrics, Goals, and Results
(1) Minimums and maximums are set by the Funding Factor.
(2) Appendix A contains a reconciliation of non-GAAP operating margin and non-GAAP gross margin to the results reported in our financial
statements.
The Company’s actual non-GAAP operating margin and non-GAAP gross margin for calendar year 2025 resulted in the achievement
levels shown in the figure above.
2025 Annual Incentive Program Individual Performance Factors. For calendar year 2025, the committee determined the
Individual Performance Factor for each NEO (other than Mr. Archer) by establishing a baseline Individual Performance Factor of 1.05
based on the Company’s performance relative to corporate-level Annual Operating Plan goals and then applying adjustments to that
baseline for individual NEOs based on differentiated individual performance.
For calendar year 2025, the corporate-level Annual Operating Plan goals spanned the following areas:
• Market performance and execution: goals relating to growth in our served addressable market; success of new product
introductions; penetration of new market opportunities and defense of established positions; and achievement of industry
share targets, among other factors.
• Safety, quality, and customer satisfaction: goals relating to safety; quality; growth of Customer Support Business Group
revenue; on-time and complete delivery of products; and customer satisfaction, among other factors.
• Human capital: goals relating to employee engagement, as measured by employee survey; and talent retention, among
other factors.
• Financial performance: goals relating to operating income; earnings per share; and gross margin, among other factors.
The committee assigned above-baseline Individual Performance Factors to two NEOs (other than Mr. Archer) based on their
differentiated individual performance. The committee assigned an Individual Performance Factor of 1.15 to Mr. Varadarajan in
recognition of his individual contributions to strong customer support and improved new product maturity at the time of introduction,
while the committee assigned an Individual Performance Factor of 1.20 to Mr. Fernandes in recognition of his individual contributions
to strong customer support and improved profitability of the Company.
In determining Mr. Archer’s Individual Performance Factor, the independent members of the Board evaluated the Company’s
performance against its corporate-level goals, Mr. Archer’s individual performance, and the performance of the other members of the
management team reporting to him, and determined to assign him an Individual Performance Factor equal to the highest level of
individual performance achieved by the other NEOs.
Calendar Year 2025 Annual Incentive Program Payout Decisions. Based on the above results and decisions, for the calendar
year 2025 AIP, the committee approved the payouts for each NEO as shown below, which were less than the maximum payout
available under the Funding Factor:
Lam Research Corporation 2026 Proxy Statement 39
-- 51 of 186 --
88?+68-/8>3@/#<91<+7#+C9?>=09<+6/8.+<*/+<
&2>65I64FE:G6'77:46C
,2C86E
H2C5
'AA@CEF?:EJ
%2I:>F>H2C5'AA@CEF?:EJ
F?5:?824E@C @7
,2C86EH2C5'AA@CEF?:EJ
!?5:G:5F2=
(6C7@C>2?46
24E@C
@CA@C2E6
(6C7@C>2?46
24E@C
(C@7:E23:=:EJ
(6C7@C>2?46
24E@C
4EF2=
(2J@FED
1?CEJ>O*H9>;H
!EK=B7I/;JJ?D=;H
0;I>7I7O;;0;I>7 37H7:7H7@7D
+;?B'#;HD7D:;I
37>?:37>;:?
7B9KB7J;:8OCKBJ?FBO?D=;79>+",WI7DDK7B87I;I7B7HO7IE<,9JE8;H 8OJ>;?HH;IF;9J?L;J7H=;J7M7H:EFFEHJKD?JOF;H9;DJ7=;
1>;#KD:?D=#79JEHH;IKBJ;:?D&-<KD:?D=7JE<J7H=;J7M7H:EFFEHJKD?JO<EHJ>;97B;D:7HO;7H87I;:EDJ>;79JK7BDED $-EF;H7J?D=
C7H=?DH;IKBJI7D:J>;IF;9?<?9=E7B:;J7?B;:KD:;HXC 77>*57,.7=2?.";80;*6>7-270*,=8;8;98;*=.".;/8;6*7,.*,=8;*7-
";8/2=*+252=B".;/8;6*7,.*,=8;Y78EL;
7B9KB7J;:8OCKBJ?FBO?D=;79>+",WIJ7H=;J7M7H:EFFEHJKD?JO ?D:EBB7HI 8O;79>E<? J>; EHFEH7J;-;H<EHC7D9;#79JEHE< ?? J>;
-HE<?J78?B?JO-;H<EHC7D9;#79JEHE< 7D:??? J>7J+",WI?D:?L?:K7B-;H<EHC7D9;#79JEH
+6/8.+<*/+< 88?+68-/8>3@/#<91<+7#+<+7/>/<=
&D#;8HK7HO J>;9ECC?JJ;;I;JJ>;J7H=;J7M7H:EFFEHJKD?JO<EH;79>+",7I7F;H9;DJ7=;E<87I;I7B7HO7D:I;J7C7N?CKC
7M7H:EFFEHJKD?JO;GK7BJEJ?C;IJ>;J7H=;J7M7H:EFFEHJKD?JO#EH97B;D:7HO;7H J7H=;J7M7H:EFFEHJKD?J?;I?D9H;7I;:<EH
I;L;H7B+",I9ECF7H;:JEJ>;FH?EHO;7H?DEH:;HJEH;C7?D9ECF;J?J?L;H;B7J?L;JEEKH-;;H$HEKF1>;J7H=;J7M7H:EFFEHJKD?JO<EH
;79>+",?II>EMD8;BEM
88?+68-/8>3@/#<91<+7&+<1/>A+<."::9<>?83>3/=09<+6/8.+<*/+<
&2>65I64FE:G6'77:46C
,2C86EH2C5'AA@CEF?:EJ
@72D6+2=2CJ
1?CEJ>O*H9>;H
!EK=B7I/;JJ?D=;H
0;I>7I7O;;0;I>7 37H7:7H7@7D
+;?B'#;HD7D:;I
37>?:37>;:?
1>;9ECC?JJ;;7FFHEL;:DED $-EF;H7J?D=C7H=?D7IJ>;7DDK7BC;JH?9<EHJ>;#KD:?D=#79JEH7D:J>; EHFEH7J;-;H<EHC7D9;
#79JEH 7FFHEL;:DED $-=HEIIC7H=?D7IJ>;7DDK7BC;JH?9<EHJ>;-HE<?J78?B?JO-;H<EHC7D9;#79JEH 7D:I;JJ>;7DDK7B=E7BI<EH
J>;#KD:?D=#79JEH J>; EHFEH7J;-;H<EHC7D9;#79JEH 7D:J>;-HE<?J78?B?JO-;H<EHC7D9;#79JEH EDI?IJ;DJM?J>J>;FHE=H7C:;I?=D
J>; EHFEH7J;-;H<EHC7D9;#79JEH7D:-HE<?J78?B?JO-;H<EHC7D9;#79JEH=E7BI7H;CEH;:?<<?9KBJJE79>?;L;J>7DJ>;#KD:?D=#79JEH
=E7B&D:?L?:K7B-;H<EHC7D9;#79JEHC;JH?9I7D:=E7BIM;H;7BIE;IJ78B?I>;:<EH;79>+", 87I;:ED9EHFEH7J; B;L;BDDK7B
,F;H7J?D=-B7D=E7BI7D:?D:?L?:K7BF;H<EHC7D9;BB EHFEH7J; -HE<?J78?B?JO 7D:&D:?L?:K7B-;H<EHC7D9;#79JEH=E7BIM;H;:;I?=D;:
JE8;IJH;J9>=E7BI
43-!+623)+38/:+64-6'2
/=318
,KH)1&-?I:;I?=D;:JE7JJH79J7D:H;J7?DJEFJ7B;DJ FHEL?:;9ECF;J?J?L;B;L;BIE<9ECF;DI7J?ED 7B?=DF7OM?J>79>?;L;C;DJE<
8KI?D;IIE8@;9J?L;I7D:M?J>IJE9AF;H<EHC7D9;EL;H7CKBJ? O;7HF;H?E: H;M7H:EKH+",I<EHEKJIJ7D:?D= ECF7DOF;H<EHC7D9;
7D:9H;7J;IJE9A>EB:;HL7BK;EL;HJ>;BED= J;HC
2D:;HJ>;9KHH;DJ)1&- 7JJ>;8;=?DD?D=E<;79>CKBJ? O;7HF;H<EHC7D9;F;H?E: J7H=;J7M7H:EFFEHJKD?J?;I;NFH;II;:7I720
:EBB7HL7BK; F;H<EHC7D9;C;JH?9I 7D:J>;C?NE<L;>?9B;IKI;:7H;;IJ78B?I>;:<EHJ>;FHE=H7C
2D:;HJ>;)1&- I;HL?9; 87I;:/02IL;IJED7D7DDK7B87I?IEL;HJ>H;;O;7HI M>?B;*7HA;J 87I;:-/02I9B?<<L;IJ7<J;H
J>H;;O;7HI B?<< H7J>;HJ>7D7DDK7B L;IJ?D=FHEL?:;I<EH8EJ>H;J;DJ?ED7D:<EH7B?=D?D=+",IM?J>BED=;H J;HCIJE9A>EB:;H?DJ;H;IJI
-- 52 of 186 --
;?3>C(/23-6/=
1>;;GK?JOL;>?9B;IKI;:?DEKH)1&-7H;7I<EBBEMI
&#;?3>C(/23-6/=
BF:EJ.69:4=6D .6DE:?8 ,6C>D
%2C<6E 32D65(*+-D
Z ","3-IE<
17H=;JM7H:
,FFEHJKD?JO
Z 03-IE<17H=;J
M7H:,FFEHJKD?JO
Z M7H:I9B?<<L;IJEDJ>;J>?H:7DD?L;HI7HOE<
J>;#;8HK7HO =H7DJ:7J;J>;X$H7DJ
!7J;Y IK8@;9JJEI7J?I<79J?EDE<7C?D?CKC
F;H<EHC7D9;H;GK?H;C;DJ7D:9EDJ?DK;:
;CFBEOC;DJ
Z M7H:IJ>7JL;IJ7JJ>;;D:E<J>;
F;H<EHC7D9;F;H?E:7H;:?IJH?8KJ;:?DI>7H;I
E<EKH9ECCEDIJE9A
Z 1>;J7H=;JDKC8;HE<*7HA;J 87I;:-/02I=H7DJ;:?I:;J;HC?D;:8O
:?L?:?D=J>;7FFB?978B;F;H9;DJ7=;E<J>;J7H=;JEFFEHJKD?JO8OJ>;
JH7:?D=:7O7L;H7=;E<J>;9BEI?D=FH?9;E<EKH9ECCEDIJE9AFH?EHJE
J>;$H7DJ!7J; HEKD:;::EMDJEJ>;D;7H;IJI>7H;
Z 1>;DKC8;HE<I>7H;IH;FH;I;DJ;:8OJ>;*7HA;J 87I;:-/02IJ>7J
97D8;;7HD;:EL;HJ>;F;H<EHC7D9;F;H?E:?I:;J;HC?D;:799EH:?D=JE
J>;F;H<EHC7D9;F7H7C;J;HI:;I9H?8;:?DJ>;<?=KH;8;BEM
+6CG:46 32D65*+-D
Z ","3-IE<
17H=;JM7H:
,FFEHJKD?JO
Z 03-IE<17H=;J
M7H:,FFEHJKD?JO
Z M7H:IL;IJED; J>?H:EDJ>;<?HIJ I;9ED:
7D:J>?H:7DD?L;HI7H?;IE<J>;$H7DJ!7J;
IK8@;9JJE9EDJ?DK;:;CFBEOC;DJ
Z M7H:I7H;:?IJH?8KJ;:?DI>7H;IE<EKH
9ECCEDIJE9AKFEDL;IJ?D=
Z 1>;DKC8;HE</02I=H7DJ;:?I:;J;HC?D;:8O:?L?:?D=J>;7FFB?978B;
F;H9;DJ7=;E<J>;J7H=;JEFFEHJKD?JO8OJ>;JH7:?D=:7O7L;H7=;E<
J>;9BEI?D=FH?9;E<EKH9ECCEDIJE9AFH?EHJEJ>;$H7DJ!7J;
HEKD:;::EMDJEJ>;D;7H;IJI>7H;
+<5/>,+=/.#$%'#/<09<7+8-/#+<+7/>/<=
(2C2>6E6C ,6C>D
(6C7@C>2?46(6C:@5 1>H;;O;7HI<HECJ>;<?HIJ8KI?D;II:7O?D#;8HK7HO#;8HK7HO J>HEK=>#;8HK7HO
(6C7@C>2?46!?56I -%)50;C?9ED:K9JEH0;9JEH1EJ7B/;JKHD&D:;N EH50,5?D:;N
&F>36C@7+92C6D Z 7I;:EDEKHH;B7J?L;10/F;H<EHC7D9;9ECF7H;:JEJ>;10/F;H<EHC7D9;E<J>;9ECFED;DJIE<J>;50,5?D:;N ED
7F;H9;DJ?B;H7DA87I?I1>;10/F;H<EHC7D9;?IC;7IKH;:KI?D=J>;7L;H7=;9BEI?D=FH?9;<EHJ>;JH7:?D=:7OI
FH?EHJEJ>;:7J;IJ>;F;H<EHC7D9;F;H?E:8;=?DI7D:;D:I 7IIKC?D=J>7J7DO:?L?:;D:IF7?:7H;H;?DL;IJ;:EDJ>;
;N :?L?:;D::7J;-;H9;DJ?B;H7DA?IHEKD:;::EMDJEJ>;D;7H;IJED;J;DJ>E<7F;H9;DJ?B;KI?D=9EDL;DJ?ED7B
HEKD:?D=
Z J78B;H;<B;9J?D=J>;FEJ;DJ?7BF7OEKJI?II>EMD8;BEM?DJ>;<?=KH;8;BEM
Z 1>;<?D7BI>7H;I7M7H:;:97DDEJ;N9;;:E<J>;J7H=;J?<EKH10/?ID;=7J?L;EL;HJ>;F;H<EHC7D9;F;H?E:
+<5/>,+=/.#$%'#9>/8>3+6#+C9?>=
$2>MD,+*(6C46?E:=6*2?<
@>A2C65E@0+'0!?56I
%2C<6E 32D65(*+-D,92E2?62C?65
@7,2C86E
J>F;H9;DJ?B;EHCEH;
J>F;H9;DJ?B;
J>F;H9;DJ?B;
);IIJ>7DJ>F;H9;DJ?B;
1>;H;IKBJIE<J>;L;IJ?D=9H?J;H?7H;<B;9J?D=J>;DKC8;HE<*7HA;J 87I;:-/02IJ>7J97D8;;7HD;: 7H;B?D;7HBO?DJ;HFEB7J;:8;JM;;DJ>;IJ7J;:
F;H9;DJ?B;I7D:F;H9;DJ7=;I1>;H;IKBJE<J>;L;IJ?D=9H?J;H?7?IHEKD:;::EMDJEJ>;D;7H;IJM>EB;DKC8;H
+6/8.+<*/+< &#/-3=398=
&1*3)&7%*&7 )*(.8.438+479-* #2D:;HEKH)1&- J>;9ECC?JJ;;I;JI7J7H=;J7M7H:EFFEHJKD?JO<EH;79>
F7HJ?9?F7DJ87I;:EDJ>;+",WIFEI?J?ED7D:H;IFEDI?8?B?J?;I ECF7DO7D:?D:?L?:K7BF;H<EHC7D9; 7D:7D7II;IIC;DJE<
9ECF;J?J?L;9ECF;DI7J?ED:7J71>;J7H=;J7M7H:EFFEHJKD?J?;I<EH;79>F7HJ?9?F7DJ7H;;NFH;II;:?D720:EBB7HL7BK;,D
#;8HK7HO J>;9ECC?JJ;;C7:;7=H7DJKD:;HJ>;)1&-E<*7HA;J 87I;:-/02I7D:I;HL?9; 87I;:/02I EDJ>;
J;HCII;J<EHJ>?DJ>;J78B;IJ?JB;:X %":>2=B'.12,5.<F7D:X *;4.=+*<.-"#$&".;/8;6*7,."*;*6.=.;<F
78EL; M?J>79EC8?D;:L7BK;;GK7BJEJ>;+",WIJEJ7BJ7H=;J7M7H:EFFEHJKD?JO 7I:;J;HC?D;:8OJ>;9ECC?JJ;;7D:I>EMD8;BEM
1>;97B;D:7HO;7HJ7H=;J7CEKDJI<EH;79>+",M;H;?D9H;7I;:<HEC97B;D:7HJ7H=;JEFFEHJKD?J?;I7<J;HJ7A?D=
?DJE9EDI?:;H7J?EDEKH+",IW9EDJH?8KJ?EDI7D:H;IFEDI?8?B?J?;I 7D:EKH:;I?H;JE9EDJ?DK;JE?D9;DJ?L?P;EKJF;H<EHC7D9;7D:JE
FHEL?:;7FFHEFH?7J;?D9;DJ?L;EFFEHJKD?J?;I?D7>?=>BO9ECF;J?J?L;C7HA;J*7HA;JC;:?7DBED= J;HC?D9;DJ?L;:7J779HEII+",HEB;I
?D9H;7I;:8O7FFHEN?C7J;BOO;7H EL;H O;7HED7L;H7=; M?J>CEH;FHEDEKD9;:?D9H;7I;I<EH*H#;HD7D:;IW7D:!H37>;:?WI
HEB;I&D7::?J?ED 7IM7IDEJ;:78EL;M?J>H;IF;9JJE*H37H7:7H7@7D J>;9ECC?JJ;;7BIE7:@KIJ;:>?I9ECF;DI7J?EDJEH;<B;9JJ>;
8HE7:;HHEB;7D:?D9H;7I;:H;IFEDI?8?B?J?;I>;M7I7IIKC?D=?D?D9EDD;9J?EDM?J>>?I7FFE?DJC;DJ7I >?;<,F;H7J?D=,<<?9;H
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 53 of 186 --
&#A+<.<+8>=
&2>65I64FE:G6'77:46C
,2C86EH2C5
'AA@CEF?:EJ
%2C<6E 32D65(*+-
H2C5
+6CG:46 32D65
*+-H2C5
1?CEJ>O*H9>;H
!EK=B7I/;JJ?D=;H
0;I>7I7O;;0;I>7 37H7:7H7@7D
+;?B'#;HD7D:;I
37>?:37>;:?
17H=;J7M7H:EFFEHJKD?J?;I;NFH;II;:7I720:EBB7HL7BK; 7H;7FFHEL;:8OJ>;9ECC?JJ;;7D:9EDL;HJ;:JE7M7H:IEDJ>;=H7DJ:7J;7I
:;I9H?8;:?DJ>;<?=KH;78EL;J?JB;:X)1&-"GK?JO3;>?9B;IYKI?D=J>;JH7:?D=:7O7L;H7=;E<J>;9BEI?D=FH?9;E<EKH9ECCEDIJE9A
FH?EHJEJ>;$H7DJ!7J;17H=;J7M7H:EFFEHJKD?J?;I:?<<;H<HECJ>;7CEKDJII>EMD?DXCA.,>=2?.869.7<*=287%*+5.<Y<EBBEM?D=J>?I !
M>?9>H;FH;I;DJJ>;=H7DJ:7J;<7?HL7BK;E<J>;7M7H:I:;J;HC?D;:?D799EH:7D9;M?J>0
1>;DKC8;HE<*7HA;J 87I;:-/02I7M7H:;:?IH;<B;9J;:7JJ7H=;J1>;<?D7BDKC8;HE<I>7H;IJ>7JC7O8;;7HD;:M?BB8;JEE<J7H=;J
&1*3)&7%*&7 #<&7)&>4:98&D#;8HK7HO J>;9ECC?JJ;;:;J;HC?D;:J>;F7OEKJI<EHJ>;97B;D:7HO;7H
)1&-M7H:IE<*7HA;J 87I;:-/02I-H?EHJEEKH)1&- J>;DKC8;HE<I>7H;IH;FH;I;DJ;:8OJ>;*7HA;J
87I;:-/02I;7HD;:EL;HJ>;F;H<EHC7D9;F;H?E:M7I87I;:EDEKHH;B7J?L;10/F;H<EHC7D9;9ECF7H;:JEJ>;C7HA;JFH?9;
F;H<EHC7D9;E<J>;50,5?D:;N7I:;I9H?8;:?DJ>;J78B;8;BEM0J7HJ?D=M?J>EKH)1&- J>;9ECC?JJ;;8;=7DC;7IKH?D=
H;B7J?L;10/F;H<EHC7D9;<EHJ>;*7HA;J 87I;:-/02I8OJ>;F;H9;DJ?B;H7DA?D=E<J>; ECF7DOWI10/H;B7J?L;JEJ>;10/I<EHJ>;
9ECF7D?;IC7A?D=KFJ>;F;H<EHC7D9;?D:;N 7I:;I9H?8;:?DJ>;J78B;J?JB;:X *;4.=+*<.-"#$&".;/8;6*7,.
"*;*6.=.;<F78EL;
+<5/>,+=/.#$%'#/<09<7+8-/#+<+7/>/<=
(2C2>6E6C ,6C>D
(6C7@C>2?46(6C:@5 1>H;;O;7HI<HECJ>;<?HIJ8KI?D;II:7O?D#;8HK7HO#;8HK7HO J>HEK=>'7DK7HO
(6C7@C>2?46!?56I -%)50;C?9ED:K9JEH0;9JEH1EJ7B/;JKHD&D:;N EHX50,5?D:;NY
&F>36C@7+92C6D Z 7I;:EDEKHH;B7J?L;10/F;H<EHC7D9;9ECF7H;:JEJ>;C7HA;JFH?9;F;H<EHC7D9;E<J>;-;H<EHC7D9;&D:;N IK8@;9J
JE79;?B?D=7II>EMD?DJ>;<?=KH;8;BEM1>;10/F;H<EHC7D9;EHC7HA;JFH?9;F;H<EHC7D9;?IC;7IKH;:KI?D=J>;
9BEI?D=FH?9;<EHJ>;JH7:?D=:7OIFH?EHJEJ>;:7J;IJ>;F;H<EHC7D9;F;H?E:8;=?DI7D:;D:I 7IIKC?D=J>7J7DO
:?L?:;D:IF7?:EDEKH9ECCEDIJE9A7H;H;?DL;IJ;:EDJ>;;N :?L?:;D::7J;9EDI?IJ;DJM?J>J>;JH;7JC;DJE<
:?L?:;D:I?DJ>;-;H<EHC7D9;&D:;N
Z -EJ;DJ?7BF7OEKJI7H;7II>EMD?DJ>;<?=KH;8;BEM1>;H;IKBJE<J>;L;IJ?D=<EHCKB7?IHEKD:;::EMDJEJ>;D;7H;IJ
M>EB;DKC8;H
+<5/>,+=/.#$%'#9>/8>3+6#+C9?>=
$2>MD,+*92?86(6C7@C>2?46
@>A2C65E@0+'0!?56I92?86(6C7@C>2?46
%2C<6E 32D65(*+-D,92E2?62C?65
@7,2C86E
EHCEH;
;GK7BJE?D:;N
EHB;II
1>;H;IKBJIE<J>;L;IJ?D=<EHCKB7H;<B;9J?D=J>;DKC8;HE<*7HA;J 87I;:-/02IJ>7J97D8;;7HD;: 7H;B?D;7HBO?DJ;HFEB7J;:8;JM;;DJ>;IJ7J;:
F;H9;DJ7=;I
7I;:EDJ>;F7H7C;J;HII;J<EHJ>78EL; J>; ECF7DOWI10/F;H<EHC7D9;EL;HJ>;J>H;; O;7HF;H<EHC7D9;F;H?E:M7I;GK7BJE
7D:J>;F;H<EHC7D9;E<J>;50,5?D:;N87I;:EDC7HA;JFH?9; EL;HJ>;I7C;J>H;; O;7HF;H<EHC7D9;F;H?E:M7I;GK7B
JE)7CWIIJE9AFH?9;EKJF;H<EHC;:J>;50,5?D:;N8O M>?9>H;IKBJ;:?DJ>;C7N?CKCFEII?8B;F;H<EHC7D9;
F7OEKJE<E<J>;J7H=;JDKC8;HE<*7HA;J 87I;:-/02I=H7DJ;:JE;79>+",7I;:EDIK9>H;IKBJI J>;9ECC?JJ;;C7:;J>;
<EBBEM?D=F7OEKJIJE;79>+",<EHJ>;)1&-M7H:E<*7HA;J 87I;:-/02I
-- 54 of 186 --
&# +<5/>,+=/.#$%'A+<.#+C9?>=
&2>65I64FE:G6'77:46C
,2C86E%2C<6E 32D65
(*+-D
4EF2=(2J@FE@7%2C<6E 32D65(*+-D
@7,2C86EH2C5'AA@CEF?:EJ
1?CEJ>O*H9>;H
!EK=B7I/;JJ?D=;H
0;I>7I7O;;0;I>7 37H7:7H7@7D
+;?B'#;HD7D:;I
37>?:37>;:?
425+37'8/43+)4:+6=46>1';(')0?41/)=
1>; ECF7DOWI-EB?9O<EHJ>;/;9EL;HOE<"HHED;EKIBOM7H:;: ECF;DI7J?EDJ>;X B7M879A-EB?9OY <?HIJ8;97C;;<<;9J?L;?D
?D9ECFB?7D9;M?J>0" HKB;I7D:+7I:7GWI<?D7BB?IJ?D=IJ7D:7H:IKD:;HJ>;!E:: #H7DA47BB0JH;;J/;<EHC7D: EDIKC;H
-HEJ;9J?ED9J-KHIK7DJJEJ>;J;HCIE<J>; B7M879A-EB?9O M>?9>7FFB?;IJEJ>; ECF7DOWI9KHH;DJ7D:<EHC;HX0;9J?EDE<<?9;HIY
M?J>?DJ>;C;7D?D=E</KB;7 < KD:;HJ>;"N9>7D=;9J J>; ECF7DOCKIJH;9EKF ED7FH; J7N87I?I J>;;N9;II7CEKDJE<
9;HJ7?D?D9;DJ?L; 87I;:9ECF;DI7J?ED=H7DJ;: ;7HD;: EHL;IJ;:M>EBBOEH?DF7HJEDJ>;7JJ7?DC;DJE<7DO<?D7D9?7BH;FEHJ?D=
C;7IKH;?D9BK:?D=H;B7J?L;JEJ7BI>7H;>EB:;HH;JKHD IK9>7I97I>7M7H:IKD:;HEKH&-EH*7HA;J 87I;:-/02I7M7H:;:KD:;HEKH
)1&- :KH?D=J>;J>H;;9ECFB;J;:<?I97BO;7HI?CC;:?7J;BOFH;9;:?D=J>;:7J;EDM>?9>J>; ECF7DO?IH;GK?H;:JEFH;F7H;7D
799EKDJ?D=H;IJ7J;C;DJD799EKDJ?D=H;IJ7J;C;DJ?D9BK:;I7DOH;GK?H;:H;IJ7J;C;DJJE9EHH;9J7D;HHEH?DFH;L?EKIBO?IIK;:
<?D7D9?7BIJ7J;C;DJIJ>7J?IC7J;H?7BJEJ>;FH;L?EKIBO?IIK;:<?D7D9?7BIJ7J;C;DJI EHJ>7JMEKB:H;IKBJ?D7C7J;H?7BC?IIJ7J;C;DJ?<J>;
;HHEHM;H;9EHH;9J;:?DJ>;9KHH;DJF;H?E:EHB;<JKD9EHH;9J;:?DJ>;9KHH;DJF;H?E:1>; B7M879A-EB?9O7FFB?;IH;=7H:B;IIE<<7KBJ
<H7K: EHC?I9ED:K9J
&D7::?J?ED FKHIK7DJJEJ>; ECF7DOWI;N;9KJ?L;I;L;H7D9;FEB?9O 7I<KHJ>;H:;J7?B;:?DJ>;I;9J?EDJ?JB;: ECA.,>=2?.
869.7<*=287%*+5.<C"8=.7=2*5"*B6.7=<>987%.;627*=2878;1*70.2787=;85F8;BEM ?DJ>;;L;DJE<7J;HC?D7J?ED<EH 7KI;
7I:;<?D;:?DJ>;;N;9KJ?L;I;L;H7D9;FEB?9O E<7DOE<J>;9EL;H;:;N;9KJ?L;I ?D9BK:?D=;79>E<J>;+",I IK9>9EL;H;:;N;9KJ?L;
MEKB:<EH<;?J7BBKDL;IJ;:;GK?JO7M7H:I ?D9BK:?D=7DOKDL;IJ;:IJE9AEFJ?EDI I;HL?9; 87I;:/02I 7D:*7HA;J 87I;:-/02I>;B:
8OIK9>9EL;H;:;N;9KJ?L;7JJ>;J?C;E<J;HC?D7J?ED
37/*+6!6'*/3-41/)='3*+*-/3-'3*1+*-/3-64./(/8/43
4;>7L;7:EFJ;:FEB?9?;I7D:FHE9;:KH;I ?D9BK:?D=EKH?DI?:;HJH7:?D=FEB?9O =EL;HD?D=J>;FKH9>7I; I7B; 7D:EJ>;H:?IFEI?J?EDIE<
EKHI;9KH?J?;I8OEKH:?H;9JEHI E<<?9;HI ;CFBEO;;I 7D:EJ>;H?D:?L?:K7BI7IIE9?7J;:M?J>KI 7IM;BB7IJ>; ECF7DO?JI;B< J>7JM;
8;B?;L;7H;H;7IED78BO:;I?=D;:JEFHECEJ;9ECFB?7D9;M?J>?DI?:;HJH7:?D=B7MI HKB;I 7D:H;=KB7J?EDI 7D:+7I:7GB?IJ?D=
IJ7D:7H:I9EFOE<EKH?DI?:;HJH7:?D=FEB?9O?I<?B;:7I"N>?8?JJEEKHDDK7B/;FEHJ
IF7HJE<J>;I;FEB?9?;I7D:FHE9;:KH;I M;FHE>?8?JEKH:?H;9JEHI E<<?9;HI ;CFBEO;;I 7D:EJ>;H?D:?L?:K7BI7IIE9?7J;:M?J>KI<HEC
;D=7=?D=?D7 >;:=?D=JH7DI79J?EDI IK9>7IX97I>B;IIY9EBB7HI <EHM7H:I7B;I ;GK?JOIM7FI7D:EJ>;HI?C?B7H7HH7D=;C;DJI8
I>EHJI7B;IEH9 XFKJYEHX97BBYEFJ?EDJH7DI79J?EDIM?J>H;IF;9JJE ECF7DOI;9KH?J?;I0K9>F;HIEDI7H;7BIEFHE>?8?J;:<HEC
FB;:=?D= ECF7DOI;9KH?J?;I
84)0;3+67./59/*+1/3+7
#EHI;D?EHL?9;FH;I?:;DJI7D:78EL; M;7BIE>7L;IJE9AEMD;HI>?F=K?:;B?D;IJ>7J<EIJ;H7B?=DC;DJM?J>EKHBED= J;HCIJH7J;=O,KH
IJE9AEMD;HI>?F=K?:;B?D;I<EHEKH+",I7D:9;HJ7?DEJ>;HI;D?EH;N;9KJ?L;I7H;I>EMD8;BEM1>;H;B;L7DJ:EBB7H7CEKDJ?I
JH7DIB7J;:?DJE7DKC8;HE<I>7H;I8O:?L?:?D=J>;7FFB?978B;CKBJ?FB;E<87I;I7B7HO8OJ>;7L;H7=;9BEI?D=FH?9;E<EKH9ECCED
IJE9A<EHJ>;JH7:?D=:7OIJ>HEK=>J>;B7IJJH7:?D=:7OE<J>;CEIJH;9;DJBO 9ECFB;J;:<?I97BO;7H7IE<J>;C;7IKH;C;DJ:7J;
0>7H;I9EKDJ;:JEM7H:J>;C?D?CKCIJE9AEMD;HI>?FH;GK?H;C;DJIKD:;HEKH=K?:;B?D;I?D9BK:;? I>7H;IEMD;:EKJH?=>J 7D:??
I>7H;I>;B:?DEKHA FB7D&D7::?J?ED KD:;HEKH=K?:;B?D;I KD;7HD;:F;H<EHC7D9;7M7H:I7D:KD;N;H9?I;:EFJ?EDIEHFEHJ?EDI
J>;H;E< 7H;DEJ?D9BK:;:JEM7H:C;;J?D=J>;H;GK?H;C;DJI,MD;HI>?FB;L;BI7II>EMD8;BEMCKIJ8;79>?;L;:M?J>?D<?L;O;7HIE<
7FFE?DJC;DJJEJ>;7FFB?978B;FEI?J?ED&D9H;7I;:H;GK?H;C;DJI:K;JEFHECEJ?EDIEH7D?D9H;7I;?DJ>;EMD;HI>?F=K?:;B?D;CKIJ8;
79>?;L;:M?J>?D<?L;O;7HIE<IK9>FHECEJ?EDEH9>7D=;?DJ>;=K?:;B?D;I,KHEMD;HI>?F=K?:;B?D;I7H;H;L?;M;:8OJ>;9ECC?JJ;;ED
7D7DDK7B87I?IJJ>;;D:E<<?I97BO;7H 7BB+",IM;H;?D9ECFB?7D9;M?J>EKHIJE9AEMD;HI>?F=K?:;B?D;IEH>7L;7F;H?E:E<
J?C;H;C7?D?D=KD:;HJ>;=K?:;B?D;IJEC;;JJ>;H;GK?H;:EMD;HI>?FB;L;B
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 55 of 186 --
B/-?>3@/%>9-5"A8/<=23:?3./638/=
(@D:E:@? F:56=:?6D
-H;I?:;DJ7D: >?;<"N;9KJ?L;,<<?9;H N87I;I7B7HO
"N;9KJ?L;3?9;-H;I?:;DJI N87I;I7B7HO
0;D?EH3?9;-H;I?:;DJI N87I;I7B7HO
+8/6+2+3866'3-+2+387
1>;;GK?JO7M7H:7=H;;C;DJI=H7DJ;:JE+",IKD:;HEKH)1&-?D9BK:;J;HCIJ>7JFHEL?:;<EH<7LEH78B;L;IJ?D=JH;7JC;DJ
?DJ>;;L;DJE<9;HJ7?DGK7B?<?;:H;J?H;C;DJI1>;9ECC?JJ;;7FFHEL;:J>;I;7M7H:7=H;;C;DJIJE>;BF7JJH79J7D:H;J7?DEKH+",I
7D:JE<79?B?J7J;IK99;II?ED7D:JH7DI?J?EDFB7DD?D=?D9EDD;9J?EDM?J>+",H;J?H;C;DJI
#EH7::?J?ED7B?D<EHC7J?ED78EKJJ>;I;7=H;;C;DJI7D::;J7?B78EKJFEIJ J;HC?D7J?ED8;D;<?JIKD:;HJ>;I;7=H;;C;DJI I;;J>;EC
A.,>=2?.869.7<*=287%*+5.<C"8=.7=2*5"*B6.7=<&987%.;627*=2878;1*70.2787=;85FI;9J?ED8;BEM
+:+6'3)+.'3-+/343864166'3-+2+387
1>; ECF7DO>7I7:EFJ;:7D;N;9KJ?L;I;L;H7D9;FEB?9O7D:;N;9KJ?L;9>7D=;?D9EDJHEBFEB?9O M>?9>7H;?DJ;D:;:JE>;BF7JJH79J
7D:H;J7?DEKH+",I 7D:JE<79?B?J7J;7ICEEJ>JH7DI79J?ED7D:JH7DI?J?EDFB7DD?D=?D9EDD;9J?EDM?J>9>7D=;?D9EDJHEB;L;DJI1>;
I;L;H7D9;FEB?9OFHEL?:;I<EH:;I?=D7J;:F7OC;DJI?DJ>;;L;DJE<7D?DLEBKDJ7HOJ;HC?D7J?EDE<;CFBEOC;DJ :;7J>EH:?I78?B?JO 7I
IK9>J;HCI7H;:;<?D;:?DJ>;FEB?9O1>;9>7D=;?D9EDJHEBFEB?9OFHEL?:;I<EH:;I?=D7J;:F7OC;DJI?DJ>;97I;E<79>7D=;?D9EDJHEB
EH7D79GK?I?J?ED8OJ>; ECF7DO ?D;79>97I;M>;D9EKFB;:M?J>7D?DLEBKDJ7HOJ;HC?D7J?ED?; 7:EK8B;JH?==;H?IH;GK?H;:8;<EH;
F7OC;DJ?IC7:;:K;JE79>7D=;?D9EDJHEBEH79GK?I?J?ED8OJ>; ECF7DO 7IIK9>J;HCI7H;:;<?D;:?DJ>;FEB?9O
#EH7::?J?ED7B?D<EHC7J?ED78EKJJ>;I;7HH7D=;C;DJI7D::;J7?B78EKJFEIJ J;HC?D7J?EDF7OC;DJIKD:;HJ>;I;7HH7D=;C;DJI I;;J>;
ECA.,>=2?.869.7<*=287%*+5.<C"8=.7=2*5"*B6.7=<&987%.;627*=2878;1*70.2787=;85FI;9J?ED8;BEM
8.+6+3+,/8748:'/1'(1+84112514=++7
+<>%-9>>$9.38936381//=
!KH?D=<?I97BO;7H J>; ECF7DOF7?:<?B?D=<;;I7D:H;B7J;:B;=7B<;;I?D9KHH;:?D9EDD;9J?EDM?J><?B?D=I8O*HH9>;H7D:*H
;JJ?D=;HKD:;HJ>;%7HJ 09EJJ /E:?DEDJ?JHKIJ&CFHEL;C;DJI9JJ>;X%0/9JY 1>;<?B?D=IM;H;H;GK?H;:8;97KI;J>;:EBB7HL7BK;
E<I>7H;I>;B:8O;79>E<*HH9>;H7D:*H;JJ?D=;H;N9;;:;:J>H;I>EB:I;IJ78B?I>;:KD:;HJ>;%0/9J :K;JEIJE9AFH?9;
7FFH;9?7J?ED7D:J>;L;IJ?D=E<;GK?JO7M7H:I=H7DJ;:KD:;HEKH)1&-1>;9ECC?JJ;;9EDI?:;HI?J7FFHEFH?7J;JEF7OJ>;I;;NF;DI;I
8;97KI;J>;O7HEI;7I7H;IKBJE<J>;EF;H7J?EDE<J>; ECF7DOWI;GK?JO9ECF;DI7J?EDFHE=H7C*HH9>;H7D:*H;JJ?D=;H7H;
;79>H;IFEDI?8B;<EHJ7N;I:K;7I7H;IKBJE<EKHF7O?D=J>;<?B?D=7D:B;=7B<;;I 7D:J>;OM;H;DEJFHEL?:;:J7N=HEII KFF7OC;DJI
1>;7CEKDJE<J>;<?B?D=7D:B;=7B<;;IF7?:7FF;7HI?DJ>;XBB,J>;H ECF;DI7J?EDY9EBKCD?DJ>;E$>66*;B869.7<*=287%*+5.Y
8;BEM
6/->3@//0/<</.97:/8=+>398#6+8
1>; ECF7DOC7?DJ7?DI7D"B;9J?L;!;<;HH;: ECF;DI7J?ED-B7DJ>7J7BBEMI;B?=?8B;;CFBEO;;I?D9BK:?D=7BBJ>;+",I JE
LEBKDJ7H?BO:;<;HH;9;?FJE<7BBEH7FEHJ?EDE<87I;I7B7HO7D:9;HJ7?D?D9;DJ?L;9ECF;DI7J?EDF7OC;DJIKDJ?B7:7J;EH:7J;I;B;9J;:8O
J>;F7HJ?9?F7J?D=;CFBEO;;1>?I7BBEMIJ>;;CFBEO;;JE:;<;HJ7N;IED:;I?=D7J;:9ECF;DI7J?ED7CEKDJI&D7::?J?ED J>; ECF7DO
?IE8B?=7J;:JEF7O7B?C?J;: ECF7DO9EDJH?8KJ?EDJEJ>;FB7D<EH7BB;B?=?8B;;CFBEO;;I
%?::6/7/8>+6/+6>2+8.)/60+</
4;FHEL?:;9;HJ7?D>;7BJ>7D:M;B<7H;8;D;<?JIJEEKH+",IJ>7J7H;DEJ=;D;H7BBO7L7?B78B;JEEJ>;H;CFBEO;;I ?D9BK:?D=J>;
F7OC;DJE<FH;C?KCI<EHIKFFB;C;DJ7BBED= J;HC:?I78?B?JO?DIKH7D9;7D:7::?J?ED7BLEBKDJ7HO>;7BJ>I;HL?9;I
4;7BIEFHEL?:;FEIJ H;J?H;C;DJC;:?97B7D::;DJ7B?DIKH7D9;9EL;H7=;<EH;B?=?8B;<EHC;H;N;9KJ?L;E<<?9;HIKD:;HEKH/;J?H;;%;7BJ>
-B7DI IK8@;9JJE9;HJ7?D;B?=?8?B?JOH;GK?H;C;DJI1>;FHE=H7CM7I9BEI;:JE;N;9KJ?L;E<<?9;HIM>E@E?D;:J>; ECF7DOEH8;97C;
;N;9KJ?L;E<<?9;HIJ>HEK=>FHECEJ?ED;<<;9J?L;EDEH7<J;H'7DK7HO 4;>7L;7D?D:;F;D:;DJ79JK7H?7BL7BK7J?EDE<FEIJ
H;J?H;C;DJ8;D;<?JI<EH;B?=?8B;+",I9ED:K9J;:7DDK7BBO?D799EH:7D9;M?J>$-1>;CEIJH;9;DJL7BK7J?EDM7I9ED:K9J;:?D'KD;
7D:H;<B;9J;:J>;H;J?H;C;DJ8;D;<?JE8B?=7J?ED<EHJ>;+",I7II>EMD8;BEM
-- 56 of 186 --
!"#9=>$/>3</7/8>/8/03>",631+>398=
&2>65I64FE:G6'77:46C
D@7"F?6
1?CEJ>O*H9>;H
!EK=B7I/;JJ?D=;H U
0;I>7I7O;;0;I>7 37H7:7H7@7D U
+;?B'#;HD7D:;I U
37>?:37>;:?
*;IIHI;JJ?D=;H 37H7:7H7@7D7D:#;HD7D:;I7H;DEJ;B?=?8B;JEF7HJ?9?F7J;KD:;HJ>;J;HCIE<J>;FHE=H7C
%"!# !#"
41+4,8.+425+37'8/43'3*92'3+7496)+7422/88++
,KHE7H:>7I:;B;=7J;:9;HJ7?DH;IFEDI?8?B?J?;IJEJ>;9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;J>HEK=>7<EHC7B9>7HJ;H1>;
9ECC?JJ;;EL;HI;;IJ>;9ECF;DI7J?EDFHE=H7CI?DM>?9>EKH ",7D:>?I:?H;9JH;FEHJIM>E7H;;N;9KJ?L;EHI;D?EHL?9;FH;I?:;DJI
F7HJ?9?F7J;1>;?D:;F;D:;DJC;C8;HIE<EKHE7H:7FFHEL;J>;9ECF;DI7J?EDF79A7=;I7D:F7OEKJI<EHEKH ",,KH ",?IDEJ
FH;I;DJ<EH7DO:;9?I?EDIH;=7H:?D=>?I9ECF;DI7J?EDF79A7=;I7D:F7OEKJI
ECC?JJ;;H;IFEDI?8?B?J?;I?D9BK:; 8KJ7H;DEJB?C?J;:JE
Z H;L?;M?D=7D:7FFHEL?D=J>; ECF7DOWI;N;9KJ?L;9ECF;DI7J?EDF>?BEIEF>O E8@;9J?L;I 7D:IJH7J;=?;I
Z H;L?;M?D=7D:7FFHEL?D=J>;7FFHEFH?7J;F;;H=HEKF9ECF7D?;I<EHFKHFEI;IE<;L7BK7J?D=J>; ECF7DOWI9ECF;DI7J?ED
9ECF;J?J?L;D;II
Z H;L?;M?D= 7D:7FFHEL?D=M>;H;7FFHEFH?7J; ;GK?JO 87I;:9ECF;DI7J?EDFB7DI
Z 97KI?D=J>;E7H:JEF;H<EHC7F;H?E:?9F;H<EHC7D9;;L7BK7J?EDE<EKH ",
Z H;9ECC;D:?D=JEJ>;?D:;F;D:;DJC;C8;HIE<J>;E7H:9EHFEH7J;=E7BI7D:E8@;9J?L;IKD:;HJ>; ECF7DOWI
9ECF;DI7J?EDFB7DI 9ECF;DI7J?EDF79A7=;I;= 7DDK7B87I;I7B7HOB;L;B 7DDK7B97I>?D9;DJ?L;7M7H: BED= J;HC
?D9;DJ?L;7M7H:7D:7DO;CFBEOC;DJ7=H;;C;DJ I;L;H7D9;7HH7D=;C;DJ 9>7D=; ?D 9EDJHEB7HH7D=;C;DJ ;GK?JO=H7DJ EH
IF;9?7BEHIKFFB;C;DJ7B8;D;<?JI 7D:7DOC7J;H?7B7C;D:C;DJJE7DOE<J>;<EH;=E?D= 7FFB?978B;JEEKH ", 7D:
9ECF;DI7J?EDF7OEKJI<EHEKH ",
Z 7DDK7BBOH;L?;M?D=M?J>EKH ",J>;F;H<EHC7D9;E<J>; ECF7DOWIEJ>;H;N;9KJ?L;E<<?9;HI?DB?=>JE<J>; ECF7DOWI
;N;9KJ?L;9ECF;DI7J?ED=E7BI7D:E8@;9J?L;I7D:7FFHEL?D=J>;9ECF;DI7J?EDF79A7=;I7D:9ECF;DI7J?EDF7OEKJI<EH
IK9>?D:?L?:K7BI
Z H;L?;M?D=7D:H;9ECC;D:?D=<EH7FFHEFH?7J;E7H:79J?ED7BB97I> ;GK?JO 87I;: 7D:EJ>;H9ECF;DI7J?EDF79A7=;I 7D:
9ECF;DI7J?EDF7OEKJI7FFB?978B;JEJ>;9>7?H7D:EJ>;HDED ;CFBEO;;C;C8;HIE<J>;E7H:
Z EL;HI;;?D=C7D7=;C;DJWI:;J;HC?D7J?ED7IJEM>;J>;HJ>;9ECF;DI7J?EDFEB?9?;I7D:FH79J?9;I ?D9BK:?D=J>EI;H;B7J;:JE
F7O;GK?JOB7MI 9H;7J;H?IAIJ>7J7H;H;7IED78BOB?A;BOJE>7L;7C7J;H?7B7:L;HI;;<<;9JEDJ>; ECF7DO
Z H;L?;M?D=J>;H;IKBJIE<X07OED-7OYLEJ;I7D:9EDI?:;H?D=M>;J>;H7DO7:@KIJC;DJIJEJ>; ECF7DOWI;N;9KJ?L;
9ECF;DI7J?EDFHE=H7C7H;7FFHEFH?7J;7D:
Z ;IJ78B?I>?D=IJE9AEMD;HI>?F=K?:;B?D;I7FFB?978B;JEJ>; ECF7DOWI;N;9KJ?L;E<<?9;HI7D:H;9ECC;D:?D=JEJ>;E7H:
IJE9AEMD;HI>?F=K?:;B?D;I7FFB?978B;JEJ>;9>7?H7D:EJ>;HC;C8;HIE<J>;E7H:
1>;9ECC?JJ;;?I7KJ>EH?P;:JE:;B;=7J;?JI7KJ>EH?JO7D:H;IFEDI?8?B?J?;I7I?J:;;CIFHEF;H7D:9EDI?IJ;DJM?J>B;=7BH;GK?H;C;DJIJE
?JIC;C8;HI 7DOEJ>;H9ECC?JJ;;E<J>;E7H:7D:EHED;EHCEH;E<<?9;HIE<J>; ECF7DO ?D799EH:7D9;M?J>J>;FHEL?I?EDIE<J>;
!;B7M7H;$;D;H7B EHFEH7J?ED)7M#EH7::?J?ED7B?D<EHC7J?EDEDJ>;9ECC?JJ;;WIH;IFEDI?8?B?J?;I7D:7KJ>EH?J?;I I;;X8?.;7*7,.
*==.;<C8;98;*=.8?.;7*7,.C8*;-8662==..<C869.7<*=287*7->6*7#.<8>;,.<8662==..Y78EL;
&DEH:;HJE97HHOEKJJ>;I;H;IFEDI?8?B?J?;I J>;9ECC?JJ;;H;9;?L;I7D:H;L?;MI?D<EHC7J?ED 7D7BOI;I 7D:FHEFEI7BIFH;F7H;:8OEKH
C7D7=;C;DJ7D:8OJ>;9ECC?JJ;;WI9ECF;DI7J?ED9EDIKBJ7DJI;;XC#85.8/8662==..-?2<8;<Y8;BEM
41+4,422/88++*:/7467
1>;9ECC?JJ;;?I7KJ>EH?P;:JE;D=7=;?JIEMD?D:;F;D:;DJ7:L?IEHIJE7II?IJ?D97HHO?D=EKJ?JIH;IFEDI?8?B?J?;I1>;9ECC?JJ;;>7I
;D=7=;:J>;I;HL?9;IE< ECF;DI?7 &D9X ECF;DI?7Y 7D7J?ED7B9ECF;DI7J?ED9EDIKBJ?D=<?HC 7IJ>;9ECC?JJ;;WI9ECF;DI7J?ED
9EDIKBJ7DJ ECF;DI?7FHEL?:;IJ>;9ECC?JJ;;M?J>?D:;F;D:;DJ7D:E8@;9J?L;=K?:7D9;H;=7H:?D=J>;7CEKDJ7D:JOF;IE<
9ECF;DI7J?ED<EHEKH9>7?H DED ;CFBEO;;:?H;9JEHI 7D:;N;9KJ?L;E<<?9;HI 7D:>EMJ>;I;7CEKDJI7D:JOF;IE<9ECF;DI7J?ED
9ECF7H;JEEJ>;H9ECF7D?;IW9ECF;DI7J?EDFH79J?9;I 7IM;BB7I=K?:7D9;EDC7HA;JJH;D:I ;LEBL?D=H;=KB7JEHOH;GK?H;C;DJI F;;H
=HEKF9ECFEI?J?ED 7D:EJ>;HC7JJ;HI7IH;GK;IJ;:8OJ>;9ECC?JJ;;
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 57 of 186 --
/;FH;I;DJ7J?L;IE< ECF;DI?7H;=KB7HBO7JJ;D:9ECC?JJ;;C;;J?D=I?D9BK:?D=;N;9KJ?L;I;II?EDIM?J>EKJC7D7=;C;DJFH;I;DJ
9ECCKD?97J;M?J>J>;9ECC?JJ;;9>7?HEKJI?:;E<C;;J?D=I 7D:7II?IJJ>;9ECC?JJ;;M?J>?JI9EDI?:;H7J?EDE<F;H<EHC7D9;C;JH?9I
7D:=E7BI ECF;DI?7H;FEHJIJEJ>;9ECC?JJ;; DEJJEC7D7=;C;DJJJ>;9ECC?JJ;;WIH;GK;IJ ECF;DI?7C;;JIM?J>C;C8;HIE<
C7D7=;C;DJJE=7J>;H7D::?I9KII?D<EHC7J?EDJ>7J?IH;B;L7DJJE7:L?I?D=J>;9ECC?JJ;;1>;9ECC?JJ;;C7OH;FB79; ECF;DI?7EH
>?H;7::?J?ED7B7:L?IEHI7J7DOJ?C; ECF;DI?7>7IDEJFHEL?:;:7DOEJ>;HI;HL?9;IJEJ>;9ECC?JJ;;EHJEEKHC7D7=;C;DJ 7D:>7I
H;9;?L;:DE9ECF;DI7J?ED<HECKIEJ>;HJ>7DM?J>H;IF;9JJEJ>;I;HL?9;I:;I9H?8;:78EL;1>;9ECC?JJ;;7II;II;:J>;
?D:;F;D:;D9;E< ECF;DI?7FKHIK7DJJE0" HKB;I7D:+7I:7GB?IJ?D=IJ7D:7H:I ?D9BK:?D=J>;<EBBEM?D=<79JEHI J>;78I;D9;E<
EJ>;HI;HL?9;IFHEL?:;:8O?JJEJ>; ECF7DO J>;<;;IF7?:JE?J8OJ>; ECF7DO7I7F;H9;DJ7=;E<?JIJEJ7BH;L;DK; ?JI
FEB?9?;I7D:FHE9;:KH;IJEFH;L;DJ9ED<B?9JIE<?DJ;H;IJ J>;78I;D9;E<7DO8KI?D;IIEHF;HIED7BH;B7J?EDI>?FIM?J>9ECC?JJ;;
C;C8;HI7D:M?J>EKH;N;9KJ?L;E<<?9;HI7D: J>;<79JJ>7J?J:E;IDEJEMD7DO)7C9ECCEDIJE9A1>;9ECC?JJ;;7II;II;:J>?I
?D<EHC7J?ED7D:9ED9BK:;:J>7JJ>;MEHAE< ECF;DI?7>7:DEJH7?I;:7DO9ED<B?9JE<?DJ;H;IJ
41+4,'3'-+2+38
,KH ", M?J>IKFFEHJ<HECEKH>KC7DH;IEKH9;I7D:<?D7D9;EH=7D?P7J?EDI :;L;BEFIH;9ECC;D:7J?EDI<EHJ>;9ECF;DI7J?EDE<EKH
EJ>;H;N;9KJ?L;E<<?9;HI1OF?97BBO J>;I;H;9ECC;D:7J?EDI9EL;H87I;I7B7H?;I &-J7H=;J7M7H:EFFEHJKD?J?;I )1&-J7H=;J7M7H:
EFFEHJKD?J?;I 7D:J>;9H?J;H?7KFEDM>?9>J>;I;7M7H:EFFEHJKD?J?;IC7O8;;7HD;: 7IM;BB7I79JK7BF7OEKJ7CEKDJIKD:;HJ>;&-
7D:)1&-
1>;9ECC?JJ;;9EDI?:;HIEKH ",WIH;9ECC;D:7J?EDIM?J>?DJ>;9EDJ;NJE<9ECF;J?J?L;9ECF;DI7J?ED:7J7 J>; ECF7DOWI
9ECF;DI7J?EDF>?BEIEF>O7D:E8@;9J?L;I 9KHH;DJ8KI?D;II9ED:?J?EDI J>;7:L?9;E< ECF;DI?7 7D:7DOEJ>;H<79JEHI?J9EDI?:;HI
H;B;L7DJ
,KH ",7D:9;HJ7?DEJ>;HC;C8;HIE<C7D7=;C;DJ7JJ;D:9ECC?JJ;;C;;J?D=I7JJ>;H;GK;IJE<J>;9ECC?JJ;;8KJB;7L;J>;
C;;J?D=<EH7DO:;B?8;H7J?EDIH;B7J;:JE7D::;9?I?EDIH;=7H:?D=J>;?HEMD9ECF;DI7J?ED M>;DJ>;9ECC?JJ;;C;;JI?D;N;9KJ?L;
I;II?ED 7D:7J7DOEJ>;HJ?C;H;GK;IJ;:8OJ>;9ECC?JJ;;
++664956')8/)+7'3* 96:+='8'
&D;IJ78B?I>?D=J>;JEJ7B9ECF;DI7J?EDB;L;BIE<EKH;N;9KJ?L;E<<?9;HI 7IM;BB7IJ>;C?N7D:M;?=>J?D=E<?D:?L?:K7B9ECF;DI7J?ED
;B;C;DJI J>;9ECC?JJ;;CED?JEHI9ECF;DI7J?ED:7J7<HEC7=HEKFE<9ECF7H78BOI?P;:9ECF7D?;I?DJ>;J;9>DEBE=O?D:KIJHOJ>;
X-;;H$HEKFY 1>;9ECC?JJ;;I;B;9JIJ>;9ECF7D?;I9EDIJ?JKJ?D=EKH-;;H$HEKF87I;:EDJ>;?H9ECF7H78?B?JOJEEKHB?D;IE<
8KI?D;II7D:?D:KIJHO 7DDK7BH;L;DK; 7D:C7HA;J97F?J7B?P7J?ED 7D:EKH8;B?;<J>7JM;7H;B?A;BOJE9ECF;J;M?J>J>;C<EH;N;9KJ?L;
J7B;DJ,KH-;;H$HEKF?I<E9KI;:EDFK8B?9I;C?9ED:K9JEH I;C?9ED:K9JEH;GK?FC;DJ 7D:C7J;H?7BI9ECF7D?;IJ>7J<?B;IJ7D:7H:
H;FEHJIM?J>J>;0" 7I:EC;IJ?9?IIK;HI 7D:I?C?B7HBO I?P;:>?=> J;9>DEBE=O;GK?FC;DJ7D:>7H:M7H;9ECF7D?;IM?J>7=BE87B
FH;I;D9;7D:7I?=D?<?97DJ?DL;IJC;DJ?DH;I;7H9>7D::;L;BEFC;DJ1>;J78B;8;BEMIKCC7H?P;I>EMJ>;97B;D:7HO;7H-;;H
$HEKF9ECF7D?;I9ECF7H;JEJ>; ECF7DO
#//<<9?:$/@/8?/+8. +<5/>+:3>+63D+>398
%6EC:4
$2>*6D62C49
% ,2C86E7@C(66CC@FA
(66CC@FA
%65:2?
%
/;L;DK;B7IJ9ECFB;J;:H;FEHJ;:<EKHGK7HJ;HI7IE<'KBO FFHEN?C7J;BOJEJ?C;I)7C
*7HA;J 7F?J7B?P7J?ED :7O7L;H7=;7IE<'KBO FFHEN?C7J;BOJEJ?C;I)7C
7I;:EDJ>;I;9H?J;H?7 J>;-;;H$HEKF7D:J7H=;JIC7O8;CE:?<?;:<HECJ?C;JEJ?C;,KH-;;H$HEKFM7IH;L?;M;:?DK=KIJ
JE;DIKH;J>7JEKH-;;H$HEKF9EDJ?DK;IJE<?JM?J>?DEKH-;;H$HEKF9H?J;H?7EKJB?D;:78EL; 7D:DE9>7D=;IM;H;C7:;<EH
97B;D:7HO;7H9ECF;DI7J?ED:;9?I?EDI,KH-;;H$HEKF9EDI?IJIE<J>;9ECF7D?;IB?IJ;:7I<EBBEMI
#//<<9?:97:+83/=09<+6/8.+<*/+<
:L7D9;:*?9HE!;L?9;I &D9 ?I9E0OIJ;CI &D9 *?9HE9>?F1;9>DEBE=O&D9EHFEH7J;: .K7B9ECC&D9EHFEH7J;:
=?B;DJ1;9>DEBE=?;I &D9 EHD?D=&D9EHFEH7J;: *?9HED1;9>DEBE=O &D9 1;N7I&DIJHKC;DJI&D9
D7BE=!;L?9;I &D9 &DJ;B EHFEH7J?ED +3&!& EHFEH7J?ED
FFB?;:*7J;H?7BI &D9 () EHFEH7J?ED +5-0;C?9ED:K9JEHI+3
HE7:9EC&D9 *7HL;BB1;9>DEBE=O &D9 ,+0;C?9ED:K9JEH EHFEH7J?ED
4;:;H?L;H;L;DK; C7HA;J97F?J7B?P7J?ED 7D:+",9ECF;DI7J?ED:7J7<HECFK8B?9<?B?D=IC7:;8OEKH-;;H$HEKF9ECF7D?;IM?J>
J>;0" 7D:<HECEJ>;HFK8B?9BO7L7?B78B;IEKH9;I/7:<EH:1;9>DEBE=O0KHL;O:7J7C7O8;KI;:JEIKFFB;C;DJ9ECF;DI7J?ED:7J7
-- 58 of 186 --
<HECFK8B?9<?B?D=I7ID;;:;:1>;9ECC?JJ;;H;L?;MI9ECF;DI7J?EDFH79J?9;I7D:I;B;9J;::7J7ED87I;I7B7HO 8EDKIJ7H=;JI JEJ7B
97I>9ECF;DI7J?ED ;GK?JO7M7H:I 7D:JEJ7B9ECF;DI7J?ED:H7MD<HECJ>;-;;H$HEKF9ECF7D?;I7D:EHJ>;/7:<EH:1;9>DEBE=O
0KHL;O7I7H;<;H;D9;JE>;BF;DIKH;9ECF;DI7J?EDF79A7=;I7H;9EDI?IJ;DJM?J>C7HA;JDEHCI
7I;F7OB;L;BI<EH;79>;N;9KJ?L;E<<?9;H7H;=;D;H7BBOI;JM?J>H;<;H;D9;JEC7HA;J 9ECF;J?J?L;B;L;BI7D:?DH;<B;9J?EDE<;79>
E<<?9;HWIIA?BBI ;NF;H?;D9;I 7D:F;H<EHC7D9;37H?78B;F7OJ7H=;J7M7H:EFFEHJKD?J?;I7D:JEJ7B:?H;9J9ECF;DI7J?ED<EH;79>
;N;9KJ?L;E<<?9;H7H;=;D;H7BBO:;I?=D;:JE:;B?L;HC7HA;J 9ECF;J?J?L;9ECF;DI7J?ED<EHJ>;79>?;L;C;DJE<IJH;J9>=E7BI M?J>
:EMDI?:;H?IA<EHKD:;HF;H<EHC?D=7D:KFI?:;H;M7H:<EHEL;HF;H<EHC?D=#EHJ>EI;;N;9KJ?L;E<<?9;HIM>E7H;D;MJEJ>;?HHEB;I
9ECF;DI7J?ED7HH7D=;C;DJIC7O8;:;I?=D;:JE:;B?L;H8;BEM C7HA;J9ECF;DI7J?ED<EH7F;H?E:E<J?C;%EM;L;H J>;9ECC?JJ;;
:E;IDEJXJ7H=;JYF7O7J7DOIF;9?<?9F;H9;DJ?B;/7J>;H ?D:?L?:K7BF7OFEI?J?ED?D=:;F;D:IED7L7H?;JOE<<79JEHI IK9>7IFH?EH@E8
F;H<EHC7D9; @E8I9EF;7D:H;IFEDI?8?B?J?;I IA?BBI;J FH?EH;NF;H?;D9; J?C;?DFEI?J?ED ?DJ;HD7B9ECF7H?IEDIE<F7OB;L;BI<EHI?C?B7H
IA?BBB;L;BIEHFEI?J?EDI EKH=E7BIJE7JJH79J7D:H;J7?D;N;9KJ?L;J7B;DJ ECF7DOF;H<EHC7D9; 7D:=;D;H7BC7HA;J9ED:?J?EDI
77+772+384,425+37'8/43/70
*7D7=;C;DJ M?J>J>;7II?IJ7D9;E< ECF;DI?7 J>;9ECC?JJ;;WI?D:;F;D:;DJ9ECF;DI7J?ED9EDIKBJ7DJ 9ED:K9J;:79ECF;DI7J?ED
H?IA7II;IIC;DJ?D7D:9ED9BK:;:J>7JH?IAI7H?I?D=<HECJ>; ECF7DOWI9KHH;DJ;CFBEO;;9ECF;DI7J?EDFHE=H7CI7H;DEJ
H;7IED78BOB?A;BOJE>7L;7C7J;H?7B7:L;HI;;<<;9JEDJ>; ECF7DO
41/)/+7'3*6')8/)+7+1'8+*84!/2/3-4,58/43;'6*7
IM7IDEJ;:78EL; EKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C?D9BK:;I7BED= J;HC?D9;DJ?L;FHE=H7C EH)1&- M>?9>?I:;I9H?8;:?D
CEH;:;J7?B?DEC) *7-) 869.7<*=287";80;*6<F78EL;1>;)1&-9EDI?IJIE<7C?NE<L;>?9B;I M>?9>?DFH?EH
O;7HI>7I?D9BK:;:IJE9AEFJ?EDI<EH;N;9KJ?L;I7JJ>;B;L;BE<I;D?EHL?9;FH;I?:;DJEH78EL;"N;9KJ?L;I8;BEMJ>;B;L;BE<I;D?EH
L?9;FH;I?:;DJ 7D:DED ;N;9KJ?L;;CFBEO;;IM>E:EDEJF7HJ?9?F7J;?DJ>;)1&- >7L;>?IJEH?97BBODEJ8;;D;B?=?8B;JEH;9;?L;IJE9A
EFJ?EDI;=?DD?D=M?J>EKH97B;D:7HO;7H)1&- J>;9ECC?JJ;;7:@KIJ;:J>;C?NE<L;>?9B;I7D:H;CEL;:IJE9AEFJ?EDI
<HECEKHF7OC?N
,KHIJ7D:7H:FH79J?9;?I<EHJ>;9ECC?JJ;;JE7DDK7BBO7FFHEL;J>;=H7DJE<;GK?JO7M7H:IKD:;HJ>;)1&-<EHJ>;9KHH;DJ97B;D:7HO;7H
7J;79>H;=KB7HBOI9>;:KB;:#;8HK7HOC;;J?D=E<J>;9ECC?JJ;;&D7::?J?ED J>;9ECC?JJ;;H;9ECC;D:IJEJ>;?D:;F;D:;DJ
C;C8;HIE<J>;E7H:J>;7FFHEL7BE<;GK?JO7M7H:IJEJ>; ",KD:;HJ>;)1&-<EHJ>;9KHH;DJ97B;D:7HO;7H 7D:J>;?D:;F;D:;DJ
C;C8;HIE<EKHE7H:J>;DH;L?;M7D:7FFHEL;IK9>7M7H:IJEJ>; ",:KH?D=J>;?HH;=KB7HBOI9>;:KB;:#;8HK7HOC;;J?D=1>;
=H7DJ:7J;<EH7BBE<J>;7<EH;C;DJ?ED;:7DDK7B;GK?JO7M7H:IKD:;HJ>;)1&- ?D9BK:?D=IJE9AEFJ?EDI ?<7DO ?I=;D;H7BBOED*7H9>
E<;79>7FFB?978B;97B;D:7HO;7H KDB;II*7H9><7BBIED707JKH:7OEH70KD:7O ?DM>?9>97I;M;=;D;H7BBO=H7DJ7M7H:IEDJ>;
FH;9;:?D=#H?:7OEHIK99;;:?D=*ED:7O
1>;=H7DJ:7J;<EH7DDK7B;GK?JO7M7H:IKD:;HJ>;)1&-E99KHI7J7J?C;M>;DJ>; ECF7DO?I=;D;H7BBODEJ;NF;9J;:JE8;?D
FEII;II?EDE<C7J;H?7BDED FK8B?9?D<EHC7J?EDH;=7H:?D=EKH8KI?D;II 7D:7J7J?C;M>;DJ>; ECF7DO?IDEJ;NF;9J;:JE>7L;
H;9;DJBO:?I9BEI;: EHJE8;?CC?D;DJBO:?I9BEI?D= C7J;H?7BDED FK8B?9?D<EHC7J?ED
4;C7O=H7DJ;GK?JO7M7H:I ?D9BK:?D=EFJ?EDI JE+",I7D:EJ>;H;B?=?8B;;N;9KJ?L;IEKJI?:;E<EKH7DDK7B7M7H:9O9B;<EHD;M
>?H;I FHECEJ?EDI H;9E=D?J?ED H;J;DJ?ED EHEJ>;HFKHFEI;I&D:;J;HC?D?D=M>;DJE=H7DJE<< 9O9B;IJE9AEFJ?ED7M7H:I J>;
9ECC?JJ;;=;D;H7BBOMEKB:I;;AJE:EIE7J7J?C;M>;DJ>; ECF7DO?IDEJ;NF;9J;:JE8;?DFEII;II?EDE<C7J;H?7BDED FK8B?9
?D<EHC7J?EDH;=7H:?D=EKH8KI?D;II 7D:7J7J?C;M>;DJ>; ECF7DO?IDEJ;NF;9J;:JE>7L;H;9;DJBO:?I9BEI;: EHJE8;?CC?D;DJBO
:?I9BEI?D= C7J;H?7BDED FK8B?9?D<EHC7J?ED
!KH?D=<?I97BO;7H J>; ECF7DO:?:DEJ? J?C;J>;:?I9BEIKH;E<C7J;H?7BDED FK8B?9?D<EHC7J?ED<EHJ>;FKHFEI;E<7<<;9J?D=J>;
L7BK;E<;N;9KJ?L;9ECF;DI7J?ED EH?? =H7DJ7DOIJE9AEFJ?EDIJE7DOE<?JI+",I?D7DOF;H?E:8;=?DD?D=<EKH8KI?D;II:7OIFH?EHJE
J>;<?B?D=E<7F;H?E:?9H;FEHJED#EHC . #EHC (EH9KHH;DJH;FEHJED#EHC (J>7J:?I9BEI;IC7J;H?7BDED FK8B?9?D<EHC7J?ED
7D:;D:?D=ED;8KI?D;II:7O7<J;HJ>;<?B?D=E<IK9>#EHC . #EHC (EH#EHC (
!'<'3*))4938/3-437/*+6'8/437
&+B+>39890G#+<+-2?>/H#+C7/8>=
0;9J?EDI$7D:E<J>;&DJ;HD7B/;L;DK; E:;J>;X E:;Y FHEL?:;J>7JX:?IGK7B?<?;:?D:?L?:K7BIYM?J>?DJ>;C;7D?D=E<J>;
E:;M>?9>=;D;H7BBO?D9BK:;I9;HJ7?DE<<?9;HI :?H;9JEHI 7D:;CFBEO;;IE<J>; ECF7DO C7O8;IK8@;9JJE7::?J?ED7BJ7N?<J>;O
H;9;?L;F7OC;DJIEH8;D;<?JI?D9EDD;9J?EDM?J>79>7D=;?D9EDJHEBE<J>; ECF7DOJ>7J;N9;;:9;HJ7?DFH;I9H?8;:B?C?JI1>;
ECF7DOEH?JIIK99;IIEHC7O7BIE<EH<;?J7:;:K9J?EDEDJ>;7CEKDJIIK8@;9JJEJ>?I7::?J?ED7BJ7N
4;:?:DEJFHEL?:;7DOE<EKH;N;9KJ?L;E<<?9;HI 7DO:?H;9JEH EH7DOEJ>;HI;HL?9;FHEL?:;HM?J>7X=HEII KFYEHEJ>;HH;?C8KHI;C;DJ
F7OC;DJ<EH7DOJ7NB?78?B?JOJ>7JJ>;?D:?L?:K7BC?=>JEM;7I7H;IKBJE<J>;7FFB?97J?EDE<I;9J?EDI$EH:KH?D=<?I97BO;7H
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 59 of 186 --
2026, and we have not agreed and are not otherwise obligated to provide any individual with such a “gross-up” or other
reimbursement as a result of the application of sections 280G and 4999.
Internal Revenue Code Section 409A
Section 409A of the Code imposes significant additional taxes on an executive officer, director, or service provider that receives non-
compliant “deferred compensation” that is within the scope of section 409A. Among other things, section 409A potentially applies to
cash awards under the LTIP, if any, the Elective Deferred Compensation Plan, certain equity awards, and severance arrangements.
To assist our employees in avoiding additional taxes under section 409A, we have structured the LTIP, the Elective Deferred
Compensation Plan, and our equity awards in a manner intended to qualify them for exemption from, or compliance with, section
409A.
Accounting for Stock-Based Compensation
We follow ASC 718 for accounting for our stock options and other stock-based awards. ASC 718 requires companies to calculate the
grant date “fair value” of their stock option grants and other equity awards using a variety of assumptions. This calculation is
performed for accounting purposes. ASC 718 also requires companies to recognize the compensation cost of stock option grants and
other stock-based awards in their income statements over the period that an employee is required to render service in exchange for
the option or other equity award.
Compensation Committee Report
The compensation and human resources committee has reviewed and discussed with management the Compensation Discussion
and Analysis required by Item 402(b) of SEC Regulation S-K. Based on this review and discussion, the compensation and human
resources committee has recommended to the Board that the Compensation Discussion and Analysis be included in this proxy
statement and the Company’s Annual Report on Form 10-K.
This Compensation Committee Report shall not be deemed “filed” with the SEC for purposes of federal securities law, and it shall not,
under any circumstances, be incorporated by reference into any of the Company’s past or future SEC filings. The report shall not be
deemed soliciting material.
MEMBERS OF THE COMPENSATION AND HUMAN RESOURCES COMMITTEE
Jyoti K. Mehra (Chair)
Michael R. Cannon
Mark Fields
Abhijit Y. Talwalkar
Compensation Committee Interlocks and Insider Participation
None of the compensation and human resources committee members who served during fiscal year 2026 have ever been an officer
or employee of Lam Research. None of our executive officers who served during fiscal year 2026 served as a member of the board of
directors or compensation committee of any entity that has one or more executive officers who served on our Board or compensation
and human resources committee during fiscal year 2026.
48
-- 60 of 186 --
B/-?>3@/97:/8=+>398&+,6/=
1>;<EBBEM?D=J78B;II>EM9ECF;DI7J?ED?D<EHC7J?ED<EHEKHD7C;:;N;9KJ?L;E<<?9;HI
%?77+<C97:/8=+>398&+,6/
&2>62?5(C:?4:A2=(@D:E:@?
:D42=
162C
+2=2CJ
@?FD
+E@4<
H2C5D
'AE:@?
H2C5D
&@? BF:EJ
!?46?E:G6(=2?
@>A6?D2E:@?
=='E96C
@>A6?D2E:@?
,@E2=
1?CEJ>O*H9>;H
";.<2-.7=12./A.,>=2?.!//2,.;
U U
U U
U
!EK=B7I/;JJ?D=;H
A.,>=2?.'2,.";.<2-.7=12./
27*7,2*5!//2,.;
U U
U U
U
0;I>7I7O;;0;I>7 37H7:7H7@7D
A.,>=2?.'2,.";.<2-.7=12./
!9.;*=270!//2,.;
U
U
+;?B'#;HD7D:;I
$.728;'2,.";.<2-.7=58+*5
><=86.;!9.;*=287<
U U
37>?:37>;:?
$.728;'2,.";.<2-.7=12./
%.,178580B*7-$><=*27*+252=B
!//2,.;
U
U
1>;J7H=;JL7BK;E<*HH9>;HWII;HL?9; 87I;:/027D:*7HA;J 87I;:-/027M7H:IKD:;HJ>;)1&-M7I <EH<?I97BO;7H
<EH<?I97BO;7H 7D: <EH<?I97BO;7H1>;J7H=;JL7BK;E<*H;JJ?D=;HWII;HL?9; 87I;:/027D:*7HA;J
87I;:-/027M7H:IM7I <EH<?I97BO;7H <EH<?I97BO;7H 7D: <EH<?I97BO;7H1>;J7H=;J
L7BK;E<*H37H7:7H7@7DWII;HL?9; 87I;:/027D:*7HA;J 87I;:-/027M7H:IM7I <EH<?I97BO;7H <EH<?I97BO;7H
7D: <EH<?I97BO;7H1>;J7H=;JL7BK;E<*H#;HD7D:;IWI;HL?9; 87I;:/027D:*7HA;J 87I;:-/027M7H:IM7I
<EH<?I97BO;7H1>;J7H=;JL7BK;E<!H37>;:?WII;HL?9; 87I;:/027D:*7HA;J 87I;:-/027M7H:IM7I <EH<?I97B
O;7H <EH<?I97BO;7H 7D: <EH<?I97BO;7H1>;7CEKDJII>EMD?DJ>?I9EBKCDH;FH;I;DJJ>;L7BK;E<
I;HL?9; 87I;:/027D:*7HA;J 87I;:-/027M7H:I=H7DJ;: ?D799EH:7D9;M?J>0 %EM;L;H FKHIK7DJJE0" HKB;I J>;I;L7BK;I7H;
DEJH;:K9;:8O7D;IJ?C7J;<EHJ>;FHE878?B?JOE<<EH<;?JKH;#EH<?I97BO;7H J>;7==H;=7J;=H7DJ:7J;<7?HL7BK;E<J>;/027D:*7HA;J
87I;:-/027M7H:IJ>7JC7O8;;7HD;:8O;79>+",7IIKC?D=J>;>?=>;IJB;L;BE<F;H<EHC7D9;9ED:?J?EDI<EHJ>;*7HA;J 87I;:-/02
7M7H:IM?BB8;79>?;L;:?I7I<EBBEMI*HH9>;H *H;JJ?D=;H *H37H7:7H7@7D *H#;HD7D:;I
7D:!H37>;:? 1>;<7?HL7BK;E<I;HL?9; 87I;:/02IM7I97B9KB7J;:87I;:EDJ>;<7?HC7HA;JL7BK;E<J>; ECF7DOWI
9ECCEDIJE9A7JJ>;:7J;E<=H7DJ :?I9EKDJ;:<EH:?L?:;D:I8;97KI;J>;/02I:EDEJ>7L;:?L?:;D:;GK?L7B;DJH?=>JI1>;<7?HL7BK;E<*7HA;J
87I;:-/02I=H7DJ;:?D<?I97BO;7HKD:;HJ>;)1&-ED#;8HK7HO M7I97B9KB7J;:KI?D=7*EDJ; 7HBEI?CKB7J?ED
CE:;BKI?D=J>;7IIKCFJ?EDII>EMD8;BEM#EH7::?J?ED7B:;J7?BIH;=7H:?D=J>;=H7DJII;;E;*7=<8/"5*7*<.-@*;-</8;2<,*5).*; F
8;BEM
%2C<6E 32D65(*+-H2C5.2=F2E:@?DDF>AE:@?D
IA64E65.@=2E:=:EJ *:D< 7C66!?E6C6DE*2E6 IA64E65,6C>162CD :G:56?51:6=5
1>;J7H=;JL7BK;E<IJE9AEFJ?ED7M7H:IKD:;HJ>;)1&-<EH<?I97BO;7HM7I <EH*HH9>;H <EH*H;JJ?D=;H
<EH*H37H7:7H7@7D 7D: <EH!H37>;:?1>;7CEKDJII>EMD?DJ>?I9EBKCDH;FH;I;DJJ>;L7BK;E<J>;IJE9AEFJ?ED7M7H:I
=H7DJ;: ?D799EH:7D9;M?J>0 %EM;L;H FKHIK7DJJE0" HKB;I J>;I;L7BK;I7H;DEJH;:K9;:8O7D;IJ?C7J;<EHJ>;FHE878?B?JOE<
<EH<;?JKH;
-B;7I;H;<;HJEX55!=1.;869.7<*=287%*+5./8;2<,*5).*; YM>?9>?CC;:?7J;BO<EBBEMIJ>?IJ78B; <EH7::?J?ED7B?D<EHC7J?ED
/;FH;I;DJIJ>;7CEKDJ;7HD;:7D:IK8I;GK;DJBOF7?:KD:;HJ>;97B;D:7HO;7H&-
/;FH;I;DJIJ>;7CEKDJ;7HD;:7D:IK8I;GK;DJBOF7?:KD:;HJ>;97B;D:7HO;7H&-
/;FH;I;DJIJ>;7CEKDJ;7HD;:7D:IK8I;GK;DJBOF7?:KD:;HJ>;97B;D:7HO;7H&-
/;FH;I;DJIF7J;DJ7M7H:I
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 61 of 186 --
66">2/<97:/8=+>398&+,6/09<3=-+6*/+<
@>A2?J%2E49:?8
@?EC:3FE:@?E@
E96@>A2?JMD
+64E:@?<(=2?
@>A2?J (2:5
$@?8 ,6C>
:D23:=:EJ!?DFC2?46
(C6>:F>D
@>A2?J
@?EC:3FE:@?E@E96
=64E:G6676CC65
@>A6?D2E:@?(=2?
'E96C
,@E2=
1?CEJ>O*H9>;H
!EK=B7I/;JJ?D=;H
0;I>7I7O;;0;I>7 37H7:7H7@7D U U
+;?B'#;HD7D:;I U
37>?:37>;:? U
/;FH;I;DJI 7 <?B?D=<;;F7?:8OJ>; ECF7DO?D9EDD;9J?EDM?J>7<?B?D=8O*HH9>;HKD:;HJ>;%0/9J7D: B;=7B<;;IE<
F7?:8OJ>; ECF7DO?D9EDD;9J?EDM?J>J>;FH;F7H7J?EDE<*HH9>;HWI%0/9J<?B?D=
/;FH;I;DJI 7 <?B?D=<;;F7?:8OJ>; ECF7DO?D9EDD;9J?EDM?J>7<?B?D=8O*H;JJ?D=;HKD:;HJ>;%0/9J7D: B;=7B<;;IE<
F7?:8OJ>; ECF7DO?D9EDD;9J?EDM?J>J>;FH;F7H7J?EDE<*H;JJ?D=;HWI%0/9J<?B?D=
/;FH;I;DJI7C7J9>?D=EH;CFBEO;; :;I?=D7J;:9>7H?J78B;9EDJH?8KJ?EDC7:;8OJ>; ECF7DOFKHIK7DJJE?JI;CFBEO;;=?<JC7J9>7D:
LEBKDJ;;H?ICFHE=H7C M>?9>?I7L7?B78B;JE7BB ECF7DO;CFBEO;;I
<+8>=90#6+8+=/.A+<.=09<3=-+6*/+<
DE:>2E65FEFC6
(2J@FED-?56C
&@? BF:EJ!?46?E:G6
(=2?H2C5D
DE:>2E65FEFC6
(2J@FED-?56C
BF:EJ!?46?E:G6(=2?
H2C5D
=='E96C
+E@4<H2C5D
&F>36C@7
+92C6D@7
+E@4<@C-?:ED
C2?E2E6
2:C.2=F6
@7+E@4<
2?5'AE:@?
H2C5D
&2>6 H2C5,JA6
C2?E
2E6
AAC@G65
2E6
,2C86E
%2I:>F>
,2C86E
%2I:>F>
1?CEJ>O*H9>;H
DDK7B&D9;DJ?L;-HE=H7C +
)1&- "GK?JO
*;4.=+*<.-"#$&<
$.;?2,.+*<.-#$&<
!EK=B7I/
;JJ?D=;H
DDK7B&D9;DJ?L;-HE=H7C +
)1&- "GK?JO
*;4.=+*<.-"#$&<
$.;?2,.+*<.-#$&<
0;I>7I7O;;
0;I>7
37H7:7H7@7D
DDK7B&D9;DJ?L;-HE=H7C +
)1&- "GK?JO
*;4.=+*<.-"#$&<
$.;?2,.+*<.-#$&<
+;?B'#;HD7D:;I
DDK7B&D9;DJ?L;-HE=H7C +
)1&- "GK?JO
*;4.=+*<.-"#$&<
$.;?2,.+*<.-#$&<
37>?:37>;:?
DDK7B&D9;DJ?L;-HE=H7C +
)1&- "GK?JO
*;4.=+*<.-"#$&<
$.;?2,.+*<.-#$&<
1>;97B;D:7HO;7H&-J7H=;J7D:C7N?CKC;IJ?C7J;:<KJKH;F7OEKJIH;<B;9J;:?DJ>?IJ78B;M;H;97B9KB7J;:KI?D=J>;87I;I7B7HO<EH
97B;D:7HO;7HM7H:IF7OEKJIH7D=;<HECJEE<J7H=;J
1>;7CEKDJIH;FEHJ;:H;FH;I;DJJ>;J7H=;J7D:C7N?CKCDKC8;HE<*7HA;J 87I;:-/02IJ>7JC7OL;IJEDJ>;J;HCI:;I9H?8;:?DXT
ECF;DI7J?ED!?I9KII?ED7D:D7BOI?IY78EL;1>;DKC8;HE<I>7H;IJ>7JC7O8;;7HD;:?I;GK7BJE<HECJEE<J7H=;J
1>;7CEKDJIH;FEHJ;:H;FH;I;DJJ>;<7?HL7BK;E<*7HA;J 87I;:-/027D:I;HL?9; 87I;:/027M7H:I=H7DJ;::KH?D=<?I97BO;7H?D
799EH:7D9;M?J>0 %EM;L;H FKHIK7DJJE0" HKB;I J>;I;L7BK;I7H;DEJH;:K9;:8O7D;IJ?C7J;<EHJ>;FHE878?B?JOE<<EH<;?JKH;#EH
:;J7?BIH;=7H:?D=J>;7IIKCFJ?EDIKI;:JE97B9KB7J;J>;<7?HL7BK;E<7M7H:I=H7DJ;::KH?D=<?I97BO;7H I;;DEJ;JEJ>;X0KCC7HO
ECF;DI7J?ED178B;Y78EL;
-- 62 of 186 --
(4) The Market-based PRSUs will vest on the third anniversary of the grant date, subject to continued employment. The actual conversion of
Market-based PRSUs into shares of Lam common stock following the conclusion of the three-year performance period will range from 0% to
150% of the target amount, depending upon the percentile ranking of Lam’s TSR relative to the TSR of the companies in the XSOX index over
the applicable three-year performance period.
(5) The RSUs will vest in three equal installments on the first, second, and third anniversaries of the grant date, subject to continued employment.
Lam Research Corporation 2026 Proxy Statement 51
-- 63 of 186 --
"?>=>+8.381;?3>CA+<.=+>3=-+6*/+< */+<8.
1?CEJ>O*H9>;H
U U
U U
U U
U U
U U
U U
U
U
U
U
!EK=B7I/
;JJ?D=;H
U U
U U
U U
U U
U U
U U
U
0;I>7I7O;;
0;I>7
37H7:7H7@7D
U U
U U
U U
U U
U U
U U
U
U
U
U
+;?B'#;HD7D:;I
U U
U U
U U
U U
U U
U U
U
37>?:37>;:?
U U
U U
U
U U
U U
U U
U
U
U
'AE:@?H2C5D +E@4<H2C5D
&2>6
C2?E
2E6
&F>36C@7
+64FC:E:6D
-?56C=J:?8
-?6I6C4:D65
'AE:@?D
I6C4:D23=6
&F>36C@7
+64FC:E:6D
-?56C=J:?8
-?6I6C4:D65
'AE:@?D
-?6I6C4:D23=6
'AE:@?
I6C4:D6
(C:46
'AE:@?
IA:C2E:@?
2E6
&F>36C@7
+92C6D@C
-?:ED@7
+E@4<,92E
2G6&@E
.6DE65
%2C<6E.2=F6
@7+92C6D@C
-?:ED@7
+E@4<,92E
2G6&@E
.6DE65
BF:EJ!?46?E:G6
(=2?H2C5D
&F>36C@7
-?62C?65
+92C6D -?:ED@C
'E96C*:89ED
,92E 2G6&@E
.6DE65
BF:EJ!?46?E:G6
(=2?H2C5D
%2C<6E@C(2J@FE
.2=F6@7-?62C?65
+92C6D -?:ED@C
'E96C*:89ED,92E
2G6&@E.6DE65
-- 64 of 186 --
7B9KB7J;:8OCKBJ?FBO?D=J>;DKC8;HE<KDL;IJ;:KD?JI8O J>;9BEI?D=FH?9;E<EKH9ECCEDIJE9AED'KD; M>?9>M7IJ>;
B7IJJH7:?D=:7OE<<?I97BO;7H
1>;/02IM?BBL;IJ?DJ>H;;;GK7B?DIJ7BBC;DJIEDJ>;<?HIJ I;9ED: 7D:J>?H:7DD?L;HI7H?;IE<J>;=H7DJ:7J; IK8@;9JJE9EDJ?DK;:;CFBEOC;DJ
1>;*7HA;J 87I;:-/02IM?BBL;IJEDJ>;J>?H:7DD?L;HI7HOE<J>;=H7DJ:7J; IK8@;9JJE9EDJ?DK;:;CFBEOC;DJ1>;*7HA;J 87I;:-/02I7H;
I>EMD7JJ>;?HJ7H=;J7CEKDJ1>;79JK7B9EDL;HI?EDE<J>;*7HA;J 87I;:-/02I?DJEI>7H;IE<)7C9ECCEDIJE9A<EBBEM?D=J>;9ED9BKI?EDE<
J>;J>H;; O;7HF;H<EHC7D9;F;H?E:M?BBH7D=;<HECJEE<J>7JJ7H=;J7CEKDJ :;F;D:?D=KFEDJ>;F;H9;DJ?B;H7DA?D=E<)7CWI10/
H;B7J?L;JEJ>;10/E<J>;9ECF7D?;I?DJ>;50,5?D:;NEL;HJ>;7FFB?978B;J>H;; O;7HF;H<EHC7D9;F;H?E:
1>;IJE9AEFJ?EDI8;9EC;;N;H9?I78B;?DJ>H;;;GK7B?DIJ7BBC;DJIEDJ>;<?HIJ I;9ED: 7D:J>?H:7DD?L;HI7H?;IE<J>;=H7DJ:7J; IK8@;9JJE
9EDJ?DK;:;CFBEOC;DJ
1>;*7HA;J 87I;:-/02IM?BBL;IJEDJ>;J>?H:7DD?L;HI7HOE<J>;=H7DJ:7J; IK8@;9JJE9EDJ?DK;:;CFBEOC;DJ1>;*7HA;J 87I;:-/02I7H;
I>EMD7JJ>;?HJ7H=;J7CEKDJ1>;79JK7B9EDL;HI?EDE<J>;*7HA;J 87I;:-/02I?DJEI>7H;IE<)7C9ECCEDIJE9A<EBBEM?D=J>;9ED9BKI?EDE<
J>;J>H;; O;7HF;H<EHC7D9;F;H?E:M?BBH7D=;<HECJEE<J>7JJ7H=;J7CEKDJ :;F;D:?D=KFED)7CWI10/F;H<EHC7D9;9ECF7H;:JE
J>;C7HA;JFH?9;F;H<EHC7D9;E<J>;50,5?D:;NEL;HJ>;7FFB?978B;J>H;; O;7HF;H<EHC7D9;F;H?E:
":>398B/<-3=/=+8.%>9-5(/=>/.?<3813=-+6*/+<
'AE:@?H2C5D +E@4<H2C5D
&2>6
&F>36C@7
+92C6D4BF:C65
@?I6C4:D6
.2=F6*62=:K65
@?I6C4:D6
&F>36C@7
+92C6D4BF:C65
@?.6DE:?8
.2=F6*62=:K65
@?.6DE:?8
1?CEJ>O*H9>;H
!EK=B7I/;JJ?D=;H
0;I>7I7O;;0;I>7 37H7:7H7@7D U U
+;?B'#;HD7D:;I U U
37>?:37>;:? U U
1>;J78B;I>EMI7BBIJE9AEFJ?EDI;N;H9?I;:7D:J>;L7BK;H;7B?P;:KFED;N;H9?I; 7D:7BB/02I7D:*7HA;J 87I;:-/02IL;IJ;:7D:J>;
L7BK;H;7B?P;:KFEDL;IJ?D=
!98;?+6303/./0/<</.97:/8=+>398
&2>6
I64FE:G6
@?EC:3FE:@?D
:?1
*68:DEC2?E
@?EC:3FE:@?D
:?1
88C682E6
2C?:?8D:?
1
88C682E6
2=2?462E
:D42=
162C ?5
1?CEJ>O*H9>;H
!EK=B7I/;JJ?D=;H
0;I>7I7O;;0;I>7 37H7:7H7@7D U U U U
+;?B'#;HD7D:;I
37>?:37>;:? U U U U
1>;;DJ?H;7CEKDJE<;79>;N;9KJ?L;WI9EDJH?8KJ?EDI?D<?I97BO;7H?IH;FEHJ;:?D;79>H;IF;9J?L;+",WI9ECF;DI7J?ED?DEKH<?I97BO;7H
X0KCC7HO ECF;DI7J?ED178B;Y78EL;
/;FH;I;DJIJ>;7CEKDJJ>7J)7C9H;:?J;:JEJ>;"B;9J?L;!;<;HH;: ECF;DI7J?ED-B7DJ>;X"! -Y M>?9>?IE<J>;;N;9KJ?L;WII7B7HO
9EDJH?8KJ?ED:KH?D=97B;D:7HO;7HI7D: JE7C7N?CKC7DDK7B8;D;<?JE< 1>;I;7CEKDJI7H;?D9BK:;:?DJ>;X0KCC7HO
ECF;DI7J?ED178B;Y7D:XBB,J>;H ECF;DI7J?ED178B;<EH#?I97B6;7HY78EL;
1>;+",I:?:DEJH;9;?L;78EL; C7HA;JEHFH;<;H;DJ?7B;7HD?D=I?D<?I97BO;7H
1>;<?I97BO;7H ;D:87B7D9;?D9BK:;I <EH*HH9>;H7D: <EH*H;JJ?D=;HJ>7JM;H;FH;L?EKIBOH;FEHJ;:?DEKH0KCC7HO
ECF;DI7J?ED178B;I?DFH;L?EKIO;7HI1>;<?I97BO;7H ;D:87B7D9;?D9BK:;I <EH*HH9>;H7D: <EH*H;JJ?D=;H
J>7JM7I9EDJH?8KJ;:7<J;H!;9;C8;H EH9EDIJ?JKJ;I;7HD?D=IEDIK9>9EDJH?8KJ?EDI 7D:M>?9>?IIK8@;9JJE:?IJH?8KJ?ED?DJ>;;L;DJE<
7 >7D=;?D EDJHEB7I:;<?D;:?DJ>;"! - 7I:;I9H?8;:?DXC"8=.7=2*5"*B6.7=<>987%.;627*=2878;1*70.2787=;85C5.,=2?.
./.;;.-869.7<*=287"5*7Y8;BEM
48+38/'1'=2+387"543!+62/3'8/4346.'3-+/3438641
1>;?D:;F;D:;DJC;C8;HIE<EKHE7H:>7L;7:EFJ;:7D;N;9KJ?L;I;L;H7D9;FEB?9OJ>;XI;L;H7D9;FEB?9OY 7D:7D;N;9KJ?L;
9>7D=;?D9EDJHEBFEB?9OJ>;X9>7D=;?D9EDJHEBFEB?9OY M>?9>7H;7FFB?978B;JEEKH+",I1>;FEB?9?;IM;H;7C;D:;:8OJ>;
?D:;F;D:;DJC;C8;HIE<EKHE7H: ;<<;9J?L;*7O 1>;<EBBEM?D=?I7IKCC7HOE<J>;FEB?9?;I
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 65 of 186 --
Executive Severance Policy
The severance policy applies to individuals serving as our CEO, president, executive vice president, and senior vice president (each,
a “covered executive”), including each of our NEOs. However, certain provisions of the severance policy apply only to individuals
serving as CEO, president or executive vice president (each, a “Tier 1 executive”), currently including Mr. Archer, Mr. Bettinger, and
Mr. Varadarajan.
The severance policy provides that if an Involuntary Termination (as defined in the severance policy) of a Tier 1 executive’s
employment occurs, other than in connection with a Change in Control or an Acquisition (each as defined in the severance policy),
the Tier 1 executive will be entitled to: (1) a lump-sum cash payment equal to 100% (150% for our CEO) of the Tier 1 executive’s
then-current annual base salary, plus an amount equal to 50% (100% for our CEO) of the average of the last five annual payments
made to the Tier 1 executive under the short-term variable compensation or any predecessor or successor programs (the “Short-Term
Program,” and such average, the “Five-Year Average Amount”), plus an amount equal to the pro-rata amount the Tier 1 executive
would have earned under the Short-Term Program for the calendar year in which the Tier 1 executive’s employment is terminated had
the Tier 1 executive’s employment continued until the end of such calendar year, such pro-rata portion to be calculated based on the
corporate performance results achieved under the Short-Term Program for the full calendar year (but assuming individual
performance at the lesser of (i) the target level and (ii) the average of the individual performance results for the other executives
under such program for the full calendar year) and the number of full months elapsed prior to the termination date; (2) certain medical
benefits; (3) vesting, as of the date of termination, of a pro rata portion of the unvested stock option or RSU awards that are solely
service-based and which were granted to the Tier 1 executive at least 12 months prior to the termination date; and (4) a cash
payment equal to the product of (x) a pro rata portion (based on the time from the first day of the Performance Period (as defined in
the award agreements) until the earlier of the termination date or the last day of the Performance Period) of the unvested Market-
based PRSU and/or other performance-based RSU awards granted to the Tier 1 executive, as adjusted for the Company’s
performance (calculated as set forth in the award agreements) over the time from the first day of the Performance Period until the
earlier of the termination date or the last day of the Performance Period and (y) the closing stock price on the date of termination.
If the Company carries out an Acquisition (as defined in the severance policy) during the period of a covered executive’s employment,
and if there is an Involuntary Termination of the covered executive’s employment on or after the date of the initial public
announcement of, or within the 24 months following the consummation of, the Acquisition, the covered executive will be entitled to:
(1) a lump-sum cash payment equal to 150% (200% for our CEO) of the covered executive’s then current annual base salary, plus an
amount equal to 150% (200% for our CEO) of the Five-Year Average Amount, plus an additional amount equal to a pro rata amount
(based on the number of full months worked in the calendar year during which the termination occurs) of the Five-Year Average
Amount; (2) certain medical benefits; (3) vesting, as of the date of termination, of the unvested stock option or RSU awards that are
solely service-based granted to the covered executive prior to the Acquisition; and (4) a cash payment equal to the product of (x) the
sum of (i) a pro rata portion (based on time from the first day of the Performance Period until the earlier of the closing of the
Acquisition or the last day of the Performance Period) of the unvested Market-based PRSUs/performance-based RSUs as adjusted
for the Company’s performance (calculated as set forth in the award agreements) over the time from the first day of the Performance
Period until the closing of the acquisition and (ii) a pro rata portion (based on time from the day following the closing of the Acquisition
until the last day of the Performance Period) of the target number of unvested Market-based PRSUs/performance-based RSUs (i.e.,
unadjusted for performance) and (y) the closing stock price on the closing date of the Acquisition.
If a Tier 1 executive’s employment is terminated due to disability or in the event of the Tier 1 executive’s death, the Tier 1 executive
(or the Tier 1 executive’s estate) will be entitled to: (1) the pro rata amount the Tier 1 executive would have earned under the Short-
Term Program for the calendar year in which the Tier 1 executive’s employment is terminated had the Tier 1 executive’s employment
continued until the end of such calendar year, such pro rata portion to be calculated based on the corporate performance results
achieved under the Short-Term Program for the full calendar year (but assuming individual performance at the lesser of (i) the target
level and (ii) the average of the individual performance results for the other executives under such program for the full calendar year)
and the number of full months elapsed prior to the termination date; (2) certain medical benefits; (3) vesting, as of the date of
termination, of any unvested stock option and RSU awards that are solely service-based and which are granted to the Tier 1
executive prior to the date of termination; and (4) vesting, as of the date of termination, of a portion of the unvested Market-based
PRSU/performance-based RSU awards granted to the Tier 1 executive, as adjusted for the Company’s performance (calculated as
set forth in the award agreements) over the time from the first day of the Performance Period until the earlier of the termination date
or the last day of the Performance Period.
If the employment of a covered executive who is not a Tier 1 executive is terminated due to disability or in the event of the covered
executive’s death, the covered executive (or the covered executive’s estate) will be entitled to: (1) the pro rata amount the covered
executive would have earned under the Short-Term Program for the calendar year in which the covered executive’s employment is
terminated had the covered executive’s employment continued until the end of such calendar year, such pro rata portion to be
calculated based on the corporate performance results achieved under the Short-Term Program for the full calendar year (but
assuming individual performance at the lesser of (i) the target level and (ii) the average of the individual performance results for the
other executives under such program for the full calendar year) and the number of full months elapsed prior to the termination date;
(2) vesting, as of the date of termination, of any unvested stock option and RSU awards that are solely service-based and which are
granted to the covered executive prior to the date of termination; and (3) vesting, as of the date of termination, of a portion of the
unvested Market-based PRSU/performance-based RSU awards granted to the covered executive, as adjusted for the Company’s
54
-- 66 of 186 --
performance (calculated as set forth in the award agreements) over the time from the first day of the Performance Period until the
earlier of the termination date or the last day of the Performance Period.
If a covered executive voluntarily resigns, the covered executive will be entitled to no additional benefits (except as the covered
executive may be eligible for under the Company’s Retiree Health Plans), outstanding stock options, RSUs and Market-based
PRSUs/performance-based RSUs will cease to vest on the termination date, and stock options will be canceled unless they are
exercised within 90 days after the termination date. All RSUs and Market-based PRSUs/performance-based RSUs will be canceled
on the termination date.
The severance policy conditions all payments and benefits upon a covered executive’s performance in all material respects of their
confidentiality and non-compete obligations to the Company. The severance policy also requires a covered executive to execute a
release in favor of the Company, which includes a non-solicitation obligation for a period of six months following the termination of the
covered executive’s employment, to receive the payments described above. Any compensation that is paid to a covered executive by
the Company is subject to any applicable compensation recovery policy.
The severance policy may be amended at any time; provided, however, that any amendment that would adversely affect a covered
executive will not be applicable without such covered executive’s consent until the later of (i) 18 months following the date of such
amendment, or (ii), if the amendment occurs during the Change In Control Protection Period (as defined in the change in control
policy), the end of the Change In Control Protection Period.
Executive Change in Control Policy
The change in control policy applies to individuals serving as covered executives, including each of our NEOs.
The change in control policy provides that if a Change in Control of the Company (as defined in the change in control policy) occurs
during the period of a covered executive’s employment, and if there is an Involuntary Termination of the covered executive’s
employment on or after the date of the initial public announcement of the transaction or within the 24 months following the Change in
Control, the covered executive will be entitled to: (1) a lump-sum cash payment equal to 150% (200% for our CEO) of the covered
executive’s then current annual base salary, plus an amount equal to 150% (200% for our CEO) of the Five-Year Average Amount,
plus an additional amount equal to a pro rata amount (based on the number of full months worked in the calendar year during which
the termination occurs) of the Five-Year Average Amount; (2) certain medical benefits; (3) vesting, as of the date of termination, of the
unvested stock option or RSU awards that are solely service-based granted to the covered executive prior to the Change in Control;
and (4) conversion of any Market-based PRSUs/performance-based RSUs outstanding as of the Change in Control into a cash
award payable at time of termination calculated as set forth in the award agreements (pursuant to the Company’s current form of
Market-based PRSU award agreement, the cash award would be equal to the product of (x) the sum of (i) a pro rata portion (based
on time from the first day of the Performance Period until the earlier of the closing of the Change in Control or the last day of the
Performance Period) of the unvested Market-based PRSUs/performance-based RSUs as adjusted for the Company’s performance
(calculated as set forth in the award agreements) over the time from the first day of the Performance Period until the closing of the
Change in Control and (ii) a pro rata portion (based on time from the day following the closing of the Change in Control until the last
day of the Performance Period) of the target number of unvested Market-based PRSUs/performance-based RSUs (i.e. unadjusted for
performance) and (y) the closing stock price on the closing date of the Change in Control).
If the Company is acquired by another entity in connection with a Change in Control of the Company (as defined in the severance
policy) during the period of a covered executive’s employment, and there is or will be no market for the Company’s common stock,
and if the acquiring company does not provide the covered executive with stock options and RSU awards comparable to the
unvested stock option or RSU awards that are not performance-based that are granted to the covered executive prior to the Change
in Control, then regardless of whether the covered executive’s employment is terminated, the covered executive will be entitled to the
vesting, immediately prior to the Change in Control, of all such unvested stock option or RSU awards that are not performance-based
that are granted to the covered executive prior to the Change in Control.
The change in control policy conditions all payments and benefits upon a covered executive’s performance in all material respects of
their confidentiality and non-compete obligations to the Company. The change in control policy also requires a covered executive to
execute a release in favor of the Company, which includes a non-solicitation obligation for a period of six months following the
termination of the covered executive’s employment, to receive the payments described above. Any compensation that is paid to a
covered executive by the Company is subject to any applicable compensation recovery policy.
The change in control policy may be amended at any time; provided, however, that any amendment that would adversely affect a
covered executive will not be applicable without such covered executive’s consent until the later of (i) 18 months following the date of
such amendment, or (ii) if the amendment occurs during the Change In Control Protection Period, the end of the Change In Control
Protection Period.
Equity Plans
In addition to the above, certain of our stock plans provide for accelerated benefits after certain events. While the applicable triggers
under each plan vary, these events generally include: (1) a merger or consolidation in which the Company is not the surviving entity,
(2) a sale of substantially all of the Company’s assets, including a liquidation or dissolution of the Company, or (3) a change in the
Lam Research Corporation 2026 Proxy Statement 55
-- 67 of 186 --
EMD;HI>?FE<CEH;J>7DE<EKHEKJIJ7D:?D=I;9KH?J?;I8OJ;D:;HE<<;HEHI?C?B7HJH7DI79J?ED<J;H7:;I?=D7J;:;L;DJ J>;L;IJ?D=
E<IEC;EH7BBE<J>;7M7H:I=H7DJ;:KD:;HJ>;I;FB7DIC7O8;?CC;:?7J;BO799;B;H7J;:?D<KBB EH9;HJ7?D7M7H:IC7O8;7IIKC;:
IK8IJ?JKJ;: H;FB79;: EHI;JJB;:?D97I>8O7IKHL?L?D=9EHFEH7J?EDEH?JIF7H;DJ1>;IF;9?<?9JH;7JC;DJE<7M7H:I?D7F7HJ?9KB7H
JH7DI79J?EDM?BB8;:;J;HC?D;:8OJ>;E7H:7D:EHJ>;J;HCIE<J>;7FFB?978B;JH7DI79J?ED:E9KC;DJI
;?3>CA+<.1<//7/8>=
&D7::?J?EDJEJ>;78EL; J>;;GK?JO7M7H:7=H;;C;DJI=H7DJ;:JE+",IKD:;HEKHBED= J;HC?D9;DJ?L;FHE=H7C?D9BK:;
J;HCIJ>7JFHEL?:;<EH<7LEH78B;L;IJ?D=JH;7JC;DJ?DJ>;;L;DJE<7.K7B?<?;:/;J?H;C;DJ7I:;<?D;:?DJ>;7M7H:7=H;;C;DJI
J;HC?D7J?EDE<I;HL?9;GK7B?<?;I7I7X.K7B?<?;:/;J?H;C;DJYEDBO?<7BBE<J>;<EBBEM?D=9ED:?J?EDI7H;I7J?I<?;: J>;+",>7I7J
B;7IJ<?L;O;7HIE<9EDJ?DKEKII;HL?9;M?J>J>; ECF7DOEH7H;B7J;:;DJ?JO J>;+",?I7=;EHEB:;H J>;IKCE<J>;+",WI
7=;FBKIO;7HIE<I;HL?9;;GK7BIEH;N9;;:I J>;+",FHEL?:;I7:L7D9;MH?JJ;DDEJ?9;E<?DJ;DJJEH;J?H;7JB;7IJ:7OI7D:
DECEH;J>7DCEDJ>IFH?EHJEJ>;H;J?H;C;DJ:7J;7D: J>;+",;N;9KJ;I7D::E;IDEJH;LEA; 7=;D;H7BH;B;7I;E<9B7?CI?D
<7LEHE<J>; ECF7DO&D7::?J?ED J>;.K7B?<?;:/;J?H;C;DJCKIJE99KH 7JB;7IJCEDJ>I<EBBEM?D=J>;=H7DJ:7J;E<J>;
7FFB?978B;7M7H:7D: <EH*7HA;J 87I;:-/02I FH?EHJEJ>;7FFB?978B;F;H<EHC7D9;L;IJ?D=:7J;
#EHI;HL?9; 87I;:/02I=H7DJ;:JE+",IKD:;HEKH)1&- KFED7.K7B?<?;:/;J?H;C;DJ FHEL?:;:J>7JJ>;+",>7IDEJ
L?EB7J;:7DOH;IJH?9J?L;9EL;D7DJJEM>?9>>;EHI>;?IIK8@;9J7IE<J>;H;J?H;C;DJ:7J; 7BBKDL;IJ;:/02IL;IJ?D<KBB7IE<IK9>:7J;
#EH*7HA;J 87I;:-/02I=H7DJ;:JE+",IKD:;HEKH)1&- KFED7.K7B?<?;:/;J?H;C;DJFH?EHJEJ>;-;H<EHC7D9;3;IJ?D=
!7J;7I:;<?D;:?DJ>;7M7H:7=H;;C;DJ J>;*7HA;J 87I;:-/02IH;C7?DEKJIJ7D:?D=7D:9EDJ?DK;JE8;;B?=?8B;JEL;IJEDJ>;
EH?=?D7B-;H<EHC7D9;3;IJ?D=!7J; M?J>L;IJ?D=:;J;HC?D;:87I;:ED79JK7B ECF7DOF;H<EHC7D9;EL;HJ>;<KBBF;H<EHC7D9;F;H?E:
7I?<J>;+",>7:H;C7?D;:;CFBEO;:J>HEK=>J>;-;H<EHC7D9;3;IJ?D=!7J; IK8@;9JJEJ>;+",WI9EDJ?DK;:9ECFB?7D9;M?J>7BB
H;IJH?9J?L;9EL;D7DJIJEM>?9>>;EHI>;?IIK8@;9J7IE<J>;-;H<EHC7D9;3;IJ?D=!7J;
IE<J>;B7IJ:7OE<<?I97BO;7H DED;E<J>;I;7M7H:I>7:8;;DEKJIJ7D:?D=<EH7JB;7IJCEDJ>I<EBBEM?D=J>;=H7DJ:7J; IE
DED;E<J>;+",IM;H;;B?=?8B;<EH7.K7B?<O?D=/;J?H;C;DJ
#9>/8>3+6#+C7/8>=>9!+7/.B/-?>3@/"003-/<=':98&/<738+>3989<2+81/3898><96
1>;J78B;I8;BEMIKCC7H?P;J>;FEJ;DJ?7BF7OC;DJIJEEKH+",I 7IIKC?D=7D;CFBEOC;DJJ;HC?D7J?EDEH9>7D=;?D9EDJHEBE<J>;
ECF7DO7IE<J>;;D:E<<?I97BO;7H1>;I;7CEKDJI7H;97B9KB7J;:7IIKC?D=J>7JJ>;;CFBEOC;DJJ;HC?D7J?EDEH9>7D=;?D
9EDJHEBE99KHIEDJ>;B7IJ8KI?D;II:7OE<<?I97BO;7H 'KD; 1>;9BEI?D=FH?9;F;HI>7H;E<EKH9ECCEDIJE9AED
'KD; M7I1>;I>EHJ J;HC?D9;DJ?L;FHE=H7CFHEH7J77CEKDJI7H;97B9KB7J;:8OCKBJ?FBO?D=J>;7FFB?978B;FHEH7J7
F;H9;DJ7=;8OJ>;J7H=;J9JK7BF;H<EHC7D9;M?BBDEJ8;ADEMDKDJ?B7<J;HJ>;;D:E<97B;D:7HO;7H
#9>/8>3+6#+C7/8>=>9!"=':98&/<738+>3989<2+81/3898><96
(@E6?E:2=(2J>6?EDE@%C C496C-A@?,6C>:?2E:@?@C92?86:?@?EC@=2D@7"F?6
!?G@=F?E2CJ,6C>:?2E:@?
.@=F?E2CJ
,6C>:?2E:@?
:D23:=:EJ
@C62E9
@C
2FD6
&@E7@C
2FD6
92?86:?@?EC@=
@C4BF:D:E:@?3J
$2>
@>A6?D2E:@?
0;L;H7D9; U U U
0>EHJ J;HC&D9;DJ?L; O;7H7L;H7=; U U U
0>EHJ J;HC&D9;DJ?L;FHEH7J7 U U
)ED= J;HC&D9;DJ?L;I
0JE9A,FJ?EDI2DL;IJ;:7D:99;B;H7J;: U U
0;HL?9; 87I;:/;IJH?9J;:0JE9A2D?JI2DL;IJ;:7D:99;B;H7J;: U U
-;H<EHC7D9; 87I;:/;IJH?9J;:0JE9A2D?JI2DL;IJ;:7D:99;B;H7J;: U U
6?67:ED2?5(6CBF:D:E6D
%;7BJ>;D;<?J EDJ?DK7J?ED/;J?H;;%;7BJ>-B7DI
,@E2=
-- 68 of 186 --
(@E6?E:2=(2J>6?EDE@%C 6EE:?86C-A@?,6C>:?2E:@?@C92?86:?@?EC@=2D@7"F?6
!?G@=F?E2CJ,6C>:?2E:@?
.@=F?E2CJ
,6C>:?2E:@?
:D23:=:EJ
@C62E9
@C
2FD6
&@E7@C
2FD6
92?86:?@?EC@=
@C4BF:D:E:@?3J
$2>
@>A6?D2E:@?
0;L;H7D9; U U U
0>EHJ J;HC&D9;DJ?L; O;7H7L;H7=; U U U
0>EHJ J;HC&D9;DJ?L;FHEH7J7 U U
)ED= J;HC&D9;DJ?L;I
0JE9A,FJ?EDI2DL;IJ;:7D:99;B;H7J;: U U
0;HL?9; 87I;:/;IJH?9J;:0JE9A2D?JI2DL;IJ;:7D:99;B;H7J;: U U
-;H<EHC7D9; 87I;:/;IJH?9J;:0JE9A2D?JI2DL;IJ;:7D:99;B;H7J;: U U
6?67:ED2?5(6CBF:D:E6D
%;7BJ>;D;<?J EDJ?DK7J?ED ,/;D;<?J U U
,@E2= L L
(@E6?E:2=(2J>6?EDE@%C .2C252C2;2?-A@?,6C>:?2E:@?@C92?86:?@?EC@=2D@7"F?6
!?G@=F?E2CJ,6C>:?2E:@?
.@=F?E2CJ
,6C>:?2E:@?
:D23:=:EJ
@C62E9
@C
2FD6
&@E7@C
2FD6
92?86:?@?EC@=
@C4BF:D:E:@?3J
$2>
@>A6?D2E:@?
0;L;H7D9; U U U
0>EHJ J;HC&D9;DJ?L; O;7H7L;H7=; U U U
0>EHJ J;HC&D9;DJ?L;FHEH7J7 U U
)ED= J;HC&D9;DJ?L;I
0JE9A,FJ?EDI2DL;IJ;:7D:99;B;H7J;: U U
0;HL?9; 87I;:/;IJH?9J;:0JE9A2D?JI2DL;IJ;:7D:99;B;H7J;: U U
-;H<EHC7D9; 87I;:/;IJH?9J;:0JE9A2D?JI2DL;IJ;:7D:99;B;H7J;: U U
6?67:ED2?5(6CBF:D:E6D
%;7BJ>;D;<?J EDJ?DK7J?ED ,/;D;<?J U U
,@E2= L L
(@E6?E:2=(2J>6?EDE@%C 6C?2?56D-A@?,6C>:?2E:@?@C92?86:?@?EC@=2D@7"F?6
!?G@=F?E2CJ,6C>:?2E:@?
.@=F?E2CJ
,6C>:?2E:@?
:D23:=:EJ
@C62E9
@C
2FD6
&@E7@C
2FD6
92?86:?@?EC@=
@C4BF:D:E:@?3J
$2>
@>A6?D2E:@?
0;L;H7D9; U U U U
0>EHJ J;HC&D9;DJ?L; O;7H7L;H7=; U U U U
0>EHJ J;HC&D9;DJ?L;FHEH7J7 U U U
)ED= J;HC&D9;DJ?L;I
0JE9A,FJ?EDI2DL;IJ;:7D:99;B;H7J;: U U U
0;HL?9; 87I;:/;IJH?9J;:0JE9A2D?JI2DL;IJ;:7D:99;B;H7J;: U U U
-;H<EHC7D9; 87I;:/;IJH?9J;:0JE9A2D?JI2DL;IJ;:7D:99;B;H7J;: U U U
6?67:ED2?5(6CBF:D:E6D
%;7BJ>;D;<?J EDJ?DK7J?ED ,/;D;<?J U U
,@E2= L L
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 69 of 186 --
(@E6?E:2=(2J>6?EDE@C .2965:-A@?,6C>:?2E:@?@C92?86:?@?EC@=2D@7"F?6
!?G@=F?E2CJ,6C>:?2E:@?
.@=F?E2CJ
,6C>:?2E:@?
:D23:=:EJ
@C62E9
@C
2FD6
&@E7@C
2FD6
92?86:?@?EC@=
@C4BF:D:E:@?3J
$2>
@>A6?D2E:@?
0;L;H7D9; U U U U
0>EHJ J;HC&D9;DJ?L; O;7H7L;H7=; U U U U
0>EHJ J;HC&D9;DJ?L;FHEH7J7 U U U
)ED= J;HC&D9;DJ?L;I
0JE9A,FJ?EDI2DL;IJ;:7D:99;B;H7J;: U U U
0;HL?9; 87I;:/;IJH?9J;:0JE9A2D?JI2DL;IJ;:7D:99;B;H7J;: U U U
-;H<EHC7D9; 87I;:/;IJH?9J;:0JE9A2D?JI2DL;IJ;:7D:99;B;H7J;: U U
6?67:ED2?5(6CBF:D:E6D
%;7BJ>;D;<?J EDJ?DK7J?ED/;J?H;;%;7BJ>-B7DI
,@E2=
6/->3@//0/<</.97:/8=+>398#6+8
I:;I9H?8;:78EL;?DXC869.7<*=2872<,><<287*7-7*5B<2<C) *7-) 869.7<*=287";80;*6<C!=1.;
.7./2=< 8=?*25*+5.=8556958B..<C5.,=2?../.;;.-869.7<*=287"5*7F J>; ECF7DOC7?DJ7?DI7D"B;9J?L;!;<;HH;:
ECF;DI7J?ED-B7D?DM>?9>J>;+",I7H;;B?=?8B;JEF7HJ?9?F7J;&D7::?J?EDJEJ>;FEJ;DJ?7BF7OC;DJII>EMD?DJ>;J78B;I78EL; ?D
J>;;L;DJE<7 >7D=;?D EDJHEB7I:;<?D;:?DJ>;"B;9J?L;!;<;HH;: ECF;DI7J?ED-B7D 7BB7CEKDJI9H;:?J;:JE7F7HJ?9?F7J?D=
+",WI799EKDJEJ>;HJ>7D7CEKDJI9EDJH?8KJ;:J>HEK=>!;9;C8;H 7D:;7HD?D=IJ>;H;ED M?BB8;:?IJH?8KJ;:?D7BKCF IKC
F7OC;DJEDJ>;<?HIJ8KI?D;II:7OE<J>;J>CEDJ><EBBEM?D=IK9> >7D=;?D EDJHEB1>;87B7D9;7D:7FFB?978B;7CEKDJIE<;79>
+",WI799EKDJ7IE<J>;;D:E<<?I97BO;7H7H;I;J<EHJ>?DDEJ;JEJ>;J78B;X 87:>*52/2.-./.;;.-869.7<*=287YEDF7=;
2D:;HJ>;"B;9J?L;!;<;HH;: ECF;DI7J?ED-B7D 7CEKDJIC7O8;M?J>:H7MDEH:?IJH?8KJ;:<HECJ>;FB7DJ>HEK=>FH; I9>;:KB;:
F7OC;DJIEHKFED:;7J> H;J?H;C;DJ :?I78?B?JOEH7I;F7H7J?ED<HECI;HL?9; 7I;B;9J;:?D7:L7D9;8OJ>;F7HJ?9?F7DJ?D799EH:7D9;
M?J>J>;J;HCIE<J>;FB7D
"#+C$+>39
&D799EH:7D9;M?J>0" HKB;I M;7H;FHEL?:?D=J>;H7J?EE<J>;7DDK7BJEJ7B9ECF;DI7J?EDE<EKH ",JEJ>;C;:?7DE<J>;7DDK7B
JEJ7B9ECF;DI7J?EDE<EKH;CFBEO;;IEJ>;HJ>7DEKH ", 1>;<?I97BO;7H7DDK7BJEJ7B9ECF;DI7J?EDE<EKH ", *HH9>;H
M7I J>;<?I97BO;7H7DDK7BJEJ7B9ECF;DI7J?EDE<EKHC;:?7D9ECF;DI7J;:;CFBEO;;EJ>;HJ>7DEKH ", M7I
7D:J>;H7J?EE<J>;I;7CEKDJIM7IJE
1>?IF7OH7J?E?I7H;7IED78B;;IJ?C7J;97B9KB7J;:?D7C7DD;H9EDI?IJ;DJM?J>0" HKB;I87I;:EDEKH>KC7DH;IEKH9;IIOIJ;CE<
H;9EH:7D:J>;C;J>E:EBE=O:;I9H?8;:8;BEM;97KI;J>;0" HKB;I<EH?:;DJ?<O?D=J>;C;:?7D9ECF;DI7J;:;CFBEO;;7D:
97B9KB7J?D=J>;F7OH7J?E87I;:EDJ>7J;CFBEO;;WI7DDK7BJEJ7B9ECF;DI7J?ED7BBEM9ECF7D?;IJE7:EFJ7L7H?;JOE<C;J>E:EBE=?;I JE
7FFBO9;HJ7?D;N9BKI?EDI 7D:JEC7A;H;7IED78B;;IJ?C7J;I7D:7IIKCFJ?EDIJ>7JH;<B;9JJ>;?H9ECF;DI7J?EDFH79J?9;I J>;F7OH7J?E
H;FEHJ;:8OEJ>;H9ECF7D?;IC7ODEJ8;9ECF7H78B;JEJ>;F7OH7J?EH;FEHJ;:78EL; 7IEJ>;H9ECF7D?;IC7O>7L;:?<<;H;DJ
;CFBEOC;DJ7D:9ECF;DI7J?EDFH79J?9;I7D:C7OKJ?B?P;:?<<;H;DJC;J>E:EBE=?;I ;N9BKI?EDI ;IJ?C7J;I 7D:7IIKCFJ?EDI?D
97B9KB7J?D=J>;?HEMDF7OH7J?EI
#EHFKHFEI;IE<?:;DJ?<O?D=EKHC;:?7D9ECF;DI7J;:;CFBEO;;?D<?I97BO;7H M;KI;:EKH=BE87B;CFBEO;;FEFKB7J?ED7IE<
'KD; ?:;DJ?<?;:87I;:EDEKH>KC7DH;IEKH9;IIOIJ;CIE<H;9EH:4;KI;:JEJ7B:?H;9J9ECF;DI7J?ED7IEKH9EDI?IJ;DJBO
7FFB?;:9ECF;DI7J?EDC;7IKH;<EHIK9>FEFKB7J?ED&DJ>?I9EDJ;NJ JEJ7B:?H;9J9ECF;DI7J?EDC;7DIJ>;IKCE<J>;7FFB?978B;7DDK7B
87I;I7B7H?;I:;J;HC?D;:7IE<'KD; J>;?D9;DJ?L;97I>J7H=;J7CEKDJF7O78B;<EHI;HL?9;?D97B;D:7HO;7H 7D:J>;
7FFHEL;:L7BK;E<J>;7DDK7B;GK?JO7M7H:I=H7DJ;::KH?D=<?I97BO;7H<EHEKH=BE87B;CFBEO;;FEFKB7J?ED4;7DDK7B?P;:J>;
7DDK7B87I;I7B7HO7D:?D9;DJ?L;97I>J7H=;J7CEKDJI<EH7BB;CFBEO;;IM>E:?:DEJMEHA<EHJ>;;DJ?H;O;7H$?L;D?JI=BE87B
FEFKB7J?ED J>; ECF7DOKI;:J>;<EH;?=D9KHH;D9O;N9>7D=;H7J;I?D;<<;9J7JJ>;;D:E<<?I97BO;7HJE:;J;HC?D;J>;7DDK7B
JEJ7B:?H;9J9ECF;DI7J?ED7D:J>;H;<EH;J>;C;:?7D9ECF;DI7J;:;CFBEO;;<J;H?:;DJ?<O?D=EKHC;:?7D9ECF;DI7J;:;CFBEO;; M;
J>;D97B9KB7J;:J>;7DDK7BJEJ7B9ECF;DI7J?ED<EHEKHC;:?7D9ECF;DI7J;:;CFBEO;;<EH<?I97BO;7HKI?D=J>;I7C;
C;J>E:EBE=OKI;:<EHEKH ",7II;J<EHJ>?DJ>;X$>66*;B869.7<*=287%*+5.FE<J>?IFHENOIJ7J;C;DJ
-- 70 of 186 --
#+C(/<=?=#/<09<7+8-/
1>;<EBBEM?D=:?I9BEIKH;>7I8;;DFH;F7H;:?D799EH:7D9;M?J>J>;F7OL;HIKIF;H<EHC7D9;:?I9BEIKH;H;GK?H;C;DJII;J<EHJ>?D&J;C
L E</;=KB7J?ED0 (KD:;HJ>;"N9>7D=;9J M>?9>H;GK?H;IJ>;FH;I;DJ7J?EDE<9;HJ7?D?D<EHC7J?ED78EKJJ>;H;B7J?EDI>?F
8;JM;;DJ>;9ECF;DI7J?EDE<EKH+",I7D:EKHF;H<EHC7D9;CEKDJIH;FEHJ;:7IX ECF;DI7J?ED9JK7BBO-7?:Y:?<<;H<HECJ>;
9ECF;DI7J?ED7CEKDJI:?I9BEI;:;BI;M>;H;?DJ>?IFHENOIJ7J;C;DJ7D::EDEJH;<B;9JJ>;L7BK;E<J>;9ECF;DI7J?ED79JK7BBO
H;9;?L;:8OJ>;+",I ?D9BK:?D=EKH ", M>EI;HL;I7IEKHFH?D9?F7B;N;9KJ?L;E<<?9;HX-",Y #EH?D<EHC7J?ED78EKJ>EMEKH
;N;9KJ?L;9ECF;DI7J?EDFHE=H7CI;;AIJE7B?=DF7OM?J>F;H<EHC7D9; FB;7I;H;<;HJEXCA.,>=2?.869.7<*=287*7-!=1.;
7/8;6*=287C869.7<*=2872<,><<287*7-7*5B<2<Y8;=?DD?D=EDF7=;
#+C(/<=?=#/<09<7+8-/
:D42=
162C
+F>>2CJ
@>A6?D2E:@?
,23=6,@E2=7@C
('
@>A6?D2E:@?
4EF2==J(2:5E@
('
G6C286
+F>>2CJ
@>A6?D2E:@?
,23=6,@E2=7@C
&@? ('&2>65
I64FE:G6
'77:46CD
G6C286
@>A6?D2E:@?
4EF2==J(2:5E@
&@? ('&2>65
I64FE:G6
'77:46CD
.2=F6@7!?:E:2=:I65
!?G6DE>6?E2D65'?
&6E!?4@>6
:?
E9@FD2?5D
&@? (
'A6C2E:?8
!?4@>62D2
(6C46?E286
@7*6G6?F6
,@E2=
+92C69@=56C
*6EFC?
(66CC@FA
,@E2=
+92C69@=56C
*6EFC?
1?CEJ>O*H9>;HM7IEKH ",<EH;79>E<J>;O;7HIFH;I;DJ;:,KHEJ>;H+",I EJ>;HJ>7DJ>; ", :KH?D=J>;O;7HIFH;I;DJ;:M;H;7I
<EBBEMI
Z #6!EK=B7I/;JJ?D=;H 0;I>7I7O;;0;I>7 37H7:7H7@7D +;?B'#;HD7D:;I 7D:37>?:37>;:?
Z #6!EK=B7I/;JJ?D=;H -7JH?9A')EH: L7%7HJ;H 7D:0;I>7I7O;;0;I>7 37H7:7H7@7D
Z #6!EK=B7I/;JJ?D=;H -7JH?9A')EH: 0;I>7I7O;;0;I>7 37H7:7H7@7D 7D:37>?:37>;:?
Z #6!EK=B7I/;JJ?D=;H -7JH?9A')EH: 37>?:37>;:? 7D:0;I>7I7O;;0;I>7 37H7:7H7@7D
Z #6!EK=B7I/;JJ?D=;H -7JH?9A')EH: 37>?:37>;:? 7D:0;I>7I7O;;0;I>7 37H7:7H7@7D
1>;<EBBEM?D=J78B;IFH;I;DJJ>;7CEKDJI:;:K9J;:<HEC7D:7::;:JEEKH ",WIJEJ7B9ECF;DI7J?ED<EH;79>O;7H 7IM;BB7IJ>;7L;H7=;
7CEKDJI:;:K9J;:<HEC7D:7::;:JEJ>;7L;H7=;E<J>;JEJ7B9ECF;DI7J?ED<EHJ>;EJ>;H+",I EJ>;HJ>7DJ>; ", <EH;79>O;7H 7IH;FEHJ;:?D
J>;0KCC7HO ECF;DI7J?ED178B; ?DEH:;HJE:;J;HC?D;J>;X9ECF;DI7J?ED79JK7BBOF7?:YJEEKH ",7D:J>;7L;H7=;X9ECF;DI7J?ED79JK7BBO
F7?:YJEJ>;EJ>;H+",I ?D799EH:7D9;M?J>0" HKB;I+;?J>;HEKH ",DEHJ>;EJ>;H+",IF7HJ?9?F7J;:?D7DO:;<?D;:8;D;<?JEH79JK7H?7B
F;DI?EDFB7DI?D9BK:?D=IKFFB;C;DJ7BFB7DI :KH?D=J>;O;7HIFH;I;DJ;: 7D:DEIK9>FB7DI7H;H;FEHJ;:?DJ>;0KCC7HO ECF;DI7J?ED178B;
I7H;IKBJ DE?D<EHC7J?EDH;=7H:?D=:;:K9J?EDIEH7::?J?EDIH;B7J;:JEF;DI?EDFB7DI?IFH;I;DJ;:
#EHFKHFEI;IE<J>;I;7:@KIJC;DJI J>;<7?HL7BK;E<;GK?JO7M7H:IM7I:;J;HC?D;:7I<EBBEMI? <EHI;HL?9; 87I;:/02I7J<?I97BO;7H ;D: KI?D=
J>;9BEI?D=FH?9;E<J>; ECF7DOWI9ECCEDIJE9AEDJ>;B7IJJH7:?D=:7OFH;9;:?D=J>;<?I97BO;7H ;D:?? <EH*7HA;J 87I;:-/02I7J<?I97BO;7H
;D: KI?D=7*EDJ; 7HBEI?CKB7J?EDCE:;BM?J>7IIKCFJ?EDI<EH;NF;9J;:LEB7J?B?JO H?IA <H;;?DJ;H;IJH7J; ;NF;9J;:J;HC7D::?L?:;D:O?;B:
:;J;HC?D;:7IE<J>;<?I97BO;7H ;D:??? <EHI;HL?9; 87I;:/02I7D:*7HA;J 87I;:-/02IKFEDL;IJ?D= KI?D=J>;9BEI?D=FH?9;E<J>;
ECF7DOWI9ECCEDIJE9AEDJ>;L;IJ?D=:7J;?L <EHIJE9AEFJ?ED7M7H:I7J<?I97BO;7H ;D: KI?D=7B79A 09>EB;IEFJ?EDL7BK7J?EDCE:;BM?J>
7IIKCFJ?EDI<EH;NF;9J;:LEB7J?B?JO H?IA <H;;?DJ;H;IJH7J; ;NF;9J;:J;HC7D::?L?:;D:O?;B::;J;HC?D;:7IE<J>;<?I97BO;7H ;D:7D:L <EHIJE9A
EFJ?ED7M7H:IKFEDL;IJ?D= KI?D=7B79A 09>EB;IEFJ?EDL7BK7J?EDCE:;BM?J>7IIKCFJ?EDI<EH;NF;9J;:LEB7J?B?JO H?IA <H;;?DJ;H;IJH7J; ;NF;9J;:
J;HC7D::?L?:;D:O?;B::;J;HC?D;:7IE<J>;L;IJ?D=:7J;
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 71 of 186 --
'
5;FDE>6?ED 1 1 1 1 1
+F>>2CJ@>A6?D2E:@?,23=6+,,@E2=
!;:K9J 0 1X0JE9AM7H:IY9EBKCDL7BK;
!;:K9J 0 1X,FJ?EDM7H:IY9EBKCDL7BK; U U
::O;7H ;D:<7?HL7BK;E<;GK?JO7M7H:I=H7DJ;:?DJ>;<?I97B
O;7HJ>7J7H;EKJIJ7D:?D=7D:KDL;IJ;:7IE<J>;<?I97BO;7H ;D:
::!;:K9J O;7H EL;H O;7H9>7D=;?D<7?HL7BK;E<;GK?JO
7M7H:I=H7DJ;:?DFH?EHO;7HIJ>7J7H;EKJIJ7D:?D=7D:KDL;IJ;:
7IE<J>;<?I97BO;7H ;D:
::L;IJ?D=:7J;<7?HL7BK;E<;GK?JO7M7H:I=H7DJ;:7D:L;IJ;:
?DJ>;<?I97BO;7H U U U U U
::!;:K9J O;7H EL;H O;7H9>7D=;?D<7?HL7BK;E<;GK?JO
7M7H:I=H7DJ;:?DFH?EHO;7HIJ>7JL;IJ;:?DJ>;<?I97BO;7H
!;:K9J <7?HL7BK;7IE<FH?EHO;7H ;D:E<;GK?JO7M7H:I=H7DJ;:
?DFH?EHO;7HIJ>7J<7?B;:JEL;IJ?DJ>;<?I97BO;7H U U U U U
:::EBB7HL7BK;E<:?L?:;D:I;7HD?D=IF7?:ED;GK?JO7M7H:I?D
J>;<?I97BO;7H U U U U U
@>A6?D2E:@?4EF2==J(2:5
'E96C&'DG6C286
5;FDE>6?ED 1 1 1 1 1
+F>>2CJ@>A6?D2E:@?,23=6+,,@E2=
!;:K9J 0 1X0JE9AM7H:IY9EBKCDL7BK;
!;:K9J 0 1X,FJ?EDM7H:IY9EBKCDL7BK; U
::O;7H ;D:<7?HL7BK;E<;GK?JO7M7H:I=H7DJ;:?DJ>;<?I97B
O;7HJ>7J7H;EKJIJ7D:?D=7D:KDL;IJ;:7IE<J>;<?I97BO;7H ;D:
::!;:K9J O;7H EL;H O;7H9>7D=;?D<7?HL7BK;E<;GK?JO
7M7H:I=H7DJ;:?DFH?EHO;7HIJ>7J7H;EKJIJ7D:?D=7D:KDL;IJ;:
7IE<J>;<?I97BO;7H ;D:
::L;IJ?D=:7J;<7?HL7BK;E<;GK?JO7M7H:I=H7DJ;:7D:L;IJ;:
?DJ>;<?I97BO;7H U U U U
::!;:K9J O;7H EL;H O;7H9>7D=;?D<7?HL7BK;E<;GK?JO
7M7H:I=H7DJ;:?DFH?EHO;7HIJ>7JL;IJ;:?DJ>;<?I97BO;7H
!;:K9J <7?HL7BK;7IE<FH?EHO;7H ;D:E<;GK?JO7M7H:I=H7DJ;:
?DFH?EHO;7HIJ>7J<7?B;:JEL;IJ?DJ>;<?I97BO;7H U U U U U
:::EBB7HL7BK;E<:?L?:;D:I;7HD?D=IF7?:ED;GK?JO7M7H:I?D
J>;<?I97BO;7H U U U U U
@>A6?D2E:@?4EF2==J(2:5
1EJ7BI>7H;>EB:;HH;JKHD?I97B9KB7J;:87I;:EDJ>;L7BK;E<7D?D?J?7B<?N;:?DL;IJC;DJE<ED'KD; J>HEK=>J>;;D:E<J>;B?IJ;:<?I97B
O;7H 7D:7IIKC?D=:?L?:;D:I7H;H;?DL;IJ;:
1>;F;;H=HEKFKI;:?IJ>;-%)50;C?9ED:K9JEH0;9JEH1EJ7B/;JKHD&D:;N M>?9>?IJ>;I7C;F;;H=HEKFKI;:?D-7HJ&& &J;CE<EKH#EHC
(
FF;D:?N9EDJ7?DI7H;9ED9?B?7J?EDE<DED $-EF;H7J?D=?D9EC;7I7F;H9;DJ7=;E<H;L;DK;JEJ>;H;IKBJIH;FEHJ;:?DEKH<?D7D9?7BIJ7J;C;DJI
$/6+>398=23:/>A//897:/8=+>398->?+66C#+3.+8.#/<09<7+8-/
1>;<EBBEM?D==H7F>IFH;I;DJJ>;H;B7J?EDI>?FI8;JM;;D? X9ECF;DI7J?ED79JK7BBOF7?:YX -Y 7I:?I9BEI;:?DJ>;-7O3;HIKI
-;H<EHC7D9;J78B; 9ECF7H;:JEEKH10/?? EKH10/9ECF7H;:JEJ>;10/E<J>;-%)50;C?9ED:K9JEH0;9JEH1EJ7B/;JKHD&D:;N
M>?9>?IJ>; ECF7DOWIXF;;H=HEKFY<EHFKHFEI;IE<J>;-7O3;HIKI-;H<EHC7D9;J78B;??? -7I:?I9BEI;:?DJ>;-7O3;HIKI
-;H<EHC7D9;J78B;9ECF7H;:JEEKHD;J?D9EC;7D:?L -7I:?I9BEI;:?DJ>;-7O3;HIKI-;H<EHC7D9;J78B;9ECF7H;:JEEKH
DED $-EF;H7J?D=?D9EC;7I7F;H9;DJ7=;E<H;L;DK;
FF;D:?N9EDJ7?DI7H;9ED9?B?7J?EDE<DED $-EF;H7J?D=?D9EC;7I7F;H9;DJ7=;E<H;L;DK;JEJ>;H;IKBJIH;FEHJ;:?DEKH<?D7D9?7BIJ7J;C;DJI
-- 72 of 186 --
Relationships Between CAP and Performance and Company TSR and Peer Group TSR
Total Shareholder Return (Value
of initial $100 investment)(1)
Compensation Actually Paid (in
thousands)
$10,267
$35,458
$71,745
$14,697
$320,643
$3,030 $8,925 $15,027 $7,039
$63,019
$72 $99
$175 $161
$633
$85 $111
$175 $179
$430
CAP to CEO Average CAP to Other NEOs
Company TSR PHLX Semiconductor Sector Total Return Index TSR
FY2022 FY2023 FY2024 FY2025 FY2026
$0
$100
$200
$300
$400
$500
$600
$700
$0
$50,000
$100,000
$150,000
$200,000
$250,000
$300,000
$350,000
Net Income (in millions)
Compensation Actually Paid (in
thousands)
$10,267
$35,458
$71,745
$14,697
$320,643
$3,030 $8,925 $15,027 $7,039
$63,019
$4,605 $4,511
$3,828
$5,358
$7,265
CAP to CEO Average CAP to Other NEOs Net Income
FY2022 FY2023 FY2024 FY2025 FY2026
$2,000
$4,000
$6,000
$8,000
$0
$50,000
$100,000
$150,000
$200,000
$250,000
$300,000
$350,000
Non-GAAP Operating Income
as a Percentage of Revenue
Compensation Actually Paid (in
thousands)
$10,267
$35,458
$71,745
$14,697
$320,643
$3,030 $8,925 $15,027 $7,039
$63,019
31.3% 30.7% 30.3%
32.3%
35.8%
CAP to CEO Average CAP to Other NEOs Non-GAAP Operating Income as a Percentage of Revenue(2)
FY2022 FY2023 FY2024 FY2025 FY2026
20.0%
25.0%
30.0%
35.0%
40.0%
$0
$50,000
$100,000
$150,000
$200,000
$250,000
$300,000
$350,000
(1) Total shareholder return is calculated based on the value of an initial fixed investment of $100 on June 25, 2021 through the end of the listed fiscal
year, and assuming dividends are reinvested.
(2) Appendix A contains a reconciliation of non-GAAP operating income as a percentage of revenue to the results reported in our financial statements.
Lam Research Corporation 2026 Proxy Statement 61
-- 73 of 186 --
&+,?6+<3=>9038+8-3+6#/<09<7+8-/ /+=?</=
1>;<EBBEM?D=J78B;?D9BK:;I7DKDH7DA;:B?IJE<J>;<?D7D9?7BF;H<EHC7D9;C;7IKH;IJ>7J ?DEKH7II;IIC;DJ H;FH;I;DJJ>;CEIJ
?CFEHJ7DJ<?D7D9?7BF;H<EHC7D9;C;7IKH;IKI;:8OKIJEB?DA9ECF;DI7J?ED79JK7BBOF7?:JEEKH+",I <EH<?I97BO;7H JEEKH
F;H<EHC7D9;#EHCEH;?D<EHC7J?ED78EKJ>EMJ>;I;C;7IKH;I<79JEH?DJEEKH;N;9KJ?L;9ECF;DI7J?EDFHE=H7C FB;7I;H;<;HJEXC
A.,>=2?.869.7<*=287*7-!=1.;7/8;6*=287C869.7<*=2872<,><<287*7-7*5B<2<Y8;=?DD?D=EDF7=;
38+8-3+6#/<09<7+8-/ /+=?</=
+ED $-EF;H7J?D=?D9EC;7I7F;H9;DJ7=;E<H;L;DK; ECF7DO 0;B;9J;:*;7IKH;
/;B7J?L;10/:;<?D;:7IJ>; ECF7DOWI10/H;B7J?L;JEJ>;10/E<J>;-%)50;C?9ED:K9JEH0;9JEH1EJ7B/;JKHD&D:;N
+ED $-=HEIIC7H=?D7I7F;H9;DJ7=;E<H;L;DK;
%/-?<3>3/=?>29<3D/.09<==?+8-/?8./<;?3>C97:/8=+>398#6+8=
1>;<EBBEM?D=J78B;FHEL?:;I?D<EHC7J?ED 7IE<'KD; H;=7H:?D=I;9KH?J?;I7KJ>EH?P;:<EH?IIK7D9;KD:;HJ>; ECF7DOWI
;GK?JO9ECF;DI7J?EDFB7DI1>; ECF7DOWI;GK?JO9ECF;DI7J?EDFB7DI?D9BK:;J>;"CFBEO;;0JE9A-KH9>7I;-B7D7I
7C;D:;: J>;X "0--Y J>;0JE9A&D9;DJ?L;-B7D7I7C;D:;: J>;X-B7DY 7D:J>;0JE9A&D9;DJ?L;-B7DJ>;
X-B7DY 1>;-B7D;NF?H;:ED+EL;C8;H 0?D9;+EL;C8;H J>; ECF7DO>7I?IIK;:7M7H:IKD:;HJ>;
"0--7D:J>;-B7D1>;-B7DM7I7FFHEL;:7JJ>;7DDK7BC;;J?D=E<IJE9A>EB:;HI-B;7I;I;;X'8=270
";898<*5<C ";898<*5 8 99;8?*58/=1.-89=2878/=1.*6 $=8,47,.7=2?."5*7Y?DJ>;-HENO0J7J;C;DJ<EH
7::?J?ED7B?D<EHC7J?ED
;?3>C97:/8=+>398#6+8809<7+>398
(=2?2E68@CJ
&F>36C@7
+64FC:E:6DE@36
!DDF65-A@?
I6C4:D6@7
'FEDE2?5:?8'AE:@?D
/2CC2?ED 2?5*:89ED
2
/6:89E65 G6C286
I6C4:D6(C:46@7
'FEDE2?5:?8
'AE:@?D /2CC2?ED
2?5*:89ED
3
&F>36C@7+64FC:E:6D
*6>2:?:?8G2:=23=67@C
FEFC6!DDF2?46-?56C
BF:EJ@>A6?D2E:@?(=2?D
6I4=F5:?8D64FC:E:6D
C67=64E65:?4@=F>?2
4
"GK?JO9ECF;DI7J?EDFB7DI7FFHEL;:8OI;9KH?JO>EB:;HI
"GK?JO9ECF;DI7J?EDFB7DIDEJ7FFHEL;:8OI;9KH?JO>EB:;HI U U U
,@E2=
4;?=>J;: 7L;H7=;;N;H9?I;FH?9;I:EDEJ?D9BK:;I;HL?9; 87I;:/02IEH*7HA;J 87I;:-/02I M>?9>7H;I;JJB;:<EHDE9EDI?:;H7J?ED
&D9BK:;I I>7H;I?IIK78B;KFEDI;HL?9; 87I;:/02IL;IJ?D= *7HA;J 87I;:-/02IL;IJ?D=EHIJE9AEFJ?ED;N;H9?I;IKD:;HJ>;
-B7D7D: I>7H;I?IIK78B;KFEDI;HL?9; 87I;:/02IL;IJ?D= *7HA;J 87I;:-/02IL;IJ?D=EHIJE9AEFJ?ED;N;H9?I;IKD:;HJ>;
-B7D1>;I>7H;JEJ7B7IIKC;II>7H;IM?BB8;?IIK;:7JJ>;C7N?CKCL;IJ?D=7CEKDJ<EHEKJIJ7D:?D=*7HA;J 87I;:-/02I
&D9BK:;I I>7H;I7L7?B78B;<EH<KJKH;?IIK7D9;KD:;HJ>;-B7D7D: I>7H;I7L7?B78B;<EH<KJKH;?IIK7D9;KD:;HJ>;
"0--BBE<J>;I>7H;I7L7?B78B;<EH<KJKH;?IIK7D9;KD:;HJ>;"0--7H;7L7?B78B;JEFKH9>7I;:KH?D=J>;9KHH;DJFKH9>7I;F;H?E:
8KJJ>;79JK7BDKC8;HE<I>7H;IJ>7J97D8;FKH9>7I;::;F;D:IEDJ>;FKH9>7I;FH?9; M>?9>?IDEJ<?N;:KDJ?BJ>;;D:E<J>;FKH9>7I;F;H?E:
7D:?IIK8@;9JJEB?C?JIEDFKH9>7I;I8O?D:?L?:K7BI1>;DKC8;HE<I>7H;IJ>7JC7O8;FKH9>7I;:8O7D?D:?L?:K7B?DJ>;9KHH;DJFKH9>7I;
F;H?E:KD:;HJ>;"0--97DDEJ;N9;;: I>7H;I7D:J>;JEJ7B<7?HC7HA;JL7BK;E<I>7H;IJ>7J97D8;FKH9>7I;:8O7D?D:?L?:K7B
:KH?D=797B;D:7HO;7H97DDEJ;N9;;:
-- 74 of 186 --
7(-6%66)45
?.3>9773>>//$/:9<>
1>;7K:?J9ECC?JJ;;EF;H7J;IKD:;H7MH?JJ;D9>7HJ;H7:EFJ;:8OJ>;E7H:J>7JEKJB?D;I?JIFKHFEI;7D:H;IFEDI?8?B?J?;I1>;7K:?J
9ECC?JJ;;H;L?;MI7D:7II;II;IJ>;7:;GK79OE<?JI9>7HJ;H7JB;7IJ7DDK7BBO7D: M>;D7FFHEFH?7J; H;9ECC;D:IJEJ>;E7H:
9>7D=;IJE?JI9>7HJ;HJEH;<B;9JJ>;;LEBL?D=HEB;E<J>;7K:?J9ECC?JJ;;1>;9>7HJ;HE<J>;7K:?J9ECC?JJ;;?I7L7?B78B;EDJ>;
&DL;IJEHII;9J?EDE<EKHM;8I?J;7J27?.<=8;5*6;.<.*;,1,86,8;98;*=.08?.;7*7,.
1>;7K:?J9ECC?JJ;;?I9ECFEI;:;DJ?H;BOE<:?H;9JEHIM>EC;;JJ>;?D:;F;D:;D9;H;GK?H;C;DJIE<+7I:7G7D:J>;0" 7D:M>E
EJ>;HM?I;I7J?I<OJ>;H;GK?H;C;DJI<EH7K:?J9ECC?JJ;;I;HL?9;?CFEI;:8OJ>;"N9>7D=;9J"79>C;C8;HE<J>;7K:?J9ECC?JJ;;?I
78B;JEH;7:7D:KD:;HIJ7D:<KD:7C;DJ7B<?D7D9?7BIJ7J;C;DJI7IH;GK?H;:8OJ>;+7I:7GB?IJ?D=IJ7D:7H:I#KHJ>;H J>;E7H:>7I
:;J;HC?D;:J>7J*HH7D:J7D:*IIH;DD7D7D:*7O;H7H;X7K:?J9ECC?JJ;;<?D7D9?7B;NF;HJIY7I:;<?D;:?DJ>;0" HKB;I
1>; ECF7DOWIC7D7=;C;DJ 7K:?J9ECC?JJ;; 7D:?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HC(-*$))- >7L;IF;9?<?98KJ
:?<<;H;DJH;IFEDI?8?B?J?;IH;B7J?D=JE)7CWI<?D7D9?7BH;FEHJ?D=)7CWIC7D7=;C;DJ?IH;IFEDI?8B;<EHJ>;FH;F7H7J?ED FH;I;DJ7J?ED 7D:
?DJ;=H?JOE<<?D7D9?7BIJ7J;C;DJI7D:<EHJ>;IOIJ;CE<?DJ;HD7B9EDJHEB7D:J>;<?D7D9?7BH;FEHJ?D=FHE9;II(-*$))-X(-*$Y >7I
J>;H;IFEDI?8?B?JOJE;NFH;II7DEF?D?EDEDJ>;<?D7D9?7BIJ7J;C;DJI7D:J>;IOIJ;CE<?DJ;HD7B9EDJHEBEL;H<?D7D9?7BH;FEHJ?D= 87I;:
EDJ>;7K:?JJ>;O9ED:K9J;:?D799EH:7D9;M?J>J>;IJ7D:7H:IE<J>;-K8B?9 ECF7DO99EKDJ?D=,L;HI?=>JE7H:20 J>;
X- ,Y 1>;7K:?J9ECC?JJ;;?IH;IFEDI?8B;<EHCED?JEH?D=7D:EL;HI;;?D=J>;I;FHE9;II;I1>;7K:?J9ECC?JJ;;H;B?;IEDJ>;
;NF;HJ?I;7D:ADEMB;:=;E<C7D7=;C;DJ J>;?DJ;HD7B7K:?J:;F7HJC;DJ 7D:J>;?D:;F;D:;DJ7K:?JEH?D97HHO?D=EKJ?JIEL;HI?=>J
H;IFEDI?8?B?J?;I
&D799EH:7D9;M?J>7FFB?978B;B7M J>;7K:?J9ECC?JJ;;>7IKBJ?C7J;7KJ>EH?JO7D:H;IFEDI?8?B?JO<EHI;B;9J?D= 9ECF;DI7J?D=
;L7BK7J?D= 7D: M>;D7FFHEFH?7J; H;FB79?D=J>; ECF7DOWI?D:;F;D:;DJ7K:?J<?HC 7D:;L7BK7J;I?JI?D:;F;D:;D9;1>;7K:?J
9ECC?JJ;;>7IJ>;7KJ>EH?JOJE;D=7=;?JIEMDEKJI?:;7:L?IEHI ?D9BK:?D=;NF;HJI7IJ>;9ECC?JJ;;9EDI?:;HID;9;II7HOJE97HHOEKJ
?JIH;IFEDI?8?B?J?;I 7F7HJ<HEC9EKDI;BEH7:L?IEHI>?H;:8OC7D7=;C;DJ
&DJ>?I9EDJ;NJ7D:?D9EDD;9J?EDM?J>J>;7K:?J;:<?D7D9?7BIJ7J;C;DJI9EDJ7?D;:?DJ>; ECF7DOWIDDK7B/;FEHJED#EHC (<EH
J>;<?I97BO;7H;D:;:'KD; J>;7K:?J9ECC?JJ;;JEEAJ>;<EBBEM?D=79J?EDI
Z /;9;?L;:7D::?I9KII;:J>;7K:?J;:<?D7D9?7BIJ7J;C;DJIM?J> ECF7DOC7D7=;C;DJ
Z !?I9KII;:M?J>(-*$J>;C7JJ;HIH;GK?H;:JE8;:?I9KII;:8O7FFB?978B;H;GK?H;C;DJIE<J>;- ,7D:J>;0"
Z /;9;?L;:7D::?I9KII;:J>;MH?JJ;D:?I9BEIKH;I7D:J>;B;JJ;H<HEC(-*$7IF;H7FFB?978B;H;GK?H;C;DJIE<J>;- ,
H;=7H:?D=J>;?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HCWI9ECCKD?97J?EDIM?J>J>;7K:?J9ECC?JJ;;9ED9;HD?D=
?D:;F;D:;D9; 7D::?I9KII;:M?J>(-*$?JI?D:;F;D:;D9;7D:
Z 7I;:EDJ>;<EH;=E?D=H;L?;MI7D::?I9KII?EDI H;9ECC;D:;:JEJ>;E7H:J>7JJ>;7K:?J;:<?D7D9?7BIJ7J;C;DJI8;?D9BK:;:
?DJ>; ECF7DOWIDDK7B/;FEHJED#EHC (<EHJ>;<?I97BO;7H;D:;:'KD; <EH<?B?D=M?J>J>;0"
1>?IK:?J ECC?JJ;;/;FEHJI>7BBDEJ8;:;;C;:X<?B;:YM?J>J>;0" <EHFKHFEI;IE<<;:;H7BI;9KH?J?;IB7M 7D:?JI>7BBDEJ KD:;H
7DO9?H9KCIJ7D9;I 8;?D9EHFEH7J;:8OH;<;H;D9;?DJE7DOE<J>; ECF7DOWIF7IJEH<KJKH;0" <?B?D=I1>;H;FEHJI>7BBDEJ8;
:;;C;:IEB?9?J?D=C7J;H?7B
%%*+', -!,'%%!,,
;2,;*7-=1*2;
=*;.77*7
81727..7
.=1*7B*B.;
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 75 of 186 --
$/6+>398=23:A3>28./:/8./8>$/13=>/</.#?,63---9?8>3813<7
(-*$))-X(-*$Y >7II;HL;:7IEKH?D:;F;D:;DJ7K:?JEHI?D9;0;FJ;C8;H-H;L?EKIBO "HDIJ6EKD=))-X"6Y >7:
I;HL;:?DJ>?IHEB;
88?+6@+6?+>398+8.%/6/->398908./:/8./8>$/13=>/</.#?,63---9?8>3813<7
1>;7K:?J9ECC?JJ;;7DDK7BBO;L7BK7J;IJ>;F;H<EHC7D9;E<J>; ECF7DOWI?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HC ?D9BK:?D=
J>;I;D?EH7K:?J;D=7=;C;DJJ;7C 7D::;J;HC?D;IM>;J>;HJEH;;D=7=;J>;J>;D 9KHH;DJ799EKDJ?D=<?HCEH9EDI?:;HEJ>;H7K:?J
<?HCI#79JEHI9EDI?:;H;:8OJ>;7K:?J9ECC?JJ;;?D:;9?:?D=M>;J>;HJEH;J7?D7D799EKDJ?D=<?HC?D9BK:; J>;<?HCWI=BE87B
97F78?B?J?;IJE>7D:B;J>;8H;7:J>7D:9ECFB;N?JOE<J>; ECF7DOWI=BE87BEF;H7J?EDI J>;<?HCWIJ;9>D?97B;NF;HJ?I;7D:
ADEMB;:=;E<J>; ECF7DOWI?D:KIJHO7D:=BE87BEF;H7J?EDI J>;GK7B?JO7D:97D:EHE<J>;<?HCWI9ECCKD?97J?EDIM?J>J>;7K:?J
9ECC?JJ;;7D:C7D7=;C;DJ J>;<?HCWI?D:;F;D:;D9; J>;GK7B?JO7D:;<<?9?;D9OE<J>;I;HL?9;IFHEL?:;:8OJ>;<?HC ?D9BK:?D=
?DFKJ<HECC7D7=;C;DJEDJ>;<?HCWIF;H<EHC7D9;7D:>EM;<<;9J?L;BOJ>;<?HC:;CEDIJH7J;:?JI?D:;F;D:;DJ@K:=C;DJ E8@;9J?L?JO
7D:FHE<;II?ED7BIA;FJ?9?IC J>;7FFHEFH?7J;D;IIE<J>;<?HCWI<;;I7D: J>;<?HCWIJ;DKH;7IEKH?D:;F;D:;DJ7K:?JEH ?D9BK:?D=
J>;8;D;<?JIE<J>7JJ;DKH; 7D:J>;9EDJHEBI7D:FHE9;II;I?DFB79;IK9>7IHEJ7J?EDE<A;OF7HJD;HI J>7J>;BF;DIKH;J>;<?HCWI
9EDJ?DK;:?D:;F;D:;D9;?DB?=>JE<IK9>J;DKH;
8./:/8./8>$/13=>/</.#?,63---9?8>3813<7@+6?+>398+8.%/6/->3983126312>=
!?56A6?56?46@?EC@=D
F5:E@>>:EE66'G6CD:89ET,L;HI?=>J?D9BK:;IH;=KB7HFH?L7J;I;II?EDIM?J>J>;<?HC :?I9KII?EDIM?J>J>;<?HC78EKJJ>;I9EF;
E<?JI7K:?J7D:8KI?D;II?CF;H7J?L;I 79ECFH;>;DI?L;7DDK7B;L7BK7J?EDM>;D:;J;HC?D?D=M>;J>;HJE;D=7=;J>;<?HC 7D::?H;9J
?DLEBL;C;DJ8OJ>;7K:?J9ECC?JJ;;7D:?JI9>7?H?DJ>;I;B;9J?EDE<7D;M=BE87B9EEH:?D7J?D=F7HJD;H?D9EDD;9J?EDM?J>J>;
C7D:7J;:HEJ7J?EDE<J>?IFEI?J?ED
$:>:ED@?&@? F5:E+6CG:46DT1>;7K:?J9ECC?JJ;;FH;7FFHEL;I7BBFHE<;II?ED7BI;HL?9;I?D9BK:?D=7K:?JI;HL?9;I7D:
F;HC?II?8B;DED 7K:?JI;HL?9;I FHEL?:;:8OJ>;<?HC?D799EH:7D9;M?J>?JIFH; 7FFHEL7BFEB?9O
:C>MD!?E6C?2=!?56A6?56?46(C@46DDT1>;?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HC9ED:K9JIF;H?E:?9?DJ;HD7BH;L?;MIE<
?JI7K:?J7D:EJ>;HMEHA 7II;II;IJ>;7:;GK79OE<F7HJD;HI7D:EJ>;HF;HIEDD;BMEHA?D=EDJ>; ECF7DOWI799EKDJ 7D:HEJ7J;I
J>;B;7:7IIKH7D9;;D=7=;C;DJF7HJD;H J>;=BE87B9EEH:?D7J?D=F7HJD;H 7D:EJ>;HF7HJD;HIEDJ>;;D=7=;C;DJ9EDI?IJ;DJM?J>
?D:;F;D:;D9;7D:HEJ7J?EDH;GK?H;C;DJI;IJ78B?I>;:8OJ>;- ,7D:0"
+EC@?8*68F=2E@CJC2>6H@C<T&D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HCI7H;IK8@;9JJE- ,?DIF;9J?EDI F;;HH;L?;MI
7D:- ,7D:0" EL;HI?=>J
2+81/388./:/8./8>$/13=>/</.#?,63---9?8>3813<7
,D 7D:;<<;9J?L;7IE< 0;FJ;C8;H J>;7K:?J9ECC?JJ;;7FFHEL;:J>;:?IC?II7BE<"67IJ>; ECF7DOWI?D:;F;D:;DJ
H;=?IJ;H;:FK8B?9799EKDJ?D=<?HC
1>;7K:?JH;FEHJIE<"6EDJ>; ECF7DOWI<?D7D9?7BIJ7J;C;DJI7IE<7D:<EHJ>;<?I97BO;7HI;D:;:'KD; 7D:'KD;
:?:DEJ9EDJ7?D7D7:L;HI;EF?D?EDEH7:?I9B7?C;HE<EF?D?ED DEHM;H;J>;OGK7B?<?;:EHCE:?<?;:7IJEKD9;HJ7?DJO 7K:?JI9EF;EH
799EKDJ?D=FH?D9?FB;I
!KH?D=J>;<?I97BO;7HI;D:;:'KD; 7D:'KD; 7D:J>;IK8I;GK;DJ?DJ;H?CF;H?E:J>HEK=>0;FJ;C8;H J>;H;
M;H;? DEX:?I7=H;;C;DJIYM?J>?DJ>;C;7D?D=E<&J;C7 ?L E</;=KB7J?ED0 (7D:J>;H;B7J;:?DIJHK9J?EDI 8;JM;;DJ>;
ECF7DO7D:"6ED7DOC7JJ;HE<799EKDJ?D=FH?D9?FB;IEHFH79J?9;I <?D7D9?7BIJ7J;C;DJ:?I9BEIKH; EH7K:?J?D=I9EF;EHFHE9;:KH;I
M>?9>:?I7=H;;C;DJI ?<DEJH;IEBL;:JE"6WII7J?I<79J?ED MEKB:>7L;97KI;:"6JEC7A;H;<;H;D9;J>;H;JE?D?JIH;FEHJI7D:?? DE
XH;FEHJ78B;;L;DJIYM?J>?DJ>;C;7D?D=E<&J;C7 L E</;=KB7J?ED0 (
1>;7K:?J9ECC?JJ;;7FFHEL;:J>;;D=7=;C;DJE<(-*$7IJ>; ECF7DOWI?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HC<EHJ>;
ECF7DOWI<?I97BO;7H7K:?JED0;FJ;C8;H !KH?D=J>;<?I97BO;7HI;D:;:'KD; 7D:'KD; 7D:J>;
IK8I;GK;DJ?DJ;H?CF;H?E:J>HEK=>0;FJ;C8;H D;?J>;HJ>; ECF7DO DEH7DOED;ED8;>7B<E<J>; ECF7DO 9EDIKBJ;:(-*$
H;=7H:?D=? J>;7FFB?97J?EDE<799EKDJ?D=FH?D9?FB;IJE7IF;9?<?;:JH7DI79J?ED;?J>;H9ECFB;J;:EHFHEFEI;: EHJ>;JOF;E<7K:?J
EF?D?EDJ>7JC?=>J8;H;D:;H;:EDJ>; ECF7DOWI<?D7D9?7BIJ7J;C;DJI 7D:D;?J>;H7MH?JJ;DH;FEHJDEHEH7B7:L?9;M7IFHEL?:;:JE
J>; ECF7DOJ>7J(-*$9ED9BK:;:M7I7D?CFEHJ7DJ<79JEH9EDI?:;H;:8OJ>; ECF7DO?DH;79>?D=7:;9?I?ED7IJEJ>;799EKDJ?D=
7K:?J?D=EH<?D7D9?7BH;FEHJ?D=?IIK;EH?? 7DOC7JJ;HJ>7JM7I;?J>;HJ>;IK8@;9JE<7X:?I7=H;;C;DJYM?J>?DJ>;C;7D?D=E<&J;C
7 ?L E</;=KB7J?ED0 ( EH7XH;FEHJ78B;;L;DJYM?J>?DJ>;C;7D?D=E<&J;C7 L E</;=KB7J?ED0 (
1>;9>7D=;?D?D:;F;D:;DJH;=?IJ;H;:799EKDJ?D=<?HCM7IFH;L?EKIBO:?I9BEI;:?DJ>; ECF7DOWI KHH;DJ/;FEHJED#EHC (<?B;:
M?J>J>;0" ED0;FJ;C8;H 9EFOE<"6WIH;B7J;:B;JJ;H :7J;:0;FJ;C8;H M7I?D9BK:;:7I7D;N>?8?JJEIK9>
<?B?D=
-- 76 of 186 --
//=366/.,C"?<8./:/8./8>$/13=>/</.#?,63---9?8>3813<7
1>;7K:?J9ECC?JJ;;EL;HI;;IJ>;7K:?J7D:DED 7K:?JI;HL?9;IFHEL?:;:8OEKH?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HC ?I
H;IFEDI?8B;<EHJ>;FH; 7FFHEL7BE<<;;I<EHEKH?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HC H;L?;MI7D:7FFHEL;IJ>;7K:?JFB7D
7D:7IIE9?7J;:<;;I 7D:H;9;?L;IF;H?E:?9H;FEHJIEDJ>;<;;IF7?:
1>;7K:?J9ECC?JJ;;?DIEC;97I;I7KJ>EH?P;IEKH?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HCJEFHEL?:;DED 7K:?JI;HL?9;I1>;
7K:?J9ECC?JJ;;KD:;HIJ7D:IJ>;D;;:<EHEKH?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HCJEC7?DJ7?DE8@;9J?L?JO7D:?D:;F;D:;D9;
7IJ>;7K:?JEHE<EKH<?D7D9?7BIJ7J;C;DJI7D:EKH?DJ;HD7B9EDJHEBEL;H<?D7D9?7BH;FEHJ?D=99EH:?D=BO J>;7K:?J9ECC?JJ;;>7IIEK=>J
JEC?D?C?P;H;B7J?EDI>?FIJ>7J9EKB:7FF;7HJE?CF7?H(-*$WIE8@;9J?L?JO7D:>7IEDBOFH; 7FFHEL;:F;HC?II?8B; I;B;9J;:JOF;IE<
DED 7K:?JI;HL?9;IM>;H;?J8;B?;L;:J>7J(-*$M7I8;IJIK?J;:JEF;H<EHCJ>;MEHA7D::;J;HC?D;:J>7J(-*$WIF;H<EHC7D9;E<J>;
I;HL?9;IMEKB:DEJ?CF7?H?JI?D:;F;D:;D9;7D:M7I?DJ>;8;IJ?DJ;H;IJE<J>; ECF7DO7D:?JIIJE9A>EB:;HI&D9EDD;9J?EDM?J>J>;
7FFE?DJC;DJE<(-*$7IEKH?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HC J>;7CEKDJE<DED 7K:?JI;HL?9;I8?BB;:EH;NF;9J;:JE8;
8?BB;:?D9H;7I;:9ECF7H;:JEJ>;FH?EH<?I97BO;7H8;97KI;J>;7K:?J9ECC?JJ;;:;J;HC?D;:J>7J9EDJ?DK?D=JEH;J7?D(-*$JEFHEL?:;
9;HJ7?DJ7N9ECFB?7D9;7:L?9; M>?9>(-*$>7:8;;DFHEL?:?D=FH?EHJE?JI7FFE?DJC;DJ M7I?DJ>; ECF7DOWI8;IJ?DJ;H;IJI:K;JE
(-*$WIKD?GK;;NF;HJ?I;7D:MEKB:DEJ?CF7?H?JI?D:;F;D:;D9;
1>;J78B;8;BEMIKCC7H?P;IJ>;<;;I8?BB;:8O(-*$<EH<?I97BO;7H7D:J>;<;;I8?BB;:8O"6<EH<?I97BO;7H
:D42=162C
:D42=162C
K:?J#;;I
K:?J /;B7J;:#;;I U U
17N#;;I
BB,J>;H#;;I U U
,',$
K:?J#;;IH;FH;I;DJ<;;I<EHFHE<;II?ED7BI;HL?9;IFHEL?:;:?D9EDD;9J?EDM?J>J>;7K:?JIE<7DDK7B<?D7D9?7BIJ7J;C;DJIK:?J#;;I7BIE
?D9BK:;H;L?;MIE<GK7HJ;HBO<?D7D9?7BIJ7J;C;DJI 7K:?JI;HL?9;IH;B7J;:JEEJ>;HIJ7JKJEHOEHH;=KB7JEHO<?B?D=IEH;D=7=;C;DJI 7D:<;;IH;B7J;:
JEJ>;?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HCWI7K:?JE<J>;;<<;9J?L;D;IIE<J>; ECF7DOWI?DJ;HD7B9EDJHEBEL;H<?D7D9?7BH;FEHJ?D=
FKHIK7DJJEI;9J?EDE<J>;07H87D;I ,NB;O9J
17N#;;IH;FH;I;DJ<;;I<EHFHE<;II?ED7BI;HL?9;IH;B7J;:JEJH7:;9ECFB?7D9; 9KIJECI 7D::KJ?;I
17N#;;IH;FH;I;DJ<;;I<EHFHE<;II?ED7BI;HL?9;I<EHJ7NFB7DD?D= J7N9ECFB?7D9; 7D:H;L?;MI;HL?9;IH;B7J;:JE<EH;?=DJ7N9ECFB?7D9;7D:
7II?IJ7D9;M?J>J7N7K:?JI7D:7FF;7BI
1>;7K:?J9ECC?JJ;;H;L?;M;:IKCC7H?;IE<J>;I;HL?9;IFHEL?:;:8O(-*$7D:J>;H;B7J;:<;;I:KH?D=<?I97BO;7H7D:>7I
:;J;HC?D;:J>7JJ>;FHEL?I?EDE<DED 7K:?JI;HL?9;IM7I9ECF7J?8B;M?J>C7?DJ7?D?D=J>;?D:;F;D:;D9;E<(-*$7IJ>; ECF7DOWI
?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HC1>;7K:?J9ECC?JJ;;EH?JI:;B;=7J;7FFHEL;:E<J>;I;HL?9;I7D:H;B7J;:<;;
7CEKDJI<EHI;HL?9;IFHEL?:;:8O(-*$:KH?D=<?I97BO;7H
#963-C98?.3>9773>>//#</::<9@+690?.3>+8.!98?.3>%/<@3-/=
&J?IJ>;H;IFEDI?8?B?JOE<J>;7K:?J9ECC?JJ;;JE7FFHEL; ?D799EH:7D9;M?J>I;9J?EDI> 7D:? E<J>;"N9>7D=;9J7D:J>;HKB;I
7D:H;=KB7J?EDIE<J>;0" 7BBFHE<;II?ED7BI;HL?9;IJE8;FHEL?:;:JEKI8OEKH?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HC
FHEL?:;:J>7JJ>;7K:?J9ECC?JJ;;C7ODEJ7FFHEL;7DODED 7K:?JI;HL?9;IFHEI9H?8;:8OI;9J?ED= E<J>;"N9>7D=;9J?DJ>;
78I;D9;E<7D7FFB?978B;;N;CFJ?ED
&J?IEKHFEB?9OJ>7JJ>;7K:?J9ECC?JJ;;FH; 7FFHEL;I7BB7K:?J7D:F;HC?II?8B;DED 7K:?JI;HL?9;IFHEL?:;:8OEKH?D:;F;D:;DJ
H;=?IJ;H;:FK8B?9799EKDJ?D=<?HC 9EDI?IJ;DJM?J>J>;9H?J;H?7I;J<EHJ>?DJ>;7K:?J9ECC?JJ;;9>7HJ;H7D:7FFB?978B;B7MI7D:
H;=KB7J?EDI1>;7K:?J9ECC?JJ;;>7I:;B;=7J;:JEJ>;9>7?HE<J>;7K:?J9ECC?JJ;;J>;7KJ>EH?JOJEFH; 7FFHEL;IK9>I;HL?9;I
FHEL?:;:J>7JJ>;9>7?HI>7BBH;FEHJ7DO:;9?I?EDIJEFH; 7FFHEL;IK9>I;HL?9;IJEJ>;<KBB7K:?J9ECC?JJ;;7J?JID;NJH;=KB7HC;;J?D=
1>;I;I;HL?9;IC7O?D9BK:;7K:?JI;HL?9;I 7K:?J H;B7J;:I;HL?9;I J7NI;HL?9;I 7D:EJ>;HI;HL?9;I,KH?D:;F;D:;DJH;=?IJ;H;:FK8B?9
799EKDJ?D=<?HC7D:EKHC7D7=;C;DJ7H;H;GK?H;:JEF;H?E:?97BBOH;FEHJJEJ>;7K:?J9ECC?JJ;;H;=7H:?D=J>;;NJ;DJE<I;HL?9;I
FHEL?:;:8OEKH?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HCFKHIK7DJJE7DOIK9>FH; 7FFHEL7B
/<>+38$/6+>398=23:=+8.$/6+>/.#+<>C&<+8=+->398=
1>;7K:?J9ECC?JJ;;?IH;IFEDI?8B;<EHJ>;H;L?;M7D:EL;HI?=>JE<7BBH;B7J;:F7HJOJH7DI79J?EDIH;GK?H;:JE8;:?I9BEI;:JEJ>;FK8B?9
KD:;H0" HKB;I7D:7FFHEL;IEHH7J?<?;IIK9>JH7DI79J?EDIFKHIK7DJJE?JIMH?JJ;D9>7HJ;H&D7::?J?ED J>; ECF7DOC7?DJ7?DI7
MH?JJ;D9E:;E<;J>?9IJ>7JH;GK?H;I7BB;CFBEO;;I E<<?9;HI 7D::?H;9JEHIJE79J;J>?97BBOM>;D>7D:B?D=7DO79JK7BEH7FF7H;DJ
9ED<B?9JIE<?DJ;H;IJ?DF;HIED7B7D:FHE<;II?ED7BH;B7J?EDI>?FI7D:JEFHECFJBOH;FEHJ7DOIK9>?IIK;IJEJ>; ECF7DOWIB;=7B
:;F7HJC;DJ
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 77 of 186 --
No family relationships exist among any of our directors and executive officers. Other than the executive officer and director
compensation arrangements discussed above and the matter below, the Company did not participate in any transaction since the
beginning of fiscal year 2026 in which a director, director nominee, executive officer, beneficial owner of more than 5% of Lam’s
common stock, or one of their immediate family members had a material interest and the amount involved exceeded $120,000.
On January 25, 2024, BlackRock filed an amendment to Schedule 13G reporting the beneficial ownership, together with certain
subsidiaries, of 117,779,780 shares of our common stock, or approximately 9.41% of the shares outstanding on September 4, 2026.
As a result of beneficially owning more than 5% of our common stock, BlackRock may be deemed to have been a related person of
the Company during fiscal year 2026. The Company invests in certain BlackRock money market funds. The Company received
approximately $24.2 million in interest and/or dividends from these funds during fiscal year 2026.
66
-- 78 of 186 --
$26-1+42325%/5
#<9:9=+6!9 6/->398903</->9<!9738//=
2FEDJ>;H;9ECC;D:7J?EDE<J>;DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;; J>;E7H:>7IDEC?D7J;:<EH;B;9J?EDJEJ>;E7H:
DEC?D;;IM>E7H;:?H;9JEHIE<J>; ECF7DO7IE<J>;:7J;E<J>?IFHENOIJ7J;C;DJBBE<J>;DEC?D;;IM;H;CEIJH;9;DJBO;B;9J;:8O
IJE9A>EB:;HI7JJ>;7DDK7BC;;J?D=E<IJE9A>EB:;HIM?J>J>;;N9;FJ?EDE<!H!;L=7D M>EM7I7FFE?DJ;:JEJ>;E7H:ED
#;8HK7HO
DEC?D;;M?BB8;;B;9J;:7I7:?H;9JEH7JJ>;7DDK7BC;;J?D=EDBO?<J>;LEJ;I97IJ<EHIK9>DEC?D;;WI;B;9J?ED;N9;;:J>;LEJ;I97IJ
7=7?DIJIK9>DEC?D;;WI;B;9J?EDDODEC?D;;M>E<7?BIJEH;9;?L;7<<?HC7J?L;7FFHEL7B<HEC>EB:;HIE<7C7@EH?JOE<J>;LEJ;I97IJ?D
IK9>DEC?D;;WI;B;9J?ED7JJ>;7DDK7BC;;J?D= ;?J>;H8OFHENOEH?DF;HIED M?BB>7L;J>;?HFH;L?EKIBOIK8C?JJ;:H;I?=D7J?EDFHECFJBO
9EDI?:;H;:8OJ>;E7H:?D799EH:7D9;M?J>EKH9EHFEH7J;=EL;HD7D9;=K?:;B?D;I1>;J;HCE<E<<?9;E<;79>F;HIED;B;9J;:7I7
:?H;9JEHM?BB8;KDJ?BJ>;D;NJ7DDK7BC;;J?D=E<IJE9A>EB:;HIEHKDJ?BJ>;?HIK99;IIEH?I;B;9J;:7D:GK7B?<?;:EHJ>;?H;7HB?;HH;I?=D7J?ED
EHH;CEL7B
2DB;IIEJ>;HM?I;?DIJHK9J;: J>;F;EFB;D7C;:EDJ>;FHENO97H:7IFHENO>EB:;HIJ>;X-HENO%EB:;HIY M?BBLEJ;J>;FHEN?;IH;9;?L;:
8OJ>;C<EHJ>;DEC?D;;ID7C;:8;BEM&<7DODEC?D;;E<J>; ECF7DOI>EKB::;9B?D;EH8;KD78B;JEI;HL;7I7:?H;9JEH7IE<
J>;J?C;E<J>;7DDK7BC;;J?D= J>;DJ>;FHEN?;IM?BB8;LEJ;:<EH7DOIK8IJ?JKJ;DEC?D;;:;I?=D7J;:8OJ>;J>;D 9KHH;DJE7H:JE<?BB
J>;L797D9O1>; ECF7DO?IDEJ7M7H;E<7DODEC?D;;M>EM?BB8;KD78B; EHM?BB:;9B?D; JEI;HL;7I7:?H;9JEH
1>;DEC?D;;I<EH;B;9J?EDEHH;;B;9J?ED>7L;8;;DDEC?D7J;:<EH;B;9J?EDJEJ>;E7H:?D799EH:7D9;M?J>J>;9H?J;H?77D:FHE9;:KH;I
:?I9KII;:78EL;?DX8?.;7*7,.*==.;<C 8;98;*=.8?.;7*7,.Y
*<.7*(947554.392*39 IF7HJE<EKH8E7H:H;<H;I>C;DJFB7DD?D= J>;E7H:?:;DJ?<?;:J>;:;I?H78?B?JOE<7K=C;DJ?D=?JIIA?BBI
7D:;NF;H?;D9;M?J>79KHH;DJFK8B?99ECF7DO ",M?J>;NF;H?;D9;?DJ>;I;C?9ED:K9JEH;9EIOIJ;C7D:J;9>DEBE=OB;7:;HI>?F!H
!;L=7DM7I?:;DJ?<?;:7I7:?H;9JEH97D:?:7J;8OJ>;E7H:7D:?DJHE:K9;:JEJ>;E7H:8O*H17BM7BA7HM?J>EKJJ>;?DLEBL;C;DJE<7
I;7H9><?HC&D9EDD;9J?EDM?J>J>;7II;IIC;DJE<!H!;L=7DWI97D:?:79O8OJ>;DEC?D7J?D=7D:9EHFEH7J;=EL;HD7D9;9ECC?JJ;;
7D:J>;E7H: !H!;L=7DC;JM?J>EKHE7H:9>7?H DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;;9>7?H 7::?J?ED7B8E7H:C;C8;HI 7D:
EKHFH;I?:;DJ7D: ", 7IM;BB7IH;FH;I;DJ7J?L;IE<J>; ECF7DOWI;N;9KJ?L;C7D7=;C;DJJ;7C#EBBEM?D=J>;I;C;;J?D=I KFED
J>;H;9ECC;D:7J?EDE<J>;DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;; J>;E7H:7FFE?DJ;:!H!;L=7DJEJ>;E7H:1>;E7H:
8;B?;L;IJ>7J!H!;L=7DWI;N;9KJ?L;B;7:;HI>?F;NF;H?;D9;7D::;;FJ;9>DEBE=O;NF;HJ?I;<KHJ>;HIJH;D=J>;DIJ>;E7H:WIEL;HI?=>J
7D::?H;9J?EDE<)7CWI8KI?D;II7D:BED= J;HCIJH7J;=O
42.3**4&7)4397.':9.438 4;8;B?;L;J>7J;79>E<EKHDEC?D;;I M>?B;I;HL?D=7I7:?H;9JEH7D:EHE<<?9;HE<J>; ECF7DO
>7I:;LEJ;:7:;GK7J;J?C;JEJ>;E7H:7D:F;H<EHC;:J>;?H:KJ?;IM?J>9H?J?97B7JJH?8KJ;IIK9>7I>ED;IJO ?DJ;=H?JO M?I:EC 7D:7D
7:>;H;D9;JE>?=>;J>?97BIJ7D:7H:I"79>DEC?D;;>7I:;CEDIJH7J;:IJHED=8KI?D;II79KC;D 7D78?B?JOJEC7A;?D:;F;D:;DJ
7D7BOJ?97B?DGK?H?;I JEKD:;HIJ7D:J>; ECF7DOWI8KI?D;II;DL?HEDC;DJ7D:JE;N;H9?I;IEKD:@K:=C;DJ 7IM;BB7I79ECC?JC;DJJE
J>; ECF7DO7D:?JI9EH;L7BK;I4;8;B?;L;J>;DEC?D;;I>7L;:?L;HI;L?;MFE?DJI IA?BBI 879A=HEKD:I 7D:;NF;H?;D9;IJ>7JM?BB
;D9EKH7=;7HE8KIJ:;9?I?ED C7A?D=FHE9;II<EHJ>;E7H:
, '*'!*,'*+*'%%&+.',N'*O ', !*,'*&'%!&++,
'*, $'/
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 79 of 186 --
!9738//=09<3</->9<
&379>2C <-2/<
-4)'6245-1')
+)
#?,63--97:+8C
.3</->9<=23:386+=>03@/
C/+<=
#2,152121642/5
16)41%6-21%/3/'
=5*7.*3(*
1?CEJ>O*H9>;H>7II;HL;:7IJ>; ECF7DOWI-H;I?:;DJ7D: >?;<"N;9KJ?L;,<<?9;HI?D9;
!;9;C8;H*HH9>;H@E?D;:J>; ECF7DO?D'KD;7IEKH;N;9KJ?L;L?9;FH;I?:;DJ
9>?;<EF;H7J?D=E<<?9;H 7D:M7IFHECEJ;:JEFH;I?:;DJ7D:9>?;<EF;H7J?D=E<<?9;H?D'7DK7HO
-H?EHJE@E?D?D=KI >;IF;DJO;7HI7J+EL;BBKI0OIJ;CI &D9?DL7H?EKIJ;9>DEBE=O
:;L;BEFC;DJ7D:8KI?D;IIB;7:;HI>?FHEB;I ?D9BK:?D=CEIJH;9;DJBO7I9>?;<EF;H7J?D=E<<?9;H
<HEC'7DK7HOJE'KD;;N;9KJ?L;L?9;FH;I?:;DJE<4EHB:M?:;07B;I *7HA;J?D= 7D:
KIJEC;H07J?I<79J?ED<HEC0;FJ;C8;HJE'7DK7HO7D:;N;9KJ?L;L?9;FH;I?:;DJE<
J>;-" 3!7D:"B;9JHE<?BBKI?D;II2D?JI<HEC+EL;C8;HJE0;FJ;C8;H%?I
J;DKH;7J+EL;BBKI7BIE?D9BK:;:7II?=DC;DJI7II;D?EH:?H;9JEHE<J;9>DEBE=O<EH+EL;BBKI
0OIJ;CI'7F7D<HECJE7D:I;D?EH:?H;9JEHE<J;9>DEBE=O<EHJ>;"B;9JHE<?BB
KI?D;II2D?J<HECFH?BJEFH?B%;IJ7HJ;:>?I97H;;H?D7J1;AJHED?N M>;H;
>;M7IH;IFEDI?8B;<EHFHE9;II:;L;BEFC;DJ<EH>?=> IF;;:8?FEB7H?DJ;=H7J;:9?H9K?JI
*HH9>;H>7II;HL;:7I7C;C8;HE<J>;8E7H:E<:?H;9JEHIE<'E>DIED EDJHEBI&DJ;HD7J?ED7B
FB9I?D9;*7H9> M>;H;>;?I7C;C8;HE<J>;=EL;HD7D9;7D:IKIJ7?D78?B?JO9ECC?JJ;;
%;7BIEI;HL;IEDJ>;&DJ;HD7J?ED7BE7H:E<!?H;9JEHI<EH0"*&#HECJE *H
H9>;HI;HL;:7I9>7?HE<J>;8E7H:<EHJ>;+7J?ED7B$"* EDIEHJ?KC
*HH9>;H9ECFB;J;:J>;-HE=H7C<EH*7D7=;C;DJ!;L;BEFC;DJ7JJ>;%7HL7H:$H7:K7J;
09>EEBE<KI?D;II7D:;7HD;:70:;=H;;?D7FFB?;:F>OI?9I<HECJ>; 7B?<EHD?7&DIJ?JKJ;E<
1;9>DEBE=O
:&1.+.(&9.438
1>;E7H:>7I9ED9BK:;:J>7J*HH9>;HI>EKB:I;HL;7I7:?H;9JEHE<J>; ECF7DO8;97KI;
E<>?IIJHED=B;7:;HI>?F>?IADEMB;:=;7D:;NF;H?;D9;79GK?H;:<HEC>?I9KHH;DJI;HL?9;7I
-H;I?:;DJ >?;<"N;9KJ?L;,<<?9;H7D:7:?H;9JEHE<J>; ECF7DO 7D:>?IF7IJI;HL?9;7I
-H;I?:;DJ7D: >?;<,F;H7J?D=,<<?9;H 7D:7I"N;9KJ?L;3?9;-H;I?:;DJ7D: >?;<,F;H7J?D=
,<<?9;HE<J>; ECF7DO>?I:;;FADEMB;:=;7D:KD:;HIJ7D:?D=E<I;C?9ED:K9JEHFHE9;II?D=
;GK?FC;DJJ;9>DEBE=?;I>?IKD:;HIJ7D:?D=E<EKH9KIJEC;HIC7HA;JI7D:D;;:I7D:>?I
C;H=;HI7D:79GK?I?J?EDI;NF;H?;D9;
*>"0.118&3)=5*7.*3(*8
Z &D:KIJHO(DEMB;:=;
Z KIJEC;H!;;F1;9>DEBE=O(DEMB;:=;
Z *7HA;J?D= !?IHKFJ?L;1;9>DEBE=O 7D:0JH7J;=O"NF;H?;D9;
Z );7:;HI>?F"NF;H?;D9;
Z #?D7D9;"NF;H?;D9;
Z $BE87BKI?D;II"NF;H?;D9;
Z *"NF;H?;D9;
Z ECF7H7J?L;E7H:$EL;HD7D9;"NF;H?;D9;
Z O8;HI;9KH?JO"NF;H?;D9;
Z %KC7D 7F?J7B*7D7=;C;DJ"NF;H?;D9;
Z /?IA*7D7=;C;DJ"NF;H?;D9;
Z *7DK<79JKH?D=,F;H7J?EDI"NF;H?;D9;
-- 80 of 186 --
<3-<+8.>
-4)'6245-1')
+)
9+<.9773>>//=
>7(-6
=
=
>203)15%6-21%1(70%1
)5274')5
=
>20-1%6-1+%1(28)41%1')
=
#?,63--97:+8C
.3</->9<=23:=386+=>03@/
C/+<=
#)1-+-6%/1'
#76%1-:1'
#36-21%4))%/6,1'
>",)%')4-',203%1;
*240)4
>)1653/;!-421%1'*240)4
=5*7.*3(*
"H?9(H7D:J?IJ>;<EHC;H"N;9KJ?L;3?9;-H;I?:;DJ7D: >?;<#?D7D9?7B,<<?9;HE<HE7:9EC
EHFEH7J?ED 7FEI?J?ED>;>;B:<HEC*7H9>KDJ?B?JIC;H=;HM?J>L7=E1;9>DEBE=?;I
)?C?J;:?D#;8HK7HO#HEC0;FJ;C8;HJE*7H9> *HH7D:JI;HL;:7I
-H;I?:;DJ7D: >?;<"N;9KJ?L;,<<?9;HE<L7D?H->7HC79;KJ?97BI &D9-H?EHJEL7D?H
->7HC79;KJ?97BI *HH7D:JM7I"N;9KJ?L;3?9;-H;I?:;DJ #?D7D9;7D:1;9>D?97B,F;H7J?EDI
7D: >?;<#?D7D9?7B,<<?9;HE<BB;H=7D&D9 M>;H;>;7BIE>;B:7DKC8;HE<EJ>;HI;D?EH
FEI?J?EDI<EBBEM?D=>?I7HH?L7BJ>;H;?D*7O
*HH7D:J>7II;HL;:7I7C;C8;HE<J>;8E7H:E<:?H;9JEHIE<+KJ7D?N &D9I?D9;*7O
M>;H;>;I;HL;I7I9>7?HE<J>;7K:?J9ECC?JJ;;7D:7C;C8;HE<J>;I;9KH?JO7D:FH?L79O
9ECC?JJ;;,FJ?ED 7H;%;7BJ> &D9I?D9;*7O M>;H;>;I;HL;I7I7C;C8;HE<J>;
9ECF;DI7J?ED9ECC?JJ;;7D:J>;GK7B?JO J;9>DEBE=O7D:9ECFB?7D9;9ECC?JJ;; 7D:
FH;L?EKIBOI;HL;:7I7C;C8;HE<J>;<?D7D9;7D:?DL;IJC;DJ9ECC?JJ;;7D:$;D!?=?J7B&D9
<EHC;HBO+EHJED)?<;)E9A &D9 I?D9;#;8HK7HO M>;H;>;?IJ>;9>7?HE<J>;7K:?J
9ECC?JJ;;7D:I;HL;IEDJ>;DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;;
%;FH;L?EKIBOI;HL;:EDJ>;8E7H:E<:?H;9JEHIE<1>;*79;H?9> ECF7DO<HEC'KD;JE
'KD;!;DJIFBO0?HED7&D9<EHC;HBO!;DJIFBO&DJ;HD7J?ED7B &D9 <HECJE
67>EE&D9<HEC*7H9>JE'KD;3;HJ;N->7HC79;KJ?97BI &D9<HECJE
7D:L7D?H->7HC79;KJ?97BI<HECJE
*HH7D:J;7HD;:7D*:;=H;;<HECJ>;%7HL7H:$H7:K7J;09>EEBE<KI?D;II7D:7
0:;=H;;?D9>;C?97B;D=?D;;H?D=<HECJ>;*7II79>KI;JJI&DIJ?JKJ;E<1;9>DEBE=O%;>7I
9ECFB;J;:J>;+62)7MT+7I:7G O8;H09>EB7H-HE=H7C7D:J>;200;9H;J0;HL?9;7D:
J>;+7J?ED7BIIE9?7J?EDE< EHFEH7J;!?H;9JEHI O8;HI;9KH?JO-HE=H7C
:&1.+.(&9.438
1>;E7H:>7I9ED9BK:;:J>7J*HH7D:JI>EKB:I;HL;7I7:?H;9JEHE<J>; ECF7DO8;97KI;
E<>?I<?D7D9?7B;NF;HJ?I;?D9BK:?D=7I7<EHC;H9>?;<<?D7D9?7BE<<?9;HE<7FK8B?9BOJH7:;:
9ECF7DOJ>7J?I79KIJEC;HE<EKH9KIJEC;HI>?IADEMB;:=;E<7D:;NF;H?;D9;?DJ>;
I;C?9ED:K9JEH?D:KIJHO7D:EJ>;HJ;9>DEBE=O?D:KIJH?;I>?IC;H=;HI7D:79GK?I?J?EDI
;NF;H?;D9;>?I8E7H:=EL;HD7D9;;NF;H?;D9;<HECI;HL?9;EDEJ>;HFK8B?99ECF7DO8E7H:I
?D9BK:?D=7I7D7K:?J9ECC?JJ;;C;C8;H7D:9>7?H 79ECF;DI7J?ED9ECC?JJ;;C;C8;H 7D:7
DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;;C;C8;H7D:9>7?H7D:>?I9O8;HI;9KH?JO;NF;HJ?I;
*>"0.118&3)=5*7.*3(*8
Z &D:KIJHO(DEMB;:=;
Z KIJEC;H!;;F1;9>DEBE=O(DEMB;:=;
Z *7HA;J?D= !?IHKFJ?L;1;9>DEBE=O 7D:0JH7J;=O"NF;H?;D9;
Z );7:;HI>?F"NF;H?;D9;
Z #?D7D9;"NF;H?;D9;
Z $BE87BKI?D;II"NF;H?;D9;
Z *"NF;H?;D9;
Z ECF7H7J?L;E7H:$EL;HD7D9;"NF;H?;D9;
Z O8;HI;9KH?JO"NF;H?;D9;
Z %KC7D 7F?J7B*7D7=;C;DJ"NF;H?;D9;
Z /?IA*7D7=;C;DJ"NF;H?;D9;
Z *7DK<79JKH?D=,F;H7J?EDI"NF;H?;D9;
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 81 of 186 --
>+ </88+8
-4)'6245-1')
+)
9+<.9773>>//
>7(-6
=
#?,63--97:+8C
.3</->9<=23:=386+=>03@/
C/+<=
>%()1'))5-+1!;56)05
1'
>/%1)6%&5
=5*7.*3(*
&J7*H;DD7D?IJ>;<EHC;H0;D?EH3?9;-H;I?:;DJ >?;<#?D7D9?7B,<<?9;HE<H?IJ7+;JMEHAI
&D9 79BEK:D;JMEHA?D=IEBKJ?EDI9ECF7DO 7FEI?J?EDI>;>;B:<HEC*7OJE#;8HK7HO
,L;H>;H97H;;H *IH;DD7D>7I>;B:I;L;H7BA;O<?D7D9;HEB;I#HEC*7H9>JE
*7O I>;I;HL;:7I >?;<#?D7D9?7B,<<?9;HE<.K7DJKC097F; EHFEH7J?ED-H?EHJE
@E?D?D=.K7DJKC097F; I>;I;HL;:7IJ>; >?;<#?D7D9?7B,<<?9;HE<&D<?D;H7 EHFEH7J?ED<HEC
'KBOJE#;8HK7HO 7D:7I3?9;-H;I?:;DJE<#?D7D9;7D: EHFEH7J; EDJHEBB;H<HEC
'KBOJE'KBO#HECJE *IH;DD7D>;B:L7H?EKIHEB;I7J*7NJEH
EHFEH7J?ED ?D9BK:?D=3?9;-H;I?:;DJE<#?D7D9;<EHJ>;9ECF7DOWIMEHB:M?:;EF;H7J?EDI
*IH;DD7D>7II;HL;:7I7C;C8;HE<J>;8E7H:E<:?H;9JEHIE<+;NJ>EF0OIJ;CI&D9
I?D9;*7H9>-B7D;J)78I- I?D9;'KD; M>;H;I>;I;HL;I7IJ>;9>7?HE<J>;
7K:?J9ECC?JJ;; 7:;D9;!;I?=D0OIJ;CI &D9I?D9;*7H9> M>;H;I>;I;HL;I7IJ>;
9>7?HE<J>;9EHFEH7J;=EL;HD7D9;7D:DEC?D7J?D=9ECC?JJ;;7D:7C;C8;HE<J>;7K:?J
9ECC?JJ;;7D: ECCKD?JO0;HL?9;I=;D9O *EKDJ7?D3?;MI?D9;FH?B
0>;FH;L?EKIBOI;HL;:EDJ>;8E7H:E<:?H;9JEHIE<)E=*;&D &D9<HEC+EL;C8;HJE
0;FJ;C8;H
*IH;DD7DIJK:?;:799EKDJ?D= <?D7D9; 7D:C7D7=;C;DJ7JJ>;&DIJ?JKJ;E< >7HJ;H;:
99EKDJ7DJI?D&H;B7D: GK7B?<O?D=7I79>7HJ;H;:799EKDJ7DJ7D:<;BBEME<J>;?DIJ?JKJ;&D
7::?J?ED *IH;DD7D?I7FK8B?9799EKDJ?D=7BKCD7E<!;BE?JJ;1EK9>; >7L?D=MEHA;:7J
J>;<?HC?D8EJ>&H;B7D:7D:J>;2D?J;:0J7J;I
:&1.+.(&9.438
1>;E7H:>7I9ED9BK:;:J>7J*IH;DD7DI>EKB:I;HL;7I7:?H;9JEHE<J>; ECF7DO
8;97KI;E<>;H;NJ;DI?L;<?D7D9?7B7D:799EKDJ?D=;NF;HJ?I;>;H;N;9KJ?L;B;7:;HI>?F
;NF;H?;D9;<HEC>;HHEB;I7I9>?;<<?D7D9?7BE<<?9;H7D:EJ>;H<?D7D9;FEI?J?EDI7J9ECF7D?;I?D
J>;J;9>DEBE=O?D:KIJHO7D:>;H;NJ;DI?L;8E7H:;NF;H?;D9;7I7:?H;9JEHEDEJ>;HFK8B?9
9ECF7DO8E7H:I ?D9BK:?D=I;HL?9;ED7K:?J7D:=EL;HD7D9;7D:DEC?D7J?D=9ECC?JJ;;I
*>"0.118&3)=5*7.*3(*8
Z &D:KIJHO(DEMB;:=;
Z *7HA;J?D= !?IHKFJ?L;1;9>DEBE=O 7D:0JH7J;=O"NF;H?;D9;
Z );7:;HI>?F"NF;H?;D9;
Z #?D7D9;"NF;H?;D9;
Z $BE87BKI?D;II"NF;H?;D9;
Z *"NF;H?;D9;
Z ECF7H7J?L;E7H:$EL;HD7D9;"NF;H?;D9;
Z O8;HI;9KH?JO"NF;H?;D9;
Z /?IA*7D7=;C;DJ"NF;H?;D9;
-- 82 of 186 --
Anirudh Devgan
Director since 2026
Age 57
Board Committee:
• Innovation and Technology
° Member: since 2026
Public company
directorships in last five
years:
• Cadence Design Systems,
Inc.
Experience
Anirudh Devgan has served as chief executive officer and a member of the board of directors
since December 2021, and as president since November 2017, of Cadence Design Systems,
Inc., a computational software company. Prior to becoming president of Cadence, he served
as executive vice president and general manager of the Digital & Signoff and System &
Verification groups at Cadence. Prior to joining Cadence in 2012, Dr. Devgan served as
corporate vice president and general manager of the Custom Design Business Unit at Magma
Design Automation, Inc. Previous roles Dr. Devgan has held include management and
technical positions at IBM, where he received numerous awards including the IBM
Outstanding Innovation Award. Dr. Devgan is the recipient of the IEEE/SEMI Phil Kaufman
Award, has been inducted into the National Academy of Engineering, is an IEEE Fellow, has
authored numerous research papers, and holds several patents.
Dr. Devgan earned Ph.D. and M.S. degrees in Electrical and Computer Engineering from
Carnegie Mellon University, and a B.Tech. in Electrical Engineering from the Indian Institute of
Technology, Delhi.
Qualifications
The Board has concluded that Dr. Devgan should serve as a director of the Company because
of his deep semiconductor ecosystem and technology expertise; his public company executive
leadership experience; his global business and strategic experience; his board governance
experience from service on another public company board; and his recognized technical
achievements and innovation leadership.
Key Skills and Experiences
• Industry Knowledge
• Customer/Deep Technology Knowledge
• Marketing, Disruptive Technology, and Strategy Experience
• Leadership Experience
• Finance Experience
• Global Business Experience
• M&A Experience
• Comparative Board/Governance Experience
• Cybersecurity Experience
• Human Capital Management Experience
• Risk Management Experience
• Manufacturing/Operations Experience
Lam Research Corporation 2026 Proxy Statement 71
-- 83 of 186 --
928 38//8
-4)'6245-1')
+)
9+<.9773>>//
>7(-6
=
#?,63--97:+8C
.3</->9<=23:=386+=>03@/
C/+<=
>2+1-<%16")',12/2+;
!2/76-21524324%6-21
>!;1)25)%/6,1'*240)4
=5*7.*3(*
'E>D*!?D;;DI;HL;:7I7D,F;H7J?D=:L?IEH7J B7OJED !K8?B?;H/?9;)) 7FH?L7J;
;GK?JO?DL;IJC;DJ<?HC <HEC'7DK7HOJE!;9;C8;H-H;L?EKIBO *H!?D;;DI;HL;:
?DL7H?EKII;D?EHB;7:;HI>?FHEB;I7J$;D;H7B"B;9JH?9 ECF7DOX$"Y <HECJE
M>;H;>;C7D7=;:I;L;H7BA;O8KI?D;II:?L?I?EDIE<$"*EIJH;9;DJBO <HECJE
>;M7IFH;I?:;DJ7D:9>?;<;N;9KJ?L;E<<?9;HE<)ED:ED 87I;:$"%;7BJ>97H;;<EH;J>7J >;
I;HL;:7IFH;I?:;DJ7D:9>?;<;N;9KJ?L;E<<?9;HE<$"1H7DIFEHJ7J?ED<HECJE&D
7::?J?ED >;I;HL;:?DI;L;H7B?DJ;HD7J?ED7BC7D7=;C;DJHEB;I?DI?77D:"KHEF;:KH?D=>?I
J?C;7J$"
*H!?D;;D>7II;HL;:7I7C;C8;HE<J>;8E7H:E<:?H;9JEHIE< E=D?P7DJ1;9>DEBE=O
0EBKJ?EDI EHFEH7J?EDI?D9;FH?B M>;H;>;?IJ>;9>7?HE<J>;<?D7D9;7D:IJH7J;=O
9ECC?JJ;;7D:7C;C8;HE<J>;7K:?J9ECC?JJ;;7D:FH;L?EKIBOI;HL;:7I7C;C8;HE<J>;
DEC?D7J?D= =EL;HD7D9;7D:FK8B?97<<7?HI9ECC?JJ;;
%;FH;L?EKIBOI;HL;:EDJ>;8E7H:IE<:?H;9JEHIE< 7H;IJH;7C!;DJ7B)) <HECFH?BJE
,9JE8;H%;7BE=?9I &D9<HEC'KD;JE,9JE8;H0OD;EI%;7BJ> &D9<HEC
!;9;C8;HJE0;FJ;C8;H7D:*;HH?C79A->7HC79;KJ?97BI &D9<HEC'KD;JE
,9JE8;H
*H!?D;;D;7HD;:70:;=H;;?D9ECFKJ;HI9?;D9;7D:8?EBE=?97BI9?;D9;I<HECJ>;
2D?L;HI?JOE<3;HCEDJ
:&1.+.(&9.438
1>;E7H:>7I9ED9BK:;:J>7J*H!?D;;DI>EKB:I;HL;7I7:?H;9JEHE<J>; ECF7DO8;97KI;
E<>?IB;7:;HI>?FIA?BBI7D:>?I;NJ;DI?L;=BE87BC7D7=;C;DJ7D:EF;H7J?EDI;NF;H?;D9;
79HEIII;L;H7B?D:KIJH?;I ?D9BK:?D=>;7BJ>97H; J;9>DEBE=O 7D:?DJ;HD7J?ED7BC7D7=;C;DJ
7D:>?I8E7H:=EL;HD7D9;;NF;H?;D9;<HECI;HL?9;EDFK8B?99ECF7DO8E7H:IM?J>=BE87B
EF;H7J?EDI
*>"0.118&3)=5*7.*3(*8
Z *7HA;J?D= !?IHKFJ?L;1;9>DEBE=O 7D:0JH7J;=O"NF;H?;D9;
Z );7:;HI>?F"NF;H?;D9;
Z #?D7D9;"NF;H?;D9;
Z $BE87BKI?D;II"NF;H?;D9;
Z *"NF;H?;D9;
Z ECF7H7J?L;E7H:$EL;HD7D9;"NF;H?;D9;
Z O8;HI;9KH?JO"NF;H?;D9;
Z %KC7D 7F?J7B*7D7=;C;DJ"NF;H?;D9;
Z /?IA*7D7=;C;DJ"NF;H?;D9;
Z *7DK<79JKH?D=,F;H7J?EDI"NF;H?;D9;
-- 84 of 186 --
+<53/6.=
-4)'6245-1')
+)
>203)15%6-21%1(70%1
)5274')5
=
#?,63--97:+8C
.3</->9<=23:=386+=>03@/
C/+<=
>#1'24324%6)(
>)46</2&%/2/(-1+51'
*240)4
>"%'))1)*-'-%/243
*240)4
> "%')!2/76-215243
*240)4
=5*7.*3(*
*H#?;B:I>7II;HL;:7I70;D?EH:L?IEH7J1-$ 7F?J7B)- 7=BE87B7BJ;HD7J?L;7II;J<?HC
I?D9;,9JE8;H#HEC,9JE8;HJE#;8HK7HO >;I;HL;:7I&DJ;H?C >?;<
"N;9KJ?L;,<<?9;HE<%;HJP$BE87B%EB:?D=I &D9 M>?9>EF;H7J;IJ>;%;HJP 1>H?<JO7D:!EBB7H
H;DJ7B97H8H7D:I-H?EHJE%;HJP$BE87B *H#?;B:II;HL;:7I-H;I?:;DJ7D: >?;<"N;9KJ?L;
,<<?9;HE<#EH:*EJEH ECF7DO<HEC'KBOJE*7O 7D:7I >?;<,F;H7J?D=,<<?9;H
<HEC!;9;C8;HJE'KBO%;@E?D;:#EH:?D7D:I;HL;:?DL7H?EKIB;7:;HI>?F
FEI?J?EDIJ>HEK=>EKJ>?IJ;DKH; ?D9BK:?D=7I"N;9KJ?L;3?9;-H;I?:;DJ7D:-H;I?:;DJ
C;H?97I"N;9KJ?L;3?9;-H;I?:;DJ7D: >?;<"N;9KJ?L;,<<?9;H #EH:E<"KHEF;7D:-H;C?;H
KJECEJ?L;$HEKF >7?H7D: >?;<"N;9KJ?L;,<<?9;H -H;C?;HKJECEJ?L;$HEKF7D:
-H;I?:;DJ7D: >?;<"N;9KJ?L;,<<?9;H *7P:7*EJEH EHFEH7J?ED
%;>7II;HL;:7I7C;C8;HE<J>;8E7H:E<:?H;9JEHIE<.2) ,**&D9EHFEH7J;:I?D9;
'KD; M>;H;>;?I7C;C8;HE<J>;7K:?J9ECC?JJ;;17D?KC&D9I?D9;0;FJ;C8;H
-B7DL?;M &D9I?D9;FH?BEEC? )-I?D9;0;FJ;C8;H B7II?9 EBB?I?EDI?D9;*7O
&D<EC;:?7)J:I?D9;!;9;C8;H
*H#?;B:IFH;L?EKIBOI;HL;:EDJ>;8E7H:E<:?H;9JEHIE<%;HJP$BE87B%EB:?D=I &D9<HEC
'KD;JE*7O1-$-79;;D;<?9?7B&& EHF<HECFH?BJEFH?B1-$-79;
0EBKJ?EDI EHF<HECFH?BJE!;9;C8;H#EH:*EJEH ECF7DO<HEC'KBOJE
*7O7D:&*<HEC*7H9>JEFH?B
*H#?;B:I;7HD;:7D*:;=H;;<HEC%7HL7H:KI?D;II09>EEB7D:7?D"9EDEC?9I
<HEC/KJ=;HI2D?L;HI?JO
:&1.+.(&9.438
1>;E7H:>7I9ED9BK:;:J>7J*H#?;B:II>EKB:I;HL;7I7:?H;9JEHE<J>; ECF7DO8;97KI;
E<>?I;NJ;DI?L;EF;H7J?ED7B;NF;H?;D9;?D;N;9KJ?L;C7D7=;C;DJFEI?J?EDI?DJ>;7KJECEJ?L;
?D:KIJHO ?D9BK:?D=B;7:?D=9ECFB;N=BE87B8KI?D;IIEH=7D?P7J?EDI>?I;NJ;DI?L;;NF;H?;D9;
I;HL?D=EDEJ>;HFK8B?99ECF7DO8E7H:I7D:>?I<?D7D9?7B;NF;HJ?I;
*>"0.118&3)=5*7.*3(*8
Z &D:KIJHO(DEMB;:=;
Z *7HA;J?D= !?IHKFJ?L;1;9>DEBE=O 7D:0JH7J;=O"NF;H?;D9;
Z );7:;HI>?F"NF;H?;D9;
Z #?D7D9;"NF;H?;D9;
Z $BE87BKI?D;II"NF;H?;D9;
Z *"NF;H?;D9;
Z ECF7H7J?L;E7H:$EL;HD7D9;"NF;H?;D9;
Z %KC7D 7F?J7B*7D7=;C;DJ"NF;H?;D9;
Z /?IA*7D7=;C;DJ"NF;H?;D9;
Z *7DK<79JKH?D=,F;H7J?EDI"NF;H?;D9;
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 85 of 186 --
9C?+81
-4)'6245-1')
+)
9+<.9773>>//
E 1128%6-21%1(")',12/2+;
=
=5*7.*3(*
%E(OK(7D=>7II;HL;:7I7-HE<;IIEH?DJ>;!;F7HJC;DJE<0OIJ;CI0;C?9ED:K9JEH
"D=?D;;H?D=7J6EDI;?2D?L;HI?JOI?D9;*7H9>-H?EHJE>?I9KHH;DJFEI?J?ED !H(7D=
I;HL;:7I"N;9KJ?L;3?9;-H;I?:;DJ7D:%;7:E</;I;7H9>7JJ>;0;C?9ED:K9JEH/! ;DJ;H
E<07CIKD="B;9JHED?9I E )J: <HECJE;<EH;J>7J >;I;HL;:7I"N;9KJ?L;3?9;
-H;I?:;DJ7D:B;7:;HE<FHE9;II:;L;BEFC;DJ7JJ>;0;C?9ED:K9JEH/! ;DJ;H<HECJE
7I0;D?EH3?9;-H;I?:;DJ7D:J;7CB;7:;H<HECJE 7D:7I3?9;-H;I?:;DJ
H;IFEDI?8B;<EHJ>;IOIJ;CB7H=; I97B;?DJ;=H7J?EDFHE9;II7H9>?J;9JKH;J;7C7D:7:L7D9;:
J;9>DEBE=O:;L;BEFC;DJ<HECJE!H(7D=@E?D;:07CIKD=7I7H;I;7H9>7D:
:;L;BEFC;DJ;D=?D;;H?D%;?IJ>;7KJ>EHEH9E 7KJ>EHE<DKC;HEKI?DJ;HD7J?ED7B
F7F;HI
!H(7D=FH;L?EKIBOI;HL;:EDJ>;8E7H:IE<:?H;9JEHIE<J>;0;C?9ED:K9JEH/;I;7H9>
EHFEH7J?ED<HECJE7D:0"*1" %<HECJE
!H(7D=;7HD;:7->!?DC7J;H?7BI9?;D9;7D:;D=?D;;H?D=<HEC0J7D<EH:2D?L;HI?JO 7*0
:;=H;;?DC7J;H?7BI9?;D9;7D:;D=?D;;H?D=<HEC(EH;7:L7D9;:&DIJ?JKJ;E<09?;D9;7D:
1;9>DEBE=O 7D:70:;=H;;?DC;J7BBKH=?97B;D=?D;;H?D=<HEC%7DO7D=2D?L;HI?JO
:&1.+.(&9.438
1>;E7H:>7I9ED9BK:;:J>7J!H(7D=I>EKB:I;HL;7I7:?H;9JEHE<J>; ECF7DO8;97KI;E<
>?I:;97:;IE<;NF;H?;D9;?DI;C?9ED:K9JEH;D=?D;;H?D=7D::;L;BEFC;DJ>?I;NJ;DI?L;
ADEMB;:=;7D:;NF;H?;D9;79GK?H;:7I7D;N;9KJ?L;E<7C7@EHI;C?9ED:K9JEHC7DK<79JKH;H
>?I:;;FADEMB;:=;7D:KD:;HIJ7D:?D=E<J>;I;C?9ED:K9JEH;GK?FC;DJ?D:KIJHO7D:
J;9>DEBE=?;I7D:>?I;NF;H?;D9;7I7I;D?EH;N;9KJ?L;E<07CIKD= 7C7@EH9ECF7DO
9KIJEC;H
*>"0.118&3)=5*7.*3(*8
Z &D:KIJHO(DEMB;:=;
Z KIJEC;H!;;F1;9>DEBE=O(DEMB;:=;
Z );7:;HI>?F"NF;H?;D9;
Z $BE87BKI?D;II"NF;H?;D9;
Z *7DK<79JKH?D=,F;H7J?EDI"NF;H?;D9;
-- 86 of 186 --
/>2+8C +C/<
-4)'6245-1')
+)
9+<.9773>>//=
>7(-6
=
>1128%6-21%1(")',12/2+;
=
>20-1%6-1+%1(28)41%1')
"
#?,63--97:+8C
.3</->9<=23:=386+=>03@/
C/+<=
>56)4%%&51'
> 2:1'
>)9/)66%'.%4(16)434-5)
203%1;
>%48)//")',12/2+;*240)4
>!)034%*240)4
=5*7.*3(*
;J>7DO'*7O;HI;HL;:7I7D"N;9KJ?L;:L?IEHE<0?H?I 7F?J7B$HEKF)) 7FH?L7J;;GK?JO
<?HC <HEC*7OJE0;FJ;C8;H-H?EHJEJ>7JI>;I;HL;:7I7D"N;9KJ?L;-7HJD;H<HEC
'7DK7HOJEFH?B0>;M7IJ>;"N;9KJ?L;3?9;-H;I?:;DJ EHFEH7J;!;L;BEFC;DJ
7D:1;9>DEBE=OE<0;CFH7"D;H=O<HEC+EL;C8;HJE'7DK7HO#HEC0;FJ;C8;H
JE!;9;C8;H *I*7O;HM7IJ>;-H;I?:;DJ7D: >?;<"N;9KJ?L;,<<?9;HE<&N?7
M>?9>M7IKBJ?C7J;BO79GK?H;:8O(;OI?=>J1;9>DEBE=?;I?D#HEC*7OJE*7O
*I*7O;HI;HL;:7I0;D?EH3?9;-H;I?:;DJ7D:$;D;H7B*7D7=;HE<%;MB;JJ -79A7H:
ECF7DOWIX%-Y +;JMEHA?D=8KI?D;IIKD?J7D:J>;+;JMEHA#KD9J?ED3?HJK7B?P7J?ED8KI?D;II
KD?J#HECKDJ?B I>;I;HL;:7I3?9;-H;I?:;DJ 4EHB:M?:;*7HA;J?D=7D:BB?7D9;I
E<%-WI"DJ;HFH?I;0;HL;HI0JEH7=;7D:+;JMEHA?D=$HEKF-H?EHJE@E?D?D=%- I>;>;B:
B;7:;HI>?FHEB;I7JBK; E7J0OIJ;CI &D9 ?I9E0OIJ;CI &D97D:FFB; &D9
0>;>7II;HL;:7I7C;C8;HE<J>;8E7H:IE<:?H;9JEHIE<*7?DIFH?D="D;H=O &D9I?D9;
,9JE8;H0;9KHED?N&D9I?D9;'7DK7HOIJ;H7)78I &D9I?D9;'KD; M>;H;
I>;?I7C;C8;HE<J>;7K:?J9ECC?JJ;;7D:7C;C8;HE<J>;9ECF;DI7J?ED9ECC?JJ;;
%;MB;JJ-79A7H:"DJ;HFH?I; ECF7DOI?D9;'KD; M>;H;I>;?I7C;C8;HE<J>;7K:?J
9ECC?JJ;; 7C;C8;HE<J>;?DJ;=H7J?ED9ECC?JJ;; 7D:9>7?HE<J>;J;9>DEBE=O9ECC?JJ;;
7D:EN &D9I?D9;FH?B M>;H;I>;?IJ>;9>7?HE<J>;8E7H:7D:J>;9>7?HE<J>;
9ECF;DI7J?ED9ECC?JJ;;7D:M7IFH;L?EKIBO7C;C8;HE<J>;EF;H7J?D=9ECC?JJ;;
*I*7O;HFH;L?EKIBOI;HL;:EDJ>;8E7H:IE<:?H;9JEHIE< ;B;IJ?7B&<HECFH?BJE
#;8HK7HO"B;9JHED?9I<EH&C7=?D=&D9<HEC'KBOJE,9JE8;HC8H?&D9<HEC
+EL;C8;HJE'KBO*7HL;BB1;9>DEBE=O &D9<HEC*7OJE'KD;0;CFH7
<HEC'KD;JE0;FJ;C8;H7<J;HI;HL?D=<HEC#;8HK7HOJE+EL;C8;H7D:
&N?7<HEC0;FJ;C8;HJE!;9;C8;H
*I*7O;H;7HD;:7D*0:;=H;;?D O8;HI;9KH?JO/?IA7D:0JH7J;=O<HEC+;M6EHA
2D?L;HI?JO 7D*:;=H;;<HEC 02 *EDJ;H;O7O7D:70:;=H;;?DFEB?J?97BI9?;D9;
<HEC07DJ7 B7H72D?L;HI?JO
:&1.+.(&9.438
1>;E7H:>7I9ED9BK:;:J>7J*I*7O;HI>EKB:I;HL;7I7:?H;9JEHE<J>; ECF7DO8;97KI;
E<>;HB;7:;HI>?FIA?BBI7D:>;H;NF;H?;D9;?DEF;H7J?ED7BHEB;I7J9ECF7D?;I?DL7H?EKI
J;9>DEBE=O?D:KIJH?;I ?D9BK:?D=D;JMEHAI D;JMEHAC7D7=;C;DJ I;HL;HI I;9KH?JOIEBKJ?EDI
9O8;HI;9KH?JO 7D:?DJ;HD;JJ;9>DEBE=O7D:>;H8E7H:=EL;HD7D9;;NF;H?;D9;<HECI;HL?9;ED
EJ>;H8E7H:I
*>"0.118&3)=5*7.*3(*8
Z &D:KIJHO(DEMB;:=;
Z *7HA;J?D= !?IHKFJ?L;1;9>DEBE=O 7D:0JH7J;=O"NF;H?;D9;
Z );7:;HI>?F"NF;H?;D9;
Z #?D7D9;"NF;H?;D9;
Z $BE87BKI?D;II"NF;H?;D9;
Z *"NF;H?;D9;
Z ECF7H7J?L;E7H:$EL;HD7D9;"NF;H?;D9;
Z O8;HI;9KH?JO"NF;H?;D9;
Z %KC7D 7F?J7B*7D7=;C;DJ"NF;H?;D9;
Z /?IA*7D7=;C;DJ"NF;H?;D9;
Z *7DK<79JKH?D=,F;H7J?EDI"NF;H?;D9;
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 87 of 186 --
C9>3 /2<+
-4)'6245-1')
+)
9+<.9773>>//
>203)15%6-21%1(70%1
)5274')5
"
"
=5*7.*3(*
'OEJ?(*;>H7>7II;HL;:7IJ>;"N;9KJ?L;3?9;-H;I?:;DJE<%KC7D/;IEKH9;IE<$?B;7:
09?;D9;I &D9 78?EF>7HC79;KJ?97B9ECF7DO I?D9;'KBO0>;FH;L?EKIBOI;HL;:7I3?9;
-H;I?:;DJE<%KC7D/;IEKH9;IE<$?B;7:<HEC,9JE8;HJE'KBO-H?EHJE@E?D?D=
$?B;7: I>;>;B:FEI?J?EDIE<?D9H;7I?D=H;IFEDI?8?B?JOM?J>+EL7HJ?I->7HC79;KJ?97BI
EHFEH7J?ED7D:?JI7<<?B?7J;I <HECJ>HEK=>,9JE8;H CEIJH;9;DJBO7I3?9;
-H;I?:;DJE<%KC7D/;IEKH9;IE<+EL7HJ?I<HEC'KBOJE,9JE8;H
*I*;>H7;7HD;:7D*:;=H;;?DFEB?J?9I<HEC'7M7>7HB7B+;>HK2D?L;HI?JO 7D:7
:;=H;;?DFEB?J?97BI9?;D9;<HEC!;B>?2D?L;HI?JO
:&1.+.(&9.438
1>;E7H:>7I9ED9BK:;:J>7J*I*;>H7I>EKB:I;HL;7I7:?H;9JEHE<J>; ECF7DO8;97KI;
E<>;HB;7:;HI>?F7D:?DJ;HD7J?ED7B8KI?D;II;NF;H?;D9;?D7>?=> J;9>DEBE=O?D:KIJHO>;H
IK8IJ7DJ?7B>KC7D97F?J7B7D:J7B;DJ:;L;BEFC;DJ;NF;H?;D9; ?D9BK:?D=;NF;H?;D9;7IJ>;
>;7:E<>KC7DH;IEKH9;IE<7FK8B?99ECF7DOM?J>=BE87BEF;H7J?EDI>;H=EL;HD7D9;
;NF;H?;D9;7D:>;H9O8;HI;9KH?JO;NF;H?;D9;
*>"0.118&3)=5*7.*3(*8
Z &D:KIJHO(DEMB;:=;
Z );7:;HI>?F"NF;H?;D9;
Z $BE87BKI?D;II"NF;H?;D9;
Z *"NF;H?;D9;
Z ECF7H7J?L;E7H:$EL;HD7D9;"NF;H?;D9;
Z O8;HI;9KH?JO"NF;H?;D9;
Z %KC7D 7F?J7B*7D7=;C;DJ"NF;H?;D9;
Z /?IA*7D7=;C;DJ"NF;H?;D9;
-- 88 of 186 --
,2343>*&+6A+65+<
,%-4
-4)'6245-1')
+)
9+<.9773>>//=
>203)15%6-21%1(70%1
)5274')5
=
=
!
>1128%6-21%1(")',12/2+;
=
>20-1%6-1+%1(28)41%1')
=
=
!
#?,63--97:+8C
.3</->9<=23:=386+=>03@/
C/+<=
>(8%1')(-'42)8-')51'
>- ,;6,0")',12/2+-)51'
>"211)'6-8-6;6(
=5*7.*3(*
8>?@?J617BM7BA7H?IJ>;<EHC;H-H;I?:;DJ7D: >?;<"N;9KJ?L;,<<?9;HE<)0& EHFEH7J?ED 7
FEI?J?ED>;>;B:<HEC*7OKDJ?BJ>;9ECFB;J?EDE<)0&WIC;H=;HM?J>L7=E1;9>DEBE=?;I
?D*7O#HECJE *H17BM7BA7HM7I;CFBEO;:8O&DJ;B EHFEH7J?EDJ&DJ;B >;
>;B:7DKC8;HE<I;D?EHC7D7=;C;DJFEI?J?EDI ?D9BK:?D=7I EHFEH7J;3?9;-H;I?:;DJ7D:
E $;D;H7B*7D7=;HE<J>;!?=?J7B"DJ;HFH?I;$HEKF M>?9>M7I9ECFH?I;:E<&DJ;BWI8KI?D;II
9B?;DJ I;HL;H IJEH7=;7D:9ECCKD?97J?EDI8KI?D;II 7D:7I3?9;-H;I?:;DJ7D:$;D;H7B
*7D7=;H<EHJ>;&DJ;B"DJ;HFH?I;-B7J<EHC$HEKF M>;H;>;<E9KI;:ED:;L;BEF?D= C7HA;J?D=
7D:IKFFEHJ?D=&DJ;B8KI?D;IIIJH7J;=?;I<EH;DJ;HFH?I;9ECFKJ?D=-H?EHJE@E?D?D=&DJ;B *H
17BM7BA7H>;B:I;D?EH;D=?D;;H?D=7D:C7HA;J?D=FEI?J?EDI7J0;GK;DJ ECFKJ;H0OIJ;CI
M>?9>B7J;H8;97C;7F7HJE<&*?FEB7H&DJ;=H7J;:1;9>DEBE=O &D97D:)7JJ?9;
0;C?9ED:K9JEH&D9
*H17BM7BA7H>7II;HL;:7I7C;C8;HE<J>;8E7H:E<:?H;9JEHIE<:L7D9;:*?9HE!;L?9;I
&D9 I?D9;'KD; M>;H;>;?I7C;C8;HE<J>;9ECF;DI7J?ED7D:B;7:;HI>?FH;IEKH9;I
9ECC?JJ;;7D:J>;9>7?HE<J>;?DDEL7J?ED7D:J;9>DEBE=O9ECC?JJ;;1" EDD;9J?L?JO)J:
I?D9;*7H9> M>;H;>;?IJ>;9>7?HE<J>;C7D7=;C;DJ:;L;BEFC;DJ7D:9ECF;DI7J?ED
9ECC?JJ;;7D:?/>OJ>C1;9>DEBE=?;I&D9 I?D9;*7O M>;H;>;?IJ>;9>7?HE<J>;8E7H:
7D:7C;C8;HE<J>;9ECF;DI7J?ED7D:>KC7D97F?J7BC7D7=;C;DJ9ECC?JJ;;7D:J>;
DEC?D7J?D=7D:9EHFEH7J;=EL;HD7D9;9ECC?JJ;;
%;FH;L?EKIBOI;HL;:7I7C;C8;HE<J>;8E7H:E<:?H;9JEHIE<)0&<HEC*7OJE*7O
7D:J>;200;C?9ED:K9JEH&D:KIJHOIIE9?7J?ED<HEC*7OJE*7O%;M7I
7::?J?ED7BBO7C;C8;HE<J>;20:;B;=7J?ED<EH4EHB:0;C?9ED:K9JEH EKD9?BFHE9;;:?D=I
*H17BM7BA7H;7HD;:70:;=H;;?D;B;9JH?97B;D=?D;;H?D=<HEC,H;=ED0J7J;2D?L;HI?JO
:&1.+.(&9.438
1>;E7H:>7I9ED9BK:;:J>7J*H17BM7BA7HI>EKB:I;HL;7I7:?H;9JEHE<J>; ECF7DO
8;97KI;E<>?I;NF;H?;D9;?DJ>;I;C?9ED:K9JEH?D:KIJHO ?D9BK:?D=7IJ>;<EHC;H9>?;<
;N;9KJ?L;E<<?9;HE<7I;C?9ED:K9JEH9ECF7DO7D:>?IFH;L?EKIHEB;?DJ>;I;C?9ED:K9JEH
?D:KIJHOWIJH7:;7IIE9?7J?ED>?IJ;9>DEBE=O;NF;H?;D9;>?I8KI?D;II7D:EF;H7J?EDI
B;7:;HI>?FHEB;I7JEJ>;HI;C?9ED:K9JEH9ECF7D?;IJ>7J?D9BK:;79KIJEC;HE<J>; ECF7DO
>?I<?D7D9;;NF;H?;D9;>?I=BE87B8KI?D;II;NF;H?;D9;>?IC;H=;HI7D:79GK?I?J?EDI
;NF;H?;D9;>?I8E7H:=EL;HD7D9;;NF;H?;D9;<HECI;HL?9;EDEJ>;HFK8B?99ECF7DO8E7H:I
?D9BK:?D=7I9>7?HE<7DEJ>;H8E7H:7D:>?I9O8;HI;9KH?JO;NF;HJ?I;
*>"0.118&3)=5*7.*3(*8
Z &D:KIJHO(DEMB;:=;
Z KIJEC;H!;;F1;9>DEBE=O(DEMB;:=;
Z *7HA;J?D= !?IHKFJ?L;1;9>DEBE=O 7D:0JH7J;=O"NF;H?;D9;
Z );7:;HI>?F"NF;H?;D9;
Z #?D7D9;"NF;H?;D9;
Z $BE87BKI?D;II"NF;H?;D9;
Z *"NF;H?;D9;
Z ECF7H7J?L;E7H:$EL;HD7D9;"NF;H?;D9;
Z %KC7D 7F?J7B*7D7=;C;DJ"NF;H?;D9;
Z /?IA*7D7=;C;DJ"NF;H?;D9;
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 89 of 186 --
#<9:9=+6!9 .@3=9<C(9>/>9::<9@/"?<!+7/.B/-?>3@/"003-/<
97:/8=+>398
0;9J?EDE<J>;"N9>7D=;9J;D78B;IJ>; ECF7DOWIIJE9A>EB:;HIJELEJ;JE7FFHEL; ED7D7:L?IEHO DED 8?D:?D=87I?I EKH
D7C;:;N;9KJ?L;E<<?9;H9ECF;DI7J?ED 7I:?I9BEI;:?DJ>?IFHENOIJ7J;C;DJ?D799EH:7D9;M?J>0" HKB;IBJ>EK=>J>;LEJ;?I
7:L?IEHO7D:?IDEJ8?D:?D=EDKIEHEDEKHE7H: EKH9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;7D: 7I7FFHEFH?7J; EKH
E7H: M?BBJ7A;?DJE799EKDJJ>;EKJ9EC;E<J>;LEJ;M>;D9EDI?:;H?D=<KJKH;;N;9KJ?L;9ECF;DI7J?ED:;9?I?EDI7D:M?BB;L7BK7J;
M>;J>;H7DO79J?EDI7H;D;9;II7HOJE7::H;IIIJE9A>EB:;H9ED9;HDI
4;8;B?;L;J>7JEKH9ECF;DI7J?EDF>?BEIEF>O>7I7BBEM;:KIJE7JJH79J H;J7?D 7D:CEJ?L7J;GK7B?<?;:;N;9KJ?L;E<<?9;HIM>E>7L;
9EDJH?8KJ;:JEEKHIK99;II#EHCEH;?D<EHC7J?EDH;=7H:?D=J>;9ECF;DI7J?EDE<EKHD7C;:;N;9KJ?L;E<<?9;HI EKH9ECF;DI7J?ED
F>?BEIEF>O EKH07OED-7OH;IKBJI7D:EKHH;IFEDI; M;;D9EKH7=;OEKJEH;7:J>;I;9J?EDE<J>?IFHENOIJ7J;C;DJ;DJ?JB;:
X869.7<*=287*==.;< CA.,>=2?.869.7<*=287*7-!=1.;7/8;6*=287C869.7<*=2872<,><<287*7-7*5B<2< YJ>;
9ECF;DI7J?EDJ78B;I 7D:J>;D7HH7J?L;<EBBEM?D=J>;9ECF;DI7J?EDJ78B;I<EH7CEH;:;J7?B;::?I9KII?EDE<EKH9ECF;DI7J?EDFEB?9?;I
7D:FH79J?9;I
4;7H;7IA?D=<EHIJE9A>EB:;H7FFHEL7B ED7D7:L?IEHO DED 8?D:?D=87I?I E<J>;<EBBEM?D=H;IEBKJ?ED
V*+'$. J>7JJ>;IJE9A>EB:;HIE<)7C/;I;7H9> EHFEH7J?EDJ>; ECF7DO >;H;8O7FFHEL; ED7D7:L?IEHO87I?I J>;
9ECF;DI7J?EDE<J>; ECF7DOWID7C;:;N;9KJ?L;E<<?9;HI 7I:?I9BEI;:FKHIK7DJJE&J;CE<0" /;=KB7J?ED0 ( ?D9BK:?D=J>;
X869.7<*=2872<,><<287*7-7*5B<2< YJ>;9ECF;DI7J?EDJ78B;I 7D:7DOH;B7J;:D7HH7J?L;:?I9BEIKH;?D9BK:;:?DJ>;FHENO
IJ7J;C;DJW
"79>FHENOH;9;?L;:8OJ>;-HENO%EB:;HIM?BB8;LEJ;:X#,/YJ>;7:L?IEHO7FFHEL7BE<J>;9ECF;DI7J?EDE<EKHD7C;:;N;9KJ?L;
E<<?9;HI KDB;IIJ>;IJE9A>EB:;HFHEL?:;IEJ>;H?DIJHK9J?EDI
1>?ILEJ;?IDEJ?DJ;D:;:JE7::H;II7DOIF;9?<?9?J;CE<9ECF;DI7J?ED 8KJH7J>;HJ>;EL;H7BB9ECF;DI7J?EDE<EKHD7C;:;N;9KJ?L;
E<<?9;HI7D:J>;FEB?9?;I7D:FH79J?9;I:;I9H?8;:?DJ>?IFHENOIJ7J;C;DJ
4;FHEL?:;<EH7DDK7B7:L?IEHOLEJ;IJE7FFHEL;J>;9ECF;DI7J?EDE<EKHD7C;:;N;9KJ?L;E<<?9;HI2DB;IICE:?<?;: J>;D;NJ
7:L?IEHOLEJ;JE7FFHEL;EKHD7C;:;N;9KJ?L;E<<?9;H9ECF;DI7J?EDM?BB8;7JEKH7DDK7BC;;J?D=E<IJE9A>EB:;HI
0JE9A>EB:;H7FFHEL7BE<-HEFEI7B+EH;GK?H;IJ>;7<<?HC7J?L;LEJ;E<J>;>EB:;HIE<7C7@EH?JOE<J>;EKJIJ7D:?D=I>7H;IE<9ECCED
IJE9A>7L?D=LEJ?D=FEM;HFH;I;DJ ?DF;HIEDEH8OFHENO 7JJ>;7DDK7BC;;J?D=
, '*'!*,'*+*'%%&+.',N'*O, ((*'.$ '&&.!+'*1 &'& !&!&
+!+ ''-*&%0-,!.'!*'%(&+,!'&
-- 90 of 186 --
#<9:9=+6!9 $+>303-+>39890>2/::938>7/8>90# #+=9?<
8./:/8./8>$/13=>/</.#?,63---9?8>3813<709<3=-+6*/+<
0JE9A>EB:;HI7H;8;?D=7IA;:JEH7J?<OJ>;7FFE?DJC;DJE<(-*$7IJ>; ECF7DOWI?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HC<EH
<?I97BO;7HBJ>EK=>J>;7K:?J9ECC?JJ;;>7IJ>;IEB;7KJ>EH?JOJE7FFE?DJJ>; ECF7DOWI?D:;F;D:;DJH;=?IJ;H;:FK8B?9
799EKDJ?D=<?HC 7I7C7JJ;HE<=EE:9EHFEH7J;=EL;HD7D9; J>;E7H:IK8C?JI?JII;B;9J?EDJEEKHIJE9A>EB:;HI<EHH7J?<?97J?ED&<J>;
IJE9A>EB:;HI:EDEJH7J?<OJ>;7FFE?DJC;DJE<(-*$ J>;7K:?J9ECC?JJ;;M?BB9EDJ;CFB7J;M>;J>;HJEH;9EDI?:;HJ>;7FFE?DJC;DJ
"L;D?<J>;IJE9A>EB:;HIH7J?<OJ>;7FFE?DJC;DJ J>;7K:?J9ECC?JJ;;C7O ?D?JI:?I9H;J?ED 7FFE?DJ7:?<<;H;DJ?D:;F;D:;DJ7K:?JEH7J
7DOJ?C;?<?J:;J;HC?D;IJ>7JIK9>9>7D=;MEKB:8;?DJ>; ECF7DOWI8;IJ?DJ;H;IJI7D:?DJ>;8;IJ?DJ;H;IJIE<EKHIJE9A>EB:;HI
"79>FHENOH;9;?L;:8OJ>;-HENO%EB:;HIM?BB8;LEJ;:X#,/YJ>;H7J?<?97J?EDE<J>;7FFE?DJC;DJE<(-*$ KDB;IIJ>;IJE9A>EB:;H
FHEL?:;IEJ>;H?DIJHK9J?EDI
,KH7K:?J9ECC?JJ;;M?BBC;;JF;H?E:?97BBOM?J>(-*$JEH;L?;M8EJ>7K:?J7D:DED 7K:?JI;HL?9;IF;H<EHC;:8O(-*$ 7IM;BB7IJ>;
<;;I9>7H=;:<EHJ>EI;I;HL?9;ICED=EJ>;HJ>?D=I J>;9ECC?JJ;;;N7C?D;IJ>;;<<;9JJ>7JJ>;F;H<EHC7D9;E<DED 7K:?JI;HL?9;I ?<
7DO C7O>7L;KFEDJ>;?D:;F;D:;D9;E<J>;?D:;F;D:;DJH;=?IJ;H;:FK8B?9799EKDJ?D=<?HCBBFHE<;II?ED7BI;HL?9;IFHEL?:;:8O
(-*$ ?D9BK:?D=DED 7K:?JI;HL?9;I ?<7DO 7H;IK8@;9JJE7FFHEL7B8OJ>;7K:?J9ECC?JJ;;?D799EH:7D9;M?J>7FFB?978B;I;9KH?J?;I
B7MI HKB;I 7D:H;=KB7J?EDI#EHCEH;?D<EHC7J?ED I;;X>-2=*==.;<C >-2=8662==..#.98;=Y7D:X>-2=*==.;<C#.5*=287<129
@2=17-.9.7-.7=#.02<=.;.-">+52,,,8>7=2702;6Y78EL;
H;FH;I;DJ7J?L;E<(-*$?I;NF;9J;:JE8;FH;I;DJ7JJ>;7DDK7BC;;J?D=7D:JE>7L;7DEFFEHJKD?JOJEC7A;7IJ7J;C;DJ?<J>;OIE
:;I?H;1>;H;FH;I;DJ7J?L;?I7BIE;NF;9J;:JE8;7L7?B78B;JEH;IFED:JE7FFHEFH?7J;GK;IJ?EDI<HECJ>;IJE9A>EB:;HI
0JE9A>EB:;H7FFHEL7BE<-HEFEI7B+EH;GK?H;IJ>;7<<?HC7J?L;LEJ;E<J>;>EB:;HIE<7C7@EH?JOE<J>;EKJIJ7D:?D=I>7H;IE<9ECCED
IJE9A>7L?D=LEJ?D=FEM;HFH;I;DJ ?DF;HIEDEH8OFHENO 7JJ>;7DDK7BC;;J?D=
, '*'!*,'*+*'%%&+.',N'*O, *,!!,!'&', (('!&,%&,'
#(%$$(+'-*!&(&&,*!+,*(-$!'-&,!&!*%'*!+$1*
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 91 of 186 --
#<9:9=+6!9 %>9-5296./<#<9:9=+6
'E>D >;L;::;D H;I?:?D=7J+;BIEDL;DK; +E /;:ED:E;79> J>;8;D;<?9?7BEMD;HE<I>7H;IE<J>;
ECF7DOWI9ECCEDIJE9A >7IDEJ?<?;:KIJ>7J>;?DJ;D:IJEFH;I;DJJ>;<EBBEM?D=FHEFEI7B7JJ>;7DDK7BC;;J?D=&D799EH:7D9;M?J>
J>;7FFB?978B;HKB;IE<J>;0" M;>7L;I;J<EHJ>*H >;L;::;DWIFHEFEI7B8;BEM;N79JBO7IIK8C?JJ;:JEKIBBIJ7J;C;DJI
9EDJ7?D;:?DJ>;IJE9A>EB:;HFHEFEI7B7H;J>;IEB;H;IFEDI?8?B?JOE<J>;FHEFED;DJ
1>;E7H:-&&!%'-+$1H;9ECC;D:IJ>7JOEKLEJ;X!&+,YJ>?IFHEFEI7B<EHJ>;H;7IEDII;J<EHJ>8;BEMJ>;FHEFEI7B
(C@A@D2=CEE2:?23=6+92C69@=56C*:89EE@2==7@C2+A64:2=+92C69@=56C%66E:?8
0>7H;>EB:;HI7IAEKHE7H:E<!?H;9JEHIJEJ7A;J>;IJ;FID;9;II7HOJE7C;D:J>;7FFHEFH?7J;9ECF7DO=EL;HD?D=:E9KC;DJIJE
=?L;J>;EMD;HIE<79EC8?D;:E<EKHEKJIJ7D:?D=9ECCEDIJE9AJ>;FEM;HJE97BB7IF;9?7BI>7H;>EB:;HC;;J?D=0K9>7
IF;9?7BI>7H;>EB:;HC;;J?D=97D8;7D;7IOJE9EDL;D;EDB?D;I>7H;>EB:;HC;;J?D=
1>;9KHH;DJ)/ 5IF;9?7BC;;J?D=HKB;>7I<79JEHI;79>E<M>?9>79J?D=7BED;C7A;7I>7H;>EB:;H97BB<EH7IF;9?7BI>7H;>EB:;H
C;;J?D=KD7JJ7?D78B;
/;GK?H;E<I>7H;IJEIKFFEHJ7I>7H;>EB:;H97BB<EH7IF;9?7BI>7H;>EB:;HC;;J?D=?DIJ;7:E<J>;<?=KH;?DIJ7J;B7M
!?IGK7B?<O?D=7IK8IJ7DJ?7B8BE9AE<)/ 5I>7H;I<HEC8;?D=F7HJE<J>;=HEKF
0>7H;>EB:;HIE<CEH;J>7D9ECF7D?;II>7L;LEJ;:EDIF;9?7BI>7H;>EB:;HC;;J?D=FHEFEI7BI7D:DEJED;E<9ECF7D?;I
>7L;9?J;:;L;DED;;N7CFB;E<7IF;9?7BC;;J?D=97BB;:<EH8OI>7H;>EB:;H;L;H79JK7BBOJ7A?D=FB79;7J79ECF7DOJ>7J>7:@KIJED;
E<J>;78EL;H;GK?H;C;DJI
ECF7D?;IB?A;JE7:EFJJ>;H;GK?H;C;DJEHJ>;78EL;:?IGK7B?<?97J?ED9B7KI;8;97KI;J>;OADEMJ>;OM?BB8;F;H<;9JBOI7<;<HEC
;L;HO79JK7BBO>7L?D=JE9ED:K9J7I>7H;>EB:;H97BB;:IF;9?7BI>7H;>EB:;HC;;J?D=)/ 5>7I7:EFJ;:8EJ>J>;H;GK?H;C;DJ7D:
J>;78EL;:?IGK7B?<?97J?ED9B7KI;1>KI)/ 59KHH;DJBO>7IJ>;FHEJ;9J?EDE<?DIKH7D9;FEB?9?;IJ>7J7IF;9?7BI>7H;>EB:;HC;;J?D=
97BB;:<EH8OI>7H;>EB:;HIM?BBD;L;HJ7A;FB79;
-B;7I;LEJ;O;I
EE2:?23=6+92C69@=56C*:89EE@2==7@C2+A64:2=+92C69@=56C%66E:?8C(C@A@D2=
'AA@D:?8+E2E6>6?E@7E96@2C5@7:C64E@CD
#-*4&7)4+.7*(94787*(422*3)8&;49*"#9-*894(0-41)*7574548&1
1>;E7H:>7I97H;<KBBO9EDI?:;H;:J>;FHEFEI7B7D:8;B?;L;IJ>7J?J?IDEJ?DJ>;8;IJ?DJ;H;IJIE<EKHIJE9A>EB:;HI 9EDI?:;H?D=EKH
;N?IJ?D=IJE9A>EB:;HH?=>J<EH97BB?D=IF;9?7BC;;J?D=I,KH8OB7MI=?L;IJE9A>EB:;HIM>E>7L;EMD;:7JB;7IJE<EKH9ECCED
IJE9A 9EDJ?DKEKIBO<EH7JB;7IJED;O;7H J>;H?=>JJE97BB7IF;9?7BC;;J?D=E<IJE9A>EB:;HI1>;EMD;HI>?FJ>H;I>EB:7:EFJ;:8O
J>;E7H:7B?=DIM?J>C7HA;JFH79J?9;I 7D:J>;ED; O;7H>EB:?D=F;H?E:?ID;9;II7HOJE>;BFFH;L;DJC?IKI;E<J>;IF;9?7BC;;J?D=
FHE9;II EDI;GK;DJBO J>;E7H:-&&!%'-+$1H;9ECC;D:I7LEJ;!&+,J>?IFHEFEI7B<EHJ>;<EBBEM?D=H;7IEDI
"94(0-41)*78(:77*391>-&;*&2*&3.3,+:17.,-994(&11&85*(.&12**9.3,<-.(-.87*&843&'1*&3).39-*'*89.39*7*8984+&11
4+4:7894(0-41)*78
4;H;9E=D?P;J>;?CFEHJ7D9;E<FHEL?:?D=IJE9A>EB:;HIJ>;78?B?JOJE97BBIF;9?7BC;;J?D=IM>;D7FFHEFH?7J;,KH8OB7MIF;HC?J
IJE9A>EB:;HIM>E>7L;EMD;: ?DJ>;7==H;=7J; 7JB;7IJE<J>;EKJIJ7D:?D=I>7H;IE<EKH9ECCEDIJE9A9EDJ?DKEKIBO<EH7J
B;7IJED;O;7H JE97BB7IF;9?7BC;;J?D=E<IJE9A>EB:;HI IK8@;9JJE9;HJ7?D9KIJEC7HOH;GK?H;C;DJI1>;I;H;GK?H;C;DJI7H;?DJ;D:;:
JE;DIKH;J>7JEKHIJE9A>EB:;HIH;9;?L;7:;GK7J; J?C;BO 7D:799KH7J;?D<EHC7J?ED?D9EDD;9J?EDM?J>7IF;9?7BC;;J?D=7D:JE7LE?:
J>;KDD;9;II7HOKI;E<H;IEKH9;IJ>7JMEKB:H;IKBJ<HEC>EB:?D=IF;9?7BC;;J?D=IH;:KD:7DJBO?D9BEI;FHEN?C?JOJEEKH7DDK7B
C;;J?D=IEHEJ>;HIJE9A>EB:;HC;;J?D=I?DM>?9>7I?C?B7H?J;CM7I9EDI?:;H;:
,KH8OB7MI=H7DJEKHIJE9A>EB:;HI7C;7D?D=<KBH?=>JJE97BB7IF;9?7BC;;J?D=M?J>7FFHEFH?7J;EMD;HI>?FJ>H;I>EB:7D:>EB:?D=
F;H?E:H;GK?H;C;DJIJ>7J7B?=DM?J>EKHIJE9A>EB:;HIW?DJ;H;IJI4;8;B?;L;J>7JJ>;9KHH;DJEMD;HI>?FJ>H;I>EB:7D:ED; O;7H
-- 92 of 186 --
holding period are reasonable and strike the appropriate balance between enhancing the ability of our stockholders to act on
important and urgent matters, while at the same time protecting against misuse of the special meeting right by a small number of
short-term stockholders whose interests may not be shared by the vast majority of our stockholders. The Board believes that the
rights set forth in our bylaws are in the best interests of all of our stockholders.
A 20% ownership threshold appropriately balances the interests of all stockholders and is in line with market practice
The Board believes that special meetings should be limited to circumstances in which more than a small number or percentage of our
stockholders determine that a matter is sufficiently critical or time-sensitive that it must be addressed between annual meetings. The
20% threshold in our bylaws ensures that a special meeting of stockholders may only be called by a stockholder or group of
stockholders with a more substantial stake in our Company and who share interest in a common topic. This threshold strikes the
appropriate balance by safeguarding stockholder interests and preventing corporate waste, while at the same time ensuring that
stockholders have the ability to call special meetings when appropriate. A threshold at 10% of our outstanding common stock or the
lowest percentage of stockholders as governed by Delaware law, as requested by the proposal, would allow a small number of
stockholders to use the right to call a special meeting as a means to advance special interest agendas, or goals not widely shared by
our stockholders as a whole, or to apply short-term oriented pressure that is inconsistent with the long-term interests of the Company
and our stockholders, all at the expense of our other stockholders. Furthermore, the Board believes that failure to aggregate sufficient
stock ownership to reach the 20% ownership threshold is a strong indicator that a sufficient interest among the majority of
stockholders does not exist to call a special meeting.
The 20% ownership threshold included in our bylaws is in line with market practice and, notably, is actually lower than the most
common special meeting ownership threshold of 25%. As of August 2026, within the S&P 500, 80% of companies provide
stockholders the right to call a special meeting of stockholders. Of those companies, approximately 60% have adopted an ownership
threshold of 20% or higher for allowing stockholders to call a special meeting, with the most common ownership threshold being 25%,
while only about 23% have adopted a special meeting ownership threshold of 10% or less. The Board believes that the 20%
ownership threshold is appropriate for our Company and in line with market practice.
The one-year holding requirement protects the Company and our broader stockholder base against misuse of special
meetings by short-term stockholders with narrow interests
Eliminating the one-year holding requirement would allow individuals or special-interest stockholder groups with short-term agendas
to call a special meeting immediately after purchasing our common stock. Enabling stockholders who have not held a financial stake
in the Company for a meaningful period of time to call a special meeting would result in outsized attention and resources being
devoted to special interests inconsistent with the long-term goals of the Company, and would come at the expense of stockholders
who seek a long-term investment in the Company. The nominal one-year holding requirement appropriately safeguards stockholder
interests and prevents corporate waste, while preserving the ability for stockholders to call special meetings when appropriate.
Stockholders also have the ability to act by written consent for any action required or permitted to be taken at an annual or special
meeting of stockholders. This right enables our stockholders to take action outside of annual or special meetings and, in the event an
urgent or strategic matter of importance arises which demands an immediate stockholder response, stockholders may make use of
their ability to act by written consent, which is not limited to stockholders who have held our common stock for at least one year.
In addition, the one-year holding period included in our bylaws is consistent with the minimum holding period established by the SEC
under Rule 14a-8 of the Exchange Act, which enables a stockholder to include a proposal in an issuer’s proxy statement. In adopting
the holding requirements under Rule 14a-8, the SEC indicated that the holding period should be calibrated such that a stockholder
has some meaningful “economic stake or investment interest” in a company before the stockholder may draw on company and
stockholder resources and command the time and attention of other stockholders to consider and vote on the proposal. The Board
believes the SEC’s reasoning is equally applicable to the Company’s one-year holding requirement for requesting a special meeting,
as stockholders who have held shares for at least one year show an appreciation of, and commitment to, the long-term success of
the Company and its efforts to create sustainable value.
Our stockholders rejected a similar proposal from the proponent at our 2025 annual meeting of stockholders
At our 2025 annual meeting of stockholders, our stockholders rejected a similar proposal from the proponent requesting that the
Company allow stockholders holding just 10% of our common stock or the lowest percentage of stockholders as governed by
Delaware law to call a special meeting and to remove the one-year holding period requirement for stockholders’ right to call a special
meeting. This prior vote indicates stockholder concurrence with our balanced approach to safeguarding stockholders’ right to call
special meetings, including both the 20% ownership threshold and the one-year holding period established in our existing special
meeting right.
Our special meeting requirements strike an appropriate balance and protect against waste
Special meetings of stockholders can be disruptive to business operations, incur substantial expenses and harm long-term
stockholder interests. The Board, management and employees must devote a significant amount of time and attention preparing for
such meetings, which distracts from their primary focus of maximizing long-term financial returns for stockholders and operating our
business in the best interest of all stockholders. In addition, with each special meeting of stockholders, we will likely incur significant
Lam Research Corporation 2026 Proxy Statement 81
-- 93 of 186 --
;NF;DI;IJEFH;F7H;J>;:?I9BEIKH;IH;GK?H;:<EHIK9>C;;J?D=I FH?DJ7D::?IJH?8KJ;C7J;H?7BI IEB?9?JFHEN?;I7D:J78KB7J;LEJ;II7
H;IKBJ IF;9?7BC;;J?D=IE<IJE9A>EB:;HII>EKB:8;B?C?J;:JE9?H9KCIJ7D9;IM>;H;7IK8IJ7DJ?7BDKC8;HE<IJE9A>EB:;HIM?J>7
9ECC?JJ;:<?D7D9?7BIJ7A;?DJ>; ECF7DO8;B?;L;7C7JJ;H?IIK<<?9?;DJBOKH=;DJEH;NJH7EH:?D7HOJE@KIJ?<O97BB?D=7IF;9?7BC;;J?D=
$*-&;*.251*2*39*)89743,&3)*++*(9.;*(47547&9*,4;*73&3(*541.(.*89-&9574;.)*894(0-41)*78<.9-2*&3.3,+:1
455479:3.9.*894*3,&,*.3425&3>&++&.78
1>;DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;;E<J>;E7H:H;=KB7HBOH;L?;MIJ>; ECF7DOWI9EHFEH7J;=EL;HD7D9;FH79J?9;I4;7H;
9ECC?JJ;:JE;<<;9J?L;9EHFEH7J;=EL;HD7D9;FEB?9?;IJ>7JFHEL?:;IK<<?9?;DJ7L;DK;I<EHIJE9A>EB:;HIJEC;7D?D=<KBBO;D=7=;?D
ECF7DO7<<7?HI1>;E7H:8;B?;L;IJ>7JEKH;N?IJ?D==EL;HD7D9;IJHK9JKH;?I?DB?D;M?J>8;IJFH79J?9;I FHECEJ;I:?H;9JEH
799EKDJ78?B?JO FHEJ;9JIIJE9A>EB:;HIW?DJ;H;IJI 7D::;CEDIJH7J;IEKHH;IFEDI?L;D;II7D:M?BB?D=D;IIJE;D=7=;M?J>IJE9A>EB:;HI
7D:JEFHEL?:;J>;CM?J>7C;7D?D=<KBLE?9;,KH9EHFEH7J;=EL;HD7D9;IJHK9JKH;?D9BK:;I
Z !?56A6?56?E@2C5BBE<J>; ECF7DOWI9KHH;DJE7H:C;C8;HI7H;?D:;F;D:;DJ;N9;FJ<EHJ>; ",
Z !?56A6?56?E@>>:EE66D"79>E<J>;E7H:WIJ>H;;A;OIJ7D:?D=9ECC?JJ;;IUJ>;7K:?J9ECC?JJ;; J>;9ECF;DI7J?ED
7D:>KC7DH;IEKH9;I9ECC?JJ;; 7D:J>;DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;;U7H;9ECFH?I;:IEB;BOE<?D:;F;D:;DJ
:?H;9JEHI
Z !?56A6?56?E@2C5$6256CD9:A1>; ECF7DOC7?DJ7?DII;F7H7J; ",7D:E7H:9>7?HHEB;I 7D:J>;E7H:9>7?H?I
9KHH;DJBO7D?D:;F;D:;DJ:?H;9JEH
Z ??F2==64E:@?@7:C64E@CD1>; ECF7DOWI:?H;9JEHIIJ7D:<EH;B;9J?EDED7D7DDK7B87I?I
Z +EC@?8:C64E@C*67C6D9>6?E2?5G2=F2E:@?(C24E:46D4;H;=KB7HBOH;L?;MJ>;9ECFEI?J?EDE<J>;E7H:7D:I;;A
M7OIJE:;;F;D7D:C7?DJ7?DJ>;E7H:WI;NF;HJ?I;4;>7L;7D7DDK7B;L7BK7J?EDFHE9;II<EHJ>;E7H: ;79>E7H:
9ECC?JJ;; 7D:;79>:?H;9JEH
Z (C@IJ446DD0JE9A>EB:;HIC7ODEC?D7J;:?H;9JEHIJ>HEK=>J>;;N?IJ?D=FHENO799;IIH?=>JJ>7J?I9EDI?IJ;DJM?J>C7HA;J
FH79J?9;
Z %2;@C:EJ@7.@E6D2DE+E2?52C51>; ECF7DO>7I7C7@EH?JOE<LEJ;I97IJIJ7D:7H:<EHKD9EDJ;IJ;:;B;9J?EDIE<
:?H;9JEHI7D:7:?H;9JEHH;I?=D7J?EDFEB?9O
Z *6E:C6>6?E(@=:4J+E:?H;9JEHC7O8;DEC?D7J;:<EH;B;9J?EDJEI;HL;7D;MJ;HC7<J;H>7L?D=7JJ7?D;:J>;7=;E<
O;7HI
Z @2C5@>>F?:42E:@?0JE9A>EB:;HIC7O9EDJ79JJ>;E7H: 7DOE7H:9ECC?JJ;; EH7DO?D:?L?:K7B:?H;9JEH
Z +E@4<9@=56C*:89EE@4E3J/C:EE6?@?D6?E0JE9A>EB:;HIC7O79J8OMH?JJ;D9EDI;DJ?D799EH:7D9;M?J>J>;
ECF7DOWI ;HJ?<?97J;E<&D9EHFEH7J?ED7D:8OB7MI
4;;D=7=;H;=KB7HBOM?J>EKHIJE9A>EB:;HIJE:?I9KII=EL;HD7D9;7D:EJ>;HC7JJ;HI JE;DIKH;J>7JC7D7=;C;DJ7D:J>;E7H:
KD:;HIJ7D:7D:7::H;II?IIK;IJ>7J7H;?CFEHJ7DJJEJ>; ECF7DOWIIJE9A>EB:;HI#;;:879A<HECJ>;I;;D=7=;C;DJI?IFHEL?:;:JE
J>;DEC?D7J?D=7D:=EL;HD7D9;9ECC?JJ;;E<J>;E7H: M>?9>?DJKHD:;9?:;IM>;J>;H;D>7D9;C;DJIJEEKH ECF7DOWIFEB?9?;I7D:
FH79J?9;IMEKB:8;7FFHEFH?7J;JEC;;JIJE9A>EB:;H;NF;9J7J?EDI ?D9BK:?D=J>EI;H;B7J?D=JE9KHH;DJ?IIK;IEH;C;H=?D=JH;D:I,KH
7DDK7BIJE9A>EB:;HC;;J?D=7BBEMI:?H;9J<;;:879AJ>HEK=>LEJ?D=ED:?H;9JEHDEC?D;;I ;N;9KJ?L;9ECF;DI7J?ED 7K:?JEHI;B;9J?ED
7D:EJ>;HC7JJ;HI 7IM;BB7I;D=7=;C;DJM?J>C7D7=;C;DJ7D:J>;E7H:
1>;I;9EHFEH7J;=EL;HD7D9;FEB?9?;IFHEL?:;EKHIJE9A>EB:;HIM?J>DKC;HEKIEFFEHJKD?J?;IJE8;>;7H:7D:JE;D=7=;:?H;9JBOM?J>
J>;E7H:&DB?=>JE<J>;I;;N?IJ?D=EFFEHJKD?J?;I<EHIJE9A>EB:;H;D=7=;C;DJ JE=;J>;HM?J>J>;;N?IJ?D=H?=>JIJE97BB7IF;9?7B
C;;J?D=7D:JE79J8OMH?JJ;D9EDI;DJ J>;E7H:8;B?;L;IJ>7J7<KHJ>;HH;:K9;:J>H;I>EB:7D:EHJ>;H;CEL7BE<J>;>EB:?D=F;H?E:7I
H;GK;IJ;:8OJ>;FHEFEI7BMEKB:DEJC7A;7C;7D?D=<KB:?<<;H;D9;?DEKHIJE9A>EB:;HIW78?B?JOJE;D=7=;M?J>J>;E7H:J>7JMEKB:
EKJM;?=>J>;IK8IJ7DJ?7BD;=7J?L;I7IIE9?7J;:M?J>J>;FHEFEI7B
43(1:8.43
#EHJ>;78EL;H;7IEDI J>;E7H:>7I:;J;HC?D;:J>7J?J?IDEJ?DJ>;8;IJ?DJ;H;IJIE<EKHIJE9A>EB:;HIJE7:EFJJ>?IFHEFEI7B!E?D=
IE?IKDD;9;II7HO?DB?=>JE<J>;;N?IJ?D=8OB7MI M>?9>7BBEMIJE9A>EB:;HIM>EEMD7JB;7IJE<EKH9ECCEDIJE9A9EDJ?DKEKIBO
<EH7JB;7IJED;O;7HJE97BB7IF;9?7BC;;J?D=E<IJE9A>EB:;HI7D:FHEL?:;CKBJ?FB;7BJ;HD7J?L;7L;DK;I<EHIJE9A>EB:;HIJE;D=7=;
M?J>J>; ECF7DO7D:J>;E7H:1>;E7H:-&&!%'-+$1KH=;IIJE9A>EB:;HIJELEJ;!&+,J>?IFHEFEI7B
0JE9A>EB:;H7FFHEL7BE<-HEFEI7B+EH;GK?H;IJ>;7<<?HC7J?L;LEJ;E<J>;>EB:;HIE<7C7@EH?JOE<J>;I>7H;IE<9ECCEDIJE9A
>7L?D=LEJ?D=FEM;HFH;I;DJ ?DF;HIEDEHH;FH;I;DJ;:8OFHENO 7JJ>;7DDK7BC;;J?D=
, '*'!*,'*+*'%%&+.',N!&+,O, +,'# '$*(*'('+$
-- 94 of 186 --
Other Voting Matters
We are not aware of any other matters to be submitted at the annual meeting. If any other matters properly come before the annual
meeting, the Proxy Holders intend to vote the shares they represent in their discretion. It is important that your stock holdings be
represented at the meeting, regardless of the number of shares you hold. We urge you to complete, sign, date, and return the
accompanying proxy card in the enclosed postage-paid envelope, or vote your shares by telephone or internet, as described in this
proxy statement.
Lam Research Corporation 2026 Proxy Statement 83
-- 95 of 186 --
$26-1+%1())6-1+1*240%6-21
809<7+>39898-/<8381%963-3>+>398+8.(9>381
+3+6'1
1>;E7H:IEB?9?JIOEKHFHENO<EHJ>;7DDK7BC;;J?D=JE8;>;B:L?HJK7BBOED+EL;C8;H 7J7C-79?<?91?C; EH7J7DO
EJ>;HJ?C;<EBBEM?D=7:@EKHDC;DJEHFEIJFED;C;DJJ>;H;E<6EK7H;?DL?J;:JEF7HJ?9?F7J;?DJ>;7DDK7BC;;J?D=7D:JELEJ;EDJ>;
FHEFEI7BI:;I9H?8;:?DJ>?IFHENOIJ7J;C;DJ
+)46*'8+
,DBOIJE9A>EB:;HIE<H;9EH:7JJ>;9BEI;E<8KI?D;IIED0;FJ;C8;H J>;X/;9EH:!7J;Y 7H;;DJ?JB;:JEH;9;?L;DEJ?9;E<J>;
7DDK7BC;;J?D=7D:JELEJ;EDJ>;FHEFEI7BI:;I9H?8;:?DJ>?IFHENOIJ7J;C;DJ
.'6+79878'3*/3-
IE<J>;/;9EH:!7J; I>7H;IE<9ECCEDIJE9AM;H;EKJIJ7D:?D=
94692
0JE9A>EB:;HI>EB:?D=7C7@EH?JOE<EKHI>7H;IE<9ECCEDIJE9AEKJIJ7D:?D=7D:;DJ?JB;:JELEJ;7JJ>;7DDK7BC;;J?D=CKIJ8;
FH;I;DJ?DF;HIEDEHH;FH;I;DJ;:8OFHENOJE9EDIJ?JKJ;7GKEHKCGKEHKC?IH;GK?H;:JEJH7DI79J8KI?D;II7JJ>;7DDK7BC;;J?D=
3?HJK7B7JJ;D:7D9;7JJ>;7DDK7BC;;J?D=9EDIJ?JKJ;IFH;I;D9;?DF;HIED<EHFKHFEI;IE<7GKEHKC7JJ>;7DDK7BC;;J?D=8IJ;DJ?EDI
7D:8HEA;HDED LEJ;I ?<7DO M?BB8;9EKDJ;:?D:;J;HC?D?D=M>;J>;H7GKEHKC?IFH;I;DJ
375+)8464,1+)8/437
1>; ECF7DO>7I7FFE?DJ;:7C;C8;HE<J>; ECF7DOWIB;=7B:;F7HJC;DJJEI;HL;7I?DIF;9JEHE<;B;9J?EDI7JJ>;7DDK7BC;;J?D=
1>;?DIF;9JEHM?BB:;J;HC?D;M>;J>;H7GKEHKC?IFH;I;DJ7D:J78KB7J;J>;LEJ;I
#48/3-
"79>I>7H;E<9ECCEDIJE9A?I;DJ?JB;:JEED;LEJ;ED;79>:?H;9JEHDEC?D;;7D:;79>EJ>;HC7JJ;HJE8;LEJ;:ED7JJ>;7DDK7B
C;;J?D=0JE9A>EB:;HIC7O97IJLEJ;I8O=H7DJ?D=7FHENO8O&DJ;HD;J J;B;F>ED; EHC7?B8O<EBBEM?D=J>;?DIJHK9J?EDIEDJ>;+EJ?9;
LEJ?D=?DIJHK9J?ED<EHC EHFHENO97H:0JE9A>EB:;HIC7O7BIE97IJLEJ;I8O&DJ;HD;J:KH?D=J>;7DDK7BC;;J?D=
"94(0-41)*74+!*(47)"-&7*8!*,.89*7*).3%4:7&2*&<OEKHI>7H;IE<9ECCEDIJE9A7H;H;=?IJ;H;::?H;9JBO?DOEKHD7C;
M?J>EKHJH7DI<;H7=;DJ ECFKJ;HI>7H;&D9 OEK7H;9EDI?:;H;:JE8; M?J>H;IF;9JJEJ>EI;I>7H;IE<9ECCEDIJE9A J>;IJE9A>EB:;H
E<H;9EH: 7D:J>;I;FHENOC7J;H?7BI7H;8;?D=I;DJ:?H;9JBOJEOEK8OKI
*3*+.(.&1<3*7"-&7*8!*,.89*7*).39-*&2*4+&740*7&,*.72&30479-*742.3**&<OEKHI>7H;IE<9ECCED
IJE9A7H;>;B:8O78HEA;H7=;<?HC 87DA EHEJ>;HDEC?D;; OEK7H;9EDI?:;H;:J>;8;D;<?9?7BEMD;HE<I>7H;IE<9ECCEDIJE9A>;B:
?DXIJH;;JD7C; Y7D:J>;I;FHENOC7J;H?7BI7H;8;?D=<EHM7H:;:JEOEK<HECJ>7J8HEA;H7=;<?HC 87DA EHEJ>;HDEC?D;;
#48/3-64)+*96+7
"L;D?<OEKFB7DJE7JJ;D:J>;7DDK7BC;;J?D= M;H;9ECC;D:J>7JOEKLEJ;OEKHI>7H;IFH?EHJEJ>;C;;J?D=IEJ>7JOEKHLEJ;M?BB8;
9EKDJ;:?<OEKB7J;H:;9?:;DEJJE EH7H;KD78B;JE L?HJK7BBO7JJ;D:J>;7DDK7BC;;J?D=
31.3*:7.3,9-*33:&1**9.3,1>?IO;7HWI7DDK7BC;;J?D=M?BB8;7L?HJK7BC;;J?D=0JE9A>EB:;HIE<H;9EH:C7OLEJ;
;B;9JHED?97BBO:KH?D=J>;C;;J?D=8OL?I?J?D=J>;C;;J?D=M;8I?J;7J?2;=>*5<1*;.185-.;6..=270,86#( 7D:<EBBEM?D=J>;
?DIJHK9J?EDIFHEL?:;:EDJ>;M;8I?J;1ELEJ;:KH?D=J>;C;;J?D= 7IJE9A>EB:;HM?BBD;;:J>; :?=?J9EDJHEBDKC8;H?D9BK:;:EDJ>;?H
+EJ?9;EHFHENO97H:8;D;<?9?7BEMD;HE<I>7H;II>EKB:H;<;HJEJ>;LEJ?D=?DIJHK9J?EDIFHEL?:;:8OJ>;8;D;<?9?7BEMD;HWI8HEA;H7=;
<?HC 87DA EHEJ>;HDEC?D;;>EB:?D=IK9>I>7H;I<EHJ>;8;D;<?9?7BEMD;H&<OEK7H;78;D;<?9?7BEMD;HE<I>7H;I7D:OEKH+EJ?9;EH
LEJ?D=?DIJHK9J?ED<EHC?D:?97J;IJ>7JOEKC7OLEJ;J>EI;I>7H;IJ>HEK=>@@@9;8AB?8=.,86 J>;DOEKC7O7JJ;D: F7HJ?9?F7J;?D
7D:LEJ;7JJ>;7DDK7BC;;J?D=M?J>J>; :?=?J799;II9E:;?D:?97J;:EDJ>7J+EJ?9;EHLEJ?D=?DIJHK9J?ED<EHC3EJ?D=;B;9JHED?97BBO
:KH?D=J>;C;;J?D=8O7IJE9A>EB:;H7I:;I9H?8;:>;H;M?BBH;FB79;7DOFH;L?EKILEJ;IE<J>7JIJE9A>EB:;HIK8C?JJ;:8OFHENO
-- 96 of 186 --
In Advance of the Annual Meeting. If you are a stockholder of record, you may vote in advance of the meeting in any of the
following ways:
• over the Internet by visiting www.proxyvote.com and following the instructions provided on the website;
• over the telephone by calling 1-800-690-6903 and following the instructions provided in the recorded message; and
• by mail by returning a completed, signed, and dated proxy card in the enclosed postage-paid envelope.
If you are a beneficial owner, you may direct your brokerage firm, bank, or other nominee how to vote in advance of the annual
meeting by following the instructions in your voting instruction form.
Effect of Not Casting Your Vote
Stockholder of Record: Shares Registered in Your Name. If you are a stockholder of record and do not vote in one of the ways
described above, your shares will not be voted at the annual meeting and will not be counted toward the quorum requirement.
Beneficial Owner: Shares Registered in the Name of a Brokerage Firm, Bank, or Other Nominee. If you are the beneficial
owner and do not direct your brokerage firm, bank, or other nominee how to vote your shares, your brokerage firm, bank, or other
nominee will only be able to vote your shares with respect to proposals considered to be “routine.” Your brokerage firm, bank, or other
nominee is not entitled to vote your shares with respect to “non-routine” proposals, which we refer to as a “broker non-vote.” Whether
a proposal is considered routine or non-routine is subject to stock exchange rules and final determination by the stock exchange.
Even with respect to routine matters, some brokers are choosing not to exercise discretionary voting authority. As a result, we urge
you to direct your brokerage firm, bank, or other nominee how to vote your shares on all proposals to ensure that your vote is
counted.
Changing Your Vote
Stockholders of record may revoke their proxy or change their votes at any time before the polls close by (1) properly submitting a
later-dated proxy by the Internet, telephone, or mail by returning a proxy card, (2) timely delivering a later-dated written notice of
revocation or properly completed proxy card to the Company’s Secretary at our principal executive offices at 4650 Cushing Parkway,
Fremont, California 94538, or (3) submitting a vote electronically during the annual meeting. A beneficial owner of shares held in
street name may revoke or change any prior voting instructions by contacting the stockholder of record (i.e., the bank, brokerage firm,
or other nominee holding your shares) or submitting a vote electronically during the annual meeting.
Voting Instructions
If a stockholder properly votes over the Internet, by telephone, or by returning a signed and dated proxy card, the Proxy Holders will
vote the shares represented by such proxy in accordance with the stockholder’s voting instructions. If a stockholder properly votes
over the Internet, by telephone, or by returning a signed and dated proxy card but does not provide specific voting instructions, the
Proxy Holders will vote the shares represented by such proxy in accordance with the Board’s recommendations. Such shares will be
counted toward the quorum requirement.
We are not aware of any matters to be presented at the annual meeting other than those described in this proxy statement. If any
other matters are properly presented for consideration at the annual meeting, the Proxy Holders will vote on those matters in their
discretion.
Voting on Proposals
The matters to be voted on at the annual meeting, the Board’s recommendation, the applicable voting standard, and treatment of
abstentions and broker non-votes, if any, are as follows:
Lam Research Corporation 2026 Proxy Statement 85
-- 97 of 186 --
!E6>D@7FD:?6DD
@2C5
*64@>>6?52E:@?
.@E:?8
+E2?52C5
,C62E>6?E@7
3DE6?E:@?D
,C62E>6?E@7C@<6C&@?
.@E6D !7?J
"B;9J?EDE<:?H;9JEHDEC?D;;IJE
I;HL;KDJ?BJ>;D;NJ7DDK7BC;;J?D=E<
IJE9A>EB:;HI7D:KDJ?BJ>;?HH;IF;9J?L;
IK99;IIEHI7H;;B;9J;:7D:GK7B?<?;:
'*6249
:C64E@C&@>:?66
*7@EH?JOE<LEJ;I
97IJ
+E;<<;9JEDJ>;
EKJ9EC;
+E;<<;9JEDJ>;EKJ9EC;
:L?IEHOLEJ;JE7FFHEL;EKHD7C;:
;N;9KJ?L;E<<?9;H9ECF;DI7J?ED
'* *7@EH?JOE<
LEJ?D=FEM;H
FH;I;DJ
07C;;<<;9J7I
X7=7?DIJYLEJ;
+E;<<;9JEDJ>;EKJ9EC;
/7J?<?97J?EDE<J>;7FFE?DJC;DJE<(-*$
))-7IEKH?D:;F;D:;DJH;=?IJ;H;:
FK8B?9799EKDJ?D=<?HC<EH<?I97BO;7H
'* *7@EH?JOE<
LEJ?D=FEM;H
FH;I;DJ
07C;;<<;9J7I
X7=7?DIJYLEJ;
+E;<<;9JEDJ>;EKJ9EC;
0JE9A>EB:;HFHEFEI7B ?<FHEF;HBO
FH;I;DJ;:7JJ>;7DDK7BC;;J?D=
!&+, *7@EH?JOE<
LEJ?D=FEM;H
FH;I;DJ
07C;;<<;9J7I
X7=7?DIJYLEJ;
+E;<<;9JEDJ>;EKJ9EC;
DEC?D;;M?BB8;;B;9J;:7I7:?H;9JEH7JJ>;7DDK7BC;;J?D=EDBO?<J>;LEJ;I97IJ<EHIK9>DEC?D;;WI;B;9J?ED;N9;;:J>;LEJ;I97IJ7=7?DIJIK9>
DEC?D;;WI;B;9J?ED&<7D?D9KC8;DJ<7?BIJEH;9;?L;J>;H;GK?H;:C7@EH?JO J>;?HFH;L?EKIBOIK8C?JJ;:H;I?=D7J?EDM?BB8;FHECFJBO9EDI?:;H;:8OJ>;
E7H:8IJ;DJ?EDI7D:8HEA;HDED LEJ;I ?<7DO M?BBDEJ8;9EKDJ;:7ILEJ;I97IJEDJ>;C7JJ;H7D:M?BB>7L;DE;<<;9JEDJ>;EKJ9EC;E<J>;
;B;9J?ED0JE9A>EB:;HI:EDEJ>7L;9KCKB7J?L;LEJ?D=H?=>JI<EHJ>;;B;9J?EDE<:?H;9JEHI
1>;7<<?HC7J?L;LEJ;E<J>;>EB:;HIE<7C7@EH?JOE<J>;I>7H;IE<9ECCEDIJE9A>7L?D=LEJ?D=FEM;HFH;I;DJ ?DF;HIEDEHH;FH;I;DJ;:8OFHENO 7J
J>;7DDK7BC;;J?D=
#48/3-(= 01'3'68/)/5'387
&<OEK7H;7F7HJ?9?F7DJ?D)7CWI07L?D=I-BKI-B7D )7C/;I;7H9>A J>;XA -B7DY M>E>;B:I>7H;IE<9ECCEDIJE9A?D
OEKHF;HIED7BA -B7D799EKDJ7IE<J>;/;9EH:!7J; OEKC7OLEJ; 8OFHENO OEKH?DJ;H;IJ?DJ>EI;I>7H;I7I>;B:8OJ>;A
-B7D8O<EBBEM?D=J>;?DIJHK9J?EDI<EH&DJ;HD;JEHJ;B;F>ED;LEJ?D=EDJ>;FHENO97H: EH8OH;JKHD?D=79ECFB;J;: I?=D;: 7D::7J;:
FHENO97H:?DJ>;;D9BEI;:FEIJ7=; F7?:;DL;BEF;1>;A -B7DJHKIJ;;M?BBLEJ;?D799EH:7D9;M?J>OEKH?DIJHK9J?EDI6EKHLEJ?D=
?DIJHK9J?EDICKIJ8;H;9;?L;:8ODEB7J;HJ>7DFC"7IJ;HD1?C;ED,9JE8;H &<OEKHLEJ?D=?DIJHK9J?EDI7H;DEJ
H;9;?L;:8OJ>7JJ?C; OEKHI>7H;IE<9ECCEDIJE9AM?BB8;LEJ;:8OJ>;A -B7DJHKIJ;;?D799EH:7D9;M?J>J>;A -B7D
:E9KC;DJI=;D;H7BBO?DJ>;I7C;FHEFEHJ?ED7IJ>;JHKIJ;;LEJ;IJ>EI;I>7H;I<EHM>?9>?JH;9;?L;:J?C;BOLEJ?D=?DIJHK9J?EDI
#48/3-+79187
4;M?BB7DDEKD9;FH;B?C?D7HOLEJ?D=H;IKBJI7JJ>;7DDK7BC;;J?D=7D:H;FEHJ<?D7BLEJ?D=H;IKBJI?D79KHH;DJH;FEHJED#EHC (M?J>?D
<EKH8KI?D;II:7OI7<J;HJ>;7DDK7BC;;J?D=
:'/1'(/1/8=4,64<='8+6/'17
1>;+EJ?9;E<DDK7B*;;J?D=E<0>7H;>EB:;HI J>;FHENOIJ7J;C;DJ7D:J>;799ECF7DO?D=FHENO97H: 7D:DDK7B
/;FEHJ7H;<?HIJ8;?D=C7:;7L7?B78B;EHC7?B;:JEEKHIJE9A>EB:;HI;DJ?JB;:JELEJ;7JJ>;7DDK7BC;;J?D=EDEH78EKJ0;FJ;C8;H
1>;FHENOC7J;H?7BIM?BB8;C7?B;:JEIJE9A>EB:;HIM>E>7L;:;I?=D7J;:7FH;<;H;D9;<EH7FH?DJ;:9EFO0JE9A>EB:;HIM>E
FH;L?EKIBO9>EI;JEH;9;?L;FHENOC7J;H?7BI;B;9JHED?97BBOM?BB8;I;DJ7D;C7?BM?J>?DIJHK9J?EDIED>EMJE799;IIJ>?IO;7HWIFHENO
C7J;H?7BI7D:J>;FHENOLEJ?D=M;8I?J;
4;>7L;7BIEFHEL?:;:EKHIJE9A>EB:;HI799;IIJEEKHFHENOC7J;H?7BIEL;HJ>;&DJ;HD;J?D799EH:7D9;M?J>HKB;I7D:H;=KB7J?EDI
7:EFJ;:8OJ>;0" 1>;I;C7J;H?7BI7H;7L7?B78B;EDEKHM;8I?J;7J27?.<=8;5*6;.<.*;,1,864;M?BB<KHD?I> M?J>EKJ9>7H=; 7
FH?DJ;:9EFOE<J>;I;C7J;H?7BI7D:EKHDDK7B/;FEHJ?D9BK:?D=;N>?8?JI EDH;GK;IJ8OJ;B;F>ED; 8OC7?BJE
&DL;IJEH/;B7J?EDI )7C/;I;7H9> EHFEH7J?ED KI>?D=-7HAM7O #H;CEDJ 7B?<EHD?7 EH8O;C7?BJE
27?.<=8;;.5*=287<5*6;.<.*;,1,86
48/)+4,38+63+8:'/1'(/1/8=
4;7H;<KHD?I>?D=J>;FHENOC7J;H?7BIJEEKHIJE9A>EB:;HIFH?C7H?BOL?7J>;&DJ;HD;J?DIJ;7:E<C7?B?D=FH?DJ;:9EF?;I1>?IFHE9;II
7BBEMIKIJE;NF;:?J;EKHIJE9A>EB:;HIWH;9;?FJE<FHENOC7J;H?7BI BEM;HJ>;9EIJIE<FH?DJ?D=7D:C7?B?D=J>;FHENOC7J;H?7BI 7D:
H;:K9;J>;;DL?HEDC;DJ7B?CF79JE<EKH7DDK7BC;;J?D=&<OEKH;9;?L;:7+EJ?9;E<&DJ;HD;JL7?B78?B?JOE<-HENO*7J;H?7BIJ>;
X+EJ?9;Y OEKM?BBDEJH;9;?L;7FH?DJ;:9EFOE<J>;FHENOC7J;H?7BIKDB;IIOEKH;GK;IJED;1>;+EJ?9;FHEL?:;I?DIJHK9J?EDIED>EM
JE799;IIJ>;FHENOC7J;H?7BI<EHJ>;7DDK7BC;;J?D=L?7J>;&DJ;HD;J >EMJEH;GK;IJ7FH?DJ;:I;JE<FHENOC7J;H?7BI 7D:>EMJELEJ;
OEKHI>7H;I1>;+EJ?9;7BIEFHEL?:;I?DIJHK9J?EDIED>EMJE;B;9JJEH;9;?L;7BB<KJKH;FHENOC7J;H?7BI;B;9JHED?97BBOEH?DFH?DJ;:
<EHC&<OEK9>EEI;JEH;9;?L;<KJKH;FHENOC7J;H?7BI;B;9JHED?97BBO OEKM?BBH;9;?L;7D;C7?B;79>O;7HM?J>?DIJHK9J?EDIED>EMJE
799;IIJ>;FHENOC7J;H?7BI7D:FHENOLEJ?D=I?J;
-- 98 of 186 --
64<= 41/)/8'8/434787
1>; ECF7DOM?BB8;7HJ>;9EIJE<7BBFHENOIEB?9?J7J?ED79J?L?J?;I,KH:?H;9JEHI E<<?9;HI 7D:EJ>;H;CFBEO;;IC7OIEB?9?JFHEN?;I
F;HIED7BBOEH8OJ;B;F>ED; ;C7?B EHEJ>;H9ECCKD?97J?EDC;7DI M?J>EKJ7DO9EIJJE)7C/;I;7H9>&D7::?J?ED M;>7L;H;J7?D;:
!#(?D= E &D9JE7II?IJ?DE8J7?D?D=FHEN?;I8OC7?B <79I?C?B; EH;C7?B<HEC8HEA;HI 87DADEC?D;;I 7D:EJ>;H?DIJ?JKJ?EDI<EH
J>;7DDK7BC;;J?D=1>;;IJ?C7J;:9EIJE<IK9>I;HL?9;I?I FBKIH;7IED78B;EKJ E< FE9A;J;NF;DI;I4;7H;H;GK?H;:JE
H;GK;IJJ>7J8HEA;HI7D:EJ>;HDEC?D;;IM>E>EB:IJE9A?DJ>;?HD7C;I<KHD?I>EKHFHENOC7J;H?7BIJEJ>;8;D;<?9?7BEMD;HIE<J>;
IJE9A 7D:M;CKIJH;?C8KHI;J>;I;8HEA;HI7D:EJ>;HDEC?D;;I<EHJ>;;NF;DI;IE<:E?D=IE?D799EH:7D9;M?J>IJ7JKJEHO<;;
I9>;:KB;I
">2/< //>381809<7+>398
#/689'1++8/3-
4;7H;KJ?B?P?D=7L?HJK7BC;;J?D=<EHC7J<EHEKH7DDK7BC;;J?D=JEFHEL?:;79EDI?IJ;DJ;NF;H?;D9;JE7BBIJE9A>EB:;HIH;=7H:B;IIE<
=;E=H7F>?9BE97J?EDL?HJK7BC;;J?D=7BIE;D>7D9;IIJE9A>EB:;H799;II7D:;D=7=;C;DJ7D:H;:K9;IJ>;;DL?HEDC;DJ7B?CF79JE<
EKH7DDK7BC;;J?D=&DIJHK9JKH?D=EKHL?HJK7B7DDK7BC;;J?D= EKH=E7B?IJE;D>7D9;H7J>;HJ>7D9EDIJH7?DIJE9A>EB:;HF7HJ?9?F7J?ED?D
J>;C;;J?D= 7D:M;>7L;:;I?=D;:J>;C;;J?D=JEFHEL?:;IJE9A>EB:;HIM?J>J>;I7C;H?=>JI7D:EFFEHJKD?J?;IJEF7HJ?9?F7J;7IJ>;O
MEKB:>7L;7J7D?D F;HIEDC;;J?D=
'68/)/5'8/3-/38.+339'1++8/3-
BBIJE9A>EB:;HIE<H;9EH:7IE<J>;9BEI;E<8KI?D;IIEDJ>;/;9EH:!7J;7H;;DJ?JB;:JE7JJ;D: F7HJ?9?F7J;?D 7D:LEJ;7JJ>;7DDK7B
C;;J?D=L?HJK7BBO1E7JJ;D:7D:F7HJ?9?F7J;?DJ>;7DDK7BC;;J?D= ?D9BK:?D=JELEJ;7D:7IAGK;IJ?EDI IJE9A>EB:;HIE<H;9EH:I>EKB:
L?I?JJ>;C;;J?D=M;8I?J;7J?2;=>*5<1*;.185-.;6..=270,86#( ;DJ;HJ>; :?=?J9EDJHEBDKC8;H?D9BK:;:EDJ>;?H+EJ?9;EH
FHENO97H: 7D:<EBBEMJ>;?DIJHK9J?EDIEDJ>;M;8I?J;&<OEK7H;78;D;<?9?7BEMD;HE<I>7H;I>;B:?DIJH;;JD7C;7D:OEKH+EJ?9;EH
LEJ?D=?DIJHK9J?ED<EHC?D:?97J;IJ>7JOEKC7OLEJ;J>EI;I>7H;IJ>HEK=>@@@9;8AB?8=.,86 J>;DOEKC7O7JJ;D: F7HJ?9?F7J;?D
7D:LEJ;7JJ>;7DDK7BC;;J?D=M?J>J>; :?=?J799;II9E:;?D:?97J;:EDJ>7J+EJ?9;EHLEJ?D=?DIJHK9J?ED<EHC,J>;HM?I;
IJE9A>EB:;HIM>E>EB:J>;?HI>7H;I?DIJH;;JD7C;I>EKB:9EDJ79JJ>;?H8HEA;H7=;<?HC 87DA EHEJ>;HDEC?D;;FH;<;H78BO7JB;7IJ<?L;
:7OI8;<EH;J>;7DDK7BC;;J?D= 7D:E8J7?D7XB;=7BFHENOY?DEH:;HJE8;78B;JE7JJ;D: F7HJ?9?F7J;?D EHLEJ;7JJ>;7DDK7BC;;J?D=
70/3-9+78/437
0JE9A>EB:;HIM>EM?I>JEIK8C?J7GK;IJ?ED:KH?D=J>;7DDK7BC;;J?D=C7OBE=?DJEJ>;L?HJK7BC;;J?D=FB7J<EHC7J
?2;=>*5<1*;.185-.;6..=270,86#( 8;=?DD?D=7J7C-79?<?91?C;ED+EL;C8;H JOF;J>;?HGK;IJ?EDM>;H;
?D:?97J;: 7D:9B?9AJEIK8C?J
4;7IAJ>7JOEKB?C?JOEKHGK;IJ?EDIJEJ>EI;J>7J7H;H;B;L7DJJEJ>;7DDK7BC;;J?D=EHEKH8KI?D;II7D:J>7J9ECFBOM?J>J>;7DDK7B
C;;J?D=HKB;IE<9ED:K9J.K;IJ?EDIC7ODEJ8;7::H;II;:?<J>;O7H; 7CED=EJ>;HJ>?D=I ?HH;B;L7DJJEEKH8KI?D;II H;B7J;:JE
F;D:?D=EHJ>H;7J;D;:B?J?=7J?ED :?IEH:;HBO EHH;F;J?J?EKIE<IJ7J;C;DJI7BH;7:OC7:;&D7::?J?ED GK;IJ?EDIC7O8;=HEKF;:8OJEF?9
8OEKHC7D7=;C;DJ.K;IJ?EDIM?BB8;7::H;II;::KH?D=J>;7FFHEFH?7J;FEHJ?EDIE<J>;C;;J?D= 7D:M;C7O7BIEH;IFED:8O
FEIJ?D=7DIM;HIEDEKHM;8I?J;7<J;HJ>;7DDK7BC;;J?D=
84)0.41*+6))49387 .'6/3-8.+ '2+'78'2+'3***6+77 84)0.41*+6741*/3-918/51+
))49387
1EH;:K9;J>;;NF;DI;E<:;B?L;H?D=:KFB?97J;FHENOC7J;H?7BIJEIJE9A>EB:;HIM>EC7O>7L;CEH;J>7DED;799EKDJ>EB:?D=)7C
/;I;7H9>IJE9A8KJM>EI>7H;J>;I7C;7::H;II M;>7L;7:EFJ;:7FHE9;:KH;7FFHEL;:8OJ>;0" 97BB;:X>EKI;>EB:?D=Y2D:;H
J>?IFHE9;:KH; IJE9A>EB:;HIE<H;9EH:M>E>7L;J>;I7C;7::H;II7D:B7IJD7C;M?BBH;9;?L;EDBOED;9EFOE<EKHFHENOIJ7J;C;DJ
7D:7DDK7BH;FEHJKDB;IIED;E<J>;IJE9A>EB:;HIDEJ?<?;IEKH?DL;IJEHH;B7J?EDI:;F7HJC;DJJ>7JED;EHCEH;E<J>;CM7DJJEH;9;?L;
I;F7H7J;9EF?;I1>?IFHE9;:KH;H;:K9;I:KFB?97J;C7?B?D=I7D:J>;H;<EH;I7L;IFH?DJ?D=7D:C7?B?D=9EIJI 7IM;BB7ID7JKH7B
H;IEKH9;I0JE9A>EB:;HIM>EF7HJ?9?F7J;?D>EKI;>EB:?D=M?BB9EDJ?DK;JE>7L;799;IIJE7BBFHENOC7J;H?7BI7J
27?.<=8;5*6;.<.*;,1,86 7IM;BB7IJ>;78?B?JOJEIK8C?JI;F7H7J;FHENOLEJ?D=?DIJHK9J?EDI<EH;79>799EKDJJ>HEK=>J>;?DJ;HD;JEH
8OJ;B;F>ED;
0JE9A>EB:;HI>EB:?D=CKBJ?FB;799EKDJIE<)7C9ECCEDIJE9AC7OH;GK;IJI;F7H7J;9EF?;IE<J>;FHENOC7J;H?7BI8O9EDJ79J?D=KI
8OJ;B;F>ED; 8OC7?BJE&DL;IJEH/;B7J?EDI )7C/;I;7H9> EHFEH7J?ED KI>?D=-7HAM7O #H;CEDJ 7B?<EHD?7
EH8O;C7?BJE27?.<=8;;.5*=287<5*6;.<.*;,1,86 0JE9A>EB:;HIC7O7BIE9EDJ79JKI8OJ;B;F>ED; C7?BEH;C7?BJEH;GK;IJ
9EDIEB?:7J?EDE<FHENOC7J;H?7BIC7?B;:JECKBJ?FB;799EKDJI7JJ>;I7C;7::H;II
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 99 of 186 --
Stockholder-Initiated Proposals and Nominations for 2027 Annual Meeting
Proposals submitted under SEC rules for inclusion in the Company’s proxy statement. Stockholder-initiated proposals (other
than director nominations) may be eligible for inclusion in our proxy statement for next year’s 2027 annual meeting of stockholders (in
accordance with SEC Rule 14a-8) and for consideration at the 2027 annual meeting of stockholders. The Company must receive a
stockholder proposal no later than May 27, 2027 for the proposal to be eligible for inclusion under SEC Rules. Any stockholder
interested in submitting a proposal or nomination is advised to contact legal counsel familiar with the detailed securities law
requirements for submitting proposals or nominations for inclusion in a company’s proxy statement.
Proposed nominations of directors under Company bylaws for Proxy Access. Our bylaws provide for “Proxy Access.” Pursuant
to the Proxy Access provisions of our bylaws, a stockholder, or a group of up to 20 stockholders, owning at least 3% of our
outstanding common stock continuously for at least three years can nominate and include in our proxy materials director nominees
constituting up to the greater of two individuals or 20% of the Board, provided that the stockholders and the nominees satisfy the
requirements specified in our bylaws. If a stockholder or group of stockholders wishes to nominate one or more director candidates to
be included in our proxy statement for the 2027 annual meeting of stockholders pursuant to Proxy Access, all of the information
required by our bylaws must be received by the Secretary of the Company no earlier than April 27, 2027, and no later than May 27,
2027.
Proposals and nominations under Company bylaws for presentation at the annual meeting but for which the proponent
does not seek to include materials in our proxy statement. Stockholders may also submit proposals for consideration and
nominations of director candidates for election at the 2027 annual meeting by following certain requirements set forth in our bylaws.
These proposals will not be eligible for inclusion in the Company’s proxy statement for the 2027 annual meeting of stockholders
unless they are submitted in compliance with then applicable SEC rules or pursuant to the Proxy Access described above; however,
they will be presented for consideration at the 2027 annual meeting of stockholders if the requirements established by our bylaws for
stockholder proposals and nominations have been satisfied.
Our bylaws establish requirements for stockholder proposals and nominations not included in our proxy statement to be considered at
the annual meeting. Assuming that the 2027 annual meeting of stockholders takes place at roughly the same date next year as the
2026 annual meeting (and subject to any change in our bylaws—which would be publicly disclosed by the Company—and to any
provisions of then-applicable SEC rules), a stockholder of record not seeking to include materials in our proxy statement must submit
the proposal or nomination in writing and it must be received by the Secretary of the Company no earlier than July 11, 2027, and no
later than August 10, 2027.
In addition to satisfying the requirements under our bylaws and providing the information required thereunder to the Company,
stockholders who intend to solicit proxies in support of director nominees other than our nominees must provide notice that sets forth
any additional information required by Rule 14a-19 under the Exchange Act to comply with the universal proxy rules, which notice
must be postmarked or transmitted electronically to us at our principal executive offices no later than September 6, 2027. However, if
the date of the 2027 annual meeting is changed by more than 30 calendar days from the anniversary date of the 2026 annual
meeting, then notice must be provided by the later of 60 calendar days prior to the date of the 2027 annual meeting or the 10th
calendar day following the day on which public announcement of the date of the 2027 annual meeting is first made.
For a full description of the requirements for submitting a proposal or nomination, see the Company’s bylaws. Submissions or
questions should be sent to: Secretary, Lam Research Corporation, 4650 Cushing Parkway, Fremont, California 94538.
Lam Research Corporation
4650 Cushing Parkway
Fremont, California
Telephone: 510-572-0200
Dated: September 24, 2026
88
-- 100 of 186 --
33)1(-')5
::/8.3BF809<7+>398$/1+<.381!98#38+8-3+6 /+=?</=
1>; ECF7DOH;FEHJI?JI<?D7D9?7BH;IKBJI?D799EH:7D9;M?J>799EKDJ?D=FH?D9?FB;I=;D;H7BBO799;FJ;:?DJ>;2D?J;:0J7J;IX$-Y
%EM;L;H J>; ECF7DOWIC7D7=;C;DJKI;I9;HJ7?DDED $-<?D7D9?7BC;7IKH;IJE;L7BK7J;J>; ECF7DOWIEF;H7J?D=7D:<?D7D9?7B
H;IKBJI1>; ECF7DO8;B?;L;IJ>;FH;I;DJ7J?EDE<DED $-H;IKBJI?IKI;<KBJE?DL;IJEHI<EH7D7BOP?D=8KI?D;IIJH;D:I7D:
9ECF7H?D=F;H<EHC7D9;JEFH?EHF;H?E:I 7BED=M?J>;D>7D9?D=?DL;IJEHIW78?B?JOJEL?;MJ>; ECF7DOWIH;IKBJI<HECC7D7=;C;DJWI
F;HIF;9J?L;1>;I;DED $-<?D7D9?7BC;7IKH;I7H;FHEL?:;:7IIKFFB;C;DJ7B?D<EHC7J?EDJEJ>;<?D7D9?7BC;7IKH;IJ>; ECF7DO
:?I9BEI;IJ>7J7H;97B9KB7J;:7D:FH;I;DJ;:?D799EH:7D9;M?J>$-+ED $-<?D7D9?7BC;7IKH;II>EKB:DEJ8;9EDI?:;H;:7
IK8IJ?JKJ;<EH EHIKF;H?EHJE <?D7D9?7BC;7IKH;I:;J;HC?D;:EH97B9KB7J;:?D799EH:7D9;M?J>$-1>; ECF7DOWI:;<?D?J?EDIE<?JI
DED $-<?D7D9?7BC;7IKH;IC7ODEJ8;9ECF7H78B;JEI?C?B7HBOJ?JB;:C;7IKH;IH;FEHJ;:8OEJ>;H9ECF7D?;I
1>;9ECF;DI7J?ED7D:>KC7DH;IEKH9;I9ECC?JJ;;>7I;B;9J;:JEKI;8EJ>DED $-=HEIIC7H=?D7I7F;H9;DJ7=;E<H;L;DK;
7D:DED $-EF;H7J?D=?D9EC;7I7F;H9;DJ7=;E<H;L;DK;?D9EDD;9J?EDM?J>7II;II?D=7D:C7A?D=:;J;HC?D7J?EDIH;B7J;:JE
;N;9KJ?L;9ECF;DI7J?EDC7JJ;HI+ED $-=HEIIC7H=?D7I7F;H9;DJ7=;E<H;L;DK;?I:;J;HC?D;:8O:?L?:?D=DED $-=HEII
C7H=?D M>?9>?I7DED $-<?D7D9?7BC;7IKH; 8OH;L;DK; M>?9>?I7$-<?D7D9?7BC;7IKH;1>;$-C;7IKH;CEIJ:?H;9JBO
9ECF7H78B;JEDED $-=HEIIC7H=?D?I$-=HEIIC7H=?D+ED $-=HEIIC7H=?D?D9BK:;I7:@KIJC;DJIJEJ>;CEIJ
9ECF7H78B;$-<?D7D9?7BC;7IKH; $-=HEIIC7H=?D JE;N9BK:;J>;?CF79JE<9;HJ7?D?J;CI7I<KHJ>;H?D:?97J;:8;BEM
&D7::?J?ED DED $-EF;H7J?D=?D9EC;7I7F;H9;DJ7=;E<H;L;DK;?I:;J;HC?D;:8O:?L?:?D=DED $-EF;H7J?D=?D9EC; M>?9>?I
7DED $-<?D7D9?7BC;7IKH; 8OH;L;DK; M>?9>?I7$-<?D7D9?7BC;7IKH;1>;$-C;7IKH;CEIJ:?H;9JBO9ECF7H78B;JE
DED $-EF;H7J?D=?D9EC;?I$-EF;H7J?D=?D9EC;+ED $-EF;H7J?D=?D9EC;?D9BK:;I7:@KIJC;DJIJEJ>;CEIJ9ECF7H78B;
$-<?D7D9?7BC;7IKH; $-EF;H7J?D=?D9EC; JE;N9BK:;J>;?CF79JE<9;HJ7?D?J;CI7I<KHJ>;H?D:?97J;:8;BEM
436477'6-/3'7'+6)+38'-+4,+:+39+
+ED $-=HEIIC7H=?D7I7F;H9;DJ7=;E<H;L;DK;?I:;H?L;:<HECH;IKBJI:;J;HC?D;:?D799EH:7D9;M?J>$-M?J>9>7H=;I7D:
9H;:?JI?DJ>;<EBBEM?D=B?D;?J;CI;N9BK:;:<HEC$-H;IKBJI
Z <EH97B;D:7HO;7H7CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:J>HEK=>9;HJ7?D8KI?D;II9EC8?D7J?EDI7D:
;B;9J?L;:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JO?D9H;7I;
435+6'8/3-3)42+'7'+6)+38'-+4,+:+39+
+ED $-EF;H7J?D=?D9EC;7I7F;H9;DJ7=;E<H;L;DK;?I:;H?L;:<HECH;IKBJI:;J;HC?D;:?D799EH:7D9;M?J>$-M?J>9>7H=;I
7D:9H;:?JI?DJ>;<EBBEM?D=B?D;?J;CI;N9BK:;:<HEC$-H;IKBJI
Z <EH<?I97BO;7H7CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:J>HEK=>9;HJ7?D8KI?D;II9EC8?D7J?EDI;B;9J?L;
:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JO?D9H;7I;MEHA<EH9;EFJ?C?P7J?ED9>7H=;I7D:?CF7?HC;DJE<BED= B?L;:7II;JI
Z <EH<?I97BO;7H7CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:J>HEK=>9;HJ7?D8KI?D;II9EC8?D7J?EDI7D:;B;9J?L;
:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JO?D9H;7I;
Z <EH97B;D:7HO;7H7CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:J>HEK=>9;HJ7?D8KI?D;II9EC8?D7J?EDI;B;9J?L;
:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JO?D9H;7I;7D:?CF7?HC;DJE<BED= B?L;:7II;JI
Z <EH<?I97BO;7H7CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:J>HEK=>9;HJ7?D8KI?D;II9EC8?D7J?EDI;B;9J?L;
:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JO?D9H;7I;H;IJHK9JKH?D=9>7H=;I D;JJH7DI<EHC7J?ED7B9EIJI7D:?CF7?HC;DJE<BED=
B?L;:7II;JI
Z <EH<?I97BO;7H7CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:J>HEK=>9;HJ7?D8KI?D;II9EC8?D7J?EDI;B;9J?L;
:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JO?D9H;7I;H;IJHK9JKH?D=9>7H=;I D;JFHE:K9JH7J?ED7B?P7J?ED9EIJI7D:
JH7DI<EHC7J?ED7B9EIJI7D:
Z <EH<?I97BO;7H7CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:J>HEK=>9;HJ7?D8KI?D;II9EC8?D7J?EDI7D:;B;9J?L;
:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JO:;9H;7I;
)7C/;I;7H9> EHFEH7J?ED-HENO0J7J;C;DJ
-- 101 of 186 --
#>9!98#$/-98-363+>398<9== +<138
1>;<EBBEM?D=7H;H;9ED9?B?7J?EDIE<$-=HEIIC7H=?DJEDED $-=HEIIC7H=?D 7IM;BB7I7FH;I;DJ7J?EDE<$-=HEIIC7H=?D
7I7F;H9;DJ7=;E<H;L;DK;7D:DED $-=HEIIC7H=?D7I7F;H9;DJ7=;E<H;L;DK; <EH97B;D:7HO;7H
-?2F5:E65
:?E9@FD2?5D 6I46AEA6C46?E286D
2=6?52C162C
- + (8C@DD>2C8:?
-H; J7NDED $-?J;CI
CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:J>HEK=>9;HJ7?D8KI?D;II9EC8?D7J?EDI
"B;9J?L;:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JOL7BK7J?ED?D9H;7I;
&@? (8C@DD>2C8:?
- + (8C@DD>2C8:?2DA6C46?E@7C6G6?F6
&@? (8C@DD>2C8:?2D2A6C46?E@7C6G6?F6
#>9!98#$/-98-363+>398":/<+>3818-97/
1>;<EBBEM?D=7H;H;9ED9?B?7J?EDIE<$-EF;H7J?D=?D9EC;JEDED $-EF;H7J?D=?D9EC; 7IM;BB7I7FH;I;DJ7J?EDE<$-
EF;H7J?D=?D9EC;7I7F;H9;DJ7=;E<H;L;DK;7D:DED $-EF;H7J?D=?D9EC;7I7F;H9;DJ7=;E<H;L;DK; <EHJ>;<?I97BO;7HI
;D:;:'KD; 'KD; 'KD; 'KD; 'KD; 7D:97B;D:7HO;7H
-?2F5:E65
:?E9@FD2?5D 6I46AEA6C46?E286D
:D42=162C?565
"F?6 "F?6 "F?6 "F?6 "F?6
- + (@A6C2E:?8:?4@>6
-H; J7NDED $-?J;CI
CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:
J>HEK=>9;HJ7?D8KI?D;II9EC8?D7J?EDI
"B;9J?L;:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JO
L7BK7J?ED?D9H;7I;:;9H;7I;
/;IJHK9JKH?D=9>7H=;I D;J U U U
-HE:K9JH7J?ED7B?P7J?ED9EIJI U U U U
1H7DI<EHC7J?ED7B9EIJI U U U
4EHA<EH9;EFJ?C?P7J?ED9>7H=;I U U U U
&CF7?HC;DJE<BED= B?L;:7II;JI U U U
&@? (@A6C2E:?8:?4@>6
- + (@A6C2E:?8:?4@>62DA6C46?E@7C6G6?F6
&@? (@A6C2E:?8:?4@>62D2A6C46?E@7C6G6?F6
2=6?52C162C
- + (@A6C2E:?8:?4@>6
-H; J7NDED $-?J;CI
CEHJ?P7J?EDH;B7J;:JE?DJ7D=?8B;7II;JI79GK?H;:J>HEK=>9;HJ7?D8KI?D;II9EC8?D7J?EDI
"B;9J?L;:;<;HH;:9ECF;DI7J?ED H;B7J;:B?78?B?JOL7BK7J?ED?D9H;7I;
&CF7?HC;DJE<BED= B?L;:7II;JI
&@? (@A6C2E:?8:?4@>6
- + (@A6C2E:?8:?4@>62DA6C46?E@7C6G6?F6
&@? (@A6C2E:?8:?4@>62D2A6C46?E@7C6G6?F6
-- 102 of 186 --
'!&%&&%
%'$&%!*!" %%"!
).@56;4A<;
"$
'6G@)C:
!!'$#"$&#'$%'!&&"%&"! "$ 1"&%'$&%*!&"
<?A5236@0.9F2.?2;121B;2
"$
&$!%&"!$#"$&#'$%'!&&"%&"! "$ 1"&%'$&%*!&"
<?A52A?.;@6A6<;=2?6<13?<:A<
<::6@@6<;3692;B:/2?
$%$"$#"$&"!
E.0A;.:2<3?246@A?.;A.@@=20636216;6A@05.?A2?
29.D.?2
%A.A2<?<A52?7B?6@160A6<;<36;0<?=<?.A6<;<?<?4.;6G.A6<; $%:=9<F2?12;A6360.A6<;!<
B@56;4#.?8D.F?2:<;A.963<?;6.
11?2@@<3=?6;06=.92E20BA6C2<33602@ ,6=<12
$246@A?.;AH@A292=5<;2;B:/2?6;09B16;4.?2.0<12
%20B?6A62@?246@A2?21=B?@B.;AA<%20A6<; /<3A520A
&6A92<32.0509.@@ &?.16;4%F:/<9@ !.:2<32.052E05.;42<;D5605?246@A2?21
<::<;%A<08#.?(.9B2 #2?%5.?2 $* &52!.@1.>%A<08 .?82A
!.@1.>9</.9%2920A .?82A
%20B?6A62@?246@A2?21=B?@B.;AA<%20A6<; 4<3A520A
!<;2
&6A92<309.@@
#C9>86I:7N8=:8@B6G@>;I=:G:<>HIG6CI>H6L:AA @CDLCH:6HDC:9>HHJ:G 6H9:;>C:9>C,JA:D;I=:-:8JG>I>:H8I 3:H(D
#C9>86I:7N8=:8@B6G@>;I=:G:<>HIG6CI>HCDIG:FJ>G:9ID;>A:G:EDGIHEJGHJ6CIID-:8I>DCDG-:8I>DC9D;I=:8I 3:H(D
#C9>86I:7N8=:8@B6G@L=:I=:GI=:G:<>HIG6CI=6H;>A:96AAG:EDGIHG:FJ>G:9ID7:;>A:97N-:8I>DCDG9D;I=:-:8JG>I>:HM8=6C<:8ID;9JG>C<I=:
EG:8:9>C<BDCI=HDG;DGHJ8=H=DGI:GE:G>D9I=6II=:G:<>HIG6CIL6HG:FJ>G:9ID;>A:HJ8=G:EDGIH 6C9=6H7::CHJ7?:8IIDHJ8=;>A>C<G:FJ>G:B:CIH;DGI=:E6HI
96NH 3:H(D
#C9>86I:7N8=:8@B6G@L=:I=:GI=:G:<>HIG6CI=6HHJ7B>II:9:A:8IGDC>86AAN:K:GN#CI:G68I>K:6I6 >A:G:FJ>G:9ID7:HJ7B>II:9EJGHJ6CIID,JA:D;,:<JA6I>DC- .P
D;I=>H8=6EI:G9JG>C<I=:EG:8:9>C<BDCI=HDG;DGHJ8=H=DGI:GE:G>D9I=6II=:G:<>HIG6CIL6HG:FJ>G:9IDHJ7B>IHJ8=;>A:H 3:H(D
#C9>86I:7N8=:8@B6G@L=:I=:GI=:G:<>HIG6CI>H6A6G<:688:A:G6I:9;>A:G 6C688:A:G6I:9;>A:G 6CDC 688:A:G6I:9;>A:G 6HB6AA:GG:EDGI>C<8DBE6CN DG6C:B:G<>C<<GDLI=
8DBE6CN -::I=:9:;>C>I>DCHD;VA6G<:688:A:G6I:9;>A:G WV688:A:G6I:9;>A:G WVHB6AA:GG:EDGI>C<8DBE6CNW6C9V:B:G<>C<<GDLI=8DBE6CNW>C,JA:7 D;I=:M8=6C<:
8I
&6G<:688:A:G6I:9;>A:G 88:A:G6I:9;>A:G
(DC 688:A:G6I:9;>A:G -B6AA:GG:EDGI>C<8DBE6CN
B:G<>C<<GDLI=8DBE6CN
#;6C:B:G<>C<<GDLI=8DBE6CN >C9>86I:7N8=:8@B6G@>;I=:G:<>HIG6CI=6H:A:8I:9CDIIDJH:I=::MI:C9:9IG6CH>I>DCE:G>D9;DG8DBEAN>C<L>I=6CNC:LDGG:K>H:9
;>C6C8>6A688DJCI>C<HI6C96G9HEGDK>9:9EJGHJ6CIID-:8I>DC6D;I=:M8=6C<:8I
#C9>86I:7N8=:8@B6G@L=:I=:GI=:G:<>HIG6CI=6H;>A:96G:EDGIDC6C96II:HI6I>DCID>IHB6C6<:B:CIUH6HH:HHB:CID;I=::;;:8I>K:C:HHD;>IH>CI:GC6A8DCIGDADK:G;>C6C8>6A
G:EDGI>C<JC9:G-:8I>DC7D;I=:-6G76C:H )MA:N8I/ - 77NI=:G:<>HI:G:9EJ7A>8688DJCI>C<;>GBI=6IEG:E6G:9DG>HHJ:9>IH6J9>IG:EDGI
#;H:8JG>I>:H6G:G:<>HI:G:9EJGHJ6CIID-:8I>DC7D;I=:8I >C9>86I:7N8=:8@B6G@L=:I=:GI=:;>C6C8>6AHI6I:B:CIHD;I=:G:<>HIG6CI>C8AJ9:9>CI=:;>A>C<G:;A:8II=:
8DGG:8I>DCD;6C:GGDGIDEG:K>DJHAN>HHJ:9;>C6C8>6AHI6I:B:CIH
#C9>86I:7N8=:8@B6G@L=:I=:G6CND;I=DH::GGDG8DGG:8I>DCH6G:G:HI6I:B:CIHI=6IG:FJ>G:96G:8DK:GN6C6ANH>HD;>C8:CI>K: 76H:98DBE:CH6I>DCG:8:>K:97N6CND;I=:
G:<>HIG6CIUH:M:8JI>K:D;;>8:GH9JG>C<I=:G:A:K6CIG:8DK:GNE:G>D9EJGHJ6CIIDP 7
#C9>86I:7N8=:8@B6G@L=:I=:GI=:G:<>HIG6CI>H6H=:AA8DBE6CN6H9:;>C:9>C,JA:7 D;I=:8I 3:H(D
.=:6<<G:<6I:B6G@:IK6AJ:D;I=:,:<>HIG6CIUHDBBDC-ID8@ E6GK6AJ: =:A97NCDC 6;;>A>6I:HD;I=:,:<>HIG6CI 6HD;:8:B7:G I=:A6HI7JH>C:HH96N
D;I=:,:<>HIG6CIUHBDHIG:8:CIAN8DBEA:I:9H:8DC9;>H86AFJ6GI:G L6H DBBDC-ID8@=:A97N:68=:M:8JI>K:D;;>8:G 9>G:8IDG 6C9E:GHDCL=DDLCH
BDG:I=6CD;I=:DJIHI6C9>C<DBBDC-ID8@=6H7::C:M8AJ9:9;GDBI=>H8DBEJI6I>DC76H:9DCI=:6HHJBEI>DCI=6IHJ8=E:GHDCHB6N7:9::B:9ID7:6;;>A>6I:H
.=>H9:I:GB>C6I>DCD;6;;>A>6I:HI6IJH>HCDIC:8:HH6G>AN68DC8AJH>K:9:I:GB>C6I>DCD;HJ8=HI6IJH;DGDI=:GEJGEDH:H
HD;J<JHI I=:,:<>HIG6CI=69 I=DJH6C9DJIHI6C9>C<H=6G:HD;DBBDC-ID8@
-------------------------
<0B:2;A@;0<?=<?.A21/F$232?2;02
*6GIHD;I=:,:<>HIG6CIUH*GDMN-I6I:B:CI;DGI=:CCJ6A'::I>C<D;-ID8@=DA9:GH:ME:8I:9ID7:=:A9DCDG67DJI(DK:B7:G 6G:>C8DGEDG6I:97NG:;:G:C8:>CID
*6GI###D;I=>HCCJ6A,:EDGIDC DGB % M8:EI6H:MEG:HHAN>C8DGEDG6I:97NG:;:G:C8:=:G:>C I=:,:<>HIG6CIUH*GDMN-I6I:B:CIH=6AACDI7:9::B:9ID7:E6GID;I=>H
G:EDGI
-- 103 of 186 --
"#"" "$
%" "$"
$$$#
#.42
#.?A
#I:B JH>C:HH
#I:B ,>H@ 68IDGH
#I:B /CG:HDAK:9-I6;;DBB:CIH
#I:B N7:GH:8JG>IN
#I:B *GDE:GI>:H
#I:B &:<6A*GD8::9>C<H
#I:B '>C:-6;:IN>H8ADHJG:H
#.?A
#I:B '6G@:I;DGI=:,:<>HIG6CIUHDBBDCFJ>IN ,:A6I:9-ID8@=DA9:G'6II:GH6C9#HHJ:G*JG8=6H:HD;FJ>IN
-:8JG>I>:H
#I:B 4,:H:GK:95
#I:B '6C6<:B:CIUH>H8JHH>DC6C9C6ANH>HD; >C6C8>6ADC9>I>DC6C9,:HJAIHD;)E:G6I>DCH
#I:B +J6CI>I6I>K:6C9+J6A>I6I>K:>H8ADHJG:H7DJI'6G@:I,>H@
#I:B >C6C8>6A-I6I:B:CIH6C9-JEEA:B:CI6GN6I6
#I:B =6C<:H>C6C9>H6<G::B:CIHL>I=88DJCI6CIHDC88DJCI>C<6C9 >C6C8>6A>H8ADHJG:
#I:B DCIGDAH6C9*GD8:9JG:H
#I:B )I=:G#C;DGB6I>DC
#I:B >H8ADHJG:,:<6G9>C< DG:><C$JG>H9>8I>DCHI=6I*G:K:CI#CHE:8I>DC
#.?A
#I:B >G:8IDGH M:8JI>K:);;>8:GH6C9DGEDG6I:!DK:GC6C8:
#I:B M:8JI>K:DBE:CH6I>DC
#I:B -:8JG>IN)LC:GH=>ED;:GI6>C:C:;>8>6A)LC:GH6C9'6C6<:B:CI6C9,:A6I:9-ID8@=DA9:G'6II:GH
#I:B :GI6>C,:A6I>DCH=>EH6C9,:A6I:9.G6CH68I>DCH 6C9>G:8IDG#C9:E:C9:C8:
#I:B *G>C8>E6A88DJCI6CI ::H6C9-:GK>8:H
#.?A(
#I:B M=>7>IH >C6C8>6A-I6I:B:CI-8=:9JA:H
#I:B DGB %-JBB6GN
M=>7>I#C9:M
-><C6IJG:H
&6B,:H:6G8=DGEDG6I>DC %
-- 104 of 186 --
PART I
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K (“Form 10-K” or “2026 Form 10-K”) contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this report are
forward-looking statements. In some cases, forward-looking statements can be identified by words such as “aim,” “accelerate,”
“anticipate,” “assume,” “believe,” “become,” “continue,” “can,” “commit,” “could,” “drive,” “estimate,” “focus,” “forecast,” “goal,” “grow,”
“target,” “expect,” “increase,” “intend,” “likely,” “may,” “maintain,” “objective,” “ongoing,” “opportunity,” “pipeline,” “plan,” “possible,”
“potential,” “predict,” “probable,” “progress,” “project,” “scale,” “seek,” “should,” “strategy,” “sustain,” “transition,” “will,” “work,” “would,”
or variations of these words or other similar expressions. However, the absence of these words or similar expressions does not mean
that a statement is not forward-looking. Forward-looking statements in this report include, but are not limited to, statements
concerning: our future results of operations and financial condition; our commitment to driving semiconductor breakthroughs; trends
related to demand for electronic systems, including for high performance, energy efficient and highly integrated semiconductor
devices, semiconductor manufacturer adoption of vertical scaling and advanced integration approaches, technology inflections,
including increasing manufacturing complexity and precision requirements, and demand for our technologies and services; our belief
regarding our position in deposition, etch, and clean markets and perceived opportunities for sustainable differentiation for us due to
several specified factors; the performance and benefits of our products and services; trends related to increasing requirements for
semiconductor device density, performance, and energy efficiency and demand for energy- and compute-intensive applications and
related effects; our research and development strategy, and beliefs and expectations regarding perceived opportunities and continued
investments in research and development; our efforts to maintain relationships with customers; customers continuing to establish joint
ventures, alliances, and licensing arrangements and related effects on our competitive position and market opportunities; our beliefs
regarding our third-party outsourcing arrangements and our ability to manage related risks; our efforts to comply with new and
changing regulations and efforts to grow our business; our acquisition strategy; our environmental, social and governance (“ESG”)
goals and targets; our efforts to compete in the markets we serve, to strengthen and enhance our products and services, and to
maintain customer service and support; our ability to succeed in the marketplace and the implications of a semiconductor
manufacturer selecting and qualifying a supplier’s equipment; our ability to continue to meet the expectations of our customers in the
presence of competition and our expectations regarding our competitors’ performance; our intellectual property strategy; our
approach to human capital and employment, recruitment and development activities; our environmental health and safety (“EHS”)
goals and certifications; our belief regarding the condition of our facilities; our capital allocation strategy, including our intention to pay
quarterly dividends, our focus to return a portion of our free cash flow to stockholders over time through dividends and share
repurchases, and expected sources of funds for capital return activities; continued growth of wafer fabrication investment in calendar
year 2026, including the role of the artificial intelligence (“AI”) market in driving higher spending across both the memory and non-
memory market segments; our belief regarding demand for semiconductors and technology inflections in the semiconductor industry
driving sustainable growth and increasing served available market for our products and services in the deposition, etch, and clean
businesses; customer investments driving demand for our products and services; beliefs, estimates, and assumptions relating to our
significant accounting policies, including with respect to revenue recognition, inventory valuation, and income taxes; our expectations
regarding the sufficiency of our liquidity to support our anticipated business activities through the next twelve months based on
anticipated cash flows and our current business outlook; the use of net proceeds from the commercial paper Program; our ability to
access the capital markets; the dependence of our liquidity on our future revenues and ability to manage costs; off-balance sheet
arrangements and contractual obligations; expectations regarding deferred revenue; estimates and expectations regarding equity-
based compensation plans; our evaluation, expectations, and beliefs regarding deferred income taxes and carryforwards; our
evaluation of uncertain tax positions and related effects if recognized; financial instruments and related fair value estimates and
assumptions, and credit concentration risks; obligations under our deferred compensation plans; commitments and contingencies,
including our beliefs regarding the materiality of legal proceedings and probability of a material loss; and other statements included in
Part I, Item 1, “Business,” Part I, Item 1A, “Risk Factors,” Part II, Item 7, “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” and elsewhere in this Form 10-K.
These forward-looking statements are not a guarantee of future performance and involve a number of risks, uncertainties, and other
factors that could cause our actual results or outcomes, or the timing of our results or outcomes, to differ materially from those
expressed or implied in this Form 10-K. Such risks, uncertainties, and other factors include, among others, the following:
• our assumptions related to continued expansion of the wafer fabrication equipment market, growth of deposition and etch
intensity, and scaling of our operating framework may prove invalid;
• business, economic, political and/or regulatory conditions in the consumer electronics industry, including wafer fabrication
equipment spending, the semiconductor industry and the overall economy may deteriorate or change;
• the actions, performance, or investment levels of our customers and competitors may be inconsistent with our expectations;
• customer and product mix, including across market segments and geographical regions, may change;
• we may be unable to effectively manage and implement pricing actions, realize the value of our products and technology,
successfully commercialize new products and technologies, or execute on perceived opportunities;
• we may be unable to achieve anticipated operational, manufacturing, supply chain, procurement, and scale efficiencies;
• customer technology transitions, capacity expansions, and fab construction projects may have different timing or be less
successful than we expect;
• we may be unable to manage operating expenses effectively while continuing to invest in research and development,
product innovation, customer support, and future growth opportunities;
Lam Research Corporation 2026 10-K 3
-- 105 of 186 --
• trade regulations, export controls, tariffs, trade disputes, and other geopolitical developments may inhibit our ability to sell
our products;
• supply chain cost increases, tariffs, and other inflationary pressures have impacted and may continue to impact our
profitability;
• supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products;
• natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or
other events beyond our control may impact our operations and revenue in affected areas; and
• the other factors described in Part I, Item 1, “Business,” Part I, Item 1A, “Risk Factors,” Part II, Item 7, “Management’s
Discussion and Analysis of Financial Condition and Results of Operations,” and Part II, Item 7A “Quantitative and
Qualitative Disclosures About Market Risk” of this Form 10-K and other documents we file from time to time with the
Securities and Exchange Commission (“SEC”), such as our quarterly reports on Form 10-Q and our current reports on Form
8-K.
You should evaluate all forward-looking statements made in this Form 10-K in the context of these risks, uncertainties, and other
factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date
hereof and are based on our current beliefs, expectations, and assumptions about future events. Except as required by law, we do
not undertake any obligation to revise or update these forward-looking statements as a result of events or circumstances that occur
after the date of this report or to reflect the occurrence or effect of anticipated or unanticipated events.
Item 1. Business
Incorporated in 1980, Lam Research Corporation (“Lam Research,” “Lam,” “we,” “our,” “us,” or the “Company”) is a Delaware
corporation, headquartered in Fremont, California. We maintain a network of facilities throughout Asia, Europe, and the United States
in order to meet the needs of our dynamic customer base.
Additional information about Lam Research is available on our website at www.lamresearch.com. The content on any website
referred to in this Form 10-K is not a part of or incorporated by reference in this Form 10-K unless expressly noted.
Our Annual Report on Form 10-K, Quarterly Reports on Forms 10-Q, Current Reports on Forms 8-K, Proxy Statements and all other
filings we make with the SEC are available on our website, free of charge, as soon as reasonably practical after we file them with or
furnish them to the SEC and are also available online at the SEC’s website at www.sec.gov.
The Lam Research logo, Lam Research, and all product and service names used in this report are either registered trademarks or
trademarks of Lam Research Corporation or its subsidiaries in the United States and/or other countries. All other marks mentioned
herein are the property of their respective holders.
We are a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. We have built a strong
global presence with core competencies in areas such as nanoscale manufacturing enablement, chemistry, plasma and fluidics,
advanced systems engineering, and a broad range of operational disciplines. Our products and services are designed to help our
customers build smaller and better performing devices that are used in a variety of electronic products, including mobile phones,
personal computers, cloud and enterprise servers, wearables, automotive vehicles, and data storage devices.
Our customer base includes leading semiconductor memory, foundry, and integrated device manufacturers (“IDMs”) that make
products such as non-volatile memory (“NVM”), dynamic random-access memory (“DRAM”), and logic devices. Their continued
success is part of our commitment to driving semiconductor breakthroughs that define the next generation. Our core technical
competency is integrating hardware, process, materials, software, and process control enabling results on the wafer.
Semiconductor manufacturing, our customers’ business, involves the fabrication of multiple dies or integrated circuits (“ICs”) on a
wafer. This involves the repetition of a set of core processes and can require hundreds of individual steps. Fabricating these devices
requires a sequence of highly sophisticated process technologies to integrate an increasing array of new materials with precise
control at the atomic scale. Along with meeting technical requirements, wafer processing equipment must deliver high productivity
and be cost-effective.
Demand for electronic systems supporting artificial intelligence, cloud infrastructure, communications, automotive, industrial and other
intelligent systems is driving the need for high performance, energy efficient and highly integrated semiconductor devices. To meet
these requirements, semiconductor manufacturers are adopting vertical scaling approaches, including three-dimensional (“3D”)
architecture, more sophisticated patterning schemes, new materials, and advanced integration approaches, as traditional two-
dimensional scaling is becoming more challenging. These technology inflections are increasing manufacturing complexity and
precision requirements in the production of semiconductors driving demand for our advanced semiconductor fabrication technologies
and services.
We believe we are in a strong position with our leadership and expertise in deposition, etch, and clean markets to facilitate some of
the most significant innovations in semiconductor device manufacturing. Several factors create opportunity for sustainable
differentiation for us: (i) our focus on research and development, with several on-going programs relating to sustaining engineering,
product and process development, and concept and feasibility; (ii) our ability to effectively leverage cycles of learning from our broad
installed base; (iii) our collaborative focus with semi-ecosystem partners, including our close-to-customer focus; (iv) our ability to
Lam Research Corporation 2026 10-K 4
-- 106 of 186 --
>9:CI>;N6C9>CK:HI>CI=:7G:69I=D;DJGEGD9J8IEDGI;DA>DIDB::II:8=CDAD<N>C;A:8I>DCH6C9KDJG;D8JHDC9:A>K:G>C<DJGBJAI>
EGD9J8IHDAJI>DCHL>I=6<D6AID:C=6C8:I=:K6AJ:D;&6BUHHDAJI>DCHIDDJG8JHIDB:GH
1:6AHD699G:HHEGD8:HH:H;DG768@ :C9L6;:G A:K:AE68@6<>C<V1&*W L=>8=>H6C6AI:GC6I>K:IDIG69>I>DC6AL>G:7DC9>C<6C986C
D;;:G6HB6AA:G;DGB;68IDG >C8G:6H:9>CI:G8DCC:8IHE::96C976C9L>9I= 6C9ADL:GEDL:G8DCHJBEI>DC 6BDC<DI=:G7:C:;>IH 1:
D;;:G69K6C8:9E68@6<>C<HDAJI>DCHI=6IHJEEDGI;6C DJIE6C:A A:K:AE68@6<>C< 6EGD8:HH>CL=>8=8=>EHDG8=>EA:IH6G:8JI;GDB6
A6G<:;DGB6IHJ7HIG6I:H=::IH:K:G6AI>B:HI=:H>O:D;6IG69>I>DC6AH>A>8DCL6;:G L=>8=>C8G:6H:HN>:A96C9G:9J8:HL6HI:6C9
HDAJI>DCHI=6IB::II=:C::9;DGHI68@>C<D;=><=76C9L>9I=B:BDGNV"'W #C699>I>DC DJGEGD9J8IH6G:L:AA HJ>I:9;DGG:A6I:9
B6G@:IHI=6IG:ANDCH:B>8DC9J8IDGEGD8:HH:H6C9G:FJ>G:EGD9J8I>DC EGDK:CB6CJ;68IJG>C<86E67>A>IN HJ8=6H8DBEA:B:CI6GN
B:I6A DM>9: H:B>8DC9J8IDG>B6<:H:CHDGHV#-W6C9B>8GD :A:8IGDB:8=6C>86AHNHI:BHV''-W
)JGJHIDB:G-JEEDGIJH>C:HH!GDJEV-!WEGDK>9:HEGD9J8IH6C9H:GK>8:HIDB6M>B>O:>CHI6AA:9:FJ>EB:CIE:G;DGB6C8:
EG:9>8I67>A>IN 6C9DE:G6I>DC6A:;;>8>:C8N 1:D;;:G67GD69G6C<:D;H:GK>8:HID9:A>K:GK6AJ:I=GDJ<=DJII=:A>;:8N8A:D;DJG:FJ>EB:CI
>C8AJ9>C<8JHIDB:GH:GK>8: HE6G:H JE<G69:H 6C9C:L6C9G:;JG7>H=:9CDC A:69>C<:9<:EGD9J8IH>CDJG9:EDH>I>DC :I8= 6C98A:6C
B6G@:IH '6CND;I=:I:8=C>86A69K6C8:HI=6IL:>CIGD9J8:>CDJGC:L:HIEGD9J8IH6G:6AHD6K6>A67A:6HJE<G69:H L=>8=EGDK>9:
8JHIDB:GHL>I=68DHI :;;:8I>K:HIG6I:<N;DG:MI:C9>C<I=:E:G;DGB6C8:6C986E67>A>I>:HD;I=:>G:M>HI>C<L6;:G;67G>86I>DCA>C:H
-:GK>8:D;;:G>C<H>C8AJ9:;A::IA:K:AFJ>EB:CI#CI:AA><:C8:RHDAJI>DCHIDB6M>B>O:I=:EGD9J8I>K>IND;DJG8JHIDB:GHI=GDJ<=HNHI:B
JEI>B:DG6K6>A67>A>INDEI>B>O6I>DC I=GDJ<=EJI>BEGDK:B:CIH 6C99:;:8IG:9J8I>DC )JGHE6G:HEGD9J8IA>C:D;;:GHGJCC>C<8DHI
DEI>B>O6I>DCEGD<G6BH6C9;D8JH:HDCEGD9J8IA>;::MI:CH>DCID=:AE8JHIDB:GH>C8G:6H:I=:G:IJGCDCI=:>G86E>I6AEJG8=6H:H
99>I>DC6AAN L>I=>C-! DJG,:A>6CI EGD9J8IA>C:D;;:GHC:L6C9G:;JG7>H=:9CDC A:69>C<:9<:EGD9J8IH>C9:EDH>I>DC :I8=6C9
8A:6CB6G@:IH;DGI=DH:6EEA>86I>DCHI=6I9DCDIG:FJ>G:I=:BDHI69K6C8:9L6;:GEGD8:HH>C<86E67>A>IN
$A>3D2CB
.?82A #?<02@@==960.A6<; &205;<9<4F #?<1B0A@
:EDH>I>DC
':I6A >ABH A:8IGD8=:B>86A:EDH>I>DCVWDEE:G
)I=:G
-,R;6B>AN
=:B>86A06EDG:EDH>I>DCV0W
IDB>8&6N:G:EDH>I>DCV&W
.JC<HI:C'DAN79:CJB
&./-R;6B>AN
>:A:8IG>8 >ABH *A6HB6 :C=6C8:90V*0W
&
0.),R;6B>AN
-IG>@:GR ;6B>AN
I8=
DC9J8IDGI8= ,:68I>K:#DCI8= %>NDR;6B>AN
0:GHNHR':I6A;6B>AN
@6G6R;6B>AN
>:A:8IG>8I8= ,:68I>K:#DCI8= A:MR;6B>AN
06CI:MR;6B>AN
.=GDJ<= H>A>8DC0>6V.-0W
I8=
::E,:68I>K:#DCI8= -NC9>DCR;6B>AN
-:A:8I>K:I8= -:A:8I>K:I8= G<DHR;6B>AN
*G:KDHR;6B>AN
-:A>HR;6B>AN
A:6C
16;:GA:6C>C< 1:IA:6C )-R 0 *G>B:R
60>C8>R -*-:G>:H
;6B>A>:H
:K:AA:6C>C< GN*A6HB6A:6C DGDCJHR;6B>AN
GN,:H>HI *=DIDG:H>HI6C9
*6II:GC.G6CH;:G
MIG:B:JAIG6K>DA:IV/0WA>I=D<G6E=N6C9
(JB:G>86AE:GIJG:/0A>I=D<G6E=N
:I=:GR;6B>AN
4?>B8C8>=$A>24BB4B0=3$A>3D2C0<8;84B
:EDH>I>DCEGD8:HH:H8G:6I:A6N:GHD;9>:A:8IG>8>CHJA6I>C<6C9B:I6A8DC9J8I>C<B6I:G>6AHJH:9ID7J>A96H:B>8DC9J8IDG9:K>8:
:E:C9>C<DCI=:INE:D;B6I:G>6A6C9HIGJ8IJG:7:>C<B69: 9>;;:G:CII:8=C>FJ:H6G::BEADN:9 A:8IGD8=:B>86A9:EDH>I>DC8G:6I:H
I=:8DEE:GL>G>C<>CI:G8DCC:8II=6IA>C@H9:K>8:H>C6C>CI:<G6I:98>G8J>IV#WDGV8=>EW *A6I>C<D;8DEE:G6C9DI=:GB:I6AH>H6AHD
JH:9;DG.-06C91&*6EEA>86I>DCH .>CNBDAN79:CJBDGIJC<HI:C8DCC:8IDGH6C9I=>C76GG>:GH6G:B69:L>I=I=:EG:8>H>DCD;
8=:B>86AK6EDG9:EDH>I>DC6C96IDB>8A6N:G9:EDH>I>DC L=>8=699HDCAN6;:LA6N:GHD;6IDBH6I6I>B: *A6HB6 :C=6C8:90
=><= 9:CH>INEA6HB60 6C9&6G:JH:9ID;DGBI=:8G>I>86A>CHJA6I>C<A6N:GHI=6I>HDA6I:6C9EGDI:8I6AAD;I=:H::A:8IG>86A
HIGJ8IJG:H &6HIAN EDHI 9:EDH>I>DCIG:6IB:CIHHJ8=6HJAIG6K>DA:II=:GB6AEGD8:HH>C<6G:JH:9ID>BEGDK:9>:A:8IG>8;>ABEGDE:GI>:H
&6B,:H:6G8=DGEDG6I>DC %
-- 107 of 186 --
ALTUS® Product Family
Tungsten and/or molybdenum deposition is used to form conductive features such as contacts, vias, and wordlines on a chip. These
features are small, often narrow, and use only a small amount of metal, so minimizing resistance and achieving complete fill can be
difficult. At these nanoscale dimensions, even slight imperfections can impact device performance or cause a chip to fail. Our ALTUS®
systems combine CVD and ALD technologies to deposit the highly conformal or selective films as needed for advanced tungsten or
molybdenum metallization (ALTUS® Halo) applications in both logic and memory. The Multi-Station Sequential Deposition architecture
enables nucleation layer formation and bulk CVD/ALD fill to be performed in the same chamber (“in situ”). Our ALD technologies are
used in the metal deposition of barrier films to achieve high step coverage with precise composition control relative to a conventional
process.
SABRE® Product Family
Copper deposition lays down the electrical wiring for most semiconductor devices. Even the smallest defect - say, a microscopic
pinhole or dust particle - in these conductive structures can impact device performance, from loss of speed to complete failure. The
SABRE® ECD product family, which helped pioneer the copper interconnect transition, offers the precision needed for copper
damascene manufacturing in logic and memory. System capabilities include copper deposition directly on various liner materials,
which is important for next-generation metallization schemes and cobalt deposition for logic applications. For advanced packaging
applications, such as forming conductive bumps, redistribution layers, TSV filling, and wafer level bonding, the SABRE® 3D family
combines Lam’s SABRE Electrofill® technology with additional innovation to deliver the high-quality films needed at high productivity.
The modular architecture can be configured with multiple plating and pre/post-treatment cells, providing flexibility to address a variety
of packaging applications, including HBM.
Striker® Product Family
Advanced logic, memory, and imaging devices require high quality conformal dielectric films for continued device performance and
area scaling, that can be addressed by ALD process. The Striker® single-wafer ALD products provide dielectric film solutions
spanning a wide range of applications including low-k spacers for capacitance scaling tied to device speed, void dielectric gapfills in
high aspect ratio features for isolation and device performance, high modulus patterning spacer materials that help define critical
dimensions in the multiple patterning schemes. Striker® ALD products deliver targeted high quality dielectric films with excellent
productivity and defect performance needed for these applications, through process and hardware innovations.
VECTOR® Product Family
Dielectric film deposition processes are used to form some of the most difficult-to-produce insulating layers in a semiconductor
device, including those used in the latest transistors and 3D structures. In some applications, these films require dielectric films to be
exceptionally uniform and defect free since slight imperfections are multiplied greatly in subsequent layers. Our VECTOR® PECVD
products are designed to provide the performance and flexibility needed to create these enabling structures within a wide range of
challenging device applications. As a result of its design, VECTOR® produces superior thin film quality, along with exceptional within-
wafer and wafer-to-wafer uniformity.
Etch Processes and Product Families
Etch processes create chip features by selectively removing dielectric, metal, silicon and poly silicon materials, including films that
have been added during deposition. Reactive ion etch processing enables device-critical formation steps to enable transistor
performance, create storage capacitors, and memory cells. Low temperature, cryogenic etching enables the use of new, novel
chemistries to deliver increased high aspect ratio etch capability.
Akara® Product Family
Advanced conductor etch processes enable precise patterning of complex 3D semiconductor structures at angstrom-scale
dimensions. Our Akara® product family delivers a high degree of process control for next-generation logic and memory devices,
including gate-all-around architectures and advanced DRAM and NAND nodes. Akara® incorporates proprietary plasma technologies,
to enhance etch precision, selectivity, and defect control. Integrated with Lam’s Sense.i® platform and Equipment Intelligence®
solutions, Akara® is designed to support high-volume manufacturing, improve yield, and reduce overall cost of ownership.
Argos®, Prevos®, and Selis® Product Families
Selective etch processes enable the removal of targeted materials from wafer surfaces while preserving adjacent materials and are
used in the fabrication of advanced logic and memory devices that require precise control at nanoscale dimensions. Semiconductor
device architectures continue to evolve to address increasing requirements for device density, performance, and energy efficiency,
including transitions from FinFET-based logic devices to gate-all-around and nanosheet structures, and from planar to
three-dimensional memory architectures. These transitions require manufacturing processes capable of selectively and uniformly
removing materials in three dimensions, increasing the importance of process control and selectivity to avoid damage to neighboring
or underlying layers as device structures become more complex.
Lam Research Corporation 2026 10-K 6
-- 108 of 186 --
Flex® Product Family
Dielectric etch carves patterns in insulating materials to create barriers between the electrically conductive parts of a semiconductor
device. For advanced devices, these structures can be extremely tall and thin and involve complex, sensitive materials. Slight
deviations from the target feature profile - even at the atomic level - can negatively affect electrical properties of the device. To
precisely create these challenging structures, our Flex® product family offers differentiated technologies and application-focused
capabilities for critical dielectric etch applications. Uniformity, repeatability, and tunability are enabled by a unique multi-frequency,
small-volume, confined plasma design. Flex® offers in situ multi-step etch and continuous plasma capability that delivers high
productivity with low defectivity.
Kiyo® Product Family
Conductor etch helps shape the electrically active materials used in the parts of a semiconductor device. Even a slight variation in
these miniature structures can degrade device performance. In fact, these structures are so tiny and sensitive that etch processes
push the boundaries of the basic laws of physics and chemistry. Our Kiyo® product family delivers the high-performance capabilities
needed to precisely and consistently form these features precisely and with high productivity. Proprietary Hydra technology in Kiyo®
products improves CD uniformity by correcting for incoming pattern variability, and atomic-scale variability control with production-
worthy throughput.
Syndion® Product Family
Plasma etch processes used to remove silicon deep into the wafer are collectively referred to as deep silicon etch. These may be
deep trenches for CMOS image sensors, trenches for power devices, TSVs for packaging, and other high aspect ratio features. The
Syndion® etch product family is optimized for deep silicon etch, providing the fast process switching with depth and cross-wafer
uniformity control required to achieve precision etch results. The systems support both conventional single-step etch and rapidly
alternating process, which minimizes damage and delivers precise depth uniformity.
Vantex® Product Family
Dielectric etch processes remove non-conductive materials during the manufacturing of a semiconductor device. Leading-edge
memory devices have especially challenging structures, such as extremely deep holes and trenches, that must be manufactured with
tight tolerances. Our latest dielectric etch system, Vantex® creates high aspect ratio device features while maintaining critical
dimension (“CD”) uniformity and selectivity. Vantex® is part of our Sense.i® platform and offers advanced RF technology and
repeatable wafer-to-wafer performance enabled by Equipment Intelligence® solutions to meet the needs of advanced memory
manufacturing, primarily in 3D NAND high aspect ratio hole, trench, contact, and capacitor cell applications.
Versys® Metal Product Family
Metal etch processes play a key role in connecting the individual components that form an IC, such as forming wires and electrical
connections. These processes can also be used to drill through metal hardmasks that are used to form the wiring for advanced
devices. To enable these critical etch steps, the Versys® Metal product family provides high-productivity capability on a flexible
platform. Superior CD, profile uniformity, and uniformity control are enabled by a symmetrical chamber design with independent
process tuning features.
Clean Processes and Product Families
Clean techniques are used between manufacturing steps to clear away particles, contaminants, residues and other unwanted
material that could later lead to defects and to prepare the wafer surface for subsequent processing. Wet processing technologies
can be used for wafer cleaning and etch applications. Plasma bevel cleaning is used to enhance die yield by removing unwanted
materials from the wafer’s edge that could impact the device area.
Coronus® Product Family
Bevel cleaning removes unwanted masks, residues, and films from the edge of a wafer between manufacturing steps. If not cleaned,
these materials become defect sources. For instance, they can flake off and re-deposit on the device area during subsequent
processes. Even a single particle that lands on a critical part of a device can ruin the entire chip. By inserting bevel clean processes
at strategic points, these potential defect sources can be eliminated and more functional chips produced. By combining the precise
control and flexibility of plasma with technology that protects the active die area, the Coronus® bevel clean family cleans the wafer’s
edge to enhance die yield. The systems provide active die area protection by using plasma processing with proprietary confinement
technology. Applications include post-etch, pre- and post-deposition, pre-lithography, and metal film removal to prevent arcing during
plasma etch or deposition steps.
DV-Prime®, Da Vinci®, EOS®, and SP Series Product Families
Wafer cleaning is performed repeatedly during semiconductor device manufacturing and is a critical process that affects product yield
and reliability. Unwanted microscopic materials - some no bigger than the tiny structures themselves - need to be cleaned effectively.
At the same time, these processes must selectively remove residues that are chemically similar to the device films. For advanced
WLP, the wet clean steps used between processes that form the package and external wiring have surprisingly complex
Lam Research Corporation 2026 10-K 7
-- 109 of 186 --
requirements. These processes are called on to completely remove specific materials and leave other fragile structures undisturbed.
In IoT products that include power devices, MEMS and image sensors, there is a unique requirement for wafer backside wet etch to
uniformly thin the silicon wafer while protecting the device side of the wafer.
Based on our pioneering single-wafer spin technology, the DV-Prime® and Da Vinci® products provide the process flexibility needed
with high productivity to address a wide range of wafer cleaning steps throughout the manufacturing process flow. As the latest of
Lam’s wet clean products, EOS® delivers exceptionally low on-wafer defectivity and high throughput to address progressively
demanding wafer cleaning applications. With a broad range of process capability, our SP Series products deliver cost-efficient,
production-proven wet clean and silicon wet etch solutions for challenging WLP and IoT applications.
Dry Resist Process and Product Family
Dry EUV resist technology is a patterning approach used in advanced semiconductor device manufacturing that enables both
increases in device scaling and pattern density as well as reductions in cost and complexity. In contrast to conventional wet-spin
processing, dry resist films are formed through gas-phase deposition, resulting in superior molecular purity and image fidelity with
less environmental impact. An additional advantage, unique to dry resist technology, is its ability to create customized mixtures,
layers, and gradients within the film itself, further enhancing pattern fidelity and device yield, and reducing overall lithography process
running costs. Following EUV exposure, latent device images in the dry resist film are also developed using a completely dry process,
eliminating the possibility of pattern distortions and collapse which are common in wet spin processing. By eliminating liquid
chemicals, dry EUV resist processing provides the semiconductor device industry with the most capable and beneficial EUV
patterning processes.
Aether® Product Family
Aether® enables vacuum-based formation of resist underlayers and films and utilizes dry development processes to improve pattern
fidelity at small pitch dimensions. Increasing demand for energy- and compute-intensive applications continues to drive the need for
higher memory density and lower cost per bit, for which industry adoption of EUV lithography is an important enabler. Lam’s dry
photoresist technologies support the patterning process from resist application and stack formation through pattern transfer,
integrating with subsequent etch and cleaning steps used in device fabrication. Dry processing also reduces the use of liquid
chemicals and energy compared to conventional wet resist processes.
Fiscal Periods Presented
All references to fiscal years apply to our fiscal years, which ended June 28, 2026, June 29, 2025, and June 30, 2024.
Research and Development
The market for semiconductor capital equipment is characterized by rapid technological change and product innovation. Our ability to
achieve and maintain our competitive advantage depends in part on our continued and timely development of new products and
enhancements to existing products. Accordingly, we devote a significant portion of our personnel and financial resources to research
and development (“R&D”) programs and seek to maintain close and responsive relationships with our customers and suppliers.
We believe current challenges for customers at various points in the semiconductor manufacturing process present opportunities for
us. We expect to continue to make substantial investments in R&D to meet our customers’ product needs, support our growth
strategy, and enhance our competitive position.
Marketing, Sales, and Service
Our marketing, sales, and service efforts are focused on building long-term relationships with our customers and targeting product
and service solutions designed to meet their needs. These efforts are supported by a team of product marketing and sales
professionals as well as equipment and process engineers who work closely with individual customers to develop solutions for their
wafer processing needs. We maintain ongoing service relationships with our customers and have an extensive network of service
engineers in place throughout the United States (“U.S.”), China, Europe, India, Japan, Korea, Southeast Asia, and Taiwan. We
believe that comprehensive support programs and close working relationships with customers are essential to maintaining high
customer satisfaction and our competitiveness in the marketplace.
We provide standard warranties for our systems. The warranty provides that systems will be free from defects in material and
workmanship and will conform to agreed-upon specifications. The warranty is limited to repair of the defect or replacement with new
or like-new equivalent goods and is valid when the buyer provides prompt notification within the warranty period of the claimed defect
or non-conformity and also makes the items available for inspection and repair.
Lam Research Corporation 2026 10-K 8
-- 110 of 186 --
International Sales
A significant portion of our sales and operations occur outside the United States and, therefore, may be subject to certain risks,
including but not limited to compliance with U.S. and international laws and regulations, including U.S. export restrictions; tariffs and
other barriers; difficulties in staffing and managing non-U.S. operations; adverse tax consequences; foreign currency exchange rate
fluctuations; changes in currency controls; and economic and political conditions. Any of these factors may have a material adverse
effect on our business, financial position, and results of operations and cash flows. For geographical reporting, revenue is attributed
to the geographic location in which the customers’ facilities are located. Refer to Note 19 of our Consolidated Financial Statements,
included in Part II, Item 8 of this 2026 Form 10-K, for the attribution of revenue by geographic region.
Long-lived Assets
Refer to Note 19 of our Consolidated Financial Statements, included in Part II, Item 8 of this 2026 Form 10-K, for information
concerning the geographic locations of long-lived assets.
Customers
Our customers include many of the world’s leading semiconductor manufacturers. Customers continue to establish joint ventures,
alliances, and licensing arrangements which have the potential to positively or negatively impact our competitive position and market
opportunities. Refer to Note 9 of our Consolidated Financial Statements, included in Part II, Item 8 of this report, for information
concerning customer concentrations. Our most significant customers during the fiscal years ending June 28, 2026, June 29, 2025,
and June 30, 2024 included Micron Technology, Inc., Samsung Electronics Company, Ltd., SK hynix Inc., and Taiwan Semiconductor
Manufacturing Company.
A material reduction in orders from our customers could adversely affect our results of operations and projected financial condition.
Our business depends upon the expenditures of semiconductor manufacturers. Semiconductor manufacturers’ businesses, in turn,
depend on many factors, including their economic capability, the current and anticipated market demand for ICs, and the availability
of equipment capacity to support that demand.
Manufacturing
Our manufacturing operations mainly consist of assembling and testing components, sub-assemblies, and modules that are then
integrated into finished systems prior to shipment to or at the location of our customers. The assembly and testing of our products is
conducted predominately in cleanroom environments.
We have agreements with third parties to outsource certain aspects of our manufacturing, production warehousing, and logistics
functions. These outsourcing contracts may provide us more flexibility to scale our operations up or down in a timely and cost-
effective manner. We believe that we have selected reputable providers and have secured their performance on terms documented in
written contracts. However, it is possible that one or more of these providers could fail to perform as we expect, and such failure could
have an adverse impact on our business and have a negative effect on our operating results and financial condition. Overall, we
believe we have effective mechanisms to manage risks associated with our outsourcing relationships. Refer to Note 17 of our
Consolidated Financial Statements, included in Part II, Item 8 of this report, for further information concerning our outsourcing
commitments, reported as a component of purchase obligations.
Certain components and sub-assemblies that we include in our products may only be obtained from a single supplier. For certain of
these products, we are engaged in efforts to obtain and qualify alternative sources of supply and in some circumstances, protect
against potential supply challenges by carrying inventory in excess of current need. Any prolonged inability to obtain these
components could have an adverse effect on our operating results and could unfavorably impact our customer relationships.
Compliance with Government Regulations
As a public company with global operations, we are subject to the laws of multiple jurisdictions and the rules and regulations of
various governing bodies, including, but not limited to, those related to import and export controls and other trade restrictions, national
and economic security (including receipt or use of designated technologies), intellectual property rights, taxes, financial and other
disclosures, corporate governance, data protection, privacy, anti-corruption, such as the Foreign Corrupt Practices Act and other local
laws prohibiting corrupt payments to governmental officials, anti-boycott, compliance, conflict minerals or other social responsibility
legislation, immigration or travel regulations, antitrust regulations, foreign ownership and investment, employment and labor, product
and manufacturing regulations, environmental, health, and safety requirements, human rights, and laws or regulations relating to
carbon emissions, such as the recent reporting requirements imposed by the State of California that require companies to provide
climate-related disclosures, as well as other laws or regulations imposed in response to climate change concerns, among others.
Each of these laws, rules, and regulations imposes costs on our business, including financial costs and our management’s attention
associated with compliance. Efforts to comply with new and changing regulations have resulted in, and are likely to continue to result
in, reduced net income, increased capital expenditures, and a diversion of management’s time and attention from revenue-generating
activities to compliance activities. As we seek to expand our operations into new jurisdictions, grow our business in existing
jurisdictions, or as laws, regulations, and standards, or the interpretation or enforcement of such laws, regulations, and standards,
evolve, the scope and complexity of our compliance obligations may increase. If we are alleged or found by a court or regulatory
agency not to be in compliance with the laws, regulations, or standards, our business, financial condition, competitive position, and/or
Lam Research Corporation 2026 10-K 9
-- 111 of 186 --
results of operations could be adversely affected. For additional details, please refer to “Legal, Regulatory and Tax Risks – We Are
Exposed to Various Risks from Our Regulatory Environment” and “Legal, Regulatory and Tax Risks – Intellectual Property, Indemnity,
Misuse of Third-Party Information, and Other Claims Against Us Can Be Costly and We Could Lose Significant Rights That Are
Necessary to Our Continued Business and Profitability” in Item 1A: Risk Factors.
Regulations that impact trade, including tariffs, export controls, additional taxes, trade barriers, sanctions, the termination or
modification of trade agreements, trade zones, and other duty mitigation initiatives, and any reciprocal retaliatory actions, can
increase our manufacturing costs, decrease margins, reduce the competitiveness of our products, disrupt our supply chain
operations, or inhibit our ability to sell products or provide services, all of which has had and in the future could have a material
adverse effect on our business, results of operations, or financial condition. For additional details regarding the impacts of compliance
with trade laws and regulations, please refer to “Business and Operational Risks – Our Future Success Depends Heavily on
International Sales and the Management of Global Operations” and “Legal, Regulatory and Tax Risks – Our Sales to Customers in
China, a Significant Region for Us, Have Been Impacted, and are Likely to be Materially and Adversely Affected by Export License
Requirements and Other Regulatory Changes, or Other Governmental Actions in the Course of the Trade Relationship Between the
U.S. and China” in Item 1A: Risk Factors.
Proposed regulations under consideration could require that we transition away from the usage of products containing a class of
chemicals known as per- and polyfluoroalkyl substances (“PFAS”), which could adversely impact our business, operations, revenue,
costs, and competitive position. For additional details regarding the impacts of compliance with laws and regulations related to PFAS,
please refer to “Business and Operational Risks – Disruptions to Our Supply Chain and Outsource Providers Could Impact Our Ability
to Meet Demand, Increase Our Costs, and Adversely Impact Our Revenue and Results of Operations” in Item 1A: Risk Factors.
We are subject to income, transaction, and other taxes in the United States and various foreign jurisdictions that impact our tax rate
and profitability. For additional details regarding the impacts of compliance with tax laws and regulations, please refer to “Legal,
Regulatory and Tax Risks – Our Financial Results May Be Adversely Impacted by Higher than Expected Tax Rates or Exposure to
Additional Tax Liabilities” in Item 1A: Risk Factors.
An important element of our management strategy is to review acquisition prospects that would complement our existing products,
augment our market coverage and distribution ability, enhance our technological capabilities, or accomplish other strategic objectives.
However, for regulatory or other reasons, we may not be successful in our attempts to acquire or dispose of businesses, products, or
technologies. For additional details regarding the impacts of regulations on acquisitions or dispositions we may attempt, please refer
to “Business and Operational Risks – If We Choose to Acquire or Dispose of Businesses, Product Lines, and Technologies, We May
Encounter Unforeseen Costs and Difficulties That Could Impair Our Financial Performance” in Item 1A: Risk Factors.
We are subject to a variety of domestic and international governmental regulations related to the handling, discharge, and disposal of
toxic, volatile, or otherwise hazardous chemicals. For additional details regarding the impacts of compliance with environmental laws
and regulations, please refer to “Legal, Regulatory and Tax Risks – Increasing and Evolving Environmental Regulations May
Adversely Affect Our Operating Results” in Item 1A: Risk Factors.
Product, People and Planet
We seek to innovate at the atomic scale – plus help to create a sustainable world where our people, communities, and the
environment thrive. Our Global Impact Report for calendar year 2025 details, among other items, a number of ESG goals. One such
goal is to achieve net zero emissions by 2050, which we are working to achieve in part by meeting a number of interim targets related
to our environmental impact. There have been no material impacts to capital expenditures or our results of operations associated with
this goal, and there are no material cash commitments associated with the goal as of the fiscal year ended June 28, 2026.
Information contained on our website or in our annual Global Impact Report is not incorporated by reference into this or any other
report we file with the Securities and Exchange Commission, or the SEC.
Competition
The semiconductor capital equipment industry is characterized by rapid change and is highly competitive throughout the world. To
compete effectively, we invest significant financial resources targeted to strengthen and enhance our product and services portfolio
and to maintain customer service and support locations globally. Semiconductor manufacturers evaluate capital equipment suppliers
in many areas, including but not limited to process performance, productivity, defect control, customer support, and overall cost of
ownership, which can be affected by many factors such as equipment design, reliability, software advancements, and similar factors.
Our ability to succeed in the marketplace depends upon our ability to manufacture and ship products on a timeline that meets our
customers’ needs, maintain existing products, and introduce product enhancements and new products that meet customer
requirements on a timely basis. In addition, semiconductor manufacturers must make a substantial investment to qualify and integrate
new capital equipment into semiconductor production lines. As a result, once a semiconductor manufacturer has selected a particular
supplier’s equipment and qualified it for production, the manufacturer generally maintains that selection for that specific production
application and technology node as long as the supplier’s products demonstrate performance to specification in the installed base.
Accordingly, we may experience difficulty in selling to a given customer if that customer has qualified a competitor’s equipment. We
Lam Research Corporation 2026 10-K 10
-- 112 of 186 --
must also continue to meet the expectations of our installed base of customers through the delivery of high-quality and cost-efficient
spare parts in the presence of competition from third-party spare parts providers.
We face significant competition with all of our products and services. Our primary competitor in the dielectric and metals deposition
market is Applied Materials, Inc. For ALD and PECVD, we also compete against ASM International and Wonik IPS. In the etch
market, our primary competitors are Applied Materials, Inc.; Hitachi, Ltd.; and Tokyo Electron, Ltd., and our primary competitors in the
wet clean market are Screen Holding Co., Ltd.; Semes Co., Ltd.; and Tokyo Electron, Ltd.
We face competition from a number of established and emerging equipment companies in the industry. We expect our competitors to
continue to improve the design and performance of their current products and processes, to introduce new products and processes
with enhanced price/performance characteristics, and to provide more comprehensive offerings of products. If our competitors make
acquisitions or enter into strategic relationships with leading semiconductor manufacturers, or other entities, covering products similar
to those we sell, our ability to sell our products to those customers could be adversely affected. Government and other initiatives to
encourage local semiconductor manufacturing and supply chain in countries outside of the U.S., including China, could increase
competition from domestic equipment and spare parts manufacturers in those countries. Additionally, the U.S. Government has
enacted a number of export controls regulating the sales of certain technologies to customers in China, including entity listings of
multiple customers, thus restricting the sales of equipment and spare parts by U.S. equipment suppliers. This provides an advantage
to our international competitors that are not subject to these restrictions. There can be no assurance that we will continue to compete
successfully in the future.
Patents and Licenses
Our policy is to seek patents on inventions relating to new or enhanced products and processes developed as part of our ongoing
research, engineering, manufacturing, and support activities. We currently hold a number of U.S. and foreign patents and applications
covering various aspects of our products and processes. Our patents, which cover innovative and valuable aspects of our past and
present core products, have current durations ranging from approximately one to twenty years. We believe that, although the patents
we own and may obtain in the future will be of value, they alone will not determine our success. Our success depends principally
upon our research and development, engineering, marketing, support, and delivery skills. However, in the absence of patent
protection, we may be vulnerable to competitors who attempt to imitate our products, manufacturing techniques, and processes and
may be more limited in our ability to exclude competitors than would otherwise be the case. In addition, other companies and
inventors may receive patents that contain claims applicable to our products and processes. The sale of products covered by patents
of others could require licenses that may not be available on terms acceptable to us, or at all. For further discussion of legal matters,
see Item 3, “Legal Proceedings,” of this report.
Human Capital
Lam is proud to be a driving force in shaping the global semiconductor talent workforce. In labs, manufacturing centers, and offices
worldwide, our people combine deep technical expertise with connection and collaboration. We promote continuous learning among
employees at every level and offer resources to help people thrive inside and outside the workplace. Beyond supporting professional
development, we offer programs designed to enhance safety and well-being, foster teamwork and connection, and support future-
ready communities worldwide.
As of August 4, 2026, we had approximately 23,300 regular full-time employees, of which over 26% were engaged in research and
development. Approximately 38% of our regular full-time employees are located in the United States, 56% in Asia, and 6% in Europe.
Employment, Recruitment and Development
Our talented people are what makes our success possible. Many of our recruitment efforts are carried out through partnerships with
key universities. In fact, many of our senior executives began their careers with us right out of college, demonstrating that programs
that recruit university students have the potential to contribute to our leadership pipeline. To tap into the best and brightest students,
we prioritize core initiatives including an internship program, campus events, and thesis awards and scholarships. Through the spirit
of continuous improvement, we accelerate skill building and development, create career opportunities, and expand professional
networks for employees. We provide a wide range of opportunities globally to support our commitment to developing the best talent.
Our mentorship, coaching, and professional development programs support this commitment along with our self-directed online
learning platform that intelligently aligns content with skill building needs. Additionally, our leadership development programs are
designed to scale leadership across our business, empowering leaders to motivate, inspire, and lead employees through change,
ultimately accelerating business outcomes.
Employee Engagement
Employee engagement (i.e. satisfaction) and voice are critical to Lam’s culture. We conduct a global survey at a regular cadence to
gather input from employees on culture, career opportunity, and manager effectiveness. We also solicit employee feedback through
in-person and online employee forums, engagement sessions, all-employee meetings, conversations with managers, and our Human
Resource Support and Employee Relations programs.
Lam Research Corporation 2026 10-K 11
-- 113 of 186 --
(>C0;&4F0A3B
)JG.DI6A,:L6G9HEGD<G6B>C8DGEDG6I:H68DBEG:=:CH>K:8DBE:CH6I>DC6C97:C:;>IHE68@6<:6>B:96IHJEEDGI>C<:BEADN::H6C9
I=:>G;6B>A>:HL>I=;>C6C8>6A E=NH>86A 6C9B:CI6AL:AA 7:>C<EGD<G6BHI=6IB::II=:>GC::9H 1:8DC9J8I6C6CCJ6AG:K>:LD;H6A6G>:H
6C97:C:;>IHE68@6<:HJH>C<I=>G9 E6GIN7:C8=B6G@>C<HJGK:NHID:CHJG:I=6IDJGD;;:G>C<H6G:6A><C:9L>I=I=:B6G@:IEA68:6C9
6IIG68I>K:IDIDEI6A:CI 1:D;;:GDJG:BEADN::H68DBE:I>I>K:@7:C:;>I 6C:BEADN::HID8@EJG8=6H:EA6C IJ>I>DC
G:>B7JGH:B:CI 6C96CCJ6A86H=7DCJH:H -ID8@6L6G9H6G:D;;:G:9ID:M:8JI>K:H6C9H:A:8I:BEADN::H
1:G:8D<C>O:I=:>BEDGI6C8:D;I>B:6L6N;GDBLDG@ HDL:D;;:G6CCJ6AE6>9=DA>96NH6C9I>B:D;;IDG:A6M6C9G:8=6G<:DGI6@:
86G:D;E:GHDC6A7JH>C:HH 99>I>DC6AAN L:D;;:GE6>9E6G:CI6AA:6K:7:C:;>IH;DGE6G:CIHL:A8DB>C<6C:L8=>A9IDI=:;6B>ANI=GDJ<=
7>GI= 69DEI>DC DG;DHI:G86G:EA68:B:CI
<?;>H4440;C70=3 '054CH
*G>DG>I>O>C<I=:=:6AI= H6;:IN 6C9L:AA 7:>C<D;DJG:BEADN::H>H8G>I>86AIDDJGDC<D>C<HJ88:HH 1:>CK:HI>C:9J86I>DC 6L6G:C:HH
BDC>IDG>C< 6C9EG:K:CI>DCEGD<G6BHID=:AEG:8D<C>O:6C98DCIGDAH6;:IN=6O6G9H )JG<D6A>HID6EEANDJG"-EDA>8>:H EGD<G6BH
6C9G:HEDCH:EA6CHID6CNL=:G:L:DE:G6I:6C9ID:MI:C9I=:BID6CNDC:L=DLDG@HDCDJGH>I:HL>I=I=:>CI:CIIDEGDK>9:6H6;:
:CK>GDCB:CI9JG>C<7DI=GDJI>C:6C9:MIG6DG9>C6GN8>G8JBHI6C8:H *:DEA:B6C6<:GH>C;>:A9HJEEDGI B6CJ;68IJG>C< ,
L6G:=DJH: 6C9AD<>HI>8HDE:G6I>DCHJC9:G<D;DGB6AH6;:INA:69:GH=>EIG6>C>C<7>6CCJ6AANID:C=6C8:I=:>GH@>AAH>CH6;:IN
B6C6<:B:CI6C98DBBJC>86I>DC 1:H8G::C8DCIG68IDGHUH6;:INE:G;DGB6C8:6C9G:FJ>G:8DCIG68IDG8DBEA>6C8:L>I=HE:8>;>:9H6;:IN
HI6C96G9H
1:BDC>IDGDJGH6;:INE:G;DGB6C8:6II=::CI:GEG>H: G:<>DC6A 6C9H>I:A:K:AH NJH>C<DJG<AD76A>C8>9:CIIG68@>C<HNHI:B DJG
8DGEDG6I:"-I:6B86C6HH:HH6C9BDC>IDGH6;:INIG:C9HIDG:EDGIID7JH>C:HHJC>IH6C9:M:8JI>K:A:69:GH=>E6H6E6GID;FJ6GI:GAN
G:K>:LH 1:B6>CI6>CBJAI> H>I:8:GI>;>86I>DCH;DG#-) I=:<AD76AANG:8D<C>O:9HI6C96G9;DGD88JE6I>DC6A=:6AI=6C9H6;:IN
B6C6<:B:CIHNHI:BH
=5>A<0C8>=01>DC>DAG42DC8E4#55824AB
HD;J<JHI I=::M:8JI>K:D;;>8:GHD;&6B,:H:6G8=L:G:6H;DAADLH
!.:2 42 #<@6A6<;@
.>BDI=N' G8=:G *G:H>9:CI =>:;M:8JI>K:);;>8:G
DJ<A6H, :II>C<:G M:8JI>K:0>8:*G:H>9:CI =>:; >C6C8>6A);;>8:G
-:H=6H6N::-:H=606G696G6?6C M:8JI>K:0>8:*G:H>9:CI =>:;)E:G6I>C<);;>8:G
(:>A$ :GC6C9:H -:C>DG0>8:*G:H>9:CI !AD76AJHIDB:G)E:G6I>DCH
K6 "6GI:G -:C>DG0>8:*G:H>9:CI =>:;&:<6A);;>8:G6C9-:8G:I6GN
06=>906=:9> -:C>DG0>8:*G:H>9:CI =>:;.:8=CDAD<N6C9-JHI6>C67>A>IN);;>8:G
%6GI=>@:N6C%6GI=>@,6BBD=6C -:C>DG0>8:*G:H>9:CI !AD76A)E:G6I>DCH6C9CI:GEG>H:-DAJI>DCH
.>BDI=N' G8=:G =6HH:GK:96HDJGEG:H>9:CI6C98=>:;:M:8JI>K:D;;>8:G6C96H6B:B7:GD;DJGD6G9D;>G:8IDGHH>C8:
:8:B7:G *G>DGIDI=>H =:H:GK:96HDJGEG:H>9:CI6C98=>:;DE:G6I>C<D;;>8:G ;GDB$6CJ6GNID(DK:B7:G 'G
G8=:G?D>C:9JH>C$JC:6HDJG:M:8JI>K:K>8:EG:H>9:CI 8=>:;DE:G6I>C<D;;>8:G *G>DGID?D>C>C<JH =:HE:CIN:6GH6I
(DK:AAJH-NHI:BH #C8 V(DK:AAJHW>CK6G>DJHI:8=CDAD<N9:K:ADEB:CI6C97JH>C:HHA:69:GH=>EGDA:H >C8AJ9>C<BDHIG:8:CIAN6H
8=>:;DE:G6I>C<D;;>8:G;GDB$6CJ6GNID$JC::M:8JI>K:K>8:EG:H>9:CID;1DGA9L>9:-6A:H '6G@:I>C< 6C9JHIDB:G
-6I>H;68I>DC;GDB-:EI:B7:GID$6CJ6GN6C9:M:8JI>K:K>8:EG:H>9:CID;I=:*06C9A:8IGD;>AAJH>C:HH/C>IH;GDB
(DK:B7:GID-:EI:B7:G ">HI:CJG:6I(DK:AAJH6AHD>C8AJ9:96HH><CB:CIH6HH:C>DG9>G:8IDGD;I:8=CDAD<N;DG(DK:AAJH
-NHI:BH$6E6C;GDBID6C9H:C>DG9>G:8IDGD;I:8=CDAD<N;DGI=:A:8IGD;>AAJH>C:HH/C>I;GDBEG>AIDEG>A ":
HI6GI:9=>H86G::G>C6I.:@IGDC>M L=:G:=:L6HG:HEDCH>7A:;DGEGD8:HH9:K:ADEB:CI;DG=><= HE::97>EDA6G#H 'G G8=:G=6H
H:GK:96H6B:B7:GD;I=:7D6G9D;9>G:8IDGHD;$D=CHDCDCIGDAH#CI:GC6I>DC6AEA8H>C8:'6G8= L=:G:=:>H6B:B7:GD;I=:
<DK:GC6C8:6C9HJHI6>C67>A>IN8DBB>II:: ":6AHDH:GK:HDCI=:#CI:GC6I>DC6AD6G9D;>G:8IDGH;DG-'# GDBID 'G
G8=:GH:GK:96H8=6>GD;I=:7D6G9;DGI=:(6I>DC6A!'DCHDGI>JB 'G G8=:G8DBEA:I:9I=:*GD<G6B;DG'6C6<:B:CI
:K:ADEB:CI6II=:"6GK6G9!G69J6I:-8=DDAD;JH>C:HH6C9:6GC:96 - 9:<G::>C6EEA>:9E=NH>8H;GDBI=:6A>;DGC>6#CHI>IJI:D;
.:8=CDAD<N
DJ<A6H, :II>C<:G>HDJG:M:8JI>K:K>8:EG:H>9:CI6C98=>:;;>C6C8>6AD;;>8:GL>I=G:HEDCH>7>A>IN;DG >C6C8: .6M .G:6HJGN 6C9
#CK:HIDG,:A6I>DCH6C9DGEDG6I:C6ANI>8H *G>DGID?D>C>C<I=:DBE6CN>C 'G :II>C<:GH:GK:96HH:C>DGK>8:EG:H>9:CI6C9
8=>:;;>C6C8>6AD;;>8:GD;K6<D.:8=CDAD<>:HCDLGD698DB #C8 ;GDBID GDBID =:H:GK:96HK>8:EG:H>9:CI
D; >C6C8:6C98DGEDG6I:8DCIGDAA:G6I2>A>CM #C8 6C9;GDBID =:L6H8=>:;;>C6C8>6AD;;>8:G6IJHIDB:G 'G
:II>C<:GLDG@:96I#CI:ADGEDG6I>DC;GDBID L=:G:=:=:A9H:K:G6AH:C>DG A:K:A;>C6C8:EDH>I>DCH >C8AJ9>C<8DGEDG6I:
EA6CC>C<6C9G:EDGI>C<8DCIGDAA:G6C9'6A6NH>6H>I:DE:G6I>DCH8DCIGDAA:G 'G :II>C<:G8JGG:CIANH:GK:HDCI=:D6G9D;>G:8IDGHD;
&6II>8:-:B>8DC9J8IDGDGEDG6I>DC6C9I=:#C9JHIG>6A9K>HDGND6G9D;I=:/C>K:GH>IND;1>H8DCH>CDAA:<:D;C<>C::G>C<6C9;GDB
ID =:H:GK:9DCI=:-'#D6G9D;#C9JHIGN&:69:GH 'G :II>C<:G:6GC:96C' 9:<G::>C;>C6C8:;GDBI=:
/C>K:GH>IND;'>8=><6C6C96 - 9:<G::>C:8DCDB>8H;GDBI=:/C>K:GH>IND;1>H8DCH>C>C'69>HDC
&6B,:H:6G8=DGEDG6I>DC %
-- 114 of 186 --
Sesha Varadarajan is our chief operating officer, a position he has held since March 2026. Mr. Varadarajan previously served as
senior vice president of the Global Products Group beginning March 2023; senior vice president and general manager of the
Deposition Business Unit beginning February 2018; and group vice president of the Deposition product group beginning September
2013. Previously, he served as the head of the PECVD/Electrofill Business Unit between June 2012 and September 2013. Prior to
our acquisition of Novellus in June 2012, Mr. Varadarajan was senior vice president and general manager of Novellus’ PECVD and
Electrofill Business Units. He joined Novellus in 1999 as a process engineer with the Electrofill Business Unit and held various roles
in that business unit before being appointed director of technology in 2004. Between 2006 and 2008, he worked in the PECVD
Business Unit, initially as director of technology, until being promoted to product general manager. In 2009, he returned to the
Electrofill Business Unit as vice president and general manager. In mid-2011, he was promoted to senior vice president and general
manager, where he was also responsible for the PECVD Business Unit. Mr. Varadarajan earned an M.S. degree in manufacturing
engineering and material science from Boston University and a B.S. degree in mechanical engineering from the University of Mysore.
Neil J. Fernandes is our senior vice president of Global Customer Operations, a position he has held since March 2023. Previously,
he was group vice president of Business Development and Sales Operations and held other senior sales and customer-focused
leadership positions at Lam. He joined the company in 2012 through the acquisition of Novellus, where he was the vice president of
Sales Operations. Prior to that role, he held range of management positions in product marketing and process engineering at
Novellus, Gasonics and Watkins-Johnson. Mr. Fernandes earned an M.S. degree in mechanical engineering from the University of
Texas at Austin and a B.E. in mechanical engineering from the Manipal Institute of Technology.
Ava A. Harter is our senior vice president, chief legal officer and secretary. She joined us in July 2024 and is responsible for all global
legal matters, ethics and compliance, and corporate secretary work. Prior to joining us, she served as executive vice president and
chief legal officer at Whirlpool Corporation, a home appliance and consumer products company, from December 2020 to March 2024,
and as senior vice president, general counsel, and corporate secretary at Owens Corning, a building and construction materials
company, from May 2015 to November 2020. Prior to that, she held legal roles at General Electric and The Dow Chemical Company.
She also worked at the law firms of Jones Day and Thompson Hine LLP and was an adjunct professor at the Case Western Reserve
University Law School. Ms. Harter earned her J.D. from Northwestern University School of Law, an M.B.A. in sociology from the
University of Nebraska, and a B.A. in political science from Northwestern University.
Vahid Vahedi is our senior vice president, chief technology and sustainability officer, a position he has held since March 2024. Dr.
Vahedi previously served as senior vice president and chief technology officer beginning March 2023; senior vice president and
general manager of the Etch business unit beginning February 2018; and group vice president of the Etch product group beginning
March 2012. Previously, he served as vice president of Etch Business Product Management and Marketing, vice president of
Dielectric Etch, vice president of Conductor and 3DIC Etch, and director of Conductor Etch Technology Development. He joined us in
1995. He earned his Ph.D., M.S., and B.S. degrees in electrical engineering and computer science from the University of California at
Berkeley.
Karthik Rammohan has served as senior vice president, global operations and enterprise solutions since March 2026. He previously
served as group vice president, global operations, beginning May 2022; group vice president and general manager of the customer
support business group, beginning September 2020; corporate vice president and deputy general manager of the customer support
business group, beginning June 2018; and vice president, global business operations and customer support business group,
beginning March 2015. Earlier in his tenure with the Company, Dr. Rammohan held various finance roles. Prior to joining the
Company, Dr. Rammohan spent 10 years at Novellus in finance, treasury, and business development roles. He previously served as
a staff process engineer at National Semiconductor and as a product engineer at International Rectifier. Dr. Rammohan holds an
M.B.A. from Cornell University, a Ph.D. and M.S. in materials science and engineering from the University of Southern California, and
a B.S. in metallurgical engineering from the Indian Institute of Technology, Bombay.
Item 1A. Risk Factors
In addition to the other information in this Annual Report on Form 10-K (“2026 Form 10-K”), the following risk factors should be
carefully considered in evaluating us and our business because the occurrence of any of these factors could materially and adversely
affect our business, results of operations, financial condition, and price of our Common Stock, and they could cause our actual results
to differ materially from those contemplated in any forward-looking statements. Some of the factors, events, and contingencies
discussed below may have occurred in the past, but the disclosures below are not representations as to whether or not the factors,
events, or contingencies have occurred in the past and instead reflect our beliefs and opinions as to the factors, events, or
contingencies that could materially and adversely affect us in the future. The risks and uncertainties described below are not the only
ones we face. Our operations could also be affected by factors, events, or uncertainties that are not presently known to us or that we
currently do not consider to present a material risk to us and our business. Therefore, the following discussion of risk factors should
not be considered a complete statement of all the potential risks or uncertainties that we face. No priority or significance is intended
by, nor should be attached to, the order in which the risk factors appear.
Lam Research Corporation 2026 10-K 13
-- 115 of 186 --
INDUSTRY AND CUSTOMER RISKS
We Depend on Creating New Products and Processes and Enhancing Existing Products and Processes for Our
Success; Consequently, We Are Subject to Risks Associated with Rapid Technological Change
Rapid technological changes in semiconductor manufacturing processes subject us to increased pressure to develop technological
advances that enable those processes. We believe that our future success depends in part upon our ability to develop and offer new
products with improved capabilities and to continue to enhance our existing products. If new products or existing products have
reliability, quality, design, or safety problems, our performance may be impacted by reduced orders, higher manufacturing costs,
delays in acceptance of and payment for new products, additional service and warranty expenses, and loss of market share. If we are
unable to develop and manufacture products successfully, or the products that we introduce fail in the marketplace, our business,
results of operations and financial condition could be materially and adversely affected. For more than 25 years, the primary driver of
technology advancement in the semiconductor industry has been to shrink the lithography that prints the circuit design on
semiconductor chips. That driver could be approaching its technological limit, leading semiconductor manufacturers to investigate
more complex changes in multiple technologies in an effort to continue technology development. In addition, the emergence of “big
data” and new tools such as machine learning and AI that capitalize on the availability of large data sets is leading semiconductor
manufacturers and equipment manufacturers to pursue new products and approaches that exploit those tools to advance technology
development. In the face of uncertainty on which technology solutions will become successful, we will need to focus our efforts on
developing the technology changes that are ultimately successful in supporting our customers’ requirements. Our failure to develop
and offer the correct technology solutions in a timely manner with productive and cost-effective products could adversely affect our
business in a material way. Our failure to commercialize new products in a timely manner could result in loss of market share,
unanticipated costs, and inventory obsolescence, which would adversely affect our business, results of operations and financial
condition.
In order to develop new products and processes and enhance existing products and processes, we expect to continue to make
significant investments in R&D, to investigate the acquisition of products and technologies, to invest in or acquire businesses or
technologies, and to pursue joint development relationships with customers, suppliers, or other members of the industry. Our
investments and acquisitions may not be as successful as we may expect, particularly in the event that we invest in or acquire
product lines and technologies that are new to us. We may find that acquisitions are not available to us, for regulatory or other
reasons, and that we must therefore limit ourselves to collaboration and joint venture development activities that do not have the
same benefits as acquisitions. Pursuing development through collaboration and/or joint development activities rather than through an
acquisition may pose substantial challenges for management, including those related to aligning business objectives; sharing
confidential information, intellectual property and data; sharing value with third parties; and realizing synergies that might have been
available in an acquisition but are not available through a joint development project. We must manage product transitions and joint
development relationships successfully, as the introduction of new products could adversely affect our sales of existing products and
certain jointly developed technologies may be subject to restrictions on our ability to share that technology, which could limit our
market for products incorporating those technologies. Future technologies, processes, or product developments, including as a result
of adoption of AI, may render our current product offerings obsolete, leaving us with non-competitive products, obsolete inventory, or
both. Moreover, customers may adopt new technologies or processes to address the complex challenges associated with next-
generation devices, or may adopt new technologies, including those based upon AI, that reduce their reliance on us for process
development. This shift could reduce the size of our addressable markets, increase the relative size of markets in which we either do
not compete or have relatively low market share, or reduce our competitiveness within the markets in which we do compete.
We Face a Challenging and Complex Competitive Environment
We face significant competition from multiple competitors, and our competitors may be able to develop products comparable or
superior to those we offer or may adapt more quickly to new technologies or evolving customer requirements. In particular, while we
continue to develop product enhancements that we believe will address future customer requirements, we may fail in a timely manner
to identify those future customer requirements, to devote appropriate resources to developing products to address those
requirements, or to complete the development or introduction of these additional product enhancements successfully, or these
product enhancements may not achieve market acceptance or be competitive. Accordingly, competition may intensify, and we may be
unable to continue to compete successfully in our markets, which could have a material adverse effect on our revenues, results of
operations, and financial condition.
With increased consolidation efforts in our industry, as well as the emergence and strengthening of new, regional competitors and the
impact of AI, we may face increasing competitive pressures. Other companies continue to develop systems and/or acquire
businesses and products that are competitive to ours and may introduce new products and product capabilities that may affect our
ability to sell and support our existing or new products. We face a greater risk if our competitors enter into strategic relationships with
leading semiconductor manufacturers covering products addressing applications similar to those we sell or may develop products for,
as this could adversely affect our ability to sell products to those manufacturers for those applications. We also face greater risk if our
competitors acquire, or otherwise obtain control over, third parties that supply us with key intellectual property, technology, materials,
components, software, or other inputs critical to our products and processes, as this could limit or condition our access to these
inputs, result in the termination or non-renewal of licenses or supply arrangements, restrict our ability to use or develop certain
technologies, or otherwise disadvantage us relative to our competitors, which could adversely affect our product development,
processes, and competitive position.
Lam Research Corporation 2026 10-K 14
-- 116 of 186 --
We believe that to remain competitive we must devote significant financial resources to offer products that meet our customers’
needs, to maintain customer service and support centers worldwide, and to invest in product and process R&D. Technological
changes and developing technologies have required, and are expected to continue to require, new and costly investments. Certain of
our competitors, including those that are created and financially backed by foreign governments, have substantially greater financial
resources and more extensive engineering, manufacturing, marketing, and customer service and support resources than we do and
therefore have the potential to offer customers a more comprehensive array of products and/or product capabilities, which enables
them to achieve additional relative success in the semiconductor equipment industry. These competitors may deeply discount or give
away products similar to those that we sell, challenging or even exceeding our ability to make similar accommodations and
threatening our ability to sell those products. We also face competition from our own customers, who in some instances have
established affiliated entities that manufacture equipment similar to ours. In addition, we face competition from companies that exist in
a more favorable legal or regulatory environment than we do, who are able to sell products for certain applications at certain
customers that we are prohibited from selling to under applicable export controls, allowing the freedom of action in ways that we may
be unable to match and potentially contributing to the strengthening of such companies’ ability to compete with us. In many cases,
speed to solution is necessary for customer satisfaction and our competitors may be better positioned to achieve these objectives.
For these reasons, we may fail to continue to compete successfully worldwide.
Once a Semiconductor Manufacturer Commits to Purchase a Competitor’s Semiconductor Manufacturing
Equipment, the Manufacturer Typically Continues to Purchase That Competitor’s Equipment, Making It More
Difficult for Us to Sell Our Equipment to That Customer
Semiconductor manufacturers must make a substantial investment to qualify and integrate wafer processing equipment into a
semiconductor production line. We believe that once a semiconductor manufacturer selects a particular supplier’s processing
equipment, the manufacturer generally relies upon that equipment for that specific production line application for an extended period
of time, especially for customers that are more focused on tool reuse. Accordingly, we expect it to be more difficult to sell our products
to a given customer for a product line application if that customer initially selects a competitor’s equipment for the same product line
application.
The Semiconductor Capital Equipment Industry Is Subject to Variability and Periods of Rapid Growth or
Decline; We Therefore Face Risks Related to Our Strategic Resource Allocation Decisions
The semiconductor capital equipment industry has historically been characterized by rapid changes in demand. Variability in our
customers’ business plans may lead to changes in demand for our equipment and services, which could negatively impact our results
of operations and cash flows. The variability in our customers’ investments during any particular period is dependent on several
factors, including, but not limited to, electronics demand, economic conditions (both general and in the semiconductor and electronics
industries), industry supply and demand, prices for semiconductors, and our customers’ ability to develop and manufacture
increasingly complex and costly semiconductor devices. The changes in demand may require our management to adjust spending
and other resources allocated to operating activities, which can be made more challenging due to the multi-year nature of
investments made in certain technology programs and other initiatives.
During periods of rapid growth or decline in demand for our products and services, we may face significant challenges in maintaining
adequate financial and business controls, management processes, information systems, and procedures for training, assimilating,
and managing our workforce, and in appropriately sizing our supply chain infrastructure and facilities, work force, and other
components of our business on a timely basis. If we do not adequately meet these challenges during periods of increasing or
declining demand, our results of operations and financial condition may be negatively impacted.
We regularly assess our strategic resource allocation choices in response to the changing business environment. If we do not
adequately adapt to the changing business environment, we may lack the infrastructure and resources to scale up our business to
meet customer expectations and compete successfully during a period of growth, which could have a material adverse effect on our
business, reputation, results of operations, financial condition, and/or our market share, or we may expand our capacity and
resources too rapidly and/or beyond what is appropriate for the actual demand environment, which could result in excess fixed costs
and have a material adverse effect on our results of operations and financial condition. For example, the growth of AI technologies
and related infrastructure has been and is expected to continue to be a significant driver of capital equipment expenditures by
semiconductor manufacturers across both the memory and non-memory market segments and requires us to respond (sometimes
rapidly) to changes in demand for our products and services, including by expanding our equipment manufacturing capabilities and
hiring additional personnel. If we are unable to effectively scale our business to meet our customers’ requirements in response to AI-
driven demand, we may lose market share, and our business, reputation, results of operations, and financial condition could be
harmed.
During transitional periods, as is the case with the rapid adoption of AI technologies, resource allocation decisions can have a
significant impact on our future performance, particularly if we have not accurately anticipated industry changes. Our success will
depend, to a significant extent, on the ability of our executive officers and other members of our senior management to identify and
respond to these challenges effectively.
Future Declines in the Semiconductor Industry, and the Overall World Economic Conditions on Which It Is
Significantly Dependent, Could Have a Material Adverse Impact on Our Results of Operations and Financial
Condition
Our business depends on the capital equipment expenditures of semiconductor manufacturers, which in turn depend on the current
and anticipated market demand for integrated circuits. With the consolidation of customers within the industry, the semiconductor
Lam Research Corporation 2026 10-K 15
-- 117 of 186 --
capital equipment market has in the past experienced and may in the future experience rapid changes in demand driven both by
changes in the market generally and the plans and requirements of particular customers. The economic, regulatory, political, and
business conditions occurring nationally, globally, or in any of our key sales regions, which are often unpredictable, have historically
impacted and may in the future impact customer demand for our products and services and normal commercial relationships with our
customers, suppliers, and creditors. Additionally, in times of economic uncertainty, our customers’ budgets for our products, or their
ability to access credit to purchase them, could be adversely affected. This would limit their ability to purchase our products and
services. As a result, changing economic, regulatory, political or business conditions can cause material adverse changes to our
results of operations and financial condition, including, but not limited to:
• a decline in demand for our products and/or services;
• an increase in reserves on accounts receivable due to our customers’ inability to pay us;
• an increase in reserves on inventory balances due to excess or obsolete inventory as a result of our inability to sell such
inventory;
• valuation allowances on deferred tax assets;
• restructuring charges;
• asset impairments including the potential impairment of goodwill and other intangible assets;
• a decline in the value of our investments;
• exposure to claims from our suppliers for payment on inventory that is ordered in anticipation of customer purchases that
do not come to fruition; and
• challenges maintaining reliable and uninterrupted sources of supply.
For example, the growth of AI technologies and related infrastructure has been and is expected to continue to be a significant driver
of capital equipment expenditures of semiconductor manufacturers across both the memory and non-memory market segments we
serve. However, customer decisions regarding the amount and timing of capital expenditures and the demand for our products and
services could change rapidly and be impacted by factors outside of our control. These factors may include, without limitation:
changes in actual or anticipated AI-driven demand for AI-related infrastructure or compute power to support AI models, tools, and
other applications, including due to slower-than-anticipated adoption of AI technologies, increases in compute efficiency, or
oversupply of AI-related infrastructure compute power; advances in fabrication processes, technology inflections or changes in
technology architectures; new and emerging technologies or market drivers; actual or anticipated production capacity, utilization, and
volumes of semiconductor manufacturers relative to demand for semiconductor devices; changes in end-user demand or behavior;
the timing of or constraints on increases to AI-related infrastructure or semiconductor manufacturing capacity; the availability and
cost of capital, including increases in interest rates or tightening in global capital markets; the availability and amount of government
subsidies and incentives; the regulation of AI or related infrastructure technologies by government or other regulatory agencies; and
geopolitical or macroeconomic instability, including wars, terrorism, political unrest, public health emergencies, inflation, recessionary
conditions, trade restrictions, export controls, boycotts, and other business disruptions.
Fluctuating levels of investment by semiconductor manufacturers may materially affect our aggregate shipments, revenues, results of
operations, and cash flows. Where appropriate, we endeavor to attempt to respond to these fluctuations with cost management
programs aimed at aligning our expenditures with anticipated revenue streams, which sometimes result in restructuring charges.
Even during periods of reduced revenues, we must continue to invest in R&D and maintain extensive ongoing worldwide customer
service and support capabilities to remain competitive, which may harm our profitability and other financial results.
We Have a Limited Number of Key Customers
Sales to a limited number of large customers constitute a significant portion of our overall shipments, revenue, cash flows, and
profitability. As a result, the actions of even one customer may subject us to variability in those areas is difficult to predict. In addition,
large customers may be able to negotiate requirements that result in decreased pricing, increased costs, and/or lower margins for us,
and limitations on our ability to share technology with others. Similarly, significant portions of our credit risk may, at any given time, be
concentrated among a limited number of customers so that the failure of even one of these key customers to pay its obligations to us
could significantly impact our results of operations, and financial condition.
Strategic Alliances and Customer Consolidation May Have Negative Effects on Our Business
Semiconductor manufacturing companies from time to time enter into strategic alliances or consolidate with one another to expedite
the development of processes and other manufacturing technologies and/or achieve economies of scale. The outcomes of such an
alliance can be the definition of a particular tool set for a certain function and/or the standardization of a series of process steps that
use a specific set of manufacturing equipment. In addition, the outcomes of consolidation can potentially lead to an overall reduction
in the market for semiconductor manufacturing equipment as customers’ operations achieve economies of scale and/or increased
purchasing power based on their higher volumes. In certain instances, this could work to our disadvantage if a competitor’s tools or
equipment become the standard equipment for such functions or processes. Additional outcomes of such consolidation may include
our customers re-evaluating their future supplier relationships to consider our competitors’ products and/or gaining additional
influence over the pricing of products and the control of intellectual property or data.
Similarly, our customers may partner with, or follow the lead of, educational or research institutions that establish processes for
accomplishing various tasks or manufacturing steps. If those institutions utilize a competitor’s equipment when they establish those
processes, it is likely that customers will tend to use the same equipment in setting up their own manufacturing lines. Even if they
select our equipment, the institutions and the customers that follow their lead could impose conditions on acceptance of that
Lam Research Corporation 2026 10-K 16
-- 118 of 186 --
equipment, such as adherence to standards and requirements or limitations on how we license our proprietary rights, that increase
our costs or require us to take on greater risk. These actions could adversely impact our market share, results of operations, and
financial condition.
BUSINESS AND OPERATIONAL RISKS
Our Revenues and Results of Operations Are Variable
Our revenues and results of operations may fluctuate significantly from quarter to quarter or year to year due to a number of factors,
not all of which are in our control. We manage our expense levels based in part on our expectations of future revenues. Because our
operating expenses are based in part on anticipated future revenues, and a certain amount of those expenses are relatively fixed, a
change in the timing of recognition of revenue and/or the level of gross profit from a small number of transactions can unfavorably
affect results of operations in a particular quarter or year. Factors that may cause our results of operations to fluctuate include, but are
not limited to:
• legal, tax, accounting, or regulatory changes (including, but not limited to, changes in import/export regulations and
tariffs, such as regulations imposed by the U.S. government restricting exports to China or regulations imposed by other
countries restricting the export of certain materials or the re-export of products containing such materials, or potential
additional tariffs on imports, and tariffs imposed by other countries) or changes in the interpretation or enforcement of
existing requirements;
• the impact of stagnating or worsening business and economic conditions, including inflationary pressures, general
economic slowdown or a recession, actual or anticipated changes in interest rates, reductions in government spending
or other changes in monetary policy, or adverse financial or commodity markets activity or macroeconomic conditions,
including as a result of geopolitical conflicts;
• changes in average selling prices, customer mix, and product mix;
• foreign currency exchange rate fluctuations;
• economic conditions in the electronics and semiconductor industries in general and specifically the semiconductor
equipment industry;
• changes in industry trends or demand drivers for semiconductor chips and semiconductor equipment, including changes
in the level of investment in AI and related infrastructure;
• the size and timing of orders from customers;
• changes in our deferred revenue balance, including as a result of factors such as volume purchase agreements, multi-
year service contracts, back orders, and down payments toward purchases;
• consolidation of the customer base, which may result in the investment decisions of one customer or market having a
significant effect on demand for our products or services;
• the failure of our suppliers or outsource providers to perform their obligations in a manner consistent with our
expectations or to meet increases in demand for their products or services, including due to limited production capacity
or constrained access to raw materials or components (such as rare earth elements), which could result in delays, higher
costs, or an inability to fulfill orders;
• the impact of manufacturing difficulties or constraints on expanding manufacturing capacity by us or our customers or
suppliers;
• customer cancellations or delays in shipments, installations, customer payments, and/or customer acceptances;
• the extent that customers continue to purchase and use our products and services in their business;
• any disruption to our relationship with, or loss of business from, customers, including due to actual or alleged non-
compliance with contractual or other customer requirements, applicable laws, rules, or regulations, or breaches of
customer trust;
• our customers’ reuse of existing and installed products, to the extent that such reuse decreases their need to purchase
new products or services;
• our ability to develop, introduce, and market new, enhanced, and competitive products in a timely manner;
• our competitors’ introduction of new products;
• legal or technical challenges to our products and technologies;
• transportation, communication, demand, information technology, or supply disruptions based on factors outside our
control, such as strikes, force majeure events, wars, terrorist activities, international conflict, epidemics, pandemics,
outbreaks of diseases or other global health emergencies, or natural or man-made disasters (including disasters
resulting from climate change), including earthquakes, wildfires, hurricanes, flooding, and heat waves;
• management of supply chain risks; and
• changes in our estimated effective tax rate.
Lam Research Corporation 2026 10-K 17
-- 119 of 186 --
Our Business Relies on Technology, Data, Intellectual Property and Other Sensitive Information That is
Susceptible to Cybersecurity and Other Threats or Incidents
Our business is dependent upon the use and protection of technology, data, intellectual property and other sensitive information,
which may be owned by, or licensed to, us or third parties, such as our customers and vendors. We maintain and rely upon certain
critical information systems for the creation, transmission, use and storage of much of this information, and for the effective operation
of our business. These information systems include, but are not limited to, telecommunications, the Internet, our corporate intranet,
various computer hardware and software applications (some of which may be integrated into the products that we sell or be required
in order to provide the services that we offer), network communications, and email. These information systems may be owned and
maintained by us, our outsourced providers, or third parties such as vendors, contractors, customers and Cloud providers. In addition,
we make use of Software-as-a-Service (“SaaS”) products for certain important business functions that are provided by third parties
and hosted on their own networks and servers, or third-party networks and servers, all of which rely on networks, email and/or the
Internet for their function.
The technology, data, intellectual property and other sensitive information we seek to protect, and the information systems used to
store, process, or transmit such information, are subject to loss, unauthorized access, unauthorized release, misappropriation,
misuse, disruption, breach, degradation, or failure, any of which could have a material adverse effect on our business or operations.
Such events may result from various possible causes, including mistakes or unauthorized actions by our employees, contractors, or
other third parties, or cyberattacks or other malicious activities by third parties, including industrial, corporate, or other espionage,
criminal hackers, or state-sponsored intrusions, by methods that include exploitation of known or unknown software or hardware
vulnerabilities, viruses, malware, ransomware, social engineering (such as phishing schemes), credential harvesting, denial of service
attacks, destructive or inadequate code, software or hardware failure, power failures, or physical damage to computers, hard drives,
communication lines, or networking equipment, in each case with respect to us or the third-party product and service providers upon
which we rely. We or our third-party product and service providers may not be able to anticipate, identify, or implement effective
preventive measures against cyberattacks or data security incidents and, even if timely identified, we or our third-party product and
service providers may not be able to remediate such attacks or incidents in a timely and effective manner, or to mitigate or avoid
adverse impacts resulting from any such attacks or incidents. These threats continue to evolve and may include the use of tools and
techniques that change frequently or may be disguised or difficult to detect, or designed to circumvent security controls, evade
detection, or remove forensic evidence, or remain dormant until a triggering event, or that may continue undetected for an extended
period of time, which may hinder our or our third-party product and service providers’ ability to identify, investigate, and remediate
attacks or incidents in a timely and effective manner, or to mitigate or avoid adverse impacts resulting from any such attacks or
incidents. In addition, the development and deployment of AI models, tools, and other applications expose us, our customers,
suppliers, and other third-party providers to increased and novel risks and vulnerabilities, including prompt injection, hallucinations,
errors, and other issues related to AI agents, as well as the risk of compromise of valuable intellectual property. For example, the
autonomous nature of agentic AI increases the risk that agents learn to circumvent security controls, and certain generative AI
systems and large language models may, in order to satisfy user prompts, access or retrieve data using the credentials, permissions,
or access rights of the user or connected systems, which may increase the risk of unauthorized access, data leakage, or improper
use of sensitive or proprietary information. To the extent AI capabilities improve and are increasingly adopted, they may be used to
introduce, identify, or exploit vulnerabilities and to implement increasingly sophisticated cybersecurity attacks and could materially
and adversely impact our business or operations. In addition, even if we or our third-party product and service providers are able to
develop patches or other mitigations to address newly identified vulnerabilities, the pace at which AI enables the discovery and
exploitation of such vulnerabilities may exceed our or our third-party product and service providers’ ability to implement such patches
and mitigations quickly enough to prevent the exploitation of such vulnerabilities.
We experience cybersecurity and other threats and incidents in the course of our operations. Although past threats and incidents
have not resulted in a material adverse effect, we may incur material losses related to cybersecurity and other threats or incidents in
the future. Cybersecurity or other incidents could have a material adverse effect on our business. Such adverse effects might include:
• loss of (or inability to access, e.g. through ransomware) confidential and/or sensitive information stored on these critical
information systems or transmitted to or from those systems;
• the shutdown or disruption of the proper function of our products, services and/or operations;
• the failure of our or our customers’ manufacturing processes;
• errors in the output of our work or our customers’ work;
• the loss or public exposure of the personal or other confidential information of our employees, customers or other
parties;
• the unauthorized public release of customer financial and business plans, customer orders and operational results;
• exposure to claims from our employees or third parties who are adversely impacted by such incidents;
• misappropriation or theft of our or a customer’s, supplier’s or other party’s assets or resources, including technology,
data, intellectual property or other sensitive information and costs associated therewith;
• reputational damage;
• diminution in the value of our investment in research, development and engineering; or
• our failure to meet, or violation of, regulatory or other legal obligations, such as the timely publication or filing of financial
statements, tax information, and other required communications.
While we have implemented International Organization for Standardization (“ISO”) 27001 compliant security procedures and virus
protection software, intrusion prevention systems, identity and access control, and emergency recovery processes, and we carefully
Lam Research Corporation 2026 10-K 18
-- 120 of 186 --
select our third-party providers of information systems, to mitigate risks to the information systems that we rely on and to the
technology, data, intellectual property and other sensitive information we seek to protect, those security procedures and mitigation
and protection systems cannot be guaranteed to be fail-safe, and we may still suffer cybersecurity and other incidents, which could
have a material adverse effect on our business or operations. It has been difficult and may continue to be difficult to hire and retain
employees with substantial cybersecurity acumen. In addition, there have been and may continue to be instances of our policies and
procedures not being effective in enabling us to identify risks, threats and incidents in a timely manner, or at all, to mitigate the impact
of such incidents when they occur, or to respond expediently, appropriately and effectively when incidents occur and repair any
damage caused by such incidents, and such occurrences could have a material adverse effect on our business.
We Use Artificial Intelligence in Our Business, and Challenges with Properly Managing Its Use Could Result in
Reputational Harm, Competitive Harm, and Legal Liability, and Materially and Adversely Affect Our Results of
Operations.
We are increasingly using AI tools as part of our business, including internally developed machine learning tools and large language
models provided by third parties. For example, we use or are seeking to use AI tools to enhance research and development,
manufacturing, installation, and servicing of our products, services delivery, supply chain management, sales and marketing, and
compliance activities. We are also pursuing additional opportunities to incorporate AI tools, including agentic AI, into our business,
including our products and services, and we expect this trend to continue. There are significant risks involved in developing and
deploying AI, and there can be no assurance that our usage of AI will enhance our business, products or services, including our
productivity, operational efficiency, effectiveness, or profitability. For example, if the AI tools we utilize are flawed or fail to execute
properly, our ability to deliver our products and services to our customers may be adversely impacted. In addition, our competitors
may incorporate AI tools into their products or operational processes more quickly or more successfully than us, which could have a
material adverse effect on our competitive position, reputation and results of operations.
The intellectual property rights, including patent and copyright rights, associated with artificial intelligence have not been fully
addressed by U.S. and foreign courts, and there remains uncertainty and ongoing litigation in different jurisdictions as to the degree
and extent of protection warranted for artificial intelligence-generated technologies and relevant system inputs and outputs. The
courts and regulators have not clearly defined the scope for artificial intelligence-generated content, algorithms or trained models. If
we fail to secure or maintain protection for the intellectual property rights concerning technologies developed using artificial
intelligence, or later have our intellectual property rights invalidated or otherwise diminished, our competitors may be able to take
advantage of our research and development efforts to develop competing products, which could adversely affect our business,
reputation, results of operations, or financial condition.
Our use or future adoption of artificial intelligence in our business, which may include tools developed by third parties, could expose
us to breach of a data or software license, website terms of service claims, claimed violations of privacy rights or other tort claims.
Further, although we have taken measures to prohibit such use, our employees’ use of third-party or publicly available artificial
intelligence or other software tools may inadvertently result in the disclosure of our intellectual property, proprietary information or
other sensitive or confidential data into the public domain, which could expose us to legal liability, diminish the value of our intellectual
property, weaken our competitive position and harm our reputation.
Our Future Success Depends Heavily on International Sales and the Management of Global Operations
Non-U.S. sales accounted for approximately 93% of total revenue in each of the fiscal years 2026, 2025, and 2024. We expect that
international sales will continue to account for a substantial majority of our total revenue in future years.
We are subject to various challenges related to international sales and the management of global operations including, but not limited
to:
• domestic and international trade regulations, policies, practices, relations, disputes, and issues;
• domestic and international tariffs, export controls, and other barriers;
• developing customers and/or suppliers who may have limited access to capital resources;
• global or national economic and political conditions;
• changes in currency controls;
• differences in the enforcement of intellectual property and contract rights in varying jurisdictions;
• our ability to respond to customer and foreign government demands for locally sourced systems, spare parts, and
services and to develop the necessary relationships with local suppliers;
• changes in and compliance with U.S. and international laws and regulations affecting foreign operations, including U.S.
and international trade restrictions and sanctions, international data privacy regulations, such as the General Data
Protection Regulation, anti-bribery, anti-corruption, anti-boycott, environmental, tax, and labor laws;
• fluctuations in interest and foreign currency exchange rates;
• the need for technical support resources in different locations; and
• our ability to secure and retain qualified people, and effectively manage people, in all necessary locations for the
successful operation of our business.
Lam Research Corporation 2026 10-K 19
-- 121 of 186 --
There is inherent risk that political, diplomatic and national security influences can lead to trade disputes, impacts and/or disruptions,
in particular those affecting the semiconductor industry. This can adversely affect our business in China, Japan, Korea, and/or Taiwan
and perhaps the entire Asia Pacific region or worldwide. A significant trade dispute, impact, and/or disruption in any area where we do
business could have a materially adverse impact on our future results of operations and cash flows. For example, the conflict that
began in February 2026 between the United States, Israel, a number of states in the Persian Gulf, and Iran has led to significant
regional instability and disruption in the Middle East, including the closure of or restrictions on the Strait of Hormuz, threatened or
actual attacks on vessels in the Red Sea, and threatened or actual attacks on transportation and energy infrastructure, which has
significantly and adversely affected the supply and prices of oil, refined oil products and byproducts, liquid natural gas, as well as
certain other industrial commodities, such as aluminum, helium, bromine, and sulfur. Some of these commodities are important to the
semiconductor industry. As a result, this instability and disruption has adversely affected, and may in the future materially and
adversely affect, our business, results of operations, and financial condition. The extent to which we may be affected by this conflict
will depend on various factors, including the scope, severity, and duration of the conflict and the extent to which the conflict, or
additional laws, sanctions, or trade restrictions arising from or related to the conflict, further disrupt the availability or cost of critical
inputs used in the semiconductor industry. Continuation or escalation of this conflict may also magnify the impact of other risks
identified in this 2026 Form 10-K.
Tariffs, export controls, additional taxes, trade barriers, sanctions, the termination or modification of trade agreements, trade zones,
and other duty mitigation initiatives, and any reciprocal retaliatory actions, can increase our manufacturing costs, decrease margins,
reduce the competitiveness of our products, disrupt our supply chain operations, or inhibit our ability to sell products or provide
services, all of which has had and in the future could have a material adverse effect on our business, results of operations, or
financial condition. For example, our business requires steel and aluminum to manufacture our products, and the imposition of tariffs
on steel and aluminum imports into the United States increased our manufacturing costs in fiscal year 2026, which adversely
impacted our margins. Certain of our international sales depend on our ability to obtain export licenses from the U.S. or foreign
governments. Our inability to obtain such licenses, or an expansion of the number or kinds of sales for which export licenses are
required, has limited and could in the future further limit the market for our products and has had and could in the future have an
adverse impact on our revenues. As is discussed below under the heading “Our Sales to Customers in China, a Significant Region for
Us, Have Been Impacted, and are Likely to Be Materially and Adversely Affected by Export License Requirements and Other
Regulatory Changes, or Other Governmental Actions in the Course of the Trade Relationship Between the U.S. and China,” the U.S.
government has in recent years imposed new controls, including expanded export license requirements and restrictions on sales to
certain Chinese entities that significantly impact trade with China. In addition, the U.S. government has an ongoing process of
assessing technologies that may be subject to new or additional export controls, and it is possible that such additional controls, if and
when imposed, could further adversely impact our ability to sell our products outside the United States. The implementation by the
U.S. government of broad export controls restricting access to our technology (such as recent controls limiting exports to China) may
cause customers with international operations to reconsider their use of and reliance on our products, which could adversely impact
our future revenue and profits and strengthen competitors who are not subject to such restrictions. Furthermore, there are risks that
foreign governments may, among other things, take retaliatory actions; insist on the use of local suppliers; compel companies to
partner with local companies to design and supply equipment on a local basis, requiring the transfer of intellectual property rights and/
or local manufacturing; utilize their influence over their judicial systems to respond to intellectual property disputes or issues; and
provide special incentives to government-backed local customers to buy from local competitors, even if their products are inferior to
ours; all of which could adversely impact our ability to compete as well as our revenues and margins. For example, China is the
primary source of supply of certain rare earth elements critical to the manufacture of certain of our products. The Chinese
government has imposed export controls and license requirements on certain rare earth elements and on certain products that
contain Chinese-origin rare earth elements that are manufactured outside of China (which have been suspended in part until
November 2026 (unless extended)) and could expand such controls or licensing requirements in the future. Such measures could
delay or prevent our suppliers from sourcing the materials, or producing the components, required for us to manufacture our
products, and increase the costs of such materials or components. In addition, to the extent these controls require us to obtain export
licenses for certain products manufactured outside of China, we would experience increased compliance burdens, may be unable to
obtain the required licenses, and may be unable to obtain materials or components necessary to meet our production requirements or
product specifications in a timely manner, or at all, or on commercially acceptable terms. The occurrence of any of these risks could
materially and adversely affect our business, results of operations, financial condition, and margins.
Our customers (and their customers and other downstream parties) may also be adversely affected by the tariffs, export controls, and
other trade issues described above. Additionally, certain materials are primarily available in a limited number of countries, including
rare earth elements, minerals, and metals. The supplies, equipment, raw materials, and other inputs necessary for the businesses of
our customers and other downstream parties could become more difficult to obtain for various reasons, including, but not limited to,
business interruptions of suppliers, reduced availability of labor, transit disruptions, consolidation in their supply chain, export controls,
sanctions, trade restrictions, tariffs, geopolitical tensions, economic circumstances, conflict, or political conditions. If the ability of
downstream parties to source the inputs needed to produce their products is impaired, then demand for our products may be
adversely impacted. This could have a material adverse effect on our business, results of operations, or financial condition.
We are exposed to potentially adverse movements in foreign currency exchange rates. The majority of our sales and expenses are
denominated in U.S. dollars. However, we are exposed to foreign currency exchange rate fluctuations primarily related to revenues
denominated in Japanese yen and expenses denominated in euro, Korean won, Malaysian ringgit, and Indian rupee. Currently, we
hedge certain anticipated foreign currency cash flows, primarily anticipated revenues denominated in Japanese yen and expenses
denominated in euro, Korean won, Malaysian ringgit, and Indian rupee. In addition, we enter into foreign currency hedge contracts to
Lam Research Corporation 2026 10-K 20
-- 122 of 186 --
minimize the short-term impact of the foreign currency exchange rate fluctuations on certain foreign currency denominated monetary
assets and liabilities, primarily cash, third-party accounts receivables, accounts payables, and intercompany receivables and
payables. We believe these are our primary exposures to currency rate fluctuation. We expect to continue to enter into hedging
transactions, for the purposes outlined, for the foreseeable future. However, these hedging transactions may not achieve their desired
effect because differences between the actual timing of the underlying exposures and our forecasts of those exposures may leave us
either over or under hedged on any given transaction. Moreover, by hedging these foreign currency denominated revenues,
expenses, monetary assets, and liabilities, we may miss favorable currency trends that would have been advantageous to us but for
the hedges. Additionally, we are exposed to short-term foreign currency exchange rate fluctuations on non-U.S. dollar-denominated
monetary assets and liabilities (other than those currency exposures previously discussed), and currently we do not enter into foreign
currency hedge contracts against these exposures. Therefore, we are subject to potential unfavorable foreign currency exchange rate
fluctuations to the extent that we transact business (including intercompany transactions) in these currencies.
The magnitude of our overseas business also affects where our cash is generated. Certain uses of cash, such as share repurchases,
payment of dividends, or the repayment of our indebtedness, can usually only be made with onshore cash balances. Since the
majority of our cash is generated outside of the United States, this may impact certain business decisions and outcomes with respect
to our priorities for the use of cash or the need for alternative sources of liquidity if our subsidiaries are unable to provide sufficient
funds for us.
Disruptions to Our Supply Chain and Outsource Providers Could Impact Our Ability to Meet Demand, Increase
Our Costs, and Adversely Impact Our Revenue and Results of Operations
Our supply chain has played and will continue to play a key role in our product development, manufacturing operations, field
installation, and customer support. Our business depends on our timely supply of products and services to meet the demand from our
customers, which depends in significant part on the timely delivery of parts, materials, and services, including components and
subassemblies, from our direct suppliers to us, and to our direct suppliers by other companies. In addition, outsource providers have
played and will continue to play a key role both in the manufacturing and customer-focused operations described above, and in many
of our transactional and administrative functions, such as information technology, facilities management, and certain elements of our
finance organization. These providers and suppliers might suffer financial setbacks, be acquired by third parties that restrict or
preclude further business with us, become subject to exclusivity arrangements that preclude further business with us, or be unable to
meet our requirements or expectation due to their independent business decisions or force majeure events that could interrupt or
impair their continued ability to perform as we expect. We may also experience significant interruptions of our manufacturing
operations, delays in our ability to deliver or install products or perform services or to recognize revenue, increased costs, or
customer order cancellations as a result of:
• the failure or inability to accurately forecast demand and obtain sufficient quantities of quality parts on a cost-effective
basis;
• volatility in the availability and cost of parts, materials or services, including increased costs due to tariffs, foreign export
controls, rising inflation or interest rates or other market conditions;
• difficulties or delays in obtaining required import or export approvals (including those that may be required under the
Chinese export controls on rare earth elements described above);
• restrictions on the import and sale of products that incorporate technologies developed or manufactured in whole or in
part in certain countries;
• shipment delays and increased costs of shipment due to transportation interruptions, capacity constraints, or fuel
shortages;
• shortages of semiconductor or other components or materials as a result of increases in demand or decreases in supply,
including as a result of export restrictions on particular parts or materials used by us or our direct or indirect suppliers;
• information technology or infrastructure failures, including those of a third-party supplier or service provider; and
• transportation or supply disruptions based on factors outside our control, such as strikes, force majeure events, wars,
terrorist activities, international conflict, widespread outbreak of illness, or natural or man-made disasters (including
disasters resulting from climate change), including earthquakes, wildfires, hurricanes, flooding, and heat waves.
Demand for electronic products and other factors have resulted in, and may in the future result in, a shortage of parts, materials, and
services needed to manufacture, deliver, and install our products, as well as delays in and unpredictability of shipments due to
transportation interruptions. Such shortages, delays, and unpredictability have adversely impacted, and may in the future impact, our
suppliers’ ability to meet our demand requirements. Difficulties in obtaining sufficient and timely supply of parts, materials, or services,
and delays in and unpredictability of shipments due to transportation interruptions, have adversely impacted, and may in the future
adversely impact, our manufacturing operations and our ability to meet customer demand. In addition, difficulties in obtaining parts,
materials or services necessary to deliver or install products or perform services have adversely impacted, and may in the future
adversely impact, our ability to recognize revenue, our gross margins on the revenue we recognize, and our other results of
operations. Although we are endeavoring to pass along some of the impact of increased costs to our customers to counteract
adverse impacts to our gross margins and other results of operations, such measures could be unsuccessful, or could have the effect
of reducing demand for our products or services, which would adversely impact our revenue or market share.
Further, increased restrictions imposed on a class of chemicals known as per- and polyfluoroalkyl substances (or PFAS), which are
widely used in a large number of products, including parts and materials that are incorporated into our products, may negatively
impact our supply chain due to the potentially decreased availability, or non-availability, of PFAS-containing products. Proposed
Lam Research Corporation 2026 10-K 21
-- 123 of 186 --
regulations under consideration could require that we transition away from the usage of PFAS-containing products, which could
adversely impact our business, operations, revenue, costs, and competitive position. There is no assurance that suitable
replacements for PFAS-containing parts and materials will be available at similar costs, or at all.
Although we attempt to select reputable providers and suppliers and we attempt to secure their performance on terms documented in
written contracts, it is possible that one or more of these providers or suppliers could fail to perform as we expect, or fail to secure or
protect intellectual property rights, and such failure could have an adverse impact on our business. In some cases, the requirements
of our business mandate that we obtain certain components and sub-assemblies included in our products from a single supplier or a
limited group of suppliers. Where practical, we endeavor to establish alternative sources to mitigate the risk that the failure of any
single provider or supplier will adversely affect our business, but this is not feasible in all circumstances. Some key parts are subject
to long lead-times or available only from a single supplier or limited group of suppliers, and some sourcing or subassembly is
provided by suppliers located in countries other than the countries where we conduct our manufacturing. There is therefore a risk that
a prolonged inability to obtain certain components or secure key services could impair our ability to manage operations, ship
products, and generate revenues, which could adversely affect our results of operations or market share and damage our customer
relationships.
We May Not Achieve the Expected Benefits of Our Restructuring Plans and Business Transformation Initiatives,
and These Efforts Could Have a Material Adverse Effect on Our Business, Operations, Financial Condition,
Results of Operations and Competitive Position
We have in the past undertaken, and may in the future undertake, business restructuring, realignment and transformation plans or
initiatives. While such plans or initiatives would generally have the goal of strengthening our operations and/or achieving operational
efficiencies, there can be no assurance that we will be successful in these plans and initiatives. Implementation of such plans and
initiatives may be costly and disruptive to our business, we may not be able to complete them at the cost or within the time frame
contemplated, and we may not be able to obtain the anticipated benefits within the projected timing or at all. Restructuring and
transformation may adversely affect our internal programs and our ability to recruit and retain skilled and motivated personnel, may
result in a loss of continuity, loss of accumulated knowledge and/or inefficiency during transitional periods, may require a significant
amount of management and other employees' time and focus, and may be distracting to employees and management, which may
divert attention from operating and growing our business. Additionally, reductions in our workforce may cause a reduction in our
production output capabilities which could impact our ability to manufacture or ship products to customers within a mutually beneficial
timeline. If we fail to achieve some or all of the expected benefits, it could have a material adverse effect on our business, operations,
financial condition, results of operations and competitive position.
We Face Risks Related to the Disruption of Our Primary Manufacturing and R&D Facilities
While we maintain business continuity plans, our manufacturing and R&D facilities are concentrated in a limited number of locations.
These locations are subject to disruption for a variety of reasons, such as natural or man-made disasters (including disasters
resulting from climate change), including earthquakes, wildfires, hurricanes, flooding, and heat waves, epidemics, pandemics,
outbreaks of diseases or other global health emergencies, force majeure events, war, terrorist activities, political or governmental
unrest or instability, disruptions of our information technology resources, utility interruptions, international conflict, or other events
beyond our control. Such disruptions may cause delays in developing or shipping our products, in engaging with customers on new
product applications, or in supporting customers, which could result in the loss of business or customer trust, adversely affecting our
business and results of operations.
We Are Subject to Risks Relating to Product Concentration and Lack of Product Revenue Diversification
We derive a substantial percentage of our revenues from a limited number of products. Our products are priced up to the tens of
millions of dollars per system. As a result, the inability to recognize revenue on even a few systems can cause a significantly adverse
impact on our revenues for a given quarter, and, in the longer term, the continued market acceptance of these products is critical to
our future success. Our business, results of operations, financial condition, and cash flows could therefore be adversely affected by:
• a decline in demand for even a limited number of our products;
• a failure to achieve continued market acceptance of our key products;
• export restrictions or other regulatory or legislative actions that could limit our ability to sell those products to key
customers or customers within certain markets;
• an improved version of products being offered by a competitor in the markets in which we participate;
• increased pressure from competitors that offer broader product lines;
• increased pressure from regional competitors;
• technological changes that we are unable to address with our products;
• slower than anticipated development of various target markets that utilize new technologies; or
• a failure to release new or enhanced versions of our products on a timely basis.
In addition, the fact that we offer limited product lines creates the risk that our customers may view us as less important to their
business than our competitors that offer additional products and/or product capabilities, including new products that take advantage
of “big data” or other new technologies such as machine learning and AI. This may impact our ability to maintain or expand our
business with certain customers. Such product concentration may also subject us to additional risks associated with technology
changes. Our business is affected by our customers’ use of our products in certain steps in their wafer fabrication processes. Should
Lam Research Corporation 2026 10-K 22
-- 124 of 186 --
technologies change so that the manufacture of semiconductors requires fewer steps using our products, this could have a larger
impact on our business than it would on the business of our less concentrated competitors.
We May Fail to Protect Our Critical Proprietary Technology Rights, Which Could Affect Our Business
Our success depends in part on our proprietary technology and the proprietary technology of others that we license or incorporate
into our products and services, and our ability to protect key components of that technology through patents, copyrights, trade secrets
and other forms of protection, including non-disclosure, confidentiality, and other types of contractual arrangements. The protection of
our key proprietary technology and the technology of others upon which we rely is important to achieving our goals of developing
technological expertise and new products and systems that give us a competitive advantage; increasing market penetration and
growth of our installed base; and providing comprehensive support and service to our customers. For example, as part of our strategy
to protect our technology, we currently hold a number of U.S. and foreign patents and pending patent applications, we hold exclusive
licenses under certain intellectual property rights from third parties, and we keep certain information, processes, and techniques
confidential and/or as trade secrets. However, our rights under these forms of protection afford us only limited protection and may not
be adequate in all respects. For example, our owned or licensed intellectual property rights could be challenged, invalidated,
circumvented, infringed, or misappropriated; we may fail to apply for or obtain sufficient patent protection for our technology;
governments may fail to issue patents for pending applications; or we may lose confidentiality or trade secret protections over
valuable information due to our, including our employees’, or third parties’ intentional or unintentional disclosure or other actions or
omissions. Additionally, when we seek to exercise intellectual property rights, intellectual property litigation can be expensive and
time-consuming and even if patents are issued, or trade secret processes are followed, the legal systems in certain of the countries in
which we do business might not enforce patents and other intellectual property rights as rigorously or effectively as the United States
or may favor local entities in their intellectual property enforcement. The rights granted or anticipated under any of our patents,
pending patent applications, copyrights, or trade secrets (or those of third parties on which we rely) may be narrower than we expect
or, in fact, provide no competitive advantages. Moreover, because we selectively file for patent protection in different jurisdictions, we
may not have adequate protection in all jurisdictions based on such filing decisions. Any of these circumstances could have a material
adverse impact on our business.
Our Ability to Attract, Retain, and Motivate Key Employees Is Critical to Our Success
Our ability to compete successfully depends in large part on our ability to attract, retain, and motivate key employees with the
appropriate skills, experiences, and competencies. This has been and is expected to continue to be an ongoing challenge due to
intense competition for top talent, fluctuations in industry or business economic conditions, as well as increasing geographic
expansion, and these factors in combination may result in cycles of hiring activity and workforce reductions. For example, we are
actively seeking to hire additional field and manufacturing personnel to support the growth of our business, and any failure to do so
could make it difficult to achieve our operating and strategic goals. Competition for field and manufacturing personnel is intense.
Some of the companies with which we compete for experienced employees have greater resources than us and may be able to offer
more attractive terms of employment, and we may lose key employees or fail to attract other talented personnel. Our success in
hiring and retaining employees depends on a variety of factors, including the attractiveness of our compensation and benefit
programs, global economic or political and industry conditions, our organizational structure, global competition for talent and the
availability of qualified employees, the availability of career development opportunities, the ability to obtain necessary authorizations
for workers to provide services outside their home countries, and our ability to offer a challenging and rewarding work environment. If
we are not able to successfully attract, retain, and motivate key employees, we may be unable to capitalize on market opportunities
and our results of operations may be materially and adversely affected.
If We Choose to Acquire or Dispose of Businesses, Product Lines, and Technologies, We May Encounter
Unforeseen Costs and Difficulties That Could Impair Our Financial Performance
An important element of our management strategy is to review acquisition prospects that would complement our existing products,
augment our market coverage and distribution ability, enhance our technological capabilities, or accomplish other strategic objectives.
As a result, we may seek to make acquisitions of complementary companies, products, or technologies, or we may reduce or dispose
of certain product lines or technologies that no longer fit our long-term strategies. For regulatory or other reasons, we may not be
successful in our attempts to acquire or dispose of businesses, products, or technologies, resulting in significant financial costs,
reduced or lost opportunities, and diversion of management’s attention. Managing an acquired business, disposing of product
technologies, or reducing personnel entails numerous operational and financial risks, including difficulties in assimilating acquired
operations and new personnel or separating existing business or product groups, diversion of management’s attention away from
other business concerns, amortization of acquired intangible assets, adverse customer reaction to our decision to cease support for a
product, and potential loss of key employees or customers of acquired or disposed operations. There can be no assurance that we
will be able to achieve and manage successfully any such integration of potential acquisitions, disposition of product lines or
technologies, or reduction in personnel, or that our management, personnel, or systems will be adequate to support continued
operations. Any such inabilities or inadequacies could have a material adverse effect on our business, results of operations, financial
condition, and/or cash flows.
In addition, any acquisition could result in changes such as potentially dilutive issuances of equity securities, the incurrence of debt
and contingent liabilities, the amortization of related intangible assets, and goodwill impairment charges, any of which could materially
adversely affect our business, financial condition, results of operations, cash flows, and/or the price of our Common Stock.
Lam Research Corporation 2026 10-K 23
-- 125 of 186 --
LEGAL, REGULATORY AND TAX RISKS
Increasing and Evolving Environmental Regulations May Adversely Affect Our Results of Operations
We are subject to a variety of domestic and international governmental regulations related to the handling, discharge, sale, and
disposal of toxic, volatile, or otherwise hazardous or potentially hazardous substances, and the regulatory environment is dynamic.
Failure to comply with present or future environmental regulations (such as future regulations imposed on the use or sale of PFAS or
PFAS-containing products) could result in fines being imposed on us, require us to undertake remediation activities, suspend
production, and/or cease operations, or cause our customers to not accept our products. These regulations could require us to alter
or discontinue our current operations in certain jurisdictions, acquire significant additional equipment, incur substantial other
expenses to comply with environmental regulations, or take other actions. Compliance obligations, as well as any failure to comply
with current or future regulations governing the use, handling, sale, transport, or disposal of hazardous or potentially hazardous
substances (including, but not limited to, PFAS) could subject us to future costs and liabilities that may adversely affect our results of
operations, financial condition, and ability to operate our business.
Our Sales to Customers in China, a Significant Region for Us, Have Been Impacted, and are Likely to Be
Materially and Adversely Affected by Export License Requirements and Other Regulatory Changes, or Other
Governmental Actions in the Course of the Trade Relationship Between the U.S. and China
China represents a large and fast-developing market for the semiconductor equipment industry and therefore is important to our
business. Revenue in China, which includes global customers and domestic Chinese customers with manufacturing facilities in
China, represented approximately 34%, 34%, and 42% of our total revenue for fiscal years 2026, 2025, and 2024, respectively. The
U.S. and China have historically had a complex relationship that has included actions that have impacted trade between the two
countries. In recent years, these actions have included an expansion of export license requirements imposed by the U.S.
government, which have limited the market for our products, adversely impacted our revenues, and increased our exposure to foreign
competition, and could potentially do so to an even greater extent in the future. Additionally, the U.S. government has enacted rules
aimed at restricting China’s ability to manufacture advanced semiconductors, which include restrictions on exports, reexports or
transfers to, or shipping, transmitting, transferring, or facilitating such movement to, or performing services at, customer facilities in
China engaged in certain technology end-uses, without appropriate authorizations obtained from U.S. authorities. The U.S.
Department of Commerce has also enacted rules that have expanded export license requirements for U.S. companies to sell certain
items to companies and other end-users in China that are designated as military end-users or have operations that could support
military end uses; has added additional Chinese companies to its restricted entity list and unverified list under suspicion of military-
civil fusion, support of Russia, or other factors associated with a broadening scope of national security concerns; and has expanded
an existing rule (referred to as the foreign direct product rule) in a manner that could cause foreign-made wafers, chipsets, and
certain related items produced with many of our products to be subject to U.S. licensing requirements if Huawei Technologies Co. Ltd
(“Huawei”) or its affiliates are parties to a transaction involving the items. These rules have required and may require us to apply for
and obtain additional export licenses to supply certain of our products to customers in China, and there is no assurance that we will
be issued licenses that we apply for on a timely basis or at all. In addition, our customers (including, but not limited to, Chinese
customers) may require U.S. export licenses for the use of our products in order to manufacture products, including semiconductor
wafers and integrated circuits, for those of their customers (i.e. Huawei and its affiliates) that are subject to the expanded foreign
direct product rule, which may adversely impact the demand for our products. The U.S. Department of Commerce could in the future
add additional Chinese companies to its restricted entity list or unverified list or take other actions that could expand licensing
requirements or otherwise impact the market for our products and our revenue. The implementation, interpretation, and impact on our
business of these rules and other regulatory actions taken by the U.S. government is uncertain and evolving, and these rules, other
regulatory actions or changes, and other actions taken by the governments of either the U.S. or China, or both, that have occurred
and may occur in the future could weaken our competitive position and materially and adversely affect our results of operations.
Intellectual Property, Indemnity, Misuse of Third-Party Information, and Other Claims Against Us Can Be Costly
and We Could Lose Significant Rights That Are Necessary to Our Continued Business and Profitability
Third parties may assert infringement, misappropriation, unfair competition, product liability, breach of contract, or other claims
against us. From time to time, other persons allege that our products infringe or misappropriate their patent or other intellectual
property rights. In addition, law enforcement authorities may investigate or seek criminal charges against us or our employees based
on actual or alleged improper receipt or misuse of designated technology, intellectual property, or other confidential information of
third parties, including customers, suppliers, other business partners, or competitors, including in connection with national or
economic security measures intended to protect designated technologies. We also are subject to claims arising from commercial and
other relationships, including those alleging infringement, misappropriation, breach of contract, and misuse of designated technology,
intellectual property, or other confidential information. In addition, our bylaws and other indemnity obligations provide that we will
indemnify officers and members of our Board of Directors against losses that they may incur in legal proceedings resulting from their
service to us. From time to time, in the normal course of business, we indemnify third parties with whom we enter into contractual
relationships, including customers and suppliers, with respect to certain matters. We have agreed, under certain conditions, to hold
these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other
third-party claims that our products when used for their intended purposes infringe the intellectual property rights of such other third
parties, or other claims made against certain parties. In such cases, it is our policy either to defend the claims or to negotiate licenses
or other settlements on commercially reasonable terms. However, we may be unable in the future to negotiate necessary licenses or
reach agreement on other settlements on commercially reasonable terms, or at all. Any litigation or investigations relating to these
claims by law enforcement or other parties may materially and adversely affect our business, results of operations, and financial
Lam Research Corporation 2026 10-K 24
-- 126 of 186 --
condition, and we and our employees may be subject to civil or criminal liability, fines, substantial damage awards, penalties, loss of
customer trust, and reputational damage, or could result in us agreeing to less favorable pricing terms, additional compliance
requirements or contractual conditions, all of which could adversely affect our business, financial condition, and/or results of
operations. Moreover, although we have insurance to protect us from certain claims and cover certain losses to our property, such
insurance may not cover us for the full amount of any losses, or at all, and may be subject to substantial exclusions and deductibles.
We Are Exposed to Various Risks from Our Regulatory Environment
We are subject to various risks in the jurisdictions in which we operate related to (1) new, different, inconsistent, or even conflicting
laws, rules, and regulations that may be enacted by legislative or executive bodies and/or regulatory agencies; (2) disagreements or
disputes related to international trade; and (3) the interpretation and application of laws, rules, and regulations. As a public company
with global operations, we are subject to the laws of multiple jurisdictions and the rules and regulations of various governing bodies,
including, but not limited to, those related to import and export controls and other trade restrictions, national and economic security
(including receipt or use of designated technologies), intellectual property rights, taxes, financial and other disclosures, corporate
governance, data protection, privacy, anti-corruption, such as the Foreign Corrupt Practices Act and other local laws prohibiting
corrupt payments to governmental officials, anti-boycott compliance, conflict minerals or other social responsibility legislation,
immigration or travel regulations, antitrust regulations, foreign ownership and investment, employment and labor, product and
manufacturing regulations, environmental, health, and safety requirements, human rights, and laws or regulations relating to carbon
emissions, such as the recent reporting requirements imposed by the State of California that require companies to provide climate-
related disclosures, as well as other laws or regulations imposed in response to climate change concerns, among others. Each of
these laws, rules, and regulations imposes costs on our business, including financial costs and our management’s attention
associated with compliance, that could adversely impact our competitive position and our ability to meet customer demand. There
have been, and may continue to be, instances of our compliance policies and procedures not being effective to ensure full
compliance with all of the laws, rules and regulations to which we are subject. Such instances of non-compliance have presented and
may present risks to our business, including the risk of legal, administrative, or regulatory proceedings, claims, demands, inquiries or
investigations, fines, criminal penalties, restrictions on our actions or conduct of our business, loss of customer trust, and reputational
damage. The occurrence of any of these risks could materially and adversely affect our business, financial condition, and/or results of
operations.
To maintain high standards of corporate governance and public disclosure, we intend to continue to invest appropriate resources to
comply with evolving standards. Changes in or ambiguous interpretations of laws, regulations, and standards, the speed with which
new regulations may be enacted and come into effect, and increasing numbers of overlapping and sometimes inconsistent
requirements imposed by regulatory authorities may increase the complexity of our regulatory environment and create uncertainty
regarding compliance matters or instances where we may not be in compliance. Efforts to comply with new and changing regulations
have resulted in, and are likely to continue to result in, reduced net income, increased capital expenditures, and a diversion of
management’s time and attention from revenue-generating activities to compliance activities. As we seek to expand our operations
into new jurisdictions, grow our business in existing jurisdictions, or as laws, regulations, and standards, or the interpretation or
enforcement of such laws, regulations, and standards, evolve, the scope and complexity of our compliance obligations may increase,
and we may fail to comply with such laws, regulations, and standards. If we are alleged or found by a court or regulatory agency not
to be in compliance with the laws, regulations, or standards, our business, financial condition, competitive position, and/or results of
operations could be adversely affected.
Our Financial Results May Be Adversely Impacted by Higher than Expected Tax Rates or Exposure to Additional
Tax Liabilities
We are subject to income, transaction, and other taxes in the United States and various foreign jurisdictions, and judgment is required
to determine worldwide tax liabilities. The amount of taxes we pay is subject to ongoing audits in various jurisdictions, and a material
assessment by a governing tax authority could affect our profitability. As a global company, our effective tax rate is highly dependent
upon the geographic composition of worldwide earnings and tax regulations governing each region. Changes in the split of earnings
between countries with differing statutory tax rates, in the valuation allowance of deferred tax assets, in tax laws, in material audit
assessments, or in expirations of agreements with tax authorities could adversely affect our effective tax rate. In particular, the
carrying value of deferred tax assets, which are predominantly in the United States, is dependent upon our ability to generate future
taxable income in the United States.
Our Bylaws Designate the Court of Chancery of the State of Delaware as the Sole and Exclusive Judicial Forum
for Certain Legal Actions Between the Company and its Stockholders, Which May Discourage Lawsuits with
Respect to Such Claims
Our bylaws provide that, unless we consent otherwise, the Court of Chancery of the State of Delaware will be the sole and exclusive
forum for lawsuits asserting certain stockholder claims (including claims asserted derivatively for our benefit), such as claims against
directors and officers for breach of a fiduciary duty, claims arising under any provision of the General Corporation Law of Delaware or
our certificate of incorporation or our bylaws, or claims governed by the internal affairs doctrine. This is a general summary of the
bylaw provision; you should refer to the language of the bylaws for details. While the forum provision does not generally apply to
direct claims arising under the Securities Exchange Act of 1934 or the Securities Act of 1933, derivative lawsuits that assert legal
claims arising under these statutes could fall within the provision, as recent court decisions have held.
Lam Research Corporation 2026 10-K 25
-- 127 of 186 --
As a Delaware corporation, Delaware law controls issues of our internal affairs, including duties that our directors, officers,
employees, and others owe to the Company and its stockholders. We believe that our exclusive forum provision benefits us, and our
stockholders, by permitting relatively prompt resolution of lawsuits concerning our internal affairs, promoting consistent application of
Delaware law in these lawsuits, and reducing the possibility of duplicative, costly, multi-jurisdictional litigation with the potential for
inconsistent outcomes. However, the forum provision limits a stockholder’s ability to bring a claim in a judicial forum that it believes
may be more favorable than Delaware, and this could discourage the filing of such lawsuits.
FINANCIAL, ACCOUNTING AND CAPITAL MARKETS RISKS
The Market for Our Common Stock Is Volatile, Which May Affect Our Ability to Raise Capital or Make
Acquisitions or May Subject Our Business to Additional Costs
The market price for our Common Stock is volatile and has fluctuated significantly over the past years. The trading price of our
Common Stock could continue to be highly volatile and fluctuate widely in response to a variety of factors, many of which are not
within our control or influence. These factors include, but are not limited to, the following:
• general market, semiconductor, or semiconductor equipment industry conditions;
• economic or political events, trends, and unexpected developments occurring nationally, globally, or in any of our key
sales regions such as uncertainty regarding economic and other policies and priorities;
• the impact of stagnating or worsening business and economic conditions, including inflationary pressures, general
economic slowdown or a recession, actual or anticipated changes in interest rates, reductions in government spending
or other changes in monetary policy, or adverse financial or commodity markets activity or macroeconomic conditions,
including as a result of geopolitical conflicts;
• our operating and financial performance and the performance of other companies in our industry;
• variations in quarterly results of operations and financial condition, including our liquidity, experienced by us and other
companies in our industry;
• variations in our revenues, earnings, or other business and financial metrics from forecasts by us or securities analysts
or from those experienced by other companies in our industry;
• announcements of restructurings, reductions in force, departure of key employees, and/or consolidations of operations;
• transactions in our Common Stock by major investors and certain analyst reports, news, social media activity, and
speculation;
• margin trading, short sales, hedging and derivative transactions involving our Common Stock;
• government regulations, including export controls, tariffs, or other trade restrictions;
• developments in, or claims relating to, patent, or other proprietary rights;
• technological innovations and the introduction of new products by us or our competitors;
• commercial success or failure of our new and existing products; or
• disruptions of relationships with key customers or suppliers.
In addition, the stock market experiences significant price and volume fluctuations. Historically, we have witnessed significant volatility
in the price of our Common Stock due in part to the price of and markets for semiconductors. These and other factors have adversely
affected and may again adversely affect the price of our Common Stock, regardless of our actual operating performance. In the past,
following volatile periods in the price of their stock, many companies became the object of securities class action litigation. If we are
sued in a securities class action, we could incur substantial costs, and it could divert management’s attention and resources and have
an unfavorable impact on our financial performance and the price for our Common Stock.
We May Incur Impairments to Goodwill or Long-lived Assets
We review our goodwill identified in business combinations for impairment annually or whenever events or changes in circumstances
indicate that the carrying amount of these assets may exceed the fair value. We review all other long-lived assets, including finite-
lived intangible assets, whenever events or changes in circumstance indicate that these assets may not be recoverable. The process
of evaluating the potential impairment of goodwill and other long-lived assets requires judgment. Negative industry or economic
trends, including reduced market prices of our Common Stock, reduced estimates of future cash flows, disruptions to our business,
slower growth rates, or lack of growth in our relevant business units, could lead to impairment charges against our long-lived assets,
including goodwill and other intangible assets.
When evaluating goodwill, if we conclude that it is more likely than not that the fair value of a reporting unit is less than its carrying
amount, then a quantitative impairment test is performed and we may be required to record an impairment charge in that period,
which could adversely affect our result of operations.
When evaluating other long-lived assets, if we conclude that the estimated undiscounted cash flows attributable to the assets are less
than their carrying value, we recognize an impairment loss based on the excess of the carrying amount of the assets over their
respective fair values, which could adversely affect our results of operations.
Our valuation methodology for assessing impairment requires management to make judgments and assumptions based on historical
experience and to rely heavily on projections of future operating performance. We operate in a highly competitive environment and
projections of future results of operations and cash flows may vary significantly from actual results. Additionally, if our analysis
Lam Research Corporation 2026 10-K 26
-- 128 of 186 --
indicates potential impairment, we may be required to record additional charges to earnings in our financial statements, which could
negatively affect our results of operations.
Our Leverage and Debt Service Obligations May Adversely Affect Our Financial Condition and Results of
Operations
We have $3.75 billion in aggregate principal amount of senior unsecured notes outstanding (the “Senior Notes”). Additionally, we
have funding available to us under our $2.00 billion commercial paper program and our $2.00 billion revolving credit facility, which
serves as a backstop to our commercial paper program. Our revolving credit facility also includes an option to increase the amount up
to an additional $750.0 million, for a potential total commitment of $2.75 billion. We may, in the future, decide to enter into additional
debt arrangements.
In addition, we have entered, and in the future may enter, into derivative instrument arrangements to hedge against the variability of
cash flows due to changes in the benchmark interest rate of fixed rate debt. We could be exposed to losses in the event of
nonperformance by the counterparties to our derivative instruments.
Our indebtedness could have adverse consequences, including:
• risk associated with any inability to satisfy our obligations;
• a portion of our cash flows that may have to be dedicated to interest and principal payments and may not be available for
operations, working capital, capital expenditures, expansion, acquisitions, dividends, share repurchases, or general
corporate or other purposes; and
• impairment of our ability to obtain additional financing in the future.
Our ability to meet our expenses and debt obligations will depend on our future performance, which will be affected by financial,
business, economic, regulatory, and other factors. Furthermore, our operations may not generate sufficient cash flows to enable us to
meet our expenses and service our debt and our ability to satisfy such obligations will depend in part on the ability of our subsidiaries
to provide sufficient funds to us. Such ability may be affected by our subsidiaries’ individual operating results and any limitations or
restrictions to which they may be or may become subject. As a result, we may need to enter into new financing arrangements to
obtain the necessary funds. If we determine it is necessary to seek additional funding for any reason, we may not be able to obtain
such funding or, if funding is available, obtain it on acceptable terms. If we fail to make a payment on our debt, we could be in default
on such debt, and this default could cause us to be in default on our other outstanding indebtedness. Any default on our debt could
materially and negatively affect our results of operations, financial condition, reputation, credit ratings, and cost of borrowing.
Our Credit Agreements Contain Covenant Restrictions That May Limit Our Ability to Operate Our Business
We may be unable to respond to changes in business and economic conditions, engage in transactions that might otherwise be
beneficial to us, or obtain additional financing because our debt agreements contain, and any of our other future similar agreements
may contain, covenant restrictions that limit our ability to, among other things:
• incur additional debt, assume obligations in connection with letters of credit, or issue guarantees;
• create liens;
• enter into transactions with our affiliates;
• change the nature of our business;
• sell certain assets; and
• merge or consolidate with any person.
Our ability to comply with these covenants is dependent on our future performance, which will be subject to many factors, some of
which are beyond our control, including prevailing economic conditions. In addition, our failure to comply with these covenants could
result in a default under the Senior Notes, or our other debt, which could permit the holders to accelerate such debt. If any of our debt
is accelerated, we may not have sufficient funds available to repay such debt, which could materially and negatively affect our results
of operations, financial condition, reputation, credit ratings, and cost of borrowing.
There Can Be No Assurance That We Will Continue to Declare Cash Dividends or Repurchase Our Shares at All or
in Any Particular Amounts
Our Board of Directors has declared quarterly dividends since April 2014. Our intent to continue to pay quarterly dividends and to
repurchase our shares is subject to capital availability and periodic determinations by our Board of Directors that cash dividends and
share repurchases are in the best interest of our stockholders and are in compliance with all laws and agreements applicable to the
declaration and payment of cash dividends or the repurchasing of shares by us. Future dividends and share repurchases may also be
affected by, among other factors, our views on potential future capital requirements for investments in acquisitions and the funding of
our research and development; legal risks; changes in federal, state, and international tax laws or corporate laws; contractual
restrictions, such as financial or operating covenants in our debt arrangements; availability of onshore cash flow; the ability of our
subsidiaries to provide sufficient funds for us; and changes to our business model or our priorities for the use of cash for other
purposes. Our dividend payments and share repurchases may change from time to time, and we cannot provide assurance that we
will continue to declare dividends or repurchase shares at all or in any particular amounts. A reduction or suspension in our dividend
payments or share repurchases could have a negative effect on the price of our Common Stock.
Lam Research Corporation 2026 10-K 27
-- 129 of 186 --
If One or More of Our Counterparty Financial Institutions Default on Their Obligations To Us or Fail, We May
Incur Significant Losses
As part of our hedging activities, we enter into transactions involving derivative financial instruments, which may include forward
contracts, option contracts, collars, and swaps with various financial institutions. In addition, we have significant amounts of cash,
cash equivalents, and other investments on deposit or in accounts with banks or other financial institutions both in and outside of the
United States. As a result, we are exposed to the risk of default by or failure of counterparty financial institutions, which may be
heightened during economic downturns and periods of uncertainty or volatility in the financial markets. If one of our counterparties
were to become insolvent or file for bankruptcy, our ability to recover losses incurred as a result of default, or our assets deposited or
held in accounts with such counterparty, may be limited by the counterparty's liquidity or the applicable laws governing the insolvency
or bankruptcy proceedings. In the event of default or failure of one or more of our counterparties, we could incur significant losses,
which could negatively impact our results of operations, financial condition, and liquidity.
Item 1B. Unresolved Staff Comments
None.
Item 1C. Cybersecurity
We recognize the significant role of information security in safeguarding our valuable intellectual property along with the
confidentiality, integrity and availability of the data of our customers, employees, and suppliers. We have implemented certain
policies, procedures, and systems that are designed to identify and address material risks related to cybersecurity and cybersecurity
incidents.
We have a comprehensive enterprise risk management (“ERM”) program, which is implemented by management and overseen by
our Board of Directors (“Board”).
Our identification, assessment, and management of material risks from cybersecurity threats is integrated into the Company’s overall
ERM system and processes. Our ERM program is designed to leverage existing management processes to (i) identify critical
enterprise risks, including both information security and cybersecurity risks, (ii) design and implement appropriate risk mitigation
strategies, and (iii) assess the status of risks and mitigation plans.
A key component within our ERM framework is a robust information security risk management program, which includes:
• risk assessments designed to help identify risks to our critical systems, information, services, and our broader global
information systems environment;
• a security team principally responsible for managing (i) our cybersecurity risk assessment processes, (ii) our security
controls, and (iii) our response to cybersecurity incidents;
• the use of external service providers, where appropriate, to aid in assessing specific risks, provide benchmarking data,
provide information regarding trends or recent regulatory changes applicable to our risk profile, or to test or otherwise assist
with aspects of our security processes;
• the periodic engagement of an independent third-party expert to evaluate our security capabilities;
• mandatory annual cybersecurity awareness training of our employees, including incident response personnel and senior
management, as well as conducting periodic tests with our user population to reinforce good information security practices;
• a cybersecurity incident response plan that includes procedures for responding to cybersecurity incidents, including those
impacting the Company’s manufacturing sites;
• processes to identify vulnerabilities, breach attempts and possible criminal activity by external parties; and
• processes to assess the practices of our suppliers and third-party service providers relative to protecting the security of our
information.
The Company holds ISO 27001-2022 certification for information security at our corporate headquarters. Our Chief Information
Security Officer (“CISO”), who has over 30 years of experience in information security and technology leadership, has primary
responsibility for (i) leading our global information security program, (ii) managing the cybersecurity risks identified as part of the ERM
program, and (iii) developing, implementing, and enforcing security policies and maintaining information security systems.
Our global information security program, led by our CISO, includes dedicated teams specialized in (i) identity access management,
(ii) incident response, (iii) vulnerability governance, (iv) security operations and engineering (v) governance, risk, and compliance,
and (vi) insider risk and intelligence. The members of the information security team are responsible for managing, maintaining, and
monitoring the systems and processes that prevent, detect, mitigate and remediate cybersecurity incidents, and for informing our
CISO of status of such systems and processes, as well as any significant incidents.
Our Board is responsible for overseeing our strategy and approach to addressing information security risks, including the
management and assessment of risks from cybersecurity threats, both directly and through the audit committee. The audit committee
is responsible for reviewing and monitoring the Company’s cybersecurity and information security policies and its internal controls
regarding cybersecurity and information security. In addition, the audit committee is responsible for regularly reporting to the Board on
the substance of such reviews and, as necessary, recommending to the Board such actions as it deems appropriate. Our CISO
reports on information security risks at least annually to the Board and quarterly to the audit committee or Board.
Lam Research Corporation 2026 10-K 28
-- 130 of 186 --
We experience cybersecurity and other threats and incidents in the course of our operations. To date, we have not determined that
such threats and incidents have materially and adversely affected the Company, including our business strategy, results of operations
or financial condition. Furthermore, to date, we have not determined that such threats and incidents are reasonably likely to materially
and adversely affect the Company, including our business strategy, results of operations or financial condition.
For additional information on certain risks associated with cybersecurity, please refer to “Our Business Relies on Technology, Data,
Intellectual Property and Other Sensitive information That is Susceptible to Cybersecurity and Other Threats or Incidents” in Item 1A:
Risk Factors.
Item 2. Properties
Our executive offices and principal operating and R&D facilities are located in Fremont and Livermore, California; Tualatin, Oregon;
Yongin, Gyeonggi Province, Korea; Bengaluru, India; Salzburg, Austria; and Villach, Austria. In addition, we lease or own properties
for our service, technical support, and sales personnel throughout the United States, China, Europe, India, Japan, Korea, Southeast
Asia, and Taiwan and lease or own manufacturing and warehouse facilities located in California, Ohio, Oregon, Austria, Korea,
Malaysia, and Taiwan. The Company owns the majority of the Fremont, Livermore, and Tualatin facilities, as well as the
manufacturing facilities in Sherwood, Oregon; Ohio; and Malaysia. Our Villach, Austria facility is leased; the lease includes an option
to renew the lease or purchase the facilities. Our facilities lease obligations are subject to periodic increases. We believe that our
existing facilities are well-maintained and in good operating condition.
Item 3. Legal Proceedings
Please refer to the subsection entitled “Legal Proceedings” within Note 17: Commitments and Contingencies to our Consolidated
Financial Statements included in Part II, Item 8 of this 2026 Form 10-K.
Item 4. Mine Safety Disclosures
Not applicable.
Lam Research Corporation 2026 10-K 29
-- 131 of 186 --
"$
6-0 !0A:4C5>A&468BCA0=CMB><<>=@D8CH&4;0C43'C>2:7>;34A!0CC4AB0=3BBD4A
$DA270B4B>5@D8CH'42DA8C84B
'C>2:=5>A<0C8>=
)JGDBBDC-ID8@>HIG69:9DCI=:(6H96F!AD76A-:A:8I'6G@:I-'JC9:GI=:HNB7DAV&,2 WHD;J<JHI L:=69
HID8@=DA9:GHD;G:8DG9 HJ7HI6CI>6AAN<G:6I:GCJB7:GD;=DA9:GHD;DJGDBBDC-ID8@6G:HIG::IC6B:DG7:C:;>8>6A=DA9:GH L=DH:
H=6G:H6G:=:A97N76C@H 7GD@:GH6C9DI=:G;>C6C8>6A>CHI>IJI>DCH
8E834=3B
)JGD6G9D;>G:8IDGH=6H9:8A6G:9FJ6GI:GAN9>K>9:C9HH>C8:EG>A )JG>CI:CIID8DCI>CJ:IDE6NFJ6GI:GAN9>K>9:C9H>HHJ7?:8I
ID86E>I6A6K6>A67>A>IN6C9E:G>D9>89:I:GB>C6I>DCH7NDJGD6G9D;>G:8IDGHI=6I86H=9>K>9:C9H6G:>CI=:7:HI>CI:G:HID;DJG
HID8@=DA9:GH6C96G:>C8DBEA>6C8:L>I=6AAA6LH6C96<G::B:CIH6EEA>867A:IDI=:9:8A6G6I>DC6C9E6NB:CID;86H=9>K>9:C9H7NJH
JG>C<;>H86AN:6G DJGFJ6GI:GAN9>K>9:C99:8A6G:9L6H E:GH=6G:
&4?DA270B4B>5><?0=H'70A4B
#C'6N I=:D6G9D;>G:8IDGH6JI=DG>O:9B6C6<:B:CIIDG:EJG8=6H:JEID6C699>I>DC6A 7>AA>DCD;DBBDC-ID8@I=>H
6JI=DG>O6I>DCHJEEA:B:CIHI=:G:B6>C>C<76A6C8:;GDB6CNEG>DG6JI=DG>O6I>DC .=:H:G:EJG8=6H:H86C7:8DC9J8I:9DCI=:DE:C
B6G@:IDG6HEG>K6I:EJG8=6H:H6C9B6N>C8AJ9:I=:JH:D;9:G>K6I>K:8DCIG68IHL>I=A6G<:;>C6C8>6A>CHI>IJI>DCH >C6AA86H:HHJ7?:8IID
8DBEA>6C8:L>I=6EEA>867A:A6L .=>HG:EJG8=6H:EGD<G6B=6HCDI:GB>C6I>DC96I:6C9B6N7:HJHE:C9:9DG9>H8DCI>CJ:96I6CN
I>B:
224;4A0C43'70A4&4?DA270B46A44<4=CB
)C'6G8= L::CI:G:9>CID6C688:A:G6I:9H=6G:G:EJG8=6H:6<G::B:CII=:V'6G8=-,WL>I=6;>C6C8>6A>CHI>IJI>DC
IDG:EJG8=6H:6IDI6AD; B>AA>DCD;DBBDC-ID8@ 1:IDD@6C>C>I>6A9:A>K:GND;6EEGDM>B6I:ANI=DJH6C9H=6G:H L=>8=
G:EG:H:CI:9D;I=:EG:E6NB:CI6BDJCI9>K>9:97NDJG8ADH>C<HID8@EG>8:DC'6G8= .=:IDI6ACJB7:GD;H=6G:H
G:8:>K:9JC9:GI=:'6G8=-,L6H76H:9JEDCI=:6K:G6<:96>ANKDAJB:L:><=I:96K:G6<:EG>8:D;DJGDBBDC-ID8@9JG>C<
I=:G:EJG8=6H:E:G>D9 A:HH6C6<G::9JEDC9>H8DJCI >C6AH:IIA:B:CID;I=:'6G8=-,HD88JGG:9>C$JC: G:HJAI>C<>C
I=:G:8:>EID;6EEGDM>B6I:ANI=DJH6C9699>I>DC6AH=6G:H L=>8=N>:A9:96L:><=I:9 6K:G6<:H=6G:EG>8:D; ;DGI=:
IG6CH68I>DCE:G>D9 >C8AJ9>C<I=::;;:8IHD;6:M8>H:I6MJC9:GI=:#C;A6I>DC,:9J8I>DC8I
)CEG>A L::CI:G:9>CID688:A:G6I:9H=6G:G:EJG8=6H:6<G::B:CIHI=:EG>A-,HL>I=ILD;>C6C8>6A>CHI>IJI>DCHID
G:EJG8=6H:6IDI6AD; B>AA>DCD;DBBDC-ID8@ 1:IDD@6C>C>I>6A9:A>K:GND;6EEGDM>B6I:AN B>AA>DCH=6G:H L=>8=
G:EG:H:CI:9D;I=:EG:E6NB:CI6BDJCI9>K>9:97NDJG8ADH>C<HID8@EG>8:DCEG>A .=:IDI6ACJB7:GD;H=6G:HG:8:>K:9
JC9:GI=:EG>A-,HL6H76H:9JEDCI=:6K:G6<:96>ANKDAJB:L:><=I:96K:G6<:EG>8:D;DJGDBBDC-ID8@9JG>C<I=:
G:EJG8=6H:E:G>D9 A:HH6C6<G::9JEDC9>H8DJCI >C6AH:IIA:B:CID;I=:EG>A-,HD88JGG:9>C-:EI:B7:G G:HJAI>C<>C
I=:G:8:>EID;6EEGDM>B6I:ANI=DJH6C9699>I>DC6AH=6G:H L=>8=N>:A9:96L:><=I:9 6K:G6<:H=6G:EG>8:D; ;DGI=:
IG6CH68I>DCE:G>D9 >C8AJ9>C<I=::;;:8IHD;6:M8>H:I6MJC9:GI=:#C;A6I>DC,:9J8I>DC8I
-=6G:G:EJG8=6H:H >C8AJ9>C<I=DH:JC9:GI=:G:EJG8=6H:EGD<G6B L:G:6H;DAADLH
#2?6<1
&<A.9!B:/2?
<3%5.?2@
$2=B?05.@21
C2?.42
#?602#.61
=2?%5.?2
&<A.9!B:/2?<3
%5.?2@#B?05.@21
.@#.?A<3#B/9609F
;;<B;021#9.;@
<?#?<4?.:@
:<B;A
C.69./92
';12?
$2=B?05.@2
#?<4?.:
6;A5<B@.;1@2E02=A=2?@5.?21.A.
K6>A67A:76A6C8:6HD;$JC:
+J6GI:G:C9:9-:EI:B7:G
+J6GI:G:C9:9:8:B7:G
+J6GI:G:C9:9'6G8=
EG>A '6N
'6N $JC:
.DI6A
.=:G:L:G:CDH=6G:G:EJG8=6H:H>CI=:;>H86ABDCI=:C9>C<EG>A
K:G6<:EG>8:E6>9E:GH=6G::M8AJ9:HI=::;;:8ID;688:A:G6I:9H=6G:G:EJG8=6H:68I>K>I>:H -::699>I>DC6A9>H8ADHJG:67DK:G:<6G9>C<DJG
688:A:G6I:9H=6G:G:EJG8=6H:68I>K>IN9JG>C<I=:;>H86AN:6G
&6B,:H:6G8=DGEDG6I>DC %
-- 132 of 186 --
)JGC:IH=6G:G:EJG8=6H:H6G:HJ7?:8IID6:M8>H:I6MJC9:GI=:#C;A6I>DC,:9J8I>DC8I M8>H:I6M>C8JGG:9G:9J8:HI=:6BDJCI6K6>A67A:
JC9:GG:EJG8=6H:EGD<G6BH 6H6EEA>867A: 6C9>H>C8AJ9:9>CI=:8DHID;H=6G:HG:EJG8=6H:9>CI=:DCHDA>96I:9-I6I:B:CID;-ID8@=DA9:GHU
FJ>IN6C9I=:86A8JA6I>DCD;I=:6K:G6<:EG>8:E6>9E:GH=6G:
#C8AJ9:HH=6G:HG:8:>K:96I>C>I>6ADG;>C6AH:IIA:B:CID;688:A:G6I:9H=6G:G:EJG8=6H:6<G::B:CIHH::699>I>DC6A9>H8ADHJG:H67DK:G:<6G9>C<
DJG688:A:G6I:9H=6G:G:EJG8=6H:68I>K>IN9JG>C<I=:;>H86AN:6G
K:G6<:EG>8:E6>9E:GH=6G:EG:H:CI:9>H;DGI=:FJ6GI:G:C9:9$JC:
D<D;0C8E48E4-40A&4CDA=
.=:<G6E=7:ADL8DBE6G:H&6B,:H:6G8=DGEDG6I>DCUH8JBJA6I>K:;>K: N:6GIDI6AH=6G:=DA9:GG:IJGCDCDBBDC-ID8@L>I=I=:
8JBJA6I>K:IDI6AG:IJGCHD;I=:*=>A69:AE=>6-:B>8DC9J8IDG-:8IDG.DI6A,:IJGC#C9:M I=:(6H96FDBEDH>I:.DI6A,:IJGC>C9:M 6C9
I=:-I6C96G9*DDGUHV-*W.,>C9:M .=:<G6E=IG68@HI=:E:G;DGB6C8:D;6>CK:HIB:CI>CDJGDBBDC-ID8@6C9>C
:68=D;I=:>C9>8:HL>I=I=:G:>CK:HIB:CID;6AA9>K>9:C9H;DGI=:;>K:N:6GH:C9:9$JC:
#!$&'#"#*-&)!) (*(#( &()&"
BDC<&6B,:H:6G8=DGEDG6I>DC I=:
*=>A69:AE=>6-:B>8DC9J8IDG-:8IDG.DI6A,:IJGC
#C9:M I=:(6H96FDBEDH>I:.DI6A,:IJGC#C9:M
6C9I=:-*.,#C9:M
-*.,#C9:M
(6H96FDBEDH>I:.DI6A,:IJGC#C9:M
*=>A69:AE=>6-:B>8DC9J8IDG-:8IDG.DI6A,:IJGC#C9:M
&6B,:H:6G8=DGEDG6I>DC
>CK:HI:9DC$JC: >CHID8@DG>C9:M >C8AJ9>C<G:>CK:HIB:CID;9>K>9:C9H
DENG><=IQ-I6C96G9*DDGUH 69>K>H>DCD;-*!AD76A AAG><=IHG:H:GK:9
B;2 B;2 B;2 B;2 B;2
B;2
&6B,:H:6G8=DGEDG6I>DC
*=>A69:AE=>6-:B>8DC9J8IDG-:8IDG.DI6A,:IJGC#C9:M
(6H96FDBEDH>I:.DI6A,:IJGC#C9:M
-*.,#C9:M
&6B,:H:6G8=DGEDG6I>DC %
-- 133 of 186 --
Item 6. [Reserved]
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) generally discusses
fiscal year 2026 and 2025 items and year-to-year comparisons between fiscal year 2026 and 2025 and should be read in conjunction
with our Consolidated Financial Statements and accompanying Notes to Consolidated Financial Statements included in Part II, Item 8
of this 2026 Form 10-K. A discussion of fiscal year 2024 items and year-to-year comparisons between fiscal year 2025 and 2024 that
are not included in this 2026 Form 10-K can be found in “Management’s Discussion and Analysis of Financial Condition and Results
of Operations” in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended June 29, 2025.
Executive Summary
Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry.
We have built a strong global presence with core competencies in areas like nanoscale manufacturing enablement, chemistry,
plasma and fluidics, advanced systems engineering and a broad range of operational disciplines. Our products and services are
designed to help our customers build smaller and better performing devices that are used in a variety of electronic products, including
mobile phones, personal computers, cloud and enterprise servers, wearables, automotive vehicles, and data storage devices.
Our customer base includes leading semiconductor memory, foundry, and integrated device manufacturers that make products such
as NVM, DRAM, and logic devices. Their continued success is part of our commitment to driving semiconductor breakthroughs that
define the next generation. Our core technical competency is integrating hardware, process, materials, software, and process control,
enabling results on the wafer.
Semiconductor manufacturing, our customers’ business, involves the fabrication of multiple dies or integrated circuits on a wafer. This
involves the repetition of a set of core processes and can require hundreds of individual steps. Fabricating these devices requires a
sequence of highly sophisticated process technologies to integrate an increasing array of new materials with precise control at the
atomic scale. Along with meeting technical requirements, wafer processing equipment must deliver high productivity and be cost-
effective.
Demand for electronic systems supporting artificial intelligence, cloud infrastructure, communications, automotive, industrial and other
intelligent systems is driving the need for high performance, energy efficient and highly integrated semiconductor devices. To meet
these requirements, semiconductor manufacturers are adopting vertical scaling approaches, including three-dimensional (“3D”)
architecture, more sophisticated patterning schemes, new materials, and advanced integration approaches, as traditional two-
dimensional scaling is becoming more challenging. These technology inflections are increasing manufacturing complexity and
precision requirements in the production of semiconductors driving demand for our advanced semiconductor fabrication technologies
and services.
We believe we are in a strong position with our leadership and expertise in deposition, etch, and clean markets to facilitate some of
the most significant innovations in semiconductor device manufacturing. Our Customer Support Business Group provides products
and services to maximize installed equipment performance, predictability, and operational efficiency. Several factors create
opportunities for sustainable differentiation for us: (i) our focus on research and development, with several ongoing programs relating
to sustaining engineering, product and process development, and concept and feasibility; (ii) our ability to effectively leverage cycles
of learning from our broad installed base; (iii) our collaborative focus with semi-ecosystem partners, including our close-to-customer
focus; (iv) our ability to identify and invest in the breadth of our product portfolio to meet technology inflections; and (v) our focus on
delivering our multi-product solutions with a goal to enhance the value of Lam’s solutions to our customers.
Wafer fabrication equipment investments were strong in the 2025 calendar year, and have continued to grow in 2026 with the AI
market driving higher semiconductor industry spending across both the memory and non-memory market segments. In the short
term, volatility in the semiconductor industry environment from trade restrictions, tariffs, as well as other direct and indirect risks and
uncertainties discussed in Part I, Item 1A, “Risk Factors,” have had, and in the future may have, a negative impact on our revenue
and operating margin. Over the longer term, we believe that secular demand for semiconductors, combined with technology
inflections in our industry, including 3D device scaling, multiple patterning, process flow, and advanced packaging chip integration, will
drive sustainable growth and lead to an increase in the served available market for our products and services in the deposition, etch,
and clean businesses.
Lam Research Corporation 2026 10-K 32
-- 134 of 186 --
.=:;DAADL>C<I67A:HJBB6G>O:H8:GI6>C@:N;>C6C8>6A>C;DGB6I>DC;DGI=:E:G>D9H>C9>86I:97:ADL
+2.?;121 5.;42
B;2
B;2
+ C@+
6;A5<B@.;1@2E02=A=2?@5.?21.A.=2?02;A.42@.;1
/.@6@=<6;A@
,:K:CJ:
!GDHHB6G<>C
!GDHHB6G<>C6H6E:G8:CID;IDI6AG:K:CJ: 7EH
.DI6ADE:G6I>C<:ME:CH:H
(:I>C8DB:
(:I>C8DB:E:G9>AJI:9H=6G:
>H86AN:6GG:K:CJ:>C8G:6H:9 8DBE6G:9ID;>H86AN:6G 9G>K:C7NHIGDC<8JHIDB:G9:B6C9;DGH:B>8DC9J8IDG
:FJ>EB:CIHNHI:BH E6GI>8JA6GAN;GDB8JHIDB:GHL>I=>CI=:;DJC9GNB6G@:IH:<B:CI 6HL:AA6H8JHIDB:GHJEEDGI G:A6I:9G:K:CJ:H
!GDHHB6G<>C6H6E:G8:CI6<:D;G:K:CJ:>C8G:6H:9>C;>H86AN:6G8DBE6G:9ID;>H86AN:6GA6G<:AN9J:ID;6KDG67A:
8JHIDB:GB>M E6GI>6AAND;;H:I7N6AJB>CJB6C9HI::AI6G>;; G:A6I:9HE:C9 .=:>C8G:6H:>CDE:G6I>C<:ME:CH:H>C;>H86AN:6G
8DBE6G:9ID;>H86AN:6GL6HEG>B6G>AN 9J:ID:BEADN:: G:A6I:98DHIH;GDB>C8G:6H:9=:698DJCI6C9=><=:GHJEEA>:HHE:C9>C<
;DGG:H:6G8=6C99:K:ADEB:CI
)JG86H=6C986H=:FJ>K6A:CIH6C9G:HIG>8I:986H=76A6C8:HIDI6A:96EEGDM>B6I:AN 7>AA>DC6HD;$JC: 8DBE6G:9ID
7>AA>DC6HD;$JC: 6H=;ADLHEGDK>9:9;GDBDE:G6I>C<68I>K>I>:HL:G: 7>AA>DC;DG;>H86AN:6G8DBE6G:9ID
7>AA>DC;DG;>H86AN:6G 6H=;ADLHEGDK>9:9;GDBDE:G6I>C<68I>K>I>:H>C;>H86AN:6GL:G:EG>B6G>ANJH:9;DG 7>AA>DC
>CIG:6HJGNHID8@EJG8=6H:H >C8AJ9>C<C:IH=6G:H:IIA:B:CID;:BEADN::HID8@ 76H:98DBE:CH6I>DC 7>AA>DC>C9>K>9:C9HE6>9ID
DJGHID8@=DA9:GH B>AA>DCD;86E>I6A:ME:C9>IJG:H6C9 B>AA>DCD;EG>C8>E6AE6NB:CIDC9:7I>CHIGJB:CIH6C99:7I
>HHJ6C8:8DHIH
&4BD;CB>5#?4A0C8>=B
&4E4=D4
1:<:C:G6I:G:K:CJ:EG>B6G>ANI=GDJ<=I=:H6A:6C9H:GK>8:D;H:B>8DC9J8IDGB6CJ;68IJG>C<:FJ>EB:CI :B6C9;DGDJGEGD9J8IH
6C9H:GK>8:H>H9G>K:C7N8JHIDB:GHU>CK:HIB:CIH>CL6;:G;67G>86I>DC86E68>IN I:8=CDAD<N69K6C8:B:CI6C9>CHI6AA:976H:HJEEDGI
1:EG:H:CIG:K:CJ:DC69>H6<<G:<6I:976H>HID9>;;:G:CI>6I:7:IL::CHNHI:BHG:K:CJ:6C98JHIDB:GHJEEDGI G:A6I:9G:K:CJ:
-NHI:BHG:K:CJ:>C8AJ9:HH6A:HD;C:LA:69>C< :9<::FJ>EB:CI>C9:EDH>I>DC :I8= 8A:6C6C9DI=:GL6;:G;67G>86I>DCB6G@:IH
JHIDB:GHJEEDGI G:A6I:9G:K:CJ:>C8AJ9:HH6A:HD;8JHIDB:GH:GK>8:H HE6G:H JE<G69:H 6C9CDC A:69>C< :9<::FJ>EB:CI;GDBI=:
DBE6CNUH,:A>6CIREGD9J8IA>C:
.>B>C<D;G:K:CJ:G:8D<C>I>DC9:E:C9HDC6CJB7:GD;;68IDGH >C8AJ9>C<8JHIDB:GG:FJ>G:B:CIH G:HDJG8:6K6>A67>A>IN HJEEAN 8=6>C
8DC9>I>DCH B6CJ;68IJG>C<86E68>IN 9:A>K:GNH8=:9JA:H 6C9DI=:GDE:G6I>DC6A8DCH>9:G6I>DCH
1:EG:H:CIDJGG:K:CJ:H9>H6<<G:<6I:97N<:D<G6E=>8G:<>DC76H:9DCI=:AD86I>DCD;8JHIDB:GHU;68>A>I>:HIDL=>8=EGD9J8IHL:G:
H=>EE:96C9H:GK>8:HL:G:G:C9:G:9 H><C>;>86CIEDGI>DCD;DJGG:K:CJ:>H<:C:G6I:9DJIH>9:D;I=:/C>I:9-I6I:H
.=:;DAADL>C<I67A:EG:H:CIHDJGIDI6AG:K:CJ:6C9G:K:CJ:9>H6<<G:<6I:97N<:D<G6E=>8G:<>DC
+2.?;121
B;2
B;2
,:K:CJ:>CB>AA>DCH
=>C6
.6>L6C
%DG:6
$6E6C
/C>I:9-I6I:H
-DJI=:6HIH>6
JGDE:
&6B,:H:6G8=DGEDG6I>DC %
-- 135 of 186 --
.=:;DAADL>C<I67A:EG:H:CIHDJGG:K:CJ:9>H6<<G:<6I:97:IL::CHNHI:B6C98JHIDB:GHJEEDGI G:A6I:9G:K:CJ:
+2.?;121
B;2
B;2
6;A5<B@.;1@
-NHI:BH,:K:CJ:
JHIDB:GHJEEDGI G:A6I:9G:K:CJ:6C9DI=:G
-NHI:BHG:K:CJ:>C8G:6H:97N 7>AA>DC DG >C;>H86AN:6G8DBE6G:9ID;>H86AN:6GEG>B6G>AN9J:ID;DJC9GN
:FJ>EB:CI8JHIDB:GHE:C9>C< JHIDB:GHJEEDGI G:A6I:9G:K:CJ:>C8G:6H:97N 7>AA>DC DG >C;>H86AN:6G8DBE6G:9
ID;>H86AN:6GB6>CAN9J:IDG:K:CJ:;GDBHE6G:H6C9CDC A:69>C< :9<::FJ>EB:CI
.=:E:G8:CI6<:D;A:69>C< 6C9CDC A:69>C< :9<::FJ>EB:CI6C9JE<G69:G:K:CJ:;GDB:68=D;I=:B6G@:IHL:H:GK:L6H6H
;DAADLH
+2.?;121
B;2
B;2
DJC9GN
':BDGN
&D<>8>CI:<G6I:99:K>8:B6CJ;68IJG>C<
.=:E:G8:CI6<:D;G:K:CJ:;GDBI=: DJC9GNB6G@:IH:<B:CI>C8G:6H:97N76H>HED>CIH>C;>H86AN:6G8DBE6G:9ID;>H86A
N:6G9J:IDB6IJG:CD9:HE:C9>C<6HL:AA6H>CK:HIB:CIH>CA:69>C< :9<::FJ>EB:CI .=:E:G8:CI6<:D;G:K:CJ:;GDBI=:
':BDGNB6G@:IH:<B:CI9:8G:6H:97N76H>HED>CIH>C;>H86AN:6G8DBE6G:9ID;>H86AN:6GEG>B6G>AN9J:IDI>B>C<D;
8JHIDB:G>CK:HIB:CIH
.=:9:;:GG:9G:K:CJ:76A6C8:9:8G:6H:9ID 7>AA>DC6HD;$JC: 8DBE6G:9ID 7>AA>DC6HD;$JC: EG>B6G>AN
9J:69:8G:6H:>C8JHIDB:G9DLCE6NB:CIH E6GI>6AAND;;H:I7N6C>C8G:6H:>C:6GC:9HNHI:B8G:9>IH
A>BB!0A68=
+2.?;121 5.;42
B;2
B;2
+ C@+
6;A5<B@.;1@2E02=A=2?02;A.42@.;1/.@6@=<6;A@
!GDHHB6G<>C
*:G8:CID;G:K:CJ: 7EH
.=:>C8G:6H:>C<GDHHB6G<>C6H6E:G8:CI6<:D;G:K:CJ:;DG;>H86AN:6G8DBE6G:9ID;>H86AN:6GL6HA6G<:AN9J:ID
;6KDG67A:8JHIDB:GB>M E6GI>6AAND;;H:I7N6AJB>CJB6C9HI::AI6G>;; G:A6I:9HE:C9
&4B40A270=34E4;>?<4=C
+2.?;121 5.;42
B;2
B;2
+ C@+
6;A5<B@.;1@2E02=A=2?02;A.42@.;1/.@6@=<6;A@
,:H:6G8=9:K:ADEB:CI
*:G8:CID;G:K:CJ: 7EH
1:8DCI>CJ:9IDB6@:H><C>;>86CI,>CK:HIB:CIH;D8JH:9DCA:69>C< :9<:9:EDH>I>DC :I8= 8A:6C 6C9DI=:GH:B>8DC9J8IDG
B6CJ;68IJG>C<EGD8:HH:H >H86AN:6G,:ME:CH:>C8G:6H:9K:GHJH;>H86AN:6G 9J:ID B>AA>DC>C:BEADN::
G:A6I:98DHIH;GDB>C8G:6H:9=:698DJCI6C9 B>AA>DC>C=><=:G:C<>C::G>C<HJEEA>:H:ME:CH:
&6B,:H:6G8=DGEDG6I>DC %
-- 136 of 186 --
'4;;8=64=4A0;0=33<8=8BCA0C8E4
+2.?;121 5.;42
B;2
B;2
+ C@+
6;A5<B@.;1@2E02=A=2?02;A.42@.;1/.@6@=<6;A@
-:AA>C< <:C:G6A 6C969B>C>HIG6I>K:-!
*:G8:CID;G:K:CJ: 7EH
.=:>C8G:6H:>C-!:ME:CH:9JG>C<;>H86AN:6G8DBE6G:9ID;>H86AN:6GL6HB6>CAN9G>K:C7N6C>C8G:6H:D;
B>AA>DC>C:BEADN:: G:A6I:98DHIH6H6G:HJAID;699>I>DC6A=:698DJCI
#C74A=2><4G?4=B4"4C
)I=:G>C8DB::ME:CH: C:I 8DCH>HI:9D;I=:;DAADL>C<
+2.?;121 5.;42
B;2
B;2
+ C@+
6;A5<B@.;1@2E02=A=2?02;A.42@
#CI:G:HI>C8DB:
#CI:G:HI:ME:CH:
!6>CHDC9:;:GG:98DBE:CH6I>DCEA6CG:A6I:96HH:IH C:I
DG:><C:M8=6C<:ADHH:H C:I
)I=:G C:I
#CI:G:HI>C8DB:9:8G:6H:9>C;>H86AN:6G8DBE6G:9ID;>H86AN:6GEG>B6G>AN9J:IDADL:G>CI:G:HIG6I:H6HL:AA6H6C>BE68I
;GDBHA><=IANADL:G6K:G6<:>CK:HI:986H=76A6C8:HK:GHJHI=:EG>DGN:6G
#CI:G:HI:ME:CH:9:8G:6H:9>C;>H86AN:6G8DBE6G:9ID;>H86AN:6GEG>B6G>AN9J:IDI=:B6IJG>IND; B>AA>DCD;I=:
DBE6CNUH-:C>DG(DI:H>C'6G8=
.=:<6>CHDC9:;:GG:98DBE:CH6I>DCEA6CG:A6I:96HH:IH C:IL:G:9G>K:C7N;AJ8IJ6I>DCH>CI=:;6>GB6G@:IK6AJ:D;I=:JC9:GAN>C<
;JC9H
DG:><C:M8=6C<:;AJ8IJ6I>DCHL:G:EG>B6G>AN9J:ID8JGG:C8NBDK:B:CIH6<6>CHIEDGI>DCHD;DJGJC=:9<:976A6C8:H=::I:MEDHJG:H
.=:K6G>6I>DC>CDI=:G C:I;DGI=:;>H86AN:6G8DBE6G:9ID;>H86AN:6G L6HEG>B6G>AN9G>K:C7N;AJ8IJ6I>DCH>CI=:;6>GB6G@:I
K6AJ:D;:FJ>IN>CK:HIB:CIH
=2><4(0GG?4=B4
)JGEGDK>H>DC;DG>C8DB:I6M:H6C9:;;:8I>K:I6MG6I:;DGI=:E:G>D9H>C9>86I:9L:G:6H;DAADLH
+2.?;121 5.;42
B;2
B;2
+ C@+
6;A5<B@.;1@2E02=A=2?02;A.42@.;1/.@6@=<6;A@
#C8DB:I6M:ME:CH:
;;:8I>K:I6MG6I: 7EH
.=:>C8G:6H:>CI=::;;:8I>K:I6MG6I:>C;>H86AN:6G6H8DBE6G:9ID;>H86AN:6GL6HEG>B6G>AN9J:IDI=:G:8D<C>I>DCD;
EG:K>DJHANJCG:8D<C>O:9I6M7:C:;>IH;GDBA6EH:HD;HI6IJI:HD;A>B>I6I>DC>C;>H86AN:6G6C9!AD76A'>C>BJB.6MV!'.W7:>C<
;JAAN:;;:8I>K:>C;>H86AN:6G D;;H:I7NI=:8=6C<:>CA:K:A6C9EGDEDGI>DCD;>C8DB:>C=><=:G6C9ADL:GI6M?JG>H9>8I>DCH6C9
=><=:GHID8@ 76H:98DBE:CH6I>DC:M8:HHI6M7:C:;>IH>C;>H86AN:6G
#CI:GC6I>DC6AG:K:CJ:H688DJCI;DG6H><C>;>86CIEDGI>DCD;DJGIDI6AG:K:CJ:H HJ8=I=6I6B6I:G>6AEDGI>DCD;DJGEG: I6M>C8DB:>H
:6GC:9DJIH>9:I=:/C>I:9-I6I:H #CI:GC6I>DC6AEG: I6M>C8DB:>H<:C:G6AANI6M67A:>CI=:/C>I:9-I6I:H6I6ADL:G:;;:8I>K:I6MG6I:
I=6CI=:;:9:G6AHI6IJIDGNI6MG6I: *A:6H:G:;:GID(DI:#C8DB:.6M:HIDDJGDCHDA>96I:9 >C6C8>6A-I6I:B:CIH>C*6GI## #I:BID
I=>H DGB %;DG699>I>DC6A>C;DGB6I>DC
&6B,:H:6G8=DGEDG6I>DC %
-- 137 of 186 --
The Organization for Economic Co-operation and Development’s Base Erosion and Profit Shifting 2.0 (“BEPS 2.0”) GMT was fully
effective for us this fiscal year. We assessed GMT under currently enacted legislation and determined that we met transitional safe
harbor requirements in most jurisdictions, with limited jurisdictions subject to GMT. We assessed the impact and concluded that it was
not material. The impact has been included within income tax expense in fiscal year 2026.
On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was signed into law by U.S. President Donald Trump. The impact on
income taxes due to change in legislation is required, under Accounting Standards Codification (“ASC”) 740, Income Taxes, to be
recognized in the period in which the law is enacted, which was this fiscal year. In general, the OBBBA introduced changes to U.S.
taxation, including changes in the taxation of non-U.S. income. We assessed the changes and concluded that they were not material.
The impact has been included within income tax expense in fiscal year 2026.
Deferred Income Taxes
Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for
financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Our gross
deferred tax assets were $2.26 billion and $1.90 billion at the end of fiscal years 2026 and 2025, respectively. These gross deferred
tax assets were offset by gross deferred tax liabilities of $235.5 million and $197.3 million and a valuation allowance primarily
representing our entire California deferred tax asset balance due to the single sales factor apportionment resulting in lower taxable
income in California of $464.1 million and $424.3 million at the end of fiscal years 2026 and 2025, respectively. The change in gross
deferred tax assets, gross deferred tax liabilities, and valuation allowance between fiscal year 2026 and 2025 is primarily due to
increases in gross deferred tax assets for outside basis differences of foreign subsidiaries.
We evaluate if the deferred tax assets are realizable on a quarterly basis and will continue to assess the need for changes in
valuation allowances, if any.
Uncertain Tax Positions
We re-evaluate uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes
in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Any change in recognition
or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision.
Critical Accounting Policies and Estimates
A critical accounting policy is defined as one that has both a material impact on our financial condition and results of operations and
requires us to make difficult, complex and/or subjective judgments, often as a result of the need to make estimates about matters that
are inherently uncertain. The preparation of financial statements in conformity with U.S. generally accepted accounting principles
(“GAAP”) requires management to make certain judgments, estimates and assumptions that could affect the reported amounts of
assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting
period. We base our estimates and assumptions on historical experience and on various other assumptions we believe to be
applicable and evaluate them on an ongoing basis to ensure they remain reasonable under current conditions. Actual results could
differ significantly from those estimates, which could have a material impact on our business, results of operations, and financial
condition. Our critical accounting estimates include:
• the recognition and valuation of revenue;
• the valuation of inventory, which impacts gross margin; and
• the recognition and measurement of current and deferred income taxes, including the measurement of uncertain tax
positions, which impact our provision for income tax expenses.
We believe that the following critical accounting policies reflect the more significant judgments and estimates used in the preparation
of our consolidated financial statements regarding the critical accounting estimates indicated above. See Note 2: Summary of
Significant Accounting Policies of our Consolidated Financial Statements in Part II, Item 8 of this 2026 Form 10-K for additional
information regarding our accounting policies.
Revenue Recognition: We generally consider documentation of terms with an approved purchase order as a customer contract,
provided that collection is considered probable, which is assessed based on the creditworthiness of the customer as determined by
credit checks, payment histories, and/or other circumstances. The transaction price for our contracts with customers is allocated
among the identified performance obligations and consists of both fixed and variable consideration provided it is probable that a
significant reversal of revenue will not occur when the uncertainty related to variable consideration is resolved. Fixed consideration
includes amounts to be contractually billed to the customer while variable consideration includes estimates for discounts and credits
for future usage which are based on contractual terms outlined in volume purchase agreements and other factors known at the time.
We generally invoice customers at shipment and for professional services as provided. Revenue for systems and spares are
recognized at a point in time, which is generally upon shipment or delivery. Revenue from services is recognized over time as
services are completed or ratably over the contractual period of generally one year or less. Revenue is recognized in an amount that
reflects the consideration to which we expect to be entitled in exchange for those goods or services. We elect to use the practical
expedient afforded in the accounting guidance and therefore do not disclose remaining performance obligations for contracts with a
Lam Research Corporation 2026 10-K 36
-- 138 of 186 --
duration of less than one year. Additionally, outstanding customer contracts with remaining durations more than one year are not
material as of June 28, 2026.
Inventory Valuation: Inventories are stated at the lower of cost or net realizable value using standard costs that approximate
actual cost on a first-in, first-out basis. Inventory in excess of management’s estimated usage requirement and obsolete inventory is
written down to its estimated net realizable value if less than cost. Estimates of net realizable value include but are not limited to
customer demand, management’s forecasts related to our future manufacturing schedules, technological and/or market
obsolescence, general semiconductor market conditions, and possible alternative uses.
Income Taxes: Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and
liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards.
We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. The
assessment of valuation allowances against our deferred tax assets includes estimation and judgement with respect to future
operating results and market conditions. We have an accounting policy election to record deferred taxes related to Global Intangible
Low-Taxed Income (“GILTI”).
We recognize the benefit from a tax position only if it is more likely than not that the position will be sustained upon audit based solely
on the technical merits of the tax position. We have a policy to include interest and penalties related to uncertain tax positions as a
component of income tax expense.
Recent Accounting Pronouncements
See Note 3 - Recent Accounting Pronouncements, of our Consolidated Financial Statements, included in Part II, Item 8 of this 2026
Form 10-K for details of any recently adopted or effective accounting pronouncements.
Updates Not Yet Effective
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03,
“Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of
Income Statement Expenses,” which requires disaggregation of certain expenses in the notes to the financial statements to provide
enhanced transparency into the expense captions presented on the face of the income statement. In January 2025, the FASB issued
ASU 2025-01 which clarified the effective date for entities that do not have an annual reporting period that ends on December 31st.
The guidance is effective for annual periods beginning after December 15, 2026, and interim reporting periods within annual reporting
periods beginning after December 15, 2027, with early adoption permitted. The Company is required to adopt this standard in fiscal
year 2028 for the annual reporting period ending June 25, 2028 either (1) prospectively to financial statements issued for reporting
periods after the effective date or (2) retrospectively to any or all prior periods presented in the financial statements. The Company
will apply the guidance prospectively and is currently in the process of evaluating the impact of adoption on its Consolidated Financial
Statements.
In December 2025, the FASB issued ASU 2025-10, “Accounting for Government Grants Received by Business Entities,” which
introduces guidance for recognizing, measuring, and presenting government grants, addressing diversity in practice. The guidance is
effective for annual reporting periods beginning after December 15, 2028, and interim reporting within those annual reporting periods,
with early adoption permitted. The Company is required to adopt this standard in the first quarter of fiscal year 2030. The Company
does not expect the adoption of ASU 2025-10 to have an impact on its Consolidated Financial Statements.
Liquidity and Capital Resources
Total gross cash, cash equivalents, and restricted cash balances were $5.60 billion at the end of fiscal year 2026 compared to $6.41
billion at the end of fiscal year 2025. This decrease was primarily due to Common Stock repurchases in connection with our stock
repurchase program, dividends paid, capital expenditures, and principal payments on debt instruments, partially offset by cash
provided by operating activities.
Lam Research Corporation 2026 10-K 37
-- 139 of 186 --
0B7;>FB5A><#?4A0C8=62C8E8C84B
(:I86H=EGDK>9:97NDE:G6I>C<68I>K>I>:HD; 7>AA>DC6C9 7>AA>DC 9JG>C<;>H86AN:6G6C9 G:HE:8I>K:AN 8DCH>HI:9D;
+2.?;121
B;2
B;2
6;A5<B@.;1@
(:I>C8DB:
(DC 86H=8=6G<:H
:EG:8>6I>DC6C96BDGI>O6I>DC
:;:GG:9>C8DB:I6M:H
FJ>IN 76H:98DBE:CH6I>DC:ME:CH:
=6C<:H>CDE:G6I>C<6HH:I6C9A>67>A>IN688DJCIH
)I=:G
-><C>;>86CI8=6C<:H>CDE:G6I>C<6HH:I6C9A>67>A>IN688DJCIH C:ID;;DG:><C:M8=6C<:>BE68I >C;>H86AN:6G>C8AJ9:9I=:;DAADL>C<
JH:HD;86H=>C8G:6H:H>C688DJCIHG:8:>K67A:D; 7>AA>DC6C9>CK:CIDGND; B>AA>DC 8DB7>C:9L>I=9:8G:6H:H>C9:;:GG:9
<GDHHEGD;>ID; B>AA>DC 6C9688GJ:9:ME:CH:H6C9DI=:GA>67>A>I>:HD; B>AA>DC .=:H:JH:HD;86H=L:G:D;;H:I7NI=:
;DAADL>C<HDJG8:HD;86H=>C8G:6H:>C688DJCIHE6N67A:D; B>AA>DC6C99:8G:6H:>CEG:E6>9:ME:CH:H6C9DI=:G8JGG:CI6HH:IH
D; B>AA>DC
-><C>;>86CI8=6C<:H>CDE:G6I>C<6HH:I6C9A>67>A>IN688DJCIH C:ID;;DG:><C:M8=6C<:>BE68I 9JG>C<;>H86AN:6G>C8AJ9:9I=:
;DAADL>C<HDJG8:HD;86H=>C8G:6H:H>C9:;:GG:9<GDHHEGD;>ID; 7>AA>DC 688GJ:9:ME:CH:H6C9DI=:GA>67>A>I>:HD; B>AA>DC
6C9688DJCIHE6N67A:D; B>AA>DC .=:H:HDJG8:HD;86H=L:G:D;;H:I7NI=:;DAADL>C<JH:HD;86H=>C8G:6H:H>C688DJCIH
G:8:>K67A:D; B>AA>DC EG:E6>9:ME:CH:H6C9DI=:G8JGG:CI6HH:IHD; B>AA>DC 6C9>CK:CIDGND; B>AA>DC
.=:9:8G:6H:D; B>AA>DC>CC:I86H=EGDK>9:97NDE:G6I>C<68I>K>I>:H9JG>C<;>H86AN:6G8DBE6G:9ID;>H86AN:6GL6H
EG>B6G>AN9J:ID;AJ8IJ6I>DCH>C688DJCIHG:8:>K67A:6C99:;:GG:9<GDHHEGD;>I E6GI>6AAND;;H:I7N6C>C8G:6H:>CC:I>C8DB:
0B7;>FB5A><=E4BC8=62C8E8C84B
(:I86H=JH:9;DG>CK:HI>C<68I>K>I>:H9JG>C<;>H86AN:6GH6C9L6H B>AA>DC6C9 B>AA>DC G:HE:8I>K:AN
8DCH>HI>C<EG>B6G>AND;86E>I6A:ME:C9>IJG:H
.=:>C8G:6H:D; B>AA>DC>CC:I86H=JH:9;DG>CK:HI>C<68I>K>I>:H9JG>C<;>H86AN:6G8DBE6G:9ID;>H86AN:6GL6H
EG>B6G>AN9J:ID=><=:G86E>I6A:ME:C9>IJG:HIDHJEEDGIA67>CK:HIB:CIH>CI=:/C>I:9-I6I:H6C9<AD76A<GDLI=>CB6CJ;68IJG>C<
;68>A>I>:H
0B7;>FB5A><8=0=28=62C8E8C84B
(:I86H=JH:9;DG;>C6C8>C<68I>K>I>:H9JG>C<;>H86AN:6GL6H 7>AA>DC EG>B6G>AN8DCH>HI>C<D; 7>AA>DC>CDBBDC-ID8@
G:EJG8=6H:H >C8AJ9>C<C:IH=6G:H:IIA:B:CIDC:BEADN::HID8@ 76H:98DBE:CH6I>DC 7>AA>DCD;9>K>9:C9HE6>96C9
B>AA>DCD;EG>C8>E6AE6NB:CIHDC9:7I>CHIGJB:CI6C99:7I>HHJ6C8:8DHIH E6GI>6AAND;;H:I7N B>AA>DCD;HID8@>HHJ6C8:6C9
IG:6HJGNHID8@G:>HHJ6C8:H6HHD8>6I:9L>I=DJG:BEADN::HID8@ 76H:98DBE:CH6I>DCEA6CH
(:I86H=JH:9;DG;>C6C8>C<68I>K>I>:H9JG>C<;>H86AN:6GL6H 7>AA>DC EG>B6G>AN8DCH>HI>C<D; 7>AA>DC>CDBBDC-ID8@
G:EJG8=6H:H >C8AJ9>C<C:IH=6G:H:IIA:B:CIDC:BEADN::HID8@ 76H:98DBE:CH6I>DC 7>AA>DCD;9>K>9:C9HE6>96C9
B>AA>DCD;EG>C8>E6AE6NB:CIHDC9:7I>CHIGJB:CI6C99:7I>HHJ6C8:8DHIH E6GI>6AAND;;H:I7N B>AA>DCD;HID8@>HHJ6C8:6C9
IG:6HJGNHID8@G:>HHJ6C8:H6HHD8>6I:9L>I=DJG:BEADN::HID8@ 76H:98DBE:CH6I>DCEA6CH
.=:>C8G:6H:D; B>AA>DC>CC:I86H=JH:9;DG;>C6C8>C<68I>K>I>:H9JG>C<;>H86AN:6G8DBE6G:9ID;>H86AN:6GL6H
EG>B6G>ANI=:G:HJAID;>C8G:6H:9DBBDC-ID8@G:EJG8=6H:68I>K>IN EG>C8>E6AE6NB:CIHDC9:7I>CHIGJB:CIHG:HJAI>C<;GDBB6IJG>I>:H
D;DJG-:C>DG(DI:H 6C9=><=:G9>K>9:C9HE6>96HHD8>6I:9L>I=6C>C8G:6H:99>K>9:C9G6I:
8@D838CH
!>K:CI=6II=:H:B>8DC9J8IDG>C9JHIGN>H=><=AN8DBE:I>I>K:6C9=6H=>HIDG>86AAN:ME:G>:C8:9G6E>98=6C<:H>C9:B6C9 L:7:A>:K:
I=6IB6>CI6>C>C<HJ;;>8>:CIA>FJ>9>ING:H:GK:H>H>BEDGI6CIIDHJEEDGIHJHI6>C>C<A:K:AHD;>CK:HIB:CI>C,6C986E>I6A>C;G6HIGJ8IJG:
CI>8>E6I:986H=;ADLH;GDBDE:G6I>DCH76H:9DCDJG8JGG:CI7JH>C:HHDJIADD@ 8DB7>C:9L>I=DJG8JGG:CIA:K:AHD;86H=6C986H=
:FJ>K6A:CIH6HD;$JC: 6G::ME:8I:9ID7:HJ;;>8>:CIIDHJEEDGIDJG6CI>8>E6I:9A:K:AHD;DE:G6I>DCH >CK:HIB:CIH 9:7I
H:GK>8:G:FJ>G:B:CIH 86E>I6A:ME:C9>IJG:H 86E>I6AG:9>HIG>7JI>DCH 6C99>K>9:C9HI=GDJ<=6IA:6HII=:C:MIIL:AK:BDCI=H "DL:K:G
;68IDGHDJIH>9:D;DJG8DCIGDA >C8AJ9>C<JC8:GI6>CIN>CI=:<AD76A:8DCDBN6C9I=:H:B>8DC9J8IDG>C9JHIGN 6HL:AA6H9>HGJEI>DCH>C
8G:9>IB6G@:IH =6K:>CI=:E6HI 6G:8JGG:CIAN 6C98DJA9>CI=:;JIJG: >BE68I8JHIDB:G9:B6C9;DGDJGEGD9J8IH 6HL:AA6HDJG67>A>IN
IDB6C6<:CDGB6A8DBB:G8>6AG:A6I>DCH=>EHL>I=DJG8JHIDB:GH HJEEA>:GH 6C98G:9>IDGH
&6B,:H:6G8=DGEDG6I>DC %
-- 140 of 186 --
Our capital allocation strategy includes a focus to return a portion of our free cash flow to stockholders over time through dividends
and share repurchases of Common Stock. Free cash flow is defined as net cash provided by operating activities less cash used for
capital expenditures and intangible assets. We expect to fund these capital return activities through future cash provided by operating
activities, existing cash and cash equivalents, and/or existing or future available short- and long-term financing.
In March 2026, $750.0 million principal value of our 2026 Senior Notes were settled upon maturity using available cash on hand.
In March 2026, we increased the issuance capacity under our commercial paper program (the “CP Program”) from $1.50 billion to
$2.00 billion. The net proceeds from the CP Program may be used for general corporate purposes, including repurchases of our
Common Stock from time to time under our stock repurchase program. As of June 28, 2026, we had no outstanding borrowings under
the CP Program.
Please refer to Note 14, “Long-term Debt and Other Borrowings" to our Consolidated Financial Statements, included in Part II, Item 8
of this 2026 Form 10-K for additional information.
In the longer term, liquidity will depend to a great extent on our future revenues and our ability to appropriately manage our costs
based on demand for our products and services. While we have substantial cash balances, we may require additional funding and
need or choose to raise the required funds through borrowings or public or private sales of debt or equity securities. We believe that,
if necessary, we will be able to access the capital markets on terms and in amounts adequate to meet our objectives. However,
domestic and global macroeconomic and political conditions could cause disruptions to the capital markets and otherwise make any
financing more challenging, and there can be no assurance that we will be able to obtain such financing on commercially reasonable
terms or at all.
Off-Balance Sheet Arrangements and Contractual Obligations
We have certain obligations to make future payments under various contracts, some of which are recorded on our balance sheet and
some of which are not. Certain obligations that are recorded on our balance sheet in accordance with GAAP include our long-term
debt, operating leases and finance leases; refer to Notes 14 and 15 of our Consolidated Financial Statements in Part II, Item 8 of this
2026 Form 10-K for further discussion. Our off-balance sheet arrangements and our transition tax liability are presented as purchase
obligations, refer to Note 17 of our Consolidated Financial Statements in Part II, Item 8 of this 2026 Form 10-K for further discussion.
In addition, in the ordinary course of business, we issue purchase orders based on estimates of our production needs, many times
well in advance of delivery dates. The commitments under these open purchase orders are not included in the off-balance sheet
commitments disclosed in the Notes to the Consolidated Financial Statements, as we generally have the option to cancel the
purchase orders at our convenience, reschedule, and/or adjust quantities based on our business needs. As of June 28, 2026, we
expect to fulfill approximately $727.9 million within one year related to these arrangements. We also periodically enter into contracts
for capital expenditures related to facility and equipment investments. Certain of these arrangements represent purchase obligations
with reasonably estimable future obligations and are included in our purchase obligations disclosure in the Notes of our Consolidated
Financial Statements, while others are cancellable in accordance with their contractual terms and as such are excluded from the off-
balance sheet commitments disclosure.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Interest Rate Risk
Long-Term Debt
As of June 28, 2026, we had $3.75 billion in principal amount of fixed-rate long-term debt outstanding, with a fair value of $3.16
billion. The fair value of our Senior Notes is subject to interest rate risk and market risk. Generally, the fair value of Senior Notes will
increase as interest rates fall and decrease as interest rates rise. The interest and market value changes affect the fair value of our
Senior Notes but do not impact our financial position, cash flows, or results of operations due to the fixed nature of the debt
obligations. We do not carry the Senior Notes at fair value but present the fair value of the principal amount of our Senior Notes for
disclosure purposes.
Foreign Currency Exchange (“FX”) Risk
We conduct business on a global basis in several major international currencies. As such, we are potentially exposed to adverse as
well as beneficial movements in foreign currency exchange rates. The majority of our revenues and expenses are denominated in
U.S. dollars. However, we are exposed to foreign currency exchange rate fluctuations on non-U.S. dollar transactions or cash flows.
We enter into foreign currency forward contracts to minimize the short-term impact of exchange rate fluctuations on certain foreign
currency denominated monetary assets and liabilities, primarily cash, third-party accounts receivable, accounts payable, and
intercompany receivables and payables. In addition, we hedge certain anticipated foreign currency cash flows.
To protect against adverse movements in value of anticipated non-U.S. dollar transactions or cash flows, we enter into foreign
currency forward and option contracts that generally expire within 12 months and no later than 24 months. The option contracts
include collars, an option strategy that is comprised of a combination of a purchased put option and a written call option with the
Lam Research Corporation 2026 10-K 39
-- 141 of 186 --
same expiration dates and notional amounts but with different strike prices. These foreign currency hedge contracts are designated
as cash flow hedges and are carried on our balance sheet at fair value, with the effective portion of the contracts’ gains or losses
included in accumulated other comprehensive income (loss) and subsequently recognized in earnings in the same period the hedged
revenue and/or expense is recognized. The unrealized loss of our outstanding forward and option contracts that are designated as
cash flow hedges, as of June 28, 2026, and the change in fair value of these cash flow hedges assuming a hypothetical foreign
currency exchange rate movement of plus or minus 10 percent and plus or minus 15 percent are not significant.
We also enter into foreign currency forward contracts to offset the gains and losses generated by the remeasurement of certain non-
U.S.-dollar denominated monetary assets and liabilities, primarily cash, third-party accounts receivable, accounts payable, and
intercompany receivables and payables. The change in fair value of these balance sheet derivative instruments is recorded into
earnings as a component of other income (expense), net, and offsets the change in fair value of the foreign currency denominated
monetary assets and liabilities also recorded in other income (expense), net, assuming the derivative instruments fully cover the
value of the foreign currency denominated monetary assets and liabilities. The unrealized loss of our balance sheet derivative
instruments as of June 28, 2026, and the change in fair value of these contacts, assuming a hypothetical foreign currency exchange
rate movement of plus or minus 10 percent and plus or minus 15 percent are not significant. These changes in fair values would be
offset in other income (expense), net, by corresponding changes remeasurement gains or losses on foreign currency denominated
monetary assets and liabilities, assuming the derivative instruments fully cover the value of the foreign currency denominated
monetary assets and liabilities.
Lam Research Corporation 2026 10-K 40
-- 142 of 186 --
6-0 8=0=280;'C0C4<4=CB0=3'D??;4<4=C0AH0C0
.=:G:L:G:CDG:IGDHE:8I>K:8=6C<:HIDI=:DCHDA>96I:9-I6I:B:CIHD;)E:G6I>DC;DG6CNFJ6GI:GH>CI=:ILDBDHIG:8:CI;>H86A
N:6GHI=6ILDJA9G:FJ>G:9>H8ADHJG:JC9:G#I:BD;,:<JA6I>DC- %
=34GC>>=B>;830C438=0=280;'C0C4<4=CB
#.42
DCHDA>96I:9-I6I:B:CIHD;)E:G6I>DCHT3:6GHC9:9$JC: $JC: 6C9$JC:
DCHDA>96I:9-I6I:B:CIHD;DBEG:=:CH>K:#C8DB:T3:6GHC9:9$JC: $JC: 6C9$JC:
DCHDA>96I:96A6C8:-=::IHT$JC: 6C9$JC:
DCHDA>96I:9-I6I:B:CIHD;6H= ADLHT3:6GHC9:9$JC: $JC: 6C9$JC:
DCHDA>96I:9-I6I:B:CIHD;-ID8@=DA9:GHUFJ>INT3:6GHC9:9$JC: $JC: 6C9$JC:
(DI:HIDDCHDA>96I:9 >C6C8>6A-I6I:B:CIH
,:EDGIHD;#C9:E:C9:CI,:<>HI:G:9*J7A>888DJCI>C< >GB*)#
&6B,:H:6G8=DGEDG6I>DC %
-- 143 of 186 --
"#"" "$
#$#$$$# "$#
/16.275*1,5-8+-363-45.*4-,*6*
+2.?;121
B;2
B;2
B;2
,:K:CJ:
DHID;<DD9HHDA9
,:HIGJ8IJG>C<8=6G<:H C:I 8DHID;<DD9HHDA9 T T
.DI6A8DHID;<DD9HHDA9
!GDHHB6G<>C
,:H:6G8=6C99:K:ADEB:CI
-:AA>C< <:C:G6A 6C969B>C>HIG6I>K:
,:HIGJ8IJG>C<8=6G<:H C:I DE:G6I>C<:ME:CH:H T T
.DI6ADE:G6I>C<:ME:CH:H
)E:G6I>C<>C8DB:
)I=:G>C8DB::ME:CH: C:I
#C8DB:7:;DG:>C8DB:I6M:H
#C8DB:I6M:ME:CH:
(:I>C8DB:
(:I>C8DB:E:GH=6G:
6H>8
>AJI:9
(JB7:GD;H=6G:HJH:9>CE:GH=6G:86A8JA6I>DCH
6H>8
>AJI:9
-::(DI:HIDDCHDA>96I:9 >C6C8>6A-I6I:B:CIH
&6B,:H:6G8=DGEDG6I>DC %
-- 144 of 186 --
"#"" "$
#$#$$$# "#&
/16.275*1,5
+2.?;121
B;2
B;2
B;2
(:I>C8DB:
)I=:G8DBEG:=:CH>K:>C8DB:ADHH C:ID;I6M
DG:><C8JGG:C8NIG6CHA6I>DC69?JHIB:CI
6H=;ADL=:9<:H
(:IJCG:6A>O:9<6>CH9JG>C<I=:E:G>D9
(:I<6>CHADHH:HG:8A6HH>;>:9>CIDC:I>C8DB:
K6>A67A: ;DG H6A:>CK:HIB:CIH
(:IJCG:6A>O:9<6>CH9JG>C<I=:E:G>D9 T T
(:I<6>CHG:8A6HH>;>:9>CIDC:I>C8DB: T T
T T
:;>C:97:C:;>IEA6CH C:I8=6C<:>CJCG:6A>O:98DBEDC:CI
)I=:G8DBEG:=:CH>K:ADHH>C8DB: C:ID;I6M
DBEG:=:CH>K:>C8DB:
-::(DI:HIDDCHDA>96I:9 >C6C8>6A-I6I:B:CIH
&6B,:H:6G8=DGEDG6I>DC %
-- 145 of 186 --
"#"" "$
#$#$#
/16.275*1,5-8+-363-45.*4-,*6*
B;2
B;2
--.-
6H=6C986H=:FJ>K6A:CIH
88DJCIHG:8:>K67A: A:HH6AADL6C8:D; 6HD;$JC: 6C9 6HD;$JC:
#CK:CIDG>:H
*G:E6>9:ME:CH:H6C9DI=:G8JGG:CI6HH:IH
.DI6A8JGG:CI6HH:IH
*GDE:GIN6C9:FJ>EB:CI C:I
!DD9L>AA6C9>CI6C<>7A:6HH:IH C:I
)I=:G6HH:IH
.DI6A6HH:IH
&##&#.#-(-.)%")&,-U+/#.3
.G69:688DJCIHE6N67A:
88GJ:9:ME:CH:H6C9DI=:G8JGG:CIA>67>A>I>:H
:;:GG:9EGD;>I
JGG:CIEDGI>DCD;ADC< I:GB9:7I6C9;>C6C8:A:6H:D7A><6I>DCH
.DI6A8JGG:CIA>67>A>I>:H
&DC< I:GB9:7I6C9;>C6C8:A:6H:D7A><6I>DCH
#C8DB:I6M:HE6N67A:
)I=:GADC< I:GBA>67>A>I>:H
.DI6AA>67>A>I>:H
DBB>IB:CIH6C98DCI>C<:C8>:H
-ID8@=DA9:GHU:FJ>IN
*G:;:GG:9HID8@ 6IE6GK6AJ:D; E:GH=6G:6JI=DG>O:9 H=6G:H CDC:DJIHI6C9>C< T T
DBBDCHID8@ 6IE6GK6AJ:D; E:GH=6G:6JI=DG>O:9 H=6G:H6HD;$JC:
6C9$JC: >HHJ:96C9DJIHI6C9>C< H=6G:H6HD;$JC: 6C9
H=6G:H6HD;$JC:
99>I>DC6AE6>9 >C86E>I6A
.G:6HJGNHID8@ 6I8DHI H=6G:H6HD;$JC: 6C9 H=6G:H6HD;
$JC:
88JBJA6I:9DI=:G8DBEG:=:CH>K:ADHH
,:I6>C:9:6GC>C<H
.DI6AHID8@=DA9:GHU:FJ>IN
.DI6AA>67>A>I>:H6C9HID8@=DA9:GHU:FJ>IN
-::(DI:HIDDCHDA>96I:9 >C6C8>6A-I6I:B:CIH
&6B,:H:6G8=DGEDG6I>DC %
-- 146 of 186 --
"#"" "$
#$#$$$##'#
/16.275*1,5
-" &)1- ,)')*,.#(!.#0#.#-
(:I>C8DB:
9?JHIB:CIHIDG:8DC8>A:C:I>C8DB:IDC:I86H=EGDK>9:97NDE:G6I>C<68I>K>I>:H
:EG:8>6I>DC6C96BDGI>O6I>DC
:;:GG:9>C8DB:I6M:H
FJ>IN 76H:98DBE:CH6I>DC:ME:CH:
)I=:G C:I
=6C<:H>CDE:G6I>C<6HH:I6C9A>67>A>IN688DJCIH
88DJCIHG:8:>K67A: C:ID;6AADL6C8:
#CK:CIDG>:H
*G:E6>9:ME:CH:H6C9DI=:G6HH:IH
.G69:688DJCIHE6N67A:
:;:GG:9EGD;>I
88GJ:9:ME:CH:H6C9DI=:GA>67>A>I>:H
(:I86H=EGDK>9:97NDE:G6I>C<68I>K>I>:H
-" &)1- ,)'#(0-.#(!.#0#.#-
6E>I6A:ME:C9>IJG:H6C9>CI6C<>7A:6HH:IH
*GD8::9H;GDBB6IJG>I>:HD;6K6>A67A: ;DG H6A:H:8JG>I>:H T T
*GD8::9H;GDBH6A:HD;6K6>A67A: ;DG H6A:H:8JG>I>:H T T
)I=:G C:I
(:I86H=JH:9;DG>CK:HI>C<68I>K>I>:H
+2.?;121
B;2
B;2
B;2
&6B,:H:6G8=DGEDG6I>DC %
-- 147 of 186 --
+2.?;121
B;2
B;2
B;2
-" &)1- ,)' #((#(!.#0#.#-
*G>C8>E6AE6NB:CIHDCADC< I:GB9:7I6C9;>C6C8:A:6H:D7A><6I>DCH6C9
E6NB:CIH;DG9:7I>HHJ6C8:8DHIH
.G:6HJGNHID8@EJG8=6H:H
>K>9:C9HE6>9
,:>HHJ6C8:HD;IG:6HJGNHID8@G:A6I:9ID:BEADN::HID8@EJG8=6H:EA6C
*GD8::9H;GDB>HHJ6C8:D;8DBBDCHID8@
)I=:G C:I
(:I86H=JH:9;DG;>C6C8>C<68I>K>I>:H
;;:8ID;:M8=6C<:G6I:8=6C<:HDC86H= 86H=:FJ>K6A:CIH6C9G:HIG>8I:986H=
(:I8=6C<:>C86H= 86H=:FJ>K6A:CIH6C9G:HIG>8I:986H=
6H= 86H=:FJ>K6A:CIH6C9G:HIG>8I:986H=6I7:<>CC>C<D;N:6G
6H= 86H=:FJ>K6A:CIH6C9G:HIG>8I:986H=6I:C9D;N:6G
-8=:9JA:D;CDC 86H=IG6CH68I>DCH
88GJ:9E6N67A:H;DGHID8@G:EJG8=6H:H >C8AJ9>C<6EEA>867A::M8>H:I6M
88GJ:9E6N67A:H;DG86E>I6A:ME:C9>IJG:H
>K>9:C9HE6N67A:
.G6CH;:GHD;;>C>H=:9<DD9H>CK:CIDGNIDEGDE:GIN6C9:FJ>EB:CI
-JEEA:B:CI6A9>H8ADHJG:H
6H=E6NB:CIH;DG>CI:G:HI
$20<;0696.A6<;<30.@50.@52>B6C.92;A@.;1?2@A?60A210.@5 B;2
B;2
B;2
6H=6C986H=:FJ>K6A:CIH
,:HIG>8I:986H=6C986H=:FJ>K6A:CIH
.DI6A86H= 86H=:FJ>K6A:CIH 6C9G:HIG>8I:986H=
,:HIG>8I:986H=>HG:EDGI:9L>I=>C)I=:G6HH:IH>CI=:DCHDA>96I:96A6C8:-=::IH
-::(DI:HIDDCHDA>96I:9 >C6C8>6A-I6I:B:CIH
&6B,:H:6G8=DGEDG6I>DC %
-- 148 of 186 --
"#"" "$
#$#$$$##$"#;!%$)
/16.275*1,5-8+-363-4+200215.*4-,*6*
<::<;
%A<08
%5.?2@ <::<;
%A<08
116A6<;.9
#.616;
.=6A.9 &?2.@B?F
%A<08
00B:B9.A21
"A52?
<:=?252;@6C2
;0<:2<@@ $2A.6;21
.?;6;4@ &<A.9
6A6C8:6I$JC:
#HHJ6C8:D;8DBBDCHID8@ T T T
*JG8=6H:D;IG:6HJGNHID8@ T T T
,:>HHJ6C8:D;IG:6HJGNHID8@ T T
FJ>IN 76H:98DBE:CH6I>DC:ME:CH: T T T T T
(:I>C8DB: T T T T T
)I=:G8DBEG:=:CH>K:ADHH T T T T T
6H=9>K>9:C9H9:8A6G:9 E:G8DBBDCH=6G: T T T T T
6A6C8:6I$JC:
#HHJ6C8:D;8DBBDCHID8@ T T T
*JG8=6H:D;IG:6HJGNHID8@ T T T
,:>HHJ6C8:D;IG:6HJGNHID8@ T T
FJ>IN 76H:98DBE:CH6I>DC:ME:CH: T T T T T
(:I>C8DB: T T T T T
)I=:G8DBEG:=:CH>K:>C8DB: T T T T T
6H=9>K>9:C9H9:8A6G:9 E:G8DBBDCH=6G: T T T T T
6A6C8:6I$JC:
#HHJ6C8:D;8DBBDCHID8@ T T T
*JG8=6H:D;IG:6HJGNHID8@ T T T
,:>HHJ6C8:D;IG:6HJGNHID8@ T T
FJ>IN 76H:98DBE:CH6I>DC:ME:CH: T T T T T
(:I>C8DB: T T T T T
)I=:G8DBEG:=:CH>K:ADHH T T T T T
6H=9>K>9:C9H9:8A6G:9 E:G8DBBDCH=6G: T T T T T
6A6C8:6I$JC:
-::(DI:HIDDCHDA>96I:9 >C6C8>6A-I6I:B:CIH
&6B,:H:6G8=DGEDG6I>DC %
-- 149 of 186 --
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 28, 2026
Note 1: Company and Industry Information
The Company designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the
fabrication of integrated circuits. Semiconductor manufacturing, our customers’ business, involves the complete fabrication of multiple
dies or integrated circuits on a wafer. This involves the repetition of a set of core processes and can require hundreds of individual
steps. Fabricating these devices requires highly sophisticated process technologies to integrate an increasing array of new materials
with precise control at the atomic scale. Along with meeting technical requirements, wafer processing equipment must deliver high
productivity and be cost-effective.
The Company sells its products and services primarily to companies involved in the production of semiconductors in the United
States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan.
The semiconductor industry is cyclical in nature and has historically experienced periodic downturns and upturns. Today’s leading
indicators of changes in customer investment patterns, such as electronics demand, memory pricing, and foundry utilization rates,
may not be any more reliable than in prior years. Demand for the Company’s equipment can vary significantly from period to period
as a result of various factors including, but not limited to, economic conditions; supply, demand, and prices for semiconductors;
customer capacity requirements; and the Company’s ability to develop and market competitive products. For these and other
reasons, the Company’s results of operations for fiscal years 2026, 2025, and 2024 may not necessarily be indicative of future
operating results.
Note 2: Summary of Significant Accounting Policies
The preparation of financial statements in conformity with GAAP requires management to make judgments, estimates, and
assumptions that could affect the reported amounts of assets and liabilities at the date of the financial statements and the reported
amounts of revenue and expenses during the reporting period. The Company bases its estimates and assumptions on historical
experience and on various other assumptions it believes to be applicable and evaluates them on an ongoing basis to ensure they
remain reasonable under current conditions. Actual results could differ significantly from those estimates.
Revenue Recognition: The Company generally considers documentation of terms with an approved purchase order as a customer
contract, provided that collection is considered probable, which is assessed based on the creditworthiness of the customer as
determined by credit checks, payment histories, and/or other circumstances. The transaction price for contracts with customers is
allocated among the identified performance obligations and consists of both fixed and variable consideration provided it is probable
that a significant reversal of revenue will not occur when the uncertainty related to variable consideration is resolved. Fixed
consideration includes amounts to be contractually billed to the customer while variable consideration includes estimates for
discounts and credits for future usage which are based on contractual terms outlined in volume purchase agreements and other
factors known at the time. The Company generally invoices customers at shipment and for professional services as provided.
Customer invoices are generally due within 30 to 90 days after issuance. The Company’s contracts with customers typically do not
include significant financing components as the period between the transfer of performance obligations and timing of payment are
generally within one year. Revenue for systems and spares are recognized at a point in time, which is generally upon shipment or
delivery. Revenue from services is recognized over time as services are completed or ratably over the contractual period of generally
one year or less. Revenue is recognized in an amount that reflects the consideration to which we expect to be entitled in exchange
for those goods or services. The Company elects to use the practical expedient afforded in the accounting guidance and therefore
does not disclose remaining performance obligations for contracts with a duration of less than one year. Additionally, outstanding
customer contracts with remaining durations more than one year are not material as of June 28, 2026.
Inventory Valuation: Inventories are stated at the lower of cost or net realizable value using standard costs that approximate
actual costs on a first-in, first-out basis. Management evaluates the need to record adjustments for impairment of inventory at least
quarterly. The Company’s policy is to assess the valuation of all inventories including manufacturing raw materials, work-in-process,
finished goods, and spare parts in each reporting period. Inventory in excess of management’s estimated usage requirement and
obsolete inventory is written down to its estimated net realizable value if less than cost. Estimates of net realizable value include but
are not limited to management’s forecasts related to customer demand, the Company’s future manufacturing schedules,
technological and/or market obsolescence, general semiconductor market conditions, and possible alternative uses. If future
customer demand or market conditions are less favorable than the Company’s projections, additional inventory write-downs may be
required and would be reflected in cost of goods sold in the period in which the revision is made.
Warranty: Typically, the sale of semiconductor capital equipment includes providing parts and service warranties to customers as
part of the overall price of the system. The Company provides standard warranties for its systems. The Company records a provision
for estimated warranty expenses to cost of sales for each system when it recognizes revenue. The Company does not maintain
general or unspecified reserves; all warranty reserves are related to specific systems. All actual or estimated parts and labor costs
incurred in subsequent periods are charged to those established reserves on a system-by-system basis.
Lam Research Corporation 2026 10-K 48
-- 150 of 186 --
While the Company periodically monitors the performance and cost of warranty activities, if actual costs incurred are different than its
estimates, the Company may recognize adjustments to provisions in the period in which those differences arise or are identified.
Equity-based Compensation — Employee Stock Plans: The Company recognizes the fair value of equity-based
compensation expense. The Company determines the fair value of its service-based restricted stock units based upon the fair market
value of the Company’s Common Stock at the date of grant, discounted for dividends, and estimates the fair value of its market-
based performance restricted stock units using a Monte Carlo simulation model at the date of the grant. The Company estimates the
fair value of its stock options using a Black-Scholes option valuation model. This model requires the input of subjective assumptions,
including expected stock price volatility and the estimated life of each award. The Company amortizes the fair value of equity-based
awards over the vesting periods of the award and has elected to use the straight-line method of amortization.
Income Taxes: Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and
liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards.
The Company records a valuation allowance to reduce its deferred tax assets to the amount that is more likely than not to be
realized. Realization of its net deferred tax assets is dependent on future taxable income. The Company believes it is more likely than
not that such assets will be realized; however, ultimate realization could be negatively impacted by market conditions and other
variables not known or anticipated at this time. In the event that the Company determines that it will not be able to realize all or part of
its net deferred tax assets, an adjustment will be charged to earnings in the period such determination is made. Likewise, if the
Company later determines that it is more likely than not that the deferred tax assets will be realized, then the previously provided
valuation allowance will be reversed. The Company has an accounting policy election to record deferred taxes related to GILTI.
The Company recognizes the benefit from a tax position only if it is more likely than not that the position will be sustained upon audit
based solely on the technical merits of the tax position. The Company has a policy to include interest and penalties related to
uncertain tax positions as a component of income tax expense.
Goodwill and Intangible Assets: The valuation of intangible assets acquired in a business combination requires the use of
management estimates including but not limited to estimating future expected cash flows from assets acquired and determining
discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are
inherently uncertain and unpredictable, and as a result, actual results may differ from estimates. Estimates associated with the
accounting for acquisitions may change as additional information becomes available. The Company amortizes intangible assets with
estimable useful lives over their respective estimated useful lives.
Goodwill represents the amount by which the purchase price in each business combination exceeds the fair value of the net tangible
and identifiable intangible assets acquired. Each component of the Company for which discrete financial information is available and
for which management regularly reviews the results of operations is considered a reporting unit. All goodwill acquired in a business
combination is assigned to one or more reporting units as of the acquisition date. Goodwill is assigned to the Company’s reporting
units that are expected to benefit from the synergies of the combination. The goodwill assigned to a reporting unit is the difference
between the acquisition consideration assigned to the reporting unit on a relative fair value basis and the fair value of acquired assets
and liabilities that can be specifically attributed to the reporting unit.
The Company reviews goodwill at least annually for impairment during the fourth quarter of each fiscal year and if certain events or
indicators of impairment occur between annual impairment tests. When reviewing goodwill for impairment, the Company first
performs a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its
carrying value. In performing a qualitative assessment, it considers business conditions and other factors including, but not limited to
(i) adverse industry or economic trends, (ii) restructuring actions and lower projections that may impact future operating results, (iii)
sustained decline in share price, and (iv) overall financial performance and other events affecting the reporting units. If the Company
concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then a quantitative
impairment test is performed by estimating the fair value of the reporting unit and comparing it to its carrying value, including goodwill
allocated to that reporting unit. The Company did not record impairments of goodwill during the years ended June 28, 2026, June 29,
2025, or June 30, 2024.
Impairment of Long-lived Assets (Excluding Goodwill: The Company reviews intangible assets whenever events or
circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If such indicators are present, the
Company determines whether the sum of the estimated undiscounted cash flows attributable to the assets is less than their carrying
value. If the sum is less, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over
their respective fair values. Fair value is determined by discounted future cash flows, appraisals, or other methods. The Company
recognizes an impairment charge to the extent the fair value attributable to the asset are less than the asset’s carrying value. The fair
value of the asset then becomes the asset’s new carrying value, which the Company depreciates over the remaining estimated useful
life of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value. For the periods presented,
impairment of long-lived assets were not material. In addition, for fully amortized intangible assets, we derecognize the gross cost
and accumulated amortization in the period we determine the intangible asset no longer enhances future cash flows.
Fiscal Year: The Company follows a 52/53-week fiscal reporting calendar, and its fiscal year ends on the last Sunday of June each
year. The Company’s fiscal years ending on June 28, 2026 and June 29, 2025 included 52 weeks, and the fiscal year ended June 30,
2024 included 53 weeks.
Lam Research Corporation 2026 10-K 49
-- 151 of 186 --
Principles of Consolidation: The Consolidated Financial Statements include the accounts of the Company and its wholly owned
subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Cash Equivalents and Investments: Investments purchased with an original maturity of three months or less are considered
cash equivalents. The Company also invests in certain mutual funds, which include equity and fixed-income securities, related to its
obligations under its deferred compensation plan, and such investments are classified as trading securities on the Consolidated
Balance Sheets. All of the Company’s other investments are classified as available-for-sale at the respective balance sheet dates.
The Company accounts for its investment portfolio at fair value. Investments classified as trading securities are recorded at fair value
based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as Other income
(expense), net in the Consolidated Statement of Operations. The investments classified as available-for-sale are recorded at fair
value based upon quoted market prices, and difference between the cost and fair value of available-for-sale securities is presented
as a component of accumulated other comprehensive income (loss). The Company evaluates its investments with fair value less than
amortized cost by first considering whether the Company has the intent to sell the security or whether it is more likely than not that
the Company will be required to sell the security before recovery of its amortized cost basis. In either such situation, the difference
between fair value and amortized cost is recognized as a loss in the Consolidated Statement of Operations. Where such sales are
not likely to occur, the Company considers whether a portion of the loss is the result of a credit loss. To the extent such losses are the
result of credit losses, those amounts are recognized in the Consolidated Statement of Operations. All other differences between fair
value and amortized cost are recognized in other comprehensive income. No such losses were recognized through the Consolidated
Statement of Operations during the years ended June 28, 2026, June 29, 2025 and June 30, 2024.
Allowance for Expected Credit Losses: The Company maintains an allowance for expected losses resulting from the inability of
its customers to make required payments. The Company evaluates its allowance for expected credit losses based on a combination
of factors. In circumstances where specific invoices are deemed uncollectible, the Company provides a specific allowance against the
amount due to reduce the net recognized receivable to the amount it reasonably believes will be collected. The Company also
provides allowances based on its write-off history. Bad debt expense was not material for fiscal years ended June 28, 2026, June 29,
2025, and June 30, 2024.
Property and Equipment: Property and equipment is stated at cost, less recognized impairments, if any. Equipment is
depreciated by the straight-line method over the estimated useful lives of the assets, generally three to seven years. Furniture and
fixtures are depreciated by the straight-line method over the estimated useful lives of the assets, generally five years. Software is
amortized by the straight-line method over the estimated useful lives of the assets, generally three to five years. Buildings are
depreciated by the straight-line method over the estimated useful lives of the assets, generally twenty-five years. Leasehold
improvements are generally amortized by the straight-line method over the shorter of the life of the related asset or the term of the
underlying lease. Amortization of finance leases is included with depreciation expense.
Derivative Financial Instruments: In the normal course of business, the Company’s financial position is routinely subjected to
market risk associated with interest rate and foreign currency exchange rate fluctuations. The Company’s policy is to mitigate the
effect of interest rate fluctuations on certain proposed debt instruments and exchange rate fluctuations on certain foreign currency
denominated business exposures. The Company has a policy that allows the use of derivative financial instruments to hedge foreign
currency exchange rate fluctuations on forecasted revenue and expenses and net monetary assets or liabilities denominated in
various foreign currencies. The Company carries derivative financial instruments (derivatives) on the balance sheet at their fair
values. The Company does not use derivatives for trading or speculative purposes. The Company does not believe that it is exposed
to more than a nominal amount of credit risk in its interest rate and foreign currency hedges, as counterparties are large, global and
well-capitalized financial institutions. The Company maintains an active currency hedging program and believes there is minimal risk
that appropriate derivatives to maintain the Company’s hedging program would not be available in the future.
To hedge foreign currency risks, the Company uses foreign currency exchange forward and option contracts, where possible and
prudent. These hedge contracts are valued using standard valuation formulas with assumptions about future foreign currency
exchange rates derived from existing exchange rates, interest rates, and other market factors.
The Company considers its most current forecast in determining the level of foreign currency denominated revenue and expenses to
hedge as cash flow hedges. The Company combines these forecasts with historical trends to establish the portion of its expected
volume to be hedged. The revenue and expenses are hedged and designated as cash flow hedges to protect the Company from
exposures to fluctuations in foreign currency exchange rates. If the underlying forecasted transaction does not occur, or it becomes
probable that it will not occur, the related hedge gains and losses on the cash flow hedge are reclassified from Accumulated other
comprehensive income (loss) to Other income (expense), net on the Consolidated Statement of Operations at that time.
Leases: Lease expense for operating leases is recognized on a straight-line basis over the lease term. The Company includes
renewals and terminations in the calculation of the right-of-use asset and liability when the provision is reasonably certain to be
exercised. The Company uses its incremental borrowing rate based on the information available at commencement date in
determining the present value of future lease payments when the rate implicit in the lease is unknown.
The Company has elected the following practical expedients and accounting policy elections for accounting under ASC 842: (i) leases
with an initial lease term of 12 months or less are not recorded on the balance sheet; and (ii) lease and non-lease components of a
contract are accounted for as a single lease component.
Lam Research Corporation 2026 10-K 50
-- 152 of 186 --
D0A0=C44B.=:DBE6CNUH<J6G6CI::H<:C:G6AAN>C8AJ9:8:GI6>C>C9:BC>;>86I>DCHID>IHA:HHDGH;DG:CK>GDCB:CI6AB6II:GH
EDI:CI>6ADK:G9G6;IEGDI:8I>DCD7A><6I>DCHID;>C6C8>6A>CHI>IJI>DCHG:A6I:9IDDC:D;I=:DBE6CNUHHJ7H>9>6G>:H >C9:BC>;>86I>DCHIDI=:
DBE6CNUH8JHIDB:GH;DG8:GI6>C>C;G>C<:B:CID;I=>G9 E6GIN>CI:AA:8IJ6AEGDE:GING><=IH7N>IHEGD9J8IH6C9H:GK>8:H >C9:BC>;>86I>DCH
;DG>IHD;;>8:GH6C99>G:8IDGH 6C9I=:DBE6CNUHL6GG6CIND7A><6I>DCHJC9:GH6A:HD;>IHEGD9J8IH
>E4A=<4=CBB8BC0=24 DG<DK:GCB:CI<G6CIH I=:DBE6CNG:8D<C>O:H67:C:;>I>CI=:DCHDA>96I:9-I6I:B:CID;)E:G6I>DCH
6H6G:9J8I>DCIDI=::ME:CH:;DGL=>8=I=:>C9>K>9J6A<DK:GCB:CI<G6CIV!G6CIWDGV!G6CIHW>H9:H><C:9ID8DBE:CH6I: DK:GI=:
9JG6I>DCD;I=:EGD<G6BL=:CI=:DBE6CN=6HG:6HDC67A:6HHJG6C8:I=6I>IL>AA8DBEANL>I=I=:8DC9>I>DCHJC9:GI=:!G6CI6C9I=6I
I=:!G6CIL>AA7:G:8:>K:9 !G6CIHG:A6I:9ID>CK:HIB:CIH>CEGDE:GIN6C9:FJ>EB:CI6G:G:8D<C>O:96H6G:9J8I>DCIDI=:8DHI76H>HD;
I=:JC9:GAN>C<6HH:IHL>I=6CDC<D>C<G:9J8I>DCID9:EG:8>6I>DC:ME:CH:DK:GI=:6HH:IHU:HI>B6I:9JH:;JAA>;: )E:G6I>C< G:A6I:9
<G6CIH6G:G:8DG9:96H6G:9J8I>DCID:ME:CH:>CI=:H6B:A>C:>I:BDCI=:DCHDA>96I:9-I6I:B:CIHD;)E:G6I>DC6HI=::ME:C9>IJG:
;DGL=>8=I=:>C8:CI>K:>H>CI:C9:9ID8DBE:CH6I:
>A486=DAA4=2H(A0=B;0C8>=.=:DBE6CNUHCDC / - HJ7H>9>6G>:HI=6IDE:G6I:>C6AD86A8JGG:C8N:CK>GDCB:CI L=:G:I=6I
AD86A8JGG:C8N>HI=:;JC8I>DC6A8JGG:C8N EG>B6G>AN<:C:G6I:6C9:ME:C986H=>CI=:>GAD86A8JGG:C8N 88DG9>C<AN 6AA76A6C8:H=::I
688DJCIHD;I=:H:AD86A;JC8I>DC6A8JGG:C8NHJ7H>9>6G>:H6G:IG6CHA6I:9>CID/ - 9DAA6GH6II=:;>H86AE:G>D9 :C9:M8=6C<:G6I: 6C9
>C8DB:6C9:ME:CH:688DJCIH6G:IG6CHA6I:9>CID/ - 9DAA6GHJH>C<6K:G6<:G6I:H>C:;;:8I;DGI=:E:G>D9 :M8:EI;DG8DHIHG:A6I:9ID
I=DH:76A6C8:H=::I>I:BHI=6I6G:IG6CHA6I:9JH>C<=>HIDG>86A:M8=6C<:G6I:H .=:G:HJAI>C<IG6CHA6I>DC69?JHIB:CIH6G:G:8DG9:96H
8JBJA6I>K:IG6CHA6I>DC69?JHIB:CIH6C96G:68DBEDC:CID;88JBJA6I:9DI=:G8DBEG:=:CH>K:>C8DB:ADHH ,:B:6HJG:B:CI
69?JHIB:CIH6G:G:8DG9:9>C)I=:G>C8DB::ME:CH: C:I L=:G:I=:/ - 9DAA6G>HI=:;JC8I>DC6A8JGG:C8N6C9I=:DBE6CN
IG6CH68IH>C68JGG:C8NDI=:GI=6CI=:;JC8I>DC6A8JGG:C8N
">C4 &424=C22>D=C8=6$A>=>D=24<4=CB
&424=C;H3>?C43>A5542C8E4
#C:8:B7:G I=: ->HHJ:9-/ V#C8DB:.6M:H.DE>8#BEGDK:B:CIHID#C8DB:.6M>H8ADHJG:H WL=>8=
G:FJ>G:HEJ7A>8:CI>I>:HID9>H8ADH:8DCH>HI:CI86I:<DG>:H6C9<G:6I:G9>H6<<G:<6I>DCD;>C;DGB6I>DC>CI=:G6I:G:8DC8>A>6I>DC6C9;DG
>C8DB:I6M:HE6>9 #I6AHD>C8AJ9:H8:GI6>CDI=:G6B:C9B:CIHID>BEGDK:I=::;;:8I>K:C:HHD;>C8DB:I6M9>H8ADHJG:H .=:<J>96C8:>H
:;;:8I>K:;DG;>C6C8>6AHI6I:B:CIH>HHJ:9;DG6CCJ6AE:G>D9H7:<>CC>C<6;I:G:8:B7:G L>I=:6GAN69DEI>DCE:GB>II:9 .=:
DBE6CN69DEI:9I=>HHI6C96G9EGDHE:8I>K:AN>C;>H86AN:6G;DGI=:6CCJ6AG:EDGI>C<E:G>D9:C9>C<$JC: .=:69DEI>DC
D;-/ 9>9CDI=6K:6C>BE68IDCI=:DBE6CNUHDCHDA>96I:9 >C6C8>6A-I6I:B:CIHDI=:GI=6C:ME6C9:9I6M;DDICDI:
9>H8ADHJG:H
">C4 &4E4=D4
8B066A460C8>=>5&4E4=D4
.=:;DAADL>C<I67A:EG:H:CIHI=:DBE6CNUHG:K:CJ:9>H6<<G:<6I:97:IL::CHNHI:BH6C98JHIDB:G HJEEDGIG:A6I:9G:K:CJ:
+2.?;121
B;2
B;2
B;2
6;A5<B@.;1@
-NHI:BH,:K:CJ:
JHIDB:GHJEEDGI G:A6I:9G:K:CJ:6C9DI=:G
-NHI:BHG:K:CJ:>C8AJ9:HH6A:HD;C:LA:69>C< :9<::FJ>EB:CI>C9:EDH>I>DC :I8= 8A:6C6C9DI=:GL6I:G;67G>86I>DCB6G@:IH
JHIDB:GHJEEDGI G:A6I:9G:K:CJ:>C8AJ9:HH6A:HD;8JHIDB:GH:GK>8: HE6G:H JE<G69:H 6C9CDC A:69>C< :9<::FJ>EB:CI;GDBI=:
DBE6CNUH,:A>6CIREGD9J8IA>C:
.=:DBE6CNDE:G6I:H>CDC:G:EDGI67A:7JH>C:HHH:<B:CIB6CJ;68IJG>C<6C9H:GK>8>C<D;L6;:GEGD8:HH>C<H:B>8DC9J8IDG
B6CJ;68IJG>C<:FJ>EB:CI ,:;:GID(DI:-:<B:CI !:D<G6E=>8#C;DGB6I>DC 6C9'6?DGJHIDB:GH ;DG699>I>DC6A>C;DGB6I>DC
G:<6G9>C<I=:DBE6CNUH:K6AJ6I>DCD;G:EDGI67A:7JH>C:HHH:<B:CIH6C9I=:9>H6<<G:<6I>DCD;G:K:CJ:7NI=:<:D<G6E=>8G:<>DCH>C
L=>8=I=:DBE6CNDE:G6I:H
&6B,:H:6G8=DGEDG6I>DC %
-- 153 of 186 --
99>I>DC6AAN I=:DBE6CNH:GK:HI=G::EG>B6GNB6G@:IHB:BDGN ;DJC9GN 6C9AD<>8>CI:<G6I:99:K>8:B6CJ;68IJG>C< .=:;DAADL>C<
I67A:EG:H:CIHI=:E:G8:CI6<:HD;A:69>C< 6C9CDC A:69>C< :9<::FJ>EB:CI6C9JE<G69:G:K:CJ:ID:68=D;I=:EG>B6GNB6G@:IHI=:
DBE6CNH:GK:H
+2.?;121
B;2
B;2
B;2
DJC9GN
':BDGN
&D<>8>CI:<G6I:99:K>8:B6CJ;68IJG>C<
454AA43&4E4=D4
,:K:CJ:D; 7>AA>DC>C8AJ9:9>C9:;:GG:9EGD;>I6I$JC: L6HG:8D<C>O:99JG>C<;>H86AN:6G G:EG:H:CI>C<D;I=:
7>AA>DC D;9:;:GG:9G:K:CJ:6HD;$JC:
.=:;DAADL>C<I67A:HJBB6G>O:HI=:IG6CH68I>DCEG>8:;DG8DCIG68IHI=6I=6K:CDIN:I7::CG:8D<C>O:96HG:K:CJ:6HD;$JC:
6C9L=:CI=:DBE6CN:ME:8IHIDG:8D<C>O:I=:6BDJCIH6HG:K:CJ:
2@@A5.;
+2.? +2.?@
<?2A5.;
+2.?@ &<A.9
6;A5<B@.;1@
:;:GG:9G:K:CJ:
.=>H6BDJCI>HG:EDGI:9>C:;:GG:9EGD;>IDCI=:DBE6CNHDCHDA>96I:96A6C8:-=::IH6HI=:8JHIDB:GH86C9:B6C9I=:
E:G;DGB6C8:ID7:H6I>H;>:96I6CNI>B:
">C4@D8CH10B43><?4=B0C8>=$;0=
.=:DBE6CN=6HHID8@EA6CHI=6IEGDK>9:;DG<G6CIHD;CDC FJ6A>;>:9:FJ>IN 76H:96L6G9HD;I=:DBE6CNUHDBBDC-ID8@ID
:A><>7A::BEADN::H6C9CDC :BEADN::9>G:8IDGH >C8AJ9>C<HID8@DEI>DCH H:GK>8: 76H:9G:HIG>8I:9HID8@JC>IHVH:GK>8: 76H:9,-/HW
6C9B6G@:I 76H:9E:G;DGB6C8:G:HIG>8I:9HID8@JC>IHVB6G@:I 76H:9*,-/HW CDEI>DC>H6G><=IIDEJG8=6H:DBBDC-ID8@6I6
H:IEG>8: G:HIG>8I:9HID8@JC>I6L6G9>H6C6<G::B:CIID>HHJ:6H:ICJB7:GD;H=6G:HD;DBBDC-ID8@6II=:I>B:D;K:HI>C< .=:
DBE6CN6AHD=6H6C:BEADN::HID8@EJG8=6H:EA6CI=6I6AADLH:A><>7A::BEADN::HIDEJG8=6H:>IHDBBDC-ID8@6I69>H8DJCI
I=GDJ<=E6NGDAA9:9J8I>DCH
.=:&6B,:H:6G8=DGEDG6I>DC-ID8@#C8:CI>K:*A6C 6H6B:C9:9 6C9I=:&6B,:H:6G8=DGEDG6I>DC-ID8@#C8:CI>K:
*A6C8DAA:8I>K:ANI=:V-ID8@*A6CHWL:G:6EEGDK:97NI=:HID8@=DA9:GH6C9EGDK>9:;DGI=:<G6CID;CDC FJ6A>;>:9:FJ>IN 76H:9
6L6G9HID:A><>7A::BEADN::H 8DCHJAI6CIH 69K>HDGH 6C9CDC :BEADN::9>G:8IDGHD;I=:DBE6CN6C9>IHHJ7H>9>6G>:H .=:
-ID8@#C8:CI>K:*A6CL6H6EEGDK:97NH=6G:=DA9:GHDC(DK:B7:G 6C96JI=DG>O:HJEID B>AA>DCH=6G:H6K6>A67A:;DG
>HHJ6C8:JC9:GI=:EA6C 99>I>DC6AAN B>AA>DCH=6G:HI=6IG:B6>C:96K6>A67A:;DG<G6CIJC9:GI=:DBE6CNUH-ID8@#C8:CI>K:
EA6C 6H6B:C9:9L:G:699:9IDI=:H=6G:H6K6>A67A:;DG>HHJ6C8:JC9:GI=:-ID8@#C8:CI>K:EA6C HD;$JC:
B>AA>DCH=6G:HG:B6>C6K6>A67A:;DG;JIJG:>HHJ6C8:JC9:GI=:-ID8@*A6CHIDH6I>H;NHID8@DEI>DC:M:G8>H:H6C9K:HI>C<D;6L6G9H
.=:DBE6CNG:8D<C>O:9I=:;DAADL>C<:FJ>IN 76H:98DBE:CH6I>DC:ME:CH:>C8AJ9>C<:ME:CH:G:A6I:9IDI=::BEADN::HID8@
EJG8=6H:EA6C6C9G:A6I:9>C8DB:I6M7:C:;>I>CI=:DCHDA>96I:9-I6I:B:CIHD;)E:G6I>DCH
+2.?;121
B;2
B;2
B;2
6;A5<B@.;1@
FJ>IN 76H:98DBE:CH6I>DC:ME:CH:
#C8DB:I6M7:C:;>IG:8D<C>O:9G:A6I:9ID:FJ>IN 76H:98DBE:CH6I>DC
#C8DB:I6M7:C:;>IG:6A>O:9;GDBI=::M:G8>H:6C9K:HI>C<D;DEI>DCH6C9,-/H
.=::HI>B6I:9;6>GK6AJ:D;I=:DBE6CNUH:FJ>IN 76H:96L6G9H A:HH:ME:8I:9;DG;:>IJG:H >H6BDGI>O:9DK:GI=:6L6G9HUK:HI>C<
I:GBHDC6HIG6><=I A>C:76H>H
&4BCA82C43'C>2:)=8CB
JG>C<;>H86AN:6GH 6C9 I=:DBE6CN>HHJ:97DI=H:GK>8: 76H:9,-/H6C9B6G@:I 76H:9*,-/H -:GK>8: 76H:9
,-/HINE>86AANK:HI6CCJ6AANDK:G6E:G>D9D;N:6GHDGA:HH '6G@:I 76H:9*,-/H<:C:G6AANK:HII=G::N:6GH;GDBI=:<G6CI96I:>;
8:GI6>CE:G;DGB6C8:6C9:BEADNB:CI8G>I:G>66G:68=>:K:9
&6B,:H:6G8=DGEDG6I>DC %
-- 154 of 186 --
DGI=:B6G@:I 76H:9*,-/H<G6CI:9>CI=:6C9;>H86AN:6GH I=:CJB7:GD;H=6G:HI=6I86C7::6GC:9DK:GI=:
E:G;DGB6C8:E:G>D9>H76H:9DCI=:DBE6CNUHIDI6AH=6G:=DA9:GG:IJGCV.-,WG:A6I>K:IDDI=:G8DBE6C>:H>CI=:*=>A69:AE=>6
-:B>8DC9J8IDG#C9:MV2-)2W 6C9G6C<:H;GDBIDD;I6G<:I .DI6AH=6G:=DA9:GG:IJGC>H6B:6HJG:D;HID8@EG>8:
6EEG:8>6I>DC>CI=:E:G;DGB6C8:E:G>D9 69?JHI:9;DGI=:G:>CK:HIB:CID;9>K>9:C9H ,:A6I>K:.-,E:G;DGB6C8:>HB:6HJG:9JH>C<I=:
6K:G6<:8ADH>C<EG>8:HD;:68=2-)28DBE6CN;DGI=: IG69>C<96NHEG>DGIDI=:96I:HI=:E:G;DGB6C8:E:G>D97:<>CH6C9:C9H
.=:I6G<:ICJB7:GD;H=6G:H>H:6GC:976H:9DCI=:E:G8:CI>A:G6C@>C<D;I=:DBE6CNUH.-,6BDC<I=:.-,H;DGI=:8DBE6C>:H
B6@>C<JEI=:2-)2#C9:M #;I=:DBE6CNUH.-,>HC:<6I>K:DK:GI=:E:G;DGB6C8:E:G>D9 I=:E6NDJIL>AA7:86EE:96I
G:<6G9A:HHD;I=:E:G8:CI>A:G6C@>C<
DGB6G@:I 76H:9*,-/H<G6CI:9>CI=:;>H86AN:6G I=:CJB7:GD;H=6G:HI=6I86C7::6GC:9DK:GI=:E:G;DGB6C8:E:G>D9H>H
76H:9DCI=:DBE6CNUHDBBDC-ID8@EG>8:E:G;DGB6C8:8DBE6G:9IDI=:B6G@:IEG>8:E:G;DGB6C8:D;I=:*=>A69:AE=>6
-:B>8DC9J8IDG.DI6A,:IJGC#C9:MV2-)2W 6C9G6C<:H;GDBIDD;I6G<:I .=:HID8@EG>8:E:G;DGB6C8:DGB6G@:IEG>8:
E:G;DGB6C8:>HB:6HJG:9JH>C<I=:6K:G6<:8ADH>C<EG>8:;DGI=: IG69>C<96NHEG>DGIDI=:96I:HI=:E:G;DGB6C8:E:G>D97:<>CH
6C9:C9H .=:I6G<:ICJB7:GD;H=6G:HG:EG:H:CI:97NI=:B6G@:I 76H:9*,-/H>H>C8G:6H:97ND;I6G<:I;DG:68=I=6I
DBBDC-ID8@EG>8:E:G;DGB6C8::M8::9HI=:B6G@:IEG>8:E:G;DGB6C8:D;I=:9:H><C6I:97:C8=B6G@>C9:M
.=:;DAADL>C<I67A:HJBB6G>O:HI=:DBE6CNUH8DB7>C:9H:GK>8: 76H:9,-/H6C9B6G@:I 76H:9*,-/H
!B:/2?<3
%5.?2@
6;A5<B@.;1@
)2645A21C2?.42
?.;A.A2.6?
(.9B2
)JIHI6C9>C< $JC:
!G6CI:9
0:HI:9
DG;:>I:9DG86C8:A:9
)JIHI6C9>C< $JC:
);I=: I=DJH6C9H=6G:HDJIHI6C9>C<6I$JC: I=DJH6C96G:H:GK>8: 76H:9,-/H6C9 I=DJH6C96G:
B6G@:I 76H:9*,-/H .=:;6>GK6AJ:D;I=:DBE6CNUHH:GK>8: 76H:9,-/HL6H86A8JA6I:976H:9DCI=:;6>GB6G@:IK6AJ:D;I=:
DBE6CNUHHID8@6II=:96I:D;<G6CI 9>H8DJCI:9;DG9>K>9:C9H .=:;6>GK6AJ:D;I=:DBE6CNUHB6G@:I 76H:9*,-/H<G6CI:99JG>C<
;>H86AN:6GH 6C9L6H86A8JA6I:9JH>C<6'DCI:6GADH>BJA6I>DCBD9:A6II=:96I:D;I=:<G6CI G:HJAI>C<>C6
L:><=I:96K:G6<:<G6CI 96I:;6>GK6AJ:E:GH=6G:D; 6C9 G:HE:8I>K:AN .=:IDI6A;6>GK6AJ:D;H:GK>8: 76H:9
,-/H6C9B6G@:I 76H:9,-/HI=6IK:HI:99JG>C<;>H86AN:6GH 6C9L6H B>AA>DC B>AA>DC 6C9
B>AA>DC G:HE:8I>K:AN
HD;$JC: I=:DBE6CN=69 B>AA>DCD;IDI6AJCG:8D<C>O:98DBE:CH6I>DC:ME:CH:L=>8=>H:ME:8I:9ID7:
G:8D<C>O:9DK:G6L:><=I:9 6K:G6<:G:B6>C>C<E:G>D9D;6EEGDM>B6I:AN N:6GH
'C>2:#?C8>=B
.=:DBE6CN<G6CI:9HID8@DEI>DCHL>I=6 N:6GB6M>BJB8DCIG68IJ6AI:GBID6A>B>I:9<GDJED;:M:8JI>K:D;;>8:GH9JG>C<;>H86A
N:6GH6C9 (DHID8@DEI>DCHL:G:<G6CI:99JG>C<;>H86AN:6G -ID8@DEI>DCHINE>86AANK:HIDK:G6E:G>D9D;I=G::N:6GH
DGA:HH .=:DBE6CN=69I=DJH6C9DEI>DCHDJIHI6C9>C<6I$JC: L>I=6L:><=I:9 6K:G6<::M:G8>H:EG>8:D; E:G
H=6G: D;L=>8=I=DJH6C9L:G::M:G8>H67A:L>I=6L:><=I:9 6K:G6<::M:G8>H:EG>8:D; E:GH=6G: HD;$JC: I=:
DBE6CN=69 B>AA>DCD;IDI6AJCG:8D<C>O:98DBE:CH6I>DC:ME:CH:G:A6I:9IDJCK:HI:9HID8@DEI>DCH<G6CI:96C9DJIHI6C9>C<
L=>8=>H:ME:8I:9ID7:G:8D<C>O:9DK:G6L:><=I:9 6K:G6<:G:B6>C>C<E:G>D9D;C>C:BDCI=H
'$$
.=:DBE6CN=6H6C:BEADN::HID8@EJG8=6H:EA6CI=:V-**WL=>8=6AADLH:BEADN::HID9:H><C6I:6EDGI>DCD;I=:>G76H:
8DBE:CH6I>DCID7:9:9J8I:96C9JH:9IDEJG8=6H:I=:DBE6CNUHDBBDC-ID8@6I6EJG8=6H:EG>8:E:GH=6G:D;I=:ADL:GD;
D;I=:;6>GB6G@:IK6AJ:D;I=:DBE6CNUHDBBDC-ID8@DCI=:;>GHIDGA6HI96ND;I=:6EEA>867A:EJG8=6H:E:G>D9 .NE>86AAN
:68=D;;:G>C<E:G>D9A6HIHBDCI=H6C98DCI6>CHDC:>CI:G>BEJG8=6H:96I:
JG>C<;>H86AN:6G 6EEGDM>B6I:AN I=DJH6C9H=6G:HD;I=:DBE6CNUHDBBDC-ID8@L:G:HDA9ID:BEADN::HJC9:GI=:
-** I$JC: 6EEGDM>B6I:AN B>AA>DCH=6G:HL:G:6K6>A67A:;DGEJG8=6H: 6C9I=:DBE6CN=69 B>AA>DCD;IDI6A
JCG:8D<C>O:98DBE:CH6I>DC8DHI L=>8=>H:ME:8I:9ID7:G:8D<C>O:9DK:G6G:B6>C>C<E:G>D9D;6EEGDM>B6I:ANI:CBDCI=H
&6B,:H:6G8=DGEDG6I>DC %
-- 155 of 186 --
">C4#C74A=2><4G?4=B4"4C
.=:H><C>;>86CI8DBEDC:CIHD;)I=:G>C8DB::ME:CH: C:I L:G:6H;DAADLH
+2.?;121
B;2
B;2
B;2
6;A5<B@.;1@
#CI:G:HI>C8DB:
#CI:G:HI:ME:CH:
!6>CHDC9:;:GG:98DBE:CH6I>DCEA6CG:A6I:96HH:IH C:I
DG:><C:M8=6C<:ADHH:H C:I
)I=:G C:I
#CI:G:HI>C8DB:>C;>H86AN:6G9:8G:6H:98DBE6G:9ID;>H86AN:6GEG>B6G>AN9J:IDADL:G>CI:G:HIG6I:H6HL:AA6H6C>BE68I
;GDBHA><=IANADL:G6K:G6<:>CK:HI:986H=76A6C8:HK:GHJHI=:EG>DGN:6G #CI:G:HI>C8DB:>C;>H86AN:6G9:8G:6H:98DBE6G:9ID
;>H86AN:6G EG>B6G>AN9J:IDADL:G>CI:G:HIG6I:H E6GI>6AAND;;H:I7N=><=:G6K:G6<:86H=76A6C8:H
#CI:G:HI:ME:CH:9:8G:6H:9>C;>H86AN:6G8DBE6G:9ID;>H86AN:6GEG>B6G>AN9J:IDI=:B6IJG>IND; B>AA>DCD;I=:
DBE6CNUH-:C>DG(DI:H>C'6G8= #CI:G:HI:ME:CH:9:8G:6H:9>C;>H86AN:6G8DBE6G:9ID;>H86AN:6GEG>B6G>AN9J:
IDI=:B6IJG>IND; B>AA>DCD;I=:DBE6CNUH-:C>DG(DI:H>C'6G8=
.=:<6>CHDC9:;:GG:98DBE:CH6I>DCEA6CG:A6I:96HH:IH C:I>C;>H86AN:6GH 6C9L:G:9G>K:C7N;AJ8IJ6I>DCH>CI=:
;6>GB6G@:IK6AJ:D;I=:JC9:GAN>C<;JC9H
DG:><C:M8=6C<:;AJ8IJ6I>DCH>C;>H86AN:6GH 6C9L:G:EG>B6G>AN9J:ID8JGG:C8NBDK:B:CIH6<6>CHIEDGI>DCHD;DJG
JC=:9<:976A6C8:H=::I:MEDHJG:H
.=:K6G>6I>DCH>CDI=:G C:I;DGI=:N:6G:C9:9$JC: 8DBE6G:9IDI=:N:6GH:C9:9$JC: 6C9$JC: L:G:
EG>B6G>AN9G>K:C7N;AJ8IJ6I>DCH>CI=:;6>GB6G@:IK6AJ:D;:FJ>IN>CK:HIB:CIH
">C4=2><4(0G4B
.=:8DBEDC:CIHD;>C8DB:7:;DG:>C8DB:I6M:HL:G:6H;DAADLH
+2.?;121
B;2
B;2
B;2
6;A5<B@.;1@
/C>I:9-I6I:H
DG:><C
&6B,:H:6G8=DGEDG6I>DC %
-- 156 of 186 --
-><C>;>86CI8DBEDC:CIHD;I=:EGDK>H>DC7:C:;>I;DG>C8DB:I6M:H6IIG>7JI67A:ID>C8DB:7:;DG:>C8DB:I6M:HL:G:6H;DAADLH
+2.?;121
B;2
B;2
B;2
6;A5<B@.;1@
:9:G6A
JGG:CI
:;:GG:9
-I6I:
JGG:CI
:;:GG:9
DG:><C
JGG:CI
:;:GG:9
.DI6AEGDK>H>DC;DG>C8DB:I6M:H
:;:GG:9>C8DB:I6M:HG:;A:8II=:C:II6M:;;:8ID;I:BEDG6GN9>;;:G:C8:H7:IL::CI=:86GGN>C<6BDJCIHD;6HH:IH6C9A>67>A>I>:H;DG
;>C6C8>6AG:EDGI>C<EJGEDH:H6C9I=:6BDJCIHJH:9;DG>C8DB:I6MEJGEDH:H 6HL:AA6HI=:I6M:;;:8ID;86GGN;DGL6G9H -><C>;>86CI
8DBEDC:CIHD;I=:DBE6CNUHC:I9:;:GG:9I6M6HH:IH6C9A>67>A>I>:HL:G:6H;DAADLH
B;2
B;2
6;A5<B@.;1@
:;:GG:9I6M6HH:IH
.6M86GGN;DGL6G9H
AADL6C8:H6C9G:H:GK:H
)JIH>9:76H>H9>;;:G:C8:HD;;DG:><CHJ7H>9>6G>:H
,86E>I6A>O6I>DC
)E:G6I>C<A:6H:A>67>A>I>:H
)I=:G
!GDHH9:;:GG:9I6M6HH:IH
06AJ6I>DC6AADL6C8:
(:I9:;:GG:9I6M6HH:IH
:;:GG:9I6MA>67>A>I>:H
6E>I6A6HH:IH
,><=I D; JH:6HH:IH
)I=:G
!GDHH9:;:GG:9I6MA>67>A>I>:H
(:I9:;:GG:9I6M6HH:IH
,:6A>O6I>DCD;I=:DBE6CNUHC:I9:;:GG:9I6M6HH:IH>H76H:9JEDCI=:L:><=I>C<D;6K6>A67A::K>9:C8: >C8AJ9>C<HJ8=;68IDGH6HI=:
G:8:CI:6GC>C<H=>HIDGN6C9:ME:8I:9;JIJG:I6M67A:>C8DB: .=:DBE6CN7:A>:K:H>I>HBDG:A>@:ANI=6CCDII=6IHJ8=9:;:GG:9I6M
6HH:IHL>AA7:G:6A>O:9L>I=I=::M8:EI>DCD; B>AA>DCEG>B6G>ANG:A6I:9ID6A>;DGC>69:;:GG:9I6M6HH:IH I$JC: I=:
DBE6CN8DCI>CJ:9IDG:8DG96K6AJ6I>DC6AADL6C8:IDD;;H:II=::CI>G:6A>;DGC>69:;:GG:9I6M6HH:I76A6C8:9J:IDI=:H>C<A:H6A:H
;68IDG6EEDGI>DCB:CIG:HJAI>C<>CADL:GI6M67A:>C8DB:>C6A>;DGC>6
I $JC: I=:DBE6CN=69HI6I:I6M8G:9>I86GGN;DGL6G9HD; B>AA>DC -J7HI6CI>6AAN6AAD;I=:H:8G:9>IH86C7:86GG>:9
;DGL6G9>C9:;>C>I:AN
&6B,:H:6G8=DGEDG6I>DC %
-- 157 of 186 --
.=:DBE6CN69DEI:9-/ DC6EGDHE:8I>K:76H>H7:<>CC>C<L>I=I=:;>H86AN:6G:C9:9$JC: .=:;DAADL>C<I67A:
EG:H:CIHG:FJ>G:99>H8ADHJG:HEJGHJ6CIID-/ 6C9G:8DC8>A:HI=:/ - ;:9:G6AHI6IJIDGNI6M6BDJCI6C9G6I:IDI=:
DBE6CNUHDCHDA>96I:9:;;:8I>K:6BDJCI6C9G6I:;DGI=:N:6G:C9:9$JC:
+2.?;121
B;2
:<B;A #2?02;A
6;A5<B@.;1@
#C8DB:I6M:ME:CH:8DBEJI:96I;:9:G6AHI6IJIDGNG6I:
-I6I:6C9AD86A>C8DB:I6M:H C:ID;;:9:G6A>C8DB:I6M:;;:8I
DG:><CI6M:;;:8IH
'6A6NH>6
-I6IJIDGNI6MG6I:9>;;:G:CI>6A
#C8:CI>K:6<G::B:CI
)I=:G T
)I=:G;DG:><C?JG>H9>8I>DCH
;;:8ID;8=6C<:H>CI6MA6LHDGG6I:H:C68I:9>CI=:8JGG:CIE:G>D9
;;:8ID;8GDHH 7DG9:GI6MA6LH
!AD76A>CI6C<>7A:ADL I6M:9>C8DB:
DG:><C>C8DB:>C8AJH>DCHI6M67A:6I/ - HI6IJIDGNG6I: -J7E6GI
)I=:G T
.6M8G:9>IH
,:H:6G8=6C99:K:ADEB:CI
)I=:G T
(DCI6M67A:DGCDC9:9J8I>7A:>I:BH
=6C<:H>CJC8:GI6>CI6MEDH>I>DCH
)I=:G69?JHIB:CIH T
#C8DB:I6M:ME:CH: :;;:8I>K:I6MG6I:
I$JC: I=:HI6I:6C9AD86A>C8DB:I6M:H>C)G:<DC6C9'>CC:HDI68DBEG>H:9I=:B6?DG>IND;I=:HI6I:6C9AD86A>C8DB:
I6M:H C:ID;;:9:G6AI6M:;;:8I86I:<DGN
.=::;;:8ID;8GDHH 7DG9:GI6MA6LH86I:<DGN>C8AJ9:HI=:7:C:;>ID;;DG:><CI6M8G:9>IH6HHD8>6I:9L>I=;DG:><C:6GC>C<HHJ7?:8IID/ -
I6M6I>DC .=:DBE6CNEG:H:CIHI=>H86I:<DGNDC6C:I76H>H6HI=:;DG:><CI6M8G:9>IH9>G:8IAND;;H:II=:G:A6I:9/ - I6MA>67>A>IN
&6B,:H:6G8=DGEDG6I>DC %
-- 158 of 186 --
.=:;DAADL>C<I67A:EG:H:CIHI=:G:FJ>G:99>H8ADHJG:HEG>DGIDI=:DBE6CNUH69DEI>DCD;-/ 6C9G:8DC8>A:H>C8DB:I6M
:ME:CH:EGDK>9:96II=:;:9:G6AHI6IJIDGNG6I:>C;>H86AN:6GH6C9ID68IJ6A>C8DB:I6M:ME:CH:;DGI=:;>H86AN:6GH
:C9:9$JC: 6C9$JC:
+2.?;121
B;2
B;2
6;A5<B@.;1@
#C8DB:I6M:ME:CH:8DBEJI:96I;:9:G6AHI6IJIDGNG6I:
-I6I:>C8DB:I6M:H C:ID;;:9:G6AI6M7:C:;>I
DG:><C>C8DB:I6M:96I9>;;:G:CIG6I:H
-:IIA:B:CIH6C9G:9J8I>DCH>CJC8:GI6>CI6MEDH>I>DCH
.6M8G:9>IH
-I6I:K6AJ6I>DC6AADL6C8: C:ID;;:9:G6AI6M7:C:;>I
FJ>IN 76H:98DBE:CH6I>DC
#C8G:6H:H>CJC8:GI6>CI6MEDH>I>DCH
)I=:GE:GB6C:CI9>;;:G:C8:H6C9B>H8:AA6C:DJH>I:BH
;;:8I>K:;GDB;>H86AN:6G I=:DBE6CN=6H6 N:6GI6M>C8:CI>K:GJA>C<>C'6A6NH>6;DGDC:D;>IH;DG:><CHJ7H>9>6G>:H .=:
>BE68ID;I=:I6M>C8:CI>K:9:8G:6H:9LDGA9L>9:I6M:H7N6EEGDM>B6I:AN B>AA>DC B>AA>DC 6C9 B>AA>DC;DG;>H86A
N:6GH 6C9 G:HE:8I>K:AN .=:7:C:;>ID;I=:I6M>C8:CI>K:DC9>AJI:9:6GC>C<HE:GH=6G:L6H6EEGDM>B6I:AN
6C9 >C;>H86AN:6GH 6C9 G:HE:8I>K:AN
*- !'.L6H;JAAN:;;:8I>K:;DGI=:DBE6CNI=>H;>H86AN:6G .=:DBE6CN6HH:HH:9!'.JC9:G8JGG:CIAN:C68I:9A:<>HA6I>DC
6C99:I:GB>C:9I=6I>IB:IIG6CH>I>DC6AH6;:=6G7DGG:FJ>G:B:CIH>CBDHI?JG>H9>8I>DCH L>I=A>B>I:9?JG>H9>8I>DCHHJ7?:8IID!'. .=:
DBE6CN6HH:HH:9I=:>BE68I6C98DC8AJ9:9I=6I>IL6HCDIB6I:G>6A .=:>BE68I=6H7::C>C8AJ9:9L>I=>C>C8DB:I6M:ME:CH:;DG
I=:IL:AK:BDCI=H:C9:9$JC:
)C$JAN I=:)L6HH><C:9>CIDA6L7N/ - *G:H>9:CIDC6A9.GJBE .=:>BE68IDC>C8DB:I6M:H9J:ID8=6C<:>C
A:<>HA6I>DC>HG:FJ>G:9 JC9:G- #C8DB:.6M:H ID7:G:8D<C>O:9>CI=:E:G>D9>CL=>8=I=:A6L>H:C68I:9 L=>8=L6HI=>H;>H86A
N:6G #C <:C:G6A I=: ) >CIGD9J8:9 8=6C<:H ID / - I6M6I>DC >C8AJ9>C< 8=6C<:H >C I=: I6M6I>DC D; CDC / - >C8DB: .=:
DBE6CN 6HH:HH:9 I=: 8=6C<:H 6C9 8DC8AJ9:9 I=6I I=:N L:G: CDI B6I:G>6A .=: >BE68I =6H 7::C >C8AJ9:9 L>I=>C >C8DB: I6M
:ME:CH:;DGI=:IL:AK:BDCI=H:C9:9$JC:
.=:DBE6CNUH<GDHHJC8:GI6>CI6MEDH>I>DCHL:G: B>AA>DC B>AA>DC 6C9 B>AA>DC6HD;$JC: $JC:
6C9$JC: G:HE:8I>K:AN JG>C<;>H86AN:6G <GDHHJC8:GI6>CI6MEDH>I>DCH>C8G:6H:97N B>AA>DC .=:
6BDJCID;JC8:GI6>CI6MEDH>I>DCHI=6I >;G:8D<C>O:9 LDJA9>BE68II=::;;:8I>K:I6MG6I:L6H B>AA>DC B>AA>DC 6C9
B>AA>DC 6HD;$JC: $JC: 6C9$JC: G:HE:8I>K:AN
&6B,:H:6G8=DGEDG6I>DC %
-- 159 of 186 --
.=:6<<G:<6I:8=6C<:H>CI=:76A6C8:D;<GDHHJC8:GI6>CI6MEDH>I>DCHL:G:6H;DAADLH
6;A5<B@.;1@
6A6C8:6HD;$JC:
-:IIA:B:CIH6C9:;;:8I>K:H:IIA:B:CIHL>I=I6M6JI=DG>I>:H
&6EH:D;HI6IJI:D;A>B>I6I>DCH
:8G:6H:H>C76A6C8:HG:A6I:9IDI6MEDH>I>DCHI6@:C9JG>C<EG>DGE:G>D9H
#C8G:6H:H>C76A6C8:HG:A6I:9IDI6MEDH>I>DCHI6@:C9JG>C<8JGG:CIE:G>D9
6A6C8:6HD;$JC:
-:IIA:B:CIH6C9:;;:8I>K:H:IIA:B:CIHL>I=I6M6JI=DG>I>:H
&6EH:D;HI6IJI:D;A>B>I6I>DCH
#C8G:6H:H>C76A6C8:HG:A6I:9IDI6MEDH>I>DCHI6@:C9JG>C<EG>DGE:G>D9H
:8G:6H:H>C76A6C8:HG:A6I:9IDI6MEDH>I>DCHI6@:C9JG>C<EG>DGE:G>D9H
#C8G:6H:H>C76A6C8:HG:A6I:9IDI6MEDH>I>DCHI6@:C9JG>C<8JGG:CIE:G>D9
6A6C8:6HD;$JC:
-:IIA:B:CIH6C9:;;:8I>K:H:IIA:B:CIHL>I=I6M6JI=DG>I>:H
&6EH:D;HI6IJI:D;A>B>I6I>DCH
#C8G:6H:H>C76A6C8:HG:A6I:9IDI6MEDH>I>DCHI6@:C9JG>C<EG>DGE:G>D9H
:8G:6H:H>C76A6C8:HG:A6I:9IDI6MEDH>I>DCHI6@:C9JG>C<EG>DGE:G>D9H
#C8G:6H:H>C76A6C8:HG:A6I:9IDI6MEDH>I>DCHI6@:C9JG>C<8JGG:CIE:G>D9
6A6C8:6HD;$JC:
.=:DBE6CN=69688GJ:9 B>AA>DC B>AA>DC 6C9 B>AA>DC8JBJA6I>K:AN;DG<GDHH>CI:G:HI6C9E:C6AI>:H6HD;
$JC: $JC: 6C9$JC: G:HE:8I>K:AN
.=:DBE6CN>HHJ7?:8IID6J9>IH7NHI6I:6C9;DG:><CI6M6JI=DG>I>:H .=:DBE6CN>HJC67A:IDB6@:6G:6HDC67A::HI>B6I:6HID
L=:C86H=H:IIA:B:CIH >;6CN L>I=I=:G:A:K6CII6M>C<6JI=DG>I>:HL>AAD88JG
.=:DBE6CN;>A:H/ - ;:9:G6A / - HI6I: 6C9;DG:><C>C8DB:I6MG:IJGCH HD;$JC: I6MN:6GH G:B6>CHJ7?:8I
ID:M6B>C6I>DC>CI=:?JG>H9>8I>DCHL=:G:I=:DBE6CNDE:G6I:H
.=:#CI:GC6A,:K:CJ:-:GK>8:V#,-W:M6B>C:9I=:DBE6CNUH/ - ;:9:G6A>C8DB:I6MG:IJGCH;DGI=:;>H86AN:6GH:C9:9$JC:
$JC: 6C9$JC: HD;$JC: I=:#,-EGDEDH:969?JHIB:CIHI=6IL:G:CDIH><C>;>86CI L=>8=I=:
DBE6CN6<G::9ID6C9E6>9
H6G:HJAID;I=:69DEI>DCD;-/ I=:DBE6CN=6H>C8AJ9:9I=:;DAADL>C<I67A:G:8DC8>A>C<>C8DB:I6M:HE6>9C:ID;
G:;JC9HG:8:>K:9
+2.?;121
B;2
6H=E6NB:CI;DG>C8DB:I6M:HC:ID;G:;JC9HG:8:>K:9 6;A5<B@.;1@
:9:G6A
-I6I:
DG:><C
%DG:6
)I=:G
.DI6A86H=E6NB:CIH;DG>C8DB:I6M:HC:ID;G:;JC9HG:8:>K:9
.DI6A86H=E6NB:CIH;DG>C8DB:I6M:HC:ID;G:;JC9HG:8:>K:9L6H B>AA>DC6C9 B>AA>DC 6HD;$JC: 6C9
$JC: G:HE:8I>K:AN
&6B,:H:6G8=DGEDG6I>DC %
-- 160 of 186 --
">C4"4C=2><4?4A'70A4
6H>8C:I>C8DB:E:GH=6G:>H8DBEJI:97N9>K>9>C<C:I>C8DB:7NI=:L:><=I:9 6K:G6<:CJB7:GD;8DBBDCH=6G:HDJIHI6C9>C<
9JG>C<I=:E:G>D9 >AJI:9C:I>C8DB:E:GH=6G:>H8DBEJI:9JH>C<I=:IG:6HJGNHID8@B:I=D9 ;DG9>AJI>K:HID8@DEI>DCH 6C9G:HIG>8I:9
HID8@JC>IH
.=:;DAADL>C<I67A:G:8DC8>A:HI=:>CEJIHIDI=:76H>86C99>AJI:98DBEJI6I>DCH;DGC:I>C8DB:E:GH=6G:
+2.?;121
B;2
B;2
B;2
6;A5<B@.;1@2E02=A=2?@5.?21.A.
(JB:G6IDG
(:I>C8DB:
:CDB>C6IDG
6H>86K:G6<:H=6G:HDJIHI6C9>C<
;;:8ID;EDI:CI>6A9>AJI>K:H:8JG>I>:H
BEADN::HID8@EA6CH
>AJI:96K:G6<:H=6G:HDJIHI6C9>C<
(:I>C8DB:E:GH=6G: 76H>8
(:I>C8DB:E:GH=6G: 9>AJI:9
DGEJGEDH:HD;8DBEJI>C<9>AJI:9C:I>C8DB:E:GH=6G: L:><=I:9 6K:G6<:8DBBDCH=6G:H9DCDI>C8AJ9:EDI:CI>6AAN9>AJI>K:
H:8JG>I>:HI=6I6G:6CI> 9>AJI>K:JC9:GI=:IG:6HJGNHID8@B:I=D9 .=:H:6CI> 9>AJI>K:H:8JG>I>:H >C8AJ9>C<DEI>DCH H:GK>8: 76H:9,-/H
6C9B6G@:I 76H:9*,-/H L:G:CDIB6I:G>6A;DG;>H86AN:6GH:C9:9$JC: $JC: 6C9$JC:
">C48=0=280;=BCAD<4=CB
08A*0;D4
.=:DBE6CN9:;>C:H;6>GK6AJ:6HI=:EG>8:I=6ILDJA97:G:8:>K:9;GDBH:AA>C<6C6HH:IDGE6>9IDIG6CH;:G6A>67>A>IN>C6CDG9:GAN
IG6CH68I>DC7:IL::CB6G@:IE6GI>8>E6CIH6II=:B:6HJG:B:CI96I: 1=:C9:I:GB>C>C<I=:;6>GK6AJ:B:6HJG:B:CIH;DG6HH:IH6C9
A>67>A>I>:HG:FJ>G:9DGE:GB>II:9ID7:G:8DG9:96I;6>GK6AJ: I=:DBE6CN8DCH>9:GHI=:EG>C8>E6ADGBDHI69K6CI6<:DJHB6G@:I>C
L=>8=>ILDJA9IG6CH68I 6C9>I8DCH>9:GH6HHJBEI>DCHI=6IB6G@:IE6GI>8>E6CIHLDJA9JH:L=:CEG>8>C<I=:6HH:IDGA>67>A>IN
;6>GK6AJ:=>:G6G8=N=6H7::C:HI67A>H=:9I=6IEG>DG>I>O:HI=:>CEJIHIDK6AJ6I>DCI:8=C>FJ:HJH:9IDB:6HJG:;6>GK6AJ: .=:A:K:AD;
6C6HH:IDGA>67>A>IN>CI=:=>:G6G8=N>H76H:9DCI=:ADL:HIA:K:AD;>CEJII=6I>HH><C>;>86CIIDI=:;6>GK6AJ:B:6HJG:B:CI HH:IH6C9
A>67>A>I>:H86GG>:96I;6>GK6AJ:6G:8A6HH>;>:96C99>H8ADH:9>CDC:D;I=:;DAADL>C<I=G::86I:<DG>:H
&:K:A06AJ6I>DCH76H:9DCFJDI:9EG>8:H>C68I>K:B6G@:IH;DG>9:CI>86A6HH:IHDGA>67>A>I>:HL>I=HJ;;>8>:CIKDAJB:6C9;G:FJ:C8ND;
IG6CH68I>DCH
&:K:A06AJ6I>DCH76H:9DCD7H:GK67A:>CEJIHDI=:GI=6C&:K:AEG>8:HHJ8=6HFJDI:9EG>8:H;DGH>B>A6G6HH:IHDGA>67>A>I>:H FJDI:9
EG>8:H>CB6G@:IHI=6I6G:CDI68I>K:;DG>9:CI>86A6HH:IHDGA>67>A>I>:H DGBD9:A 9:G>K:9K6AJ6I>DCHI:8=C>FJ:H;DGL=>8=6AAH><C>;>86CI
>CEJIH6G:D7H:GK67A:>CI=:B6G@:IDG86C7:8DGGD7DG6I:97ND7H:GK67A:B6G@:I96I6;DGHJ7HI6CI>6AANI=:;JAAI:GBD;I=:6HH:IHDG
A>67>A>I>:H
&:K:A06AJ6I>DCH76H:9DCJCD7H:GK67A:>CEJIHIDI=:K6AJ6I>DCB:I=D9DAD<NI=6I6G:H><C>;>86CIIDI=:B:6HJG:B:CID;;6>GK6AJ:
D;6HH:IHDGA>67>A>I>:H6C976H:9DCCDC 7>C9>C< 7GD@:G EGDK>9:9EG>8:FJDI:H6C9B6NCDI=6K:7::C8DGGD7DG6I:97ND7H:GK67A:
B6G@:I96I6
.=:DBE6CN:C<6<:HL>I=EG>8>C<K:C9DGHIDEGDK>9:;6>GK6AJ:H;DG6B6?DG>IND;>IH&:K:A>CK:HIB:CIH .=:K:C9DGHEGDK>9::>I=:G
6FJDI:9B6G@:IEG>8:DGJH:D7H:GK67A:>CEJIHL>I=DJI6EEAN>C<H><C>;>86CI69?JHIB:CIH>CI=:>GEG>8>C< -><C>;>86CID7H:GK67A:>CEJIH
>C8AJ9:>CI:G:HIG6I:H6C9N>:A98JGK:HD7H:GK67A:6I8DBBDCANFJDI:9>CI:GK6AH KDA6I>A>IN6C98G:9>IG>H@H .=:;6>GK6AJ:D;9:G>K6I>K:
8DCIG68IH>H9:I:GB>C:9JH>C<D7H:GK67A:B6G@:I>CEJIHHJ8=6HI=:;DG:><C8JGG:C8NG6I:H ;DGL6G9G6I:8JGK:H 8JGG:C8NKDA6I>A>IN
6C9>CI:G:HIG6I:H6C98DCH>9:GHCDCE:G;DGB6C8:G>H@D;I=:DBE6CN6C9>IH8DJCI:GE6GI>:H
.=:DBE6CNUHEG>B6GN;>C6C8>6A>CHIGJB:CIH>C8AJ9:>IH86H= 86H=:FJ>K6A:CIH ADC< I:GB>CK:HIB:CIH 688DJCIHG:8:>K67A:
688DJCIHE6N67A: ADC< I:GB9:7I6C9A:6H:H 6C9;DG:><C8JGG:C8NG:A6I:99:G>K6I>K:>CHIGJB:CIH .=::HI>B6I:9;6>GK6AJ:D;86H=
I>B:9:EDH>IH 688DJCIHG:8:>K67A: 6C9688DJCIHE6N67A:6EEGDM>B6I:HI=:>G86GGN>C<K6AJ:9J:IDI=:H=DGIE:G>D9D;I>B:IDI=:>G
B6IJG>I>:H .=::HI>B6I:9;6>GK6AJ:HD;A:6H:D7A><6I>DCH6EEGDM>B6I:I=:>G86GGN>C<K6AJ:6HI=:B6?DG>IND;I=:H:D7A><6I>DCH6G:
<:C:G6AANH=DGI I:GB>CC6IJG:6C9=6K:>CI:G:HIG6I:HI=6IG:H:IJEDCG:C:L6ADGBD9>;>86I>DC ,:;:GID(DI:&DC<.:GB:7I6C9
)I=:GDGGDL>C<H;DG699>I>DC6A>C;DGB6I>DCG:<6G9>C<I=:;6>GK6AJ:D;I=:DBE6CNUH-:C>DG(DI:H
&6B,:H:6G8=DGEDG6I>DC %
-- 161 of 186 --
.=:DBE6CN688DJCIH;DG>IH>CK:HIB:CIEDGI;DA>D6I;6>GK6AJ: ,:6A>O:9<6>CHADHH:H;DG>CK:HIB:CIH6A:H6G:HE:8>;>86AAN
>9:CI>;>:9 '6C6<:B:CI6HH:HH:HI=:;6>GK6AJ:D;>CK:HIB:CIH>C9:7IH:8JG>I>:HI=6I6G:CDI68I>K:ANIG69:9I=GDJ<=8DCH>9:G6I>DCD;
>CI:G:HIG6I:H6C9I=:>G>BE68IDCI=:EG:H:CIK6AJ:D;I=:86H=;ADLHID7:G:8:>K:9;GDBI=:>CK:HIB:CIH
.=:DBE6CN:K6AJ6I:H>IH>CK:HIB:CIHL>I=;6>GK6AJ:A:HHI=6C6BDGI>O:98DHI7N;>GHI8DCH>9:G>C<L=:I=:GI=:DBE6CN=6HI=:
>CI:CIIDH:AAI=:H:8JG>INDGL=:I=:G>I>HBDG:A>@:ANI=6CCDII=6II=:DBE6CNL>AA7:G:FJ>G:9IDH:AAI=:H:8JG>IN7:;DG:G:8DK:GND;
>IH6BDGI>O:98DHI76H>H #C:>I=:GHJ8=H>IJ6I>DC I=:9>;;:G:C8:7:IL::C;6>GK6AJ:6C96BDGI>O:98DHI>HG:8D<C>O:96H6ADHH>CI=:
DCHDA>96I:9-I6I:B:CID;)E:G6I>DCH 1=:G:HJ8=H6A:H6G:CDIA>@:ANIDD88JG I=:DBE6CN8DCH>9:GHL=:I=:G6EDGI>DCD;I=:ADHH
>HI=:G:HJAID;68G:9>IADHH .DI=::MI:CIHJ8=ADHH:H6G:I=:G:HJAID;8G:9>IADHH:H I=DH:6BDJCIH6G:G:8D<C>O:9>CI=:
DCHDA>96I:9-I6I:B:CID;)E:G6I>DCH AADI=:G9>;;:G:C8:H7:IL::C;6>GK6AJ:6C96BDGI>O:98DHI6G:G:8D<C>O:9>CDI=:G
8DBEG:=:CH>K:>C8DB: (DHJ8=ADHH:HL:G:G:8D<C>O:9I=GDJ<=I=:DCHDA>96I:9-I6I:B:CID;)E:G6I>DCH9JG>C<I=:IL:AK:
BDCI=H:C9:9$JC: $JC: 6C9$JC:
Investments
#CK:HIB:CIH6G:G:8DG9:9L>I=>C*G:E6>9:ME:CH:H6C9DI=:G8JGG:CI6HH:IH>CI=:DBE6CNUHDCHDA>96I:96A6C8:-=::IH HD;
$JC: 6C9$JC: I=:;6>GK6AJ: 6C96HHD8>6I:9JCG:6A>O:9ADHHEDH>I>DCH >;6CN D;BJIJ6A;JC9H6C9:FJ>IN
>CK:HIB:CIHL:G:CDIB6I:G>6A !GDHHG:6A>O:9<6>CHADHH:H;GDBH6A:HD;>CK:HIB:CIHL:G:>CH><C>;>86CI>C;>H86AN:6GH
6C9
.=:;>C6C8>6A>CHIGJB:CIHG:EDGI:9L>I=>C6H=6C986H=:FJ>K6A:CIH>CI=:DBE6CNUHDCHDA>96I:96A6C8:-=::IH6HD;$JC:
6C9$JC: 8DCH>HI:9D;I=:;DAADL>C<
B;2
B;2
6;A5<B@.;1@
'DC:NB6G@:I;JC9H;6>GK6AJ:B:6HJG:9DC6G:8JGG>C<76H>H A:K:A
6H=
.>B:9:EDH>IH
.DI6A
4A8E0C8E4=BCAD<4=CB0=34368=6
.=:DBE6CN86GG>:H9:G>K6I>K:;>C6C8>6A>CHIGJB:CIHV9:G>K6I>K:HWDC>IHDCHDA>96I:96A6C8:-=::IH6II=:>G;6>GK6AJ:H .=:
DBE6CN:CI:GH>CID;DG:><C8JGG:C8N;DGL6G98DCIG68IH6C9;DG:><C8JGG:C8NDEI>DCHL>I=;>C6C8>6A>CHI>IJI>DCHL>I=I=:EG>B6GN
D7?:8I>K:D;G:9J8>C<KDA6I>A>IND;:6GC>C<H6C986H=;ADLHG:A6I:9ID;DG:><C8JGG:C8N:M8=6C<:G6I:;AJ8IJ6I>DCH #C699>I>DC I=:
DBE6CN:CI:GH>CID>CI:G:HIG6I:HL6E6GG6C<:B:CIHIDB6C6<:>CI:G:HIG6I:G>H@ .=:8DJCI:GE6GI>:HIDI=:H:9:G>K6I>K:H6G:A6G<:
<AD76A;>C6C8>6A>CHI>IJI>DCHI=6II=:DBE6CN7:A>:K:H6G:8G:9>ILDGI=N 6C9I=:G:;DG: >I9D:HCDI8DCH>9:GI=:G>H@D;8DJCI:GE6GIN
CDCE:G;DGB6C8:ID7:B6I:G>6A
0B7;>F4364B
HD;$JC: 6C9$JC: I=:;6>GK6AJ:D;DJIHI6C9>C<86H=;ADL=:9<:HL6HCDIB6I:G>6A .=::;;:8ID;9:G>K6I>K:
>CHIGJB:CIH9:H><C6I:96H86H=;ADL=:9<:HDCI=:DBE6CNUHDCHDA>96I:9-I6I:B:CIHD;)E:G6I>DCH >C8AJ9>C<688JBJA6I:9DI=:G
8DBEG:=:CH>K:>C8DB: L6HCDIB6I:G>6A6HD;6C9;DGI=:IL:AK:BDCI=H:C9:9$JC: 6C9$JC: HD;$JC:
I=:DBE6CN=696C>BB6I:G>6AC:I<6>CDGADHH688JBJA6I:9>CDI=:G8DBEG:=:CH>K:>C8DB: C:ID;I6M G:A6I:9ID;DG:><C
:M8=6C<:86H=;ADL=:9<:H6C9>CI:G:HIG6I:8DCIG68IHL=>8=>I:ME:8IHIDG:8A6HH>;N;GDBDI=:G8DBEG:=:CH>K:>C8DB:>CID:6GC>C<H
DK:GI=:C:MIBDCI=H .=:IDI6ACDI>DC6AK6AJ:D;86H=;ADL=:9<:>CHIGJB:CIHDJIHI6C9>C<6HD;$JC: >C8AJ9:9
B>AA>DCD;7JN8DCIG68IH6C9 B>AA>DCD;H:AA8DCIG68IH
0;0=24'744C4A8E0C8E4=BCAD<4=CB
HD;$JC: 6C9$JC: I=:;6>GK6AJ:D;DJIHI6C9>C<76A6C8:H=::I9:G>K6I>K:>CHIGJB:CIHL6HCDIB6I:G>6A .=:
:;;:8ID;I=:DBE6CNUH76A6C8:H=::I9:G>K6I>K:>CHIGJB:CIHDCI=:DBE6CNUHDCHDA>96I:9-I6I:B:CIHD;)E:G6I>DCHL:G:CDI
B6I:G>6A6HD;6C9;DGI=:IL:AK:BDCI=H:C9:9$JC: .=:IDI6ACDI>DC6AK6AJ:D;76A6C8:H=::I9:G>K6I>K:>CHIGJB:CIH
DJIHI6C9>C<6HD;$JC: >C8AJ9:9 B>AA>DCD;7JN8DCIG68IH6C9 B>AA>DCD;H:AA8DCIG68IH
>=24=CA0C8>=B>5A438C&8B:
>C6C8>6A>CHIGJB:CIHI=6IEDI:CI>6AANHJ7?:8II=:DBE6CNID8DC8:CIG6I>DCHD;8G:9>IG>H@8DCH>HIEG>C8>E6AAND;86H=6C986H=
:FJ>K6A:CIH IG69:688DJCIHG:8:>K67A: 6C99:G>K6I>K:;>C6C8>6A>CHIGJB:CIHJH:9>C=:9<>C<68I>K>I>:H 6H=>HEA68:9DC9:EDH>I6I
A6G<: <AD76A;>C6C8>6A>CHI>IJI>DCH -J8=9:EDH>IHB6N7:>C:M8:HHD;>CHJG:9A>B>IH '6C6<:B:CI7:A>:K:HI=6II=:;>C6C8>6A
>CHI>IJI>DCHI=6I=DA9I=:DBE6CNUH86H=6G:8G:9>ILDGI=N6C9 688DG9>C<AN B>C>B6A8G:9>IG>H@:M>HIHL>I=G:HE:8IIDI=:H:76A6C8:H
.D:CHJG:9>K:GH>;>86I>DC6C9B>C>B>O:8DC8:CIG6I>DC I=:DBE6CNUHEDA>8NA>B>IHI=:6BDJCID;8G:9>I:MEDHJG:L>I=6CNDC:
;>C6C8>6A>CHI>IJI>DC
&6B,:H:6G8=DGEDG6I>DC %
-- 162 of 186 --
.=:DBE6CN>H:MEDH:9ID8G:9>IADHH:H>CI=::K:CID;CDCE:G;DGB6C8:7N8DJCI:GE6GI>:HDC;DG:><C8JGG:C8N6C9>CI:G:HIG6I:
=:9<:8DCIG68IHI=6I6G:JH:9IDB>I><6I:I=::;;:8ID;:M8=6C<:G6I:6C9>CI:G:HIG6I:;AJ8IJ6I>DCH6C9DC8DCIG68IHG:A6I:9ID
HIGJ8IJG:9H=6G:G:EJG8=6H:6GG6C<:B:CIH .=:H:8DJCI:GE6GI>:H6G:A6G<: <AD76A;>C6C8>6A>CHI>IJI>DCH6C9 ID96I: CDHJ8=
8DJCI:GE6GIN=6H;6>A:9IDB::I>IH;>C6C8>6AD7A><6I>DCHIDI=:DBE6CN
G:9>IG>H@:K6AJ6I>DCH >C8AJ9>C<IG69:G:;:G:C8:H 76C@G:;:G:C8:H 6C9JCG69HIG::IG6I>C<H 6G:E:G;DGB:9DC6AAC:L
8JHIDB:GH 6C9I=:DBE6CNBDC>IDGH>IH8JHIDB:GHU;>C6C8>6A8DC9>I>DC6C9E6NB:CIE:G;DGB6C8: #C<:C:G6A I=:DBE6CN9D:H
CDIG:FJ>G:8DAA6I:G6ADCH6A:H
HD;$JC: ;>K:8JHIDB:GH688DJCI:9;DG6EEGDM>B6I:AN 6C9D;688DJCIHG:8:>K67A:
G:HE:8I>K:AN HD;$JC: I=G::8JHIDB:GH688DJCI:9;DG6EEGDM>B6I:AN 6C9D;688DJCIHG:8:>K67A:
G:HE:8I>K:AN (DDI=:G8JHIDB:GH688DJCI:9;DGDGBDG:D;688DJCIHG:8:>K67A: .=:DBE6CNUH76A6C8:6C9IG6CH68I>DC6A
68I>K>IN;DG>IH6AADL6C8:;DG9DJ7I;JA688DJCIH>HCDIB6I:G>6A6HD;6C9;DGI=:N:6GH:C9:9$JC: $JC: 6C9
$JC: ,:;:GID(DI:-:<B:CI !:D<G6E=>8#C;DGB6I>DC 6C9'6?DGJHIDB:GH;DG699>I>DC6A>C;DGB6I>DCG:<6G9>C<
8JHIDB:G8DC8:CIG6I>DCH
">C4 =E4=C>A84B
#CK:CIDG>:H6G:HI6I:96II=:ADL:GD;8DHIDGC:IG:6A>O67A:K6AJ:JH>C<HI6C96G98DHIHI=6I6EEGDM>B6I:68IJ6A8DHIHDC6;>GHI >C ;>GHI
DJI76H>H #CK:CIDG>:H8DCH>HID;I=:;DAADL>C<
B;2
B;2
6;A5<B@.;1@
,6LB6I:G>6AH
1DG@ >C EGD8:HH
>C>H=:9<DD9H
">C4 $A>?4ACH0=3@D8?<4=C
*GDE:GIN6C9:FJ>EB:CI C:I >HEG:H:CI:9>CI=:I67A:7:ADL
6;A5<B@.;1@
'6CJ;68IJG>C<6C9:C<>C::G>C<:FJ>EB:CI
J>A9>C<H6C9>BEGDK:B:CIH
DBEJI:G6C98DBEJI:G G:A6I:9:FJ>EB:CI
&6C9
);;>8::FJ>EB:CI ;JGC>IJG:6C9;>MIJG:H
&:HH688JBJA6I:99:EG:8>6I>DC6C96BDGI>O6I>DC
B;2
B;2
.=:DBE6CN=6H:M8AJ9:96C>BB6I:G>6AK6AJ:D;;>C6C8:G><=ID;JH:6HH:IHG:8DG9:9L>I=>CEGDE:GIN6C9:FJ>EB:CI C:I;GDBI=:
I67A:67DK: :EG:8>6I>DC:ME:CH:9JG>C<;>H86AN:6GH 6C9L6H B>AA>DC B>AA>DC 6C9 B>AA>DC
G:HE:8I>K:AN
">C4 >>3F8;;0=3=C0=681;4BB4CB
>>3F8;;
.=:76A6C8:D;<DD9L>AAL6H 7>AA>DC6HD;$JC: 6C9$JC: G:HE:8I>K:AN HD;$JC: 6C9$JC:
B>AA>DC6C9 B>AA>DC G:HE:8I>K:AN D;I=:<DD9L>AA76A6C8:>HI6M9:9J8I>7A: 6C9I=:G:B6>C>C<76A6C8:>HCDII6M
9:9J8I>7A:9J:IDEJG8=6H:688DJCI>C<6C96EEA>867A:;DG:><CA6L (D<DD9L>AA>BE6>GB:CIHL:G:G:8D<C>O:9>C;>H86AN:6GH
DG
&6B,:H:6G8=DGEDG6I>DC %
-- 163 of 186 --
=C0=681;4BB4CB
.=:76A6C8:D;>CI6C<>7A:6HH:IH6HD;$JC: 6C9$JC: L:G: B>AA>DC6C9 B>AA>DC G:HE:8I>K:AN
8DCH>HI>C<EG>B6G>AND;86E>I6A>O:9HD;IL6G: .=::;;:8ID;>CI6C<>7A:6HH:IHDCI=:DBE6CNUHDCHDA>96I:9-I6I:B:CID;)E:G6I>DCH
>C8AJ9>C<6BDGI>O6I>DC6C9>BE6>GB:CI >;6CN L6HCDIB6I:G>6A;DG;>H86AN:6GH 6C9
">C4 22AD43G?4=B4B0=3#C74ADAA4=C 8018;8C84B
88GJ:9:ME:CH:H6C9DI=:G8JGG:CIA>67>A>I>:H8DCH>HID;I=:;DAADL>C<
B;2
B;2
6;A5<B@.;1@
88GJ:98DBE:CH6I>DC
16GG6CING:H:GK:H
#C8DB:6C9DI=:GI6M:HE6N67A:
>K>9:C9E6N67A:
)I=:G
">C4 >=6(4A<41C0=3#C74A>AA>F8=6B
HD;$JC: 6C9$JC: I=:DBE6CNUHDJIHI6C9>C<9:7I8DCH>HI:9D;I=:;DAADL>C<
B;2 B;2
:<B;A
6;A5<B@.;1@
3320A6C2
;A2?2@A
$.A2
:<B;A
6;A5<B@.;1@
3320A6C2
;A2?2@A
$.A2
>M:9 G6I: -:C>DG(DI:J:$JC: (DI:H
>M:9 G6I: -:C>DG(DI:J:$JC: (DI:H
>M:9 G6I: -:C>DG(DI:HJ:'6G8= (DI:H
>M:9 G6I: -:C>DG(DI:J:$JC: (DI:H
>M:9 G6I: -:C>DG(DI:HJ:'6G8= (DI:H
>M:9 G6I: -:C>DG(DI:HJ:'6G8= (DI:H T
.DI6A-:C>DG(DI:HDJIHI6C9>C< 6IE6G
/C6BDGI>O:99>H8DJCI
/C6BDGI>O:97DC9>HHJ6C8:8DHIH
)I=:G;>C6C8>C<6GG6C<:B:CIH
.DI6A9:7IDJIHI6C9>C< 6I86GGN>C<K6AJ:
,:EDGI:96H
JGG:CIEDGI>DCD;ADC< I:GB9:7I
&DC< I:GB9:7I
.=:DBE6CNUH8DCIG68IJ6A86H=D7A><6I>DCHG:A6I>C<ID>IHDJIHI6C9>C<9:7I6HD;$JC: L:G:6H;DAADLH
#.F:2;A@B2/F6@0.9+2.? #?6;06=.9 ;A2?2@A
6;A5<B@.;1@
T
T
T
.=:G:6;I:G
.DI6A
&6B,:H:6G8=DGEDG6I>DC %
-- 164 of 186 --
'4=8>A">C4B
)C'6N I=:DBE6CN8DBEA:I:96EJ7A>8D;;:G>C<D; B>AA>DC6<<G:<6I:EG>C8>E6A6BDJCID;I=:DBE6CNUH-:C>DG
(DI:H9J:$JC: I=:V(DI:HW B>AA>DC6<<G:<6I:EG>C8>E6A6BDJCID;I=:DBE6CNUH-:C>DG(DI:H9J:$JC:
I=:V(DI:HW 6C9 B>AA>DC6<<G:<6I:EG>C8>E6A6BDJCID;I=:DBE6CNUH-:C>DG(DI:H9J:$JC: I=:
V(DI:HW .=:DBE6CNE6NH>CI:G:HI6I6C6CCJ6AG6I:D; 6C9 DCI=: 6C9(DI:H
G:HE:8I>K:AN DC6H:B> 6CCJ6A76H>HDC$JC:6C9:8:B7:GD;:68=N:6G
)C'6G8= I=:DBE6CN8DBEA:I:96EJ7A>8D;;:G>C<D; B>AA>DC6<<G:<6I:EG>C8>E6A6BDJCID;I=:DBE6CNUH-:C>DG
(DI:H9J:'6G8= I=:V(DI:HW 7>AA>DC6<<G:<6I:EG>C8>E6A6BDJCID;I=:DBE6CNUH-:C>DG(DI:H9J:
'6G8= I=:V(DI:HW 6C9 B>AA>DC6<<G:<6I:EG>C8>E6A6BDJCID;I=:DBE6CNUH-:C>DG(DI:H9J:'6G8=
I=:V(DI:HW .=:DBE6CNE6NH>CI:G:HI6I6C6CCJ6AG6I:D; 6C9 DCI=:6C9(DI:H
G:HE:8I>K:AN DC6H:B> 6CCJ6A76H>HDC'6G8=6C9-:EI:B7:GD;:68=N:6G .=:(DI:HL:G:H:IIA:9JEDCB6IJG>IN9JG>C<
I=:I=G::BDCI=H:C9:9'6G8=
.=:DBE6CNB6NG:9::BI=: 6C9(DI:H8DAA:8I>K:ANI=:V-:C>DG(DI:HW6I6G:9:BEI>DCEG>8::FJ6A
IDD;I=:EG>C8>E6A6BDJCID;HJ8=H:G>:HVE6GW EAJH6VB6@:L=DA:WEG:B>JB6H9:H8G>7:9>CI=:>C9:CIJG:>CG:HE:8IIDI=:
-:C>DG(DI:H6C9688GJ:96C9JCE6>9>CI:G:HI7:;DG::8:B7:G ;DGI=:(DI:H 7:;DG:'6G8= ;DGI=:
(DI:H 7:;DG:-:EI:B7:G ;DGI=:(DI:H 7:;DG::8:B7:G ;DGI=:(DI:H 6C97:;DG::8:B7:G
;DGI=:(DI:H .=:DBE6CNB6NG:9::BI=:-:C>DG(DI:H6IE6G EAJH688GJ:96C9JCE6>9>CI:G:HI6I6CNI>B:DCDG6;I:G
:8:B7:G ;DGI=:(DI:H DCDG6;I:G'6G8= ;DGI=:(DI:H DCDG6;I:G-:EI:B7:G ;DGI=:
(DI:H DCDG6;I:G:8:B7:G ;DGI=:(DI:H 6C9DCDG6;I:G:8:B7:G ;DGI=:(DI:H #C699>I>DC JEDC
I=:D88JGG:C8:D;8:GI6>C:K:CIH 6H9:H8G>7:9>CI=:>C9:CIJG: I=:DBE6CNL>AA7:G:FJ>G:9IDB6@:6CD;;:GIDG:EJG8=6H:I=:
-:C>DG(DI:H6I6EG>8::FJ6AIDD;I=:EG>C8>E6A6BDJCID;I=:G:HE:8I>K:CDI: EAJH688GJ:96C9JCE6>9>CI:G:HI
-:A:8I:9699>I>DC6A>C;DGB6I>DCG:<6G9>C<I=:-:C>DG(DI:HDJIHI6C9>C<6HD;$JC: >H6H;DAADLH
$2:.6;6;4
:<?A6G.A6<;=2?6<1
.6?(.9B2<3!<A2@
2C29
F2.?@ 6;A5<B@.;1@
(DI:H
(DI:H
(DI:H
(DI:H
(DI:H
&4E>;E8=6A438C028;8CH
)C'6G8= I=:DBE6CN:HI67A>H=:96CJCH:8JG:9G:9>I<G::B:CI .=>H6<G::B:CIL6H6B:C9:9DC(DK:B7:G
I=:VB:C9:96C9,:HI6I:9G:9>I<G::B:CIW )8ID7:G I=:VC9B:C9B:CIW :7GJ6GN I=:VG9
B:C9B:CIW $JC: I=:V-:8DC9B:C9:96C9,:HI6I:9G:9>I<G::B:CIW :8:B7:G VB:C9B:CI(D ID
-:8DC9B:C9:96C9,:HI6I:9G:9>I<G::B:CIW 6C9$6CJ6GN I=:V.=>G9B:C9:96C9,:HI6I:9G:9>I<G::B:CIW
.=:.=>G9B:C9:96C9,:HI6I:9G:9>I<G::B:CIEGDK>9:H;DG6 7>AA>DCG:KDAK>C<8G:9>I;68>A>INL>I=6HNC9>86I:D;A:C9:GH
6ADC<L>I=6C:ME6CH>DCDEI>DCI=6IL>AA6AADLI=:DBE6CN HJ7?:8IID8:GI6>CG:FJ>G:B:CIH IDG:FJ:HI6C>C8G:6H:>CI=:;68>A>IND;JE
ID6C699>I>DC6A B>AA>DC ;DG6EDI:CI>6AIDI6A8DBB>IB:CID; 7>AA>DC .=:;68>A>INB6IJG:HDC$6CJ6GN
#CI:G:HIDC6BDJCIH7DGGDL:9JC9:GI=:8G:9>I;68>A>IN>H 6II=:DBE6CNUHDEI>DC 76H:9DC676H:G6I: EAJH6HEG:69D;
ID DG6C69?JHI:9I:GB-:8JG:9)K:GC><=I >C6C8>C<,6I: EAJH6HEG:69D; ID >C:68=86H:EAJH6;68>A>IN
;:: L>I=HJ8=HEG:696C9;68>A>IN;::9:I:GB>C:9>C688DG96C8:L>I=I=:.=>G9B:C9:96C9,:HI6I:9G:9>I<G::B:CI 6C9L>I=I=:
HEG:696C9;68>A>IN;::76H:9DCI=:G6I>C<D;I=:DBE6CNUHCDC 8G:9>I:C=6C8:9 H:C>DGJCH:8JG:9ADC< I:GB9:7I *G>C8>E6A6C9
6CN688GJ:96C9JCE6>9>CI:G:HI6G:9J:6C9E6N67A:JEDCB6IJG>IN 99>I>DC6AAN I=:DBE6CNL>AAE6NI=:A:C9:GH6FJ6GI:GAN
8DBB>IB:CI;::I=6IK6G>:H76H:9DCI=:DBE6CNUH8G:9>IG6I>C<6H9:H8G>7:967DK: HD;$JC: I=:DBE6CN=69CD
7DGGDL>C<HDJIHI6C9>C<JC9:GI=:8G:9>I;68>A>IN6C9L6H>C8DBEA>6C8:L>I=6AA;>C6C8>6A8DK:C6CIH
><<4A280;$0?4A$A>6A0<
#C(DK:B7:G I=:DBE6CN:HI67A>H=:968DBB:G8>6AE6E:GEGD<G6BI=:V**GD<G6BWJC9:GL=>8=I=:DBE6CNB6N>HHJ:
JCH:8JG:98DBB:G8>6AE6E:GCDI:HDC6EG>K6I:EA68:B:CI76H>HJEID6B6M>BJB6<<G:<6I:EG>C8>E6A6BDJCID; 7>AA>DC #C
$JAN I=:DBE6CN6B:C9:9I=:**GD<G6BH>O:ID6B6M>BJB6<<G:<6I:6BDJCIDJIHI6C9>C<6I6CNI>B:D; 7>AA>DC #C
'6G8= I=:**GD<G6BH>O:L6H;JGI=:G6B:C9:9ID6B6M>BJB6<<G:<6I:6BDJCIDJIHI6C9>C<6I6CNI>B:D; 7>AA>DC
.=:C:IEGD8::9H;GDBI=:**GD<G6BB6N7:JH:9;DG<:C:G6A8DGEDG6I:EJGEDH:H >C8AJ9>C<G:EJG8=6H:HD;I=:DBE6CNUH
DBBDC-ID8@;GDBI>B:IDI>B:JC9:GI=:DBE6CNUHHID8@G:EJG8=6H:EGD<G6B BDJCIH6K6>A67A:JC9:GI=:**GD<G6BB6N7:
G: 7DGGDL:9 .=:**GD<G6B>H768@HIDEE:97NI=:DBE6CNUH,:KDAK>C<G:9>IGG6C<:B:CI HD;$JC: I=:DBE6CN
=69CDDJIHI6C9>C<7DGGDL>C<HJC9:GI=:**GD<G6B
&6B,:H:6G8=DGEDG6I>DC %
-- 165 of 186 --
=C4A4BC>BC
.=:;DAADL>C<I67A:EG:H:CIHI=:6BDJCID;>CI:G:HI8DHIG:8D<C>O:9G:A6I>C<ID7DI=I=:8DCIG68IJ6A>CI:G:HI8DJEDC6C96BDGI>O6I>DC
D;I=:9:7I9>H8DJCI >HHJ6C8:8DHIH 6C9:;;:8I>K:EDGI>DCD;>CI:G:HIG6I:8DCIG68IHL>I=G:HE:8IIDI=:-:C>DG(DI:H 6C9I=:G:KDAK>C<
8G:9>I;68>A>IN9JG>C<I=:;>H86AN:6GH:C9:9$JC: $JC: 6C9$JC:
+2.?;121
B;2
B;2
B;2
6;A5<B@.;1@
DCIG68IJ6A>CI:G:HI8DJEDC
BDGI>O6I>DCD;>CI:G:HI9>H8DJCI
BDGI>O6I>DCD;>HHJ6C8:8DHIH
;;:8ID;>CI:G:HIG6I:8DCIG68IH C:I
.DI6A>CI:G:HI8DHIG:8D<C>O:9
">C4 40B4B
.=:DBE6CNA:6H:H8:GI6>CD;;>8:HE68:H B6CJ;68IJG>C<6C9L6G:=DJH:HE68:H :FJ>EB:CI 6C9K:=>8A:H 1=>A:I=:B6?DG>IND;I=:
DBE6CNUHA:6H:6GG6C<:B:CIH6G:DE:G6I>C<A:6H:H I=:DBE6CN=6H8:GI6>CA:6H:HI=6IFJ6A>;N6H;>C6C8:A:6H:H
.=:DBE6CNA:6H:HHDB:D;>IH69B>C>HIG6I>K: G:H:6G8=6C99:K:ADEB:CI6C9B6CJ;68IJG>C<;68>A>I>:H G:<>DC6AH6A:HH:GK>8:
D;;>8:H 6C98:GI6>C:FJ>EB:CIJC9:GCDC 86C8:A67A:A:6H:H :GI6>CD;I=:DBE6CNUH;68>A>INA:6H:HEGDK>9:I=:DBE6CNL>I=
DEI>DCHID:MI:C9I=:A:6H:H;DG699>I>DC6AE:G>D9H IDEJG8=6H:I=:;68>A>I>:H DGEGDK>9:;DGE:G>D9>8G:CI>C8G:6H:H76H:9DCI=:
<:C:G6AG6I:D;>C;A6I>DC
06G>67A:A:6H:E6NB:CIH6G::ME:CH:96H>C8JGG:96C96G:CDI>C8AJ9:9L>I=>CI=:G><=ID;JH:6HH:I6C9A:6H:A>67>A>IN86A8JA6I>DC
06G>67A:A:6H:E6NB:CIHEG>B6G>AN>C8AJ9:8DHIH6HHD8>6I:9L>I=I=:DBE6CNUHI=>G9 E6GINAD<>HI>8H6GG6C<:B:CIHI=6I8DCI6>CDC:DG
BDG::B7:99:9A:6H:H 06G>67A:A:6H:8DHIHL>AA;AJ8IJ6I:76H:9DC;68IDGNDJIEJI6C9B6I:G>6AG:8:>EIKDAJB:H 06G>67A:A:6H:8DHIH
;DG;>H86AN:6GH 6C9L:G: B>AA>DC B>AA>DC 6C9 B>AA>DCG:HE:8I>K:AN >C6C8:A:6H:8DHIH
>C8AJ9>C<6BDGI>O6I>DCD;G><=ID;JH:6HH:IH6C9>CI:G:HIDCA:6H:A>67>A>I>:HH=DGI I:GBG:CI6A:ME:CH:;DG6<G::B:CIHA:HHI=6CDC:
N:6G>C9JG6I>DC6C9DE:G6I>C<A:6H:8DHIHL:G:>BB6I:G>6A;DG;>H86AN:6GH 6C9 G:HE:8I>K:AN
-JEEA:B:CI6A86H=;ADL>C;DGB6I>DCG:A6I:9IDA:6H:HL6H6H;DAADLH6HD;$JC: $JC: 6C9$JC:
+2.?;121
B;2
B;2
B;2
6;A5<B@.;1@
.@5=.613<?.:<B;A@6;09B1216;A52:2.@B?2:2;A<392.@296./696A62@
)E:G6I>C<86H=;ADLHE6>9;DGDE:G6I>C<A:6H:H
>C6C8>C<86H=;ADLHE6>9;DGEG>C8>E6AEDGI>DCD;;>C6C8:A:6H:H
$645A<3B@2.@@2A@</A.6;216;2E05.;423<?92.@2</964.A6<;@
)E:G6I>C<A:6H:H
>C6C8:A:6H:H
&6B,:H:6G8=DGEDG6I>DC %
-- 166 of 186 --
-JEEA:B:CI6A76A6C8:H=::I>C;DGB6I>DCG:A6I:9IDA:6H:HL6H6H;DAADLH6HD;$JC: 6C9$JC:
B;2
B;2
6;A5<B@.;1@
"=2?.A6;492.@2@
)I=:G6HH:IH
88GJ:9:ME:CH:H6C9DI=:G8JGG:CIA>67>A>I>:H
)I=:GADC< I:GBA>67>A>I>:H
.DI6ADE:G6I>C<A:6H:A>67>A>I>:H
HD;$JC: 6C9$JC: DJIHI6C9>C<;>C6C8:A:6H:D7A><6I>DCHL:G:>BB6I:G>6A
B;2 B;2
)2645A21C2?.42
$2:.6;6;42.@2
&2?: )2645A21C2?.42
6@0<B;A$.A2
)2645A21C2?.42
$2:.6;6;42.@2
&2?: )2645A21C2?.42
6@0<B;A$.A2
6;F2.?@ 6;F2.?@
)E:G6I>C<A:6H:H
HD;$JC: I=:B6IJG>I>:HD;DE:G6I>C<A:6H:A>67>A>I>:H6G:6H;DAADLH
"=2?.A6;42.@2@
6;A5<B@.;1@
.=:G:6;I:G
.DI6AA:6H:E6NB:CIH
&:HH>BEJI:9>CI:G:HI
.DI6A
">C4 454AA43><?4=B0C8>=$;0=B
.=:DBE6CN=6H6CJC;JC9:9 CDC FJ6A>;>:99:;:GG:98DBE:CH6I>DCEA6CL=:G:7N:M:8JI>K:HB6N9:;:G6EDGI>DCD;I=:>G
8DBE:CH6I>DC *6GI>8>E6CIH:6GC6G:IJGCDCI=:>G9:;:GG:98DBE:CH6I>DC76H:9DCI=:>G6AAD86I>DCD;I=:>G688DJCI76A6C8:6BDC<
K6G>DJHBJIJ6A;JC9H .=:DBE6CN8DCIGDAHI=:>CK:HIB:CID;I=:H:;JC9H 6C9I=:E6GI>8>E6CIHG:B6>C<:C:G6A8G:9>IDGHD;I=:
DBE6CN *6GI>8>E6CIH6G:67A:ID:A:8II=:E6NB:CID;7:C:;>IHDC6HE:8>;>:996I:6IA:6HII=G::N:6GH6;I:GI=:DE:C>C<D;69:;:GG6A
HJ7 688DJCIDGJEDCG:I>G:B:CI >HIG>7JI>DCH6G:B69:>CI=:;DGBD;AJBEHJBDG6CCJ6A>CHI6AAB:CIHDK:G6E:G>D9D;JEIDN:6GH
6H:A:8I:97NI=:E6GI>8>E6CI #;CD6AI:GC6I::A:8I>DC=6H7::CB69: 6AJBEHJBE6NB:CIL>AA7:B69:JEDCI:GB>C6I>DCD;6
E6GI>8>E6CIUH:BEADNB:CIL>I=I=:DBE6CN HD;$JC: 6C9$JC: I=:A>67>A>IND;I=:DBE6CNIDI=:EA6C
E6GI>8>E6CIHL6H B>AA>DC6C9 B>AA>DC G:HE:8I>K:AN L=>8=L6HG:8DG9:9>C88GJ:9:ME:CH:H6C9DI=:G8JGG:CIA>67>A>I>:H
6C9)I=:GADC< I:GBA>67>A>I>:HDCI=:DCHDA>96I:96A6C8:-=::IH HD;$JC: 6C9$JC: I=:DBE6CN=69
>CK:HIB:CIH>CI=:6<<G:<6I:6BDJCID; B>AA>DC6C9 B>AA>DC G:HE:8I>K:AN L=>8=8DGG:A6I:IDI=:9:;:GG:98DBE:CH6I>DC
D7A><6I>DCH L=>8=L:G:G:8DG9:9>C)I=:G6HH:IHDCI=:DCHDA>96I:96A6C8:-=::IH
">C4 ><<8C<4=CB0=3>=C8=64=284B
.=:DBE6CN=6H8:GI6>CD7A><6I>DCHIDB6@:;JIJG:E6NB:CIHJC9:GK6G>DJH8DCIG68IHHDB:D;I=:H:6G:G:8DG9:9DC>IH76A6C8:
H=::I6C9HDB:6G:CDI )7A><6I>DCHI=6I6G:G:8DG9:9DCI=:DBE6CNUH76A6C8:H=::I>C8AJ9:I=:DBE6CNUHDE:G6I>C<6C9;>C6C8:
A:6H:D7A><6I>DCH )7A><6I>DCHI=6I6G:CDIG:8DG9:9DCI=:DBE6CNUH76A6C8:H=::I>C8AJ9:8DCIG68IJ6AG:A6I>DCH=>EH;DGEJG8=6H:
D7A><6I>DCH6C98:GI6>C<J6G6CI::H .=:DBE6CNUH8DBB>IB:CIHG:A6I>C<IDD;; 76A6C8:H=::I6<G::B:CIH6G:>C8AJ9:9>CI=:I67A:H
7:ADL .=:H:6BDJCIH:M8AJ9: B>AA>DCD;A>67>A>I>:HG:A6I:9IDJC8:GI6>CI6MEDH>I>DCHH::(DI:#C8DB:.6M:H;DG;JGI=:G
9>H8JHH>DC6HD;I=::C9D;I=:;>H86AN:6G7:86JH:I=:DBE6CN>HJC67A:IDG:6HDC67AN:HI>B6I:I=:JAI>B6I:6BDJCIDGI>B:D;
H:IIA:B:CI
&6B,:H:6G8=DGEDG6I>DC %
-- 167 of 186 --
#C74AD0A0=C44B
.=:DBE6CN=6H>HHJ:98:GI6>C>C9:BC>;>86I>DCHID>IHA:HHDGH;DGI6M:H6C9<:C:G6AA>67>A>INJC9:GHDB:D;>IH6<G::B:CIH .=:
DBE6CN=6H:CI:G:9>CID>CHJG6C8:8DCIG68IHI=6I6G:>CI:C9:9IDA>B>I>IH:MEDHJG:IDHJ8=>C9:BC>;>86I>DCH HD;$JC:
I=:DBE6CN=69CDIG:8DG9:96CNA>67>A>INDC>IHDCHDA>96I:9 >C6C8>6A-I6I:B:CIH>C8DCC:8I>DCL>I=I=:H:>C9:BC>;>86I>DCH 6H>I
9D:HCDI7:A>:K: 76H:9DC=>HIDG>86A:ME:G>:C8:6C9>C;DGB6I>DC8JGG:CIAN6K6>A67A: I=6I>I>HEGD767A:I=6I6CNB6I:G>6A6BDJCIHL>AA
7:E6>9JC9:GI=:H:<J6G6CI::H
!:C:G6AAN I=:DBE6CN>C9:BC>;>:H JC9:GEG: 9:I:GB>C:98DC9>I>DCH6C9A>B>I6I>DCH >IH8JHIDB:GH;DG>C;G>C<:B:CID;I=>G9 E6GIN
>CI:AA:8IJ6AEGDE:GING><=IH7NI=:DBE6CNUHEGD9J8IHDGH:GK>8:H .=:DBE6CNH::@HIDA>B>I>IHA>67>A>IN;DGHJ8=>C9:BC>INID6C
6BDJCICDIID:M8::9I=:H6A:HEG>8:D;I=:EGD9J8IHDGH:GK>8:HHJ7?:8IID>IH>C9:BC>;>86I>DCD7A><6I>DCH .=:DBE6CN9D:HCDI
7:A>:K: 76H:9DC=>HIDG>86A:ME:G>:C8:6C9>C;DGB6I>DC8JGG:CIAN6K6>A67A: I=6I>I>HEGD767A:I=6I6CNB6I:G>6A6BDJCIHL>AA7:E6>9
JC9:GI=:H:<J6G6CI::H
.=:DBE6CNEGDK>9:H<J6G6CI::H6C9HI6C97NA:II:GHD;8G:9>IID8:GI6>CE6GI>:H6HG:FJ>G:9;DG8:GI6>CIG6CH68I>DCH>C>I>6I:99JG>C<
I=:DG9>C6GN8DJGH:D;7JH>C:HH HD;$JC: I=:B6M>BJBEDI:CI>6A6BDJCID;;JIJG:E6NB:CIHI=6II=:DBE6CN8DJA97:
G:FJ>G:9IDB6@:JC9:GI=:H:6GG6C<:B:CIH6C9A:II:GHD;8G:9>IL6H B>AA>DC .=:DBE6CN9D:HCDI7:A>:K: 76H:9DC
=>HIDG>86A:ME:G>:C8:6C9>C;DGB6I>DC8JGG:CIAN6K6>A67A: I=6I>I>HEGD767A:I=6I6CNB6I:G>6A6BDJCIHL>AA7:G:FJ>G:9ID7:E6>9
#C699>I>DC I=:DBE6CN=6H:CI:G:9>CID>C9:BC>;>86I>DC6<G::B:CIHL>I=>IH9>G:8IDGH D;;>8:GH 6C98:GI6>CDI=:G:BEADN::H
8DCH>HI:CIL>I=>IHNA6LH6C9:GI>;>86I:D;#C8DGEDG6I>DC6C9JC9:GAD86AA6L I=:DBE6CNB6N7:G:FJ>G:9IDEGDK>9:
>C9:BC>;>86I>DCID>IH:BEADN::H;DG68I>DCHL>I=>CI=:H8DE:D;I=:>G:BEADNB:CI AI=DJ<=I=:DBE6CNB6>CI6>CH>CHJG6C8:
8DCIG68IHI=6I8DK:GHDB:D;I=:EDI:CI>6AA>67>A>IN6HHD8>6I:9L>I=I=:H:>C9:BC>;>86I>DC6<G::B:CIH I=:G:>HCD<J6G6CI::I=6I6AA
HJ8=A>67>A>I>:HL>AA7:8DK:G:9 .=:DBE6CN9D:HCDI7:A>:K: 76H:9DC=>HIDG>86A:ME:G>:C8:6C9>C;DGB6I>DC8JGG:CIAN6K6>A67A:
I=6I>I>HEGD767A:I=6I6CNB6I:G>6A6BDJCIHL>AA7:G:FJ>G:9ID7:E6>9JC9:GHJ8=>C9:BC>;>86I>DC6<G::B:CIHDGHI6IJIDGN
D7A><6I>DCH
$DA270B4#1;860C8>=B
*JG8=6H:D7A><6I>DCH8DCH>HID;CDC 86C8:A67A:H><C>;>86CI8DCIG68IJ6AD7A><6I>DCH:>I=:GDC6C6CCJ6A76H>HDGDK:GBJAI> N:6G
E:G>D9H .=:8DCIG68IJ6A86H=D7A><6I>DCH6C98DBB>IB:CIHI67A:EG:H:CI:97:ADL8DCI6>CHI=:DBE6CNUHB>C>BJBD7A><6I>DCH6I
$JC: JC9:GI=:H:6GG6C<:B:CIH6C9DI=:GH DGD7A><6I>DCHL>I=86C8:AA6I>DCEGDK>H>DCH I=:6BDJCIH>C8AJ9:9>CI=:
;DAADL>C<I67A:L:G:A>B>I:9IDI=:CDC 86C8:A67A:EDGI>DCD;I=:6<G::B:CII:GBHDGI=:B>C>BJB86C8:AA6I>DC;:: 8IJ6A
:ME:C9>IJG:HL>AAK6GN76H:9DCI=:KDAJB:D;IG6CH68I>DCH6C9A:C<I=D;8DCIG68IJ6AH:GK>8:EGDK>9:9
.=:DBE6CNUH8DBB>IB:CIHG:A6I:9IDI=:H:6<G::B:CIH6HD;$JC: L:G:6H;DAADLH
#.F:2;A@B2/F6@0.9+2.? #B?05.@2
"/964.A6<;@
6;A5<B@.;1@
.=:G:6;I:G
.DI6A
(A0=B8C8>=(0G 8018;8CH
)C:8:B7:G I=:V.6MJIH$D7H8IWL6HH><C:9>CIDA6L BDC<DI=:G>I:BH I=>H/ - I6MG:;DGB6HH:HH:96DC: I>B:
IG6CH>I>DCI6MDC:6GC>C<HD;8:GI6>C;DG:><CHJ7H>9>6G>:HI=6IL:G:EG:K>DJHANI6M9:;:GG:9 H6G:HJAI I=:DBE6CNG:8D<C>O:96
IDI6AIG6CH>I>DCI6MD; B>AA>DC6C9:A:8I:9IDE6NI=:DC: I>B:I6MDK:G6E:G>D9D;N:6GH 8DBB:C8>C<>CI=:IL:AK:BDCI=H
:C9:9$JC: JG>C<;>H86AN:6G I=>HDC: I>B:I6ML6H69?JHI:9 G:HJAI>C<>C6IDI6AI6MA>67>A>IN>C8G:6H:D;
6EEGDM>B6I:AN B>AA>DC L=>8=L6HHEG:69DK:GI=:H6B: N:6GE:G>D9 .=:G:B6>C>C<D7A><6I>DCG:A6I:9IDI=>H6GG6C<:B:CI
L6HH:IIA:9>C;>H86AN:6G
+0AA0=C84B
.=:DBE6CNEGDK>9:HHI6C96G9L6GG6CI>:HDC>IHHNHI:BH .=:A>67>A>IN6BDJCI>H76H:9DC68IJ6A=>HIDG>86AL6GG6CINHE:C9>C<
68I>K>IN7NINE:D;HNHI:B 8JHIDB:G 6C9<:D<G6E=>8G:<>DC BD9>;>:9;DG6CN@CDLC9>;;:G:C8:HHJ8=6HI=:>BE68ID;HNHI:B
G:A>67>A>IN>BEGDK:B:CIH HD;$JC: L6GG6CING:H:GK:HIDI6A>C< B>AA>DCL:G:G:EDGI:9>C)I=:GADC< I:GBA>67>A>I>:H 6C9
I=:G:B6>C9:GL:G:>C8AJ9:9>C88GJ:9:ME:CH:H6C9DI=:G8JGG:CIA>67>A>I>:H>CI=:DBE6CNUHDCHDA>96I:96A6C8:-=::IH
&6B,:H:6G8=DGEDG6I>DC %
-- 168 of 186 --
=6C<:H>CI=:DBE6CNUHEGD9J8IL6GG6CING:H:GK:HL:G:6H;DAADLH
+2.?;121
B;2
B;2
6;A5<B@.;1@
6A6C8:6I7:<>CC>C<D;E:G>D9
16GG6CI>:H>HHJ:99JG>C<I=:E:G>D9
-:IIA:B:CIHB69:9JG>C<I=:E:G>D9
=6C<:H>CA>67>A>IN;DGEG: :M>HI>C<L6GG6CI>:H
6A6C8:6I:C9D;E:G>D9
>E4A=<4=CBB8BC0=24
#CI=:;>H86AN:6GH:C9:9$JC: 6C9$JC: I=:DBE6CNG:8:>K:9<DK:GCB:CI6HH>HI6C8:;GDBK6G>DJH9DB:HI>8
6C9>CI:GC6I>DC6A<DK:GCB:CIH>CI=:;DGBD;86H=<G6CIHDGG:;JC967A:I6M8G:9>IH .=:!G6CIHINE>86AANHE:8>;N8DC9>I>DCHI=6IBJHI
7:B:I>CDG9:G;DGI=:!G6CIHID7::6GC:9 HJ8=6H:BEADNB:CIDG:BEADN::G:I:CI>DCI6G<:IH8DBEA:I>DCD;:BEADN::IG6>C>C<DG
I=:8DCHIGJ8I>DCDG68FJ>H>I>DCD;EGDE:GIN6C9:FJ>EB:CI6C96G:D;I:CI>B: 7DJC9 #;8DC9>I>DCH6G:CDIH6I>H;>:9DG>;I=:9JG6I>DC
E:G>D9;DGI=:6GG6C<:B:CI>HCDIB:I I=:!G6CIH6G:D;I:CHJ7?:8IIDG:9J8I>DC G:E6NB:CI DGI:GB>C6I>DC
JG>C<I=:;>H86AN:6GH:C9:9$JC: 6C9$JC: I=:DBE6CNUH86H=!G6CIHL:G:>CH><C>;>86CI JG>C<I=:;>H86A
N:6GH:C9:9$JC: 6C9$JC: I=:DBE6CNG:8D<C>O:9>BB6I:G>6AG:9J8I>DCHIDI=:8DHI76H>HD;68FJ>G:9EGDE:GIN
6C9:FJ>EB:CIG:A6I:9IDG:;JC967A:I6M8G:9>IH:6GC:9 .=>HG:9J8I>DC>CI=:8DHI76H>HD;68FJ>G:9EGDE:GIN6C9:FJ>EB:CI>H
G:8DG9:9L>I=68DGG:HEDC9>C<G:9J8I>DCIDI6M:HE6N67A:6C98A6HH>;>:9JC9:G88GJ:9:ME:CH:6C9DI=:G8JGG:CIA>67>A>I>:H DG)I=:G
ADC< I:GBA>67>A>I>:H 6H6EEGDEG>6I: >CI=:DCHDA>96I:96A6C8:-=::IH
460;$A>24438=6B
1=>A:I=:DBE6CN>HCDI8JGG:CIAN6E6GINID6CNA:<6AEGD8::9>C<HI=6I>I7:A>:K:HB6I:G>6A I=:DBE6CN>H:>I=:G69:;:C96CIDG
EA6>CI>;;>CK6G>DJH68I>DCHI=6I=6K:6G>H:C;GDBI>B:IDI>B:>CI=:CDGB6A8DJGH:D;7JH>C:HH >C8AJ9>C<>CI:AA:8IJ6AEGDE:GIN8A6>BH
.=:DBE6CN688GJ:H;DG6A>67>A>INL=:C>I>H7DI=EGD767A:I=6I6A>67>A>IN=6H7::C>C8JGG:96C9I=:6BDJCID;I=:ADHH86C7:
G:6HDC67AN:HI>B6I:9 $J9<B:CI>HG:FJ>G:9>C7DI=I=:9:I:GB>C6I>DCD;EGD767>A>IN6C9I=:9:I:GB>C6I>DC6HIDL=:I=:G6ADHH>H
G:6HDC67AN:HI>B67A: 6H:9DC8JGG:CI>C;DGB6I>DC I=:DBE6CN9D:HCDI7:A>:K:I=6I6B6I:G>6AADHH;GDB@CDLCB6II:GH>H
EGD767A:6C9I=:G:;DG:=6HCDIG:8DG9:96C688GJ6AD;6CNB6I:G>6A6BDJCI;DGA>I><6I>DCDGDI=:G8DCI>C<:C8>:HG:A6I:9ID:M>HI>C<
A:<6AEGD8::9>C<H
">C4 'C>2:&4?DA270B4$A>6A0<
#C'6N I=:D6G9D;>G:8IDGH6JI=DG>O:9I=:DBE6CNIDG:EJG8=6H:JEID6C699>I>DC6A 7>AA>DCD;DBBDC-ID8@I=>H
6JI=DG>O6I>DCHJEEA:B:CIHI=:G:B6>C>C<76A6C8:H;GDB6CNEG>DG6JI=DG>O6I>DCH .=:H:G:EJG8=6H:H86C7:8DC9J8I:9DCI=:DE:C
B6G@:IDG6HEG>K6I:EJG8=6H:H6C9B6N>C8AJ9:I=:JH:D;9:G>K6I>K:8DCIG68IHL>I=A6G<:;>C6C8>6A>CHI>IJI>DCH >C6AA86H:HHJ7?:8IID
8DBEA>6C8:L>I=6EEA>867A:A6L .=>HG:EJG8=6H:EGD<G6B=6HCDI:GB>C6I>DC96I:6C9B6N7:HJHE:C9:9DG9>H8DCI>CJ:96I6CN
I>B:
,:EJG8=6H:HJC9:GI=:G:EJG8=6H:EGD<G6BL:G:6H;DAADLH9JG>C<I=:E:G>D9H>C9>86I:9
#2?6<1
&<A.9!B:/2?
<3%5.?2@
$2=B?05.@21
&<A.9
<@A<3
$2=B?05.@2
C2?.42
#?602#.61
#2?%5.?2
:<B;AC.69./92
';12?$2=B?05.@2
#?<4?.:
6;A5<B@.;1@2E02=A=2?@5.?21.A.
K6>A67A:76A6C8:6HD;$JC:
+J6GI:G:C9:9-:EI:B7:G
+J6GI:G:C9:9:8:B7:G
+J6GI:G:C9:9'6G8=
+J6GI:G:C9:9$JC:
.=:DBE6CNUHC:IH=6G:G:EJG8=6H:H6G:HJ7?:8IID6:M8>H:I6MJC9:GI=:#C;A6I>DC,:9J8I>DC8I M8>H:I6M>C8JGG:9G:9J8:HI=:
6BDJCI6K6>A67A:JC9:GI=:G:EJG8=6H:EGD<G6B 6H6EEA>867A: 6C9>H>C8AJ9:9>CI=:8DHID;H=6G:HG:EJG8=6H:9>CI=:DCHDA>96I:9
-I6I:B:CID;-ID8@=DA9:GHUFJ>IN6C9I=:86A8JA6I>DCD;I=:6K:G6<:EG>8:E6>9E:GH=6G:
K:G6<:EG>8:E6>9E:GH=6G::M8AJ9:HI=::;;:8ID;688:A:G6I:9H=6G:G:EJG8=6H:68I>K>I>:H -::699>I>DC6A9>H8ADHJG:7:ADLG:<6G9>C<I=:
DBE6CNUH688:A:G6I:9H=6G:G:EJG8=6H:68I>K>IN9JG>C<I=:;>H86AN:6G
#C8AJ9:HH=6G:HG:8:>K:96I>C>I>6ADG;>C6AH:IIA:B:CID;688:A:G6I:9H=6G:G:EJG8=6H:6<G::B:CIHH::699>I>DC6A9>H8ADHJG:H7:ADLG:<6G9>C<
I=:DBE6CNUH688:A:G6I:9H=6G:G:EJG8=6H:68I>K>IN9JG>C<I=:;>H86AN:6G
&6B,:H:6G8=DGEDG6I>DC %
-- 169 of 186 --
Accelerated Share Repurchase Agreements
On March 11, 2026, the Company entered into an accelerated share repurchase agreement (the “March 2026 ASR”) with a financial
institution to repurchase a total of $200.0 million of Common Stock. The Company took an initial delivery of approximately 685
thousand shares, which represented 75% of the prepayment amount divided by the Company’s closing stock price on March 11,
2026. The total number of shares received under the March 2026 ASR was based upon the average daily volume weighted average
price of the Company’s Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the March
2026 ASRs occurred in June 2026, resulting in the receipt of approximately 55 thousand additional shares, which yielded a weighted-
average share price of $270.71 for the transaction period, including the effects of a 1% excise tax under the Inflation Reduction Act
On April 30, 2025, the Company entered into accelerated share repurchase agreements (the "April 2025 ASRs") with two financial
institutions to repurchase a total of $500.0 million of Common Stock. The Company took an initial delivery of approximately 5.2 million
shares, which represented 75% of the prepayment amount divided by the Company’s closing stock price on April 30, 2025. The total
number of shares received under the April 2025 ASRs was based upon the average daily volume weighted average price of the
Company’s Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the April 2025 ASRs
occurred in September 2025, resulting in the receipt of approximately 317 thousand additional shares, which yielded a weighted-
average share price of $91.00 for the transaction period, including the effects of a 1% excise tax under the Inflation Reduction Act.
The Company recorded each of the ASRs as equity transactions; as such, at the time of receipt, shares were included in treasury
stock at fair market value as of the corresponding trade date. The Company reflects shares received as a repurchase of common
stock in the weighted average common shares outstanding calculation for basic and diluted earnings per share.
Note 19: Segment, Geographic Information, and Major Customers
The Company operates in one reportable business segment: manufacturing and servicing of wafer processing semiconductor
manufacturing equipment. The Company’s material operating segments qualify for aggregation due to their customer base and
similarities in economic characteristics, nature of products and services, and processes for procurement, manufacturing, and
distribution. The Company's chief operating decision maker (“CODM”) is the Company's Chief Executive Officer.
The Company's CODM utilizes segment gross margin as the measure of profit or loss to evaluate operating segment profitability and
to assess the allocation of resources. Segment gross margin excludes both routine and non-routine expenses that are not allocated
to the reportable segment, including, but not limited to, amortization of intangible assets acquired in certain business combinations,
the change in value of the Company's elective deferred compensation-related liability, restructuring charges, impairment of long-lived
assets, and transformational charges.
Segment results are derived from the Company's internal management reporting system utilizing policies that are substantially the
same as those used for external reporting purposes. The CODM utilizes segment revenue growth in conjunction with segment gross
margin metrics in comparing forecast to actual results as well as in benchmarking to the Company's peer group.
The Company's centralized manufacturing and support organizations, including global operations and certain administrative
functions, provide support to its operating segments. Costs incurred by these organizations, as well as depreciation and amortization
and equity-based compensation expense are allocated to cost of goods sold as overhead. Consequently, depreciation and
amortization and equity-based compensation expense are not independently identifiable components within the segment’s results,
and, therefore are not provided.
With the exception of goodwill, the Company does not identify assets by operating segment. Consequently, the CODM does not
regularly review or receive discrete asset information by operating segment.
Lam Research Corporation 2026 10-K 68
-- 170 of 186 --
.=:I67A:7:ADLG:8DC8>A:HI=:DBE6CNHG:EDGI67A:H:<B:CIID>C8DB:7:;DG:>C8DB:I6M:H
+2.?;121
B;2
B;2
B;2
6;A5<B@.;1@
,:K:CJ:
#CHI6AA6I>DC6C9L6GG6CIN:ME:CH:
)I=:G8DHID;<DD9HHDA9)!-
-:<B:CI)!-
-:<B:CI<GDHHB6G<>C
,:8DC8>A>6I>DCID8DCHDA>96I:9<GDHHB6G<>C
,:HIGJ8IJG>C<8=6G<:H C:I T T
AADI=:G)!-
!GDHHB6G<>C
,:H:6G8=6C99:K:ADEB:CI
-:AA>C< <:C:G6A 6C969B>C>HIG6I>K:
,:HIGJ8IJG>C<8=6G<:H C:I DE:G6I>C<:ME:CH:H T T
)I=:G>C8DB::ME:CH: C:I
#C8DB:7:;DG:>C8DB:I6M:H
)I=:G)!->HEG>B6G>AN8DBEG>H:9D;I=:86E>I6A>O:98DHID;>CK:CIDGNHDA9 >C8AJ9>C<7DI=9>G:8I6C9>C9>G:8I8DHIH 7JI:M8AJ9:H>CHI6AA6I>DC
6C9L6GG6CIN:ME:CH:6C9I=DH:>I:BHCDI6AAD86I:9IDI=:H:<B:CI
.=:DBE6CNDE:G6I:H>CH:K:C<:D<G6E=>8G:<>DCH/C>I:9-I6I:H =>C6 JGDE: $6E6C %DG:6 -DJI=:6HIH>6 6C9.6>L6C DG
<:D<G6E=>86AG:EDGI>C< G:K:CJ:>H6IIG>7JI:9IDI=:<:D<G6E=>8AD86I>DC>CL=>8=I=:8JHIDB:GHU;68>A>I>:H6G:AD86I:9 L=>A:ADC< A>K:9
6HH:IHL=>8=>C8AJ9:HEGDE:GIN6C9:FJ>EB:CI C:I 6C9G:8D<C>O:9G><=ID;JH:6HH:IHG:EDGI:9>C)I=:G6HH:IH>CI=:DCHDA>96I:9
6A6C8:-=::IH6HD;$JC: 6C9$JC: 6G:6IIG>7JI:9IDI=:<:D<G6E=>8AD86I>DCH>CL=>8=I=:6HH:IH6G:AD86I:9
,:K:CJ:H6C9ADC< A>K:96HH:IH7N<:D<G6E=>8G:<>DCL:G:6H;DAADLH
+2.?;121
B;2
B;2
B;2
$2C2;B2 6;A5<B@.;1@
=>C6
.6>L6C
%DG:6
$6E6C
/C>I:9-I6I:H
-DJI=:6HIH>6
JGDE:
.DI6AG:K:CJ:
&6B,:H:6G8=DGEDG6I>DC %
-- 171 of 186 --
B;2
B;2
B;2
<;496C21.@@2A@ 6;A5<B@.;1@
/C>I:9-I6I:H
-DJI=:6HIH>6
%DG:6
.6>L6C
JGDE:
$6E6C
=>C6
#C;>H86AN:6G ;DJG8JHIDB:GH688DJCI:9;DG6EEGDM>B6I:AN 6C9 D;IDI6AG:K:CJ:H G:HE:8I>K:AN #C;>H86A
N:6G ILD8JHIDB:G688DJCI:9;DG6EEGDM>B6I:AN6C9D;IDI6AG:K:CJ:H #C;>H86AN:6G DC:8JHIDB:G688DJCI:9
;DG6EEGDM>B6I:AND;IDI6AG:K:CJ:H G:HE:8I>K:AN (DDI=:G8JHIDB:GH688DJCI:9;DGDGBDG:D;IDI6AG:K:CJ:H
">C4 &4BCAD2CDA8=670A64B"4C
.=:DBE6CNG:8DG9H:BEADN::H:K:G6C8:6C9H:E6G6I>DC8DHIHI=6IB::II=:G:FJ>G:B:CIH;DGG:8D<C>I>DC>C688DG96C8:L>I=I=:
G:A:K6CI<J>96C8:D;- M>IDG>HEDH6ADHI)7A><6I>DCH DG- DBE:CH6I>DC (DC G:I>G:B:CI*DHI :BEADNB:CI
:C:;>IH 6H6EEA>867A: DG>CKDAJCI6GNI:GB>C6I>DC7:C:;>IHI=6I6G:CDIEGDK>9:9JC9:GI=:I:GBHD;6CDC<D>C<7:C:;>I6GG6C<:B:CI
I=:A>67>A>IN;DGI=:8JGG:CI;6>GK6AJ:D;:ME:8I:9;JIJG:8DHIH6HHD8>6I:9L>I=6B6C6<:B:CI 6EEGDK:9G:HIGJ8IJG>C<EA6C>H
G:8D<C>O:9>CI=:E:G>D9>CL=>8=I=:EA6C>H8DBBJC>86I:9IDI=::BEADN::H6C9I=:EA6C>HCDI:ME:8I:9ID8=6C<:H><C>;>86CIAN DG
DC<D>C<7:C:;>I6GG6C<:B:CIH >C8AJH>K:D;HI6IJIDGNG:FJ>G:B:CIH :BEADN::I:GB>C6I>DC8DHIH6G:688GJ:9L=:CI=::M>HI>C<
H>IJ6I>DCDGH:ID;8>G8JBHI6C8:H>C9>86I:HI=6I6CD7A><6I>DC=6H7::C>C8JGG:9 >I>HEGD767A:I=:7:C:;>IHL>AA7:E6>9 6C9I=:
6BDJCI86C7:G:6HDC67AN:HI>B6I:9 .:GB>C6I>DC7:C:;>IH6HHD8>6I:9L>I=:BEADN::HI=6I:A:8I:9IDKDAJCI6G>ANI:GB>C6I:6HE6GID;
I=:G:HIGJ8IJG>C<EA6C6G:G:8DG9:9L=:CI=::BEADN::>GG:KD867AN688:EIHI=:D;;:G6C9I=:6BDJCI86C7:G:6HDC67AN:HI>B6I:9 #;
6EEA>867A: I=:DBE6CNG:8DG9HHJ8=8DHIH>CIDDE:G6I>C<:ME:CH:DK:GI=:I:GB>C6I:9:BEADN::HU;JIJG:H:GK>8:E:G>D97:NDC96CN
B>C>BJBDGA:<6AANG:FJ>G:9G:I:CI>DCE:G>D9 .=:B6?DG>IND;G:HIGJ8IJG>C<8=6G<:HI=6I=6K:7::C>C8JGG:97JICDIN:IE6>96G:
G:8DG9:9>C88GJ:9:ME:CH:H6C9DI=:G8JGG:CIA>67>A>I>:H>CI=:DCHDA>96I:96A6C8:-=::IH
JG>C<I=:;>H86AN:6G:C9:9$JC: I=:DBE6CN>C>I>6I:96G:HIGJ8IJG>C<EA6C9:H><C:9ID7:II:G6A><CI=:DBE6CNUH8DHI
HIGJ8IJG:L>I=>IHDJIADD@;DGI=::8DCDB>8:CK>GDCB:CI6C97JH>C:HHDEEDGIJC>I>:H /C9:GI=:EA6C I=GDJ<=$JC: I=:
DBE6CNI:GB>C6I:96EEGDM>B6I:AN :BEADN::H >C8JGG>C<:ME:CH:HG:A6I:9ID:BEADN::H:K:G6C8:6C9H:E6G6I>DC8DHIH
BEADN::H:K:G6C8:6C9H:E6G6I>DC8DHIH6G:EG>B6G>ANG:A6I:9IDH:K:G6C8: CDC 86H=H:K:G6C8: >C8AJ9>C<:FJ>IN6L6G9
8DBE:CH6I>DC:ME:CH: E:CH>DC6C9DI=:GI:GB>C6I>DC7:C:;>IH 99>I>DC6AAN I=:DBE6CNB69:6HIG6I:<>89:8>H>DCIDG:AD86I:
8:GI6>CB6CJ;68IJG>C<68I>K>I>:HIDEG: :M>HI>C<;68>A>I>:H6C9>C8JGG:98=6G<:HIDBDK:>CK:CIDGN6C9:FJ>EB:CI6C9:M>IH:A:8I:9
HJEEA>:G6GG6C<:B:CIH
(DG:HIGJ8IJG>C<8DHIHL:G:G:8DG9:99JG>C<I=:;>H86AN:6G:C9:9$JC: DG$JC: JG>C<I=:;>H86AN:6G:C9:9$JC:
C:IG:HIGJ8IJG>C<8DHIHD; B>AA>DC6C9 B>AA>DCL:G:G:8DG9:9>C,:HIGJ8IJG>C<8=6G<:H C:I 8DHID;<DD9HHDA9
6C9,:HIGJ8IJG>C<8=6G<:H C:I DE:G6I>C<:ME:CH:H G:HE:8I>K:AN>CI=:DCHDA>96I:9-I6I:B:CIHD;)E:G6I>DCH
.=:G:HIGJ8IJG>C<EA6CL6HHJ7HI6CI>6AAN8DBEA:I:96HD;$JC: 6C98JBJA6I>K:8DHIH6HD;$JC: IDI6A:9
B>AA>DC.=:6HHD8>6I:9G:HIGJ8IJG>C<A>67>A>INL6HHJ7HI6CI>6AANH6I>H;>:9>CI=:I=G::BDCI=H:C9:9-:EI:B7:G
&6B,:H:6G8=DGEDG6I>DC %
-- 172 of 186 --
Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
Lam Research Corporation:
Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting
We have audited the accompanying consolidated balance sheet of Lam Research Corporation (the Company) as of June 28, 2026,
the related consolidated statements of operations, comprehensive income, stockholders’ equity, and cash flows for the year then
ended, and the related notes (collectively, the consolidated financial statements). We also have audited the Company’s internal
control over financial reporting as of June 28, 2026, based on criteria established in Internal Control – Integrated Framework (2013)
issued by the Committee of Sponsoring Organizations of the Treadway Commission.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of
the Company as of June 28, 2026, and the results of its operations and its cash flows for the year then ended, in conformity with U.S.
generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal
control over financial reporting as of June 28, 2026 based on criteria established in Internal Control – Integrated Framework (2013)
issued by the Committee of Sponsoring Organizations of the Treadway Commission.
Basis for Opinions
The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over
financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the
accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the
Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our
audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB)
and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the
applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement,
whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audit of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the
consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such
procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial
statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as
well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial
reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness
exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits
also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits
provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to
the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of
the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are
being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could
have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes
in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements
that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that
are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments.
The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as
a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or
on the accounts or disclosures to which it relates.
Lam Research Corporation 2026 10-K 71
-- 173 of 186 --
Evaluation of sufficiency of audit evidence over revenue
As discussed in Notes 2, 4, and 19 to the consolidated financial statements, the Company recorded $23,232,690 thousand
in revenue for the year ended June 28, 2026. The Company generates revenue by designing, manufacturing, refurbishing,
and servicing semiconductor processing equipment used in the fabrication of integrated circuits. The Company’s process to
account for and recognize revenue differs across revenue streams.
We identified the evaluation of the sufficiency of audit evidence obtained over revenue as a critical audit matter. Evaluating
the sufficiency of audit evidence required subjective auditor judgment due to the number of revenue streams and separate
processes to account for and recognize revenue. This included determining the nature and extent of audit evidence obtained
over each revenue stream.
The following are the primary procedures we performed to address this critical audit matter. We applied auditor judgment to
determine the revenue streams over which procedures were performed as well as the nature and extent of such procedures.
For revenue streams where procedures were performed, we:
• evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s revenue
recognition processes, including the Company’s controls over the accurate recording of revenue
• evaluated the Company’s revenue recognition accounting policies
• evaluated, for a sample of revenue transactions, (1) the accounting for consistency with the Company’s accounting
policies, as applicable, including timing of revenue recognition, and (2) the recorded amounts by comparing them for
consistency to underlying documentation, including the customer contracts.
In addition, we evaluated the sufficiency of audit evidence obtained by assessing the results of the procedures performed,
including the appropriateness of the nature and extent of audit effort over revenue.
/s/ KPMG LLP
We have served as the Company’s auditor since 2025.
Santa Clara, California
August 7, 2026
Lam Research Corporation 2026 10-K 72
-- 174 of 186 --
Report of Independent Registered Public Accounting Firm
To the Stockholders and the Board of Directors of Lam Research Corporation
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheet of Lam Research Corporation (the Company) as of June 29, 2025,
the related consolidated statements of operations, comprehensive income, stockholders' equity and cash flows for each of the two
years in the period ended June 29, 2025, and the related notes (collectively referred to as the “consolidated financial statements”). In
our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at June
29, 2025 and the results of its operations and its cash flows for each of the two years in the period ended June 29, 2025, in
conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the
Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to
be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial
statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ Ernst & Young LLP
We served as the Company’s auditor from 1981 to 2025.
San Jose, California
August 11, 2025
Lam Research Corporation 2026 10-K 73
-- 175 of 186 --
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
Management’s Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of
1934, as amended (the “Exchange Act”)) that are designed to comply with Rules13a-15 and 15d-15 of the Exchange Act.
In designing and evaluating the disclosure controls and procedures, management, including the Chief Executive Officer and Chief
Financial Officer, recognized that any controls and procedures, no matter how well designed and operated, can provide only
reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the
cost-benefit relationship of possible controls and procedures. Accordingly, our disclosure controls and procedures have been
designed to provide reasonable assurance of achieving their objectives.
Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of
our disclosure controls and procedures as of June 28, 2026. Based upon that evaluation, our management, including our Chief
Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective at the reasonable
assurance level.
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially
affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Management’s Report on Internal Control over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in
Rules 13a-15(f) and 15d-15(f) of the Exchange Act). Management conducted an evaluation of the effectiveness of our internal control
over financial reporting as of June 28, 2026 based on criteria established in Internal Control—Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework). Based on that evaluation, management
concluded that our internal control over financial reporting was effective as of June 28, 2026 to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
GAAP.
KPMG LLP, an independent registered public accounting firm, independently assessed the effectiveness of our internal control over
financial reporting, as stated in their attestation report, which is included in Part II, Item 8 of this 2026 Form 10-K.
Item 9B. Other Information
Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements
During the Company’s fiscal quarter ended June 28, 2026, except for the following arrangements, none of the Company’s directors or
officers adopted or terminated a trading arrangement for the purchase or sale of Common Stock that was intended to satisfy the
affirmative defense conditions of Rule 10b5-1(c) (a “Rule 10b5-1 Trading Arrangement”) or a non-Rule 10b5-1 trading arrangement
(as defined in Item 408(c) of Regulation S-K).
• On April 28, 2026, Ava A. Harter, Chief Legal Officer and Secretary of the Company, adopted a Rule 10b5-1 Trading
Arrangement that provides for the potential sale of up to 15,000 shares of Common Stock resulting from the vesting of
certain service-based restricted stock units and market-based performance restricted stock units pursuant to the terms of the
Rule 10b5-1 Trading Arrangement, subject to certain vesting conditions and, with respect to the market-based performance
restricted stock units, certain performance conditions. Ms. Harter’s Rule 10b5-1 Trading Arrangement has a termination date
of April 30, 2027.
• On May 5, 2026, Seshasayee (Sesha) Varadarajan, Chief Operating Officer of the Company, adopted a Rule 10b5-1 Trading
Arrangement that provides for (i) the potential exercise of up to 27,480 stock options expiring March 2, 2027 and the
associated sale of up to 27,480 shares of Common Stock resulting from such exercise; (ii) the potential exercise of up to
12,270 stock options expiring March 1, 2028 and the associated sale of up to 12,270 shares of Common Stock resulting
from such exercise; and (iii) the potential sale of up to 20,000 shares of Common Stock, in each case pursuant to the terms
of the Rule 10b5-1 Trading Arrangement. Mr. Varadarajan’s Rule 10b5-1 Trading Arrangement has a termination date of April
20, 2027.
The Rule 10b5-1 Trading Arrangements contain pricing conditions that preclude or limit the exercise of stock options or the sale of
shares, as applicable, below predetermined minimum prices, except with respect to the potential sale of up to 20,000 shares of
Common Stock by Mr. Varadarajan, which sale is not subject to such a condition. Each of the Rule 10b5-1 Trading Arrangements will
terminate on the earlier of: (a) its respective termination date indicated above; (b) execution of all trades or expiration of all the orders
Lam Research Corporation 2026 10-K 74
-- 176 of 186 --
relating to such trades under the Rule 10b5-1 Trading Arrangement; or (c) such date as the Rule 10b5-1 Trading Arrangement is
otherwise terminated according to its terms.
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Not applicable.
Lam Research Corporation 2026 10-K 75
-- 177 of 186 --
PART III
We have omitted from this 2026 Form 10-K certain information required by Part III because we, as the Registrant, will file a definitive
proxy statement with the SEC within 120 days after the end of our fiscal year, pursuant to Regulation 14A, as promulgated by the
SEC, for our Annual Meeting of Stockholders expected to be held on or about November 3, 2026, (the “Proxy Statement”), and
certain information included in the Proxy Statement is incorporated into this report by reference.
Item 10. Directors, Executive Officers and Corporate Governance
For information regarding our executive officers required by this item, see Part I, Item 1 of this 2026 Form 10-K under the caption
“Information about our Executive Officers,” which information is incorporated into Part III by reference.
The information concerning our directors required by this Item is incorporated by reference to our Proxy Statement under the heading
“Voting Proposals — Proposal No. 1: Election of Directors — 2026 Nominees for Director.”
The information concerning our audit committee and audit committee financial experts required by this Item is incorporated by
reference to our Proxy Statement under the heading “Governance Matters — Corporate Governance — Board Committees.”
The Company has adopted a Corporate Code of Ethics that applies to all employees, officers, and directors of the Company. Our
Code of Ethics is publicly available on the Investor Relations page of our website at http://investor.lamresearch.com. We intend to
disclose future amendments to certain provisions of the Code of Ethics, and waivers of the Code of Ethics granted to executive
officers and directors, on the website within four business days following the date of the amendment or waiver.
We have adopted policies and procedures, including our insider trading policy, governing the purchase, sale, and other dispositions of
our securities by our directors, officers, employees, and other individuals associated with us, as well as the Company itself, that we
believe are reasonably designed to promote compliance with insider trading laws, rules, and regulations, and Nasdaq listing
standards. A copy of our insider trading policy is filed as Exhibit 19.1 to this 2026 Form 10-K.
If applicable, the information required by this Item concerning our compliance with Section 16(a) of the Exchange Act is incorporated
by reference to our Proxy Statement under the heading "Delinquent Section 16(a) Reports.”
Item 11. Executive Compensation
The information required by this Item is incorporated by reference to our Proxy Statement under the headings “Compensation Matters
— Executive Compensation and Other Information,” “Compensation Matters — CEO Pay Ratio,” “Compensation Matters — Pay
Versus Performance”, and “Governance Matters — Director Compensation.”
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related
Stockholder Matters
The information required by this Item is incorporated by reference to our Proxy Statement under the headings “Stock Ownership —
Security Ownership of Certain Beneficial Owners and Management” and “Compensation Matters — Securities Authorized for
Issuance Under Equity Compensation Plans.”
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information required by this Item is incorporated by reference to our Proxy Statement under the headings “Audit Matters —
Certain Relationships and Related Party Transactions” and “Governance Matters — Corporate Governance — Director
Independence Policies.”
Item 14. Principal Accountant Fees and Services
The information required by this Item is incorporated by reference to our Proxy Statement under the heading “Audit Matters —
Relationship with Independent Registered Public Accounting Firm — Fees Billed by Our Independent Registered Public Accounting
Firm" and "Audit Matters — Relationship with Independent Registered Public Accounting Firm — Policy on Audit Committee Pre-
Approval of Audit and Non-Audit Services."
Lam Research Corporation 2026 10-K 76
-- 178 of 186 --
"$&
6-0 G7818C0=38=0=280;'C0C4<4=C'2743D;4B
6 .=:;DAADL>C<9D8JB:CIH6G:;>A:96HE6GID;I=>HCCJ6A,:EDGIDC DGB %
*6<:
#C9:MID >C6C8>6A-I6I:B:CIH
DCHDA>96I:9-I6I:B:CIHD;)E:G6I>DCHT3:6GHC9:9$JC: $JC: 6C9$JC:
DCHDA>96I:9-I6I:B:CIHD;DBEG:=:CH>K:#C8DB:T3:6GHC9:9$JC: $JC: 6C9
$JC:
DCHDA>96I:96A6C8:-=::IHT$JC: 6C9$JC:
DCHDA>96I:9-I6I:B:CIHD;6H= ADLHT3:6GHC9:9$JC: $JC: 6C9$JC:
DCHDA>96I:9-I6I:B:CIHD;-ID8@=DA9:GHUFJ>INT3:6GHC9:9$JC: $JC: 6C9$JC:
(DI:HIDDCHDA>96I:9 >C6C8>6A-I6I:B:CIH
,:EDGIHD;#C9:E:C9:CI,:<>HI:G:9*J7A>888DJCI>C< >GB
#C9:MID >C6C8>6A-I6I:B:CI-8=:9JA:H
-8=:9JA:H=6K:7::CDB>II:9H>C8:I=:N6G:CDI6EEA>867A: CDIG:FJ>G:9 CDIB6I:G>6A DGI=:>C;DGB6I>DC>H
>C8AJ9:9:AH:L=:G:=:G:>C
6-0 240#700*49
(DC:
&6B,:H:6G8=DGEDG6I>DC %
-- 179 of 186 --
LAM RESEARCH CORPORATION
ANNUAL REPORT ON FORM 10-K
FOR THE FISCAL YEAR ENDED JUNE 28, 2026
EXHIBIT INDEX
3.1 Restated Certificate of Incorporation of Lam Research Corporation, dated November 4, 2025 which is incorporated by
reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed on November 6, 2025 (SEC File no.
000-12933).
3.2 Bylaws of the Registrant, as amended and restated, dated May 20, 2025 which is incorporated by reference to Exhibit
3.1 to the Registrant’s Current Report on Form 8-K filed on May 21, 2025 (SEC File No. 000-12933).
4.1 Indenture (including Form of Notes), dated as of February 13, 2015, between Registrant and The Bank of New York
Mellon Trust Company, N.A. which is incorporated by reference to Exhibit 4.1 to the Registrant’s Registration
Statement on Form S-3 filed on February 13, 2015 (SEC File No. 333-202110).
4.2 Third Supplemental Indenture, dated as of March 4, 2019 by and between Lam Research Corporation and the Bank of
New York Mellon Trust Company, N.A. as trustee which is incorporated by reference to Exhibit 4.2 to the Registrant’s
Current Report on Form 8-K filed on March 4, 2019 (SEC File No. 000-12933).
4.3 Fourth Supplemental Indenture, dated as of May 5, 2020 by and between Lam Research Corporation and the Bank of
New York Mellon Trust Company, N.A. as trustee which is incorporated by reference to Exhibit 4.2 to the Registrant’s
Current Report on Form 8-K filed on May 5, 2020 (SEC File No. 000-12933).
4.4 Description of Common Stock.
10.1* Form of Indemnification Agreement which is incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly
Report on Form 10-Q filed on January 29, 2024 (SEC File No. 000-12933).
10.2* Form of Confidentiality Agreement.
10.3* Novellus Amended Executive Voluntary Deferred Compensation Plan, as amended which is incorporated by reference
to Exhibit 10.28 to Novellus’ Quarterly Report on Form 10-Q filed on November 5, 2008 (SEC File No. 000-17157).
10.4* Form of Option Award Agreement (U.S. Participants) - 2015 Stock Incentive Plan which is incorporated by reference to
Exhibit 10.247 to the Registrant’s Current Report on Form 8-K filed on November 5, 2015 (SEC File No. 000-12933).
10.5 Form of Commercial Paper Dealer Agreement 4(a)(2) Program between Lam Research Corporation, as issuer, and the
dealer which is incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on
November 14, 2017 (SEC File No. 000-12933).
10.6* Lam Research Corporation Elective Deferred Compensation Plan which is incorporated by reference to Exhibit 4.16 to
the Registrant’s Annual Report on Form 10-K filed on August 19, 2011 (SEC File No. 000-12933).
10.7 Lam Research Corporation 1999 Employee Stock Purchase Plan, as amended which is incorporated by reference to
Exhibit 4.1 to the Registrant’s Form S-8 filed on April 30, 2019 (SEC File No. 333-231138).
10.8* 2004 Executive Incentive Plan, as Amended and Restated which is incorporated by reference to Exhibit 10.1 to the
Registrant’s Current Report on Form 8-K filed on February 9, 2023 (SEC File No. 000-12933).
10.9 2015 Stock Incentive Plan which is incorporated by reference to Exhibit 4.24 to the Registrant’s Current Report on
Form 8-K filed on November 5, 2015 (SEC File No. 000-12933).
10.10* Lam Research Corporation Elective Deferred Compensation Plan II, as amended and restated, which is incorporated
by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on October 24, 2025 (SEC File
No. 000-12933).
10.11* Executive Severance Policy, as amended and restated which is incorporated by reference to Exhibit 10.26 to the
Registrant’s Annual Report on Form 10-K filed on August 29, 2024 (SEC File No. 000-12933).
10.12* Executive Change in Control Policy, as amended and restated which is incorporated by reference to Exhibit 10.27 to
the Registrant’s Annual Report on Form 10-K filed on August 29, 2024 (SEC File No 000-12933).
10.13 Third Amended and Restated Credit Agreement dated January 27, 2025, among Lam Research Corporation,
JPMorgan Chase Bank, N.A., as administrative agent, and the other agents and lenders listed therein, which is
incorporated by reference to Exhibit 10.1 to the Registrant’s Current report on Form 8-K filed on January 29, 2025
(SEC File No. 000-12933).
10.14* Form of Option Award Agreement (U.S. Participants) - 2015 Stock Incentive Plan which is incorporated by reference to
Exhibit 10.29 to the Registrant's Annual Report on Form 10-K filed on August 17, 2021 (SEC File No. 000-12933).
10.15* Form of Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) - 2015 Stock Incentive
Plan which is incorporated by reference to Exhibit 10.31 to the Registrant's Annual Report on Form 10-K filed on
August 17, 2021 (SEC File No. 000-12933).
10.16* Form of Option Award Agreement (U.S. Participants) - 2015 Stock Incentive Plan which is incorporated by reference to
Exhibit 10.32 to the Registrant's Annual Report on Form 10-K filed on August 17, 2021 (SEC File No. 000-12933).
10.17* Form of Option Award Agreement (International Participants) - 2015 Stock Incentive Plan which is incorporated by
reference to Exhibit 10.33 to the Registrant's Annual Report on Form 10-K filed on August 17, 2021 (SEC File No.
000-12933).
Exhibit Description
Lam Research Corporation 2026 10-K 78
-- 180 of 186 --
10.18* Form of Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) - 2015 Stock Incentive
Plan which is incorporated by reference to Exhibit 10.36 to the Registrant's Annual Report on Form 10-K filed on
August 17, 2021 (SEC File No. 000-12933).
10.19* Form of Market-Based Performance Restricted Stock Unit Award Agreement (International Participants) - 2015 Stock
Incentive Plan which is incorporated by reference to Exhibit 10.37 to the Registrant's Annual Report on Form 10-K filed
on August 17, 2021 (SEC File No. 000-12933).
10.20* Non-employee Director Compensation Program, as amended which is incorporated by reference to Exhibit 10.38 to
the Registrant’s Annual Report on Form 10-K filed on August 29, 2024 (SEC File No. 000-12933).
10.21* Form of Restricted Stock Unit Agreement (U.S. Participants) - 2015 Stock Incentive Plan which is incorporated by
reference to Exhibit 10.1 to the Registrant's Quarterly Report on Form 10-Q filed on January 30, 2023 (SEC File No.
000-12933).
10.22* Form of Restricted Stock Unit Agreement (U.S. Participants) - 2015 Stock Incentive Plan which is incorporated by
reference to Exhibit 10.1 to the Registrant's Quarterly Report on Form 10-Q filed on April 29, 2024 (SEC File No.
000-12933).
10.23* Form of Restricted Stock Unit Agreement (International Participants) - 2015 Stock Incentive Plan which is incorporated
by reference to Exhibit 10.2 to the Registrant's Quarterly Report on Form 10-Q filed on April 29, 2024 (SEC File No.
000-12933).
10.24* Form of Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) - 2015 Stock Incentive
Plan which is incorporated by reference to Exhibit 10.3 to the Registrant's Quarterly Report on Form 10-Q filed on April
29, 2024 (SEC File No. 000-12933).
10.25* Form of Market-Based Performance Restricted Stock Unit Award Agreement (International Participants) - 2015 Stock
Incentive Plan which is incorporated by reference to Exhibit 10.4 to the Registrant's Quarterly Report on Form 10-Q
filed on April 29, 2024 (SEC File No. 000-12933).
10.26* Form of Restricted Stock Unit Award Agreement (U.S. Participants) - 2015 Stock Incentive Plan which is incorporated
by reference to Exhibit 10.1 to the Registrant's Quarterly Report on Form 10-Q filed on April 25, 2025 (SEC File No.
000-12933).
10.27* Form of Restricted Stock Unit Award Agreement (International Participants) - 2015 Stock Incentive Plan which is
incorporated by reference to Exhibit 10.2 to the Registrant's Quarterly Report on Form 10-Q filed on April 25, 2025
(SEC File No. 000-12933).
10.28* Form of Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) - 2015 Stock Incentive
Plan which is incorporated by reference to Exhibit 10.3 to the Registrant's Quarterly Report on Form 10-Q filed on April
25, 2025 (SEC File No. 000-12933).
10.29* Form of Market-Based Performance Restricted Stock Unit Award Agreement (International Participants) - 2015 Stock
Incentive Plan which is incorporated by reference to Exhibit 10.4 to the Registrant's Quarterly Report on Form 10-Q
filed on April 25, 2025 (SEC File No. 000-12933).
10.30* Lam Research Corporation 2025 Stock Incentive Plan which is incorporated by reference to Exhibit 10.1 to the
Registrant’s Current Report on Form 8-K filed on November 6, 2025 (SEC file No. 000-12933).
10.31* Form of Restricted Stock Unit Agreement (Board of Directors) - 2025 Stock Incentive Plan which is incorporated by
reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed on January 29, 2026 (SEC File No.
000-12933).
10.32* Form of Restricted Stock Unit Agreement - 2025 Stock Incentive Plan which is incorporated by reference to Exhibit
10.3 to the Registrant’s Quarterly Report on Form 10-Q filed on January 29, 2026 (SEC File No. 000-12933).
10.33* Form of Market-based Performance Restricted Stock Unit Agreement - 2025 Stock Incentive Plan which is
incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q filed on January 29, 2026
(SEC File No. 000-12933).
19.1 Insider Trading Policy.
21 Subsidiaries of the Registrant.
23.1 Consent of Independent Registered Public Accounting Firm.
23.2 Consent of Independent Registered Public Accounting Firm.
24 Power of Attorney (See Signature page)
31.1 Rule 13a — 14(a) / 15d — 14(a) Certification (Principal Executive Officer)
31.2 Rule 13a — 14(a) / 15d — 14(a) Certification (Principal Financial Officer)
32.1 Section 1350 Certification — (Principal Executive Officer)
32.2 Section 1350 Certification — (Principal Financial Officer)
97.1 Policy for the Recovery of Erroneously Awarded Compensation which is incorporated by reference to Exhibit 97.1 to
the Registrant’s Annual Report on Form 10-K filed on August 29, 2024 (SEC File No. 000-12933).
101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its
XBRL tags are embedded within the Inline XBRL document.
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
Exhibit Description
Lam Research Corporation 2026 10-K 79
-- 181 of 186 --
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
Exhibit Description
__________________________________
* Indicates management contract or compensatory plan or arrangement.
Lam Research Corporation 2026 10-K 80
-- 182 of 186 --
#$%"#
*JGHJ6CIIDI=:G:FJ>G:B:CIHD;-:8I>DCDG9D;I=:-:8JG>I>:HM8=6C<:8ID; 6H6B:C9:9 I=:,:<>HIG6CI=6H9JAN
86JH:9I=>H,:EDGIID7:H><C:9DC>IH7:=6A;7NI=:JC9:GH><C:9 I=:G:JCID9JAN6JI=DG>O:9
6I: J<JHI &',-,"),*),.#)(
,:<>HIG6CI
N H.>BDI=N' G8=:G
.>BDI=N' G8=:G
*G:H>9:CI6C9=>:;M:8JI>K:);;>8:G
&6B,:H:6G8=DGEDG6I>DC %
-- 183 of 186 --
'"$$")#$%"#
NH><C>C<I=>HCCJ6A,:EDGIDC DGB %7:ADL #=:G:7N6EED>CI:68=D;.>BDI=N' G8=:G6C9DJ<A6H, :II>C<:G ?D>CIAN6C9
H:K:G6AAN 6HBN6IIDGC:N >C ;68IIDH><C6AA6B:C9B:CIHIDI=>H DGB %DCBN7:=6A;6C9ID;>A:I=>H DGB %>C8AJ9>C<6AA
:M=>7>IH6C9DI=:GG:A6I:99D8JB:CIHL>I=I=:-:8JG>I>:H6C9M8=6C<:DBB>HH>DC #6JI=DG>O::68=D;BN6IIDGC:NH >C ;68IID
6EED>CI6HJ7HI>IJI:6IIDGC:N >C ;68I;DG=>BH:A;6C9E:G;DGB6CN68I>DCHI=6I=:7:A>:K:H6G:C:8:HH6GNDG6EEGDEG>6I:ID86GGN
DJII=:>CI:CI>DC6C9EJGEDH:D;I=>H*DL:GD;IIDGC:N #G6I>;N6C98DC;>GB6AAA6L;JA68I>DCHI6@:C9>G:8IANDG>C9>G:8IAN7NBN
6IIDGC:NH >C ;68I6C97N6CNEGDE:GAN6EED>CI:9HJ7HI>IJI:6IIDGC:NH >C ;68I
*JGHJ6CIIDI=:G:FJ>G:B:CIHD;I=:-:8JG>I>:HM8=6C<:8ID; 6H6B:C9:9 I=>H,:EDGI=6H7::CH><C:97:ADL7NI=:
;DAADL>C<E:GHDCHDC7:=6A;D;I=:,:<>HIG6CI6C9>CI=:86E68>I>:H6C9DCI=:96I:H>C9>86I:9
%64;.AB?2@ &6A92 .A2
#?6;06=.9E20BA6C2"33602?
H.>BDI=N' G8=:G *G:H>9:CI =>:;M:8JI>K:);;>8:G6C9>G:8IDG J<JHI
.>BDI=N' G8=:G
#?6;06=.96;.;06.9"33602?
HDJ<A6H, :II>C<:G M:8JI>K:0>8:*G:H>9:CI6C9=>:; >C6C8>6A);;>8:G J<JHI
DJ<A6H, :II>C<:G
#?6;06=.900<B;A6;4"33602?
H=G>HI>C6 DGG:>6 !GDJE0>8:*G:H>9:CI6C9=>:;88DJCI>C<);;>8:G J<JHI
=G>HI>C6 DGG:>6
"A52?6?20A<?@
%64;.AB?2@ &6A92 .A2 %64;.AB?2@ &6A92 .A2
H7=>?>I3 .6AL6A@6G =6>GB6C J<JHI H$D=C' >C::C >G:8IDG J<JHI
7=>?>I3 .6AL6A@6G $D=C' >C::C
H-D=6>A/ =B:9 >G:8IDG J<JHI H'6G@ >:A9H >G:8IDG J<JHI
-D=6>A/ =B:9 '6G@ >:A9H
HG>8% G6C9I >G:8IDG J<JHI H"D%NJ%6C< >G:8IDG J<JHI
G>8% G6C9I "D%NJ%6C<
H#I6' G:CC6C >G:8IDG J<JHI H:I=6CN$ '6N:G >G:8IDG J<JHI
#I6' G:CC6C :I=6CN$ '6N:G
H'>8=6:A, 6CCDC >G:8IDG J<JHI H$NDI>% ':=G6 >G:8IDG J<JHI
'>8=6:A, 6CCDC $NDI>% ':=G6
HC>GJ9=:K<6C >G:8IDG J<JHI
C>GJ9=:K<6C
&6B,:H:6G8=DGEDG6I>DC %
-- 184 of 186 --
BOARD OF DIRECTORS
Abhijit Y. Talwalkar
Chair
Former President
and Chief Executive Officer
LSI Corporation
Timothy M. Archer
President, Chief Executive Officer
Sohail U. Ahmed
Former Senior Vice President
and General Manager, Technology
and Manufacturing Group
Intel Corporation
Eric K. Brandt
Former Executive Vice President
and Chief Financial Officer
Broadcom Corporation
Ita M. Brennan
Former Senior Vice President
and Chief Financial Officer
Arista Networks, Inc.
Michael R. Cannon
General Partner
MRC & LBC Partners, LLC
Retired President of Global
Operations
Dell Inc.
Anirudh Devgan, Ph.D.
President
and Chief Executive Officer
Cadence Design Systems, Inc.
John M. Dineen
Former President
and Chief Executive Officer
GE Healthcare
Mark Fields
Senior Advisor
TPG Capital LP
Ho Kyu Kang, Ph.D.
Professor, Department of Systems
Semiconductor Engineering
Yonsei University
Bethany J. Mayer
Former President
and Chief Executive Officer
Ixia
Jyoti K. Mehra
Executive Vice President,
Human Resources
Gilead Sciences, Inc.
As of September 24, 2026
EXECUTIVE OFFICERS
Timothy M. Archer
President, Chief Executive Officer
Douglas R. Bettinger
Executive Vice President,
Chief Financial Officer
Seshasayee (Sesha) Varadarajan
Executive Vice President,
Chief Operating Officer
Neil J. Fernandes
Senior Vice President,
Global Customer Operations
Ava A. Harter
Senior Vice President,
Chief Legal Officer and Secretary
Vahid Vahedi, Ph.D.
Senior Vice President,
Chief Technology
and Sustainability Officer
Karthikeyan (Karthik) Rammohan, Ph.D.
Senior Vice President,
Global Operations
and Enterprise Solutions
© 2026 Lam Research Corporation
All rights reserved.
202609-01808/5K
-- 185 of 186 --
-- 186 of 186 --